Citrus Sinensis ID: 011995
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 473 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.606 | 0.582 | 0.39 | 8e-56 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.606 | 0.585 | 0.383 | 2e-53 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.627 | 0.763 | 0.375 | 6e-53 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.610 | 0.742 | 0.376 | 6e-52 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.642 | 0.713 | 0.369 | 7e-51 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.638 | 0.708 | 0.365 | 2e-50 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.600 | 0.692 | 0.385 | 4e-50 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.602 | 0.698 | 0.372 | 1e-47 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.615 | 0.638 | 0.381 | 2e-47 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.598 | 0.683 | 0.385 | 4e-47 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 218 bits (555), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 117/300 (39%), Positives = 179/300 (59%), Gaps = 13/300 (4%)
Query: 162 LRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKK----FEATVTRLNPSS 217
LR F +++ + NF + + EG +++ ++ + K V LNP
Sbjct: 127 LRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDG 186
Query: 218 -QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP 276
QG KE++ ++N L +L HPNL KL+G+ D DQR+L+YE + GSL+ ++ RS
Sbjct: 187 LQGHKEWLAEINFLGNLLHPNLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRRS--L 242
Query: 277 PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
P+ W+ R+KIAL AA+GL+FLHEE +Y +F T+NI +D D++AKLS +G A P+
Sbjct: 243 PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPD 302
Query: 337 ---TDISNSSVAAANLSV-ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392
T +S + + E + G LT KS+V+SFG+VLLE+LTGR+++D P E N
Sbjct: 303 EGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 362
Query: 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
LV+W+RP L D R ++DP+L+G F +K A+ V +A +CL ++P RP M + E L
Sbjct: 363 LVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEAL 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 115/300 (38%), Positives = 177/300 (59%), Gaps = 13/300 (4%)
Query: 162 LRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKK----FEATVTRLNPSS 217
L+ F ++ A NF + + EG +++ ++ + K V LNP
Sbjct: 121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG 180
Query: 218 -QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP 276
QG KE++ ++N L +L HPNL KL+G+ D DQR+L+YE + GSL+ ++ RS
Sbjct: 181 LQGHKEWLAEINYLGNLLHPNLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRRS--L 236
Query: 277 PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
P+ W+ R+KIAL AA+GL+FLHEE +Y +F T+NI +D +++AKLS +G A P+
Sbjct: 237 PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPD 296
Query: 337 ---TDISNSSVAAANLSV-ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392
T +S + + E + G LT KS+V+SFG+VLLE+LTGR+++D P E N
Sbjct: 297 EGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 356
Query: 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
LV+W+RP L D R ++DP+L+G F +K A+ V +A +CL ++ RP M + E L
Sbjct: 357 LVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVL 416
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 208 bits (530), Expect = 6e-53, Method: Compositional matrix adjust.
Identities = 118/314 (37%), Positives = 180/314 (57%), Gaps = 17/314 (5%)
Query: 161 TLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKK----FEATVTRLNPS 216
L+NF L E+ +A NF D + EG +++ + + K V RLN
Sbjct: 52 NLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQE 111
Query: 217 S-QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD- 274
QG +E++ ++N L L HPNL KL+G+ + + R+L+YE + GSL+ ++ R
Sbjct: 112 GFQGHREWLAEINYLGQLDHPNLVKLIGYCLEE--EHRLLVYEFMTRGSLENHLFRRGTF 169
Query: 275 GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334
P+ WNTRV++AL AA+GL FLH P Q +Y +F +NI +D +++AKLS +G A
Sbjct: 170 YQPLSWNTRVRMALGAARGLAFLHNAQP-QVIYRDFKASNILLDSNYNAKLSDFGLARDG 228
Query: 335 PETDISNSSVAAANLSV------ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
P D NS V+ + E L G L+ KS+V+SFG+VLLELL+GR+ +D P
Sbjct: 229 PMGD--NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPV 286
Query: 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
E NLV W+RP+L + RL +MDP+L+G++ L A +A +AL C+ + RPTM I
Sbjct: 287 GEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEI 346
Query: 449 FEELDRQESRKSSS 462
+ ++ +K +S
Sbjct: 347 VKTMEELHIQKEAS 360
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (521), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 114/303 (37%), Positives = 175/303 (57%), Gaps = 14/303 (4%)
Query: 161 TLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDAST----SKKFEATVTRLNPS 216
T+++F +E+ A NF SD + EG ++R + T S V RLNP
Sbjct: 45 TVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPD 104
Query: 217 S-QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY--GRS 273
QG +E++ ++N L L HPNL KL+G+ D +QR+L+YE + GSL+ ++ G
Sbjct: 105 GFQGHREWLTEINYLGQLSHPNLVKLIGYCLED--EQRLLVYEFMHKGSLENHLFANGNK 162
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333
D P+ W R+K+AL AA+GL FLH + P + +Y + +NI +D DF+AKLS +G A
Sbjct: 163 DFKPLSWILRIKVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDSDFNAKLSDFGLARD 221
Query: 334 IP---ETDISNSSVAAANLSV-ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE 389
P ++ +S + + E + G L +S+V+SFG+VLLELL GR+ LD P +
Sbjct: 222 GPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAK 281
Query: 390 ERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIF 449
E+NLV W+RP+L ++ LI+D +L ++ + A +A IA++CL EP RPTM +
Sbjct: 282 EQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVV 341
Query: 450 EEL 452
L
Sbjct: 342 RAL 344
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 7e-51, Method: Compositional matrix adjust.
Identities = 119/322 (36%), Positives = 180/322 (55%), Gaps = 18/322 (5%)
Query: 150 GPLPLPPT-----GTGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSK 204
GPLP T + L+ F +E+ A NF D + EG +++ + T+
Sbjct: 54 GPLPTLRTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTAS 113
Query: 205 K----FEATVTRLNPSS-QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
+ V +L P QG KE++ +VN L L HPNL L+G+ A + R+L+YE
Sbjct: 114 RPGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE--GENRLLVYEF 171
Query: 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319
+ GSL+ ++ R P+ W R+K+A+ AA+GLTFLHE Q +Y +F ANI +D
Sbjct: 172 MPKGSLENHLF-RRGAQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDA 229
Query: 320 DFSAKLSGYGCAGHIPETD---ISNSSVAAANLSV-ETLERGLLTPKSNVWSFGIVLLEL 375
DF+AKLS +G A P D +S + + E + G LT KS+V+SFG+VLLEL
Sbjct: 230 DFNAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEL 289
Query: 376 LTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
++GR+ +D+ + E +LV W+ P+L D +L IMD +L G++P K A T A++AL+CL
Sbjct: 290 ISGRRAMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCL 349
Query: 436 QKEPSERPTMRSIFEELDRQES 457
+ RP M + L++ ES
Sbjct: 350 NPDAKLRPKMSEVLVTLEQLES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (509), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 115/315 (36%), Positives = 174/315 (55%), Gaps = 13/315 (4%)
Query: 162 LRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKK----FEATVTRLNPSS 217
L+ F +E+ A NF D + EG +++ T+ K V +L
Sbjct: 68 LKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEG 127
Query: 218 -QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP 276
QG KE++ +VN L L HPNL KL+G+ + R+L+YE + GSL+ ++ R
Sbjct: 128 YQGHKEWLTEVNYLGQLSHPNLVKLVGYCVE--GENRLLVYEFMPKGSLENHLF-RRGAQ 184
Query: 277 PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
P+ W R+K+A+ AA+GLTFLH+ Q +Y +F ANI +D +F++KLS +G A P
Sbjct: 185 PLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPT 243
Query: 337 TDISNSSVAAANL----SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392
D ++ S + E + G LT KS+V+SFG+VLLELL+GR+ +D E++
Sbjct: 244 GDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQS 303
Query: 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
LV W+ P+L D +L IMD +L G++P K A T A +AL+CL + RP M + +L
Sbjct: 304 LVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKL 363
Query: 453 DRQESRKSSSSTVRR 467
D+ ES K + R
Sbjct: 364 DQLESTKPGTGVGNR 378
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (506), Expect = 4e-50, Method: Compositional matrix adjust.
Identities = 114/296 (38%), Positives = 171/296 (57%), Gaps = 12/296 (4%)
Query: 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTS-KKFEATVTRLNPSS-QGVKE 222
F L E+ +F D + EG +Y+ D+ K V LN QG +E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNT 282
++ +VN L L+HPNL KL+G+ D D R+L+YE + GSL+ ++ R P+ W+
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCED--DHRLLVYEFMLRGSLENHLF-RKTTAPLSWSR 173
Query: 283 RVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP---ETD 338
R+ IAL AA+GL FLH E P +Y +F T+NI +D D++AKLS +G A P ET
Sbjct: 174 RMMIALGAAKGLAFLHNAERP--VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 231
Query: 339 ISNSSVAAANLSV-ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397
+S + + E + G LT +S+V+SFG+VLLE+LTGRK++D P +E+NLV W+
Sbjct: 232 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWA 291
Query: 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
RP L D +L I+DP+L+ ++ ++AA+ +A CL + P RP M + E L+
Sbjct: 292 RPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 347
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (485), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 111/298 (37%), Positives = 165/298 (55%), Gaps = 13/298 (4%)
Query: 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFE-----ATVTRLNPSSQG 219
F +E+ NF DR + G +Y+ +D + E V + S QG
Sbjct: 64 FTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQG 123
Query: 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
+E++ +V L L HPNL KL+G+ D + R+LIYE + GS++ ++ R P+
Sbjct: 124 HREWLAEVIFLGQLSHPNLVKLIGYCCED--NHRVLIYEYMARGSVENNLFSRV-LLPLS 180
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339
W R+KIA AA+GL FLHE +Y +F T+NI +D D++AKLS +G A P D
Sbjct: 181 WAIRMKIAFGAAKGLAFLHEAKK-PVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDK 239
Query: 340 SNSSV----AAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
S+ S + E + G LTP S+V+SFG+VLLELLTGRK+LD P E+NL+
Sbjct: 240 SHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLID 299
Query: 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
W+ P L + ++ I+DP++ +P+KA + A +A CL + P RP MR I + L+
Sbjct: 300 WALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLE 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 119/312 (38%), Positives = 171/312 (54%), Gaps = 21/312 (6%)
Query: 152 LPLPPTGTGTL--RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEAT 209
L LP G G + F E+AAA NF D + EG +Y+
Sbjct: 59 LLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQV-----VA 113
Query: 210 VTRLNPSS-QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRL 268
V +L+ + QG +EF+ +V L+ L HPNL L+G+ A DG DQR+L+YE + GSL+
Sbjct: 114 VKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DG-DQRLLVYEFMPLGSLEDH 171
Query: 269 IYGRSDGPP----IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
++ D PP +DWN R+KIA AA+GL FLH++ +Y +F ++NI +D+ F K
Sbjct: 172 LH---DLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPK 228
Query: 325 LSGYGCAGHIPETDISNSSVAAAN----LSVETLERGLLTPKSNVWSFGIVLLELLTGRK 380
LS +G A P D S+ S + E G LT KS+V+SFG+V LEL+TGRK
Sbjct: 229 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 288
Query: 381 NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440
+DS P E+NLV W+RP D + + DP+LKGRFP +A +A C+Q++ +
Sbjct: 289 AIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAA 348
Query: 441 ERPTMRSIFEEL 452
RP + + L
Sbjct: 349 TRPLIADVVTAL 360
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (480), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 114/296 (38%), Positives = 166/296 (56%), Gaps = 13/296 (4%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-QGVK 221
+ F E+A A NF + I EG +Y+ V +L+ + QG K
Sbjct: 65 QTFSFRELATATKNFRQECLIGEGGFGRVYKGKL-----EKTGMIVAVKQLDRNGLQGNK 119
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDGPPIDW 280
EFI +V L+ L H +L L+G+ A DG DQR+L+YE + GSL D L+ D P+DW
Sbjct: 120 EFIVEVLMLSLLHHKHLVNLIGYCA-DG-DQRLLVYEYMSRGSLEDHLLDLTPDQIPLDW 177
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD-- 338
+TR++IAL AA GL +LH++ +Y + ANI +D +F+AKLS +G A P D
Sbjct: 178 DTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQ 237
Query: 339 -ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396
+S+ + +R G LT KS+V+SFG+VLLEL+TGR+ +D+ PK+E+NLV W
Sbjct: 238 HVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTW 297
Query: 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
++P + R + DP L+G FP KA +A CLQ+E + RP M + L
Sbjct: 298 AQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 473 | ||||||
| 255575572 | 543 | protein kinase atsik, putative [Ricinus | 0.951 | 0.828 | 0.780 | 0.0 | |
| 356568230 | 548 | PREDICTED: probable receptor-like protei | 0.936 | 0.808 | 0.796 | 0.0 | |
| 357469007 | 542 | Protein kinase 2A [Medicago truncatula] | 0.959 | 0.837 | 0.75 | 0.0 | |
| 356532163 | 549 | PREDICTED: probable receptor-like protei | 0.955 | 0.823 | 0.771 | 0.0 | |
| 388500644 | 522 | unknown [Medicago truncatula] | 0.959 | 0.869 | 0.747 | 0.0 | |
| 357506663 | 546 | Protein kinase 2A [Medicago truncatula] | 0.957 | 0.829 | 0.774 | 0.0 | |
| 225439687 | 548 | PREDICTED: probable receptor-like protei | 0.957 | 0.826 | 0.774 | 0.0 | |
| 297735543 | 660 | unnamed protein product [Vitis vinifera] | 0.957 | 0.686 | 0.770 | 0.0 | |
| 449502644 | 548 | PREDICTED: probable receptor-like protei | 0.957 | 0.826 | 0.737 | 0.0 | |
| 449439805 | 550 | PREDICTED: probable receptor-like protei | 0.957 | 0.823 | 0.726 | 0.0 |
| >gi|255575572|ref|XP_002528686.1| protein kinase atsik, putative [Ricinus communis] gi|223531858|gb|EEF33675.1| protein kinase atsik, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/464 (78%), Positives = 401/464 (86%), Gaps = 14/464 (3%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLN 60
MGCFTVLKSKKKKPE +V +KRV+P+E TPTTLPEPQIPTRSLQSAPPSFRTRVKP+ +
Sbjct: 1 MGCFTVLKSKKKKPEPSVSIKRVSPKEQTPTTLPEPQIPTRSLQSAPPSFRTRVKPVQPD 60
Query: 61 NTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLPL 120
N + NNR R SAP SLD+AE QD LA++E++E EE KSR L ++ S PQPLPL
Sbjct: 61 N--RLINNRARVKSAPESLDSAE--QDDLAAIEYDEHEELKSRVSLARDHLS--PQPLPL 114
Query: 121 PSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPP--TGTGTLRNFPLDEVAAACHNFF 178
P AA+LK GS K SGPL+ASGPLPLPP T +GTLRNF DE+ +AC NF
Sbjct: 115 P------AAALKPAGSLKFTNGSGPLYASGPLPLPPGVTQSGTLRNFSYDEIISACRNFS 168
Query: 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
SDRC+SEGLSS++YRASFGDD S+SKKFEATVTRL+ S QG KEFIN+VNTLASL+HPNL
Sbjct: 169 SDRCVSEGLSSIIYRASFGDDTSSSKKFEATVTRLHSSPQGFKEFINEVNTLASLRHPNL 228
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
CKLLG+HARDGS+QRMLIYERL+HGSLDRL+YGR DGPPIDWNTR+KIALCAAQGLTFLH
Sbjct: 229 CKLLGYHARDGSEQRMLIYERLYHGSLDRLLYGRLDGPPIDWNTRMKIALCAAQGLTFLH 288
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL 358
EEGPFQAMYNEFST NIQIDKDFSAKLSGYGC GHIPET+ISNSSVA ANLSVETLERGL
Sbjct: 289 EEGPFQAMYNEFSTGNIQIDKDFSAKLSGYGCVGHIPETEISNSSVAVANLSVETLERGL 348
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
LTPKSNVWSFGIVLLELLTGRKNLD+RHPKEERNLV+WSRPFL DDCRLSLIMDPQLKGR
Sbjct: 349 LTPKSNVWSFGIVLLELLTGRKNLDNRHPKEERNLVRWSRPFLDDDCRLSLIMDPQLKGR 408
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462
FPLKAARTVADIALRCL+K+P ERPTMR+I E L + KSS+
Sbjct: 409 FPLKAARTVADIALRCLKKDPLERPTMRAIVENLRVIQDMKSST 452
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568230|ref|XP_003552316.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/453 (79%), Positives = 401/453 (88%), Gaps = 10/453 (2%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPI-PL 59
MGCFTVLKSKKKK + ++K V+ E+ PT LPEPQ TRSLQSAPPSFRTRVKPI P+
Sbjct: 1 MGCFTVLKSKKKKSDPITYIKHVSHNENVPTVLPEPQTRTRSLQSAPPSFRTRVKPIQPI 60
Query: 60 NNTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLP 119
N KA+NNRTR LSAPS+LDAAE QDALAS+E+EEQEES+ RAG KEQRSSSPQPLP
Sbjct: 61 N---KASNNRTRTLSAPSTLDAAE--QDALASIEYEEQEESRHRAGSMKEQRSSSPQPLP 115
Query: 120 LPSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFS 179
LPSP SA LKA GSFKS +S PL ASGPLPLPPTG+ LRNF +E+AAACH+F S
Sbjct: 116 LPSPQGGSA--LKAIGSFKSVASSSPLHASGPLPLPPTGS--LRNFLYEEIAAACHHFSS 171
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
DRC+SE LSS +Y+ASFGDD S+SKKFEATVTRL+PSSQG+KEFIN+VNTLASLQHPNLC
Sbjct: 172 DRCMSECLSSTIYKASFGDDVSSSKKFEATVTRLHPSSQGLKEFINEVNTLASLQHPNLC 231
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KLLGFHAR+GS+ RML+YERL+HGSLDRL+YGRSDGP IDWNTR+KIA+CAAQGLTFLHE
Sbjct: 232 KLLGFHAREGSEHRMLVYERLYHGSLDRLLYGRSDGPSIDWNTRMKIAICAAQGLTFLHE 291
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLL 359
EGPFQAMYNEFSTANIQIDKDFSAKLSGYGC GHIPE +IS+SS A NLS+ETLE+G+L
Sbjct: 292 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHIPEEEISSSSSAVGNLSMETLEKGML 351
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
TPKSNVWSFGI LLELLTGRKNLDSRHPKEERNLVKWSRPFLAD+ RLSLIMDPQLKGRF
Sbjct: 352 TPKSNVWSFGIFLLELLTGRKNLDSRHPKEERNLVKWSRPFLADNYRLSLIMDPQLKGRF 411
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
P KAART+ADIA RCLQKEPS+RPTMR++ E L
Sbjct: 412 PSKAARTIADIAQRCLQKEPSDRPTMRTVVEHL 444
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357469007|ref|XP_003604788.1| Protein kinase 2A [Medicago truncatula] gi|355505843|gb|AES86985.1| Protein kinase 2A [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/464 (75%), Positives = 395/464 (85%), Gaps = 10/464 (2%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLN 60
MGCFT+LK KKKKP+Q V++KRV+P E +PT LPEPQ TRSLQSAPPSF+ RVKPI +
Sbjct: 1 MGCFTILKRKKKKPDQIVYVKRVSPGEDSPTVLPEPQTHTRSLQSAPPSFKIRVKPIQPS 60
Query: 61 NTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLPL 120
N KATNNR RALSAPSSLD +AEQDALA++E+EEQE SK R G KEQRS SPQPLP
Sbjct: 61 N--KATNNRIRALSAPSSLD--DAEQDALATIEYEEQEGSKYRTGSWKEQRSPSPQPLP- 115
Query: 121 PSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFSD 180
P + +LK GSFK G AS PL+ASGPLPLPP+G+ LRNF DE+AAAC NF SD
Sbjct: 116 -LPSPKGGGTLKTVGSFKLGIASSPLYASGPLPLPPSGS--LRNFSYDELAAACLNFSSD 172
Query: 181 RCISEGLSSVMYRASFGDDASTS--KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
R +SE LSS MY+ASFGDD STS KKFEATVTRL PSSQG+KEFIN+VNTLASLQHPNL
Sbjct: 173 RYMSESLSSTMYKASFGDDTSTSSSKKFEATVTRLRPSSQGLKEFINEVNTLASLQHPNL 232
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
C+LLGFHA DGS+ RML+YERL+HGSLDRL+YGRSDGP IDWNTR+KIA+CAA GL+FLH
Sbjct: 233 CRLLGFHAGDGSEHRMLVYERLYHGSLDRLLYGRSDGPSIDWNTRMKIAICAALGLSFLH 292
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL 358
EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC GH+P+ +IS+SS A NLS+ETLE+G+
Sbjct: 293 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHVPKEEISSSSSAVGNLSMETLEKGM 352
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
LTPKSNVWSFGI LLELLTGRKNLDSRHPKEERNLVKWSRPFL+D+ RLS+IMDPQLKGR
Sbjct: 353 LTPKSNVWSFGIFLLELLTGRKNLDSRHPKEERNLVKWSRPFLSDNHRLSMIMDPQLKGR 412
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462
FP KAA T+A+IA RCLQ EPSERPTM ++ E+L + + K SS
Sbjct: 413 FPSKAASTIANIAQRCLQMEPSERPTMGTVVEQLKKIQDLKHSS 456
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532163|ref|XP_003534643.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 688 bits (1776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/463 (77%), Positives = 401/463 (86%), Gaps = 11/463 (2%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPI-PL 59
MGCFTVLKSKKK+ + ++KRV+ E+ PT LPEPQ TRSLQSAPPSFRTRVKPI P+
Sbjct: 1 MGCFTVLKSKKKRSDPITYVKRVSHNENVPTVLPEPQTHTRSLQSAPPSFRTRVKPIQPI 60
Query: 60 NNTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLP 119
N K +NNR R LSAPS+LDAAE QDALAS+E+EEQEES+ RAG KE RSSSPQPLP
Sbjct: 61 N---KVSNNRARTLSAPSTLDAAE--QDALASIEYEEQEESRHRAGSMKEHRSSSPQPLP 115
Query: 120 LPSPHTQSAASLKATGSFKSGTASGP-LFASGPLPLPPTGTGTLRNFPLDEVAAACHNFF 178
LPS Q +LKA GSFKS T+ G +ASGPLPLPPTG+ LRNF +E+AAACH+F
Sbjct: 116 LPS--PQGGCALKAIGSFKSVTSGGSSYYASGPLPLPPTGS--LRNFLYEEIAAACHHFS 171
Query: 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
SDRC+SE LSS +Y+ASFGDD S+SKKFEATVTRL+PSSQG+KEFIN+VNTLASLQHPNL
Sbjct: 172 SDRCMSECLSSTIYKASFGDDVSSSKKFEATVTRLHPSSQGLKEFINEVNTLASLQHPNL 231
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
CKLLGFHAR+GS+ RML+YERL+HGSLDRL+YGRSDGP IDWNTR+KIA+CAAQGLTFLH
Sbjct: 232 CKLLGFHAREGSEHRMLVYERLYHGSLDRLLYGRSDGPSIDWNTRMKIAICAAQGLTFLH 291
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL 358
EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC GHIPE +IS+SS A NLS+ETLE+G+
Sbjct: 292 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHIPEEEISSSSSAVGNLSMETLEKGM 351
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
LTPKSNVWSFGI LLELLTGRKNLDSRHPKEERNLVKWSRPFLAD+ RLSLIMDPQLKGR
Sbjct: 352 LTPKSNVWSFGIFLLELLTGRKNLDSRHPKEERNLVKWSRPFLADNYRLSLIMDPQLKGR 411
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461
FP KAART+ADIA RCLQKEPS+RPTMR++ E L + K S
Sbjct: 412 FPSKAARTIADIAQRCLQKEPSDRPTMRTVVEHLKMIQDLKYS 454
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388500644|gb|AFK38388.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/464 (74%), Positives = 393/464 (84%), Gaps = 10/464 (2%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLN 60
MGCFT+LK KKKKP+ V++KRV+P E +PT LPEPQ TRSLQSAPPSF+ RVKPI +
Sbjct: 1 MGCFTILKRKKKKPDPIVYVKRVSPGEDSPTVLPEPQTHTRSLQSAPPSFKIRVKPIQPS 60
Query: 61 NTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLPL 120
N KATNNR RALSAPSSLD +AEQDALA++E+EEQE SK R G KEQRS SPQPLP
Sbjct: 61 N--KATNNRIRALSAPSSLD--DAEQDALATIEYEEQEGSKYRTGSWKEQRSPSPQPLP- 115
Query: 121 PSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFSD 180
P + +LK GSFK G AS PL+ASGPLPLPPTG+ LRNF DE+AAAC NF SD
Sbjct: 116 -LPSPKGGGTLKTVGSFKLGIASSPLYASGPLPLPPTGS--LRNFSYDELAAACLNFSSD 172
Query: 181 RCISEGLSSVMYRASFGDDASTS--KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
R +SE LSS MY+ASFGDD STS KKFEATVTR PSSQG+KEFIN+VNTLASLQHPNL
Sbjct: 173 RYMSESLSSTMYKASFGDDTSTSSSKKFEATVTRRRPSSQGLKEFINEVNTLASLQHPNL 232
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
C+LLGFHA DGS+ RML+YERL+HGSLDRL+YGRSDGP IDWNTR+KIA+CAA GL+FLH
Sbjct: 233 CRLLGFHAGDGSEHRMLVYERLYHGSLDRLLYGRSDGPSIDWNTRMKIAICAALGLSFLH 292
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL 358
EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC GH+P+ +IS+SS A NLS+ETLE+G+
Sbjct: 293 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHVPKEEISSSSSAVGNLSMETLEKGM 352
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
LTPKSNVWSFGI LLELLTGRKNLDSRHPKEERNLVKWSRPFL+D+ RLS+IMDPQLKGR
Sbjct: 353 LTPKSNVWSFGIFLLELLTGRKNLDSRHPKEERNLVKWSRPFLSDNHRLSMIMDPQLKGR 412
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462
FP KAA T+A+IA RCLQ EPSERPTM ++ E+L + + K SS
Sbjct: 413 FPSKAASTIANIAQRCLQMEPSERPTMGTVVEQLKKIQDLKHSS 456
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506663|ref|XP_003623620.1| Protein kinase 2A [Medicago truncatula] gi|355498635|gb|AES79838.1| Protein kinase 2A [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/462 (77%), Positives = 400/462 (86%), Gaps = 9/462 (1%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLN 60
MGCFTVLKSKKKK + ++KR++ EH P+ LPEPQ TRSLQSAPPSFRTRVKPI
Sbjct: 1 MGCFTVLKSKKKKSDSFAYVKRISHNEHAPSVLPEPQTHTRSLQSAPPSFRTRVKPI--Q 58
Query: 61 NTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLT-KEQRSSSPQPLP 119
+ KATNNR RALSAPS+LD A+ QDALAS+E+EEQEE K R G + KE RSSSPQPLP
Sbjct: 59 SVNKATNNRIRALSAPSTLDVAD--QDALASIEYEEQEELKHRGGGSMKEPRSSSPQPLP 116
Query: 120 LPSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFS 179
LPS Q +SLKA GSFK GTASGPL ASGPLPLPPTG+ LRNFP +EVAAACHNF S
Sbjct: 117 LPS--PQGGSSLKAIGSFKLGTASGPLHASGPLPLPPTGS--LRNFPYEEVAAACHNFSS 172
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
DRC+SE LSS +Y+A FGDD S SKKFEATVTRL+PSSQG+KEFIN+VNTLA+LQHPNLC
Sbjct: 173 DRCMSECLSSTIYKAYFGDDPSNSKKFEATVTRLHPSSQGLKEFINEVNTLATLQHPNLC 232
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KLLGFHARDGS+ +ML+YERL+HGSLDRL+YGRSDGP IDWNTR+KIA+CAA GLTFLHE
Sbjct: 233 KLLGFHARDGSEHKMLVYERLYHGSLDRLLYGRSDGPSIDWNTRMKIAMCAAHGLTFLHE 292
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLL 359
EGPFQAMYNEFSTANIQIDKDFSAKLSGYGC GHIPE +IS+SS A NLS+ETLE+G+L
Sbjct: 293 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHIPEEEISSSSSAVGNLSMETLEKGML 352
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
TPKSNVWSFGI LLELLTGRKNLDSRHPKEERNLVKWS+PFLAD+ RLSLIMDPQLKGR+
Sbjct: 353 TPKSNVWSFGIFLLELLTGRKNLDSRHPKEERNLVKWSKPFLADNYRLSLIMDPQLKGRY 412
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461
P KAART+ADIA RCLQKEPS+RPTMR++ E L + K S
Sbjct: 413 PSKAARTIADIAQRCLQKEPSDRPTMRTVVEHLKTIQDLKYS 454
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439687|ref|XP_002271567.1| PREDICTED: probable receptor-like protein kinase At5g15080 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/461 (77%), Positives = 396/461 (85%), Gaps = 8/461 (1%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLN 60
MGCF VLKSKKKK E+T ++KR+NPQE TPTTLPEP++ +R+LQSAPPSFRT VKP+
Sbjct: 1 MGCFKVLKSKKKKAERTAYIKRINPQELTPTTLPEPKLQSRTLQSAPPSFRTLVKPV--Q 58
Query: 61 NTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLPL 120
+ N+RTRALSAPSSL+ E QDALAS E EEQEE KSR GLTKEQRS +PQPLP
Sbjct: 59 PVKRIINSRTRALSAPSSLNTTE--QDALASNECEEQEELKSRVGLTKEQRSPNPQPLP- 115
Query: 121 PSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFSD 180
P Q LKATGSFK+G ASGPL+ASGPLPL G LRNF +E++ AC NF SD
Sbjct: 116 -LPSPQGTVVLKATGSFKAGNASGPLYASGPLPL--PPLGALRNFGYEELSNACLNFSSD 172
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
RC+SEGLSS++Y+ASFGDDAS SKK EATVTRL+PS+QG+KEFIN+VNTLASLQHP+LCK
Sbjct: 173 RCVSEGLSSIIYKASFGDDASGSKKLEATVTRLHPSTQGLKEFINEVNTLASLQHPHLCK 232
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
LLGFHAR+GSDQRML+YERL+HGSLDRL+YGRSDGP IDWNTR+K+ALCAAQGLTFLHEE
Sbjct: 233 LLGFHAREGSDQRMLVYERLYHGSLDRLLYGRSDGPSIDWNTRMKVALCAAQGLTFLHEE 292
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLT 360
GPFQAMYNEFSTANIQIDKDFSAKLSGYGC GHIPE D+ +SSVA ANLSVETLERGLLT
Sbjct: 293 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHIPEADVCSSSVAVANLSVETLERGLLT 352
Query: 361 PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFP 420
PKSNVWSFGIVLLELLTG KNLDSRHPKEERNLVKWSRP+LADDCRLSLIMDP LKGRFP
Sbjct: 353 PKSNVWSFGIVLLELLTGHKNLDSRHPKEERNLVKWSRPYLADDCRLSLIMDPHLKGRFP 412
Query: 421 LKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461
KAARTVADIA RCLQ +P ERPTMR+I E L + K S
Sbjct: 413 AKAARTVADIAQRCLQMDPLERPTMRTIVEHLKIIQDMKYS 453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735543|emb|CBI18037.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/461 (77%), Positives = 394/461 (85%), Gaps = 8/461 (1%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLN 60
MGCF VLKSKKKK E+T ++KR+NPQE TPTTLPEP++ +R+LQSAPPSFRT VKP+
Sbjct: 113 MGCFKVLKSKKKKAERTAYIKRINPQELTPTTLPEPKLQSRTLQSAPPSFRTLVKPV--Q 170
Query: 61 NTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLPL 120
+ N+RTRALSAPSSL+ E QDALAS E EEQEE KSR GLTKEQRS +PQPLP
Sbjct: 171 PVKRIINSRTRALSAPSSLNTTE--QDALASNECEEQEELKSRVGLTKEQRSPNPQPLP- 227
Query: 121 PSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFSD 180
P Q LKATGSFK+G ASGPL+AS PLP G LRNF +E++ AC NF SD
Sbjct: 228 -LPSPQGTVVLKATGSFKAGNASGPLYAS--GPLPLPPLGALRNFGYEELSNACLNFSSD 284
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
RC+SEGLSS++Y+ASFGDDAS SKK EATVTRL+PS+QG+KEFIN+VNTLASLQHP+LCK
Sbjct: 285 RCVSEGLSSIIYKASFGDDASGSKKLEATVTRLHPSTQGLKEFINEVNTLASLQHPHLCK 344
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
LLGFHAR+GSDQRML+YERL+HGSLDRL+YGRSDGP IDWNTR+K+ALCAAQGLTFLHEE
Sbjct: 345 LLGFHAREGSDQRMLVYERLYHGSLDRLLYGRSDGPSIDWNTRMKVALCAAQGLTFLHEE 404
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLT 360
GPFQAMYNEFSTANIQIDKDFSAKLSGYGC GHIPE D+ +SSVA ANLSVETLERGLLT
Sbjct: 405 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHIPEADVCSSSVAVANLSVETLERGLLT 464
Query: 361 PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFP 420
PKSNVWSFGIVLLELLTG KNLDSRHPKEERNLVKWSRP+LADDCRLSLIMDP LKGRFP
Sbjct: 465 PKSNVWSFGIVLLELLTGHKNLDSRHPKEERNLVKWSRPYLADDCRLSLIMDPHLKGRFP 524
Query: 421 LKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461
KAARTVADIA RCLQ +P ERPTMR+I E L + K S
Sbjct: 525 AKAARTVADIAQRCLQMDPLERPTMRTIVEHLKIIQDMKYS 565
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449502644|ref|XP_004161702.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/465 (73%), Positives = 389/465 (83%), Gaps = 12/465 (2%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPI-PL 59
MGCF LKSKKK Q++H K V +E PT LPEPQI TR+LQSAPPSF+TRVKP+ P
Sbjct: 1 MGCFPALKSKKKNYSQSLHDKCVKSKEIVPTKLPEPQIRTRTLQSAPPSFKTRVKPVQPA 60
Query: 60 NNTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPLP 119
N A +R R LSAPSSLDAAE QDAL+SVE+EE EE R G +KEQRS SPQPLP
Sbjct: 61 NG---AAGSRVRTLSAPSSLDAAE--QDALSSVEYEEPEEPIGRFGFSKEQRSPSPQPLP 115
Query: 120 LPSPHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFS 179
P Q +LK TGSFKS +SGPL++SGPLPLPP G +RNF +E++AACHNF +
Sbjct: 116 --LPSPQVIVALKNTGSFKSVASSGPLYSSGPLPLPPVGA--VRNFSYEEISAACHNFSA 171
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
+ C+SE LSS++YRASFGDD STSKKFEATVT +PS+QG +EF+++V+TL SLQHPNLC
Sbjct: 172 ESCVSESLSSLIYRASFGDDTSTSKKFEATVTFRHPSNQGFREFVSEVSTLTSLQHPNLC 231
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KLLGFH +GS QRML+YERLFHGSLDRL+YGRSDGPPIDWNTR+KIALCAAQGLTFLHE
Sbjct: 232 KLLGFHGHEGSGQRMLVYERLFHGSLDRLLYGRSDGPPIDWNTRIKIALCAAQGLTFLHE 291
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI--PETDISNSSVAAANLSVETLERG 357
EGPFQAMYNEFSTANIQIDKDFSAKLSGYGC G I PET+ISN+SV +A LS+ETLERG
Sbjct: 292 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGQIPTPETEISNNSVGSAYLSMETLERG 351
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417
LLTPKSNVWSFGIVLLELLTGR+NLDSR+PKEERNLVKWSRPFLADD RLSLIMDPQLKG
Sbjct: 352 LLTPKSNVWSFGIVLLELLTGRRNLDSRYPKEERNLVKWSRPFLADDGRLSLIMDPQLKG 411
Query: 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462
RFP KAARTVADIA +CLQK+PSERPTMR++ E L ++ K SS
Sbjct: 412 RFPTKAARTVADIAQKCLQKDPSERPTMRNVVEHLKIIQNLKQSS 456
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439805|ref|XP_004137676.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus] gi|449523914|ref|XP_004168968.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/465 (72%), Positives = 389/465 (83%), Gaps = 12/465 (2%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVN-PQEHTPTTLPEPQIPTRSLQSAPPSFRTRVKPI-P 58
M CFTV K+KKK+P+Q V++K VN +EH P LPEPQ+ TRSLQSAPPSFRTRVKPI P
Sbjct: 1 MPCFTVWKTKKKRPDQPVYVKPVNTKEEHLPAILPEPQLETRSLQSAPPSFRTRVKPIQP 60
Query: 59 LNNTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSRAGLTKEQRSSSPQPL 118
+NN K ++NR RALSAPS LDAAE QDAL +++++ +E K GL KEQ+SS PQPL
Sbjct: 61 VNN--KVSSNRARALSAPSYLDAAE--QDALGAIDYDAHDEPKLYIGLNKEQKSSGPQPL 116
Query: 119 PLPSPHTQSAASLKATGSFKSGTASGPLFASG--PLPLPPTGTGTLRNFPLDEVAAACHN 176
P P Q+ ASLK +GSFKS T+S PLPLPPTG+ LRNF +EV+AACH+
Sbjct: 117 P--LPSPQATASLKISGSFKSVTSSSSGSLYSSGPLPLPPTGS--LRNFSFEEVSAACHH 172
Query: 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHP 236
F SDRC+SEGLSS +Y+ASFGDD+S+ +KFEATV+RL S+QG++EF+N+VNTLAS QHP
Sbjct: 173 FSSDRCMSEGLSSFIYKASFGDDSSSLRKFEATVSRLYSSNQGLREFVNEVNTLASFQHP 232
Query: 237 NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
NLCKLLGFHARDGS+QRML+YERLFHGSLDRL+Y RS+GP IDWN+R+KIALCAAQGL F
Sbjct: 233 NLCKLLGFHARDGSEQRMLVYERLFHGSLDRLLYSRSEGPLIDWNSRMKIALCAAQGLAF 292
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER 356
LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC GHIP+ +I N+ V A+LSVETLER
Sbjct: 293 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCVGHIPDPEIPNNPVIGASLSVETLER 352
Query: 357 GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416
GLLTPKSNVWSFGIVLLELLTGR+NLD+RHPKEERNLVKWSRPFL DDCRLSLIMDPQLK
Sbjct: 353 GLLTPKSNVWSFGIVLLELLTGRRNLDNRHPKEERNLVKWSRPFLTDDCRLSLIMDPQLK 412
Query: 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461
GRFP KA+R VADIA RCL KEPSERPTMR+I E L + K S
Sbjct: 413 GRFPSKASRIVADIAQRCLLKEPSERPTMRAIVERLSSIQDVKYS 457
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 473 | ||||||
| TAIR|locus:2077768 | 557 | ATSIK [Arabidopsis thaliana (t | 0.955 | 0.811 | 0.604 | 4.3e-143 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.630 | 0.604 | 0.376 | 5.1e-51 | |
| TAIR|locus:2064920 | 435 | AT2G39110 [Arabidopsis thalian | 0.678 | 0.737 | 0.349 | 5.2e-49 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.604 | 0.583 | 0.377 | 8.5e-49 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.625 | 0.760 | 0.372 | 1.1e-48 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.689 | 0.719 | 0.342 | 4.7e-48 | |
| TAIR|locus:2053250 | 462 | AT2G28940 [Arabidopsis thalian | 0.613 | 0.627 | 0.376 | 1.2e-47 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.600 | 0.692 | 0.381 | 1.2e-47 | |
| TAIR|locus:2085069 | 418 | AT3G09830 [Arabidopsis thalian | 0.615 | 0.696 | 0.357 | 2.6e-47 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.621 | 0.759 | 0.393 | 1.4e-46 |
| TAIR|locus:2077768 ATSIK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1344 (478.2 bits), Expect = 4.3e-143, Sum P(2) = 4.3e-143
Identities = 283/468 (60%), Positives = 330/468 (70%)
Query: 1 MGCFTVLKSKKKKPEQTVHLKRVNPQEHTPTTLPEP-QIPTRSLQSAPPSFRTRVKPIPL 59
+GCF LKSKKK+ +V +KR++ +E PT LPEP +IP+R+LQSAPPSFRTRVKPI
Sbjct: 3 LGCFP-LKSKKKRG--SVSMKRLDLEESKPTALPEPPKIPSRNLQSAPPSFRTRVKPIQS 59
Query: 60 XXXXXXXXXXXXX-LSAPXXXXXXXXXXXXXXSVEFEEQEESKSRAGLTKEQRXXXXXXX 118
+SAP E+ E+ + TKE
Sbjct: 60 NNGGTGEMSSRARVMSAPSSIHGAAERDLLAGVYHDEQDEQPRDPRTSTKES-----SPQ 114
Query: 119 XXXXXXXXXAASLKATGSFKS-GTASGPLFASXXXXXXXXX--XXXXRNFPLDEVAAACH 175
+SLK GSFKS +SG L +S R+F DEV AAC+
Sbjct: 115 PLPLPSPRTGSSLKNWGSFKSFNGSSGRLSSSAAVSGPLPLPPSGSVRSFSYDEVMAACN 174
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTS--KKFEATVTRLNPSSQGVKEFINDVNTLASL 233
F SDRC+ EGLSSVMY ASFGD+ASTS KK +ATV RL+ +Q ++EFIN+VNTLASL
Sbjct: 175 AFSSDRCVMEGLSSVMYMASFGDEASTSGLKKVDATVVRLHVITQSIREFINEVNTLASL 234
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
QH NLCKL+G+HARDGSD RML+YERL GSLDRL++GRSDGPP+DWNTR+KIALCAAQG
Sbjct: 235 QHQNLCKLVGYHARDGSDTRMLVYERLALGSLDRLLHGRSDGPPLDWNTRMKIALCAAQG 294
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIXXXXXXXXXXXXET 353
LTFLHEEGPFQAMYNEFSTANIQ+DKDFSAKLSGYGCAGH PET+ ET
Sbjct: 295 LTFLHEEGPFQAMYNEFSTANIQVDKDFSAKLSGYGCAGHAPETE-TSNSSALANLSVET 353
Query: 354 LERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413
LERGLLTPKSNVWS+GIVLLE+LTGRKN+D +PKEERNLVKWSR FLADDCRLSLIMDP
Sbjct: 354 LERGLLTPKSNVWSYGIVLLEMLTGRKNMDGSYPKEERNLVKWSRAFLADDCRLSLIMDP 413
Query: 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461
QLKGRFP KAAR++ADIA +CLQ EPSERPTMR+I ++L + K S
Sbjct: 414 QLKGRFPAKAARSIADIAQKCLQVEPSERPTMRNIVDQLKIIQDMKYS 461
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 530 (191.6 bits), Expect = 5.1e-51, P = 5.1e-51
Identities = 117/311 (37%), Positives = 179/311 (57%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKK----FEATVTRLNPSS- 217
R F +++ + NF + + EG +++ ++ + K V LNP
Sbjct: 128 RKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGL 187
Query: 218 QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP 277
QG KE++ ++N L +L HPNL KL+G+ D DQR+L+YE + GSL+ ++ RS P
Sbjct: 188 QGHKEWLAEINFLGNLLHPNLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRRS--LP 243
Query: 278 IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336
+ W+ R+KIAL AA+GL+FLHEE +Y +F T+NI +D D++AKLS +G A P+
Sbjct: 244 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDE 303
Query: 337 --TDIXXXXXXXXXXXX-ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393
T + E + G LT KS+V+SFG+VLLE+LTGR+++D P E NL
Sbjct: 304 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 363
Query: 394 VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
V+W+RP L D R ++DP+L+G F +K A+ V +A +CL ++P RP M + E L
Sbjct: 364 VEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALK 423
Query: 454 RQESRKSSSST 464
K +S+
Sbjct: 424 PLPHLKDMASS 434
|
|
| TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 5.2e-49, P = 5.2e-49
Identities = 115/329 (34%), Positives = 182/329 (55%)
Query: 134 TGS-FKSGTASGPLFASXXXXXXXXXXXXXRNFPLDEVAAACHNFFSDRCISEGLSSVMY 192
+GS F S T++ S + F LD++ A NF I EG ++
Sbjct: 46 SGSEFNSDTSTATSITSSLHVLSETHSNNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVF 105
Query: 193 RASFGDDASTSKKFEATVTRLNPSS-QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251
R + + KK + V +L+ QG KE++ +VN L ++HPNL KL+G+ A D
Sbjct: 106 RGVIQNPQDSRKKIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDER 165
Query: 252 --QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNE 309
QR+L+YE + + S+ + R P+ W+TR+KIA A+GL +LH+ FQ ++ +
Sbjct: 166 GIQRLLVYEYVQNRSVQDHLSNRFIVTPLPWSTRLKIAQDTARGLAYLHQGMEFQIIFRD 225
Query: 310 FSTANIQIDKDFSAKLSGYGCAGHIPETDIXXXXXXXXXXXX----ETLERGLLTPKSNV 365
F ++NI +D++++AKLS +G A P I E ++ G LT KS+V
Sbjct: 226 FKSSNILLDENWNAKLSDFGLARMGPSDGITHVSTAVVGTIGYAAPEYIQTGHLTAKSDV 285
Query: 366 WSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAAR 425
WS+GI L EL+TGR+ D P+ E+N+++W RP L+D + +I+DP+L+G + LK+A
Sbjct: 286 WSYGIFLYELITGRRPFDRNRPRNEQNILEWIRPHLSDIKKFKMIIDPRLEGNYYLKSAL 345
Query: 426 TVADIALRCLQKEPSERPTMRSIFEELDR 454
+A +A RCL + RPTM + E L+R
Sbjct: 346 KLAAVANRCLMVKAKARPTMSQVSEMLER 374
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 8.5e-49, P = 8.5e-49
Identities = 113/299 (37%), Positives = 173/299 (57%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKK----FEATVTRLNPSS- 217
+ F ++ A NF + + EG +++ ++ + K V LNP
Sbjct: 122 KKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGL 181
Query: 218 QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP 277
QG KE++ ++N L +L HPNL KL+G+ D DQR+L+YE + GSL+ ++ RS P
Sbjct: 182 QGHKEWLAEINYLGNLLHPNLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRRS--LP 237
Query: 278 IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336
+ W+ R+KIAL AA+GL+FLHEE +Y +F T+NI +D +++AKLS +G A P+
Sbjct: 238 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDE 297
Query: 337 --TDIXXXXXXXXXXXX-ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393
T + E + G LT KS+V+SFG+VLLE+LTGR+++D P E NL
Sbjct: 298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
Query: 394 VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
V+W+RP L D R ++DP+L+G F +K A+ V +A +CL ++ RP M + E L
Sbjct: 358 VEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVL 416
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 1.1e-48, P = 1.1e-48
Identities = 116/311 (37%), Positives = 177/311 (56%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEAT-----VTRLNPSS 217
+NF L E+ +A NF D + EG +++ D++S + T V RLN
Sbjct: 54 KNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWI-DESSLAPSKPGTGIVIAVKRLNQEG 112
Query: 218 -QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG- 275
QG +E++ ++N L L HPNL KL+G+ + + R+L+YE + GSL+ ++ R
Sbjct: 113 FQGHREWLAEINYLGQLDHPNLVKLIGYCLEE--EHRLLVYEFMTRGSLENHLFRRGTFY 170
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
P+ WNTRV++AL AA+GL FLH P Q +Y +F +NI +D +++AKLS +G A P
Sbjct: 171 QPLSWNTRVRMALGAARGLAFLHNAQP-QVIYRDFKASNILLDSNYNAKLSDFGLARDGP 229
Query: 336 ETDIXXXXX----XXXXXXXETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER 391
D E L G L+ KS+V+SFG+VLLELL+GR+ +D P E
Sbjct: 230 MGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEH 289
Query: 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451
NLV W+RP+L + RL +MDP+L+G++ L A +A +AL C+ + RPTM I +
Sbjct: 290 NLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKT 349
Query: 452 LDRQESRKSSS 462
++ +K +S
Sbjct: 350 MEELHIQKEAS 360
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 4.7e-48, P = 4.7e-48
Identities = 118/345 (34%), Positives = 190/345 (55%)
Query: 129 ASLKATGSFKSGTASGPLFASXXXXXXXXXXXXXRNFPLDEVAAACHNFFSDRCISEGLS 188
A K TG +SG+++ PL + R F +++ A NF + + EG
Sbjct: 61 APTKDTGCAESGSST-PLMSGELKYSSKL-----RIFMFNDLKLATRNFRPESLLGEGGF 114
Query: 189 SVMYRASFGDDASTSKK----FEATVTRLNPSS-QGVKEFINDVNTLASLQHPNLCKLLG 243
+++ ++ + K V LNP QG KE++ ++N L +L HP+L KL+G
Sbjct: 115 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVG 174
Query: 244 FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPF 303
+ + DQR+L+YE + GSL+ ++ R+ P+ W+ R+KIAL AA+GL FLHEE
Sbjct: 175 YCMEE--DQRLLVYEFMPRGSLENHLFRRT--LPLPWSVRMKIALGAAKGLAFLHEEAEK 230
Query: 304 QAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE---TDIXXXXXXXXXXXX-ETLERGLL 359
+Y +F T+NI +D +++AKLS +G A P+ + + E + G L
Sbjct: 231 PVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHL 290
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
T KS+V+SFG+VLLE+LTGR+++D P E+NLV+W RP L D R ++DP+L+G +
Sbjct: 291 TTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHY 350
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSST 464
+K A+ +A +CL ++ RP M + E L + K +S+
Sbjct: 351 SIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKDFASS 395
|
|
| TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 113/300 (37%), Positives = 167/300 (55%)
Query: 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRA--SFGDDASTSKKFEATVTRLNPSS-QGVK 221
F E+ A F I EG +YR D K V +LN QG K
Sbjct: 90 FTFKELKIATKGFNRGLLIGEGGFGCVYRGVVDVSDSNGFDSKINVAVKQLNRQGLQGHK 149
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSD--QRMLIYERLFHGSLDRLIYGRSDGPPID 279
E+IN+VN L + HPNL KL+G+ A D QR+L+YE + + SL+ + GR +
Sbjct: 150 EWINEVNFLGVVNHPNLVKLVGYCADDDERGMQRLLVYELMCNKSLEDHLVGRVVSVSLP 209
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339
W R+KIA AAQGL +LHEE FQ ++ +F ++NI +D+ F AKLS +G A P +
Sbjct: 210 WMMRLKIAQDAAQGLAYLHEEMDFQLIFRDFKSSNILLDERFGAKLSDFGLARQGPPEGL 269
Query: 340 XXXXXXXXXXXX----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
E ++ G LT KS+VWSFG+VL EL+TGR+ +D P+ E+ L++
Sbjct: 270 GHVSTSVVGTVGYAAPEYVQTGKLTAKSDVWSFGVVLYELITGRRAVDRNRPRGEQKLLE 329
Query: 396 WSRPFLADDCRLSLIMDPQLKGRFP-LKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
W +P+++D + LI+DP+L+G++ +K+ + VA +A +CL K+P RP M + L R
Sbjct: 330 WVKPYVSDSKKFHLIVDPRLEGQYYCMKSVQRVAALANKCLMKQPKSRPKMSEVVSLLGR 389
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 113/296 (38%), Positives = 168/296 (56%)
Query: 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTS-KKFEATVTRLNPSS-QGVKE 222
F L E+ +F D + EG +Y+ D+ K V LN QG +E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNT 282
++ +VN L L+HPNL KL+G+ D D R+L+YE + GSL+ ++ R P+ W+
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCED--DHRLLVYEFMLRGSLENHLF-RKTTAPLSWSR 173
Query: 283 RVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP---ETD 338
R+ IAL AA+GL FLH E P +Y +F T+NI +D D++AKLS +G A P ET
Sbjct: 174 RMMIALGAAKGLAFLHNAERP--VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 231
Query: 339 IXXXXXXXXXXXX-ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397
+ E + G LT +S+V+SFG+VLLE+LTGRK++D P +E+NLV W+
Sbjct: 232 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWA 291
Query: 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
RP L D +L I+DP+L+ ++ ++AA+ +A CL + P RP M + E L+
Sbjct: 292 RPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 347
|
|
| TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
Identities = 107/299 (35%), Positives = 175/299 (58%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-QGVK 221
R F + ++ +A NF I EG ++R + + +S K E V +L QG K
Sbjct: 70 REFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLEDSSVKIEVAVKQLGKRGLQGHK 129
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSD--QRMLIYERLFHGSLDRLIYGRSDGPPID 279
E++ +VN L ++H NL KLLG+ A D QR+L+YE + + S++ + RS +
Sbjct: 130 EWVTEVNFLGIVEHTNLVKLLGYCAEDDERGIQRLLVYEYMPNRSVEFHLSPRSL-TVLT 188
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339
W+ R++IA AA+GLT+LHEE FQ ++ +F ++NI +D+D+ AKLS +G A P +
Sbjct: 189 WDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLDEDWKAKLSDFGLARLGPSEGL 248
Query: 340 XXXXX----XXXXXXXETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
E ++ G LT KS+VW +G+ L EL+TGR+ +D PK E+ L++
Sbjct: 249 THVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYELITGRRPVDRNRPKGEQKLLE 308
Query: 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
W RP+L+D + LI+DP+L+G++P+K+ + +A +A RCL + RP M + E +++
Sbjct: 309 WVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRCLVRNSKARPKMSEVLEMVNK 367
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 1.4e-46, P = 1.4e-46
Identities = 122/310 (39%), Positives = 171/310 (55%)
Query: 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDA-STSKK---FEATVTRLNPSS-QG 219
F +E+ A NF + I EG +Y+ G+ + S SK V +L QG
Sbjct: 72 FTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVVAVKKLKSEGFQG 131
Query: 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
KE++ +V+ L L H NL KL+G+ +G ++R+L+YE + GSL+ ++ R PI
Sbjct: 132 HKEWLTEVHYLGRLHHMNLVKLIGY-CLEG-EKRLLVYEYMPKGSLENHLFRRG-AEPIP 188
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339
W TR+K+A AA+GL+FLHE + +Y +F +NI +D DF+AKLS +G A P D
Sbjct: 189 WKTRMKVAFSAARGLSFLHEA---KVIYRDFKASNILLDVDFNAKLSDFGLAKAGPTGDR 245
Query: 340 XXXXX----XXXXXXXETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
E + G LT KS+V+SFG+VLLELL+GR LD ERNLV
Sbjct: 246 THVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVGVERNLVD 305
Query: 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455
W+ P+L D ++ IMD +L G++P K A A+IALRCL EP RP M + L +
Sbjct: 306 WAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADVLSTLQQL 365
Query: 456 E-SRKSSSST 464
E S K ST
Sbjct: 366 ETSSKKMGST 375
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 473 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-22 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-20 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-14 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-06 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.001 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.001 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.001 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.002 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 0.002 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.004 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 54/258 (20%), Positives = 103/258 (39%), Gaps = 43/258 (16%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD----- 266
+ + S + K+F+ + + L HPN+ +LLG + L+ E + G L
Sbjct: 32 KEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRK 89
Query: 267 -RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKD 320
R ++ + + + A+ A+G+ +L +F + N + +D
Sbjct: 90 SRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--------KKFVHRDLAARNCLVGED 141
Query: 321 FSAKLSGYGCAGHIPETDISNSSVAAAN----LSVETLERGLLTPKSNVWSFGIVLLELL 376
K+S +G + + + D ++ E+L+ G+ T KS+VWSFG++L E+
Sbjct: 142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201
Query: 377 T-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
T G +E ++ RL P + ++ L C
Sbjct: 202 TLGATPYPGLSNEEVLEYLR-------KGYRLP----------KPEYCPDELYELMLSCW 244
Query: 436 QKEPSERPTMRSIFEELD 453
Q +P +RPT + E L+
Sbjct: 245 QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 41/248 (16%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + +EF+ + + + L HPN+ +LLG + ++ E + G L + R G
Sbjct: 41 SEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGE--PLYIVTEYMPGGDLLD--FLRKHG 96
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
+ +++AL A+G+ +L F + N + ++ K+S +G
Sbjct: 97 EKLTLKDLLQMALQIAKGMEYLES--------KNFVHRDLAARNCLVTENLVVKISDFGL 148
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDS 384
+ I E D L + E+L+ G T KS+VWSFG++L E+ T G +
Sbjct: 149 SRDIYEDDYYRKRGGG-KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
+E L++ D RL P+ P + ++ L+C +P +RPT
Sbjct: 208 MSNEEVLELLE-------DGYRL-----PR-----PENCPDELYELMLQCWAYDPEDRPT 250
Query: 445 MRSIFEEL 452
+ E+L
Sbjct: 251 FSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 68/277 (24%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEA--TVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
R + G +Y+A T K A + + + S+ + ++ L L HPN+
Sbjct: 5 RKLGSGSFGTVYKAK---HKGTGKIV-AVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
+L+ D L+ E G L + S G P+ + KIAL +GL +LH
Sbjct: 61 VRLIDAFEDK--DHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--LSVETLER 356
G ++ + NI +D++ K++ +G A + ++ S ++ ++ E L
Sbjct: 116 SNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172
Query: 357 GLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415
G PK +VWS G++L ELLTG+ L + I+ P L
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPL 219
Query: 416 KGRFPLK--AARTVADIALRCLQKEPSERPTMRSIFE 450
+ P + D+ +CL K+PS+RPT I +
Sbjct: 220 EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 57/250 (22%), Positives = 107/250 (42%), Gaps = 38/250 (15%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
+ + S Q ++EF+ + + L HPN+ KLLG + + ++ E + G L +
Sbjct: 37 KEDASEQQIEEFLREARIMRKLDHPNVVKLLGV-CTE-EEPLYIVMEYMEGGDLLSYL-- 92
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
R + P + + + AL A+G+ +L + F + N + ++ K+S
Sbjct: 93 RKNRPKLSLSDLLSFALQIARGMEYLESKN--------FIHRDLAARNCLVGENLVVKIS 144
Query: 327 GYGCAGHIPETDISNSSVAAAN---LSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382
+G + + + D ++ E+L+ G T KS+VWSFG++L E+ T G +
Sbjct: 145 DFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY 204
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
+E +K + RL P + D+ L+C ++P +R
Sbjct: 205 PGMSNEEVLEYLK-------NGYRL----------PQPPNCPPELYDLMLQCWAEDPEDR 247
Query: 443 PTMRSIFEEL 452
PT + E L
Sbjct: 248 PTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 64/274 (23%), Positives = 111/274 (40%), Gaps = 63/274 (22%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLL 242
+ EG +Y A D T KK + + SS ++E + ++ L L HPN+ KL
Sbjct: 1 LGEGGFGTVYLAR---DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 243 GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGP 302
G + + L+ E GSL L+ + + + + ++I L +GL +LH G
Sbjct: 58 GVFEDE--NHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHSNG- 112
Query: 303 FQAMYNEFSTANIQIDKD-FSAKLSGYGCAGHIPETDISNSSVAA--ANLSVETLE-RGL 358
++ + NI +D D KL+ +G + + ++ A ++ E L +G
Sbjct: 113 --IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
+ KS++WS G++L EL P+LK
Sbjct: 171 YSEKSDIWSLGVILYEL-------------------------------------PELK-- 191
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
D+ + LQK+P +RP+ + I E L
Sbjct: 192 ----------DLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 55/253 (21%), Positives = 104/253 (41%), Gaps = 43/253 (16%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
+ + S Q ++EF+ + + L HPN+ KLLG + + M++ E + G L +
Sbjct: 37 KEDASEQQIEEFLREARIMRKLDHPNIVKLLGV-CTE-EEPLMIVMEYMPGGDLLDYL-R 93
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
++ + + + AL A+G+ +L + F + N + ++ K+S
Sbjct: 94 KNRPKELSLSDLLSFALQIARGMEYLESKN--------FIHRDLAARNCLVGENLVVKIS 145
Query: 327 GYGCAGHIPETDISNSSVAAAN---LSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382
+G + + + D ++ E+L+ G T KS+VWSFG++L E+ T G +
Sbjct: 146 DFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY 205
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF---PLKAARTVADIALRCLQKEP 439
E +K KG P + + L+C ++P
Sbjct: 206 PGMSNAEVLEYLK--------------------KGYRLPKPPNCPPELYKLMLQCWAEDP 245
Query: 440 SERPTMRSIFEEL 452
+RPT + E L
Sbjct: 246 EDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 57/283 (20%), Positives = 99/283 (34%), Gaps = 50/283 (17%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ EG +Y A D T K V + + + + ++ L L+HPN+ +
Sbjct: 5 EKLGEGSFGKVYLAR---DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L + D+ L+ E G L L+ + + L +LH +
Sbjct: 62 LYDVF--EDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 301 G-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVE 352
G P NI +D+D KL+ +G A + + + V ++ E
Sbjct: 117 GIVHRDLKP----------ENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 353 TLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412
L ++WS G++L ELLTG+ PF D +L +
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK------------------PPF-PGDDQLLELFK 207
Query: 413 PQLKGRFPL-----KAARTVADIALRCLQKEPSERPTMRSIFE 450
K + P + D+ + L K+P +R T +
Sbjct: 208 KIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 76/258 (29%), Positives = 121/258 (46%), Gaps = 30/258 (11%)
Query: 220 VKEFINDVNTLAS--------LQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
VKE INDVN++ S LQHPN+ KL+G + LI+E + +L ++
Sbjct: 720 VKE-INDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIHEYIEGKNLSEVLRN 776
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
S W R KIA+ A+ L FLH + S I ID L
Sbjct: 777 LS------WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----RL 826
Query: 332 GHIPE---TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
+P TD +++A ++ ET E +T KS+++ FG++L+ELLTG+ D+
Sbjct: 827 S-LPGLLCTDTK-CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTV--ADIALRCLQKEPSERPTMR 446
++V+W+R + DC L + +DP ++G + V ++AL C +P+ RP
Sbjct: 885 HG-SIVEWAR-YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942
Query: 447 SIFEELDRQESRKSSSST 464
+ + L+ SS T
Sbjct: 943 DVLKTLESASRSSSSCVT 960
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 60/258 (23%), Positives = 98/258 (37%), Gaps = 48/258 (18%)
Query: 201 STSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
E + + S+ KE I N++ L +HPN+ K G + + D+ ++ E
Sbjct: 21 HKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVMEF 78
Query: 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319
GSL L+ +S + + + +GL +LH G ++ + ANI +
Sbjct: 79 CSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTS 133
Query: 320 DFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTG 378
D KL +G + + +T N+ V ++ E + K+++WS GI +EL G
Sbjct: 134 DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193
Query: 379 R---KNLDS---------RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAART 426
+ L P RN KWS F
Sbjct: 194 KPPYSELPPMKALFKIATNGPPGLRNPEKWSDEF-------------------------- 227
Query: 427 VADIALRCLQKEPSERPT 444
D +CLQK P +RPT
Sbjct: 228 -KDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 61/272 (22%), Positives = 104/272 (38%), Gaps = 19/272 (6%)
Query: 191 MYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
+ R D + + V LN S Q +F ++ L +L H N+ K G +
Sbjct: 22 LCRYDPLGDNTGE---QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78
Query: 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYN 308
G LI E L GSL Y + I+ + + +G+ +L + + ++
Sbjct: 79 GGRSLRLIMEYLPSGSLR--DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHR 133
Query: 309 EFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKS 363
+ + NI ++ + K+S +G A +PE + E L + S
Sbjct: 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSAS 193
Query: 364 NVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLK 422
+VWSFG+ L EL T G + P E + RL ++ + P
Sbjct: 194 DVWSFGVTLYELFTYGDPSQ---SPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPS 250
Query: 423 AARTVADIALRCLQKEPSERPTMRSIFEELDR 454
V D+ C + EP +RP+ + +DR
Sbjct: 251 CPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 59/283 (20%)
Query: 182 CISEGLSSVMYRASFGDDASTS--KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
I G V+Y+ + K+ + +K + +++ L +L+HPN+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE----KIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAA------QG 293
K +G SD +I E +GSL ++I + P L A QG
Sbjct: 63 KYIGSI-ET-SDSLYIILEYAENGSLRQII-KKFGPFPES--------LVAVYVYQVLQG 111
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--LSV 351
L +LHE+G ++ + ANI KD KL+ +G A + + ++SV ++
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN-------LVKWSRPFLADD 404
E +E + S++WS G ++ELLTG P + N +V+ P L +
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNP------PYYDLNPMAALFRIVQDDHPPLPEG 222
Query: 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS 447
P+LK D ++C QK+P+ RPT +
Sbjct: 223 I------SPELK------------DFLMQCFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 35/255 (13%)
Query: 206 FEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
+ + L S + F+ + N + LQHP L +L +A + +I E + +GSL
Sbjct: 31 TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL---YAVVTQEPIYIITEYMENGSL 87
Query: 266 -DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
D L +G + N + +A A+G+ F+ + ++ + ANI + + K
Sbjct: 88 VDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCK 142
Query: 325 LSGYGCAGHIPETDISNSSVAAANL---SVETLERGLLTPKSNVWSFGIVLLELLT-GRK 380
++ +G A I + + + A + + E + G T KS+VWSFGI+L E++T GR
Sbjct: 143 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 381 NLDS-RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEP 439
+P+ +NL + R D+C L ++ C +++P
Sbjct: 203 PYPGMTNPEVIQNLERGYRMPRPDNCPEELY------------------ELMRLCWKEKP 244
Query: 440 SERPT---MRSIFEE 451
ERPT +RS+ E+
Sbjct: 245 EERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 59/246 (23%), Positives = 109/246 (44%), Gaps = 39/246 (15%)
Query: 217 SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP 276
S + F+ + + + +L+HPNL +LLG + ++ E + GSL + Y RS G
Sbjct: 41 STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSL--VDYLRSRGR 96
Query: 277 P-IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
I ++ AL +G+ +L E+ ++ + + N+ + +D AK+S +G A
Sbjct: 97 AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKE-- 151
Query: 336 ETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE 390
++ + L V E L + KS+VWSFGI+L E+ + + R P ++
Sbjct: 152 ----ASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207
Query: 391 --RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
++ K R M+ P V + C + +P++RPT + +
Sbjct: 208 VVPHVEKGYR------------MEA------PEGCPPEVYKVMKDCWELDPAKRPTFKQL 249
Query: 449 FEELDR 454
E+L
Sbjct: 250 REQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 51/248 (20%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY-ERLFHGSLDRLIYGR 272
S + ++ ++ L+SLQHPN+ + G RD + I+ E + GSL L+
Sbjct: 37 GDSEEELEALEREIRILSSLQHPNIVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLL--- 92
Query: 273 SDGPPIDWNTRVKIALCAAQ---GLTFLHEEG-------PFQAMYNEFSTANIQIDKDFS 322
+ I Q GL +LH G ANI +D D
Sbjct: 93 KKFGKLPEPV---IRKYTRQILEGLAYLHSNGIVHRDIKG----------ANILVDSDGV 139
Query: 323 AKLSGYGCAGHIPETDISNSSVAAAN----LSVETLERGLLTPKSNVWSFGIVLLELLTG 378
KL+ +GCA + + + + + ++ E + +++WS G ++E+ TG
Sbjct: 140 VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199
Query: 379 RKNLDSRHPKEERNLVKWSR--PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQ 436
+ P WS +A + I P + D +CL+
Sbjct: 200 ------KPP--------WSELGNPMAALYK---IGSSGEPPEIPEHLSEEAKDFLRKCLR 242
Query: 437 KEPSERPT 444
++P +RPT
Sbjct: 243 RDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 63/266 (23%), Positives = 115/266 (43%), Gaps = 35/266 (13%)
Query: 193 RASFGD-----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247
+ SFG+ D T K + L + +++ ++ L+ P + K G + +
Sbjct: 14 KGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73
Query: 248 DGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
D + +I E L GS LD L G P+D I +GL +LH E + +
Sbjct: 74 D--TKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKI 123
Query: 307 YNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--LSVETLERGLLTPKSN 364
+ + AN+ + + KL+ +G AG + +T I ++ ++ E +++ K++
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAA 424
+WS GI +EL G HP + L+ + P P L+G + +
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY----S 226
Query: 425 RTVADIALRCLQKEPSERPTMRSIFE 450
+ + + CL KEPS RPT + + +
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 35/262 (13%)
Query: 200 ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
A+ +K + V + P S V+ F+ + N + +LQH L KL HA + +I E
Sbjct: 25 ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL---HAVVTKEPIYIITEF 81
Query: 260 LFHGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318
+ GSL L + +SD G + + A+G+ F+ + ++ + ANI +
Sbjct: 82 MAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 136
Query: 319 KDFSAKLSGYGCAGHIPETDISNSSVAAANL---SVETLERGLLTPKSNVWSFGIVLLEL 375
K++ +G A I + + + A + + E + G T KS+VWSFGI+L+E+
Sbjct: 137 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 196
Query: 376 LT-GRKNLDS-RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALR 433
+T GR +P+ R L + R ++C P+ + +I +R
Sbjct: 197 VTYGRIPYPGMSNPEVIRALERGYRMPRPENC-------PE-----------ELYNIMMR 238
Query: 434 CLQKEPSERPT---MRSIFEEL 452
C + P ERPT ++S+ ++
Sbjct: 239 CWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 59/249 (23%), Positives = 106/249 (42%), Gaps = 40/249 (16%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP---- 276
K+F + L + QH N+ K G D ++++E + HG L++ + RS GP
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFL--RSHGPDAAF 108
Query: 277 ---------PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
+ + ++IA+ A G+ +L + ++ + +T N + D K+
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGD 165
Query: 328 YGCAGHIPETD---ISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383
+G + + TD + ++ + E++ T +S+VWSFG+VL E+ T K
Sbjct: 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
Query: 384 SRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
EE +C I +L R P V DI L C +++P +R
Sbjct: 226 YGLSNEE-----------VIEC----ITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRI 269
Query: 444 TMRSIFEEL 452
++ I E L
Sbjct: 270 NIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 68.2 bits (165), Expect = 2e-12
Identities = 63/252 (25%), Positives = 101/252 (40%), Gaps = 25/252 (9%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHP-NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
L S+ V+ F+ ++ LASL HP N+ KL F L+ E + GSL+ L+
Sbjct: 34 LESKSKEVERFLREIQILASLNHPPNIVKLYDF--FQDEGSLYLVMEYVDGGSLEDLLKK 91
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYGC 330
P+ + + I L +LH +G ++ + NI +D+D KL +G
Sbjct: 92 IGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGL 148
Query: 331 AGHIPETDISNSSVAAANLSVETL-----------ERGLLTPKSNVWSFGIVLLELLTGR 379
A +P+ ++S A + SV T + S++WS GI L ELLTG
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG- 207
Query: 380 KNLDSRHPKEERNLVKWSRPFLADDCRLSL-IMDPQLKGRFPLKAARTVADIALRCLQKE 438
P E + L L + L P ++ +D+ + L K+
Sbjct: 208 -----LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262
Query: 439 PSERPTMRSIFE 450
P R + S
Sbjct: 263 PKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 53/282 (18%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK----EFINDVNTLASLQHPNL 238
I E + +Y+ F + + F+ +G K N++ L + N+
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKK-------FHKGHKVLIDITENEIKNLRRIDSNNI 80
Query: 239 CKLLGFH--ARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
K+ GF D + LI E G L ++ D + + T++ +A+ +GL
Sbjct: 81 LKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYN 137
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER 356
L++ Y ++ + + +++ K+ C G E +S+ N V
Sbjct: 138 LYKY--TNKPYKNLTSVSFLVTENYKLKI---ICHGL--EKILSSPPFKNVNFMV-YFSY 189
Query: 357 GLL-------TPKSNVWSFGIVLLELLTGR---KNLDSRHPKEERNLVKWSRPFLADDCR 406
+L T K +++S G+VL E+ TG+ +NL + KE +L+ + +
Sbjct: 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLI------INKNNS 240
Query: 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
L L PL + I C + +RP ++ I
Sbjct: 241 LKL----------PLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 30/236 (12%)
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY--GRSDGPPIDW 280
F+ + + L H NL +LLG +G ++ E + G+L + GR+ I
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHNG---LYIVMELMSKGNLVNFLRTRGRALVSVIQL 102
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340
++ +L A+G+ +L + + ++ + + NI + +D AK+S +G A + +
Sbjct: 103 ---LQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLA-RVGSMGVD 155
Query: 341 NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399
NS + + E L+ + KS+VWS+G++L E+ + GR + +PK VK
Sbjct: 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR----APYPKMSLKEVK---- 207
Query: 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455
+ M+P P V + C + EP +RP+ + E+L+++
Sbjct: 208 ---ECVEKGYRMEP------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 55/266 (20%), Positives = 109/266 (40%), Gaps = 33/266 (12%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLL 242
I +G V+++ D + ++++N + +E I++ LA L + +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER--EEAIDEARVLAKLDSSYIIRYY 65
Query: 243 GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGP 302
G + ++ E +G L +L+ + G P+ + + + GL LH +
Sbjct: 66 ESFLDKG--KLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK-- 120
Query: 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI-PETDISNSSVAAAN-LSVETLERGLLT 360
+ ++ + + N+ +D + K+ G A + T+ +N+ V LS E E
Sbjct: 121 -KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 361 PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFP 420
KS+VW+ G+VL E TG +HP + N ++G FP
Sbjct: 180 EKSDVWALGVVLYECCTG------KHPFDANNQGALILKI--------------IRGVFP 219
Query: 421 ---LKAARTVADIALRCLQKEPSERP 443
++ +A + +CL K+ +RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRS-DGPPID 279
+F +V L L+H L+ A + +I E + GSL L + RS +G +
Sbjct: 48 DFQKEVQALKRLRHK---HLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLP 102
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339
+ + +A A+G+ +L E+ +++ + + NI + +D K++ +G A I E D+
Sbjct: 103 VASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DV 158
Query: 340 ---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395
S+ + + E G + KS+VWSFGI+L E+ T G+ + E + +
Sbjct: 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI- 217
Query: 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
R+ P P K + + I L C EP +RP+ +++ EELD
Sbjct: 218 ------TAGYRM-----PC-----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 47/258 (18%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY---ERLFHGSLD 266
V L P + + F+ + + L+H L +L +A + IY E + GSL
Sbjct: 35 VKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAV--CSEEEPIYIVTEYMSKGSL- 88
Query: 267 RLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325
L + +S G + V +A A+G+ +L ++ + + NI + ++ K+
Sbjct: 89 -LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKI 144
Query: 326 SGYGCAGHIPETDISNSSVAAAN----LSVETLERGLLTPKSNVWSFGIVLLELLT-GRK 380
+ +G A I E D + A + E G T KS+VWSFGI+L E++T GR
Sbjct: 145 ADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
Query: 381 NLDSRHPKE-----ERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
+E ER + RP +C P+ + D+ L+C
Sbjct: 204 PYPGMTNREVLEQVERGY-RMPRP---PNC-------PE-----------ELYDLMLQCW 241
Query: 436 QKEPSERPTMRSIFEELD 453
K+P ERPT + L+
Sbjct: 242 DKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 65/293 (22%), Positives = 124/293 (42%), Gaps = 45/293 (15%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRL-NPSSQGVKEFINDVNTLASLQHPNLC 239
R + EG ++ A + + T K V L +P+ K+F + L +LQH ++
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-------DGPPIDWNTRV------KI 286
K G DG D ++++E + HG L++ + DG P + I
Sbjct: 71 KFYGV-CGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 287 ALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI----SNS 342
A A G+ +L + ++ + +T N + + K+ +G + + TD ++
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 343 SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402
+ + E++ T +S+VWSFG++L E+ T K +P+
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK-----------------QPWF- 227
Query: 403 DDCRLSLIMDPQLKGRF---PLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
+ +++ +GR P + V DI L C Q+EP +R ++ I++ L
Sbjct: 228 -QLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 24/247 (9%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
Q + ++N L +L H N+ K G + G LI E + GSL +
Sbjct: 46 GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------ 99
Query: 276 PPIDWNTRVKIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P ++ L A Q G+ +LH + ++ + + N+ +D D K+ +G A
Sbjct: 100 -PKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
Query: 333 HIPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRH- 386
+PE + +VE L+ + S+VWSFG+ L ELLT + DS+
Sbjct: 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT---HCDSKQS 212
Query: 387 -PKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445
PK+ ++ + RL +++ ++ P + V + C + E RPT
Sbjct: 213 PPKKFEEMIGPKQG-QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271
Query: 446 RSIFEEL 452
RS+ L
Sbjct: 272 RSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 27/248 (10%)
Query: 202 TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLF 261
T K RL + K+ + +++ L P + G +G + E +
Sbjct: 25 TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG--DISICMEYMD 82
Query: 262 HGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321
GSLD+ I G I KIA+ +GLT+LHE+ + ++ + +NI ++
Sbjct: 83 GGSLDK-ILKEVQGR-IPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRG 138
Query: 322 SAKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRK 380
KL +G +G + ++ + V ++ ++ E ++ + KS++WS G+ L+EL TGR
Sbjct: 139 QIKLCDFGVSGQLVN-SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRF 197
Query: 381 NLDSRHPKEERNLVKWSRPFLADDCRLSLIMD---PQL-KGRFPLKAARTVADIALRCLQ 436
+ P L I++ P+L G+F V CL
Sbjct: 198 PYPP-----------ENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN----LCLI 242
Query: 437 KEPSERPT 444
K+P ERP+
Sbjct: 243 KDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 57/244 (23%), Positives = 103/244 (42%), Gaps = 41/244 (16%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
+F+ + + + HPN+ +L G + S M+I E + +GSLD+ + R +
Sbjct: 51 DFLTEASIMGQFDHPNIIRLEGVVTK--SRPVMIITEYMENGSLDK--FLRENDGKFTVG 106
Query: 282 TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISN 341
V + A G+ +L E + + + NI ++ + K+S +G + + +++ +
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSE-AT 162
Query: 342 SSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395
+ + + E + T S+VWSFGIV+ E+++ G ER
Sbjct: 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYG-----------ERPYWD 211
Query: 396 WSR----PFLADDCRLSLIMD-PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
S + D RL MD P + + L C QK+ +ERPT I
Sbjct: 212 MSNQDVIKAVEDGYRLPPPMDCPS-----------ALYQLMLDCWQKDRNERPTFSQIVS 260
Query: 451 ELDR 454
LD+
Sbjct: 261 TLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 38/196 (19%)
Query: 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322
GSLDR IY + G PI KIA+ +GLT+L+ + M+ + +NI ++
Sbjct: 88 GSLDR-IYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQ 142
Query: 323 AKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKN 381
KL +G +G + + I+++ V + +S E ++ G T KS+VWS GI ++EL G+
Sbjct: 143 IKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK-- 199
Query: 382 LDSRHPKEERNLVKWSRPFLADDCRLSL--IMD----------PQL-KGRFPLKAARTVA 428
++ + DD + I+D P+L FP V
Sbjct: 200 ------------FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD 247
Query: 429 DIALRCLQKEPSERPT 444
CL K+P+ERPT
Sbjct: 248 ----ACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 56/250 (22%), Positives = 107/250 (42%), Gaps = 32/250 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR----MLIYERLFHGSLDR-LIY 270
SS ++EF+ + + HPN+ KL+G R + R M+I + HG L L+
Sbjct: 41 SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM 100
Query: 271 GRSDGPPIDW--NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328
R P T V+ + A G+ +L + ++ + + N ++++ + ++ +
Sbjct: 101 SRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157
Query: 329 GCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLD 383
G + I D S + L++E+L + T S+VW+FG+ + E++T G+
Sbjct: 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217
Query: 384 SRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
E N LI +LK P V ++ +C EP RP
Sbjct: 218 GVENSEIYNY---------------LIKGNRLKQ--PPDCLEDVYELMCQCWSPEPKCRP 260
Query: 444 TMRSIFEELD 453
+ + + ++L+
Sbjct: 261 SFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 56/271 (20%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI---- 269
N SS +++ +++ N L + HP++ KL G ++DG +LI E +GSL +
Sbjct: 41 NASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRSFLRESR 98
Query: 270 -----YGRSDGP------------PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312
Y SDG + + A ++G+ +L E + ++ + +
Sbjct: 99 KVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAA 155
Query: 313 ANIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSF 368
N+ + + K+S +G + + E D S + +++E+L + T +S+VWSF
Sbjct: 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215
Query: 369 GIVLLELLT-GRKNLDSRHPKEERNLVK----WSRPFLADDCRLSLIMDPQLKGRFPLKA 423
G++L E++T G P+ NL+K RP ++C
Sbjct: 216 GVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---ENC------------------ 254
Query: 424 ARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ + ++ L C ++EP +RPT I +EL++
Sbjct: 255 SEEMYNLMLTCWKQEPDKRPTFADISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (151), Expect = 1e-10
Identities = 67/285 (23%), Positives = 111/285 (38%), Gaps = 71/285 (24%)
Query: 195 SFGD-----DASTSKKFEATVTRLNPSSQGVKEF-INDVNTLASLQHPNLCKLLGFHARD 248
SFG S K + L+ S+ +E +N+V L L HPN+ K
Sbjct: 12 SFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71
Query: 249 GSDQRMLI---Y-ERLFHGSLDRLIY-GRSDGPPID----WNTRVKIALCAAQGLTFLHE 299
G ++ I Y + G L + I + +G P + V++ L L +LH
Sbjct: 72 G---KLCIVMEYADG---GDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLHS 121
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS---NSSVAAAN-------- 348
+ ++ + NI + + KL +G IS +S+V A
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFG---------ISKVLSSTVDLAKTVVGTPYY 169
Query: 349 LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408
LS E + KS++WS G VL EL T + PF ++ L
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLK------------------HPFEGEN--LL 209
Query: 409 LIMDPQLKGRF---PLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ LKG++ P + + + ++ LQK+P ERP++ I +
Sbjct: 210 ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 61/286 (21%), Positives = 119/286 (41%), Gaps = 31/286 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRL-NPSSQGVKEFINDVNTLASLQHPNLC 239
+ + EG + D + K +L + ++EF+++ + HPN+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 240 KLLGFHARDGSDQR----MLIYERLFHGSLDR-LIYGRSDGPP--IDWNTRVKIALCAAQ 292
KL+G S Q+ M+I + HG L L+Y R G P + T +K + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN---- 348
G+ +L ++ + + N + +D + ++ +G + I D A
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 349 LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408
+++E+L + T KS+VW+FG+ + E+ T + + +P E + + +L RL
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQ---TPYPGVENHEI---YDYLRHGNRL- 234
Query: 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ P + D+ C + +P +RPT + E L+
Sbjct: 235 ---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 62/279 (22%), Positives = 121/279 (43%), Gaps = 39/279 (13%)
Query: 195 SFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254
+ D+A V R + S ++F+ +V L+ L PN+ +LLG D
Sbjct: 38 AENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD--PPLC 95
Query: 255 LIYERLFHGSLDRLIYGR--------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
+I E + +G L++ + + + ++T + +A A G+ +L E F +
Sbjct: 96 MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLNF--V 152
Query: 307 YNEFSTANIQIDKDFSAKLSGYGCAGHIPETD---ISNSSVAAAN-LSVETLERGLLTPK 362
+ + +T N + K+++ K++ +G + ++ +D + + ++ E++ G T K
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212
Query: 363 SNVWSFGIVLLELLTGRKNLDSRHPKEE-------RNLVKWSRPFLADDCRLSLIMDPQL 415
S+VW+FG+ L E+LT L P E N F D ++ L P
Sbjct: 213 SDVWAFGVTLWEILT----LCREQPYEHLTDQQVIENA---GHFFRDDGRQIYLPRPPN- 264
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ + ++ L C +++ +RPT R I L R
Sbjct: 265 -------CPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 54/252 (21%), Positives = 102/252 (40%), Gaps = 32/252 (12%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGR 272
N S + EF+N+ + + ++ +LLG + +++ E + G L L R
Sbjct: 47 NASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQPTLVVMELMAKGDLKSYLRSRR 104
Query: 273 SD------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
+ P +++A A G+ +L + + ++ + + N + +D + K+
Sbjct: 105 PEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161
Query: 327 GYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNL 382
+G I ETD + ++ E+L+ G+ T KS+VWSFG+VL E+ T
Sbjct: 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT----- 216
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
L + L+++ L ++D P + ++ C Q P R
Sbjct: 217 ----------LAEQPYQGLSNEEVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMR 265
Query: 443 PTMRSIFEELDR 454
PT I L
Sbjct: 266 PTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 46/194 (23%), Positives = 91/194 (46%), Gaps = 19/194 (9%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
V R S + KE +++ +AS+ HP++ +LLG S Q LI + + G L
Sbjct: 43 VLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL---SSQVQLITQLMPLGCLLD-- 97
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
Y R+ I + + A+G+++L E+ ++ + + N+ + K++ +G
Sbjct: 98 YVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFG 154
Query: 330 CAGHIPETDISNSSVAAAN-------LSVETLERGLLTPKSNVWSFGIVLLELLT-GRKN 381
A + D+ A +++E++ + T KS+VWS+G+ + EL+T G K
Sbjct: 155 LAKLL---DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
Query: 382 LDSRHPKEERNLVK 395
+ E +L++
Sbjct: 212 YEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 68/282 (24%), Positives = 120/282 (42%), Gaps = 34/282 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNL 238
R I +G +Y + D S +K V LN + V++F+ + + HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLID--SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 239 CKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
LLG +GS +L Y + HG L I + P + + L A+G+ +L
Sbjct: 59 LSLLGICLPSEGSPLVVLPY--MKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYL 114
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI-SNSSVAAANLSV----- 351
+ + ++ + + N +D+ F+ K++ +G A I + + S + A L V
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
E+L+ T KS+VWSFG++L EL+T P + + + +L RL
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVDSFDITV-YLLQGRRL---- 221
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
Q P + ++ L C +P RPT + ++
Sbjct: 222 -LQ-----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 57/266 (21%), Positives = 112/266 (42%), Gaps = 35/266 (13%)
Query: 193 RASFGD-----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247
+ SFG+ D T + + L + +++ ++ L+ P + + G + +
Sbjct: 14 KGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK 73
Query: 248 DGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
+ +I E L GS LD L G P++ I +GL +LH E + +
Sbjct: 74 --GTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKI 123
Query: 307 YNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--LSVETLERGLLTPKSN 364
+ + AN+ + + KL+ +G AG + +T I ++ ++ E +++ K++
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAA 424
+WS GI +EL G HP L+ + P P L+G++ +
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQY----S 226
Query: 425 RTVADIALRCLQKEPSERPTMRSIFE 450
+ + CL K+P RPT + + +
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 28/197 (14%)
Query: 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322
GSLD+L G I + +I +GL FL EE ++ + N+ ++ +
Sbjct: 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQ 141
Query: 323 AKLSGYGCAGH----IPETDIS-NSSVAAANLSVETL-ERGLLTPKSNVWSFGIVLLELL 376
KL +G +G+ + +T+I S +A + + T +S+VWS G+ +LE+
Sbjct: 142 VKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201
Query: 377 TGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD---PQLKGRFPLKAARTVADIALR 433
GR +P E ++ F +LS I+D P L P + D +
Sbjct: 202 LGR----YPYPPE-----TYANIF----AQLSAIVDGDPPTL----PSGYSDDAQDFVAK 244
Query: 434 CLQKEPSERPTMRSIFE 450
CL K P+ RPT + E
Sbjct: 245 CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 54/242 (22%), Positives = 103/242 (42%), Gaps = 32/242 (13%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG-RSDG----- 275
EF+N+ + + ++ +LLG ++ +++ E + HG L + R +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112
Query: 276 -PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334
PP +++A A G+ +L+ + + ++ + + N + DF+ K+ +G I
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 169
Query: 335 PETDISNSS----VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE 390
ETD + ++ E+L+ G+ T S++WSFG+VL E+ +
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------------- 216
Query: 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
L + L+++ L +MD + P V D+ C Q P RPT I
Sbjct: 217 --LAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
Query: 451 EL 452
L
Sbjct: 274 LL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 63/266 (23%), Positives = 113/266 (42%), Gaps = 35/266 (13%)
Query: 193 RASFGD-----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247
+ SFG+ D T + + L + +++ ++ L+ P + K G + +
Sbjct: 14 KGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73
Query: 248 DGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
+ +I E L GS LD L G D I T +K L +GL +LH E + +
Sbjct: 74 --GTKLWIIMEYLGGGSALDLLRAGPFDEFQI--ATMLKEIL---KGLDYLHSE---KKI 123
Query: 307 YNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--LSVETLERGLLTPKSN 364
+ + AN+ + + KL+ +G AG + +T I ++ ++ E +++ K++
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAA 424
+WS GI +EL G HP L+ + P P L G F +
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLTGEF----S 226
Query: 425 RTVADIALRCLQKEPSERPTMRSIFE 450
+ + CL K+PS RPT + + +
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 48/242 (19%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY-ERLFHGSLDRLI--YGR 272
+ VK+ ++ L+ LQHPN+ + LG R+ + I+ E + GSL +L+ YG
Sbjct: 42 GQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREED--NLYIFLELVPGGSLAKLLKKYGS 98
Query: 273 SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P I TR +I L GL +LH+ ++ + ANI +D + KL+ +G A
Sbjct: 99 FPEPVIRLYTR-QILL----GLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK 150
Query: 333 HIPETDISNSSVAAAN-LSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE 390
+ E + S + ++ E + + G +++WS G +LE+ TG+ P +
Sbjct: 151 QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP------PWSQ 204
Query: 391 RNLVKW--------SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
V P + D + + K D L+CLQ++PS R
Sbjct: 205 LEGVAAVFKIGRSKELPPIPDH------LSDEAK------------DFILKCLQRDPSLR 246
Query: 443 PT 444
PT
Sbjct: 247 PT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 48/236 (20%), Positives = 94/236 (39%), Gaps = 30/236 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
+FI + + L HPNL +L G + ++ E + +G L + R +W
Sbjct: 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKGKLGTEWL 102
Query: 282 TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISN 341
+ +C + + +L G ++ + + N + +D K+S +G A ++ D
Sbjct: 103 LDMCSDVC--EAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV--LDDQY 155
Query: 342 SSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396
+S V E + + KS+VWSFG+++ E+ + K P E ++
Sbjct: 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM-----PYE-----RF 205
Query: 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
S + + + P A V I C ++P +RP + + +L
Sbjct: 206 SNSEVVESVSAGYRLYR------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 32/245 (13%)
Query: 211 TRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY 270
T NP Q K+ + ++ S + P + K G + S + E GSLD IY
Sbjct: 36 TDPNPDLQ--KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IY 92
Query: 271 G--RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328
+ G I KIA +GL++LH + ++ + +NI + + KL +
Sbjct: 93 KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDF 149
Query: 329 GCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
G +G + + + + ++ E ++ + S+VWS G+ LLE+ R P+
Sbjct: 150 GVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PE 206
Query: 389 EERNL---------VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEP 439
E L V P L D +P +K + D +CL+K+P
Sbjct: 207 GEPPLGPIELLSYIVNMPNPELKD--------EPGNG----IKWSEEFKDFIKQCLEKDP 254
Query: 440 SERPT 444
+ RPT
Sbjct: 255 TRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 63/291 (21%), Positives = 121/291 (41%), Gaps = 40/291 (13%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASL 233
HN R + EG ++ A + K V L +S K+F + L +L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP------------PIDWN 281
QH ++ K G D ++++E + HG L++ + R+ GP + +
Sbjct: 65 QHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNRPAELTQS 120
Query: 282 TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI-- 339
+ IA A G+ +L + ++ + +T N + ++ K+ +G + + TD
Sbjct: 121 QMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 340 --SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397
++ + + E++ T +S+VWS G+VL E+ T K W
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ-------------PWY 224
Query: 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
+ L+++ + I ++ R P + V D+ L C Q+EP R ++ I
Sbjct: 225 Q--LSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 62/276 (22%), Positives = 106/276 (38%), Gaps = 59/276 (21%)
Query: 199 DASTSKKFEATVTRLNPS--SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256
S K V L S + +F+ + + SL H NL +L G + M++
Sbjct: 17 STSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL---THPLMMV 73
Query: 257 YERLFHGSL-DRLIYGRSDGPPID-----WNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310
E GSL DRL R D + V+I A G+ +L + + ++ +
Sbjct: 74 TELAPLGSLLDRL---RKDALGHFLISTLCDYAVQI----ANGMRYLESK---RFIHRDL 123
Query: 311 STANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-------ETLERGLLTPKS 363
+ NI + D K+ +G +P+ + + V +L V E+L + S
Sbjct: 124 AARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCAPESLRTRTFSHAS 181
Query: 364 NVWSFGIVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416
+VW FG+ L E+ T G K ++ + RP + C PQ
Sbjct: 182 DVWMFGVTLWEMFTYGEEPWAGLSGSQILK-KIDKEGERLERP---EAC-------PQ-- 228
Query: 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
+ ++ L+C P++RPT ++ E L
Sbjct: 229 ---------DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 58/259 (22%), Positives = 115/259 (44%), Gaps = 39/259 (15%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ + + + + ++++ + + +H N+ LLG ++G ++ E HG+L + R
Sbjct: 53 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP--LYVVVEYAAHGNLRDFLRAR 110
Query: 273 ----------SDGPPIDWNTRVKIALCA---AQGLTFLHEEGPFQAMYNEFSTANIQIDK 319
PP + T+ + A A+G+ FL + + ++ + + N+ + +
Sbjct: 111 RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167
Query: 320 DFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLEL 375
D K++ +G A I D +N + ++ E L + T +S+VWSFG++L E+
Sbjct: 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227
Query: 376 LTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
T + P EE L K L + R M+ P + + + C
Sbjct: 228 FTLGGSPYPGIPVEE--LFK----LLKEGYR----MEK------PQNCTQELYHLMRDCW 271
Query: 436 QKEPSERPTMRSIFEELDR 454
+ PS+RPT + + E+LDR
Sbjct: 272 HEVPSQRPTFKQLVEDLDR 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 34/237 (14%)
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP-IDWN 281
F+ + + + L+H NL +LLG + ++ E + GSL + Y RS G + +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSL--VDYLRSRGRSVLGGD 102
Query: 282 TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISN 341
+K +L + + +L E F ++ + + N+ + +D AK+S +G T
Sbjct: 103 CLLKFSLDVCEAMEYL-EANNF--VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DT 158
Query: 342 SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPF 400
+ + E L + KS+VWSFGI+L E+ + GR V + R
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIP 204
Query: 401 LADDCRLSLIMDPQLKGRFPLKA----ARTVADIALRCLQKEPSERPTMRSIFEELD 453
L D + P+++ + + A V D+ +C + + RP+ + E+L+
Sbjct: 205 LKD-------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 59/258 (22%), Positives = 108/258 (41%), Gaps = 41/258 (15%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
+ V L P + V+ F+ + N + +LQH L +L ++ + +I E + GSL
Sbjct: 32 KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYIITEYMAKGSL- 88
Query: 267 RLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325
L + +SD G + + + A+G+ ++ + ++ + AN+ + + K+
Sbjct: 89 -LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI 144
Query: 326 SGYGCAGHIPETDISNSSVAAANL---SVETLERGLLTPKSNVWSFGIVLLELLT----- 377
+ +G A I + + + A + + E + G T KS+VWSFGI+L E++T
Sbjct: 145 ADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
Query: 378 --GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
G N D L + R ++C L DI C
Sbjct: 205 YPGMSNSDVM-----SALQRGYRMPRMENCPDELY------------------DIMKTCW 241
Query: 436 QKEPSERPTMRSIFEELD 453
+++ ERPT + LD
Sbjct: 242 KEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 59/250 (23%), Positives = 110/250 (44%), Gaps = 30/250 (12%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
V R N S + KE +++ +A + P +C+LLG + L+ + + +G L L
Sbjct: 43 VLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL---TSTVQLVTQLMPYGCL--LD 97
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
Y R + I + + A+G+++L E + ++ + + N+ + K++ +G
Sbjct: 98 YVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFG 154
Query: 330 CAG--HIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDS 384
A I ET+ V +++E++ T +S+VWS+G+ + EL+T G K D
Sbjct: 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
+E +L++ RL PQ P V I ++C + RP
Sbjct: 215 IPAREIPDLLEKGE-------RL-----PQ-----PPICTIDVYMIMVKCWMIDSECRPR 257
Query: 445 MRSIFEELDR 454
R + +E R
Sbjct: 258 FRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 63/271 (23%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKL 241
I +G S +Y A D +T + E + ++N Q KE I N++ + ++PN+
Sbjct: 28 IGQGASGTVYTAM---DVATGQ--EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
L + D+ ++ E L GSL ++ +D + Q L FLH
Sbjct: 83 LDSYLV--GDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN- 135
Query: 302 PFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAAN-LSVETLERGLL 359
Q ++ + + NI + D S KL+ +G CA PE ++ V ++ E + R
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
PK ++WS GI+ +E++ G + +P L+ + P+L+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-------------TPELQN-- 238
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFE 450
P K + D RCL + +R + + + +
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 51/254 (20%), Positives = 112/254 (44%), Gaps = 26/254 (10%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
R + + +F+ ++ ++ L++PN+ +LLG D D +I E + +G L++ +
Sbjct: 53 RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQ 110
Query: 272 R---------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322
R ++ P + + +A+ A G+ +L ++ + +T N + ++
Sbjct: 111 REIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYT 167
Query: 323 AKLSGYGCAGHIPETD---ISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTG 378
K++ +G + ++ D I +V ++ E++ G T S+VW+FG+ L E+ T
Sbjct: 168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
K +E+ +++ + F + R + L V + +RC ++
Sbjct: 228 CKEQPYSLLSDEQ-VIENTGEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRD 279
Query: 439 PSERPTMRSIFEEL 452
+RPT I L
Sbjct: 280 IKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 58/269 (21%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-- 273
S+ +F + +A HPN+ KLLG A L++E + +G L+ + RS
Sbjct: 48 SADMQADFQREAALMAEFDHPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRHRSPR 105
Query: 274 ---------------DGPPIDWNT--RVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316
P+ + ++ IA A G+ +L E + ++ + +T N
Sbjct: 106 AQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162
Query: 317 IDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVL 372
+ ++ K++ +G + +I D N ++ + E++ T +S+VW++G+VL
Sbjct: 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222
Query: 373 LELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAAR 425
E+ + G + + + + N++ S P D+C L L
Sbjct: 223 WEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCP---DNCPLELY--------------- 262
Query: 426 TVADIALRCLQKEPSERPTMRSIFEELDR 454
++ C K PS+RP+ SI L R
Sbjct: 263 ---NLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 51/246 (20%), Positives = 92/246 (37%), Gaps = 62/246 (25%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
K+ + ++ TL S + P + K G ++G ++ E + GSL L+ + G
Sbjct: 44 KQLLRELKTLRSCESPYVVKCYGAFYKEGEIS--IVLEYMDGGSLADLL--KKVGK---I 96
Query: 281 NTRV--KIALCAAQGLTFLHEE--------GPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330
V IA +GL +LH + P +N+ I+ K++ +G
Sbjct: 97 PEPVLAYIARQILKGLDYLHTKRHIIHRDIKP----------SNLLINSKGEVKIADFGI 146
Query: 331 AGHIPET-DISNSSVA-AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
+ + T D N+ V +S E ++ + +++WS G+ LLE G + P
Sbjct: 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG------KFPF 200
Query: 389 EERNLVKW----------SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
+ P L + P+ + D CLQK+
Sbjct: 201 LPPGQPSFFELMQAICDGPPPSLPAEE-----FSPEFR------------DFISACLQKD 243
Query: 439 PSERPT 444
P +RP+
Sbjct: 244 PKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 34/272 (12%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKL 241
I +G S +Y A D +T + E + ++N Q KE I N++ + ++PN+
Sbjct: 27 IGQGASGTVYTAI---DIATGQ--EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
L + D+ ++ E L GSL ++ +D + Q L FLH
Sbjct: 82 LDSYLV--GDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSN- 134
Query: 302 PFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAAN-LSVETLERGLL 359
Q ++ + + NI + D S KL+ +G CA PE ++ V ++ E + R
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-RPFLADDCRLSLIMDPQLKGR 418
PK ++WS GI+ +E++ G + +P L+ + P L + RLS +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF------- 245
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
D RCL+ + R + + + +
Sbjct: 246 ---------RDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 60/250 (24%), Positives = 107/250 (42%), Gaps = 37/250 (14%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
V L P + K+F+ + + L+HP L +L + + ++ E + +GSL L
Sbjct: 35 VKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIVTELMKYGSL--LE 90
Query: 270 Y-GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328
Y G + + +A A G+ +L + ++ + + N+ + ++ K++ +
Sbjct: 91 YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADF 147
Query: 329 GCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382
G A I E DI + A + E + KS+VWSFGI+L E++T GR
Sbjct: 148 GLARVIKE-DIYEAREGA-KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
E L + + + R+ P P + + DI L C +++P +R
Sbjct: 206 PGMTNAEV--LQQVDQGY-----RM-----PC-----PPGCPKELYDIMLDCWKEDPDDR 248
Query: 443 PTMRSIFEEL 452
PT FE L
Sbjct: 249 PT----FETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 62/271 (22%), Positives = 116/271 (42%), Gaps = 32/271 (11%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKL 241
I +G S ++ A D +T + E + ++N Q KE I N++ + L++PN+
Sbjct: 27 IGQGASGTVFTAI---DVATGQ--EVAIKQINLQKQPKKELIINEILVMKELKNPNIVNF 81
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
L D+ ++ E L GSL ++ +D + Q L FLH
Sbjct: 82 LDSFLV--GDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVCRECLQALEFLHAN- 134
Query: 302 PFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAAN-LSVETLERGLL 359
Q ++ + + N+ + D S KL+ +G CA PE ++ V ++ E + R
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
PK ++WS GI+ +E++ G + +P L+ + P+L+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-------------TPELQN-- 237
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFE 450
P K + D RCL+ + +R + + + +
Sbjct: 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 39/173 (22%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI--YGRSDGPP 277
VK +++ TL L H N+ + LGF + + E + GS+ + YGR +
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYLGFE--TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 278 IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + T + +GL +LH +G ++ + N+ +D D K+S +G + +
Sbjct: 110 VRFFTEQVL-----EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---S 158
Query: 338 DISNSSVAAANLS----------VETLERGLLTPKSNVWSFGIVLLELLTGRK 380
D + ++ + + +G + K ++WS G V+LE+ GR+
Sbjct: 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 60/284 (21%), Positives = 125/284 (44%), Gaps = 26/284 (9%)
Query: 182 CISEGLSSVMYRASFGDDASTSKKFEATVT-RLNPSSQGVKEFINDVNTLASLQHPNLCK 240
C +EG+ M + D + A R + + +F+ ++ ++ L+ PN+ +
Sbjct: 24 CEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIY--------GRSDGPPIDWNTRVKIALCAAQ 292
LL D +I E + +G L++ + ++D I ++T + +A A
Sbjct: 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD---ISNSSVAAAN- 348
G+ +L ++ + +T N + K+++ K++ +G + ++ D I +V
Sbjct: 142 GMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW 198
Query: 349 LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408
+S E++ G T S+VW+FG+ L E+LT K +E+ +++ + F D R
Sbjct: 199 MSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGEFFRDQGRQV 257
Query: 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
+ P L ++ + L C ++ ERP+ + I L
Sbjct: 258 YLPKPAL-------CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 43/188 (22%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 285 KIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSV 344
KI++ +GLT+L E+ + M+ + +NI ++ KL +G +G + ++ ++NS V
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV 159
Query: 345 AAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGR--------KNLDSRHPKEERNLV- 394
+ +S E L+ T +S++WS G+ L+E+ GR K L++ +
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA 219
Query: 395 ---KWSRPFLADDCR--------LSLIMD---PQLKGRFPLKAARTVADIALRCLQKEPS 440
D L I++ P+L + D +CL+K P
Sbjct: 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGA---FSDEFQDFVDKCLKKNPK 276
Query: 441 ERPTMRSI 448
ER ++ +
Sbjct: 277 ERADLKEL 284
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKL 241
I +G S +Y A D +T + E + ++N Q KE I N++ + +HPN+
Sbjct: 27 IGQGASGTVYTAI---DVATGQ--EVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAA------QGLT 295
L + D+ ++ E L GSL ++ T + AA Q L
Sbjct: 82 LDSYLV--GDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALE 129
Query: 296 FLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAAN-LSVET 353
FLH Q ++ + + NI + D S KL+ +G CA PE ++ V ++ E
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
Query: 354 LERGLLTPKSNVWSFGIVLLELLTG 378
+ R PK ++WS GI+ +E++ G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 36/246 (14%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL- 265
+ V L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 32 KVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL---YAVVSEEPIYIVTEYMSKGSLL 88
Query: 266 DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325
D L G +G + V +A A G+ ++ ++ + +ANI + K+
Sbjct: 89 DFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKI 143
Query: 326 SGYGCAGHIPETDISNSSVAAANLSVETLERGL---LTPKSNVWSFGIVLLELLT-GR-- 379
+ +G A I + + + A + E L T KS+VWSFGI+L EL+T GR
Sbjct: 144 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
Query: 380 -KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
+++R E+ + + R DC +SL ++ L+C +K+
Sbjct: 204 YPGMNNREVLEQ--VERGYRMPCPQDCPISL------------------HELMLQCWKKD 243
Query: 439 PSERPT 444
P ERPT
Sbjct: 244 PEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 29/236 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
+F+ + L HPN+ +L+G + Q + I L G D L + R++GP +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQK---QPIYIVMELVQGG-DFLTFLRTEGPRLKVK 94
Query: 282 TRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISN 341
+++ AA G+ +L + ++ + + N + + K+S +G + E +
Sbjct: 95 ELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYA 150
Query: 342 SSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396
S+ + V E L G + +S+VWSFGI+L E + L + N +
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS----LGAVPYANLSN--QQ 204
Query: 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
+R + RL P V + RC + +P +RP+ ++ +EL
Sbjct: 205 TREAIEQGVRLPC----------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 59/258 (22%), Positives = 105/258 (40%), Gaps = 41/258 (15%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + +++F+ +++ L+ +HPN+ L + + +LI E G+LD ++ G
Sbjct: 42 SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-KLWILI-EFCDGGALDSIMLELERG 99
Query: 276 ---PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P I + R + + L FLH + ++ + NI + D KL+ +G +
Sbjct: 100 LTEPQIRYVCRQML-----EALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA 151
Query: 333 HIPETDISNSS-------VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSR 385
T + +A ++ ET + K+++WS GI L+EL
Sbjct: 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
Query: 386 HPKEERNLVKW--SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
+P R L+K S P P L P K + + D CL K+P +RP
Sbjct: 212 NPM--RVLLKILKSEP-------------PTLDQ--PSKWSSSFNDFLKSCLVKDPDDRP 254
Query: 444 TMRSIFEE--LDRQESRK 459
T + + + Q K
Sbjct: 255 TAAELLKHPFVSDQSDNK 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 50/253 (19%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG----RSDGP 276
KEF+ + + +++ HPN+ KLLG ++ + +I E + G L + R P
Sbjct: 44 KEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPP 101
Query: 277 PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI-----QIDKDFSAKLSGYGCA 331
+ + I L A+G +L E+ F ++ + + N D D K+ +G A
Sbjct: 102 LLTLKELLDICLDVAKGCVYL-EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
Query: 332 GHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-------GRK 380
I ++D + ++ E+L G T +S+VWSFG+++ E+LT
Sbjct: 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
Query: 381 NLDS-RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEP 439
N + +H L K P + + C ++P
Sbjct: 219 NQEVLQHVTAGGRLQK------------------------PENCPDKIYQLMTNCWAQDP 254
Query: 440 SERPTMRSIFEEL 452
SERPT I E L
Sbjct: 255 SERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 42/291 (14%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK-EFINDVNTLASLQHPNLCKL 241
+ EG ++ A + K V L +S+ + +F + L LQH ++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP--------------PIDWNTRVKIA 287
G +G ++++E + HG L+R + RS GP + + IA
Sbjct: 73 YGV-CTEG-RPLLMVFEYMRHGDLNRFL--RSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 288 LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI----SNSS 343
A G+ +L ++ + +T N + + K+ +G + I TD +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 344 VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403
+ + E++ T +S++WSFG+VL E+ T K W + L++
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ-------------PWYQ--LSN 230
Query: 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ I + R P V I C Q+EP +R ++ I L
Sbjct: 231 TEAIECITQGRELER-PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 63/287 (21%), Positives = 124/287 (43%), Gaps = 37/287 (12%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKL 241
I EG + ++ A+ D ST ++ V +++ Q +E + N+V + QHPN+ ++
Sbjct: 27 IGEGSTGIVCIAT---DKSTGRQ--VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 242 LGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
+ D+ ++ E L G+L D + + R + I + L + L+FLH +
Sbjct: 82 YSSYLVG--DELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHAQ 134
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAAN-LSVETLERGL 358
G ++ + + +I + D KLS +G CA E S V ++ E + R
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
+ ++WS GI+++E++ G + P + ++ + P P+LK
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-------------PKLKN- 237
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSSTV 465
K + + R L ++P++R T E L+ K+ +
Sbjct: 238 -LHKVSPRLRSFLDRMLVRDPAQRATA---AELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 51/247 (20%), Positives = 98/247 (39%), Gaps = 36/247 (14%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD- 274
Q +E + + + SL H + +LLG L+ + GSL + D
Sbjct: 49 GRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GASLQLVTQLSPLGSLLDHVRQHRDS 105
Query: 275 -GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333
P N V+IA +G+ +L E ++ + NI + D +++ +G A
Sbjct: 106 LDPQRLLNWCVQIA----KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158
Query: 334 IPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPK 388
+ D S +++E++ G T +S+VWS+G+ + E+++ G + P
Sbjct: 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
Query: 389 EERNLV-KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS 447
E +L+ K R C + + M + ++C + + RPT +
Sbjct: 219 EVPDLLEKGERLAQPQICTIDVYM------------------VMVKCWMIDENVRPTFKE 260
Query: 448 IFEELDR 454
+ E R
Sbjct: 261 LANEFTR 267
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 50/300 (16%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLC 239
I EG + RA D K A + L S ++F ++ L L HPN+
Sbjct: 10 IGEGNFGQVIRAMIKKDGL---KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 240 KLLGFHARDGSDQRMLIY---ERLFHGSL------DRLI-----YGRSDGPPIDWNTR-- 283
LLG + R +Y E +G+L R++ + + G ++
Sbjct: 67 NLLG-----ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 284 VKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA-GHIPETDISNS 342
++ A A G+ +L E+ Q ++ + + N+ + ++ ++K++ +G + G +
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178
Query: 343 SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402
+ +++E+L + T KS+VWSFG++L E+++ P+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-----------------LGGTPYCG 221
Query: 403 DDCRLSLIMDPQ-LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR-QESRKS 460
C PQ + P V ++ +C + P ERP I +L R E+RK+
Sbjct: 222 MTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 34/245 (13%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
+ L P + + F+ + + L+H L +L +A + ++ E + GSL
Sbjct: 32 RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLL 88
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
+ G G + V +A A G+ ++ ++ + ANI + ++ K++
Sbjct: 89 DFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 144
Query: 327 GYGCAGHIPETDISNSSVAAANL---SVETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382
+G A I + + + A + + E G T KS+VWSFGI+L EL T GR
Sbjct: 145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG-RFPL--KAARTVADIALRCLQKEP 439
+E ++D +G R P + ++ D+ +C +KEP
Sbjct: 205 PGMVNRE--------------------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 244
Query: 440 SERPT 444
ERPT
Sbjct: 245 EERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 73/285 (25%), Positives = 110/285 (38%), Gaps = 45/285 (15%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKL 241
I +G +Y+ + D S A V L+P S +E + N L SL HPN+ K
Sbjct: 30 IGKGTYGKVYKVTNKKDGS-----LAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 242 LG-FHARDG--SDQRMLIYERLFHGSLDRLIYG------RSDGPPIDWNTRVKIALCAAQ 292
G F+ D Q L+ E GS+ L+ G R D I + I A
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY-----ILYGALL 139
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS-NSSV------A 345
GL LH + ++ + NI + + KL +G + + T + N+SV A
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196
Query: 346 AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405
++ E + +VWS GI +EL G L HP + L K R
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFKIPR------- 247
Query: 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+P P K R+ +CL K+ RP++ + E
Sbjct: 248 ------NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 56/252 (22%), Positives = 101/252 (40%), Gaps = 38/252 (15%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
R S + + F+ + TL H N+ +L G R + M++ E + +G+LD +
Sbjct: 42 RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSNGALDSFL-- 97
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
R + + + A G+ +L E G ++ + + ++ D K+SG+
Sbjct: 98 RKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR-- 152
Query: 332 GHIPE-------TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT--GRKNL 382
+ E T +S S + E ++ + S+VWSFGIV+ E+++ R
Sbjct: 153 -RLQEDKSEAIYTTMSGKSPVLWA-APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
D ++++K + D RL P + + L C QKE ER
Sbjct: 211 DMSG----QDVIK----AVEDGFRLPA----------PRNCPNLLHQLMLDCWQKERGER 252
Query: 443 PTMRSIFEELDR 454
P I L +
Sbjct: 253 PRFSQIHSILSK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 57/255 (22%), Positives = 105/255 (41%), Gaps = 38/255 (14%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR--MLIYERLFH 262
+++ + + S EFI + + L H L +L G + QR ++ E + +
Sbjct: 28 QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV----CTKQRPIYIVTEYMSN 83
Query: 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322
G L L Y R G + +++ +G+ +L + Q ++ + + N +D
Sbjct: 84 GCL--LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGC 138
Query: 323 AKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT 377
K+S +G + ++ + D SSV + V E L + KS+VW+FG+++ E+ +
Sbjct: 139 VKVSDFGLSRYVLD-DEYTSSV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQK 437
K R E ++ RL P L A+ V I C +
Sbjct: 197 LGKMPYERFNNSETVE------KVSQGLRL---YRPHL-------ASEKVYAIMYSCWHE 240
Query: 438 EPSERPTMRSIFEEL 452
+ ERPT F++L
Sbjct: 241 KAEERPT----FQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 63/282 (22%), Positives = 119/282 (42%), Gaps = 47/282 (16%)
Query: 205 KFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY---E 258
+ +A + R+ S ++F ++ L L HPN+ LLG + R +Y E
Sbjct: 34 RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG-----ACEHRGYLYLAIE 88
Query: 259 RLFHGSL-DRLIYGR------------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQA 305
HG+L D L R S + + A A+G+ +L ++ Q
Sbjct: 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QF 145
Query: 306 MYNEFSTANIQIDKDFSAKLSGYGCA-GHIPETDISNSSVAAANLSVETLERGLLTPKSN 364
++ + + NI + +++ AK++ +G + G + + +++E+L + T S+
Sbjct: 146 IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD 205
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ-LKGRFPLKA 423
VWS+G++L E+++ P+ C PQ + PL
Sbjct: 206 VWSYGVLLWEIVS-----------------LGGTPYCGMTCAELYEKLPQGYRLEKPLNC 248
Query: 424 ARTVADIALRCLQKEPSERPTMRSIFEELDRQ-ESRKSSSST 464
V D+ +C +++P ERP+ I L+R E RK+ +T
Sbjct: 249 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 290
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS--DGP--- 276
EF + ++ LQHPN+ LLG ++ +++E L HG L + S
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKE--QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 277 --------PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328
+D + + IA+ A G+ +L ++ + + N + + + K+S +
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDF 168
Query: 329 GCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLEL 375
G + I D S S + + E + G T +S++WSFG+VL E+
Sbjct: 169 GLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 42/195 (21%)
Query: 285 KIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSV 344
KIA+ + L +LH + ++ + +N+ I+++ KL +G +G++ D ++
Sbjct: 107 KIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTI 162
Query: 345 AAANLSVETLERGLLTP---------KSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
A ER + P KS+VWS GI ++EL TG R P +
Sbjct: 163 DAGCKPYMAPER--INPELNQKGYDVKSDVWSLGITMIELATG------RFPYD-----S 209
Query: 396 WSRPFLADDCRLSLIMD---PQL-KGRFPLKAARTVADIALRCLQKEPSERPT----MRS 447
W PF +L +++ PQL +F + D +CL+K ERP ++
Sbjct: 210 WKTPFQ----QLKQVVEEPSPQLPAEKFSPE----FQDFVNKCLKKNYKERPNYPELLQH 261
Query: 448 IFEELDRQESRKSSS 462
F EL ++ +S
Sbjct: 262 PFFELHLSKNTDVAS 276
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 49/246 (19%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLGF----HARDGSDQRMLIYERLFHGSLDR-LIYGRSD 274
+++F+++ + HPN+ +L+G +G ++I + HG L L+Y R
Sbjct: 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG 103
Query: 275 GPPIDWNTR--VKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
P T+ VK A G+ +L + ++ + + N ++++ + ++ +G +
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK 160
Query: 333 HIPETDISN----SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
I D + + +++E+L + T KS+VWSFG+ + E+ T + + +P
Sbjct: 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ---TPYPG 217
Query: 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
E + + +L RL + P + + C P +RP+ ++
Sbjct: 218 VENSEI---YDYLRQGNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264
Query: 449 FEELDR 454
EL++
Sbjct: 265 RCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 32/252 (12%)
Query: 207 EATVTRLNPSSQG--VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+ T R S Q V+ ++ +A L HP++ ++LG D L E + GS
Sbjct: 32 QVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN--LFVEWMAGGS 89
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSA 323
+ L+ S + +GL++LHE Q ++ + AN+ ID
Sbjct: 90 VSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRL 143
Query: 324 KLSGYGCAGHIPETDISNSSV-------AAANLSVETLERGLLTPKSNVWSFGIVLLELL 376
+++ +G A + + + A ++ E L +VWS G V++E+
Sbjct: 144 RIADFGAAARL-AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202
Query: 377 TGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQ 436
T K N K S S P + P + + D+ LRCL+
Sbjct: 203 TA---------KPPWNAEKHSNHLALIFKIASATTAPSI----PEHLSPGLRDVTLRCLE 249
Query: 437 KEPSERPTMRSI 448
+P +RP R +
Sbjct: 250 LQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 63/254 (24%), Positives = 106/254 (41%), Gaps = 20/254 (7%)
Query: 210 VTRLNPSS-QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DR 267
V +L S+ + +++F ++ L SLQH N+ K G G L+ E L +GSL D
Sbjct: 38 VKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY 97
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
L R +D + A +G+ +L G + ++ + +T NI ++ + K+
Sbjct: 98 LQKHRER---LDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGD 151
Query: 328 YGCAGHIPETDISNSSVAAANLSV------ETLERGLLTPKSNVWSFGIVLLELLTGRKN 381
+G +P+ D V S E+L + S+VWSFG+VL EL T +
Sbjct: 152 FGLTKVLPQ-DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSD 209
Query: 382 LDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE 441
P E ++ + L ++ + P + I C +PS+
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQ 269
Query: 442 RPTMRSIFEELDRQ 455
RP+ F EL Q
Sbjct: 270 RPS----FSELALQ 279
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 54/244 (22%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN 281
EF+N+ + + ++ +LLG ++ ++I E + G L Y RS P ++ N
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKS--YLRSLRPEMENN 110
Query: 282 T---------RVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
+++A A G+ +L+ + ++ + + N + +DF+ K+ +G
Sbjct: 111 PVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
Query: 333 HIPETDISNSS----VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
I ETD + +S E+L+ G+ T S+VWSFG+VL E+ T
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------- 216
Query: 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
L + ++++ L +M+ L + P + ++ C Q P RP+ I
Sbjct: 217 ----LAEQPYQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
Query: 449 FEEL 452
+
Sbjct: 272 ISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 59/264 (22%), Positives = 113/264 (42%), Gaps = 45/264 (17%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLF 261
KK+ TV L + V+EF+ + + ++HPNL +LLG R+ +I E +
Sbjct: 28 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--FYIITEFMT 85
Query: 262 HGSLDRLIY----GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317
+G+L L Y R + + + +A + + +L E+ F ++ + + N +
Sbjct: 86 YGNL--LDYLRECNRQEVNAV---VLLYMATQISSAMEYL-EKKNF--IHRDLAARNCLV 137
Query: 318 DKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVL 372
++ K++ +G + + T + ++ A A + E+L + KS+VW+FG++L
Sbjct: 138 GENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 195
Query: 373 LELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG---RFPLKAARTVAD 429
E+ T P+ D LS + + KG P V +
Sbjct: 196 WEIAT-----------------YGMSPYPGID--LSQVYELLEKGYRMERPEGCPPKVYE 236
Query: 430 IALRCLQKEPSERPTMRSIFEELD 453
+ C Q PS+RP+ I + +
Sbjct: 237 LMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 56/240 (23%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD--GPPID 279
EF+++ +AS+ HP+L +LLG S L+ + + HG L ++ D G +
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL 111
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA----GHIP 335
N V+IA +G+ +L E + ++ + + N+ + K++ +G A G
Sbjct: 112 LNWCVQIA----KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164
Query: 336 ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLV 394
E + + +++E + T +S+VWS+G+ + EL+T G K D +E +L+
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
Query: 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ RL PQ P V + ++C + RP + + E R
Sbjct: 225 EKGE-------RL-----PQ-----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 37/269 (13%)
Query: 188 SSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247
+ +YR + +D S E +TRL S + ++ +N++ L+ LQHPN+ H
Sbjct: 15 EATLYRRT--EDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYN-HFM 69
Query: 248 DGSDQRMLI-YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
D D +LI E G+L I R G + + ++++H+ G +
Sbjct: 70 D--DNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 307 YNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN---LSVETLERGLLTPKS 363
+ + T NI + K KL +G + I ++ S + +S E + KS
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGIS-KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKS 182
Query: 364 NVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKA 423
++W+ G VL ELLT ++ D+ +P NLV I+ P+ +
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPL---NLV-VK------------IVQ---GNYTPVVS 223
Query: 424 ARTVADIAL--RCLQKEPSERPTMRSIFE 450
+ I+L LQ++P +RPT + +
Sbjct: 224 VYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 39/260 (15%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
EAT + N KE +++ +AS+ +P++C+LLG + LI + + G L
Sbjct: 46 EATSPKAN------KEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCL- 95
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
L Y R I + + A+G+ +L E + ++ + + N+ + K++
Sbjct: 96 -LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKIT 151
Query: 327 GYGCAGHI----PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKN 381
+G A + E V +++E++ + T +S+VWS+G+ + EL+T G K
Sbjct: 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
Query: 382 LDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE 441
D E ++ L RL PQ P V I ++C +
Sbjct: 212 YDGIPASEISSI-------LEKGERL-----PQ-----PPICTIDVYMIMVKCWMIDADS 254
Query: 442 RPTMRSI---FEELDRQESR 458
RP R + F ++ R R
Sbjct: 255 RPKFRELIIEFSKMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 28/246 (11%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL- 265
+ + L P + + F+ + + L+H KL+ +A + ++ E + GSL
Sbjct: 32 KVAIKTLKPGTMMPEAFLQEAQIMKKLRHD---KLVPLYAVVSEEPIYIVTEFMGKGSLL 88
Query: 266 DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325
D L G DG + V +A A G+ ++ ++ + ANI + + K+
Sbjct: 89 DFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKI 143
Query: 326 SGYGCAGHIPETDISNSSVAAANL---SVETLERGLLTPKSNVWSFGIVLLELLTGRKNL 382
+ +G A I + + + A + + E G T KS+VWSFGI+L EL+T
Sbjct: 144 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT----- 198
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
R P P + + L + + + P ++ ++ C +K+P ER
Sbjct: 199 KGRVP----------YPGMVNREVLEQV-ERGYRMPCPQGCPESLHELMKLCWKKDPDER 247
Query: 443 PTMRSI 448
PT I
Sbjct: 248 PTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 34/260 (13%)
Query: 193 RASFGD-----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247
+ SFG+ D T++ V L + +++ ++ L+ + P + K G +
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK 70
Query: 248 DGSDQRMLIYERLFHGS-LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306
+I E GS LD L G +D I GL +LHEEG +
Sbjct: 71 GSK--LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KI 120
Query: 307 YNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--LSVETLERGLLTPKSN 364
+ + ANI + ++ KL+ +G +G + T ++ ++ E +++ K++
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKAD 180
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAA 424
+WS GI +EL G L HP L+ + P P L+G K +
Sbjct: 181 IWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-------------PSLEGN---KFS 224
Query: 425 RTVADIALRCLQKEPSERPT 444
+ D CL K+P ERP+
Sbjct: 225 KPFKDFVSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 48/245 (19%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY--ERLFHGSLDRLIYGRSDGPPID 279
+F+++ L HPN+ KL+G QR IY L G D L + R +
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGV-----CTQRQPIYIVMELVPGG-DFLSFLRKKKDELK 91
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339
VK AL AA G+ +L + ++ + + N + ++ K+S +G + E D
Sbjct: 92 TKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDG 146
Query: 340 SNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------GRKNLDSRHP 387
SS + + E L G + +S+VWS+GI+L E + G N +R
Sbjct: 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206
Query: 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS 447
E+ R+S P K V + RC +P RP
Sbjct: 207 VEK-------------GYRMSC----------PQKCPDDVYKVMQRCWDYKPENRPKFSE 243
Query: 448 IFEEL 452
+ +EL
Sbjct: 244 LQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 53/245 (21%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLGF--HARDGSDQRMLIYERLFH-GSLDRLI-YGRSDG 275
+KE +++ L L+HPNL K G H +++ I+ G+L+ L+ +GR
Sbjct: 43 IKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVYIFMEYCSGGTLEELLEHGRIL- 96
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
D + L +GL +LH G ++ + ANI +D + KL +GCA +
Sbjct: 97 ---DEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKL- 149
Query: 336 ETDISNSSVA----------AANLSVETLERGLLTPK---SNVWSFGIVLLELLTGRK-- 380
+N++ A ++ E + G +++WS G V+LE+ TG++
Sbjct: 150 ---KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
Query: 381 -NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEP 439
LD+ + F + P + L+ + D RCL+ +P
Sbjct: 207 SELDNE----------FQIMF-----HVGAGHKPPIPD--SLQLSPEGKDFLDRCLESDP 249
Query: 440 SERPT 444
+RPT
Sbjct: 250 KKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 35/241 (14%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
++F+ + L HPN+ KL+G + ++ E + GSL L + R +
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGSL--LTFLRKKKNRLTV 92
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC----AGHIPE 336
++++L AA G+ +L + ++ + + N + ++ K+S +G G I
Sbjct: 93 KKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149
Query: 337 TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396
+ + E L G T +S+VWS+GI+L E + D+ +P
Sbjct: 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG---DTPYP-------GM 199
Query: 397 S----RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
S R + R+ PQL + + L+C +P RP+ I+ EL
Sbjct: 200 SNQQTRERIESGYRMPA---PQL-------CPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
Query: 453 D 453
Sbjct: 250 Q 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 183 ISEGLSSVMYRASFGDDASTSKK--FEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ EG ++ D+ ++ F TV + S V + + L L H N+
Sbjct: 14 LQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP---PIDWNTR--VKIALCAAQGLT 295
+L DG + ++Y + G+L + G P +T+ V +A+ A G++
Sbjct: 73 ILHVCIEDG-EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 296 FLHEEGPFQAMYNEFSTANIQIDKDFSAKL-----------SGYGCAGHIPETDISNSSV 344
+LH+ G ++ + + N ID++ K+ Y C G D N V
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG-----DNENRPV 183
Query: 345 AAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377
+++E+L + S+VWSFG++L EL+T
Sbjct: 184 KW--MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 57/293 (19%), Positives = 120/293 (40%), Gaps = 49/293 (16%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLC 239
I EG + +A D + +A + R+ S ++F ++ L L HPN+
Sbjct: 3 IGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLI--------------YGRSDGPPIDWNTR-- 283
LLG + R +Y + + L+ + ++ +++
Sbjct: 60 NLLG-----ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 284 VKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA-GHIPETDISNS 342
+ A A+G+ +L ++ Q ++ + + NI + +++ AK++ +G + G +
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 171
Query: 343 SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402
+ +++E+L + T S+VWS+G++L E+++ P+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------------LGGTPYCG 214
Query: 403 DDCRLSLIMDPQ-LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
C PQ + PL V D+ +C +++P ERP+ I L+R
Sbjct: 215 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 23/229 (10%)
Query: 227 VNTLASLQHPNLCKLLGFHARDGSDQRMLI-YERLFHGSLDRLIYGRSDGPPIDWNTRVK 285
+ L L N ++GF+ SD + I E + GSLD+++ + I K
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGK 107
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA 345
+++ +GL +L E+ Q M+ + +NI ++ KL +G +G + ++ ++NS V
Sbjct: 108 VSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 164
Query: 346 AAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404
+ +S E L+ + +S++WS G+ L+EL GR + KE + + RP + +
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGRPVVDGE 222
Query: 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
+ P+ P R V+ + RP M +IFE LD
Sbjct: 223 EGEPHSISPR-----PRPPGRPVSGHGM-------DSRPAM-AIFELLD 258
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 51/273 (18%)
Query: 197 GDDASTSKKFEATVTRLNPSSQGVK--EFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254
D E +V S F + ++ L H +L KL G RD + +
Sbjct: 20 SDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN---I 76
Query: 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTAN 314
++ E + G LD ++ + + W V L A L +L ++ + ++ N
Sbjct: 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL--ASALHYLEDK---KLVHGNVCGKN 131
Query: 315 IQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLE-----------RGL---LT 360
I + + + G++P +S+ + LS E R LT
Sbjct: 132 ILVARYGLNE-------GYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLT 184
Query: 361 PKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
++ WSFG LLE+ + G + L + E+ F D RL
Sbjct: 185 IAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQHRL------------ 225
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
P+ +A++ +C +P++RP+ R+I +L
Sbjct: 226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 66/296 (22%), Positives = 123/296 (41%), Gaps = 47/296 (15%)
Query: 183 ISEG-LSSVMYRASFGDDASTSKKFEATVTRL---NPSSQGVKEFINDVNTLASL-QHPN 237
+ EG V+ + G D + ++ + + + + + I+++ + + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP---------------IDWNT 282
+ LLG +DG +I E G+L Y R+ PP + +
Sbjct: 86 IINLLGACTQDGP--LYVIVEYASKGNLRE--YLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 283 RVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD---- 338
V A A+G+ +L + + ++ + + N+ + +D K++ +G A I D
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 339 ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398
+N + ++ E L + T +S+VWSFG++L E+ T + P EE L K
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFK--- 253
Query: 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
L + R MD P + + C PS+RPT + + E+LDR
Sbjct: 254 -LLKEGHR----MDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 59/296 (19%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTS--KK---FEATVTRLNPSSQGVKEFINDVNTL 230
NF ++ I +G SV+Y+A D KK FE ++ ++ + +++ L
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM------DAKARQDCLKEIDLL 56
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI-YGRSDGPPID----WNTRVK 285
L HPN+ K L + ++ ++ E G L R+I + + I W V+
Sbjct: 57 KQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA 345
+ L +H + + M+ + AN+ I KL G G S+ + A
Sbjct: 115 LC----SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGL-GRF----FSSKTTA 162
Query: 346 AANL-------SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398
A +L S E + KS++WS G +L E+ L S
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA----LQS-------------- 204
Query: 399 PFLADDCRLSLIMDPQLKGRF-PLKAARTVA---DIALRCLQKEPSERPTMRSIFE 450
PF D L + K + PL A D+ RC+ +P +RP + + +
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 40/156 (25%), Positives = 62/156 (39%), Gaps = 27/156 (17%)
Query: 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-- 348
L +LH G +Y + NI +D D KL+ +G A + ++
Sbjct: 103 VLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159
Query: 349 LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408
L+ E L + WS G++L E+LTG+ PF A+D
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------PPFYAED--RK 199
Query: 409 LIMDPQLKG--RFPLKAARTVADIALRCLQKEPSER 442
I + LK RFP + D+ LQK+P++R
Sbjct: 200 EIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 53/258 (20%), Positives = 101/258 (39%), Gaps = 40/258 (15%)
Query: 201 STSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLCKLLGFH-ARDGSDQRMLIYE 258
S ++ + L SQ +E +N++ LAS+ HPN+ + + A ++ ++ E
Sbjct: 23 SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISYKEAFLDGNKLCIVME 79
Query: 259 RLFHGSLDRLIY-GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317
G L + I + I +I + +GL LHE+ + ++ + +ANI +
Sbjct: 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILL 136
Query: 318 DKDFSAKLSGYGCA----GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLL 373
+ K+ G + ++ +T I A E + + KS++WS G +L
Sbjct: 137 VANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAP----EVWKGRPYSYKSDIWSLGCLLY 192
Query: 374 ELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVAD---I 430
E+ T ++R ++ R V+ +G++P D
Sbjct: 193 EMATFAPPFEARSMQDLRYKVQ--------------------RGKYPPIPPIYSQDLQNF 232
Query: 431 ALRCLQKEPSERPTMRSI 448
LQ +P RP I
Sbjct: 233 IRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 56/256 (21%), Positives = 108/256 (42%), Gaps = 36/256 (14%)
Query: 206 FEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY---ERLFH 262
+ + +N + ++FI + + L HP L +L G Q+ +Y E + +
Sbjct: 29 IKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV-----CTQQKPLYIVTEFMEN 83
Query: 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322
G L L Y R + + + + +G+ +L E F ++ + + N +
Sbjct: 84 GCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYL-ERNSF--IHRDLAARNCLVSSTGV 138
Query: 323 AKLSGYGCAGHIPETDISNSSVAAANL---SVETLERGLLTPKSNVWSFGIVLLELLTGR 379
K+S +G ++ + + ++SS A + E + KS+VWSFG+++ E+ T
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT-- 196
Query: 380 KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEP 439
+ + P E+++ + RL P+L A+ TV ++ C ++P
Sbjct: 197 ---EGKMPFEKKSNYEVVEMISRGF-RL---YRPKL-------ASMTVYEVMYSCWHEKP 242
Query: 440 SERPTMRSIFEELDRQ 455
RPT F EL R
Sbjct: 243 EGRPT----FAELLRA 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 44/180 (24%), Positives = 76/180 (42%), Gaps = 23/180 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-- 273
+ Q EF + + +A L HPN+ LLG ++ +++E L G L + RS
Sbjct: 47 NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPH 104
Query: 274 ---------DG---PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321
DG +D + IA+ A G+ +L ++ + + NI I +
Sbjct: 105 SDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161
Query: 322 SAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377
K+S G + I D S + + E + G + S++WSFG+VL E+ +
Sbjct: 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 14/176 (7%)
Query: 210 VTRLNPSSQG--VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR 267
V L P S G + + ++ L +L H N+ K G DG + LI E L GSL
Sbjct: 38 VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 97
Query: 268 LIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327
Y + I+ ++K A+ +G+ +L G Q ++ + + N+ ++ + K+
Sbjct: 98 --YLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGD 152
Query: 328 YGCAGHIPETDISNSSVAAANLSV------ETLERGLLTPKSNVWSFGIVLLELLT 377
+G I ETD +V S E L + S+VWSFG+ L ELLT
Sbjct: 153 FGLTKAI-ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 40/239 (16%)
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN-----------T 282
+H N+ LLG +DG ++ E G+L + R P +D++ T
Sbjct: 76 KHKNIINLLGACTQDGP--LYVLVEYASKGNLREYLRARRP-PGMDYSFDTCKLPEEQLT 132
Query: 283 RVKIALCA---AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD- 338
+ CA A+G+ +L + + ++ + + N+ + +D K++ +G A + D
Sbjct: 133 FKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189
Query: 339 ---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
+N + ++ E L + T +S+VWSFG++L E+ T + P EE L K
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFK 247
Query: 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
L + R MD P + I C PS+RPT + + E+LDR
Sbjct: 248 ----LLKEGHR----MDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 61/270 (22%), Positives = 94/270 (34%), Gaps = 52/270 (19%)
Query: 204 KKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKLLGFHARDGSDQRM-LIYERLF 261
KKF+ + + VK+ +V L L+H N+ L R G R+ L++E +
Sbjct: 32 KKFKE-----SEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG---RLYLVFEYVE 83
Query: 262 HGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321
L+ L+ G P D L Q + + H ++ + NI + +
Sbjct: 84 RTLLE-LLEASPGGLPPDAVRSYIWQLL--QAIAYCHSHN---IIHRDIKPENILVSESG 137
Query: 322 SAKLSGYGCAGHIPETDISN--SSVA-----AANLSVETLERGLLTPKSNVWSFGIVLLE 374
KL +G A + S VA A L V G +VW+ G ++ E
Sbjct: 138 VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG---KPVDVWAIGCIMAE 194
Query: 375 LLTGRK-------------------NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ- 414
LL G L H + S P A P+
Sbjct: 195 LLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS-----SNPRFA-GVAFPEPSQPES 248
Query: 415 LKGRFPLKAARTVADIALRCLQKEPSERPT 444
L+ R+P K + D CL+ +P ER T
Sbjct: 249 LERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 66/261 (25%), Positives = 104/261 (39%), Gaps = 40/261 (15%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLG-FHARD--GSDQRMLIYERLFH 262
+A V L+P +E + N L +L HPN+ K G ++ +D DQ L+ E
Sbjct: 45 KAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNG 104
Query: 263 GSLDRLIYG------RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316
GS+ L+ G R + P I + I A GL LH + ++ + NI
Sbjct: 105 GSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNIL 156
Query: 317 IDKDFSAKLSGYGCAGHIPETDIS-NSSV------AAANLSVETLERGLLTPKSNVWSFG 369
+ + KL +G + + T + N+SV A ++ E + +VWS G
Sbjct: 157 LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG 216
Query: 370 IVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVAD 429
I +EL G L HP R L K R +P P + D
Sbjct: 217 ITAIELGDGDPPLADLHPM--RALFKIPR-------------NPPPTLHQPELWSNEFND 261
Query: 430 IALRCLQKEPSERPTMRSIFE 450
+CL K+ +RPT+ + +
Sbjct: 262 FIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 52/247 (21%)
Query: 224 INDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY-ERLFHGSLDRLI-YGRSDGPPID-- 279
+++VN L L+HPN+ + D S+Q + I E G L +LI + + I+
Sbjct: 47 VSEVNILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEE 105
Query: 280 --WNTRVKIAL----C---AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330
W ++ L C + G T LH + ANI +D + + KL +G
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRD---------LKPANIFLDANNNVKLGDFGL 156
Query: 331 AGHIPETDISNSSVAAAN-------LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383
A + + S A +S E L KS++WS G ++ EL
Sbjct: 157 A-----KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL----- 206
Query: 384 SRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
P RN ++ LA S I + + + R P + + + ++ L +P +RP
Sbjct: 207 -SPPFTARNQLQ-----LA-----SKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRP 254
Query: 444 TMRSIFE 450
+ + +
Sbjct: 255 STEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 25/229 (10%)
Query: 227 VNTLASLQHPNLCKLLGFHARDGSDQRMLI-YERLFHGSLDRLIYGRSDGPPIDWNTRVK 285
+ L L N ++GF+ SD + I E + GSLD+++ P K
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGK 107
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA 345
+++ +GLT+L E+ + M+ + +NI ++ KL +G +G + ++ ++NS V
Sbjct: 108 VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 164
Query: 346 AAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404
+ +S E L+ + +S++WS G+ L+E+ GR + KE + + P D
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM--FGCPVEGDP 222
Query: 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
P+ GR PL + P RP M +IFE LD
Sbjct: 223 AESETSPRPRPPGR-PLSSY-------------GPDSRPPM-AIFELLD 256
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 63/274 (22%), Positives = 109/274 (39%), Gaps = 37/274 (13%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLL 242
I G ++V+Y A ++K L V E +V ++ HPN+ K
Sbjct: 9 IGVGATAVVYAAIC---LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 243 G-FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC---AAQGLTFLH 298
F D + L+ L GSL ++ P IA +GL +LH
Sbjct: 66 TSFVVGD---ELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSV------AAANLSVE 352
G ++ + NI + +D S K++ +G + + + V ++ E
Sbjct: 120 SNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 353 TLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
+E+ K+++WSFGI +EL TG S++P + ++
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTLQNDP----------- 224
Query: 412 DPQLK-GRFPLKAARTVADIALRCLQKEPSERPT 444
P L+ G K +++ + CLQK+PS+RPT
Sbjct: 225 -PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 48/242 (19%), Positives = 95/242 (39%), Gaps = 33/242 (13%)
Query: 222 EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG------ 275
EF +++ L H N+ +LLG R+ M I E G L + +
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGL-CREAEPHYM-ILEYTDLGDLKQFLRATKSKDEKLKP 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
PP+ +V + A G+ L + ++ + + N + K+S + +
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168
Query: 336 ETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392
++ + N+ + L+ E ++ + KS+VWSFG+++ E+ T +
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE------------ 216
Query: 393 LVKWSRPF--LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
PF L+D+ L+ + +L+ P + + RC P +RP+ +
Sbjct: 217 -----LPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
Query: 451 EL 452
L
Sbjct: 272 AL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
++F+++ + + HPN+ L G + S M++ E + +GSLD + + DG
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLR-KHDGQ-FTV 105
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340
V + A G+ +L + G ++ + + NI ++ + K+S +G + + + +
Sbjct: 106 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 341 NSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
+ + + E + T S+VWS+GIV+ E+++
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-----------------Y 205
Query: 396 WSRPFLADDCRLSLIMDPQLKGRF--PLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
RP+ + +I + R P+ + + L C QK+ +ERP I LD
Sbjct: 206 GERPYW-EMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
Query: 454 R 454
+
Sbjct: 265 K 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 54/244 (22%), Positives = 107/244 (43%), Gaps = 36/244 (14%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG--PPI 278
++F+++ + + HPN+ L G + S M+I E + +G+LD + ++DG I
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLR-QNDGQFTVI 106
Query: 279 DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE-- 336
V + A G+ +L E ++ + + NI ++ + K+S +G + + +
Sbjct: 107 QL---VGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160
Query: 337 TDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390
+D + +S + + E + T S+VWS+GIV+ E+++ G + ++
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220
Query: 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
N ++ D RL MD + + L C QK+ + RP I
Sbjct: 221 INAIE-------QDYRLPPPMD----------CPTALHQLMLDCWQKDRNARPKFGQIVS 263
Query: 451 ELDR 454
LD+
Sbjct: 264 TLDK 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 30/163 (18%), Positives = 55/163 (33%), Gaps = 44/163 (26%)
Query: 314 NIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV---------------------- 351
NI +DKD K++ +G A + S+ A
Sbjct: 132 NILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL-- 409
E L S++W+ G ++ ++LTG+ PF + L+
Sbjct: 192 ELLNEKPAGKSSDLWALGCIIYQMLTGKP------------------PFRGSNEYLTFQK 233
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
I+ + FP D+ + L +P +R + ++EL
Sbjct: 234 ILKLEYS--FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 48/255 (18%)
Query: 213 LNPSSQGVK-EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
L+PS + + F + ++ + H +L + G R GS+ M + E + HG LD +
Sbjct: 52 LDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVR-GSENIM-VEEFVEHGPLDVCLRK 109
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P+ W V L +A L++L ++ ++ NI + + G
Sbjct: 110 EKGRVPVAWKITVAQQLASA--LSYLEDK---NLVHGNVCAKNILLAR------LGL-AE 157
Query: 332 GHIPETDISNSSVAAANLSVET-LER------------GLLTPKSNVWSFGIVLLEL-LT 377
G P +S+ V+ LS E +ER L+ ++ WSFG LLE+
Sbjct: 158 GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQK 437
G L R P E+ + K R P + + +A + +CL
Sbjct: 218 GEVPLKERTPSEKERFY-------------------EKKHRLPEPSCKELATLISQCLTY 258
Query: 438 EPSERPTMRSIFEEL 452
EP++RP+ R+I +L
Sbjct: 259 EPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 48/177 (27%), Positives = 70/177 (39%), Gaps = 20/177 (11%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
P Q F+ +V L HPN+ + LG S +L+ E G L +
Sbjct: 35 TPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNR 90
Query: 274 DGPPIDWNTRV--KIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
V ++A A GL +LH+ ++++ + N Q+ D S K+ YG A
Sbjct: 91 GMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147
Query: 332 -GHIPETDISNSSVAAANLS------VETLERGLL----TPKSNVWSFGIVLLELLT 377
PE A L VE + LL T KSN+WS G+ + EL T
Sbjct: 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 62/294 (21%), Positives = 120/294 (40%), Gaps = 43/294 (14%)
Query: 183 ISEGLSSVMYRA-SFGDDASTSKKFEATVTRL---NPSSQGVKEFINDVNTLASL-QHPN 237
+ EG + RA ++G D S + ++ N + + + + I+++ + + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS--------DGP-----PIDWNTRV 284
+ LLG ++G +I E G+L + R D + + V
Sbjct: 80 IINLLGVCTQEGP--LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 285 KIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD----IS 340
A A+G+ +L + ++ + + N+ + +D K++ +G A + + D S
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 341 NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400
N + ++ E L + T +S+VWSFGI++ E+ T + P EE L K R
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LFKLLREG 252
Query: 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
D P + + C P++RPT + + E LD+
Sbjct: 253 HRMDK--------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 47/236 (19%)
Query: 225 NDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRV 284
+++ L +HPN+ G + R D+ ++ E GSL IY + GP + +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQD-IYQVTRGPL----SEL 101
Query: 285 KIA-LC--AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS- 340
+IA +C +GL +LHE G ++ + ANI + +D KL+ +G + + T I+
Sbjct: 102 QIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAK 157
Query: 341 -NSSV------AAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393
S + A +VE +G K ++W+ GI +EL + + HP R L
Sbjct: 158 RKSFIGTPYWMAPEVAAVE--RKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RAL 213
Query: 394 VKWSR-----PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
S+ P L D + S + +K +CL K+P +RPT
Sbjct: 214 FLISKSNFPPPKLKDKEKWSPVFHDFIK----------------KCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 24/175 (13%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM-LIYERLFHGSLDRLIYGRS---DGP 276
+EF ++ + LQHPN+ LLG ++ Q + +I+ H L + RS D
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKE---QPLSMIFSYCSHSDLHEFLVMRSPHSDVG 109
Query: 277 PIDWNTRVKIAL----------CAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
D + VK L A G+ FL ++ + +T N+ + + K+S
Sbjct: 110 STDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKIS 166
Query: 327 GYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377
G + D + NS + +S E + G + S++WS+G+VL E+ +
Sbjct: 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 60/263 (22%), Positives = 112/263 (42%), Gaps = 59/263 (22%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
E +++++P + +E +V L++++HPN+ + +G+ ++ + G L
Sbjct: 32 EINISKMSPKER--EESRKEVAVLSNMKHPNIVQYQESFEENGN--LYIVMDYCEGGDLY 87
Query: 267 RLIYGR-----SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321
+ I + + +DW ++ +AL LH + + NI + KD
Sbjct: 88 KKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD---------IKSQNIFLTKDG 138
Query: 322 SAKLSGYGCAGHIPETDISNSSVAAAN--------LSVETLERGLLTPKSNVWSFGIVLL 373
+ KL +G A + NS+V A LS E E KS++W+ G VL
Sbjct: 139 TIKLGDFGIA------RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLY 192
Query: 374 ELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALR 433
E+ T + ++ + K NLV L +I +G +P ++ D LR
Sbjct: 193 EMCTLKHAFEAGNMK---NLV------------LKII-----RGSYPPVSSHYSYD--LR 230
Query: 434 CL-----QKEPSERPTMRSIFEE 451
L ++ P +RP++ SI E+
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 54/262 (20%), Positives = 113/262 (43%), Gaps = 39/262 (14%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+ R + + +F+ +V L+ L+ PN+ +LLG + D +I E + +G L++ +
Sbjct: 53 ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFL 110
Query: 270 YGR----------------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTA 313
P I +++ + +AL A G+ +L ++ + +T
Sbjct: 111 SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATR 167
Query: 314 NIQIDKDFSAKLSGYGCAGHIPETD---ISNSSVAAAN-LSVETLERGLLTPKSNVWSFG 369
N + ++ + K++ +G + ++ D I +V ++ E + G T S+VW+FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 370 IVLLELLTGRKNLDSRHPKEE---RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAART 426
+ L E+L L P E +++ + F D R Q+ P +
Sbjct: 228 VTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGR-------QVYLFRPPPCPQG 276
Query: 427 VADIALRCLQKEPSERPTMRSI 448
+ ++ L+C ++ ERP+ I
Sbjct: 277 LYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP---------------I 278
+H N+ LLG +DG +I E G+L Y R+ PP +
Sbjct: 79 KHKNIINLLGACTQDGP--LYVIVEYASKGNLRE--YLRARRPPGMEYSYDIARVPDEQM 134
Query: 279 DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ V A+G+ +L + + ++ + + N+ + ++ K++ +G A + D
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 339 ----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394
+N + ++ E L + T +S+VWSFG+++ E+ T + P EE L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LF 249
Query: 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
K L + R MD P + + C PS RPT + + E+LDR
Sbjct: 250 K----LLKEGHR----MDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 28/173 (16%)
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI--YGRSDGPPIDWNTR 283
++ L LQH N+ + LG + +D + E + GS+ L+ YG + +
Sbjct: 56 EIALLKELQHENIVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV--RNF 111
Query: 284 VKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSS 343
V+ L +GL +LH G ++ + ANI +D K+S +G + + E + ++
Sbjct: 112 VRQIL---KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTK 164
Query: 344 VAAANLSV---------ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP 387
A S+ E +++ T K+++WS G +++E+LTG +HP
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG------KHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 59/272 (21%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCKL 241
I EG + ++ A+ +S K A V +++ Q +E + N+V + QH N+ ++
Sbjct: 28 IGEGSTGIVCIAT----VKSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 242 LGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
+++ D+ ++ E L G+L D + + R + I + L + L+ LH +
Sbjct: 83 --YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQ 135
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAAN-LSVETLERGL 358
G ++ + + +I + D KLS +G CA E S V ++ E + R
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
P+ ++WS GI+++E++ G + P + +++ + P P+LK
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-------------PKLKNL 239
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
K + ++ R L ++P++R T + +
Sbjct: 240 H--KVSPSLKGFLDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 49/237 (20%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
H N+ LLG G ++I E +G L + + + + + + A+G
Sbjct: 97 NHENIVNLLGACTIGGP--ILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKG 153
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSS--VAAAN--- 348
+ FL + ++ + + N+ + K+ +G A DI N S V N
Sbjct: 154 MAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA-----RDIMNDSNYVVKGNARL 205
Query: 349 ----LSVETLERGLLTPKSNVWSFGIVLLELLTGRKN------LDSRHPKEERNLVKWSR 398
++ E++ + T +S+VWS+GI+L E+ + N +DS+ K + + ++
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
Query: 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455
P A + DI C +P +RPT + I + + +Q
Sbjct: 266 PEHAPA---------------------EIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 37/156 (23%), Positives = 66/156 (42%), Gaps = 22/156 (14%)
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAANLSV 351
L +LHE G +Y + N+ +D + KL+ YG C + D +++ N
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 164
Query: 352 ETLERGLLTPKS-NVWSFGIVLLELLTGRKNLD----SRHPKEERNLVKWSRPFLADDCR 406
+ RG S + W+ G+++ E++ GR D S +P + +D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----------TEDYL 213
Query: 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
+I++ Q+ R P + A + L K+P ER
Sbjct: 214 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 27/160 (16%)
Query: 287 ALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVA 345
A GL FLHE G +Y + N+ +D + K++ +G C I +++
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158
Query: 346 AAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404
+ ++ E L P + W+ G++L E+L G+ PF DD
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS------------------PFEGDD 200
Query: 405 CR--LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
I++ ++ R+P ++ I L K P +R
Sbjct: 201 EDELFQSILEDEV--RYPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 288 LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAA 346
+C A L FLHE G +Y + N+ +D D KL+ YG C + D +++
Sbjct: 105 ICIA--LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159
Query: 347 ANLSVETLERGLLTPKS-NVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405
N + RG S + W+ G+++ E++ GR D + N +D
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TEDY 210
Query: 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
+I++ + R P + + + L K+P ER
Sbjct: 211 LFQVILEKPI--RIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 67/310 (21%), Positives = 119/310 (38%), Gaps = 48/310 (15%)
Query: 151 PLPLPPTGTGTLRNFPLDEVAAACHN--FFSD----RCISEGLSSVMYRASFGDDASTSK 204
PLPLPP + + + +A S+ I G +Y+ T +
Sbjct: 44 PLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVI---HRPTGR 100
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+ V N ++ ++ L + HPN+ K +G Q +L E + GS
Sbjct: 101 LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL--EFMDGGS 158
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDF 321
L+ G I +A A Q G+ +LH ++ + +N+ I+
Sbjct: 159 LE--------GTHI--ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAK 205
Query: 322 SAKLSGYGCAGHIPET-DISNSSVAA-ANLSVETLERGLLTPK-----SNVWSFGIVLLE 374
+ K++ +G + + +T D NSSV A +S E + L ++WS G+ +LE
Sbjct: 206 NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 375 LLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRC 434
GR + +L+ C + + P+ P A+R C
Sbjct: 266 FYLGRFPFGVGRQGDWASLM----------CAICMSQPPEA----PATASREFRHFISCC 311
Query: 435 LQKEPSERPT 444
LQ+EP++R +
Sbjct: 312 LQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322
GSLD +Y + + +IA+ +GLT+L + ++ + +N+ ++
Sbjct: 84 GSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQ 133
Query: 323 AKLSGYGCAGH----IPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377
KL +G + I +T + +N+ +A +S E + G+ S+VWS GI +EL
Sbjct: 134 VKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGE--QYGIH---SDVWSLGISFMELAL 188
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD---PQLK-GRFPLKAARTVADIALR 433
GR +P+ ++N + L L I+D P L G+F + +
Sbjct: 189 GR----FPYPQIQKN-----QGSLMPLQLLQCIVDEDPPVLPVGQF----SEKFVHFITQ 235
Query: 434 CLQKEPSERPT 444
C++K+P ERP
Sbjct: 236 CMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 47/236 (19%), Positives = 100/236 (42%), Gaps = 28/236 (11%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
++FI + + L HP L +L G L++E + HG L Y R+
Sbjct: 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSP--ICLVFEFMEHGCLSD--YLRAQRGKFSQ 99
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340
T + + L +G+ +L ++ + + N + ++ K+S +G + + +
Sbjct: 100 ETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156
Query: 341 NSSVAAANL---SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397
+S+ + S E + KS+VWSFG+++ E+ + + + P E R S
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS-----EGKTPYENR-----S 206
Query: 398 RPFLADDCRLSL-IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
+ + + P+L A+++V ++ C ++ P +RP+ + +L
Sbjct: 207 NSEVVETINAGFRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 45/280 (16%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLL 242
I EG S +Y+A+ D +T K+ RL Q + IN++ + +HPN+
Sbjct: 27 IGEGASGEVYKAT---DRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYY 81
Query: 243 GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAA--QGLTFLHEE 300
+ G + +++ E + GSL +I + N +C QGL +LH
Sbjct: 82 DSY-LVGDELWVVM-EYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS- 134
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI-PETDISNSSVA-AANLSVETLERGL 358
++ + + NI + KD S KL+ +G A + E NS V ++ E ++R
Sbjct: 135 --QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
PK ++WS GI+ +E+ G + + +E P A L LI KG
Sbjct: 193 YGPKVDIWSLGIMCIEMAEG----EPPYLRE--------PPLRA----LFLITT---KGI 233
Query: 419 FPLKAARTVADIAL----RCLQKEPSERPTMRSIFEELDR 454
PLK + +CL K+P +RP+ EEL +
Sbjct: 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPS----AEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 63/269 (23%), Positives = 113/269 (42%), Gaps = 44/269 (16%)
Query: 198 DDASTSKKFEATVTRLNPSSQGVK-EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256
D S K+ + + L+PS + + F + + + H ++ L G RD + +++
Sbjct: 25 DGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--VENIMV 82
Query: 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI- 315
E + G LD ++ +SD W + K+A A L++L ++ ++ T NI
Sbjct: 83 EEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNIL 137
Query: 316 ----QIDKDFSA--KLSGYGCAGHIPETDISNSSVAA-----ANLSVETLERGLLTPKSN 364
ID + KLS G IP T +S A VE + L+ ++
Sbjct: 138 LAREGIDGECGPFIKLSDPG----IPITVLSRQECVERIPWIAPECVE--DSKNLSIAAD 191
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAA 424
WSFG L E+ + P +++ L + R F C L + P K
Sbjct: 192 KWSFGTTLWEIC-----YNGEIPLKDKTLAEKER-FYEGQCML---VTPSCK-------- 234
Query: 425 RTVADIALRCLQKEPSERPTMRSIFEELD 453
+AD+ C+ +P++RP R+I +++
Sbjct: 235 -ELADLMTHCMNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 20/155 (12%)
Query: 292 QGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANL-- 349
+GL +LH + ++ + NI ++++ AKL+ +G +G + +T ++V
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWM 166
Query: 350 SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409
+ E ++ K+++WS GI +E+ G+ HP ++ P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP---------- 216
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
P L P K + D +CL K+P ERP+
Sbjct: 217 ---PTLSD--PEKWSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 35/289 (12%)
Query: 177 FFSD-RCISEGLSSVMYRASFGDDASTSK--KFEATVTRLNPSSQGVKEFINDVNTLASL 233
F+D R I G +Y F D T++ + S++ ++ I +V L +
Sbjct: 26 LFTDLREIGHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI 82
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+HPN + G + R+ + L+ E + D L + P+ I A QG
Sbjct: 83 KHPNSIEYKGCYLREHT--AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAITHGALQG 137
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI-PETDISNSSVAAANLSVE 352
L +LH ++ + NI + + KL+ +G A P + A +
Sbjct: 138 LAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVIL 194
Query: 353 TLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412
++ G K +VWS GI +EL ER ++ ++ ++
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL-------------AERKPPLFNMNAMSALYHIAQNES 241
Query: 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPT----MRSIFEELDRQES 457
P L+ R D CLQK P +RPT ++ +F +R E+
Sbjct: 242 PTLQSNEWSDYFRNFVD---SCLQKIPQDRPTSEELLKHMFVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 40/192 (20%)
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAANLSV 351
GL FLH +G +Y + NI +D D K++ +G C ++ + + +
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIA 164
Query: 352 ETLERGLLTPKSNV----WSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407
+ LL K N WSFG++L E+L G+ H +E L +
Sbjct: 165 PEI---LLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQ------------ 206
Query: 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER----------PTMRSI-FEELDRQE 456
S+ MD R+ + A+ DI ++ +EP R P R I + L+ +E
Sbjct: 207 SIRMDNPCYPRWLTREAK---DILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEERE 263
Query: 457 SRKSSSSTVRRA 468
V+ A
Sbjct: 264 IEPPFKPKVKSA 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 27/100 (27%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 285 KIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI-SNSS 343
K+ + + L +L E+ ++ + +NI +D + KL +G +G + ++ + S+
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 344 VAAANLSVETLERGLLTPK----SNVWSFGIVLLELLTGR 379
AA ++ E ++ PK ++VWS GI L+EL TG+
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 16/135 (11%)
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSV 351
GL LH E +Y + NI +D ++S G A IPE + V ++
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAP 170
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK---------WSRPFLA 402
E L T + W G ++ E++ G+ R K +R V +S F
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSE 230
Query: 403 DD---CRLSLIMDPQ 414
+ C++ L DP+
Sbjct: 231 EAKSICKMLLTKDPK 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 56/204 (27%)
Query: 264 SLD---RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320
SLD + +Y I KIA+ + L +L EE + ++ + +NI +D++
Sbjct: 88 SLDKFYKYVYEVLKSV-IPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRN 144
Query: 321 FSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL--------LTP--------KSN 364
+ KL +G +G + + S+A +T + G + P +S+
Sbjct: 145 GNIKLCDFGISGQLVD------SIA------KTRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL-----IMDPQLKGRF 419
VWS GI L E+ TG+ KW+ F D + I+ + F
Sbjct: 193 VWSLGITLYEVATGKFPYP-----------KWNSVF--DQLTQVVKGDPPILSNSEEREF 239
Query: 420 PLKAARTVADIALRCLQKEPSERP 443
+ V I L CL K+ S+RP
Sbjct: 240 ---SPSFVNFINL-CLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 36/134 (26%), Positives = 58/134 (43%), Gaps = 16/134 (11%)
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSV 351
GL LH+E + +Y + NI +D ++S G A H+PE V ++
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN----LVK-----WSRPFLA 402
E ++ T + W+ G +L E++ G+ R K +R LVK +S F
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSP 230
Query: 403 DD---CRLSLIMDP 413
D C++ L DP
Sbjct: 231 DARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 21/157 (13%)
Query: 290 AAQ---GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAA 346
AAQ GL LH+ +Y + N+ +D + ++S G A +
Sbjct: 101 AAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157
Query: 347 AN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405
++ E L+ + + ++ G L E++ GR R K E+ +K
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---------- 207
Query: 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
R +L M + +F A+ D+ LQK+P +R
Sbjct: 208 RRTLEMAVEYPDKFS-PEAK---DLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 218 QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP 277
G KEF+ + + +A L HP + +L+G + ML+ E G L + + R + P
Sbjct: 38 AGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELAPLGPLLKYLKKRREIPV 94
Query: 278 ID---WNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334
D +V A G+ +L E F ++ + + N+ + AK+S +G + +
Sbjct: 95 SDLKELAHQV------AMGMAYL-ESKHF--VHRDLAARNVLLVNRHQAKISDFGMSRAL 145
Query: 335 PETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT 377
+ A + E + G + KS+VWS+G+ L E +
Sbjct: 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 44/200 (22%)
Query: 271 GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330
D P+D + ++ + AQG+ FL + ++ + + N+ + AK+ +G
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 331 AGHIPETDISNSS--VAAAN-------LSVETLERGLLTPKSNVWSFGIVLLELLTGRKN 381
A DI N S V N ++ E++ + T +S+VWS+GI+L E+ + K+
Sbjct: 259 A-----RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
Query: 382 ------LDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
++S+ K + + SRP A P + I C
Sbjct: 314 PYPGILVNSKFYKMVKRGYQMSRPDFA-----------------PPEIYS----IMKMCW 352
Query: 436 QKEPSERPTMRSIFEELDRQ 455
EP+ERPT I + + RQ
Sbjct: 353 NLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 29/239 (12%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
++ I +V L L+HPN + G + ++ + L+ E + D L + P+
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHT--AWLVMEYCLGSASDLLEVHKK---PLQE 120
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI-PETDI 339
I A QGL +LH ++ + NI + + KL+ +G A P
Sbjct: 121 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF 177
Query: 340 SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399
+ A + ++ G K +VWS GI +EL ER ++
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-------------AERKPPLFNMN 224
Query: 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT----MRSIFEELDR 454
++ ++ P L+ + R D CLQK P ERP +R F DR
Sbjct: 225 AMSALYHIAQNDSPTLQSNEWTDSFRGFVDY---CLQKIPQERPASAELLRHDFVRRDR 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 292 QGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--L 349
Q L +LH +G ++ + + +I + D KLS +G I + S+ +
Sbjct: 128 QALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184
Query: 350 SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409
+ E + R + ++WS GI+++E++ G S P + ++ S P
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP---------- 234
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
P+LK K + + D R L +EP ER T + + +
Sbjct: 235 ---PKLKNAH--KISPVLRDFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 187 LSSVMYRASFGD-----DASTSKKFEATVTRLNPSSQGVKEFIN----DVNTLASLQHPN 237
L ++ R +FG+ DA T ++ +P SQ + +N ++ L +L+H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 238 LCKLLGFHARDGSDQRMLIY-ERLFHGSL-DRL-IYGRSDGPPIDWNTRVKIALCAAQGL 294
+ + G RD ++++ I+ E + GS+ D+L YG + N + QG+
Sbjct: 66 IVQYYGC-LRDPEEKKLSIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGV 119
Query: 295 TFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-----L 349
++LH ++ + ANI D + KL +G + I +S + + + +
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 350 SVETLERGLLTPKSNVWSFGIVLLELLT 377
S E + K++VWS ++E+LT
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 25/230 (10%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S++ ++ I +V L L+HPN + G + R+ + L+ E + D L +
Sbjct: 55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKK-- 110
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI- 334
P+ + A QGL +LH ++ + NI + + KL +G A +
Sbjct: 111 -PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 335 PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394
P + A + ++ G K +VWS GI +EL ER
Sbjct: 167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-------------AERKPP 213
Query: 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
++ ++ ++ P L+ + R D CLQK P +RPT
Sbjct: 214 LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 50/248 (20%)
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRM-LIYERLFHGSLDRLIYGRSDGPP--IDWNT 282
++ L L+H NL L+ R +R+ L++E + H LD L + P +D +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRK---KRLYLVFEFVDHTVLDDL-----EKYPNGLDESR 101
Query: 283 RVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET-DISN 341
K +G+ F H ++ + NI + + KL +G A + ++
Sbjct: 102 VRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
Query: 342 SSVA-----AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRK---------------- 380
VA A L V + G ++W+ G ++ E+LTG
Sbjct: 159 DYVATRWYRAPELLVGDTKYG---RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215
Query: 381 ---NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ-LKGRFPLKAARTVADIALRCLQ 436
NL RH + + + + F RL + + + L+ RFP K + V D+A +CL+
Sbjct: 216 CLGNLIPRH----QEIFQKNPLFAG--MRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLR 268
Query: 437 KEPSERPT 444
+P +RP+
Sbjct: 269 IDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 22/155 (14%)
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHIPETDISNSSVAAANLSVE 352
L FLHE G +Y + N+ +D + KL+ YG C I D +++ N
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAP 165
Query: 353 TLERGLLTPKS-NVWSFGIVLLELLTGRKNLD----SRHPKEERNLVKWSRPFLADDCRL 407
+ RG S + W+ G+++ E++ GR D S +P + +D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN-----------TEDYLF 214
Query: 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
+I++ Q+ R P + + + L K+P ER
Sbjct: 215 QVILEKQI--RIPRSLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 47/241 (19%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
++F+++ + + H N+ +L G + M+I E + +G+LD+ Y R
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTK--FKPAMIITEYMENGALDK--YLRDHDGEFSS 106
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340
V + A G+ +L + ++ + + NI ++ + K+S +G + + +
Sbjct: 107 YQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163
Query: 341 NSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
+ + + + E + T S+VWSFGIV+ E+++ +
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE--------------- 208
Query: 396 WSRPF--LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
RP+ +++ + I D + P+ V + L+C Q++ + RP I LD
Sbjct: 209 --RPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
Query: 454 R 454
+
Sbjct: 266 K 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 40/178 (22%), Positives = 63/178 (35%), Gaps = 39/178 (21%)
Query: 236 PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP-PIDW--NTRVKIALCAAQ 292
P + KL +++ D L+ E L G LI ++ G P DW ++ L
Sbjct: 57 PYVAKL--YYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLG--- 109
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN---- 348
+ LH+ G ++ + N+ ID+ GH+ TD S N
Sbjct: 110 -VEDLHQRG---IIHRDIKPENLLIDQ-----------TGHLKLTDFGLSRNGLENKKFV 154
Query: 349 -----LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-----ERNLVKW 396
L+ ET+ S+ WS G V+ E L G + P + W
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG-CAGHI-PETDISNSSVAAANLS 350
GL FLH +G +Y + N+ +D+D K++ +G C ++ + S ++
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIA 164
Query: 351 VETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410
E L+ T + WSFG++L E+L G+ H +E L + S+
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF---HGDDEDELFE------------SIR 209
Query: 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
+D R+ K ++ DI + +++P+ R
Sbjct: 210 VDTPHYPRWITKESK---DILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 55/252 (21%), Positives = 92/252 (36%), Gaps = 38/252 (15%)
Query: 215 PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD---RLIYG 271
S Q +F+ + ++ H N+ +L+G R ++ E + G L R
Sbjct: 48 CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRP 105
Query: 272 RSDGP-PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSG 327
R + P + + A A+G +L E ++ + + N + AK++
Sbjct: 106 RPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIAD 162
Query: 328 YGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKN 381
+G A I A L + E G+ T K++VWSFG++L E+ + G
Sbjct: 163 FGMARDIYRASYYRKG-GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
Query: 382 LDSRHPKEERNLV-KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440
R +E V R +DP P V I C Q P
Sbjct: 222 YPGRTNQEVMEFVTGGGR------------LDP------PKGCPGPVYRIMTDCWQHTPE 263
Query: 441 ERPTMRSIFEEL 452
+RP +I E +
Sbjct: 264 DRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 473 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.16 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.02 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.98 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.87 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.86 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.47 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.3 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.26 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.77 | |
| PLN02236 | 344 | choline kinase | 96.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.61 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.32 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.14 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.13 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.08 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.82 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.78 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.55 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.36 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.15 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.52 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.42 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.23 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.9 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.68 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 92.16 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-56 Score=444.03 Aligned_cols=289 Identities=43% Similarity=0.732 Sum_probs=250.7
Q ss_pred CCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChh-hHhHHHHHHHHHhCCCCCcc
Q 011995 161 TLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHPNLC 239 (473)
Q Consensus 161 ~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv 239 (473)
..+.|+++||..+|++|...+.||+|+||.||+|.+.++. . ++|+++...... ..+|.+|+++|.+++|||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~----~--vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGT----V--VAVKRLSSNSGQGEREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCC----E--EEEEEecCCCCcchhHHHHHHHHHhcCCCcCcc
Confidence 5677999999999999999999999999999999998862 2 444555543332 66799999999999999999
Q ss_pred cceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 240 ~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
+|+|||.+.+. +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||...+++|||||||++|||||+
T Consensus 135 ~LlGyC~e~~~-~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 135 KLLGYCLEGGE-HRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE 212 (361)
T ss_pred cEEEEEecCCc-eEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence 99999997631 699999999999999999875433 8999999999999999999999999888999999999999999
Q ss_pred CCcEEEeccCCCcccCC-CCc-cCc-ccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 320 DFSAKLSGYGCAGHIPE-TDI-SNS-SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~-~~~-~~~-~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
++++||+|||+|+..+. ... ... .||.+|++||++..+..+.++|||||||+|+||+||+.+.+...+.....++.|
T Consensus 213 ~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 99999999999977654 322 222 789999999999999999999999999999999999999987655555568899
Q ss_pred cccccccccccccccccccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 397 SRPFLADDCRLSLIMDPQLK-GRFPL-KAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
..+.+.++ .+..++|+.+. +.++. .....+..++.+|++.+|.+||+|.||++.|+.+...
T Consensus 293 ~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 293 AKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88877776 88999999987 66664 6778899999999999999999999999999776644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=401.23 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=220.2
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceee
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
+++.||+.. +.||+|..|+||++. +..+.+.+|.|++.+.......+++.+|+++++.++||+||.+||.
T Consensus 76 i~~~dle~~-------~~lG~G~gG~V~kv~---Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~yga 145 (364)
T KOG0581|consen 76 ISLSDLERL-------GVLGSGNGGTVYKVR---HKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGA 145 (364)
T ss_pred cCHHHhhhh-------hhcccCCCcEEEEEE---EcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence 677788776 999999999999999 4556788999999888888889999999999999999999999999
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcE
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
|+.++. .++|+||||++|||++++.. .+.+++....+|+.+|++||.|||+ ++ ||||||||+|||++..|+|
T Consensus 146 F~~~~~-~isI~mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeV 218 (364)
T KOG0581|consen 146 FYSNGE-EISICMEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEV 218 (364)
T ss_pred EEeCCc-eEEeehhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCE
Confidence 998743 69999999999999999843 3579999999999999999999996 66 9999999999999999999
Q ss_pred EEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCCh--HHHHhHhhhccccc
Q 011995 324 KLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP--KEERNLVKWSRPFL 401 (473)
Q Consensus 324 kl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~ 401 (473)
||||||.++.+.+....+++||..|||||.+.++.|+.++||||||++++||.+|+.||..... .....+..
T Consensus 219 KicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~------ 292 (364)
T KOG0581|consen 219 KICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC------ 292 (364)
T ss_pred EeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH------
Confidence 9999999998877777889999999999999999999999999999999999999999987411 11111111
Q ss_pred ccccccccccccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRFPLK-AARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.+.. ...+|.. ++.++++|+..||++||.+||++.|++++
T Consensus 293 -------~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 293 -------AIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -------HHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122211 1123443 88999999999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=390.75 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=211.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
..||+|+||+||+|.+++... ++++.+.. .....+.|.+|+.+|.+++|||||+++|+|.... ..++|||
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~------vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iVt 119 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDV------VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIVT 119 (362)
T ss_pred hhcccCCceeEEEEEeCCcee------EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEEE
Confidence 669999999999999987652 33333332 2222678999999999999999999999998752 2699999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccCCCcccCC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGCAGHIPE 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~ 336 (473)
|||++|+|.++++.. ....+++..++.|+.|||+||.|||++++ |||||||++|||++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999999764 35679999999999999999999999984 99999999999999997 999999999987755
Q ss_pred --CCccCcccccccCChhhhh--cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 337 --TDISNSSVAAANLSVETLE--RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 337 --~~~~~~~~t~~y~aPE~~~--~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
...+...||..|||||++. ...|+.++|||||||++|||+||+.||.+....+.... +..
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~----------------v~~ 260 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA----------------VVV 260 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----------------HHh
Confidence 3444578999999999999 56899999999999999999999999998775322111 112
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
...+..++..+...+..++.+||..||.+||++.+|+..|+.+......
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 2233344556788999999999999999999999999999988776554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.16 Aligned_cols=248 Identities=21% Similarity=0.380 Sum_probs=216.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..|..+++||+|||+.||+++ +..++..+|+|++... .+....+.+.+||+|.+.|+|||||++++||++. ++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~---~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs--~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEAR---DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS--NN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEE---EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC--Cc
Confidence 468999999999999999998 4445566677776543 3556678899999999999999999999999876 89
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|||+|+|..++|..++. ....+++.++..++.||+.||.|||+++ |||||||..|+||+++.+|||+|||||.
T Consensus 93 VYivLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceee
Confidence 999999999999999985 3457999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.+... .-.+.+|||.|+|||++.....+..+||||+|||+|-||.|++||....-.+....|.-..
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------------ 234 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------------ 234 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC------------
Confidence 88643 4467799999999999999889999999999999999999999999877666655553221
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..+|..++.++.+||.++|+.||.+|||+.+||..
T Consensus 235 ------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12366788999999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=378.89 Aligned_cols=262 Identities=23% Similarity=0.411 Sum_probs=220.3
Q ss_pred CCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCccc
Q 011995 161 TLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240 (473)
Q Consensus 161 ~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~ 240 (473)
....+..+++... +.||+|-||.||.|.+..... ++++.+.......+.|.+|+++|.+|+|+|||+
T Consensus 199 d~wei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~------vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~ 265 (468)
T KOG0197|consen 199 DPWEIPREELKLI-------RELGSGQFGEVWLGKWNGSTK------VAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVK 265 (468)
T ss_pred CCeeecHHHHHHH-------HHhcCCccceEEEEEEcCCCc------ccceEEeccccChhHHHHHHHHHHhCcccCeEE
Confidence 3445666777665 899999999999999987643 333333333455688999999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 241 l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
++|+|..+ +.+|||||||+.|+|.++|.. ..+..+.....+.++.|||+|++||++++ +|||||.+.||||+++
T Consensus 266 l~gV~~~~--~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 266 LYGVCTKQ--EPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDED 339 (468)
T ss_pred EEEEEecC--CceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccC
Confidence 99999876 579999999999999999975 34677999999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCccCccc---ccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhh
Q 011995 321 FSAKLSGYGCAGHIPETDISNSSV---AAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~~~~~~---t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 396 (473)
..+||+|||+|+....+.+....+ ...|.|||.+..+.++.+||||||||+||||+| |+.||.+....+....++
T Consensus 340 ~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le- 418 (468)
T KOG0197|consen 340 LVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE- 418 (468)
T ss_pred ceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-
Confidence 999999999999665555543333 468999999999999999999999999999998 999999887766555443
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.+.++ ..|..++.++.+++..||..+|++|||++.+...|+++...
T Consensus 419 ------~GyRl----------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 419 ------RGYRL----------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ------ccCcC----------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 22222 23778899999999999999999999999999999987653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=366.35 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=201.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..+|...+.||+|+||+||+|++.+... .+++|.+.... .....+.+..|+.+|+.++|||||.|++++..+ +.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~---~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGT---EVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCc---eEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--Ce
Confidence 4678888999999999999999876553 33333332222 445567788999999999999999999999887 89
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC------CcEEEe
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD------FSAKLS 326 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~------~~vkl~ 326 (473)
+|||||||+||+|.++|+.+ +.+++.++..++.|++.||++||+++ ||||||||.||||+.. -.+||+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEec
Confidence 99999999999999999654 37999999999999999999999999 9999999999999764 468999
Q ss_pred ccCCCcccCCCCc-cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 327 GYGCAGHIPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 327 DFGla~~~~~~~~-~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
|||+|+.+..... .+.+|++.|||||++....|+.|+|+||+|+|+|+|++|.+||......+....++....
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~------ 231 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE------ 231 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc------
Confidence 9999999976644 567999999999999999999999999999999999999999998777666554433221
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 448 (473)
+...++...+..+.+++...++.++.+|.+..+-
T Consensus 232 ---------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 232 ---------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred ---------ccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 1112233444555667777777777777665543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=370.16 Aligned_cols=253 Identities=17% Similarity=0.252 Sum_probs=207.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh------hhHhHHHHHHHHHhCCCCCcccceeeeec
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ------GVKEFINDVNTLASLQHPNLCKLLGFHAR 247 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 247 (473)
.+.|...+.||+|+||.|-+|. ...+++.+|+|++....... ....+.+|+++|++++|||||++++++..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~---e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAY---EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred cceeEeeeeecCCceeEEEEEE---EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 4567888999999999999998 56677888888876543211 23446799999999999999999999987
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---CcEE
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---FSAK 324 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~vk 324 (473)
. +..||||||+.||+|.+.+.. .+.+.+..-+.+++|++.||.|||++| |+||||||+|||+..+ ..+|
T Consensus 248 ~--ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 248 P--DSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred C--CceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEE
Confidence 6 788999999999999999954 446788888999999999999999999 9999999999999766 7799
Q ss_pred EeccCCCcccCCCC-ccCcccccccCChhhhhcCC---CCCcCCchHHHHHHHHHHcCCCCCCCCChHH-HHhHhhhccc
Q 011995 325 LSGYGCAGHIPETD-ISNSSVAAANLSVETLERGL---LTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-ERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~---~s~~sDvwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~ 399 (473)
|+|||+|+...... +.+.+||+.|.|||++.+.. +..++||||+||+||.+++|.+||.+..... ..+.+...+-
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 99999999886553 46779999999999997654 3348899999999999999999998765443 3333322111
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ........++++..+||.+||..||++|||+.|+|+.
T Consensus 400 ~--------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 A--------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred c--------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 0011245788999999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=371.10 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=217.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.+.|+....||+|+||.||+|+ +..+++.+|+|.+++.. ......-..+||.||++|.|||||+|.+...+.....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr---~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKAR---DLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEee---ecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 3456666899999999999998 66788899999998876 3444566789999999999999999999998875678
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|||+|||++ +|..++. ..+..|+..+++.++.|++.||+|||.++ |+|||||.+|||||.+|.+||+|||||+
T Consensus 193 iYlVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence 9999999987 8988884 34567999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCC---CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc-
Q 011995 333 HIPET---DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL- 407 (473)
Q Consensus 333 ~~~~~---~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 407 (473)
++... .+++.++|.||.|||.+.|.. |+.+.|+||.||||.||++|++.|.+..+.++.+.|-.......++.+.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 77543 467789999999999998864 9999999999999999999999999999888877663221111111110
Q ss_pred ---c--ccccc------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 408 ---S--LIMDP------QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 408 ---~--~~~~~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. ..+.+ .+.+. -...+....+|+..+|..||.+|.|+.++|+
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 01111 11111 1234567789999999999999999999885
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=347.19 Aligned_cols=264 Identities=18% Similarity=0.277 Sum_probs=206.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChh-hHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+.|+...++|+|+||+||+|+.+ .++..+|+|...-...... .+-.++||.+|++++|+|+|.|+++|... ..+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk---~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk--rkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK---DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK--RKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC---CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--cee
Confidence 46777899999999999999844 4556655555443333333 44568999999999999999999999776 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||+|||+. ++.+-|... ...++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.
T Consensus 77 hLVFE~~dh-TvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFART 150 (396)
T ss_pred EEEeeecch-HHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHh
Confidence 999999988 444445433 334888999999999999999999999 99999999999999999999999999998
Q ss_pred cC--CCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc-cc-------cc
Q 011995 334 IP--ETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR-PF-------LA 402 (473)
Q Consensus 334 ~~--~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-~~-------~~ 402 (473)
+. ...++..+.|.||.|||.+.+ ..|+..+|||++||++.||++|++.|.+..+.++...|.... .. ..
T Consensus 151 L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 151 LSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred hcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 85 334566788999999999988 569999999999999999999999999988777665553211 00 11
Q ss_pred c-----ccccccccccc-cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 403 D-----DCRLSLIMDPQ-LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 403 ~-----~~~~~~~~~~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. +..+....++. +...++ ..+.-+.+|+..||+.||++|++.++++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 11111111211 122222 55668899999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=350.55 Aligned_cols=259 Identities=15% Similarity=0.225 Sum_probs=206.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|++.++||+|.||.||++.. ..+++.++.|.+.... .....+....|+.+|++|+|||||+++++...++..-++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~---~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQC---LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeee---ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 466669999999999999983 3344555555444432 345567789999999999999999999865544435589
Q ss_pred EEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 255 LIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGP-FQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
||||||++|+|..++... .....+++.++++++.|++.||.++|..-+ ..|+||||||.||+|+.+|.|||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999998553 345678999999999999999999998331 139999999999999999999999999999
Q ss_pred ccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.+.... ..+.+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+.+-.+.-..|...
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg------------- 243 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG------------- 243 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-------------
Confidence 886553 24568999999999999999999999999999999999999999987544433222211
Q ss_pred cccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 411 MDPQLKGRFP-LKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 411 ~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
. ...+| ...+.++..+|..|+..||..||+.-.++..+..
T Consensus 244 ---d-~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 ---D-YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---C-CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 11124 6788999999999999999999996555555543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=354.77 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=206.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||.||.++.. .+.+.+|+|+.+... .....+...+|..||..++||+||+++-.|++. +
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~---dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKK---DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE--E 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEc---ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC--C
Confidence 457888899999999999999854 567888888766542 334567889999999999999999998777665 8
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|||+||+.||.|.-+|. ..+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||.+|+++|+||||+
T Consensus 99 kLylVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred eEEEEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccc
Confidence 9999999999999999994 3457999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
+..... ...+.+||+.|||||++.+..|+.++|+||||+++|||++|.+||...+.....+.+....
T Consensus 173 k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k----------- 241 (357)
T KOG0598|consen 173 KEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK----------- 241 (357)
T ss_pred hhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----------
Confidence 855332 3455699999999999999999999999999999999999999999888766655443221
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 444 (473)
....+...+.++++++.++|.+||.+|.-
T Consensus 242 ------~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ------LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ------CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 00113346788999999999999999963
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=333.48 Aligned_cols=265 Identities=18% Similarity=0.278 Sum_probs=215.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh-hhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+|...+.||+|.||+||+|+ +..+++.+|+|.+++....+ ......+||+.|+.++|+||+.++++|... +.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~---d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~--~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKAR---DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK--SNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEE---ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC--Cce
Confidence 357777999999999999998 55677888888877765433 346789999999999999999999999766 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
.||+|||+. +|...+.. ....++...+..++.++++||+|||.++ |+||||||.|+||+.+|.+||+|||+|+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred EEEEEeccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence 999999966 99999954 4567899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCC--ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc--------cccc
Q 011995 334 IPETD--ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR--------PFLA 402 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~ 402 (473)
+.... ....+.|.||.|||.+.|.. |+...||||.|||+.||+-|.+-|.+..+.++...+-.+. |-+.
T Consensus 151 f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 151 FGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 86543 34448899999999997764 9999999999999999999999999988887776663221 1111
Q ss_pred ---cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 403 ---DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 403 ---~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+-..+...-.+.+..-| ..++.++.+|+..+|..||.+|+|+.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111122222222 3566777999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.19 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=214.4
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeec
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHAR 247 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 247 (473)
....++|..++.||+|+|++|++|+ +..+.+.+|+||.... ..+..++.+.+|-++|.+| .||.||+|+--|.+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~---~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAR---EKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD 145 (604)
T ss_pred cCChhhcchhheeccccceeEEEee---ecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence 4556889999999999999999998 4557788888875433 2344556778899999999 89999999877766
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
+ ..+|+|+||+++|+|.++|.+ -+.|++.....++.+|+.||+|||++| ||||||||+|||||.||.+||.|
T Consensus 146 ~--~sLYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITD 217 (604)
T KOG0592|consen 146 E--ESLYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITD 217 (604)
T ss_pred c--cceEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEee
Confidence 5 899999999999999999954 357999999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccCCCC---------------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 328 YGCAGHIPETD---------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 328 FGla~~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
||.|+.+.... ...++||..|.+||++..+..++.+|||+||||||.|+.|.+||.+.++.....
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 99998774211 134789999999999999999999999999999999999999999888766555
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.|.. +.-.|+...++.+.+||.++|..||.+|+|..+|.++
T Consensus 298 kI~~------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 KIQA------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHH------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 4431 1123456666899999999999999999999888654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.53 Aligned_cols=257 Identities=21% Similarity=0.343 Sum_probs=203.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|...+.||+|+||+||++...++ +...++|......... .+.+.+|+.+|++++|||||+++|.........++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~---g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKT---GELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCC---Ccceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 4567779999999999999996653 3344455554442222 67789999999999999999999975443213689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-CCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-DFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 333 (473)
+.|||+++|+|.+++.... + .|++..+..++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||++..
T Consensus 93 i~mEy~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccc
Confidence 9999999999999996542 2 7999999999999999999999999 999999999999999 79999999999987
Q ss_pred cCC-----CCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCC-ChHHHHhHhhhcccccccccc
Q 011995 334 IPE-----TDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSR-HPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 334 ~~~-----~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 406 (473)
... .......||+.|||||++..+ ....++|||||||+++||+||.+||... ........+
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i------------ 235 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI------------ 235 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH------------
Confidence 652 223456889999999999853 3446999999999999999999999863 211111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
........+|..++.++.+|+.+|+.+||++||||.++|+..--..
T Consensus 236 ----g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 236 ----GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 0001112456778899999999999999999999999998766433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=355.65 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=207.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
..|.....||+|..|.||.|.-.. ....++++.+.+. .....+-+++|+.+|+..+|+|||.+++.|... +.+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeecc---CCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeE
Confidence 346777899999999999998433 3333444444332 223345578999999999999999999988876 8899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|||||++|+|.|.+. ...+++.+++.|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+
T Consensus 347 VVMEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 9999999999999983 345999999999999999999999999 999999999999999999999999998776
Q ss_pred CCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
... ...+.+||+.|||||++....|+++.||||||+|++||+.|++||-..++.....++.-.
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n--------------- 484 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------------- 484 (550)
T ss_pred ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc---------------
Confidence 544 345669999999999999999999999999999999999999999877666555444211
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....-..+..++..+++|+.+||+.|+.+|+++.|+|+.
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111223477889999999999999999999999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=340.30 Aligned_cols=267 Identities=19% Similarity=0.241 Sum_probs=214.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhh-HhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.|++|+||.||+|+ +..+...+|.|..+......+. -.-++||.+|.+++|||||.+-.+.....-+.+|
T Consensus 77 efe~lnrI~EGtyGiVYRak---dk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAK---DKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHhhcccCcceeEEEec---cCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34555999999999999998 5556666666666554433332 3468999999999999999999998877778899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||||||++ +|..++... ..+|...+++.++.|++.||+|||.++ |+|||||++|+|+++.|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999977 999988543 467999999999999999999999999 999999999999999999999999999988
Q ss_pred CCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc--------ccccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR--------PFLAD 403 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~ 403 (473)
... .++..++|.||.|||.+.+.. |+.+.||||+|||+.||+++.+.|.+....++.+.|-... |-+..
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 654 467779999999999998765 9999999999999999999999999988877766553111 11110
Q ss_pred c-----cccccccccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 D-----CRLSLIMDPQLKGRFPLK-AARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~-----~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
- ..........++..|+.. .++..++|+..+|..||.+|.|+.|.|+.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 011111222344455544 67889999999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=359.06 Aligned_cols=266 Identities=19% Similarity=0.247 Sum_probs=210.2
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHh--HHHHHHHHHhCC-CCCcccceeeeecCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE--FINDVNTLASLQ-HPNLCKLLGFHARDG 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~Ei~~l~~l~-HpnIv~l~g~~~~~~ 249 (473)
..++|...+.||.|+||.||+|+-. ..+..+|+|.++.+ -...++ =+||+..|++++ |||||+|.+++.+..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~---~~~~~VAIK~MK~K--f~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSK---ETGELVAIKKMKKK--FYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeec---CCCceeeHHHHHhh--hccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3567888899999999999999843 34444444433322 222333 368999999998 999999999988763
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
..+++|||||+. +|.+++..+ ...|++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||
T Consensus 83 -~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 83 -RILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred -ceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccc
Confidence 399999999966 999999665 678999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC-CccCcccccccCChhhhh-cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc----
Q 011995 330 CAGHIPET-DISNSSVAAANLSVETLE-RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD---- 403 (473)
Q Consensus 330 la~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 403 (473)
+|+.+... .++..+.|.||.|||++. .+.|+.+.|||++|||++|+++-++.|.+.++.++...+......-..
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 99988655 456678899999999985 566999999999999999999999999999888877666432111111
Q ss_pred -ccccccccccc--------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 -DCRLSLIMDPQ--------LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 -~~~~~~~~~~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+..+...++=. +..-++ +++.++.++|.+|+.+||.+||||.++++.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111 111122 488999999999999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=356.69 Aligned_cols=263 Identities=21% Similarity=0.345 Sum_probs=209.1
Q ss_pred CCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcc
Q 011995 161 TLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLC 239 (473)
Q Consensus 161 ~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv 239 (473)
....++++|+... ..||+|.||+||+|.|.++. |||+.... ...+..+.|++|+.++++-+|.||+
T Consensus 385 ~~WeIp~~ev~l~-------~rIGsGsFGtV~Rg~whGdV------AVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 385 EEWEIPPEEVLLG-------ERIGSGSFGTVYRGRWHGDV------AVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred cccccCHHHhhcc-------ceeccccccceeecccccce------EEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhe
Confidence 4455666666544 89999999999999998763 24444333 3555678899999999999999999
Q ss_pred cceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 240 ~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
-+.|||..+ .+.||..+|.|-+|+.+|+.. ...|+..+...||.||++|+.|||.++ |||||||..||+|++
T Consensus 452 LFMG~~~~p---~~AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 452 LFMGACMNP---PLAIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHE 523 (678)
T ss_pred eeehhhcCC---ceeeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEcc
Confidence 999999765 449999999999999999754 357999999999999999999999999 999999999999999
Q ss_pred CCcEEEeccCCCcccC----CCCccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 320 DFSAKLSGYGCAGHIP----ETDISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~----~~~~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
++.|||+||||+..-. ........+...|||||++.. ..|++.+||||||||+|||+||..||......+
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--- 600 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--- 600 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---
Confidence 9999999999986432 233445567789999999854 358999999999999999999999998433222
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
|-|.. ..+.. ..|. .....++..++.+|+..||..++++||.+.+||..|+.+..
T Consensus 601 -IifmV---GrG~l---~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 601 -IIFMV---GRGYL---MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -eEEEe---ccccc---Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 22211 11100 0000 01134677899999999999999999999999998888776
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=378.97 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=224.5
Q ss_pred cCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
..+.||+|.||.||+|...+.........|+||.+++ +.+...+|.+|+++|..++|||||+|+|.|..+ +.+|||
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~P~~Mv 567 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG--DPLCMV 567 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--CeeEEE
Confidence 3389999999999999987776666777788887765 344678999999999999999999999999877 899999
Q ss_pred EEeccCCChhhhhhcCC-------CC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEE
Q 011995 257 YERLFHGSLDRLIYGRS-------DG----PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~-------~~----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl 325 (473)
+|||..|||.++|.... .+ .+|+..+.+.||.|||.|++||-++. +|||||.+.|+||+++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEe
Confidence 99999999999996532 12 23889999999999999999999998 999999999999999999999
Q ss_pred eccCCCcccCCCCccCcc----cccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccc
Q 011995 326 SGYGCAGHIPETDISNSS----VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 326 ~DFGla~~~~~~~~~~~~----~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
+|||+++.+...++.... ..++||+||.+..++|+.+||||||||+|||+++ |..||.+....+-.+.+...
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g--- 721 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG--- 721 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC---
Confidence 999999998887765443 4579999999999999999999999999999998 89999887666654444321
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
++ -..|.+++.++++|+..||+.+|.+||++.||-..|+.+......
T Consensus 722 -------------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 722 -------------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred -------------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 11 134788999999999999999999999999999999988765543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=357.34 Aligned_cols=265 Identities=21% Similarity=0.344 Sum_probs=205.7
Q ss_pred hcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|++.+.||+|+||.||+|.+.. .......+++|+............+.+|+.++..+ +|||||+++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN- 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence 3578888999999999999997532 22333445555554333344456789999999999 8999999999887543
Q ss_pred CceEEEEEeccCCChhhhhhcCCC--------------------------------------------------------
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSD-------------------------------------------------------- 274 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 274 (473)
..+++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 568999999999999999864311
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc----cCcccccc
Q 011995 275 ---GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAA 347 (473)
Q Consensus 275 ---~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~ 347 (473)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134888999999999999999999999 99999999999999999999999999976533211 12234578
Q ss_pred cCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHH
Q 011995 348 NLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAART 426 (473)
Q Consensus 348 y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 426 (473)
|+|||++.+..++.++|||||||++|||++ |..||.+.......... +..+. ....+..++..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~------~~~~~----------~~~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR------LKDGT----------RMRAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH------HhcCC----------CCCCCCCCCHH
Confidence 999999998899999999999999999997 99999865432211100 00000 00113345678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 427 VADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 427 l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
+.+++.+||+.||.+|||+.+|++.|+++..+
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=352.17 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=215.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
.|....+||+|.||.||+|. +..+.+.+++|++.+.......+.+.+|+.+|..++++||.++||.+..+ ..+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~---d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g--~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAI---DNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG--TKLWI 88 (467)
T ss_pred ccccchhccccccceeeeee---eccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec--ccHHH
Confidence 46666899999999999998 66688999999999998888889999999999999999999999998876 88999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
+||||.+|++.+.|. .+..+++..+..++.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||++....
T Consensus 89 iMey~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeee
Confidence 999999999999993 4455688899999999999999999999 9999999999999999999999999998776
Q ss_pred CCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 336 ETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 336 ~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
... ..+++||+.|||||++....|+.++||||||++.+||.+|.+|+...+++.... ++..
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------------lIpk 225 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------------LIPK 225 (467)
T ss_pred chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------------eccC
Confidence 553 357799999999999998899999999999999999999999999877633221 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....+...++..+++|+..||.+||+.||+|.++|+.
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22222334667889999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=343.01 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=211.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+.|+....||.|..++||+|+.. .....+++|+..+.........+.+|+..|+.++||||++++..|..+ ..+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~---p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~--~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCI---PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD--SEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeec---ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec--cee
Confidence 356888899999999999999843 344666777777776666789999999999999999999999888876 899
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+||.||.+||+.+++...... .+++..+..|+++++.||.|||.+| .||||||+.||||+.+|.|||+|||.+..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999764333 4999999999999999999999999 99999999999999999999999998755
Q ss_pred cCCC------CccCcccccccCChhhhh--cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 334 IPET------DISNSSVAAANLSVETLE--RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 334 ~~~~------~~~~~~~t~~y~aPE~~~--~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
+... +..+.++|++|||||++. ...|+.|+||||||++.+||.+|+.||....+.......-...+....
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-- 253 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-- 253 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc--
Confidence 4322 124568899999999953 345999999999999999999999999988776655433322222111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+..+-....+..+++++..||++||.+|||++++++.
T Consensus 254 ------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 ------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011111133456689999999999999999999999863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.21 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=207.2
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CC-hhhHhHHHHHHHHHhCC-CCCcccceeeee
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SS-QGVKEFINDVNTLASLQ-HPNLCKLLGFHA 246 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~ 246 (473)
...++|..++.||+|+||.|+.|.... +...+++++..... .. ...+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 446789999999999999999998543 33555666443321 11 34566778999999998 999999999998
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEE
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKL 325 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl 325 (473)
.. ..+++||||+.+|+|.+++.. ..++.+..+..++.|++.|++|||+++ |+||||||+|||++.+ +++||
T Consensus 91 t~--~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 91 TP--TKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred cC--CeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEE
Confidence 87 669999999999999999954 457899999999999999999999999 9999999999999999 99999
Q ss_pred eccCCCcccC--CCCccCcccccccCChhhhhcCC-CC-CcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 326 SGYGCAGHIP--ETDISNSSVAAANLSVETLERGL-LT-PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 326 ~DFGla~~~~--~~~~~~~~~t~~y~aPE~~~~~~-~s-~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
+|||++.... .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+.......+....
T Consensus 163 ~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~--- 239 (370)
T KOG0583|consen 163 SDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE--- 239 (370)
T ss_pred eccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC---
Confidence 9999999883 34567789999999999999877 75 78999999999999999999999865544433322110
Q ss_pred ccccccccccccccCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKA-ARTVADIALRCLQKEPSERPTMRSIF 449 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~eil 449 (473)
-.+|..+ +.++..++.+||..||.+|+|+.+|+
T Consensus 240 ---------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 ---------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1234444 89999999999999999999999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.44 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=207.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|.+...||+|.||+||+|+ ...+.+.++++.+... ..+...+.+.+|++|++.++|||||.++++|+.. .++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgr---rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGR---RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecc---cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceE
Confidence 467777899999999999998 5556667777765443 2444567799999999999999999999999876 899
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+|.||+.| +|..+|. ....+++..+..|+.+++.||.|||+.+ |+|||+||.|||++..|.+|+||||+|+.
T Consensus 77 ~vVte~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARA 149 (808)
T ss_pred EEEehhhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhh
Confidence 999999966 9999994 4557999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
+..+. .+...||+.|||||.+.+..|+..+|+||+|||+|||++|++||...... +++.. ...+
T Consensus 150 m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv~~---I~~d-------- 215 (808)
T KOG0597|consen 150 MSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLVKS---ILKD-------- 215 (808)
T ss_pred cccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHHHH---HhcC--------
Confidence 75442 35568999999999999999999999999999999999999999653322 22221 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+. .+|.+.+..+.+|+...|.+||.+|.|-.+++.
T Consensus 216 -~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 -PV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11 236688999999999999999999999998875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=344.97 Aligned_cols=267 Identities=19% Similarity=0.298 Sum_probs=206.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||++..... ...+++++............+.+|+++|+.++||||+++++++..+ +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPS---GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCC---CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 36788999999999999999986543 3455566655443444567899999999999999999999998776 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 999999999999999954 335899999999999999999999864 399999999999999999999999999987
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc-------
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR------- 406 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 406 (473)
..........++..|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +.......
T Consensus 154 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (331)
T cd06649 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISP 231 (331)
T ss_pred ccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCc
Confidence 655444556788999999999988899999999999999999999999976554332221110 00000000
Q ss_pred -------------------------cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 407 -------------------------LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 407 -------------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
...+.............+.++.+|+.+||+.||++|||+.+|++.-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000001123567899999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.99 Aligned_cols=251 Identities=22% Similarity=0.396 Sum_probs=210.0
Q ss_pred CCCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcc
Q 011995 160 GTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239 (473)
Q Consensus 160 ~~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv 239 (473)
.....+++++|... .-||.|+.|.||+|++.+..++ ||+.+ +.-..+|+-|++|+|+|||
T Consensus 116 ~e~WeiPFe~IsEL-------eWlGSGaQGAVF~Grl~netVA-------VKKV~------elkETdIKHLRkLkH~NII 175 (904)
T KOG4721|consen 116 EELWEIPFEEISEL-------EWLGSGAQGAVFLGRLHNETVA-------VKKVR------ELKETDIKHLRKLKHPNII 175 (904)
T ss_pred hhhccCCHHHhhhh-------hhhccCcccceeeeeccCceeh-------hHHHh------hhhhhhHHHHHhccCccee
Confidence 45667888988877 7899999999999999876643 32221 2223688999999999999
Q ss_pred cceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 240 ~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
.+.|+|... .++|||||||+.|-|...|. .+..+.......|..+||.|+.|||.+. |||||||.=||||..
T Consensus 176 ~FkGVCtqs--PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~ 247 (904)
T KOG4721|consen 176 TFKGVCTQS--PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISY 247 (904)
T ss_pred eEeeeecCC--ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeec
Confidence 999999876 89999999999999999994 4567888999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 320 DFSAKLSGYGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
+..|||+|||-++...... ...+.||..|||||++.+...+.|+|||||||||||||||..||.+-+... |-|.
T Consensus 248 ~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG- 322 (904)
T KOG4721|consen 248 DDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG- 322 (904)
T ss_pred cceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe-
Confidence 9999999999988765442 345789999999999999999999999999999999999999998654322 1121
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
+-...+.-..|..++.-+.-|+++||+..|..||++++|+..|+-
T Consensus 323 -----------VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 323 -----------VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -----------ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 111122223467788999999999999999999999999999984
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.74 Aligned_cols=249 Identities=18% Similarity=0.236 Sum_probs=213.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
+-|+.++-||.|+-|.|-.|+ +..++...++|++... ........+.+||.||+.+.||||+.+|+++++. .+
T Consensus 12 GpwkLgkTLG~Gstg~vrlak---h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~--~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAK---HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK--QH 86 (786)
T ss_pred cceeccccccCCCCceehhhh---cccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC--ce
Confidence 457788999999999999998 5556666667766544 2333456788999999999999999999999876 89
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|||+||+++|.|++++.. .+++++.++++++.||+.|+.|||..+ |+||||||+|+|||..+++||+|||+|.
T Consensus 87 lylvlEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred EEEEEEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceee
Confidence 9999999999999999954 357999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCC-CccCcccccccCChhhhhcCCCC-CcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPET-DISNSSVAAANLSVETLERGLLT-PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~s-~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.-..+ ...+.||.+.|.+||++.|..|. .++||||.|||||.||||+.||++.+.......++...
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------ 228 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------ 228 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------------
Confidence 76544 45678999999999999999985 78999999999999999999999877666555444221
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
...|.+++.++++|+.+||..||++|.|++||+++-
T Consensus 229 ------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 ------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 123678889999999999999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=336.28 Aligned_cols=265 Identities=18% Similarity=0.300 Sum_probs=207.1
Q ss_pred CCCCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCC
Q 011995 159 TGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHP 236 (473)
Q Consensus 159 ~~~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~Hp 236 (473)
....+.++.+++. ......||+|++|.||+|.+.+. .+++|+..... .....+.|.+|+.+|.+++||
T Consensus 9 ~~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 78 (283)
T PHA02988 9 INDIKCIESDDID-----KYTSVLIKENDQNSIYKGIFNNK-----EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN 78 (283)
T ss_pred cCcceecCHHHcC-----CCCCeEEeeCCceEEEEEEECCE-----EEEEEeccccccccHHHHHHHHHHHHHHHhcCCC
Confidence 3455667777773 33336799999999999997443 33344333221 122246788999999999999
Q ss_pred Ccccceeeeec--CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCC
Q 011995 237 NLCKLLGFHAR--DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTA 313 (473)
Q Consensus 237 nIv~l~g~~~~--~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~ 313 (473)
|||+++|++.+ ++...+++||||+++|+|.+++.. ...+++.....++.+++.||.|||.. + ++||||||+
T Consensus 79 nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~ 152 (283)
T PHA02988 79 NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSV 152 (283)
T ss_pred CEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChh
Confidence 99999999876 434678999999999999999954 34689999999999999999999985 6 889999999
Q ss_pred ceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH
Q 011995 314 NIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER 391 (473)
Q Consensus 314 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~ 391 (473)
|||++.++.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|||++|..||......+..
T Consensus 153 nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 153 SFLVTENYKLKIICHGLEKILSSPP-FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred hEEECCCCcEEEcccchHhhhcccc-ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999999999987654322 34467889999999976 67999999999999999999999999876544332
Q ss_pred hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
..+. ... ....++..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 232 ~~i~------~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 232 DLII------NKN----------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHH------hcC----------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2211 000 011123345678999999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.24 Aligned_cols=265 Identities=20% Similarity=0.360 Sum_probs=202.3
Q ss_pred cccccCcceeecCCceEEEEEECCCC-------------eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA-------------STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 241 (473)
++|...+.||+|+||.||+|.+.+.. .....+++|+............|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46888899999999999999865432 12234555555443344456789999999999999999999
Q ss_pred eeeeecCCCCceEEEEEeccCCChhhhhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 011995 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRS----------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQA 305 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i 305 (473)
++++.+. +..++||||+.+|+|.+++.... ....+++..+..++.||+.||.|||+.+ |
T Consensus 85 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 85 LGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 9999876 77999999999999999885421 1134788999999999999999999999 9
Q ss_pred eecCCCCCceeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc--CC
Q 011995 306 MYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT--GR 379 (473)
Q Consensus 306 vHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt--G~ 379 (473)
+||||||+|||++.++.+||+|||+++....... ....++..|+|||++.++.++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999976543322 22344678999999988889999999999999999986 56
Q ss_pred CCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 380 KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 380 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.||...........+. ........ ......+..++..+.+|+.+||+.||.+|||+.+|.+.|++
T Consensus 240 ~p~~~~~~~~~~~~~~---~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDEQVIENAG---EFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHHHHHHHHH---HHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7787654333221111 00000000 00001123455789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=323.07 Aligned_cols=238 Identities=16% Similarity=0.236 Sum_probs=203.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||.|+||.|.+++.+. ++..+|+|+..... .-...+...+|..+|+.+.||+++++++-+.+. ..
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC--Ce
Confidence 456667999999999999998544 45566666654432 223346678899999999999999999888765 89
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+||||||++||.|..+|++ .++|++..+..+|.||+.||+|||+.+ |++|||||+|||||.+|.+||.|||+|+
T Consensus 119 lymvmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EEEEEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceE
Confidence 9999999999999999954 457999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... ..+.+||+.|+|||.++...|+.++|.|+|||++|||+.|.+||...++....+.|...
T Consensus 193 ~v~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--------------- 256 (355)
T KOG0616|consen 193 RVSGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--------------- 256 (355)
T ss_pred EecCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC---------------
Confidence 87554 66789999999999999999999999999999999999999999988876655444311
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSER 442 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 442 (473)
. -.||...+.++.+|+..+|+.|-.+|
T Consensus 257 -~--v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 -K--VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -c--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 13577788999999999999999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=348.76 Aligned_cols=243 Identities=19% Similarity=0.275 Sum_probs=209.0
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
..++|...++||+|.||.|+++.+..+. ..+|+|+.+... ....++..+.|..|+... +||.++.|+..|.+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~---e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~- 441 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTN---EYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK- 441 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCC---cEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-
Confidence 3567888899999999999999976544 466676665442 556778889999998888 599999999999877
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
+++|+||||+.||++..+. ....|++..+..++.+|+.||+|||+++ |||||||.+|||||.+|.+||+|||
T Consensus 442 -~~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 442 -EHLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred -CeEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccc
Confidence 8999999999999965554 3346999999999999999999999999 9999999999999999999999999
Q ss_pred CCccc--CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 330 CAGHI--PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~--~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
+++.. .....++.+||+.|||||++.+..|+.++|+|||||+||||+.|+.||.+.++.+..+-|....
T Consensus 514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--------- 584 (694)
T KOG0694|consen 514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--------- 584 (694)
T ss_pred cccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 99764 3445677899999999999999999999999999999999999999999988877666543211
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 445 (473)
..||..++.++.+++.++|.++|++|.-+
T Consensus 585 ---------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ---------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 13577888999999999999999999866
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=314.31 Aligned_cols=251 Identities=19% Similarity=0.254 Sum_probs=212.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|++++.||+|-||.||.|+.+.+. -.+++||.-.. ...+...++.+|++|-+.|+||||+++|+||.++ .
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~---~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSL---FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--K 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCC---cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--c
Confidence 467888899999999999999965543 33444443322 1334457899999999999999999999999877 8
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..||++||...|+|...|... ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+
T Consensus 96 riyLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eeEEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCce
Confidence 899999999999999999653 3556899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
...+.+...+.+||..|++||...+...+..+|+|++|++.||++.|.+||......+....+....
T Consensus 172 V~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~------------- 238 (281)
T KOG0580|consen 172 VHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD------------- 238 (281)
T ss_pred eecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-------------
Confidence 8877777778899999999999999999999999999999999999999998766444333332111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
-.+|..++..+.++|.+|+.++|.+|.+..|+++.
T Consensus 239 -----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 -----LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12366788999999999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=373.49 Aligned_cols=259 Identities=23% Similarity=0.410 Sum_probs=218.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+....+.||+|.||.||+|.+.+.......+.+++|.+.. +.+...+|.+|..+|+.++|||||+++|+|.+. ...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CCc
Confidence 3445588999999999999997765544456666666654 577788999999999999999999999999985 788
Q ss_pred EEEEEeccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 254 MLIYERLFHGSLDRLIYGRS----DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
+|++|||.+|+|..+|+... ....+.....+.++.+||+|+.||++++ +|||||...|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997531 1456899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCCccCccc----ccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccc
Q 011995 330 CAGHIPETDISNSSV----AAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 330 la~~~~~~~~~~~~~----t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
+|+.+...++....+ ...|||||.+..+.++.++|||||||++||++| |..||...+..+....+. ..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hCC
Confidence 999776655543322 368999999999999999999999999999998 999999887666543221 111
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
++ ..|..++..+.++|.+||+.+|++||++..|++.+..+.
T Consensus 922 -RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 -RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 11 237788899999999999999999999999999888654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=329.46 Aligned_cols=257 Identities=20% Similarity=0.329 Sum_probs=204.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|++.+.||+|+||.||+|.+.........++++.............+.+|+.++..++||||++++|++... +..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCcE
Confidence 46888899999999999999875443344455555554433344456789999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999998643 346899999999999999999999999 999999999999999999999999987654
Q ss_pred CCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+. ++.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~----- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DGF----- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCC-----
Confidence 22211 11234568999999999999999999999999999775 999998765443222211 100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
....+..++..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011344567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=337.99 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=207.8
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--------Ch-----hhHhHHHHHHHHHhCCCCCc
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--------SQ-----GVKEFINDVNTLASLQHPNL 238 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--------~~-----~~~~~~~Ei~~l~~l~HpnI 238 (473)
...+.|++.+.||+|.||.|-+|. +....+.+|+|+.....- .. -.+.+.+||.+|++++||||
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar---~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLAR---DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred eehhheehhhhhcCCccceEEEEe---ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 456889999999999999999998 555566777776543311 11 12578899999999999999
Q ss_pred ccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee
Q 011995 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP-IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317 (473)
Q Consensus 239 v~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl 317 (473)
|+|+++..+...+.+|||+|||..|.+...= ...+ +++.++.+++.+++.||+|||.++ ||||||||+|+||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl 243 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL 243 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence 9999999888889999999999999875432 3334 999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeccCCCcccCCC-------CccCcccccccCChhhhhcCC----CCCcCCchHHHHHHHHHHcCCCCCCCCC
Q 011995 318 DKDFSAKLSGYGCAGHIPET-------DISNSSVAAANLSVETLERGL----LTPKSNVWSFGIVLLELLTGRKNLDSRH 386 (473)
Q Consensus 318 ~~~~~vkl~DFGla~~~~~~-------~~~~~~~t~~y~aPE~~~~~~----~s~~sDvwSlGvvl~elltG~~p~~~~~ 386 (473)
+++|.|||+|||.+..+... ......||+.|||||.+.++. .+.+.||||+||+||.|+.|+.||-+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 99999999999999866322 234578999999999997743 3578999999999999999999998876
Q ss_pred hHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 387 PKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
..+..+.| ++..+.-....++.+++.+||.++|.+||++|.+..+|....-
T Consensus 324 ~~~l~~KI----------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 324 ELELFDKI----------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHHH----------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 65544433 2222222222356789999999999999999999999977654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=343.16 Aligned_cols=246 Identities=18% Similarity=0.287 Sum_probs=190.8
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
|+..+.||+|+||.||+|....+ ++.+++|+............+.+|+++++.++|+||+++++++... +.+++|
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 150 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVL 150 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCC---CCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEE
Confidence 44458999999999999986533 3455666654444444567889999999999999999999998765 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+++|+|.+.. .+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+..
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999986533 3567788899999999999999999 99999999999999999999999999987643
Q ss_pred CC--ccCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 337 TD--ISNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 337 ~~--~~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
.. .....++..|+|||++.. ...+.++|||||||++|||++|+.||............... ..
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----------~~ 290 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----------CM 290 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----------hc
Confidence 32 234578899999998743 22456899999999999999999999743322111111100 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......+..++.++.+||.+||+.||++|||+.||++.
T Consensus 291 ----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 ----SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011233556789999999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=341.05 Aligned_cols=245 Identities=18% Similarity=0.236 Sum_probs=202.2
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
..++|+....||+|+||.||+|+- ..++..+|+|+.+... ....++.++.|-.+|....+++||+||-.|.+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarK---k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-- 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARK---KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-- 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEE---ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--
Confidence 357899999999999999999984 4466777777765432 344567889999999999999999998777665
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+.+||||||++||++-.+|.. ...|++..+..++.+++.||+-||+.| +|||||||+|+|||..|++||+||||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence 899999999999999999943 457999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCC----------------------CC---------------------------ccCcccccccCChhhhhcCCCCC
Q 011995 331 AGHIPE----------------------TD---------------------------ISNSSVAAANLSVETLERGLLTP 361 (473)
Q Consensus 331 a~~~~~----------------------~~---------------------------~~~~~~t~~y~aPE~~~~~~~s~ 361 (473)
+.-+.. .+ ....+|||.|||||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 842210 00 12356899999999999999999
Q ss_pred cCCchHHHHHHHHHHcCCCCCCCCChHHHHhH-hhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCC
Q 011995 362 KSNVWSFGIVLLELLTGRKNLDSRHPKEERNL-VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440 (473)
Q Consensus 362 ~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~ 440 (473)
.+|+||||||+||||.|.+||....+.+.-.. +.|...+... -...++.++.+||.+|+. ||+
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHHhc-CHH
Confidence 99999999999999999999999888776543 3443221110 022345899999999999 999
Q ss_pred CCCC
Q 011995 441 ERPT 444 (473)
Q Consensus 441 ~RPt 444 (473)
+|.-
T Consensus 432 ~RLG 435 (550)
T KOG0605|consen 432 NRLG 435 (550)
T ss_pred HhcC
Confidence 9976
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.09 Aligned_cols=262 Identities=22% Similarity=0.391 Sum_probs=213.9
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeE-EEEEEEec--CCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKK-FEATVTRL--NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
+-...++||+|+||.||+|++......... +|++..+. ........+|.+|.++|+.++|||||++||++... ..
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--~P 235 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--EP 235 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--Cc
Confidence 334448999999999999998654332222 45555543 13456678999999999999999999999999876 88
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
++||||+|.||+|.++|.... ..++..++..++.++|.||+|||+++ +|||||...|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999996543 36999999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCcc--CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 333 HIPETDIS--NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 333 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....-... .......|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....+...
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~------------ 378 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN------------ 378 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc------------
Confidence 65422221 2235689999999999999999999999999999998 88999988776655444111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
..+-..+...+.++..++.+||..||++||+|.++.+.|+.+.....
T Consensus 379 ----~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 379 ----GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11112244667889999999999999999999999999999886655
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=346.53 Aligned_cols=260 Identities=19% Similarity=0.319 Sum_probs=201.1
Q ss_pred cccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
++|+..+.||+|+||.||+|++.. .......+++|+.+........+.+.+|+.+|..+ +|||||+++++|... +
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--G 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--C
Confidence 457778999999999999997522 12233445555544333344456789999999999 899999999999766 7
Q ss_pred ceEEEEEeccCCChhhhhhcCC----------------------------------------------------------
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS---------------------------------------------------------- 273 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 273 (473)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 8999999999999999986421
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc
Q 011995 274 --------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339 (473)
Q Consensus 274 --------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 339 (473)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 1125789999999999999999999999 99999999999999999999999999976643321
Q ss_pred c----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 340 S----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 340 ~----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
. ...++..|+|||++.+..++.++|||||||++|||++ |..||......... ..+ +..+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~--~~~----~~~~~--------- 334 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF--YKM----IKEGY--------- 334 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH--HHH----HHhCc---------
Confidence 1 1233467999999999999999999999999999998 89999765432211 111 01110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
....+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus 335 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 -RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011223456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=324.70 Aligned_cols=277 Identities=17% Similarity=0.206 Sum_probs=211.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh-hhHhHHHHHHHHHhCCCCC-cccceeeeecCC---
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ-GVKEFINDVNTLASLQHPN-LCKLLGFHARDG--- 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~--- 249 (473)
..|...++||+|+||+||+|+. ..+++.+++|..++....+ .-....+|+.+|+.++|+| ||.|++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~---~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARS---KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEE---ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 3455558899999999999994 4455777888888876533 3456789999999999999 999999998762
Q ss_pred -CCceEEEEEeccCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 250 -SDQRMLIYERLFHGSLDRLIYGRSDG-PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 250 -~~~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
...++||+||++. +|.+++...... ..++...++.++.||+.||+|||+++ |+||||||.||||+.+|.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeec
Confidence 1278999999955 999999654321 35777899999999999999999999 99999999999999999999999
Q ss_pred cCCCcccC--CCCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 328 YGCAGHIP--ETDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 328 FGla~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
||+|+... ...+++.++|.+|.|||++.+. .|+...||||+|||+.||+++++.|.+..+.++...+-.....-...
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99998764 3346777999999999999887 59999999999999999999999999987766554442111110000
Q ss_pred cccccccccc----cCC-----CCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcc
Q 011995 405 CRLSLIMDPQ----LKG-----RFP---LKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQESR 458 (473)
Q Consensus 405 ~~~~~~~~~~----l~~-----~~~---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~~~ 458 (473)
.+.....-+. ... .+. .....+..+++.+||+.+|.+|.|+..++++ +..+...
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 0000000000 000 011 1222578899999999999999999999987 6655443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=347.25 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=202.7
Q ss_pred cccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
++|+..+.||+|+||.||+|.... .....+.+++|+............+.+|+++++.+ +|+|||+++++|... +
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG--G 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--C
Confidence 467788999999999999998532 22233445555554433344456788999999999 899999999998766 7
Q ss_pred ceEEEEEeccCCChhhhhhcCC----------------------------------------------------------
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS---------------------------------------------------------- 273 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 273 (473)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 8999999999999999885421
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCcc----
Q 011995 274 ---------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS---- 340 (473)
Q Consensus 274 ---------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~---- 340 (473)
....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1135788999999999999999999999 999999999999999999999999998765332211
Q ss_pred CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCC
Q 011995 341 NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419 (473)
Q Consensus 341 ~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 419 (473)
...++..|||||++.+..++.++|||||||++|||++ |..||............. . .......
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~------~----------~~~~~~~ 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV------K----------RGYQMSR 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH------H----------cccCccC
Confidence 1233467999999988889999999999999999997 999997654322111100 0 0001111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 420 PLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 420 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
+...+.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2234578999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=335.44 Aligned_cols=247 Identities=15% Similarity=0.193 Sum_probs=201.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||.||+|.... ..+.+++|+..... .......+.+|+++++.++||||+++++++.+. +.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--Ce
Confidence 468888999999999999998543 33455566554332 223456688999999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcch
Confidence 9999999999999999854 346899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... .....+++.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 150 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------- 214 (291)
T cd05612 150 KLRDR-TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------- 214 (291)
T ss_pred hccCC-cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 66432 234568899999999998889999999999999999999999998765544332221110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 451 (473)
..++...+..+.+|+.+||+.||.+|++ +.++++.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1123344678999999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=327.39 Aligned_cols=259 Identities=21% Similarity=0.378 Sum_probs=207.1
Q ss_pred cccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||.||+|...... ...+.++++.............|.+|+.++..++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cc
Confidence 36777799999999999999875433 233455555544333444566789999999999999999999998765 77
Q ss_pred eEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
.+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcC
Confidence 8999999999999999865321 145889999999999999999999999 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHh
Q 011995 320 DFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLV 394 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~ 394 (473)
++.++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987653322 123345688999999988889999999999999999998 99999876554433222
Q ss_pred hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
... .....+..++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 240 ~~~-----------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 RSR-----------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HcC-----------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 110 01112445678999999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.39 Aligned_cols=267 Identities=20% Similarity=0.316 Sum_probs=202.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||++..... ...+++++............+.+|+++++.++|+||+++++++.++ +..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPS---GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCC---CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEE
Confidence 36899999999999999999986533 3444555555443444557799999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ .|+|+||||+|||++.++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 999999999999999954 345889999999999999999999853 299999999999999999999999999876
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh----hcccccccccc---
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK----WSRPFLADDCR--- 406 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~----~~~~~~~~~~~--- 406 (473)
..........++..|+|||.+.+..++.++|||||||++|||++|+.||............. ...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 64443444568899999999998889999999999999999999999997654433221110 00000000000
Q ss_pred ---------------------cccccccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 407 ---------------------LSLIMDPQLKGRFP-LKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 407 ---------------------~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+.... ...++ ...+.++.+|+.+||++||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEP-PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCC-CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000 00011 1245678999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=327.11 Aligned_cols=267 Identities=18% Similarity=0.251 Sum_probs=210.8
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeec---C
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR---D 248 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~---~ 248 (473)
....|...+.||+|+||.|+.+.... +++.+|+|.+... ......++..+|+.+|+.++|+|||.+++++.. +
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 34556667899999999999998544 3455555544311 244556788999999999999999999998865 3
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
....+|+|+|+| ..+|...|.. +..|+...+..+++|+++||.|+|+.+ |+||||||+|+|++.+..+||+||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence 346799999999 5599999943 445999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccC----CCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 329 GCAGHIP----ETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 329 Gla~~~~----~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|+|+... ....+..+.|.||.|||.+.. ..|+.+.||||.|||+.||++|++.|.+.+..++..++....+...
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~- 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS- 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC-
Confidence 9999885 344567788999999999855 4599999999999999999999999999888777776653332221
Q ss_pred ccccccccc----------c-----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRLSLIMD----------P-----QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~~----------~-----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+..+.. + .+...|+ ++++.+.+|+.+||..||.+|+|++|.|+.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111111 0 0111123 677889999999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.78 Aligned_cols=263 Identities=20% Similarity=0.361 Sum_probs=205.3
Q ss_pred cccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
++|++.+.||+|+||.||+|...+ +..+.+.+++|+.+........+.+..|+.++.++ +|+||++++++|...+ .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~-~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG-G 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-C
Confidence 468888999999999999997533 22344566666554333334456788999999999 8999999999887553 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCC---------------------------------------------------------
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD--------------------------------------------------------- 274 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 274 (473)
.++++|||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78999999999999999854221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC----ccCcccccccC
Q 011995 275 -GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANL 349 (473)
Q Consensus 275 -~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~ 349 (473)
...++|..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++..+.... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 126899999999999999999999998 9999999999999999999999999998763322 12223457899
Q ss_pred ChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHH
Q 011995 350 SVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVA 428 (473)
Q Consensus 350 aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 428 (473)
|||++.+..++.++|||||||++|||++ |..||.+....+... . .+... .....+...+.++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~--~----~~~~~----------~~~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC--R----RLKEG----------TRMRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH--H----HHhcc----------CCCCCCccCCHHHH
Confidence 9999999999999999999999999997 999997643322110 0 00000 00111334557899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 429 DIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 429 ~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
+++.+||+.+|++||++.||++.|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.02 Aligned_cols=241 Identities=18% Similarity=0.248 Sum_probs=195.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
+.||+|+||.||++.... .++.+++|+..... .......+.+|+.++.+++||||+++++++... +..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEe
Confidence 469999999999998544 34556666654321 233456778999999999999999999988766 78999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET- 337 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~- 337 (473)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence 9999999999853 346899999999999999999999999 999999999999999999999999998754222
Q ss_pred -CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccC
Q 011995 338 -DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416 (473)
Q Consensus 338 -~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 416 (473)
......+|+.|+|||++.+..++.++|||||||++|||++|..||...........+... +
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--------------~---- 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------E---- 211 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--------------C----
Confidence 223456899999999999989999999999999999999999999775543332222100 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 417 GRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 417 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
..++...+.++.+|+.+||+.||++|| ++.++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 122445668899999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=339.08 Aligned_cols=248 Identities=14% Similarity=0.217 Sum_probs=201.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.++.+++||||+++++++..+ +
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--N 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCC---CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--C
Confidence 35788889999999999999986543 3455566554321 223456788999999999999999999998776 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCc
Confidence 89999999999999999854 346889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
....... ....+++.|+|||++.+..++.++|||||||++|||++|..||.+.........+...
T Consensus 166 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-------------- 230 (329)
T PTZ00263 166 KKVPDRT-FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-------------- 230 (329)
T ss_pred eEcCCCc-ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------
Confidence 8664332 3457889999999999988999999999999999999999999876544332222110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 451 (473)
. ..++...+..+.+|+.+||+.||.+|++ +.+++..
T Consensus 231 --~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 --R--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --C--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 0123335577899999999999999997 6777754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=330.04 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=199.3
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.|+..+.||+|+||.||+|....+ .+.+++++..... .......+.+|+.++..++|+||+++++++.++ +..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecC---CceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeE
Confidence 367779999999999999986443 3445555443321 223345678999999999999999999988765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 9999999999999888543 2346899999999999999999999999 99999999999999999999999999977
Q ss_pred cCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 334 IPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... .....++..|+|||++.+..++.++|||||||++|||++|+.||...........+... +.
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------~~- 218 (285)
T cd05631 152 IPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------------VK- 218 (285)
T ss_pred cCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH------------hh-
Confidence 64332 23456889999999999999999999999999999999999999865432211111100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 451 (473)
.....++...+.++.+|+.+||+.||.+||+ ++++++.
T Consensus 219 -~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 -EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011234456788999999999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=332.10 Aligned_cols=260 Identities=20% Similarity=0.342 Sum_probs=206.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+|+..+.||+|+||.||+|.+..+.. ....+++|+..........+++.+|+.+++.++||||++++|+|.. ...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence 468888999999999999998754332 2334555554433344556789999999999999999999999875 457
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 8999999999999999643 345889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
...... .....+..|++||.+.+..++.++|||||||++|||++ |..||.+....+....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~-- 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GER-- 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-------CCC--
Confidence 643321 12233568999999999999999999999999999998 9999987554332221111 000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
...+..++.++.+++.+||..||.+||++.+++..|.++....
T Consensus 230 --------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0112234567899999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.68 Aligned_cols=265 Identities=17% Similarity=0.220 Sum_probs=200.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||+|....+ ...+++|+.+..........+.+|+.+++.++||||+++++++... +..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLT---ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCC---CCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEE
Confidence 5688889999999999999985433 3455566555443334456778999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++ +|.+++... +..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 80 lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred EEEeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 99999974 899888542 345789999999999999999999999 999999999999999999999999998765
Q ss_pred CCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc--------cccc
Q 011995 335 PET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP--------FLAD 403 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~ 403 (473)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|++||.+....+....+..... ....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 322 2234567899999999865 4589999999999999999999999987765544333211100 0000
Q ss_pred ccccccccccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 DCRLSLIMDPQLKG----RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.........+.... ......+.++.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000011111000 001234578899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=328.35 Aligned_cols=265 Identities=15% Similarity=0.174 Sum_probs=200.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|++.+.||+|+||.||+|+...+ ...+++++..... .....+.+.+|+++++.++|+||+++++++..+ +..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKET---KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCC---CcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC--CEE
Confidence 4688899999999999999996543 3344555544332 233456788999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+.++.+..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 99999999877765542 2346899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc--------
Q 011995 334 IPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA-------- 402 (473)
Q Consensus 334 ~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------- 402 (473)
..... .....++..|+|||++.+..++.++|||||||++|||++|++||...........+......+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 64322 2334678999999999988899999999999999999999999987654433222211100000
Q ss_pred ccccccccccccc------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 403 DDCRLSLIMDPQL------KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 403 ~~~~~~~~~~~~l------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..........+.. ...+....+.++.+|+.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 01112235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=342.77 Aligned_cols=263 Identities=17% Similarity=0.283 Sum_probs=205.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 250 (473)
.++|.+.+.||+|+||.||+|+..... .....+++|+..........+.+.+|+++|.++. |||||++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-- 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-- 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--
Confidence 356788899999999999999864322 2334455555543334444577999999999996 99999999999765
Q ss_pred CceEEEEEeccCCChhhhhhcCC---------------------------------------------------------
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRS--------------------------------------------------------- 273 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 273 (473)
+..||||||+++|+|.++|....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 78999999999999999886421
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee
Q 011995 274 ------------------------------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317 (473)
Q Consensus 274 ------------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl 317 (473)
....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 0134788899999999999999999999 9999999999999
Q ss_pred CCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHh
Q 011995 318 DKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERN 392 (473)
Q Consensus 318 ~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 392 (473)
+.++.+||+|||++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999876543221 22345678999999998889999999999999999997 999997643322111
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
.. +..+ .....+..++.++.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 351 ~~------~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NK------IKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH------HhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00 0000 0011233456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=336.42 Aligned_cols=254 Identities=17% Similarity=0.201 Sum_probs=203.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||.||+|...+. ...+++|+..... .......+.+|++++..++||||+++++++... +.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCC---CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CE
Confidence 4688899999999999999996543 3445555554321 223456788999999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.||||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 9999999999999999953 346899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-hccccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-WSRPFLADDCRLSLIM 411 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 411 (473)
.... ......+++.|+|||++.+..++.++|||||||++|||++|..||......+....+. |... ..
T Consensus 150 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~--------- 218 (333)
T cd05600 150 GIVT-YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQ--------- 218 (333)
T ss_pred cccc-ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-cc---------
Confidence 6543 3345578999999999998899999999999999999999999998766554333222 2110 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.. .......+.++.+++.+||..+|.+||++.++++.
T Consensus 219 ~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 00012456789999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.56 Aligned_cols=257 Identities=20% Similarity=0.363 Sum_probs=205.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||+|.+.........+++++............|.+|+.+++.++|+||+++++++... +..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--CceE
Confidence 57888899999999999999976543333444555544333444567789999999999999999999988765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 82 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999999543 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC--cc--CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 335 PETD--IS--NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 335 ~~~~--~~--~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
.... .. ....+..|+|||.+.+..++.++||||||+++|||++ |..||...........+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-------~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------GY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-------CC----
Confidence 4211 11 1233568999999998889999999999999999998 9999976543332221110 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
....+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011234457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=326.53 Aligned_cols=250 Identities=15% Similarity=0.250 Sum_probs=208.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
..++|++.+.||+|+||.|-+|. ....++.++++.++.. .+++..-.+.+||+||+.|+||||+.+|++|...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~---e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-- 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAY---EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-- 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehh---hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--
Confidence 34678888999999999999997 4345556666655543 2566677899999999999999999999999765
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+.+.|||||..+|.|+|++.. .+.|++.++..+++||..|+.|+|.++ ++|||||.+|||||.++++||+||||
T Consensus 126 dKIvivMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred ceEEEEEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence 899999999999999999944 457999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC-ccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPETD-ISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~~-~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+..+.... ..+++|++-|.+||++.+..| ++.+|.|||||+||-|+.|..||++.+-......+...
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G----------- 268 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG----------- 268 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-----------
Confidence 98876554 467899999999999999887 58999999999999999999999987544332222111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
.. +....+.++.-||+.||..+|++|.|+.+|...-
T Consensus 269 -----aY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 -----AY---REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----cc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 00 0123346678899999999999999999997653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=324.84 Aligned_cols=270 Identities=19% Similarity=0.239 Sum_probs=203.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC---
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD--- 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~--- 251 (473)
-.|...+++|+|+||+||+|.+... ...+|+|..-- .. +.--+|+++|+.+.|||||+|.-+|......
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~---~~~vAIKKv~~--d~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRET---EEEVAIKKVLQ--DK---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCC---CceeEEEEecC--CC---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 3577779999999999999998765 34444443321 11 2223799999999999999999887754433
Q ss_pred ceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEeccC
Q 011995 252 QRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYG 329 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFG 329 (473)
+..||||||+. +|.+.++.. ..+..++...++-++.||.+||.|||..+ |+||||||.|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence 67799999977 999988632 12456888889999999999999999998 9999999999999976 999999999
Q ss_pred CCcccCCCCcc-CcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 330 CAGHIPETDIS-NSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~~~~~~~-~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
.|+.+..+..+ +...|..|.|||.+.+.. |+.+.||||.|||+.||+-|++.|.+....++...+-.....-.++ .+
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e-~I 250 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE-DI 250 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH-HH
Confidence 99988655443 446789999999998764 9999999999999999999999999987766554442111111100 00
Q ss_pred c-------cccccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhc
Q 011995 408 S-------LIMDPQLKG-----RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQES 457 (473)
Q Consensus 408 ~-------~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~~ 457 (473)
. ....+.+.. -+....+.++.+|+.++|+.+|.+|.++.|++.. ++++..
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 0 111122211 1345677899999999999999999999999853 444443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=336.51 Aligned_cols=249 Identities=15% Similarity=0.179 Sum_probs=201.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|.+.+.. ...+++++.... ........+.+|+.++..++||||+++++++.+. +
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 104 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNED--FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--S 104 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCC--CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--C
Confidence 346888899999999999999864432 234445544322 1233456788999999999999999999999776 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..|+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCC
Confidence 89999999999999999954 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|..||...........+...
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-------------- 243 (340)
T PTZ00426 179 KVVDT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG-------------- 243 (340)
T ss_pred eecCC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--------------
Confidence 76643 234457899999999999888999999999999999999999999876544322222100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
. ..++...+..+.+++.+||+.||.+|+ +++++++.
T Consensus 244 --~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 --I--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --C--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 012344567789999999999999995 89988765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=318.41 Aligned_cols=253 Identities=18% Similarity=0.321 Sum_probs=203.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|...+.||+|+||.||+|.+.+.. +.+++++ ..........+.+|+++++.++|+||+++++++..+ +..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~---~~~~~K~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 78 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCC---ceEEEEE--ecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcE
Confidence 35777799999999999999875432 3333433 333444567889999999999999999999998765 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 79 IITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 999999999999998653 2446899999999999999999999998 999999999999999999999999998776
Q ss_pred CCCCccC---cccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDISN---SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~~---~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
....... ...+..|+|||.+.+..++.++|||||||++|||++ |..||...........+..
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-------------- 220 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------------- 220 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------------
Confidence 4432221 223567999999998899999999999999999998 9999987554332222110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
......+..++..+.+++.+||..||++||++.++++.|+.+
T Consensus 221 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 ---GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011122344568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=324.17 Aligned_cols=250 Identities=28% Similarity=0.492 Sum_probs=194.7
Q ss_pred CcceeecCCceEEEEEEC-CCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 180 DRCISEGLSSVMYRASFG-DDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
.+.||.|.||.||+|.+. ........+++++..........+.|.+|++++++++||||++++|++... +..++|||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc--cccccccc
Confidence 478999999999999988 333444555555553333444578999999999999999999999999854 66999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 338 (473)
|+++|+|.++|... ....+++..+..|+.||+.||.|||+++ ++|+||+++|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999765 2456999999999999999999999998 9999999999999999999999999997763221
Q ss_pred c----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 339 I----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 339 ~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
. ........|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------
Confidence 1 22345678999999999889999999999999999999 7899987655443222211110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
...+..++..+.+++.+||..||.+|||+.+|++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112334567899999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.30 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=215.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.+|+|+||.++..+.. ...+.+.+|.+++.. +....+..++|+.++++++|||||.+.+.|..+ +.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk---~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~--~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHK---SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED--GQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhc---cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC--Cc
Confidence 357888899999999999999743 334566677777654 445556789999999999999999999999877 55
Q ss_pred -eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 253 -RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 253 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
++|||+||+||+|.+.|.... +.-+++..+..|+.|++.|+.|||+.+ |+|||||+.||+++.++.|||+|||+|
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGla 153 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLA 153 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhh
Confidence 999999999999999997653 677999999999999999999999888 999999999999999999999999999
Q ss_pred cccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
+...... ..+..||+.||+||.+.+..|+.++|||||||++|||++-+++|...+.......+...
T Consensus 154 K~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~------------ 221 (426)
T KOG0589|consen 154 KILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG------------ 221 (426)
T ss_pred hhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc------------
Confidence 9987664 45678999999999999999999999999999999999999999887655543322211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....+...+.++..+|..||..+|..||++.++|..
T Consensus 222 -----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 -----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1123366778999999999999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=375.30 Aligned_cols=267 Identities=26% Similarity=0.464 Sum_probs=203.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
...|...+.||+|+||.||+|....+. +.+++| .+.... .....|++++++++|||||+++|+|.+. +..
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK--~~~~~~---~~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~ 758 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNG---MQFVVK--EINDVN---SIPSSEIADMGKLQHPNIVKLIGLCRSE--KGA 758 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCC---cEEEEE--EccCCc---cccHHHHHHHhhCCCCCcceEEEEEEcC--CCC
Confidence 345777889999999999999864332 333344 332211 1223568999999999999999999876 678
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+||||+++|+|.++++ .++|..+..++.||+.||+|||..+.++|+||||||+||+++.++..++. ||.+..
T Consensus 759 ~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 99999999999999993 28999999999999999999996644459999999999999999888875 666544
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.... ....++..|||||++.+..++.++|||||||++|||+||+.||..... .....+.|.+.... ......+.++
T Consensus 832 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~ 907 (968)
T PLN00113 832 LCTD--TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DCHLDMWIDP 907 (968)
T ss_pred cccC--CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-ccchhheeCc
Confidence 3221 233678899999999998999999999999999999999999954322 12234445443222 2233445555
Q ss_pred ccCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 414 QLKGR--FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 414 ~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
.+... .+.....++.+++.+||+.||++||||.||++.|+++....++
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 55332 3445667888999999999999999999999999998664443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=321.28 Aligned_cols=259 Identities=19% Similarity=0.307 Sum_probs=203.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|.+..+.. ....++++............++..|+.++.++.||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence 356777999999999999998754322 2334445444333333445678889999999999999999998743 567
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++++||+++|+|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 8999999999999999643 346899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
..... .....++..|++||.+.++.++.++|||||||++|||++ |..||.+........++.- +...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~- 230 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-------GERL- 230 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CCcC-
Confidence 54322 122345678999999998899999999999999999998 9999987655443332221 0000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
..+..+..++.+++.+||..||++|||+.|+++.|..+...
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 ---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00122346788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=333.12 Aligned_cols=242 Identities=17% Similarity=0.243 Sum_probs=195.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
+.||+|+||.||++.... ..+.+++|+.... ........+.+|+.+++.++||||+++++++... +..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEe
Confidence 469999999999998543 3445556655432 1234456788999999999999999999988765 78999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET- 337 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~- 337 (473)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 76 y~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence 9999999988843 346899999999999999999999999 999999999999999999999999998754322
Q ss_pred -CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccC
Q 011995 338 -DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416 (473)
Q Consensus 338 -~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 416 (473)
......+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+... +
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--------------~---- 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------D---- 211 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--------------C----
Confidence 223456899999999999888999999999999999999999999765543322222110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 417 GRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 417 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+.++.+|+.+||+.||.+|+ ++.++++.
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112445567899999999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.87 Aligned_cols=270 Identities=22% Similarity=0.325 Sum_probs=204.1
Q ss_pred ccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 178 FSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
...+.||+|+||+||++.+.. .......+++|+............+.+|+++++.++||||+++++++........++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 777999999999999876532 1223445556655443333456778899999999999999999999876544678999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999843 24999999999999999999999999 99999999999999999999999999876643
Q ss_pred CCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 337 TDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 337 ~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
... ....++..|++||.+.+..++.++|||||||++|||++|..||........ ....+..... ....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhhhhhh
Confidence 221 122345679999999888899999999999999999999999865432211 1111111000 000111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
+.......+...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111112224455688999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.85 Aligned_cols=260 Identities=20% Similarity=0.348 Sum_probs=203.2
Q ss_pred HhcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
..++|+..+.||+|+||.||+|.+.... .....+++++...........++.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 4578999999999999999999865321 223445555443322333456788999999999999999999998765
Q ss_pred CceEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcE
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSD-------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
...++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence 789999999999999999864321 234688899999999999999999998 9999999999999999999
Q ss_pred EEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcc
Q 011995 324 KLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 324 kl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 398 (473)
+|+|||++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876543322 12234678999999998889999999999999999999 789997765433222211000
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
. ...+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ----------------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 ----------------L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----------------c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 01133445789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.03 Aligned_cols=258 Identities=21% Similarity=0.376 Sum_probs=205.2
Q ss_pred cccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|.+.+.||+|+||.||+|...+. ....+.+++|+............+.+|+++|..++|+||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--DP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--CC
Confidence 4577779999999999999986543 2233445555544333333567899999999999999999999998876 78
Q ss_pred eEEEEEeccCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRS-----------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 321 (473)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 999999999999999996532 1245789999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhh
Q 011995 322 SAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 396 (473)
.+||+|||++........ ....++..|+|||++.+..++.++|||||||++|||++ |..||...........+..
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999999876533321 22234678999999999999999999999999999998 9999976654433222210
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
. .....+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 240 ~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 240 G-----------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred C-----------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 0001123456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=331.68 Aligned_cols=239 Identities=18% Similarity=0.206 Sum_probs=192.5
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
||+|+||.||+|...++ .+.+++|+.... ........+.+|+.++.+++||||+++++++... +..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~---~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDT---QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCC
Confidence 79999999999986543 345556655432 1334456788999999999999999999988765 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC--C
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET--D 338 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~--~ 338 (473)
++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 76 ~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc
Confidence 99999999854 346899999999999999999999999 999999999999999999999999998754322 2
Q ss_pred ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCC
Q 011995 339 ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418 (473)
Q Consensus 339 ~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 418 (473)
.....+|+.|+|||++.+..++.++|||||||++|||++|..||...........+.. . ...
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~------~------------~~~ 211 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ------E------------PLR 211 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc------C------------CCC
Confidence 2345689999999999998999999999999999999999999987654332221110 0 012
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 011995 419 FPLKAARTVADIALRCLQKEPSERPT---MRSIFE 450 (473)
Q Consensus 419 ~~~~~~~~l~~li~~cl~~dP~~RPt---~~eil~ 450 (473)
++...+.++.+++.+||..||.+||+ +.+++.
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 34456688999999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.32 Aligned_cols=263 Identities=22% Similarity=0.372 Sum_probs=205.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+|...+.||+|+||.||+|...+.........++++.... .....+.+.+|++++++++|+||+++++++... +..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--Cce
Confidence 45777899999999999999864432222222234444432 233346789999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999996532 1235899999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhh
Q 011995 321 FSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 395 (473)
+.++|+|||++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999876543321 22345678999999998889999999999999999998 999997765443222111
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
. ... ...+...+..+.+++.+||+.||.+||++.+|++.|+++.+..
T Consensus 240 ~-------~~~----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 240 Q-------GRV----------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred C-------CCC----------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 0 000 0112234578999999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.66 Aligned_cols=252 Identities=21% Similarity=0.374 Sum_probs=201.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||+|...++. . ++++.........+.+.+|+.+++.++|+||+++++++... +..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~--v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 77 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNST----K--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIY 77 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCc----e--EEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcE
Confidence 57888899999999999999865442 2 33333333344467899999999999999999999988665 7789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceec
Confidence 999999999999998653 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ....++..|+|||++.+..++.++|||||||++|||++ |..||...........+... ..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------~~---- 222 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-------YR---- 222 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-------CC----
Confidence 43321 12234567999999988889999999999999999998 99999765543322221100 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
. .....++.++.+++.+||..+|++||++.++++.|+++
T Consensus 223 --~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 --M----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 01123457789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=323.70 Aligned_cols=262 Identities=19% Similarity=0.309 Sum_probs=204.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|++.+.||+|+||.||+|...++... ..++++...........+.+.+|++++.++ +||||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLK-MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCc-ceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccc
Confidence 5788889999999999999987654321 122333333222334456789999999999 799999999998765 679
Q ss_pred EEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCC
Confidence 99999999999999996432 1235889999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCc-cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcc
Q 011995 321 FSAKLSGYGCAGHIPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~-~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 398 (473)
+.+||+|||++........ .....+..|+|||++.+..++.++|||||||++|||++ |..||...........+..
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-- 233 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 233 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--
Confidence 9999999999864322111 11223457999999988889999999999999999997 9999987654432221110
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
......+..++..+.+|+.+||+.+|.+||++.++++.|+.+...+
T Consensus 234 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 234 ---------------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0011123345678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=325.39 Aligned_cols=263 Identities=21% Similarity=0.376 Sum_probs=205.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|++.+.||+|+||.||+|.+.++. ..+.++++... ........+.+|++++.++ +|+||+++++++..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-- 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-- 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCC---ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--
Confidence 467888899999999999999875432 22223333332 2344567889999999999 899999999998765
Q ss_pred CceEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl 317 (473)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEe
Confidence 78999999999999999996432 1236899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeccCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhh
Q 011995 318 DKDFSAKLSGYGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 318 ~~~~~vkl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 395 (473)
+.++.+||+|||++....... ......+..|+|||.+.+..++.++|||||||++|||+| |..||......+....+.
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999999999999986432111 111233567999999988889999999999999999998 999997654433222111
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
. . .....+...+..+.+|+.+||+.+|.+||++.++++.|+++...+..
T Consensus 238 ~-------~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 238 Q-------G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred c-------C----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 0 0 00011233457789999999999999999999999999988766654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=316.91 Aligned_cols=249 Identities=18% Similarity=0.351 Sum_probs=198.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||++.+.+.. .++++ ...........+.+|+.++++++||||+++++++... +..+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~----~~a~K--~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQI----KVAIK--AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLY 75 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCc----eEEEE--ecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEE
Confidence 45777899999999999999875432 23333 3333333456789999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++...
T Consensus 76 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 76 IVTEFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred EEEEcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 999999999999998643 235899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
...... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... .. .
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-------~~---~ 220 (256)
T cd05114 151 LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-------FR---L 220 (256)
T ss_pred CCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------CC---C
Confidence 433222 1233467999999988889999999999999999999 99999876544332222110 00 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
..+...+..+.+++.+||+.||.+||++.++++.|.
T Consensus 221 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 -------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 012223467899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=316.80 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=202.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|.+.++ +.++++. ........+++.+|+.++++++|+||+++++++... +..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~----~~v~iK~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNT----TPVAVKT--LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPI 76 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCC----eEEEEEe--eCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC--CCe
Confidence 35688889999999999999986543 2333433 333334457799999999999999999999988765 788
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++.... +..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred eeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 99999999999999996542 456899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCccCcc---cccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDISNSS---VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~~~~~---~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
.......... .+..|+|||++.+..++.++||||||+++|||++ |+.||.+.........+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------ 220 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG------------ 220 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 6533222222 2357999999988889999999999999999999 99999876544332222100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.....+...+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 221 -----~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 -----YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00011334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.43 Aligned_cols=245 Identities=18% Similarity=0.232 Sum_probs=197.5
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC---CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||++....+....+.+++|+.... ........+.+|+.+|+.++||||+++++++..+ +..|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 6799999999999987554455666777765532 1223345678899999999999999999998776 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
||+++|+|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 80 EYLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred eCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999999853 345788999999999999999999999 999999999999999999999999998754222
Q ss_pred --CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 338 --DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 338 --~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
......+++.|+|||++.+..++.++|||||||++|||++|..||...........+... .
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~----------------~- 216 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG----------------K- 216 (323)
T ss_pred CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------------C-
Confidence 223346889999999999888999999999999999999999999876544322222110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+..+.+|+.+||+.||++|| ++.++++.
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 012334567889999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=332.36 Aligned_cols=242 Identities=17% Similarity=0.250 Sum_probs=194.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
+.||+|+||.||++.... .++.+++|+.... ........+.+|+.++..++||||+++++++... +..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEe
Confidence 469999999999998543 3345556655432 1233456678899999999999999999988766 78999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET- 337 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~- 337 (473)
|+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence 9999999988843 346899999999999999999999999 999999999999999999999999998754222
Q ss_pred -CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccC
Q 011995 338 -DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416 (473)
Q Consensus 338 -~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 416 (473)
......+++.|+|||++.+..++.++|||||||++|||++|..||...........+... +
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--------------~---- 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--------------E---- 211 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------C----
Confidence 223456889999999999889999999999999999999999999766544332222110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 417 GRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 417 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+.++.+++.+||+.||.+|+ ++.++++.
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 012445568899999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=320.59 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=202.1
Q ss_pred cccccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|.+.. +....+.++++.............+.+|+++++.++|+||+++++++... +..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cce
Confidence 467778999999999999998532 22233444454444333344456789999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSD--------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
|+||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcC
Confidence 999999999999999853211 235789999999999999999999999 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHh
Q 011995 320 DFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLV 394 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~ 394 (473)
++.+||+|||++....... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999997653322 122334567999999988889999999999999999998 99999765543322222
Q ss_pred hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.... ....+..++..+.+++.+||+.||++||++.+|++.|..
T Consensus 240 ~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQ-----------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1100 001133455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.94 Aligned_cols=257 Identities=18% Similarity=0.290 Sum_probs=209.4
Q ss_pred HHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC----Ch---hhHhHHHHHHHHHhC-CCCCcccc
Q 011995 170 VAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS----SQ---GVKEFINDVNTLASL-QHPNLCKL 241 (473)
Q Consensus 170 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~Ei~~l~~l-~HpnIv~l 241 (473)
-....++|...+.||+|..++|-++. ...+++.++++++..... +. ..+.-++|+.||+++ .||+|+++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci---~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l 88 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCI---HKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDL 88 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhh---hcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence 34456788899999999999999998 445667777777665432 11 124456799999998 79999999
Q ss_pred eeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC
Q 011995 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 321 (473)
.+++..+ ..+++|+|.|+.|.|+|+|. ...++++....+|+.|+..|++|||.++ ||||||||+|||++++.
T Consensus 89 ~D~yes~--sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 89 QDVYESD--AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNM 160 (411)
T ss_pred eeeccCc--chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecccc
Confidence 9999876 88999999999999999994 3457999999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCCcccCCC-CccCcccccccCChhhhhcC------CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh
Q 011995 322 SAKLSGYGCAGHIPET-DISNSSVAAANLSVETLERG------LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~------~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 394 (473)
++||+|||+++.+..+ .....+||++|+|||.+... .|+..+|+|++|||+|-|+.|.+||.-.....+...+
T Consensus 161 ~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 9999999999988655 45677999999999998543 4788999999999999999999999754433333333
Q ss_pred hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....- .+...-..+.+.+..+||.+||+.||.+|.|++|+|..
T Consensus 241 meGky--------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGKY--------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhccc--------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 21110 01111245778899999999999999999999999864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=320.70 Aligned_cols=263 Identities=22% Similarity=0.381 Sum_probs=205.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|.+.+.||+|+||.||++...+.........++++.+.. .......+.+|++++.+++|+||+++++++... +.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Cc
Confidence 357888899999999999999753321111122233344332 334456799999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRS----------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 322 (473)
.++||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999986432 1235899999999999999999999999 999999999999999999
Q ss_pred EEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhc
Q 011995 323 AKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 323 vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 397 (473)
+||+|||++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543321 22234678999999998889999999999999999998 99999776543322222110
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.. . ..+...+.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 239 ~~-------------~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RV-------------L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred Cc-------------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00 0 01223456799999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=320.20 Aligned_cols=261 Identities=23% Similarity=0.397 Sum_probs=204.0
Q ss_pred ccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+|+..+.||+|+||.||+|...... .....+++++............+.+|+.+++.++||||+++++++... +..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CCc
Confidence 4777899999999999999864321 122334444433333334456789999999999999999999998765 778
Q ss_pred EEEEEeccCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRS---------------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp 312 (473)
++|+||+.+|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 99999999999999885421 1235889999999999999999999998 99999999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCCh
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHP 387 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~ 387 (473)
+|||++.++.+||+|||+++...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999987653221 122244578999999988889999999999999999998 9999977654
Q ss_pred HHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
......+.. . .....+...+.++.+|+.+||+.||.+||++.++++.|+++..+
T Consensus 236 ~~~~~~~~~-------~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 ERLFNLLKT-------G----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHhC-------C----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 432222110 0 00111334557899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=325.25 Aligned_cols=266 Identities=17% Similarity=0.219 Sum_probs=196.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|.... ..+.+++|+............+.+|+.+++.++||||+++++++.+. +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeE
Confidence 4689999999999999999998543 34555666655443333445678999999999999999999998766 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+. ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 79 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EEEEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence 99999995 6888877542 345889999999999999999999999 99999999999999999999999999875
Q ss_pred cCCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH-HHhHhhhccccccccc----
Q 011995 334 IPET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-ERNLVKWSRPFLADDC---- 405 (473)
Q Consensus 334 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~---- 405 (473)
.... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||.+..... ....+.+.........
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 4322 2234567899999999865 457899999999999999999999998754322 1111111000000000
Q ss_pred ---------ccccccccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 ---------RLSLIMDPQLKGRF-PLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ---------~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.........+...+ ....+..+.+|+.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000 0012357889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.42 Aligned_cols=261 Identities=21% Similarity=0.377 Sum_probs=207.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||++...+.. .....++++.............+.+|++++.++ +|+||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence 456888899999999999999875432 233445555544433444556789999999999 899999999998765
Q ss_pred CceEEEEEeccCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee
Q 011995 251 DQRMLIYERLFHGSLDRLIYGR-------------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl 317 (473)
+..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 6899999999999999998642 22456899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHh
Q 011995 318 DKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERN 392 (473)
Q Consensus 318 ~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 392 (473)
+.++.+||+|||++........ ....++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999987644322 11233467999999988889999999999999999997 999998765444332
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.+... .....+..++..+.+|+.+||..||++|||+.++++.|+.+-
T Consensus 246 ~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEG-----------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcC-----------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 22100 001123345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=331.60 Aligned_cols=242 Identities=17% Similarity=0.247 Sum_probs=194.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
+.||+|+||.||++.... .++.+++|+.... ........+.+|++++..++||||+++++++... +..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEe
Confidence 469999999999998543 3455566655432 1233456778899999999999999999988766 78999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 76 YANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence 9999999988843 3468999999999999999999997 67 999999999999999999999999998754322
Q ss_pred --CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 338 --DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 338 --~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
......+|+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~----------------- 212 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------------- 212 (325)
T ss_pred CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 2234568999999999999899999999999999999999999998765443332221110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+.++.+|+.+||+.||.+|+ ++.++++.
T Consensus 213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 012334567899999999999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=320.94 Aligned_cols=269 Identities=17% Similarity=0.226 Sum_probs=197.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhC---CCCCcccceeeeecC--
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASL---QHPNLCKLLGFHARD-- 248 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~-- 248 (473)
++|+..+.||+|+||.||+|..... .+..+++|+.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 3688889999999999999985322 223445555544322 22334567788777766 699999999988532
Q ss_pred -CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 249 -GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 249 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
....+++||||+. ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence 2356899999996 6899988653 2345899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-hhccccccccc
Q 011995 328 YGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-KWSRPFLADDC 405 (473)
Q Consensus 328 FGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 405 (473)
||++....... .....+++.|+|||.+.+..++.++|||||||++|||++|.+||.+....+....+ ...........
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99997664332 23456789999999998888999999999999999999999999876654433222 11110000000
Q ss_pred cc-----ccccccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 RL-----SLIMDPQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ~~-----~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. ......... ..+....+..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000 0011235677889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=315.60 Aligned_cols=259 Identities=20% Similarity=0.380 Sum_probs=204.4
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC----C
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS----D 251 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----~ 251 (473)
|.+.+.||+|+||.||+|.+..+....+.++++...... .......+.+|+++++.++|+||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999976655445566666655432 23445688999999999999999999998865421 2
Q ss_pred ceEEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS---DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
..++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 4799999999999998885432 2246899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccc
Q 011995 329 GCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 329 Gla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|+++....... .....+..|++||.+.+..++.++|||||||++|||++ |..||...........+. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-------~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-------H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------c
Confidence 99986643321 11234568999999988889999999999999999999 999997655433222111 0
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
+. ....+..++..+.+++.+||+.||.+||++.+|++.|+++
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112344567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.72 Aligned_cols=260 Identities=21% Similarity=0.387 Sum_probs=210.7
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
..+.++||+|-||.|..+.... ..++|+|..+-........+|.+|+++|.+++|||||.|+|+|..+ +.+++|
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg----~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI 613 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEG----PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMI 613 (807)
T ss_pred eehhhhhcCcccceeEEEEecC----ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHH
Confidence 3445999999999999997654 3455555555555666778999999999999999999999999988 889999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
+|||++|+|.+++..... +.+.-....+|+.||+.||+||.+-+ +|||||.+.|+|+|.++++||+|||+++.+..
T Consensus 614 ~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999976432 23455667789999999999999999 99999999999999999999999999998877
Q ss_pred CCccCcc----cccccCChhhhhcCCCCCcCCchHHHHHHHHHHc--CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 337 TDISNSS----VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT--GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 337 ~~~~~~~----~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.++.... ..+.|||+|.+.-++++.++|||+||+++||+++ .+.||......+. ++-...+..+......
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~- 765 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVV- 765 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCccee-
Confidence 7665443 4589999999999999999999999999999864 7889976654432 2222223332222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
...|.-++..+.+++.+||..|-++||+++++...|++..
T Consensus 766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1225567788999999999999999999999999998653
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.53 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=198.6
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC---CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
+|++.+.||+|+||.||++....+....+.+++|+.... ......+.+..|+.++..+ +|+||+++++++..+ +
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 578889999999999999986555555666777766432 1233446688999999999 599999999888765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 89999999999999999854 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 332 GHIPETD---ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 332 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
+...... .....+|+.|+|||++.+.. ++.++|||||||++|||++|..||...........+.. ...
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~------ 224 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RIL------ 224 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHh------
Confidence 7653321 22446899999999997654 78999999999999999999999965332111110100 000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++ .++...+..+.+++.+||+.||++|| +++++++.
T Consensus 225 --~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 225 --KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111 22344567889999999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.15 Aligned_cols=262 Identities=17% Similarity=0.232 Sum_probs=210.2
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceee-eec---
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGF-HAR--- 247 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~-~~~--- 247 (473)
...++++.+.|.+|||+.||.|...... +.+++|..... .+...+.+++||++|+.|. |+|||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~---~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGG---KKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCC---ceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3467788899999999999999865443 56666665555 6778889999999999995 9999999993 222
Q ss_pred CC-CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 248 DG-SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 248 ~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
.+ .-+++|+||||.+|+|-|++..+.. ..|++.++++|+.++++|+++||...+ +|||||||-+||||+.++..|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeC
Confidence 11 2468899999999999999976543 349999999999999999999999975 59999999999999999999999
Q ss_pred ccCCCcccCCCCc-----------cCcccccccCChhhh---hcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 327 GYGCAGHIPETDI-----------SNSSVAAANLSVETL---ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 327 DFGla~~~~~~~~-----------~~~~~t~~y~aPE~~---~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
|||.++....... -....|+.|++||++ .+...++|+|||+|||+||-|+....||+......
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--- 265 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--- 265 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---
Confidence 9999865422110 122458999999987 45678999999999999999999999998643211
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
|++....-.-....+..+.+||..||+.||.+||++-+++..+-+|.....
T Consensus 266 -----------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 -----------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -----------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 122222111124788999999999999999999999999999998876543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=308.81 Aligned_cols=253 Identities=17% Similarity=0.241 Sum_probs=207.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|++...||+|.|+.||++. +..++..++++++..+. ...+.+.+.+|+.|-+.++|||||+|++-+..+ ..
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~---~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCV---HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHH---hccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc--ce
Confidence 4567777899999999999998 45566666666665542 455788999999999999999999999987665 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---CcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---FSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DFG 329 (473)
.|||+|+|.|++|..-|-.+ .-+++..+-..+.||+.+|.|+|.++ |||||+||+|+|+... .-+||+|||
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccc
Confidence 99999999999997666433 34688888999999999999999999 9999999999999533 459999999
Q ss_pred CCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 330 CAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 330 la~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+|..+... ......||++|||||++....|+..+|||+.|||||-|+.|.+||.+.......+.+....
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~---------- 228 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA---------- 228 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc----------
Confidence 99887643 3456789999999999999999999999999999999999999999866555444332111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
-...+....++++++++|+.+||..||.+|.|+.|.|+.
T Consensus 229 ----yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 229 ----YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 011222345788999999999999999999999998754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=341.12 Aligned_cols=270 Identities=14% Similarity=0.176 Sum_probs=196.0
Q ss_pred HHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC------CCccc
Q 011995 167 LDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH------PNLCK 240 (473)
Q Consensus 167 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~ 240 (473)
.+++...+++|.+.+.||+|+||+||+|.... ..+.+++|+.+.. ......+..|++++..++| .+++.
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 34555567899999999999999999998543 3345556655422 2233456677777777754 45888
Q ss_pred ceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCC
Q 011995 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 241 l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~ 319 (473)
+++++..+ ...+|+|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + ||||||||+|||++.
T Consensus 196 i~~~~~~~-~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~ 267 (467)
T PTZ00284 196 IQRYFQNE-TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMET 267 (467)
T ss_pred eEEEEEcC-CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEec
Confidence 88888754 36789999988 7789888854 34699999999999999999999984 7 999999999999987
Q ss_pred CC----------------cEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 320 DF----------------SAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 320 ~~----------------~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
++ .+||+|||++.... .......+|+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 65 49999999876432 22345678999999999999999999999999999999999999998
Q ss_pred CCChHHHHhHhhhccccccccc-------cccccc------ccccCC----------CC-CHHHHHHHHHHHHHhcccCC
Q 011995 384 SRHPKEERNLVKWSRPFLADDC-------RLSLIM------DPQLKG----------RF-PLKAARTVADIALRCLQKEP 439 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~------~~~l~~----------~~-~~~~~~~l~~li~~cl~~dP 439 (473)
+....+....+......+.... ....+. .+.... .. .......+.+||.+||++||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 7765544433321110000000 000000 000000 00 01124567899999999999
Q ss_pred CCCCCHHHHHH
Q 011995 440 SERPTMRSIFE 450 (473)
Q Consensus 440 ~~RPt~~eil~ 450 (473)
.+|||++|+|+
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999997
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.29 Aligned_cols=259 Identities=20% Similarity=0.345 Sum_probs=205.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||+||+|.+..+.. ....+++|+............+.+|+.++..++|+||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCc
Confidence 567888999999999999998644332 2334566665544455556788999999999999999999999864 457
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 8999999999999998542 346899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
...... ....++..|++||.+.+..++.++|||||||++|||++ |..||...........+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~-- 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-------GER-- 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CCc--
Confidence 643221 12234568999999988889999999999999999998 9999976544332222210 000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+...+.++.+++.+||..||++||++.++++.|+++...
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 011234557889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.02 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=199.5
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
.|...+.||+|+||.||+|....+. ...+++|+.... .......+.+|+.+|..++|||||++++++... +.+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~--~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCC--CeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEE
Confidence 3888899999999999999854331 233334333222 333445678899999999999999999999876 78999
Q ss_pred EEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 256 IYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||||+++|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999988542 22456899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~------------ 287 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK------------ 287 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 4322 234468999999999998889999999999999999999999998765443322221110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...++..++.++.+||.+||..||++||++.+++.
T Consensus 288 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 -----YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00123345678999999999999999999999875
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=315.26 Aligned_cols=258 Identities=18% Similarity=0.327 Sum_probs=203.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|....+......++++.............+..|++++..++|+||+++++++... +..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence 457888899999999999999976443333344455444333344567789999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 82 MIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999999998542 356899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccC-----cccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETDISN-----SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~~~~-----~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
........ ...+..|++||++.+..++.++|||||||++|||++ |..||...........+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-------~--- 226 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-------G--- 226 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-------C---
Confidence 54322111 122357999999988889999999999999999997 9999976544332221110 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.....+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 -------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011223457889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=335.21 Aligned_cols=261 Identities=19% Similarity=0.290 Sum_probs=203.9
Q ss_pred cccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~ 251 (473)
++|...+.||+|+||.||+|++.+. ....+.+++|+............+.+|+.+|.++. |||||++++++... .
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--G 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--C
Confidence 3566669999999999999997642 22344556665554333444567899999999997 99999999999776 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCC---------------------------------------------------------
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD--------------------------------------------------------- 274 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 274 (473)
..++||||+.+|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 89999999999999999965321
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 275 --------------------------------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 275 --------------------------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
...+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 124678889999999999999999998 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHH
Q 011995 317 IDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEER 391 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~ 391 (473)
++.++.+||+|||+++...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999997653221 122345678999999988889999999999999999998 89999765433321
Q ss_pred hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.... ..+ .....+..++.++.+|+.+||..+|.+||++.+|++.|+++.
T Consensus 352 ~~~~------~~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAI------KRG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHH------HcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1110 000 011123345688999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=317.07 Aligned_cols=259 Identities=19% Similarity=0.315 Sum_probs=201.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
+++|.+.+.||+|+||.||+|.+.+.. .....++++.............|.+|+.+++.++|+||+++++++.+. +
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--L 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 467888899999999999999875421 123333344333333344456789999999999999999999988765 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC---cEE
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD----GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF---SAK 324 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~vk 324 (473)
..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||||+|||++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 78999999999999999865421 235899999999999999999999999 99999999999998654 599
Q ss_pred EeccCCCcccCCCCcc----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPETDIS----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~~~----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||+++........ ....+..|+|||++.+..++.++|||||||++|||++ |..||...........+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-- 237 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-- 237 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence 9999999876432221 1223467999999998899999999999999999997 99999876544332222100
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
....++..++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 238 ---------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 238 ---------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ---------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0111233456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=328.77 Aligned_cols=263 Identities=20% Similarity=0.325 Sum_probs=204.1
Q ss_pred cccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
++|++.+.||+|+||.||+|...+ .....+.+++|+.+..........+.+|+.++.++ +|+||+++++++...+ .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-G 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-C
Confidence 478888999999999999998532 23345666676665443444556788999999999 7899999999886553 5
Q ss_pred ceEEEEEeccCCChhhhhhcCCC---------------------------------------------------------
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD--------------------------------------------------------- 274 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 274 (473)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 78999999999999999864210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc----cCcc
Q 011995 275 -------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI----SNSS 343 (473)
Q Consensus 275 -------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~ 343 (473)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999999 99999999999999999999999999876532211 1223
Q ss_pred cccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHH
Q 011995 344 VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLK 422 (473)
Q Consensus 344 ~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 422 (473)
++..|+|||.+.+..++.++|||||||++|||++ |..||............ +..+.. ...+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~~~~----------~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------LKEGTR----------MRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH------HhccCC----------CCCCCC
Confidence 4567999999988889999999999999999996 99999764332211110 000000 011222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 423 AARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 423 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
.+.++.+++..||+.||.+|||+.+|++.|+.+.+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 44678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=317.65 Aligned_cols=259 Identities=21% Similarity=0.349 Sum_probs=205.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|...+.. ...+.++++.............+.+|+.++..++|+||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--Q 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--C
Confidence 357888899999999999999875433 233455555543333334456788999999999999999999998765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD-------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 89999999999999999865321 234789999999999999999999998 99999999999999999999
Q ss_pred EeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||+++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~- 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG- 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC-
Confidence 999999876543321 22345678999999988889999999999999999998 999997655444332221000
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
....+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 239 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 ----------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 001233346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.15 Aligned_cols=250 Identities=18% Similarity=0.230 Sum_probs=198.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||+||+|.... .++.+++|+..... .......+.+|+++|..++|+||+++++++.+. +.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--Ce
Confidence 478889999999999999998544 34455666655321 223446678999999999999999999998876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|+||||+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccce
Confidence 9999999999999999854 346899999999999999999999999 9999999999999999999999999986
Q ss_pred ccCCCC----------------------------------------ccCcccccccCChhhhhcCCCCCcCCchHHHHHH
Q 011995 333 HIPETD----------------------------------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVL 372 (473)
Q Consensus 333 ~~~~~~----------------------------------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl 372 (473)
.+.... .....||+.|+|||++.+..++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 542211 0123589999999999988899999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHhHh-hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 011995 373 LELLTGRKNLDSRHPKEERNLV-KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT---MRSI 448 (473)
Q Consensus 373 ~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ei 448 (473)
|||++|..||......+....+ .|.... ... .....+.++.+++.+|+. +|.+|++ +.++
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~-------------~~~--~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETL-------------QFP--DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCcc-------------CCC--CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 9999999999876654432222 221110 000 011346788999999996 9999998 8888
Q ss_pred HHH
Q 011995 449 FEE 451 (473)
Q Consensus 449 l~~ 451 (473)
++.
T Consensus 294 l~h 296 (364)
T cd05599 294 KSH 296 (364)
T ss_pred hcC
Confidence 773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=321.72 Aligned_cols=260 Identities=18% Similarity=0.308 Sum_probs=204.3
Q ss_pred hcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|...+.||+|+||.||++.... .......++++..+........+.+.+|+++++++ +|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 3578889999999999999997532 12234455555444333344456789999999999 799999999998766
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+..++||||+.+|+|.+++.... ...+++.++..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 78999999999999999996532 334899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccc
Q 011995 331 AGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 331 a~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
+........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||.............. ..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------~~- 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------EG- 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH------cC-
Confidence 876543221 12234578999999998889999999999999999998 9999976554332211100 00
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.....+...+.++.+|+.+||..+|++|||+.+|++.|+++
T Consensus 261 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=322.28 Aligned_cols=262 Identities=21% Similarity=0.358 Sum_probs=207.0
Q ss_pred cccccCcceeecCCceEEEEEECCCC----eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA----STSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
++|.+.+.||+|+||.||++...+.. .....+++++............+.+|++++..+ +|+||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~- 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD- 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence 57899999999999999999753321 123345555554333344556788999999999 899999999998766
Q ss_pred CCceEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 97 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 97 -GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 789999999999999999965321 235899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHH
Q 011995 317 IDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEER 391 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~ 391 (473)
++.++.+||+|||++........ .....+..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 99999999999999876543221 11223468999999998889999999999999999998 88999765543322
Q ss_pred hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
..+.... ....+...+.++.+++.+||..+|.+||++.+|++.|+++...
T Consensus 253 ~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 253 KLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHcCC-----------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2221100 0112334567899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=334.85 Aligned_cols=250 Identities=18% Similarity=0.198 Sum_probs=196.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.|+..+.||+|+||+||+|.... +.+.+++|+..... .......+.+|++++..++|+||+++++++.+. +.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEE
Confidence 57888999999999999998544 34556666655432 233456789999999999999999999999865 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||..+ |+||||||+||||+.++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 999999999999999854 346889999999999999999999999 99999999999999999999999998753
Q ss_pred cCCC-------------------------------------------------CccCcccccccCChhhhhcCCCCCcCC
Q 011995 334 IPET-------------------------------------------------DISNSSVAAANLSVETLERGLLTPKSN 364 (473)
Q Consensus 334 ~~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~s~~sD 364 (473)
+... ......||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 3100 011346889999999999888999999
Q ss_pred chHHHHHHHHHHcCCCCCCCCChHHHHh-HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHH--hcccCCCC
Q 011995 365 VWSFGIVLLELLTGRKNLDSRHPKEERN-LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALR--CLQKEPSE 441 (473)
Q Consensus 365 vwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dP~~ 441 (473)
||||||++|||++|..||......+... ++.|.... ........+.++.+|+.+ |+..++..
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HIPPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CCCCCCCCCHHHHHHHHHHccCcccccC
Confidence 9999999999999999998765443222 22221110 000012356788899988 55666777
Q ss_pred CCCHHHHHHH
Q 011995 442 RPTMRSIFEE 451 (473)
Q Consensus 442 RPt~~eil~~ 451 (473)
|+++.+|++.
T Consensus 296 R~~~~~~l~h 305 (381)
T cd05626 296 RNGADDIKAH 305 (381)
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.77 Aligned_cols=254 Identities=20% Similarity=0.370 Sum_probs=195.5
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||+|+||.||+|.+.+.......+++|.............+.+|+.+++.++||||+++++++...+ ...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEecC
Confidence 468999999999998755443334444544332223344678889999999999999999999876543 5678999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC--
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD-- 338 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-- 338 (473)
.+|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999643 334678888999999999999999998 9999999999999999999999999987553321
Q ss_pred ----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 339 ----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 339 ----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.....++..|+|||.+.+..++.++|||||||++|||++ |.+||...........+.... ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-------------~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-------------RL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-------------CC
Confidence 112344668999999988889999999999999999999 566776544333222111100 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
..+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0122335678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.08 Aligned_cols=264 Identities=21% Similarity=0.362 Sum_probs=208.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCC-eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDA-STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||+|+||.||+|.+.+.. .....++++.............+.+|+.+++.++|+||+++++++...+ ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG-EP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-CC
Confidence 467888899999999999999976522 1233344444333333445677899999999999999999999887643 67
Q ss_pred eEEEEEeccCCChhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDG-----PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
.++++||+++|+|.+++...... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653222 56899999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccc
Q 011995 328 YGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 328 FGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
||+++.+..... ....++..|+|||++.+..++.++|||||||++||+++ |+.||...........+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK------- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------
Confidence 999986543321 12234567999999988889999999999999999999 999998765433222111
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.+... ..+..++.++.+++.+||..||++|||+.++++.|+.+.++
T Consensus 234 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11000 11223457889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=312.37 Aligned_cols=247 Identities=19% Similarity=0.371 Sum_probs=195.1
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||+|+||.||+|....+ .+.++++.............+.+|+++++.++|+||+++++++... ...++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRAD---NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecC---CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence 3699999999999986543 2334444433223344557799999999999999999999998765 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCcc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 340 (473)
++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence 999999998542 346899999999999999999999999 999999999999999999999999998765432211
Q ss_pred Cc----ccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 341 NS----SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 341 ~~----~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.. ..+..|+|||.+.++.++.++|||||||++|||++ |..||...........+... .
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-----------------~ 213 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-----------------V 213 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----------------C
Confidence 11 22356999999998889999999999999999997 99999765543322222110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
...++...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 111233456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=313.89 Aligned_cols=255 Identities=23% Similarity=0.413 Sum_probs=204.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
...+|...+.||.|+||.||+|...++ +.+++++.... .......+.+|+.+++.++|+||+++++++... +.
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~----~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 76 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNR----VRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EP 76 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCC----CcEEEEecccc-chhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CC
Confidence 356788889999999999999987653 22333333221 222456788999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++... .+..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred eEEEEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchh
Confidence 99999999999999999654 3456899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 333 HIPETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 333 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... ....++..|++||.+.+..++.++||||||+++|+|++ |+.||......+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------------- 219 (261)
T cd05148 153 LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA------------- 219 (261)
T ss_pred hcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-------------
Confidence 6643321 12234568999999988889999999999999999998 8999977654333222210
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
......+..++..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 220 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 ----GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001112345567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=332.84 Aligned_cols=260 Identities=19% Similarity=0.310 Sum_probs=222.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+....++||.|.||.||.|.|.....+ ++|+.++......++|+.|..+|+.++|||+|+|+|+|..+ ..+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslT-----vAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFY 339 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLT-----VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFY 339 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeecccee-----eehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeE
Confidence 3445568999999999999999876543 77778877778889999999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||.|||..|+|.++|+... ..-++....++++.||..|++||..++ +|||||...|+|+.++-.|||+||||++++
T Consensus 340 IiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999997653 345777888999999999999999999 999999999999999999999999999999
Q ss_pred CCCCccCccc---ccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDISNSSV---AAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~~~~~---t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..+.++...| .+.|.|||-+....++.++|||+|||+|||+.| |..||.+.+..+...+.+ .+.+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------kgyR---- 484 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------KGYR---- 484 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------cccc----
Confidence 8776655444 478999999999999999999999999999987 889999876555443332 2212
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCC
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~ 462 (473)
-+-|..|++.+.+|+..||+..|.+||+++||-+.|+.|.+..+.+
T Consensus 485 ------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 485 ------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred ------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 2237788899999999999999999999999999999888766543
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=315.17 Aligned_cols=260 Identities=18% Similarity=0.229 Sum_probs=203.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||.||+|+...+ .+.+++|..... ........+.+|+++++.++||||+++++++... +.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLD---RKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCC---CCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--Ce
Confidence 5788999999999999999986443 334445544322 2334456788999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.++|+||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999998885322 2345889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~----------~~ 222 (267)
T cd08228 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQKI----------EQ 222 (267)
T ss_pred eeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHHHH----------hc
Confidence 77643321 234577899999999888899999999999999999999999965432111 111100 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
...+ .......+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 223 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDYP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0001 1112345678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=332.20 Aligned_cols=251 Identities=16% Similarity=0.212 Sum_probs=196.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||+||+|.... ..+.+++|+..... .......+.+|+.++..++|+||+++++++.+. ..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Ce
Confidence 478889999999999999998543 34556666655321 223346788999999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+||||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 9999999999999999954 346899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCC-------------------------------------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHH
Q 011995 333 HIPETD-------------------------------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLEL 375 (473)
Q Consensus 333 ~~~~~~-------------------------------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~el 375 (473)
.+.... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 542210 1234689999999999998999999999999999999
Q ss_pred HcCCCCCCCCChHHHHhHhh-hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 011995 376 LTGRKNLDSRHPKEERNLVK-WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQ--KEPSERPTMRSIFEE 451 (473)
Q Consensus 376 ltG~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~eil~~ 451 (473)
++|..||.+....+....+. |.... .+.. ....+.++.+++.+++. .++..||+++||++.
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~~-------------~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKETL-------------IFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCcc-------------cCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99999998766544333221 11100 0000 11245678888887553 344456899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=327.12 Aligned_cols=245 Identities=19% Similarity=0.285 Sum_probs=193.3
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHH---HhCCCCCcccceeeeecCCCC
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTL---ASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l---~~l~HpnIv~l~g~~~~~~~~ 251 (473)
|.+.+.||+|+||.||+|....+ .+.+++|+..... .....+.+.+|+.++ ..++||||+++++++... +
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--D 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--C
Confidence 56678999999999999986443 3455566554321 222345566776655 566899999999998765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..|+||||+++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCC
Confidence 89999999999999988842 35999999999999999999999999 999999999999999999999999998
Q ss_pred cccCC--CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPE--TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... .......+++.|||||.+.+..++.++|||||||++|||++|..||...........+....
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------- 217 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 75422 22234568899999999998889999999999999999999999998765443332221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 218 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 -------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 012344567889999999999999999 57777663
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.42 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=201.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||+|.... ..+.+++|+..... .......+.+|++++..++|+||+++++++.++ +.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC--Ce
Confidence 468889999999999999998653 34555666654321 223456788999999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 99999999999999999543 46899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCC-------------------------------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCC
Q 011995 333 HIPETD-------------------------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKN 381 (473)
Q Consensus 333 ~~~~~~-------------------------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p 381 (473)
...... .....+|+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 654332 2334678999999999999999999999999999999999999
Q ss_pred CCCCChHHHHhHh-hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 011995 382 LDSRHPKEERNLV-KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-MRSIFEE 451 (473)
Q Consensus 382 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~ 451 (473)
|...........+ .|.... .+. ....++.++.+||.+||. ||.+||+ +.++++.
T Consensus 230 f~~~~~~~~~~~i~~~~~~~-------------~~p--~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 230 FYSDTLQETYNKIINWKESL-------------RFP--PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCHHHHHHHHhccCCcc-------------cCC--CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9876644433222 111100 000 011256889999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=317.84 Aligned_cols=257 Identities=21% Similarity=0.313 Sum_probs=201.9
Q ss_pred ccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+|...+.||+|+||.||+|...+.. ...+.+++|+............+.+|+.++..++||||+++++++... ...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--QPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--Cce
Confidence 4556689999999999999875432 233445555544333333456788999999999999999999998766 678
Q ss_pred EEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
++++||+.+++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 99999999999999985321 1235889999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhh
Q 011995 321 FSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 395 (473)
+.+||+|||+++....... ....+++.|+|||.+.++.++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876543221 22344678999999988889999999999999999998 888987765443322221
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.. . ...++..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 241 ~~----------------~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NR----------------Q-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cC----------------C-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 10 0 011234556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.69 Aligned_cols=257 Identities=18% Similarity=0.344 Sum_probs=202.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|.+.+.||+|+||.||+|...........++++.............+.+|+.++.+++||||+++++++..+ +..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CccE
Confidence 57888899999999999999864333333344444443333334457889999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++..+
T Consensus 82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999999643 346899999999999999999999999 999999999999999999999999998866
Q ss_pred CCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 335 PETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 335 ~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
..... .....+..|++||.+.+..++.++|+|||||++||+++ |..||......+....+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~-- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-------EGYR-- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-------CCCc--
Confidence 43221 11122457999999998889999999999999999886 999997655433222111 0000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
...+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011233457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.22 Aligned_cols=265 Identities=19% Similarity=0.328 Sum_probs=200.8
Q ss_pred cccccCcceeecCCceEEEEEECCC-------------CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDD-------------ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 241 (473)
++|++.+.||+|+||.||++...+. ......+++++............+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 4688889999999999999864321 112233445544433344456789999999999999999999
Q ss_pred eeeeecCCCCceEEEEEeccCCChhhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCC
Q 011995 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD--------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTA 313 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~ 313 (473)
++++... +..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+
T Consensus 85 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 85 LAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred EEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 9998776 678999999999999999865321 234788899999999999999999999 999999999
Q ss_pred ceeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc--CCCCCCCCCh
Q 011995 314 NIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT--GRKNLDSRHP 387 (473)
Q Consensus 314 NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt--G~~p~~~~~~ 387 (473)
|||++.++.++|+|||++..+..... .....+..|++||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999876543321 12233578999999988889999999999999999998 7788876544
Q ss_pred HHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.+....... +...... .. ....+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus 240 ~~~~~~~~~---~~~~~~~--~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGE---FFRDQGR--QV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHH---HHhhccc--cc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 332211100 0000000 00 001122345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=327.70 Aligned_cols=266 Identities=16% Similarity=0.229 Sum_probs=194.6
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC---C
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS---D 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~---~ 251 (473)
+|+..+.||+|+||.||+|....+ +..+++|..... ........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCC---CCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 477889999999999999985433 344555544322 122344678899999999999999999998864321 3
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred eEEEEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccc
Confidence 5899999995 689988843 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-----ccCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc--cc--
Q 011995 332 GHIPETD-----ISNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR--PF-- 400 (473)
Q Consensus 332 ~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--~~-- 400 (473)
+...... .....++..|+|||++.+ ..++.++|||||||++|||++|++||.+.........+.... +.
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7653221 123468899999999876 578999999999999999999999998765433222111000 00
Q ss_pred ----ccccc--ccccccccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 401 ----LADDC--RLSLIMDPQLKGRF---PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 401 ----~~~~~--~~~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.... .....+.......+ ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 00000000000000 01245678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.17 Aligned_cols=263 Identities=19% Similarity=0.341 Sum_probs=206.6
Q ss_pred hcccccCcceeecCCceEEEEEECC----CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 248 (473)
.++|.+.+.||+|+||.||+|.... .......+++++............+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 4678888999999999999997532 12222344444443332344567899999999999 899999999998766
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
...++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 788999999999999999965321 235789999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHH
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~ 390 (473)
|++.++.+||+|||++........ ....++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999986643221 12234568999999988889999999999999999998 8888876554443
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+.. ... ...+..++..+.+|+.+||+.+|.+||++.++++.|+++..-
T Consensus 249 ~~~~~~-------~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 249 FKLLKE-------GHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHc-------CCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 322210 000 011334567899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=335.40 Aligned_cols=250 Identities=16% Similarity=0.202 Sum_probs=196.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||++.... ..+.+++|+..... .......+.+|++++..++|||||++++++.+. +.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--Ce
Confidence 478888999999999999998543 34555666554321 233456788999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+||||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999999999853 346889999999999999999999999 9999999999999999999999999986
Q ss_pred ccCCCC-------------------------------------------------ccCcccccccCChhhhhcCCCCCcC
Q 011995 333 HIPETD-------------------------------------------------ISNSSVAAANLSVETLERGLLTPKS 363 (473)
Q Consensus 333 ~~~~~~-------------------------------------------------~~~~~~t~~y~aPE~~~~~~~s~~s 363 (473)
.+.... .....||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 331100 0023588999999999988899999
Q ss_pred CchHHHHHHHHHHcCCCCCCCCChHHHHhHh-hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011995 364 NVWSFGIVLLELLTGRKNLDSRHPKEERNLV-KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442 (473)
Q Consensus 364 DvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 442 (473)
|||||||++|||++|..||......+....+ .|.... .+.. ....+.++.+|+.+||. +|.+|
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------~~p~--~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL-------------YFPD--DIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc-------------CCCC--CCCCCHHHHHHHHHHhc-CHhhc
Confidence 9999999999999999999876654332221 221100 0000 11345788999999997 67765
Q ss_pred ---CCHHHHHHH
Q 011995 443 ---PTMRSIFEE 451 (473)
Q Consensus 443 ---Pt~~eil~~ 451 (473)
+++.++++.
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=319.62 Aligned_cols=265 Identities=18% Similarity=0.327 Sum_probs=199.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-----------eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCccccee
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-----------TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLG 243 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g 243 (473)
++|++.+.||+|+||.||++...+... ....+++|+.+..........|.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888999999999999997643211 112344444443333444567999999999999999999999
Q ss_pred eeecCCCCceEEEEEeccCCChhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCc
Q 011995 244 FHARDGSDQRMLIYERLFHGSLDRLIYGRS---------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTAN 314 (473)
Q Consensus 244 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~N 314 (473)
++... +..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 85 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 85 VCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 98765 78999999999999999985431 1124789999999999999999999999 9999999999
Q ss_pred eeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc--CCCCCCCCChH
Q 011995 315 IQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT--GRKNLDSRHPK 388 (473)
Q Consensus 315 ILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt--G~~p~~~~~~~ 388 (473)
||++.++.+||+|||++........ ....++..|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876543221 12234568999999988889999999999999999988 66788765443
Q ss_pred HHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.....+.. +......... ...+...+..+.+|+.+||+.||++||++.+|++.|++
T Consensus 240 ~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGE---FFRNQGRQIY-------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHH---hhhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 32211110 0000000000 00122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.12 Aligned_cols=265 Identities=22% Similarity=0.378 Sum_probs=203.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCee-------------eeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAST-------------SKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 241 (473)
.+|++.+.||+|+||.||+|...+.... ...+++++............+.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 5788889999999999999987543221 133445544433344556789999999999999999999
Q ss_pred eeeeecCCCCceEEEEEeccCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCC
Q 011995 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRS--------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTA 313 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~ 313 (473)
++++..+ +..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+|+||||+
T Consensus 85 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 85 LGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 9998766 78999999999999999986532 1126899999999999999999999999 999999999
Q ss_pred ceeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc--CCCCCCCCCh
Q 011995 314 NIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT--GRKNLDSRHP 387 (473)
Q Consensus 314 NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt--G~~p~~~~~~ 387 (473)
||+++.++.++|+|||++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876543322 22344678999999988889999999999999999998 7788866543
Q ss_pred HHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
....... ....... ........+..++.++.+++.+||+.||.+|||+.+|++.|++
T Consensus 240 ~~~~~~~---~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENA---GHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHH---Hhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 3321111 0010000 0000011123455789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=316.03 Aligned_cols=249 Identities=21% Similarity=0.226 Sum_probs=204.1
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.|+..+.||.|.-|+||++.+.+.. ..+|+||+.... ......+...|-+||..+.||.++.||..+..+ ...
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~---~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~--~~~ 152 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTN---CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD--KYS 152 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCC---ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc--cee
Confidence 4455599999999999999976644 677888876542 334456778899999999999999999999877 899
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|||||||+||+|..+++.+ .+..|++..+..++.+|+.||+|||..| ||+|||||+||||.++|++.|+||.|+..
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999988765 5778999999999999999999999999 99999999999999999999999998632
Q ss_pred cCC-----------------------------------C-----------------------CccCcccccccCChhhhh
Q 011995 334 IPE-----------------------------------T-----------------------DISNSSVAAANLSVETLE 355 (473)
Q Consensus 334 ~~~-----------------------------------~-----------------------~~~~~~~t~~y~aPE~~~ 355 (473)
+.. . .....+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 0 012346788899999999
Q ss_pred cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhc
Q 011995 356 RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435 (473)
Q Consensus 356 ~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl 435 (473)
|+.-+.++|+|.|||++|||+.|..||.+.+..+....|-. ..+.-.-...++..+++||+++|
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------QPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------CCCcCCCCCcchhHHHHHHHHHh
Confidence 99999999999999999999999999999887765543321 11111112367789999999999
Q ss_pred ccCCCCCCC----HHHHH
Q 011995 436 QKEPSERPT----MRSIF 449 (473)
Q Consensus 436 ~~dP~~RPt----~~eil 449 (473)
.+||.+|.. +.||-
T Consensus 373 vKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred ccChhhhhccccchHHhh
Confidence 999999998 55553
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.12 Aligned_cols=247 Identities=18% Similarity=0.339 Sum_probs=196.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
+|...+.||+|+||.||+|.+.+. ..+++|+. .........+.+|+++++.++|+||+++++++... +..++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~----~~~~iK~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 76 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGK----IDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFI 76 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCC----ccEEEEEe--ccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEE
Confidence 477779999999999999986533 22334433 22223345788999999999999999999988765 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 77 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 77 VTEYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence 99999999999999643 236899999999999999999999999 9999999999999999999999999987664
Q ss_pred CCCccCc---ccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 336 ETDISNS---SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 336 ~~~~~~~---~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
....... ..+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+...
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-------------- 217 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC--------------
Confidence 3322222 22357999999998889999999999999999999 89999765443322211100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
.....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 ---YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111334567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=318.15 Aligned_cols=274 Identities=19% Similarity=0.259 Sum_probs=200.9
Q ss_pred cccccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+|++.+.||+|+||.||++.+.. +......++++.... ......+.+.+|++++..++||||+++++++...+...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 467788999999999999998642 222344445554332 233445678999999999999999999998866555678
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999998542 345899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCcc-----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETDIS-----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~~-----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... ....+..|+|||.+.+..++.++|||||||++|||++|..++.......... .............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh-cccccccccchHHHH
Confidence 6433211 1122346999999988889999999999999999999887764332111000 000000000000000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
...........+..++.++.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111111112334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.98 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=202.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||++..... ...++++............++.+|++++.+++||||+++++++..+ +.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPS---GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCC---CeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEE
Confidence 4688899999999999999986543 3344454444333334456788999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. + ++|+||||+|||++.++.+||+|||++..
T Consensus 76 lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred EEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccc
Confidence 999999999999999543 4689999999999999999999984 6 99999999999999999999999999876
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc-------
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR------- 406 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 406 (473)
..........++..|+|||.+.+..++.++|||||||++|||++|..||........................
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 150 LIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 6544444557789999999998888999999999999999999999999765433222111110000000000
Q ss_pred -------------cccccccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 407 -------------LSLIMDPQLKGRFP-LKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 407 -------------~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
...+... .....+ ...+.++.+|+.+||..||++|||+.+|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000 000011 12456799999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.57 Aligned_cols=249 Identities=18% Similarity=0.328 Sum_probs=197.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|...+.||+|+||.||.|.+.+.. . ++++...........+.+|+.++..++||||+++++++... +..+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~----~--~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQY----D--VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIY 75 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCC----c--EEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcE
Confidence 35777899999999999999865432 1 33333333333456799999999999999999999998765 6789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+.+|+|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..
T Consensus 76 lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 76 IVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceec
Confidence 999999999999998643 236899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCccC---cccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDISN---SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~~---~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
....... ..++..|++||.+.+..++.++|||||||++|||++ |..||...........+.... .
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------~---- 219 (256)
T cd05113 151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-------R---- 219 (256)
T ss_pred CCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-------C----
Confidence 4332222 234567999999988889999999999999999998 999997655433222221100 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
...+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 220 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 ------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112234578899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.14 Aligned_cols=250 Identities=20% Similarity=0.339 Sum_probs=198.3
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||+|+||.||+|.+.......+.+++|...........+.+.+|+.+++.+.|+||+++++++.. +..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeC
Confidence 4699999999999987554433345555554433333456789999999999999999999998753 5689999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCcc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 340 (473)
++|+|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999999543 36899999999999999999999999 999999999999999999999999998766432211
Q ss_pred -----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 341 -----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 341 -----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
...++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-------~-------- 216 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-------R-------- 216 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-------c--------
Confidence 1122357999999988889999999999999999998 999997765433322221110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
...+..++..+.+++.+||..+|.+||++.+|++.|+++.
T Consensus 217 --~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 --LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0113345578999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.82 Aligned_cols=257 Identities=18% Similarity=0.353 Sum_probs=198.8
Q ss_pred ccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC----CCc
Q 011995 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG----SDQ 252 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~ 252 (473)
.+++.||+|+||.||+|.+.+... ...++++..... ........+.+|+++++.++|+||+++++++.... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~-~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDS-ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCC-eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456899999999999998765432 233444444332 23344677899999999999999999999875421 235
Q ss_pred eEEEEEeccCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGR---SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
.++||||+.+|+|.+++... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 78999999999999887422 12345899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccc
Q 011995 330 CAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 330 la~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
+++....... .....+..|++||.+.+..++.++|||||||++|||++ |+.||...........+. .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-------QG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cC
Confidence 9987643321 12234568999999998889999999999999999999 899997655433222111 00
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
... ..+..++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 11234457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=319.24 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=199.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+|+..+.||+|+||.||++.... ....+++++..... .......+.+|+.+++.++|+||+++++++... +.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeE
Confidence 47788999999999999998543 33455555544321 122345678899999999999999999988765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 9999999999999888643 2346899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCc-cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 334 IPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~~-~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
...... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.+.........+... +.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---~~---------- 218 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---VK---------- 218 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---hh----------
Confidence 643322 3346789999999998888999999999999999999999999865433221111100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
.....++...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 219 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 219 -EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001122445667899999999999999999 88888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.91 Aligned_cols=250 Identities=21% Similarity=0.394 Sum_probs=198.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|++.+.||+|+||.||+|...++.. ++++ ...........+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~----~~~k--~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~ 76 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK----VAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIY 76 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCce----eEEE--EecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcE
Confidence 467788999999999999998654432 2333 333333345679999999999999999999998743 5689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeec
Confidence 999999999999998653 2346899999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
...... ...++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------- 219 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG------------- 219 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 433221 2234567999999988889999999999999999999 89999765543322221100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.....+...+..+.+|+.+||..||.+|||+.++++.|++
T Consensus 220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 ----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=324.45 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=191.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|...++ .+.+++|+..... .......+..|..++..+ +||||+++++++.+. +.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCC---CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEE
Confidence 4699999999999986543 3445566554321 123345667788888764 999999999998776 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC--
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP-- 335 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~-- 335 (473)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 76 ey~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence 99999999999853 346899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 336 ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 336 ~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
........+|..|+|||++.+..++.++|||||||++|||++|..||......+....+.... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------~-- 213 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--------------P-- 213 (316)
T ss_pred CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------C--
Confidence 222344568899999999998889999999999999999999999998766544333222111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMR-SIFE 450 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 450 (473)
.++...+.++.+++.+||+.||.+||++. ++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12334557889999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=310.74 Aligned_cols=247 Identities=16% Similarity=0.303 Sum_probs=197.0
Q ss_pred ceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
.||+|+||.||+|.+... ...+.+++|+..... .....+++.+|+.+++.+.|+||+++++++.. +..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecC-CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecC
Confidence 589999999999976432 234455566554332 23345788999999999999999999998753 5679999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc-
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI- 339 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 339 (473)
++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||.|||++.++.+||+|||++........
T Consensus 78 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 78 ELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999999853 346899999999999999999999999 99999999999999999999999999976643321
Q ss_pred ----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 340 ----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 340 ----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
....++..|+|||.+....++.++|||||||++|||++ |..||......+....+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~----------------- 214 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG----------------- 214 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-----------------
Confidence 11223468999999988889999999999999999998 99999876544333222211
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.....+..++.++.++|.+||+.||++||++.+|.+.|+..
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01112345668899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=325.89 Aligned_cols=236 Identities=19% Similarity=0.282 Sum_probs=189.6
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|....+ .+.+++|+.... ........+..|+.++..+ +||||+++++++... +.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKES---GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCC---CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEE
Confidence 4699999999999986443 345556655432 1233456678899998877 799999999988765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC-
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 336 (473)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 Ey~~~g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence 99999999998854 346899999999999999999999999 99999999999999999999999999875422
Q ss_pred -CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 -TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 -~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------- 212 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------- 212 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 22334568999999999998889999999999999999999999998766544332221100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 445 (473)
..++...+.++.+++.+||+.||.+||++
T Consensus 213 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 01233456788999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.69 Aligned_cols=241 Identities=17% Similarity=0.231 Sum_probs=194.3
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
+.||+|+||.||++....+...+..+++++..... .......+.+|+++|.+++||||+++++++..+ +..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEcC
Confidence 67999999999999754344455666677665322 222345677899999999999999999998766 789999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC--
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET-- 337 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-- 337 (473)
+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 80 LRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999999843 346899999999999999999999999 999999999999999999999999998765433
Q ss_pred CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCC
Q 011995 338 DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417 (473)
Q Consensus 338 ~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 417 (473)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||...........+... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~------------------~~ 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------------------KL 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC------------------CC
Confidence 223456889999999998888999999999999999999999999876544332222100 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011995 418 RFPLKAARTVADIALRCLQKEPSERPTMRS 447 (473)
Q Consensus 418 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 447 (473)
.++...+.++.+++.+||+.||.+||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 123445678899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=311.11 Aligned_cols=252 Identities=22% Similarity=0.372 Sum_probs=201.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|.+.+.||+|+||.||+|...++. .+++ +.+.........+.+|+++++.++|+||+++++++.. +..+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~val--K~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~ 76 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT----RVAI--KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 76 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc----eEEE--EecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcE
Confidence 46888999999999999999865442 2333 3333333345678999999999999999999988743 5679
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeec
Confidence 999999999999999643 2346899999999999999999999999 999999999999999999999999999766
Q ss_pred CCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
...... ...++..|++||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------ 220 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------ 220 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC------------
Confidence 433221 2234567999999988889999999999999999999 888997765443322221110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
....+...+..+.+++.+||+.||++||++.++++.|++..
T Consensus 221 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 00113345678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=309.58 Aligned_cols=248 Identities=16% Similarity=0.293 Sum_probs=195.9
Q ss_pred ceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEecc
Q 011995 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLF 261 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~ 261 (473)
.||+|+||.||+|.+.... ....+++++..........+.+.+|+.++++++|+||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999865322 2233445554433334445679999999999999999999998743 57899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc--
Q 011995 262 HGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI-- 339 (473)
Q Consensus 262 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 339 (473)
+|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 78 ~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 78 GGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99999998542 346899999999999999999999999 99999999999999999999999999875533211
Q ss_pred ---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 340 ---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 340 ---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----------------~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-----------------K 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----------------C
Confidence 11122468999999988889999999999999999996 99999876544332222110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
...++..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122345568899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=326.35 Aligned_cols=246 Identities=19% Similarity=0.238 Sum_probs=195.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCC-CcccceeeeecCCCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHP-NLCKLLGFHARDGSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~ 252 (473)
+|...+.||+|+||.||+|...+. .+.+++|+.... ......+.+..|++++..+.|+ +|+.+++++... +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CE
Confidence 477889999999999999986543 345566655432 1234456788899999999765 577888887765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 9999999999999998853 345899999999999999999999999 9999999999999999999999999986
Q ss_pred ccC--CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIP--ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
... ........+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------- 216 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------- 216 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 432 22233456889999999999989999999999999999999999999876544333222100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM-----RSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 450 (473)
...++...+.++.+++.+||..||.+|++. .++++
T Consensus 217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 217 -----NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 012234456789999999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=324.11 Aligned_cols=241 Identities=20% Similarity=0.298 Sum_probs=190.3
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|...+. .+.+++|+.+... .......+..|..++..+ +||||+++++++... +.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGT---NEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCC---CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEE
Confidence 4699999999999986543 3445566554321 223345566777777654 899999999988765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 76 e~~~gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence 99999999998853 346899999999999999999999999 999999999999999999999999998754322
Q ss_pred --CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 338 --DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 338 --~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
......+|+.|+|||.+.+..++.++|||||||++|||++|..||.+.........+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------------- 212 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----------------- 212 (316)
T ss_pred CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 2234568999999999998889999999999999999999999998766543332221110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMR-SIFE 450 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 450 (473)
..++...+.++.+++.+||+.||.+||++. ++++
T Consensus 213 -~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 -PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 112344567889999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.46 Aligned_cols=257 Identities=19% Similarity=0.338 Sum_probs=203.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|...+.||+|+||.||+|....+......+++|+............|..|+.+++.++||||+++++++..+ ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--CceE
Confidence 35777899999999999999976554433445555544333444567899999999999999999999998665 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999998543 346899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCc----cCcc---cccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 335 PETDI----SNSS---VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 335 ~~~~~----~~~~---~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
..... .... .+..|++||.+.+..++.++|||||||++|||++ |..||...........+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-------~~~ 229 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------DYR 229 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-------CCc
Confidence 43221 1111 1347999999998899999999999999999886 9999977654332222210 000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
...+..++..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus 230 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011234457789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=324.77 Aligned_cols=242 Identities=18% Similarity=0.268 Sum_probs=193.7
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|...+. ...+++|+.... ........+..|++++..+ +||||+++++++... +..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCC---CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEE
Confidence 4699999999999986543 344556655432 1234456678899999876 899999999998766 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 76 E~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence 99999999988853 346899999999999999999999999 999999999999999999999999998754222
Q ss_pred --CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 338 --DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 338 --~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
......+++.|+|||++.+..++.++|||||||++|||++|+.||...........+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------~----------- 212 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------D----------- 212 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------C-----------
Confidence 233456889999999999889999999999999999999999999876654433222110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERP-------TMRSIFEE 451 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~eil~~ 451 (473)
..++...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 213 -~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 -VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 012333567889999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=325.24 Aligned_cols=246 Identities=18% Similarity=0.231 Sum_probs=196.0
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 252 (473)
+|...+.||+|+||.||+|....+ .+.+++|+..... .......+..|..++..+ +|++|+++++++... +.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CE
Confidence 577889999999999999986543 3445566554321 223345677788888877 688999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCce
Confidence 9999999999999998854 245899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 216 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------- 216 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 54322 223456889999999999999999999999999999999999999876654433222110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM-----RSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 450 (473)
...++...+.++.+++.+||+.||.+|+++ .++++
T Consensus 217 -----~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 217 -----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred -----CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 012244566889999999999999999984 55553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.66 Aligned_cols=257 Identities=20% Similarity=0.344 Sum_probs=200.0
Q ss_pred cccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.+|.....||+|+||.||++...+.. .....++++... .........+.+|+++++.++|+||+++++++... +.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVRFYGVCTEG--RP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC-cCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--Cc
Confidence 45677799999999999999754321 122333333322 22334456899999999999999999999998765 77
Q ss_pred eEEEEEeccCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSD------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 8999999999999999865321 135899999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhh
Q 011995 321 FSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 395 (473)
+.+||+|||++........ ....+++.|+|||.+.+..++.++|||||||++|||++ |.+||...........+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999999876543221 12234578999999998889999999999999999998 999997655443332221
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.... ...+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus 239 ~~~~-----------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGRE-----------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCcc-----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1100 01123445778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.95 Aligned_cols=266 Identities=15% Similarity=0.181 Sum_probs=194.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC-----
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD----- 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~----- 248 (473)
..+|...+.||+|+||.||+|...+. ...+++|+.... .....+|+.+|+.++|+|||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDT---SEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCC---CCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 45799999999999999999986543 334445443221 12345799999999999999999886532
Q ss_pred -CCCceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEE
Q 011995 249 -GSDQRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKL 325 (473)
Q Consensus 249 -~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl 325 (473)
....+++||||+++ +|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceee
Confidence 11246799999975 777666421 23457899999999999999999999999 99999999999999664 7999
Q ss_pred eccCCCcccCCC-CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc--cccc
Q 011995 326 SGYGCAGHIPET-DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--RPFL 401 (473)
Q Consensus 326 ~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~~ 401 (473)
+|||+++.+... ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+... .+..
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999999876433 23345678999999998764 5899999999999999999999999876654433222111 0000
Q ss_pred cc---------ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 AD---------DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~---------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.. ...+..+....+...++...+.++.+|+.+||++||.+|||+.|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 000000111111222344456789999999999999999999999854
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=311.12 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=194.7
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|.+.++.. .+.++++... ........+.+|++++.++ +||||+++++++... +..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC---eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence 368999999999999765432 2223333333 2334556789999999999 899999999998765 6789999
Q ss_pred EeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 258 ERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEE
Confidence 9999999999986432 1235889999999999999999999998 99999999999999999999
Q ss_pred EeccCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccc
Q 011995 325 LSGYGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 325 l~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
|+|||++....... ......+..|+|||++....++.++|||||||++|||++ |..||...........+..
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~------ 226 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 226 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC------
Confidence 99999985332111 111223567999999988889999999999999999997 9999976543332221110
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
. .....+...+.++.+++.+||..||.+|||+.++++.|+++.
T Consensus 227 -~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -C----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 000112334567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=315.44 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=203.0
Q ss_pred hcccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||.||+|..... ......+++++............+.+|+.+++.++||||+++++++..+ +
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence 46788899999999999999986431 1233455555544333344567799999999999999999999998765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS-------------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp 312 (473)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 8899999999999999996421 1235788999999999999999999999 99999999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCCh
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHP 387 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~ 387 (473)
+|||++.++.++|+|||++........ .....+..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876533321 12233567999999998899999999999999999997 8888876554
Q ss_pred HHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.+....+.... . ...+...+.++.+|+.+||+.||.+|||+.||++.|++
T Consensus 239 ~~~~~~~~~~~----------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRDGN----------------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhcCC----------------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 33222111100 0 01123445789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=304.99 Aligned_cols=255 Identities=19% Similarity=0.329 Sum_probs=204.1
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCccccee
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLG 243 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g 243 (473)
....||+.. ..||.|+.|.||+++++. +++.++||..+.....+..++++..++++...+ .|+||+++|
T Consensus 89 ~dindl~~l-------~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 89 ADINDLENL-------GDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred cChHHhhhH-------HhhcCCCccceEEEEEcc---cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence 444555544 889999999999999654 456777888877777778889999999988875 999999999
Q ss_pred eeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcE
Q 011995 244 FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 244 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
||..+ ..+++.||.|. ..++.++.. -..++++..+-++...++.||.||.+++ .|||||+||+|||+|+.|++
T Consensus 159 yFi~n--~dV~IcMelMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 159 YFITN--TDVFICMELMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred EEeeC--chHHHHHHHHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCE
Confidence 99987 67889999983 356666643 2346999999999999999999999887 69999999999999999999
Q ss_pred EEeccCCCcccCCCC-ccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhHhhhcc
Q 011995 324 KLSGYGCAGHIPETD-ISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSR 398 (473)
Q Consensus 324 kl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~ 398 (473)
|+||||++..+.... .+...|.+.|||||.+.- ..|+.++||||||+.++||.||+.||.+.+...+ ...+....
T Consensus 232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e 311 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE 311 (391)
T ss_pred EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence 999999998775543 345678899999999843 4589999999999999999999999988544322 22221111
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.|.+.+ ....+..+.+|+..||.+|+.+||...++|+.
T Consensus 312 -------------PP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -------------PPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -------------CCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 122222 22377899999999999999999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=323.77 Aligned_cols=240 Identities=20% Similarity=0.298 Sum_probs=190.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|....+ ++.+++|+..... .......+..|..++... +||||+++++++.+. +.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGK---GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCC---CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEE
Confidence 4699999999999986543 3455565554321 123445667788888764 899999999998766 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC--
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP-- 335 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~-- 335 (473)
||+.+|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 76 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence 99999999998853 346899999999999999999999999 9999999999999999999999999987432
Q ss_pred CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 336 ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 336 ~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
........+++.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--------------~-- 213 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--------------P-- 213 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------C--
Confidence 222344578999999999999999999999999999999999999998765543332221110 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMR-SIF 449 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil 449 (473)
.++...+.++.+++.+||+.||.+||++. +++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12334567889999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=308.71 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=199.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|.....||+|+||.||+|.+.+.. .+++ +...........+.+|+.+++.++|+|++++++++.. +..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~----~~~l--K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT----KVAI--KTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIY 76 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc----eEEE--EEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcE
Confidence 45888899999999999999865542 2233 3333333445678899999999999999999988743 5689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+.+|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred EEEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEc
Confidence 999999999999999653 2345899999999999999999999999 999999999999999999999999999766
Q ss_pred CCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
...... ...++..|++||.+.+..++.++|||||||++|||++ |..||.+.........+...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------- 219 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG------------- 219 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------------
Confidence 433221 2234578999999988889999999999999999999 99999876544332221110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
....++...+..+.+++.+||..||.+||++++|++.|++
T Consensus 220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 ----YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001233456789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=318.00 Aligned_cols=263 Identities=21% Similarity=0.358 Sum_probs=205.4
Q ss_pred cccccCcceeecCCceEEEEEECCC----CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDD----ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
++|.+.+.||+|+||.||++...+. ......+++|.............+.+|+.++..+ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE- 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence 5677889999999999999975321 1122334444444333444566789999999999 699999999998765
Q ss_pred CCceEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 67999999999999999996532 1245899999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHH
Q 011995 317 IDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEER 391 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~ 391 (473)
++.++.+||+|||+++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999976643221 11223467999999988889999999999999999999 89999766544333
Q ss_pred hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
..+.. ... ...+..++.++.+++.+||..||++|||+.++++.|+++....
T Consensus 247 ~~~~~-------~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 247 KLLRE-------GHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHc-------CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 22210 000 0113345578899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=315.89 Aligned_cols=273 Identities=19% Similarity=0.284 Sum_probs=202.7
Q ss_pred ccccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.|+..+.||+|+||.||.+.+.. +....+.+++|.............+.+|+++++.++|+||+++++++...+....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 46778999999999999998642 23344555566554333444557799999999999999999999998876557789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++...
T Consensus 85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999998543 336899999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 335 PETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 335 ~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... ....++..|+|||++.+..++.++|||||||++|||++++.|+...........-.+.... ... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~ 237 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM-TVT-RLVR 237 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc-cHH-HHHH
Confidence 43221 1234556799999998888999999999999999999987765332110000000000000 000 0000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
..........+..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000001111334568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=321.14 Aligned_cols=248 Identities=18% Similarity=0.285 Sum_probs=212.1
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
=|...+.||+|.|++|-+|+ +..++.+++||++.... ..-....+.+|+..|+.++|||||+||++..+. ..+|
T Consensus 19 LYDLekTlG~GHFAVVKLAr---HVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ--TKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLAR---HVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ--TKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhh---hhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc--ceEE
Confidence 36666889999999999997 77888888888876543 344557789999999999999999999987655 8899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~ 333 (473)
||+|+-++|+|+|+|.+. ...+.+....+++.||+.||.|+|+.+ +|||||||+||.+- .-|.|||.|||++..
T Consensus 94 LiLELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999999999654 445899999999999999999999998 99999999998775 569999999999976
Q ss_pred cC-CCCccCcccccccCChhhhhcCCCC-CcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IP-ETDISNSSVAAANLSVETLERGLLT-PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~-~~~~~~~~~t~~y~aPE~~~~~~~s-~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
+. .....+.+|+..|-|||++.+..|+ +++||||||||||.|++|++||...++.+....| +
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------------m 232 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------------M 232 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------------h
Confidence 64 4466788999999999999999986 7899999999999999999999987766644333 2
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
|-.. ..|..++.++++||..||+.||.+|.+.+||...
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2221 2377899999999999999999999999999753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=343.49 Aligned_cols=277 Identities=18% Similarity=0.344 Sum_probs=224.7
Q ss_pred CcCCCHHHHHHHhcc---------cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHH
Q 011995 162 LRNFPLDEVAAACHN---------FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTL 230 (473)
Q Consensus 162 ~~~~~~~el~~~~~~---------f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l 230 (473)
...++|++--++... ..+.++||.|-||.||+|+++-... +.+.|++|.++ ..+....+|+.|..||
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgk--re~~VAIKTLK~GytekqrrdFL~EAsIM 684 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGK--REITVAIKTLKAGYTEKQRRDFLSEASIM 684 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCC--cceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence 344666554444333 3466899999999999999866543 34445555555 3566678899999999
Q ss_pred HhCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCC
Q 011995 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310 (473)
Q Consensus 231 ~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 310 (473)
.+++||||++|.|+.... ..++||.|||++|+|+.+|+.+ .+.|.+.+..-++++|+.|+.||-+.+ +|||||
T Consensus 685 GQFdHPNIIrLEGVVTks--~PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDL 757 (996)
T KOG0196|consen 685 GQFDHPNIIRLEGVVTKS--KPVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDL 757 (996)
T ss_pred ccCCCCcEEEEEEEEecC--ceeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhh
Confidence 999999999999998765 7899999999999999999764 456999999999999999999999999 999999
Q ss_pred CCCceeeCCCCcEEEeccCCCcccCCCC---ccCccc--ccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCC
Q 011995 311 STANIQIDKDFSAKLSGYGCAGHIPETD---ISNSSV--AAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDS 384 (473)
Q Consensus 311 kp~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~--t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~ 384 (473)
...|||++.+..+||+|||+++.+.++. +++..| ...|.|||.+...+++.+||||||||++||.++ |+.||.+
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 9999999999999999999999775443 222222 378999999999999999999999999999876 9999998
Q ss_pred CChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCCcc
Q 011995 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSST 464 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~ 464 (473)
....+-...++ ++.++ .-|.+++..+.+|+..||++|-.+||.+.+|+..|+++-..-.+=+.
T Consensus 838 mSNQdVIkaIe-------~gyRL----------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~ 900 (996)
T KOG0196|consen 838 MSNQDVIKAIE-------QGYRL----------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT 900 (996)
T ss_pred cchHHHHHHHH-------hccCC----------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence 77665444332 22222 12678889999999999999999999999999999998765555333
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.11 Aligned_cols=259 Identities=17% Similarity=0.330 Sum_probs=204.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||+|.+.+.......++++...........+.+.+|+.+++.++|+||+++++++.+ +..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 4577789999999999999987544222233444444433334456789999999999999999999998864 5678
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999543 335899999999999999999999998 999999999999999999999999998766
Q ss_pred CCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... .....+..|+|||.+....++.++|||||||++|||++ |..||......+....+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------~~--- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------RL--- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------cC---
Confidence 43321 11223467999999988889999999999999999986 999997765443322221110 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
..+..++..+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11334567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=331.94 Aligned_cols=248 Identities=18% Similarity=0.199 Sum_probs=194.0
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.|+..+.||+|+||.||+|.... ..+.+++|+..... .......+.+|+.+++.++|+|||++++++.+. +.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEE
Confidence 57888999999999999998544 34455566554321 223456788999999999999999999998866 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999999999998543 45889999999999999999999999 99999999999999999999999999753
Q ss_pred cCCC-------------------------------------------------CccCcccccccCChhhhhcCCCCCcCC
Q 011995 334 IPET-------------------------------------------------DISNSSVAAANLSVETLERGLLTPKSN 364 (473)
Q Consensus 334 ~~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~s~~sD 364 (473)
+... ......||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 2100 001236789999999999889999999
Q ss_pred chHHHHHHHHHHcCCCCCCCCChHHHHhH-hhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011995 365 VWSFGIVLLELLTGRKNLDSRHPKEERNL-VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443 (473)
Q Consensus 365 vwSlGvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 443 (473)
||||||++|||++|++||......+.... +.|... +........+.++.+++.+|+ .+|.+|+
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIPPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCCCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 99999999999999999987665443221 222110 000012245677888888876 5999999
Q ss_pred C---HHHHHH
Q 011995 444 T---MRSIFE 450 (473)
Q Consensus 444 t---~~eil~ 450 (473)
+ +.++++
T Consensus 295 ~~~~~~ei~~ 304 (382)
T cd05625 295 GKNGADEIKA 304 (382)
T ss_pred CCCCHHHHhc
Confidence 7 888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.06 Aligned_cols=242 Identities=20% Similarity=0.278 Sum_probs=193.4
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|....+ ...+++|+.+.. ........+.+|++++..+ +||||+++++++... +.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCC---CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEE
Confidence 4699999999999986543 344556655432 1233456678899999888 799999999998765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC-
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 336 (473)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence 99999999988853 346999999999999999999999999 99999999999999999999999999865322
Q ss_pred -CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 -TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 -~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......++..|+|||++.+..++.++|||||||++|||++|..||...........+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------------------ 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------------------ 211 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------------------
Confidence 2223446889999999999999999999999999999999999999876543322211100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTM-----RSIFEE 451 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~~ 451 (473)
...++...+..+.+|+.+||+.||.+||++ .++++.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 001233456789999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=307.56 Aligned_cols=250 Identities=20% Similarity=0.336 Sum_probs=198.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||++...+.. ++++... .....+.+.+|+.++++++|+|++++++++...+ +..+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~k~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNK-----VAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCc-----EEEEEeC---CCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceE
Confidence 46888899999999999999865432 2333332 2233567899999999999999999999875442 6789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence 999999999999998653 2345899999999999999999999999 999999999999999999999999998755
Q ss_pred CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.... .....+..|+|||++.+..++.++|||||||++|||++ |..||...........+.. +
T Consensus 153 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-------~--------- 215 (256)
T cd05082 153 SSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------G--------- 215 (256)
T ss_pred cccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-------C---------
Confidence 3322 23344568999999988889999999999999999997 9999976544332221110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.....+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00112334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=330.23 Aligned_cols=253 Identities=14% Similarity=0.145 Sum_probs=198.7
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
..++|+..+.||+|+||.||++.... ..+.+++|+.... ........+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-- 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-- 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 35689999999999999999998644 3345556655421 1223345578899999999999999999988765
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence 789999999999999999843 24788899999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC---ccCcccccccCChhhhhcC----CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 331 AGHIPETD---ISNSSVAAANLSVETLERG----LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 331 a~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
+....... .....+|+.|+|||++.+. .++.++|||||||++|||++|..||...........+.....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC----
Confidence 87654332 2345689999999998653 378999999999999999999999987654433222211000
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE--RPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 451 (473)
.+........+.++.+|+.+||..+|.+ |+++.++++.
T Consensus 265 ----------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ----------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000001235688999999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=333.34 Aligned_cols=250 Identities=19% Similarity=0.191 Sum_probs=196.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||.||+|.... ..+.+++|+..... .......+.+|+++|..++|+||+++++++.++ +.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CE
Confidence 368889999999999999998544 34556666554321 122346688999999999999999999998766 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 9999999999999999954 345888999999999999999999999 9999999999999999999999999975
Q ss_pred ccCCC---------------------------------------------CccCcccccccCChhhhhcCCCCCcCCchH
Q 011995 333 HIPET---------------------------------------------DISNSSVAAANLSVETLERGLLTPKSNVWS 367 (473)
Q Consensus 333 ~~~~~---------------------------------------------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwS 367 (473)
.+... ......||+.|||||++.+..++.++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 32100 001246889999999999989999999999
Q ss_pred HHHHHHHHHcCCCCCCCCChHHHHhHh-hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC---
Q 011995 368 FGIVLLELLTGRKNLDSRHPKEERNLV-KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP--- 443 (473)
Q Consensus 368 lGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP--- 443 (473)
|||++|||++|+.||......+....+ .|... +.......++.++.+++.+|+ .+|.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIPSQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 999999999999999876654432222 22110 000011235677888999876 5999999
Q ss_pred CHHHHHHH
Q 011995 444 TMRSIFEE 451 (473)
Q Consensus 444 t~~eil~~ 451 (473)
++.++++.
T Consensus 294 t~~ell~h 301 (376)
T cd05598 294 GADEIKAH 301 (376)
T ss_pred CHHHHhCC
Confidence 89999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=330.78 Aligned_cols=252 Identities=15% Similarity=0.165 Sum_probs=196.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||.||++....+ .+.+++|+.... ........+.+|+.+++.++||||+++++++.++ +
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSS---QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--K 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCC---CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence 57899999999999999999986543 345555554321 1223345678999999999999999999998765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 89999999999999999843 24888999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---ccCcccccccCChhhhhcC----CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 332 GHIPETD---ISNSSVAAANLSVETLERG----LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 332 ~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
....... .....+|+.|+|||++.+. .++.++|||||||++|||++|..||...........+... .
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~------~ 263 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH------K 263 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C
Confidence 8664322 2345689999999999754 3788999999999999999999999876544332222100 0
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE--RPTMRSIFEE 451 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 451 (473)
. .+........+..+.+++.+||..++.+ |+++.++++.
T Consensus 264 ~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 N--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred c--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0000011245678899999999855543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=315.64 Aligned_cols=252 Identities=18% Similarity=0.263 Sum_probs=197.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||+|.... ....+++++............+.+|++++.+++||||+++++++..+ +..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEE
Confidence 357778999999999999998543 34456666655444445567799999999999999999999999876 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 76 ICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred EEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 999999999996542 3678899999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh-Hhhhccccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN-LVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.........++..|+|||++.+..++.++|||||||++|+|++|..||.......... ...+. ..+.+.
T Consensus 146 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~ 215 (279)
T cd06619 146 VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QCIVDE 215 (279)
T ss_pred ccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HHHhcc
Confidence 5444455678899999999998889999999999999999999999996533211100 00000 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..........+.++.+++.+||+.||.+||+++++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000012345678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=296.30 Aligned_cols=264 Identities=19% Similarity=0.270 Sum_probs=209.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC---CC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD---GS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~---~~ 250 (473)
-++|.+.+.||+|||+-||.+. +..+.+.+|+|.+.... .+..+..++|++..++++||||++++++...+ +.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~---~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVK---GLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeec---ccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3579999999999999999997 66677777777665543 56778899999999999999999999887543 44
Q ss_pred CceEEEEEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
.+.||+++|...|+|.+.+..... +..+++.+++.|+.+|++||++||+..+ ++.||||||.|||+++.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEecc
Confidence 679999999999999999976543 4478999999999999999999999985 59999999999999999999999999
Q ss_pred CCcccCCC-----------CccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh
Q 011995 330 CAGHIPET-----------DISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 330 la~~~~~~-----------~~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 395 (473)
.++...-. +......|..|.|||.+.- ...+.++|||||||+||+|+.|..||+.... . ..-+
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~-GgSl- 251 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-Q-GGSL- 251 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-c-CCeE-
Confidence 98765321 1123345889999999853 3478999999999999999999999975332 1 1100
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.-.+.+..+.-.-....++.+.++|..||+.||.+||++.+++..++.+-
T Consensus 252 -----------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 -----------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01111112111112236789999999999999999999999999998763
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=310.72 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=203.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||+|....+ .+.++++...... .......+.+|+.+++.++|+||+++++++..+ +.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLD---GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCC---CceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--Ce
Confidence 4688889999999999999985433 3344454433221 223456788999999999999999999998876 78
Q ss_pred eEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 999999999999999885422 2356899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... .....++..|+|||++.+..++.++||||||+++|||++|..||........ ..... +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----------~~~ 222 (267)
T cd08229 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKK----------IEQ 222 (267)
T ss_pred hccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhhh----------hhc
Confidence 7664322 2234677899999999888899999999999999999999999975432211 11110 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
...+.. .....+..+.+++.+||..||.+|||+.+|++.++++.
T Consensus 223 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 001111 12346678999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=307.39 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=198.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||+|++|.||+|.+.........++++...........+.+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 4689999999999997654333334455554443333556789999999999999999999998865 6789999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC--
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD-- 338 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-- 338 (473)
++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999965432 56899999999999999999999999 9999999999999999999999999998764421
Q ss_pred ---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 339 ---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 339 ---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
.....++..|++||.+.+..++.++|||||||++|||++ |..||......+....+.. ....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~~~-------- 219 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EGER-------- 219 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cCCc--------
Confidence 112345678999999998889999999999999999998 9999976554432222210 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 --LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0112334578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=308.38 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=200.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..++||+|+||.||+|...++ +.+++|. +.........+.+|+.++++++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~a~K~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGH----TKVAIKS--LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPI 75 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCC----ceEEEEE--ecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCc
Confidence 35788889999999999999986543 3344443 33333445789999999999999999999988643 578
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+.+++|.+++... .+..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 76 YIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceee
Confidence 9999999999999998653 3457899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... ...++..|+|||++.+..++.++||||||+++|||++ |..||............. ..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~----- 219 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RG----- 219 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cC-----
Confidence 6432221 2234578999999988889999999999999999999 999998665433222111 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.....+...+.++.+++.+||..+|++||++++++..|+.+
T Consensus 220 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 220 -----YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 00011233457899999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=306.28 Aligned_cols=251 Identities=21% Similarity=0.426 Sum_probs=202.8
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||+|+||.||+|...........+++++............+.+|++++..++|+||+++++++... ...++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC--CceEEEEEec
Confidence 46999999999999976542334455555554433333467899999999999999999999998774 7899999999
Q ss_pred cCCChhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 261 FHGSLDRLIYGRSD------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 261 ~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
++++|.+++..... ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999965311 367999999999999999999999999 999999999999999999999999999877
Q ss_pred CCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 335 PETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 335 ~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
.... .....++..|+|||.+....++.++|||||||++|||++ |..||...........+.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------~----- 223 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-------G----- 223 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------C-----
Confidence 5432 233456789999999988889999999999999999999 6999987644332222110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
.....+..++.++.+++.+||..||.+|||+.++++.|+
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011224455788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=313.33 Aligned_cols=247 Identities=20% Similarity=0.314 Sum_probs=207.0
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
|.+..+||+|+||.||+|.++. .+..++++.+.. ....++++.||.+|.++..+++|++||.+... ..+|+|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIV 106 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIV 106 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEee
Confidence 4445889999999999998544 444444444433 35678999999999999999999999988765 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
||||..|++.|+++.+ ..+|.+.++..++...+.||+|||... -||||||..||||+-+|.+||+|||+|..+..
T Consensus 107 MEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 9999999999999654 568999999999999999999999998 89999999999999999999999999988765
Q ss_pred CC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 337 TD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 337 ~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
.. .++..||+-|||||+++.-.|+.++||||||+...||..|++||.+.++......+. .+|.
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T~PP 246 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------TKPP 246 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------CCCC
Confidence 53 356689999999999999999999999999999999999999998876544221111 1122
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..-.-|...+.++.+|++.||.+.|++|-|+-++++.
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2223377889999999999999999999999988764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.00 Aligned_cols=260 Identities=16% Similarity=0.196 Sum_probs=206.2
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeec
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 247 (473)
++....++|.+.+.||+|+||+||+|.... ..+.+++|+..... .......+.+|+.++..++|+||+++++.+..
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 333445799999999999999999998543 34566677665543 33445678899999999999999999877654
Q ss_pred CCC------CceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 248 DGS------DQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 248 ~~~------~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
... ..+++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN 179 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC
Confidence 321 13689999999999999986432 2456899999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCC----CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 321 FSAKLSGYGCAGHIPET----DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~----~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
+.+||+|||+++..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99999999998765422 12345789999999999998999999999999999999999999987654332221110
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ....++..++.++.+++.+||+.||.+||++.++++.
T Consensus 260 ~-----------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 G-----------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-----------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 0011244556889999999999999999999999864
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=308.45 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=191.8
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||+|+||.||+|.+.++. ....++++..+..........+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY-TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEECC
Confidence 46899999999999875432 33444455544443344456789999999999999999999998765 7789999999
Q ss_pred cCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC
Q 011995 261 FHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338 (473)
Q Consensus 261 ~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 338 (473)
++|+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 99999999965322 235678888999999999999999999 9999999999999999999999999987553332
Q ss_pred c----cCcccccccCChhhhhcC-------CCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 339 I----SNSSVAAANLSVETLERG-------LLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 339 ~----~~~~~t~~y~aPE~~~~~-------~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
. ....++..|+|||++.+. .++.++|||||||++|||++ |..||......+...... . . .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~----~---~ 226 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-R----E---Q 226 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-h----c---c
Confidence 1 123456789999998642 35789999999999999996 999997655433221110 0 0 0
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
.....++.+ ....+..+.+++.+|| .+|++|||+.+|++.|+
T Consensus 227 ~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011111111 2234467889999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.64 Aligned_cols=252 Identities=18% Similarity=0.206 Sum_probs=213.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 250 (473)
...|+..+.||+|.||.||+++... +++.+++|++.... .......+.+|+.+|+++. |||||.+++.+.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-- 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-- 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--
Confidence 4568888999999999999998544 46666777665442 2335578999999999998 99999999999877
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC----CcEEEe
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD----FSAKLS 326 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~vkl~ 326 (473)
+.+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEe
Confidence 7999999999999999999664 3999999999999999999999999 9999999999999533 579999
Q ss_pred ccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 327 GYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 327 DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
|||++...... .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.........+.....
T Consensus 182 DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------ 255 (382)
T KOG0032|consen 182 DFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------ 255 (382)
T ss_pred eCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence 99999888653 45667999999999999999999999999999999999999999998876655543332211
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.......++..+.+||..|+..||.+|+|+.++|+.
T Consensus 256 --------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 --------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22223345678999999999999999999999999995
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=331.89 Aligned_cols=258 Identities=17% Similarity=0.219 Sum_probs=191.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|.... +.+.+++|+. ....+.+|+++|++++|||||++++++... ...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~-------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 158 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAG-------QRGGTATEAHILRAINHPSIIQLKGTFTYN--KFT 158 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEech-------hhhhhHHHHHHHHhCCCCCCCCEeEEEEEC--Cee
Confidence 3579999999999999999998543 3344445432 134578999999999999999999998765 788
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++|+|++. ++|..++.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++..
T Consensus 159 ~lv~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EEEEecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 99999984 689888843 346899999999999999999999999 99999999999999999999999999975
Q ss_pred cCC---CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCCh-------HHHH-hHhhhccccc-
Q 011995 334 IPE---TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP-------KEER-NLVKWSRPFL- 401 (473)
Q Consensus 334 ~~~---~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~-------~~~~-~~~~~~~~~~- 401 (473)
... .......+|+.|+|||++.+..++.++|||||||++|||++|..||..... .... .++.......
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 422 223345789999999999988999999999999999999999988753221 0111 1111000000
Q ss_pred ----cccccccc---------ccccccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 402 ----ADDCRLSL---------IMDPQLKGRF--PLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 402 ----~~~~~~~~---------~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....+.. ...+.....+ ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0000000000 1134668899999999999999999999985
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=314.29 Aligned_cols=246 Identities=17% Similarity=0.237 Sum_probs=192.3
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
||+|+||+||++.... ..+.+++|+..... .....+.+..|+++++.++|+||+++++++... ...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCC
Confidence 7999999999998543 33455555544321 222346678899999999999999999888765 7899999999
Q ss_pred cCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC-
Q 011995 261 FHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD- 338 (473)
Q Consensus 261 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 338 (473)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..+....
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 999999887542 23456899999999999999999999999 9999999999999999999999999987654332
Q ss_pred -ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhhhcccccccccccccccccccC
Q 011995 339 -ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVKWSRPFLADDCRLSLIMDPQLK 416 (473)
Q Consensus 339 -~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 416 (473)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||......... ..... +....
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-------------~~~~~-- 217 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-------------ILNDS-- 217 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh-------------hcccC--
Confidence 23346789999999999999999999999999999999999999764322111 11110 00000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 417 GRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 417 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+..+.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 122445668899999999999999999 77888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=327.43 Aligned_cols=252 Identities=16% Similarity=0.177 Sum_probs=199.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||++....+ .+.+++|+..... .......+.+|+.++..++|+||+++++++.+. +.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--Ce
Confidence 4788899999999999999985443 3455566555321 233456788999999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCe
Confidence 99999999999999999543 346899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCc---cCcccccccCChhhhh------cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 333 HIPETDI---SNSSVAAANLSVETLE------RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 333 ~~~~~~~---~~~~~t~~y~aPE~~~------~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
....... ....+|+.|+|||++. ...++.++|||||||++|||++|..||...........+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---- 226 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR---- 226 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC----
Confidence 6643322 2236789999999986 45678999999999999999999999987654433222211000
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+........+.++.+|+.+||. +|.+||++.++++.
T Consensus 227 ----------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ----------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00000012356788999999997 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.85 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=203.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||+||++....+ ++.+++++............+.+|+++++.++||||+++++++... +.++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPT---GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCC---CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEE
Confidence 4677779999999999999986543 3445555555444455567899999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||+++++|.+++.. ...+++..+..++.+++.+|.|||+ ++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 80 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 99999999999998854 3468999999999999999999997 46 99999999999999999999999999876
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH-----HHhHhhhcccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-----ERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 408 (473)
..........++..|+|||++.+..++.++|||||||++|||++|..||....... ......+.....
T Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 226 (284)
T cd06620 154 LINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV------- 226 (284)
T ss_pred hhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-------
Confidence 54333344567899999999988889999999999999999999999998654321 111111111000
Q ss_pred cccccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 409 LIMDPQLKGRFP-LKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 409 ~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
... ...++ ...+.++.+|+.+||+.||++|||+.|+++...-+.
T Consensus 227 ---~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 227 ---QEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ---hcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 000 00111 125578999999999999999999999998754333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.77 Aligned_cols=265 Identities=17% Similarity=0.228 Sum_probs=198.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||+|+... ....+++|.............+.+|+.++++++|+||+++++++..+ +..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEE
Confidence 568888999999999999998543 33445566555443344445678999999999999999999998766 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+.+ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred EEEeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceec
Confidence 99999965 888887543 345889999999999999999999999 999999999999999999999999998754
Q ss_pred CCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc--------ccc
Q 011995 335 PET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF--------LAD 403 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~ 403 (473)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....+...... +..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 322 2233467889999999865 45889999999999999999999999876654433332211000 000
Q ss_pred ccccccccccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 DCRLSLIMDPQLKG----RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.........+.... ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000 011235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=310.09 Aligned_cols=250 Identities=16% Similarity=0.250 Sum_probs=199.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC----ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS----SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
++|...+.||+|++|.||+|...+ ..+.+++++...... ......+.+|++++++++||||+++++++.++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--
Confidence 578999999999999999998543 234455555443221 12245688999999999999999999999776
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 799999999999999999854 245889999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 331 AGHIPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 331 a~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
+........ ....++..|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---------- 220 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---------- 220 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh----------
Confidence 875532211 23356789999999998889999999999999999999999997654332221110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.......++...+..+.+++.+||..+|.+|||+.++++.
T Consensus 221 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 ------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001112344566789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=313.01 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=201.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||++..... .+.++++.............+.+|++++.+++|+||+++++++..+ +..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPT---GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCC---CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEE
Confidence 3677889999999999999986533 3445555554443444557899999999999999999999988776 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999999999886533344789999999999999999999974 6 99999999999999999999999999876
Q ss_pred cCCCCccCcccccccCChhhhhcCC------CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGL------LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~------~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
..........++..|+|||.+.+.. ++.++|||||||++|||++|..||.............
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~------------ 220 (286)
T cd06622 153 LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS------------ 220 (286)
T ss_pred ccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH------------
Confidence 6544444556778999999985543 4789999999999999999999997644322211111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.+. ....++..++.++.+|+.+||+.+|.+||++.+++..
T Consensus 221 -~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 -AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00000 0112344577889999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=322.29 Aligned_cols=248 Identities=18% Similarity=0.277 Sum_probs=191.5
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.++..+ +||||+++++++.+. +.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKT---RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEE
Confidence 4699999999999986543 3455666655321 233456688999999998 799999999998766 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC--
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP-- 335 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~-- 335 (473)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 76 e~~~~g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence 99999999988843 346999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH--HHhHhhhccccccccccccccccc
Q 011995 336 ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE--ERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 336 ~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
........+|..|+|||++.+..++.++|||||||++|||++|+.||....... ......+.. ..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 220 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF---------QVILEK 220 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH---------HHHHcC
Confidence 222334578999999999999899999999999999999999999996422111 000000000 000011
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPT------MRSIFE 450 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~eil~ 450 (473)
. ..++..++.++.+++.+||+.||.+|++ ++++++
T Consensus 221 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 221 Q--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 1124455678999999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=319.11 Aligned_cols=263 Identities=20% Similarity=0.345 Sum_probs=205.3
Q ss_pred cccccCcceeecCCceEEEEEECCCC----eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA----STSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
.+|.+.+.||+|+||.||+|...+.. .....+++++...........++.+|++++.++ +|+||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD- 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence 36888899999999999999753211 111233444433333344567899999999999 899999999998765
Q ss_pred CCceEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||
T Consensus 91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 68899999999999999986532 1245889999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHH
Q 011995 317 IDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEER 391 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~ 391 (473)
++.++.+||+|||+++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999876543221 11233467999999998889999999999999999998 88999776544432
Q ss_pred hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
..+... .....+...+..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 247 ~~~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 247 KLLKEG-----------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHcC-----------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 222100 000113344578999999999999999999999999999887444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=307.25 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=202.5
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
+|+..+.||+|+||.||++.... ..+.++++..+........+.+.+|+.+++.++|+||+++++++.+. +.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEE
Confidence 47788999999999999998543 34556666665544445567888999999999999999999998765 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 76 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence 99999999999988543 3446889999999999999999999999 9999999999999999999999999987664
Q ss_pred CCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 336 ETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 336 ~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
... .....++..|+|||++.+..++.++||||||+++|+|++|..||...........+....
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 216 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS--------------- 216 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC---------------
Confidence 322 223467788999999988889999999999999999999999998655433222111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....+...+..+.+|+.+||+.||++||++.+|+..
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 --YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 001233456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=308.20 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=189.0
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||+|+||.||+|...+.. ....++++.............+.+|+.+++.++|+||+++++++... ...++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGM-SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCC-CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEeC
Confidence 35899999999999764432 22233344333333344456788999999999999999999998765 7899999999
Q ss_pred cCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC
Q 011995 261 FHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338 (473)
Q Consensus 261 ~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 338 (473)
++|+|.+++..... ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 99999999965422 234578888999999999999999999 9999999999999999999999999986543221
Q ss_pred c----cCcccccccCChhhhhc-------CCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 339 I----SNSSVAAANLSVETLER-------GLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 339 ~----~~~~~t~~y~aPE~~~~-------~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
. ....++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--------~ 226 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE--------Q 226 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc--------c
Confidence 1 22234567999999753 346789999999999999999 78898765443322111100 0
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
...+..+ ..+...+..+.+++..|| .||++|||+.+|++.|.
T Consensus 227 ~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 DIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0011111 123345577888999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=312.30 Aligned_cols=261 Identities=21% Similarity=0.370 Sum_probs=201.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|++.+.||+|+||.||+|...+.. .....+++|.............+.+|+.+++.++|+||+++++++... +
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--Q 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--C
Confidence 567889999999999999999765321 122344444433222233445688999999999999999999998765 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD-------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 88999999999999999964321 234577888999999999999999999 99999999999999999999
Q ss_pred EeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||+++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---- 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM---- 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 999999876543221 12234567999999998889999999999999999998 788997654433222111
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.... ...+...+..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 236 ---~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 ---DGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---cCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0000 0112334578999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=305.37 Aligned_cols=250 Identities=19% Similarity=0.266 Sum_probs=201.6
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...+.||+|+||.||+|....+. +.++++..... ........+.+|+++++.++||||+++++++... +..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADK---RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCC---cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEE
Confidence 4777799999999999999875443 44445544432 2344567889999999999999999999998766 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceec
Confidence 999999999999999653 2457899999999999999999999998 999999999999999999999999998766
Q ss_pred CCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... ....++..|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 215 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR---------------- 215 (256)
T ss_pred cCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----------------
Confidence 43321 233567899999999988899999999999999999999999987653332211110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....++...+..+.+++.+||+.+|++||++.++++.
T Consensus 216 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 -GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00011223456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.15 Aligned_cols=259 Identities=20% Similarity=0.342 Sum_probs=205.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCee-eeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAST-SKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+|+..+.||+|+||.||+|.+.++... ...+++++............+.+|+.++.+++|+||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence 4677779999999999999987554322 233444444333334455788999999999999999999999875 678
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++..
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999999643 345899999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
...... .....+..|++||.+....++.++|||||||++|||++ |..||......+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER--------- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC---------
Confidence 643221 11123467999999988889999999999999999998 9999987655443322221000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+..++..+.+++.+||..||.+||++.++++.|+++.+.
T Consensus 230 --------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 --------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 011223446789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=305.63 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=201.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||.|+||.||+|...+. .+++|.... .....+++.+|+.+++.++|+||+++++++... +..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~-----~v~iK~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQ-----KVAVKCLKD--DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPL 75 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCc-----EEEEEEecc--chhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCe
Confidence 35678889999999999999986532 333444332 223567899999999999999999999998764 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred EEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccc
Confidence 99999999999999986532 236899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... .....+..|+|||.+.+..++.++||||||+++|||++ |..||...........+.. +
T Consensus 152 ~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------~-------- 215 (256)
T cd05039 152 ASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-------G-------- 215 (256)
T ss_pred ccccc-ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-------C--------
Confidence 63322 23344568999999988889999999999999999997 9999976654332221110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.....+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 --YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00111234467899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=321.29 Aligned_cols=249 Identities=17% Similarity=0.274 Sum_probs=190.8
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|....+ .+.+++|+.... ........+.+|+.++.++ +||||+++++++... +..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKT---ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCC---CCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEE
Confidence 4699999999999986543 344556555432 2334456678899998877 899999999998776 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC-
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 336 (473)
||+++|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 E~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence 99999999988843 346899999999999999999999999 99999999999999999999999999875422
Q ss_pred -CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH--HhHhhhccccccccccccccccc
Q 011995 337 -TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 337 -~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.......+|..|+|||++.+..++.++|||||||++|||++|..||........ .....+.. ..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~i~~~ 220 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---------QVILEK 220 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH---------HHHhcC
Confidence 222345789999999999999999999999999999999999999953211100 00000000 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPT------MRSIFEE 451 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~eil~~ 451 (473)
...++...+..+.+++.+||+.||.+||+ +.++++.
T Consensus 221 --~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 --QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11234556688999999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.01 Aligned_cols=252 Identities=22% Similarity=0.404 Sum_probs=201.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|.+.+.||+|+||.||+|...++ +.+++| .+.........+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~----~~~~vK--~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGT----TKVAVK--TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPI 76 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCC----ceEEEE--EecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecC--Cce
Confidence 46788899999999999999986543 223333 3333344567899999999999999999999988765 678
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++... .+..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred EEEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcccccee
Confidence 9999999999999999653 3456899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
+...... ....+..|+|||.+.+..++.++|||||||++|||++ |+.||.+.........+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------------ 220 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG------------ 220 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 6432211 2233568999999998889999999999999999998 99999765543322221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.....+...+.++.+++.+||..+|.+||++.++++.|+.
T Consensus 221 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 -----YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001122335789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=321.80 Aligned_cols=241 Identities=19% Similarity=0.205 Sum_probs=187.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHH-HHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVN-TLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||+||+|....+ .+.+++|+..... .......+..|.. +++.++|+||+++++++... +..|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAE---EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCC---CCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEE
Confidence 4699999999999986543 3445566554321 1222344455544 56788999999999988766 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC-
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 336 (473)
||+++|+|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence 99999999999854 345788889999999999999999999 99999999999999999999999999875422
Q ss_pred -CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 -TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 -~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......+|+.|+|||++.+..++.++|||||||++|||++|..||...........+.. ..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----------------~~- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----------------KP- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh----------------CC-
Confidence 223345789999999999999999999999999999999999999987655443222110 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..++...+..+.+++.+||+.||.+|+++.+.+.
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 213 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0112345678899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.74 Aligned_cols=259 Identities=19% Similarity=0.259 Sum_probs=204.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||+|.... .++.++++..+.. ........+.+|++++++++|+||+++++++... +.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--Ce
Confidence 678999999999999999998653 2344455544322 1233457789999999999999999999998776 78
Q ss_pred eEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.++||||+++|+|.+++... .....+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 89999999999999988542 22456899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||........ ...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~------ 222 (267)
T cd08224 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKI----EK------ 222 (267)
T ss_pred eeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-HHHhhh----hc------
Confidence 7654322 2234577889999999888899999999999999999999999965432110 111100 00
Q ss_pred ccccccCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 410 IMDPQLKGRFPL-KAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 410 ~~~~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
......+. ..+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 223 ----~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 ----CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00011122 55678999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=312.59 Aligned_cols=249 Identities=16% Similarity=0.224 Sum_probs=190.5
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
||+|+||.||++..... ++.++++...... .......+..|+++++.++||||+++++++..+ ...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccC---CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecC
Confidence 79999999999986543 3445555443221 122334566799999999999999999988765 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC-c
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD-I 339 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 339 (473)
++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 76 ~g~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee
Confidence 999999888543 2345899999999999999999999999 9999999999999999999999999987664332 2
Q ss_pred cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCC
Q 011995 340 SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419 (473)
Q Consensus 340 ~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 419 (473)
....++..|+|||++.+..++.++|||||||++|||++|..||...........+.. .... ..... .
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~----------~~~~~-~ 218 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR--RTLE----------DEVKF-E 218 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH--Hhhc----------ccccc-c
Confidence 334678899999999988899999999999999999999999976433211111100 0000 00000 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 420 PLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 420 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
....+.++.+++.+||+.||.+||+++|+++.+.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1235678899999999999999999977664433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=322.13 Aligned_cols=237 Identities=20% Similarity=0.220 Sum_probs=186.6
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHH-HHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVN-TLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|....+ ++.+++|+..... .......+..|.. +++.++||||+++++++... +..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKAD---GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCC---CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEE
Confidence 4699999999999986443 3455566554321 2223345555555 56789999999999988765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC-
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 336 (473)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence 99999999998853 346899999999999999999999999 99999999999999999999999999875422
Q ss_pred -CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 -TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 -~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......+|+.|+|||++.+..++.++|||||||++|||++|..||......+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------~- 212 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK----------------P- 212 (323)
T ss_pred CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC----------------C-
Confidence 2223456899999999999989999999999999999999999999876544332222100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMR 446 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 446 (473)
..++...+..+.+++.+||+.||.+||++.
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 -LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 011233467899999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.99 Aligned_cols=249 Identities=17% Similarity=0.255 Sum_probs=202.2
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
.+||+|+|-+||+|........+.+-.+++..+..+....++|..|+.+|+.|+|+|||++|.++.+....++.+|.|+|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 67999999999999854443333333344444445667778999999999999999999999999887667799999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEeccCCCcccCCCCc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYGCAGHIPETDI 339 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~~~~~~ 339 (473)
..|+|..|+.+ ...++...++.|++||+.||.|||++.| +|||||||.+||+|+.+ |.|||+|+|||........
T Consensus 126 TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 126 TSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 99999999954 4468889999999999999999999986 59999999999999865 9999999999998877777
Q ss_pred cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH-HHhHhhhcccccccccccccccccccCCC
Q 011995 340 SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-ERNLVKWSRPFLADDCRLSLIMDPQLKGR 418 (473)
Q Consensus 340 ~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 418 (473)
....|||.|||||.+. ..|+..+||||||+.++||+|+..||..-.... ....+.-... ...+..
T Consensus 202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK----P~sl~k--------- 267 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK----PAALSK--------- 267 (632)
T ss_pred ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC----HHHhhc---------
Confidence 7789999999999997 789999999999999999999999997644332 2222211100 001112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 419 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
--.+++++||.+||.. .++|+|+.|+|+.
T Consensus 268 ---V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 ---VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1236789999999999 9999999999863
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=327.94 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=204.4
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|...+.||.|+||.||.|+ +..+...+++|...... +......++.|+..|.+++|||+|.+-|+|..+ ...|
T Consensus 28 f~dLrEIGHGSFGAVYfAr---d~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFAR---DVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEee---ccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHH
Confidence 6666899999999999998 44444555565554432 344567899999999999999999999999877 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
|||||| -||-.|+|.- ...++-+..+..|..+.++||+|||+++ .||||||..||||++.|.|||+|||.|...
T Consensus 103 LVMEYC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc
Confidence 999999 5688888743 4567999999999999999999999999 999999999999999999999999998776
Q ss_pred CCCCccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
. ...+++|||.|||||++. .+.|+-++||||||++..||...++|+...+......-|....
T Consensus 177 ~--PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------------- 241 (948)
T KOG0577|consen 177 A--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------- 241 (948)
T ss_pred C--chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-------------
Confidence 3 346789999999999984 5779999999999999999999999998877655433222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
.|.+. ....+..+++|+..||++-|.+|||.+++++.--
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 11121 3577899999999999999999999999987543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=319.47 Aligned_cols=241 Identities=18% Similarity=0.231 Sum_probs=192.0
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 252 (473)
+|+..+.||+|+||.||+|.... ..+.+++|+..... .......+..|+.++..+. |++|+++++++... +.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CE
Confidence 46777999999999999998544 34455666654321 2334566788999998885 56778888887765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccc
Confidence 9999999999999999853 346899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|..||...........+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------- 216 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------- 216 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 54322 223446889999999999888999999999999999999999999876544332222110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 445 (473)
...++...+.++.+++.+||+.||.+|++.
T Consensus 217 -----~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 -----NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011234456788999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=310.46 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=196.7
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC--
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG-- 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~-- 249 (473)
+++.|+..+.||+|+||.||+|...+.. ..+++++... .......+.+|+.++.++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~~aik~~~~--~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTG---QLAAIKVMDV--TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCC---cEEEEEEEEc--CCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4567888899999999999999865433 3444554433 233456788999999998 7999999999987542
Q ss_pred --CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 250 --SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 250 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
....++||||+.+++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEcc
Confidence 24689999999999999998653 2456899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccCCC--CccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc
Q 011995 328 YGCAGHIPET--DISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 328 FGla~~~~~~--~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
||++...... ......++..|+|||++. +..++.++|||||||++|||++|..||..............
T Consensus 155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---- 230 (272)
T cd06637 155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---- 230 (272)
T ss_pred CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----
Confidence 9998765332 223346788999999986 33578899999999999999999999976543332211110
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. ..+.. .....+..+.+|+.+||..||.+|||+.++++
T Consensus 231 ---~------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 ---N------PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---C------CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00000 12234567899999999999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.87 Aligned_cols=259 Identities=17% Similarity=0.248 Sum_probs=191.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|.+.+.||+|+||.||+|...... ..+++|.. ....+.+|+++|++++|+|||++++++... +..+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~---~~vavK~~-------~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~ 236 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYP---QRVVVKAG-------WYASSVHEARLLRRLSHPAVLALLDVRVVG--GLTC 236 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCC---CEEEEecc-------cccCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEE
Confidence 36888999999999999999865432 33334421 234567899999999999999999998776 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|||++ .++|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 237 lv~e~~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEcc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 999999 46898888542 346999999999999999999999999 999999999999999999999999999765
Q ss_pred CCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCC--------hHHHHhHhhhcccccc
Q 011995 335 PETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRH--------PKEERNLVKWSRPFLA 402 (473)
Q Consensus 335 ~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~--------~~~~~~~~~~~~~~~~ 402 (473)
.... .....+|..|+|||++.+..++.++|||||||++|||++|..++.... ......++.+......
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 4321 123468999999999999899999999999999999999876553221 1112222222211100
Q ss_pred ccc-----ccc-c-------cccccc-CCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 403 DDC-----RLS-L-------IMDPQL-KGRFP--LKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 403 ~~~-----~~~-~-------~~~~~l-~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.-. .+. . ...+.. ...+. ...+.++.+||.+||+.||.+|||+.|+|+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000 0 000000 00000 1234578899999999999999999999975
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.64 Aligned_cols=264 Identities=17% Similarity=0.230 Sum_probs=208.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-C-----CCcccceeeeecC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-H-----PNLCKLLGFHARD 248 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~g~~~~~ 248 (473)
-+|++.+.||+|+||.|-+|. +..+...+|+|+++.+ ..-..+...|+.+|..++ | -|+|++++||...
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~---d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAY---DHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEEecccccceeEEEE---ecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 378899999999999999998 4456667777776643 344566778999999996 4 3899999999877
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC--CcEEEe
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD--FSAKLS 326 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~vkl~ 326 (473)
+++|||+|.+ ..+|.++|..+ ....|+...+..|+.||+.||.+||..+ |||+||||+||||.+- ..+||+
T Consensus 261 --~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 261 --NHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred --cceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEE
Confidence 8999999999 45999999765 3556999999999999999999999999 9999999999999643 479999
Q ss_pred ccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc---------
Q 011995 327 GYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--------- 397 (473)
Q Consensus 327 DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------- 397 (473)
|||.+++....-+ ....+..|.|||++.|..|+.+.||||||||+.||++|.+.|.+.++.++...+...
T Consensus 334 DFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 334 DFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999998766554 677889999999999999999999999999999999999999999887766554210
Q ss_pred ------cccccc-cccc-----cc--------------------cccc-c---cCCCCCHHHHHHHHHHHHHhcccCCCC
Q 011995 398 ------RPFLAD-DCRL-----SL--------------------IMDP-Q---LKGRFPLKAARTVADIALRCLQKEPSE 441 (473)
Q Consensus 398 ------~~~~~~-~~~~-----~~--------------------~~~~-~---l~~~~~~~~~~~l~~li~~cl~~dP~~ 441 (473)
..+... .... .. ...| . +...+.......+.+|+.+||..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 111111 0000 00 0001 0 001112244567899999999999999
Q ss_pred CCCHHHHHHH
Q 011995 442 RPTMRSIFEE 451 (473)
Q Consensus 442 RPt~~eil~~ 451 (473)
|+|+.+.|+.
T Consensus 493 R~tp~qal~H 502 (586)
T KOG0667|consen 493 RITPAQALNH 502 (586)
T ss_pred cCCHHHHhcC
Confidence 9999999874
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=311.39 Aligned_cols=244 Identities=20% Similarity=0.377 Sum_probs=187.2
Q ss_pred ceeecCCceEEEEEECCCC-------------------eeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCCCCCcccc
Q 011995 182 CISEGLSSVMYRASFGDDA-------------------STSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQHPNLCKL 241 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~-------------------~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l 241 (473)
.||+|+||.||+|.+.... .......++++.+... ......+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999863211 1122334555555432 2234578889999999999999999
Q ss_pred eeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC
Q 011995 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 321 (473)
++++... ...++||||+++|+|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 82 ~~~~~~~--~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRG--SENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeC--CceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 9999876 788999999999999998854 2346899999999999999999999998 99999999999997643
Q ss_pred -------cEEEeccCCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHH-HcCCCCCCCCChHHHHh
Q 011995 322 -------SAKLSGYGCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLEL-LTGRKNLDSRHPKEERN 392 (473)
Q Consensus 322 -------~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~el-ltG~~p~~~~~~~~~~~ 392 (473)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||| ++|..||......+...
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred cccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999987644222 22346778999998865 4589999999999999998 57999997654433222
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
..... .. ++......+.++|.+||+.+|++|||+.+|++.|.
T Consensus 233 ~~~~~---------------~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FYEKK---------------HR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHhc---------------cC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11100 00 11122357899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.05 Aligned_cols=264 Identities=16% Similarity=0.180 Sum_probs=202.3
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|.+.+.||+|+||+||+|.... ....+++++..... .......|..|+.+|..++|||||+++++|.....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 445789999999999999999998654 34455555554432 33445778999999999999999999998876555
Q ss_pred CceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CceeecCCCCCceeeCC------
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGP----FQAMYNEFSTANIQIDK------ 319 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----~~ivHrDlkp~NILl~~------ 319 (473)
..+||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||..+. ..||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 77999999999999999986422 23569999999999999999999998541 13999999999999964
Q ss_pred -----------CCcEEEeccCCCcccCCCCc-cCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCCCCCCC
Q 011995 320 -----------DFSAKLSGYGCAGHIPETDI-SNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRKNLDSR 385 (473)
Q Consensus 320 -----------~~~vkl~DFGla~~~~~~~~-~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~p~~~~ 385 (473)
.+.+||+|||++..+..... ....+|+.|+|||++.+ ..++.++||||||||||||++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 34589999999987643322 34468999999999864 45889999999999999999999999765
Q ss_pred ChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 011995 386 HPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE--ELDRQ 455 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~--~L~~l 455 (473)
............. +.+. ....+.++.+||..||+.+|.+||++.++|. .+..+
T Consensus 247 ~~~~qli~~lk~~--------------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 247 NNFSQLISELKRG--------------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcHHHHHHHHhcC--------------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 4333211110000 0000 1123578999999999999999999999994 44433
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.32 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=197.5
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|+..+.||.|+||+||+|....+ .+.++++...... .......+.+|+++++.++|+||+.+++++..+ +..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCC---CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEE
Confidence 56678999999999999986543 3445555443321 122345578899999999999999999888765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred EEEEeccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 999999999999888643 2346999999999999999999999999 999999999999999999999999998655
Q ss_pred CCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 335 PET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 335 ~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
... ......++..|+|||.+.+..++.++|+|||||++|||++|..||...........+.... ...
T Consensus 153 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~--~~~---------- 220 (285)
T cd05632 153 PEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV--LET---------- 220 (285)
T ss_pred CCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh--hcc----------
Confidence 332 2234567899999999998889999999999999999999999998765433222221100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFEE 451 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 451 (473)
...++...+..+.+|+..||+.||++||+ +.++++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01123345677899999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=321.76 Aligned_cols=240 Identities=18% Similarity=0.179 Sum_probs=188.4
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHH-HHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVN-TLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|.... .++.+++|+..... .......+..|.. +++.++||||+++++++..+ +..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEE
Confidence 469999999999998543 34455666654321 2233455666665 46778999999999988765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC-
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 336 (473)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence 99999999988843 346899999999999999999999999 99999999999999999999999999875422
Q ss_pred -CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 -TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 -~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......+++.|+|||++.+..++.++|||||||++|||++|..||...........+... ..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--------------~~-- 213 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--------------PL-- 213 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--------------Cc--
Confidence 2233456889999999999999999999999999999999999999876544432222100 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIF 449 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 449 (473)
.++...+..+.+++.+||+.||.+||++++.+
T Consensus 214 --~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 --VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 01223457788999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.18 Aligned_cols=259 Identities=19% Similarity=0.348 Sum_probs=201.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|.+..+.. ....+++++...........++.+|+.+++.++|+||++++|++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 456777999999999999998754332 2233344443322233334578899999999999999999999864 346
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++++||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 7999999999999998543 345899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
...... ....++..|++||.+.+..++.++|||||||++|||++ |..||.+.........+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------~~- 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-------RL- 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------CC-
Confidence 643221 12234678999999988889999999999999999997 999997654433322221100 00
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
..+..++..+.+++..||..+|++||++.++++.|.++...
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01223446789999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=308.71 Aligned_cols=259 Identities=18% Similarity=0.302 Sum_probs=201.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCe--eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS--TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.+|+....||+|+||.||+|+...... ..+.++++.............+.+|++++++++|+||+++++++.+. +.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--EP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--Cc
Confidence 468888999999999999999754332 22334444433222223457799999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDG------PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
.++||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 89999999999999999654321 26899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccc
Q 011995 327 GYGCAGHIPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 327 DFGla~~~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
|||++....... .....++..|++||.+.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~------ 233 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA------ 233 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc------
Confidence 999986543222 223355678999999988889999999999999999998 8889965443322211110
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
..+....+..++..+.+++.+||+.||.+||++.++++.|.+
T Consensus 234 ----------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 ----------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred ----------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 000001122345789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=324.90 Aligned_cols=259 Identities=14% Similarity=0.150 Sum_probs=199.9
Q ss_pred HHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeee
Q 011995 168 DEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFH 245 (473)
Q Consensus 168 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 245 (473)
.++....++|+..+.||+|+||.||++....+ .+.+++|+.... ........+.+|+.++..++||||+++++++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~---~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCC---CcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34445568999999999999999999986543 345556654421 1223345678899999999999999999988
Q ss_pred ecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEE
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl 325 (473)
..+ ..+++||||+++|+|.+++.. ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 113 ~~~--~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 113 QDD--RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EcC--CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence 765 789999999999999999843 24888999999999999999999999 999999999999999999999
Q ss_pred eccCCCcccCCCC---ccCcccccccCChhhhhcC----CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 326 SGYGCAGHIPETD---ISNSSVAAANLSVETLERG----LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 326 ~DFGla~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
+|||++....... .....+|+.|||||++.+. .++.++|||||||++|||++|..||...........+....
T Consensus 184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9999997664322 2345689999999999654 37899999999999999999999998765543322221100
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE--RPTMRSIFEEL 452 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~L 452 (473)
. .+........+..+.++|..||..++.+ |+++.+|++..
T Consensus 264 ~--------------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 N--------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred C--------------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 0000012245688999999999844433 78999988854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=310.78 Aligned_cols=271 Identities=21% Similarity=0.270 Sum_probs=204.6
Q ss_pred ccccCcceeecCCceEEEEEECCC-CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDD-ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.|...+.||+|+||.||+|.+... ....+.+++++............|.+|+++++.++|+||+++++++...+....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 466669999999999999987543 3344556666554332223467899999999999999999999998875557899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999643 235899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcc-----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc--cccccc
Q 011995 335 PETDIS-----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL--ADDCRL 407 (473)
Q Consensus 335 ~~~~~~-----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 407 (473)
...... ....+..|++||.+.+..++.++|||||||++|||++|..|+......... +..+.. .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHHHH
Confidence 532111 123345699999998888999999999999999999999998653221100 000000 000000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
...+........+..++.++.+++.+||+.+|.+|||+.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 001111111112334457899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.29 Aligned_cols=245 Identities=20% Similarity=0.358 Sum_probs=194.0
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||.|+||.||+|...++ ..+++++............+.+|++++..++||||+++++++... +..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDK----TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEecCC----cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence 3689999999999986543 233444433322333445788999999999999999999998766 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCcc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 340 (473)
++++|.+++... ...+++..+..++.+++.+|.|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 999999998543 345899999999999999999999999 999999999999999999999999998754332211
Q ss_pred ---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccccccC
Q 011995 341 ---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416 (473)
Q Consensus 341 ---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 416 (473)
....+..|+|||++.+..++.++||||||+++|||++ |..||...........+.. . ..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------~----------~~ 212 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------G----------YR 212 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-------C----------CC
Confidence 1233567999999998889999999999999999998 9999977654433222210 0 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 417 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
..++..++..+.+++.+||..+|++||++.++++.|.
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1123345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.59 Aligned_cols=267 Identities=17% Similarity=0.205 Sum_probs=194.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhC---CCCCcccceeeeecC---
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASL---QHPNLCKLLGFHARD--- 248 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~--- 248 (473)
+|+..+.||+|+||.||+|...++ .+.+++|....... ......+.+|++++..+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHS---GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCC---CcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 477889999999999999986543 34555555544322 22234566777777665 799999999987642
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
.....++||||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 2256899999997 4888888543 2345899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-hhccccccccc-
Q 011995 329 GCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-KWSRPFLADDC- 405 (473)
Q Consensus 329 Gla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~- 405 (473)
|++....... .....++..|+|||++.+..++.++|||||||++|||++|.+||...........+ .+.........
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9998664332 23446788999999999888999999999999999999999999776544332211 11100000000
Q ss_pred ---cc-ccccccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 ---RL-SLIMDPQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ---~~-~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. .....+... ..+...++..+.+++.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000000 0111245677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=321.49 Aligned_cols=267 Identities=15% Similarity=0.194 Sum_probs=197.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC-
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS- 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~- 250 (473)
..++|+..+.||+|+||.||++.... .++.+++|+.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 45789999999999999999998533 3455556655432 233445678899999999999999999998865421
Q ss_pred ---CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 251 ---DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 251 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEec
Confidence 357999999965 67666632 3788999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc--cc-----
Q 011995 328 YGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--RP----- 399 (473)
Q Consensus 328 FGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~----- 399 (473)
||++...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||.+.+.......+... .+
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9999765333 223457789999999999989999999999999999999999999876543221111000 00
Q ss_pred ---------ccccccc-----ccccccc-cc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 ---------FLADDCR-----LSLIMDP-QL--KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ---------~~~~~~~-----~~~~~~~-~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+...... ....... .. ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0000000 00 000112235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=308.01 Aligned_cols=254 Identities=21% Similarity=0.266 Sum_probs=196.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|++.+.||+|+||.||+|....+ .+.+++++.... .......+.+|+.++..++|+||+++++++... +..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~---~~~~aik~~~~~-~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHT---GELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCC---CeEEEEEEEecC-ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEE
Confidence 35788899999999999999986443 334445554433 223345678999999999999999999998766 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..
T Consensus 82 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 82 WICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 999999999999998853 246899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCC--ccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETD--ISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
..... .....++..|+|||.+. ...++.++|||||||++|||++|+.||............ .. .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~---------~ 224 (267)
T cd06646 156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SK---------S 224 (267)
T ss_pred ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ec---------C
Confidence 54322 22345778999999984 344788999999999999999999999654332211100 00 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
....+... .....+..+.+++.+||..||++||++++|++.|
T Consensus 225 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00011111 1223457899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=323.70 Aligned_cols=266 Identities=17% Similarity=0.246 Sum_probs=196.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC---C
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS---D 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~---~ 251 (473)
+|+..+.||+|+||.||++.... .++.+++|+.... ......+.+.+|+++++.++|+||+++++++..... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 47788999999999999998543 3344455544322 122345678899999999999999999999876521 2
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred eEEEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccce
Confidence 6899999996 588887743 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc--ccccc-
Q 011995 332 GHIPETD---ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP--FLADD- 404 (473)
Q Consensus 332 ~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--~~~~~- 404 (473)
....... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+..... ...+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 7653322 2234568899999999774 478999999999999999999999987765544333221100 00000
Q ss_pred ----cccccc----ccc-ccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 ----CRLSLI----MDP-QLK--GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ----~~~~~~----~~~-~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....+ ..+ ... ..+....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 000 000 01122346788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=321.62 Aligned_cols=268 Identities=15% Similarity=0.198 Sum_probs=199.0
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC-
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG- 249 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~- 249 (473)
...++|+..+.||+|+||.||++... ...+.+++|+..... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEec---CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 45678999999999999999999843 344555565544322 3334567889999999999999999999876432
Q ss_pred ---CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 250 ---SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 250 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
....++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEe
Confidence 1357999999965 67776632 4788999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc--------
Q 011995 327 GYGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-------- 397 (473)
Q Consensus 327 DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-------- 397 (473)
|||+++...... .....+|..|+|||++.+..++.++|||||||++|||++|+.||.+.........+...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999998654332 23456789999999999888999999999999999999999999876543322111000
Q ss_pred --------cccccccccccccccccc--------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 398 --------RPFLADDCRLSLIMDPQL--------KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 398 --------~~~~~~~~~~~~~~~~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..+.........+..+.. ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000000000 001122345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.17 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=196.7
Q ss_pred cceeecCCceEEEEEECCCC---eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDA---STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|+..+.. ...+.++++.............+.+|+.+++.++||||+++++++... +..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEEE
Confidence 46999999999999875432 112333444333222234567889999999999999999999998765 6799999
Q ss_pred EeccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-----cEEEecc
Q 011995 258 ERLFHGSLDRLIYGRS----DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-----SAKLSGY 328 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~vkl~DF 328 (473)
||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999996432 2245789999999999999999999998 99999999999999877 8999999
Q ss_pred CCCcccCCCCcc----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccc
Q 011995 329 GCAGHIPETDIS----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 329 Gla~~~~~~~~~----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|++......... ....+..|+|||++.++.++.++|||||||++|||++ |..||......+....+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------- 228 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA------- 228 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-------
Confidence 998765433221 2234578999999999999999999999999999998 9999976554332222110
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.. ....+...+..+.+++.+||..+|.+||++.+|++.|++
T Consensus 229 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 011233456789999999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=325.76 Aligned_cols=250 Identities=16% Similarity=0.224 Sum_probs=195.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||.||++..... .+.+++|+.+... .......+.+|+.++..++|+||+++++.+.+. +.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDT---GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCC---CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 4688889999999999999986543 3455566554321 233456788899999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+||||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 9999999999999999853 346899999999999999999999999 9999999999999999999999999986
Q ss_pred ccCCCC-------------------------------------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHH
Q 011995 333 HIPETD-------------------------------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLEL 375 (473)
Q Consensus 333 ~~~~~~-------------------------------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~el 375 (473)
.+.... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 442110 1134688999999999999999999999999999999
Q ss_pred HcCCCCCCCCChHHHHhHhh-hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 011995 376 LTGRKNLDSRHPKEERNLVK-WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT---MRSIFEE 451 (473)
Q Consensus 376 ltG~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 451 (473)
++|..||...........+. |.... .... ....+.++.+++.+|+ .||.+|++ +.++++.
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~-------------~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKETL-------------VFPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCce-------------ecCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99999998766544332221 11000 0000 1124578889998876 49999985 6666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=323.01 Aligned_cols=262 Identities=20% Similarity=0.323 Sum_probs=216.8
Q ss_pred CcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcc
Q 011995 162 LRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLC 239 (473)
Q Consensus 162 ~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv 239 (473)
...++.++|... ++||+|.||+|++|.|.. ..++.+.|+||.+.. -......|++|+.+|.+|+|+|+|
T Consensus 104 kclIpee~i~l~-------e~LG~GsFgvV~rg~Wt~--psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hli 174 (1039)
T KOG0199|consen 104 KCLIPEEQIKLY-------ELLGEGSFGVVKRGTWTQ--PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLI 174 (1039)
T ss_pred ceeccHHHHHHH-------HHhcCcceeeEeeccccC--CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCccee
Confidence 344677777665 899999999999999976 344555566665553 334678999999999999999999
Q ss_pred cceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 240 ~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
+|||+..+ ...+||||+++.|||.+.|+. .....|-......++.|||.||.||..++ +|||||...|+||..
T Consensus 175 RLyGvVl~---qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllas 247 (1039)
T KOG0199|consen 175 RLYGVVLD---QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLAS 247 (1039)
T ss_pred EEeeeecc---chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecc
Confidence 99999875 568899999999999999987 34567888899999999999999999999 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCCcc-----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhH
Q 011995 320 DFSAKLSGYGCAGHIPETDIS-----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNL 393 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 393 (473)
...|||+||||.+-+..++.. .......|.|||.+....++.++|||+|||++|||+| |+.||.+.........
T Consensus 248 prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 248 PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN 327 (1039)
T ss_pred cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh
Confidence 999999999999988654321 2234578999999999999999999999999999998 8999998877665544
Q ss_pred hhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 394 VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
++ ++.++. -+..+++++++++..||..+|++|||+..|.+.+-..+
T Consensus 328 iD-------~~erLp----------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 328 ID-------AGERLP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred cc-------ccccCC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 43 111221 26788999999999999999999999999986655444
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.79 Aligned_cols=265 Identities=17% Similarity=0.229 Sum_probs=198.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||+|.... ....++++.............+.+|+.+++.++|+||+++++++..+ +..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEE
Confidence 568888999999999999998543 23445555555443334445678999999999999999999998766 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred EEEeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 9999996 5898888543 346889999999999999999999999 999999999999999999999999998754
Q ss_pred CCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc------
Q 011995 335 PET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC------ 405 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 405 (473)
... ......++..|+|||.+.+. .++.++|||||||++|||++|++||......+....+...........
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 322 22334568899999998654 478899999999999999999999987665443322211100000000
Q ss_pred --ccccccccccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 --RLSLIMDPQLKGR----FPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 --~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.......+..... ....++..+.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000111111 11235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=328.15 Aligned_cols=250 Identities=19% Similarity=0.294 Sum_probs=202.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
-|.+...||.|+||.||+|...+.. .++.+...-..+....+.|+-||+||..+.||+||+|++.|+.+ +.+||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~----~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwi 106 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETK----LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWI 106 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccch----hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEE
Confidence 3666789999999999999854322 22222222223556678899999999999999999999988776 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
+.|||.||.++.++.. -+..|.+.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||++....
T Consensus 107 liEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch
Confidence 9999999999988854 3567999999999999999999999999 9999999999999999999999999875443
Q ss_pred CC--CccCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 336 ET--DISNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 336 ~~--~~~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
.. ....+.||++|||||++.. .+|++++||||||++|.||..+.+|-...++......+....|
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP--------- 252 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--------- 252 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC---------
Confidence 22 3457789999999998743 5699999999999999999999999887666554333322211
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
|.+. -|...+..+.+|+.+||.+||..||++.++++.
T Consensus 253 ----PTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 ----PTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----Cccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1111 156778899999999999999999999998864
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=305.58 Aligned_cols=250 Identities=18% Similarity=0.278 Sum_probs=195.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC----CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP----SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
.+|...+.||+|+||.||+|...+. .+.+++++..... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDT---GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCC---CcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 4789999999999999999985433 3445555544332 12234568899999999999999999998876544
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCC
Confidence 678999999999999999854 235889999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCC-----CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 331 AGHIPET-----DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 331 a~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
+...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~---------- 222 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---------- 222 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh----------
Confidence 8754321 1123356789999999988889999999999999999999999997654322211110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.......++......+.+++ .||..+|++||+++||++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 ------TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011223445567788888 677789999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=318.76 Aligned_cols=237 Identities=18% Similarity=0.208 Sum_probs=185.5
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHH-HHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVN-TLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|+...+ ...+++|+..... .......+..|+. +++.++||||+++++++.+. +..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSD---GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCC---CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEE
Confidence 4699999999999986543 3445555554321 2223345555654 67889999999999988765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC-
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE- 336 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~- 336 (473)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence 99999999988843 346888999999999999999999999 99999999999999999999999999875322
Q ss_pred -CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 -TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 -~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......+++.|+|||.+.+..++.++|||||||++|||++|..||...+.......+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----------------~- 212 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----------------P- 212 (321)
T ss_pred CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC----------------C-
Confidence 2223446889999999999888999999999999999999999999876543322221100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMR 446 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 446 (473)
..++...+..+.+++.+||+.||.+|+++.
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 -LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 012334567889999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.81 Aligned_cols=261 Identities=15% Similarity=0.220 Sum_probs=188.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
...+|.+.+.||+|+||.||+|...... ..+++|+.. ......|+.++++++|+||+++++++... ..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~valK~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 131 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQP---DPVVLKIGQ-------KGTTLIEAMLLQNVNHPSVIRMKDTLVSG--AI 131 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCC---ceEEEEeCC-------ccccHHHHHHHHhCCCCCCcChhheEEeC--Ce
Confidence 4467999999999999999999965442 333344321 12345799999999999999999999876 77
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+ .++|.+++.. ....+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred eEEEEEcc-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccc
Confidence 89999999 4688888854 3456899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCC-CCCChHHH-------HhHhhhccccccc
Q 011995 333 HIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNL-DSRHPKEE-------RNLVKWSRPFLAD 403 (473)
Q Consensus 333 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~-~~~~~~~~-------~~~~~~~~~~~~~ 403 (473)
..... ......+|..|+|||++.+..++.++|||||||++|||+++..++ ........ ..+..........
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 54322 223456889999999999989999999999999999999865544 33211100 0000000000000
Q ss_pred cccc---------ccccc--cccCC---CC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRL---------SLIMD--PQLKG---RF----PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~---------~~~~~--~~l~~---~~----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+ ....+ ...+. .+ ..+.+.++.+||.+||+.||.+|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 00000 00000 00 01334567789999999999999999999863
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=320.04 Aligned_cols=243 Identities=18% Similarity=0.263 Sum_probs=188.3
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.++.++ +|+||+.+++++... +.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKN---DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEE
Confidence 4699999999999986544 3445566555331 233456688999999888 699999999988765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC--
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP-- 335 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~-- 335 (473)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 76 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence 99999999988843 346999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 336 ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 336 ~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
........+|+.|+|||++.+..++.++|||||||++|||++|..||.............+. ...+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~---------~~~~~~~-- 218 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL---------FQVILEK-- 218 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH---------HHHHHhC--
Confidence 22233457899999999999999999999999999999999999999643221110000000 0000000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 445 (473)
...++...+..+.+++.+||..||.+|+++
T Consensus 219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 012344566788999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=311.51 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=196.7
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|+..+.||+|+||.||++..... .+.++++...... .......+.+|+.+++.++|+||+.+++.+.+. +..+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCC---CceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEE
Confidence 66778999999999999986543 3455555443321 222345678899999999999999999988765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999999999988543 2345899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 335 PETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 335 ~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.... .....++..|+|||++.+..++.++|||||||++|||++|..||.............. ...
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~----------- 218 (285)
T cd05630 153 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVK----------- 218 (285)
T ss_pred CCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhh-----------
Confidence 4322 2334678999999999988999999999999999999999999976432211111100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFE 450 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~ 450 (473)
.....++...+.++.+|+.+||+.||++||| +.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0001123345678899999999999999999 889887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.29 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=197.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|+..+.||+|+||.||+|....+ ...++++....... .....+.+|+.+++.++|+||+++++++... ...|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~ 93 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELW 93 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCC---CcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEE
Confidence 4688889999999999999985432 33444554443322 2346788999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 99999999999999843 34889999999999999999999999 999999999999999999999999998765
Q ss_pred CCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.......... .+.. .. .
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~~~----~~-------~ 233 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIAT----NG-------T 233 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HHhc----CC-------C
Confidence 3322 223467789999999988889999999999999999999999997655432211 1100 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.+ ..+......+.+++.+||..||++||++.+|++.
T Consensus 234 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000 1133456778999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.44 Aligned_cols=244 Identities=20% Similarity=0.379 Sum_probs=188.3
Q ss_pred cceeecCCceEEEEEECCCCe-----eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 181 RCISEGLSSVMYRASFGDDAS-----TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
+.||+|+||.||+|.+.+... ......++++...........+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR---DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec---CCcEE
Confidence 468999999999999765431 1112223333333222236788999999999999999999999876 45789
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-------cEEEecc
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-------SAKLSGY 328 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-------~vkl~DF 328 (473)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 78 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999999643 226899999999999999999999998 99999999999999887 7999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhcC--CCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccc
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLERG--LLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~~--~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
|++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.............+..
T Consensus 153 g~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~------- 223 (259)
T cd05037 153 GIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH------- 223 (259)
T ss_pred Cccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-------
Confidence 99876543 2233456789999999876 68999999999999999999 577886654322111111000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
..+......+.+++.+||..+|.+|||+.+|++.|+
T Consensus 224 ------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 ------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001111278899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=305.16 Aligned_cols=245 Identities=20% Similarity=0.360 Sum_probs=186.9
Q ss_pred cceeecCCceEEEEEECCCCe-------eeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 181 RCISEGLSSVMYRASFGDDAS-------TSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
+.||+|+||.||+|++..... ..+.+.++++.+.. .......+.+|+.++..++||||+++++++..+ ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--VE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CC
Confidence 368999999999998643221 12223344443332 223345788899999999999999999998765 67
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc-------EEE
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS-------AKL 325 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-------vkl 325 (473)
.++||||+++|+|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 89999999999999888542 346899999999999999999999999 999999999999987654 899
Q ss_pred eccCCCcccCCCCccCcccccccCChhhhh-cCCCCCcCCchHHHHHHHHHH-cCCCCCCCCChHHHHhHhhhccccccc
Q 011995 326 SGYGCAGHIPETDISNSSVAAANLSVETLE-RGLLTPKSNVWSFGIVLLELL-TGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 326 ~DFGla~~~~~~~~~~~~~t~~y~aPE~~~-~~~~s~~sDvwSlGvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+...... .
T Consensus 154 ~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------~ 224 (262)
T cd05077 154 SDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-------G 224 (262)
T ss_pred CCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-------c
Confidence 999998655322 2345678899999986 456899999999999999997 6888887654332211110 0
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
... .......++.+|+.+||+.||.+||++.+|++.|+
T Consensus 225 ~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 01122467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=302.23 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=199.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||++.+.++.. ++++...........+.+|+++++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~------~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~ 76 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTK------VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIY 76 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCcc------EEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeE
Confidence 568888999999999999998654332 3333333333445778999999999999999999998765 5689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence 999999999999999653 3456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
...... ...++..|++||++....++.++|||||||++|+|++ |..||...........+... ...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------~~~--- 222 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------YRM--- 222 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-------CCC---
Confidence 432221 2234567999999988889999999999999999998 99999875543322221110 000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
..+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 11233457899999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=313.89 Aligned_cols=198 Identities=17% Similarity=0.223 Sum_probs=158.4
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
++.||+|+||+||+|...+.. ..+.++++..... .....+.+|+.+|++++||||+++++++........++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~-~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCC-CCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 368999999999999865432 2344445544322 223567899999999999999999998876555778999999
Q ss_pred ccCCChhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee----CCCCcEEEeccC
Q 011995 260 LFHGSLDRLIYGRS------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI----DKDFSAKLSGYG 329 (473)
Q Consensus 260 ~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFG 329 (473)
+. ++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 58887774221 1235899999999999999999999999 9999999999999 456889999999
Q ss_pred CCcccCCC-----CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCC
Q 011995 330 CAGHIPET-----DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSR 385 (473)
Q Consensus 330 la~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~ 385 (473)
+++..... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99766432 22345678999999999764 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=309.42 Aligned_cols=265 Identities=18% Similarity=0.229 Sum_probs=196.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...+.||+|++|.||+|+...+ ...+++++..... .......+.+|+.+++.++||||+++++++..+ +..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKT---GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCC---CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEE
Confidence 477789999999999999986543 3345555544432 223346788999999999999999999999865 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+. ++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 9999996 689888865444467999999999999999999999999 999999999999999999999999998755
Q ss_pred CCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-h-hcccc------ccc
Q 011995 335 PET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-K-WSRPF------LAD 403 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~-~~~~~------~~~ 403 (473)
... ......+++.|+|||.+.+. .++.++|||||||++|||++|++||............ . +..+. ...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 322 12333567899999998654 4789999999999999999999999876543322111 0 00000 000
Q ss_pred ccccc----cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 DCRLS----LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ~~~~~----~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..... ........ ......+.++.++|.+||+.||.+|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000000 011235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=306.10 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=201.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||.|+||.||+|....+ ...+++++............+.+|+++++.++|+||+++++++.++ ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRT---NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCC---CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEE
Confidence 3678889999999999999986543 3455566655544445567789999999999999999999998766 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceee
Confidence 999999999999998532 6899999999999999999999999 999999999999999999999999999776
Q ss_pred CCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
... ......++..|++||.+.+..++.++|||||||++|||++|..||...........+... ..
T Consensus 149 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------------~~ 215 (274)
T cd06609 149 TSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-------------NP 215 (274)
T ss_pred cccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-------------CC
Confidence 543 223446678899999999888999999999999999999999999765533222111100 00
Q ss_pred cccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLK-AARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.+ +.. .+.++.+++.+||..||++|||++++++.
T Consensus 216 ~~~----~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 PSL----EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCC----cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 111 55778999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=323.09 Aligned_cols=254 Identities=18% Similarity=0.331 Sum_probs=212.7
Q ss_pred cCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
..++||+|-||.||+|++.+.. .++.++|+++.-+ ......+.|+.|..+|+.++|||||+|+|+|.+ ...|||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wiv 468 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIV 468 (974)
T ss_pred HHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEE
Confidence 3489999999999999987653 4455566666544 355667889999999999999999999999976 679999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
||+++.|.|..+|..+ ...|+..+...++.||+.+|+|||+.. +|||||...|||+.....|||+|||+++.+..
T Consensus 469 mEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999999654 346899999999999999999999999 99999999999999999999999999998877
Q ss_pred CCccCcc---cccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 337 TDISNSS---VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 337 ~~~~~~~---~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..+.... ..+.|||||.+.-..++.++|||-|||.+||+++ |..||.+-...+.. ..+..+.+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeR------ 610 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGER------ 610 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCC------
Confidence 6554432 2478999999999999999999999999999986 99999875432211 11222222
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
-..|.+++..+..++.+||.+||.+||.+.+|...|.++...
T Consensus 611 ----lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 611 ----LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ----CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 234788999999999999999999999999999999987653
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=307.13 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=203.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||.|++|.||++...+ ....++++.............+.+|++++++++|+||+++++++.......++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 467888999999999999999654 33455566555444445567899999999999999999999998766556799
Q ss_pred EEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccc
Confidence 999999999999887432 23456899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCCh--HHHHhHhhhccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP--KEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..........++..|++||.+.+..++.++|||||||++|+|++|..||..... ........+.... .
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~----- 224 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----P----- 224 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-----C-----
Confidence 544333344567899999999988899999999999999999999999976522 1111112211100 0
Q ss_pred ccccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRF--PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.+.... ....+..+.+|+.+||..+|.+|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00000000 12346789999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.34 Aligned_cols=261 Identities=15% Similarity=0.151 Sum_probs=201.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||.||+|.... .++.+++|+.+... .....+++.+|+++++.++||||+++++++.+. +.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CE
Confidence 578899999999999999998543 34455566554322 233456799999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 253 RMLIYERLFHGSLDRLIYGRS--------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
.++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEE
Confidence 999999999999999885321 1234677888999999999999999999 99999999999999999999
Q ss_pred EeccCCCcccCCC--------------------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCC
Q 011995 325 LSGYGCAGHIPET--------------------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDS 384 (473)
Q Consensus 325 l~DFGla~~~~~~--------------------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~ 384 (473)
|+|||++...... ......||+.|||||.+.+..++.++|||||||++|||+||..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999765211 01123588999999999999999999999999999999999999976
Q ss_pred CChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhcc
Q 011995 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-TMRSIFEELDRQESR 458 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~l~~~ 458 (473)
........... +.++.... -...++..+.+++.+||..||++|+ +++++++.|+.+...
T Consensus 234 ~~~~ki~~~~~--------------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 234 KKGRKISYRDV--------------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred cchhhhhhhhh--------------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 43222111000 00000000 0124457789999999999999996 678888888876553
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=318.49 Aligned_cols=267 Identities=14% Similarity=0.180 Sum_probs=197.8
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC--
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG-- 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-- 249 (473)
..++|...+.||+|+||.||++.... ..+.+++|+.... ........+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 45789999999999999999998533 3344555554432 22344567889999999999999999999875432
Q ss_pred --CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 250 --SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 250 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
....|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEe
Confidence 1357999999965 77777632 3788999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc-------
Q 011995 328 YGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP------- 399 (473)
Q Consensus 328 FGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~------- 399 (473)
||+++...... .....++..|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.....
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99997664332 2344678999999999999999999999999999999999999987665443222210000
Q ss_pred ---------ccccccc-----ccccccccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 ---------FLADDCR-----LSLIMDPQL---KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ---------~~~~~~~-----~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+...... ...+....+ ...........+.+|+.+||+.||.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 000000000 001112234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=303.26 Aligned_cols=250 Identities=16% Similarity=0.242 Sum_probs=197.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC----ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS----SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
++|...+.||+|+||.||+|...++ ++.++++....... ......+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~---~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADT---GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCC---CcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 5788899999999999999986543 34555555443321 2234678899999999999999999998876544
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
..+++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcc
Confidence 6788999999999999998532 35788999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC-----CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 331 AGHIPET-----DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 331 a~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
+...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------- 223 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--------- 223 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---------
Confidence 8755321 22334577899999999888899999999999999999999999976533322111110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.......+...+..+.+++.+||. +|++||++++|++
T Consensus 224 -------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 -------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001112355667788999999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.93 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=202.9
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCccccee
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLG 243 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g 243 (473)
+.++.+....++|+..+.||+|+||.||++..... .+.+++++... .......+.+|+.+++.+ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~---~~~~~ik~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKN---GSKAAVKILDP--IHDIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCC---CceeEEEeecc--ccchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 44566777889999999999999999999986443 34444554332 222346688999999999 6999999999
Q ss_pred eeecC---CCCceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 244 FHARD---GSDQRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 244 ~~~~~---~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
++... ..+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~ 159 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTT 159 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECC
Confidence 87532 236789999999999999987532 23456899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCC--ccCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 320 DFSAKLSGYGCAGHIPETD--ISNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
++.+||+|||++....... .....++..|+|||++.. ..++.++|||||||++|||++|+.||..........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 9999999999987654322 233467889999999853 347889999999999999999999997654332211
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
..... ..+.+ ..+...+..+.+++.+||+.||++|||+.||++.+
T Consensus 240 ~~~~~-------------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KIPRN-------------PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hcccc-------------CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11000 00000 01223356789999999999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=301.32 Aligned_cols=249 Identities=18% Similarity=0.381 Sum_probs=196.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|+..+.||+|+||.||+|.+.++. .++++. ..........+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~~k~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKR----KVAIKT--IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPIC 75 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCC----eEEEEE--CCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceE
Confidence 35777799999999999999865332 233333 333333456789999999999999999999988765 6889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ...+++..+..++.+++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred EEEEcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeec
Confidence 999999999999998543 345889999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCcc---CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDIS---NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~~---~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. +. ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~---~~ 220 (256)
T cd05112 151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-------GF---RL 220 (256)
T ss_pred ccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------CC---CC
Confidence 433222 2234568999999998889999999999999999998 9999976554332221110 00 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
. .+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 221 ~-------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 Y-------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0 12223578999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.90 Aligned_cols=246 Identities=20% Similarity=0.339 Sum_probs=197.4
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
|+..+.||.|+||.||+|....+ ...+++++............+.+|++++++++|+||+++++++..+ +..++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRT---KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCC---CeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEE
Confidence 55558899999999999986443 3345555554444445567889999999999999999999998765 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 81 MEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999999998842 35899999999999999999999998 99999999999999999999999999876643
Q ss_pred CCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 337 TDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 337 ~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
... ....++..|+|||.+.+..++.++|||||||++|||++|..||...........+ .. .
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~----------~ 216 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-------PK----------N 216 (277)
T ss_pred cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-------hc----------C
Confidence 321 2235678899999999888999999999999999999999999754432211110 00 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0111233456789999999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.90 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=198.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|+..+.||.|+||.||+|.... ....++++..... .......+.+|+.+++.++|+||+++++++... +.++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSFLVG--DELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecc-cCchHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceEE
Confidence 468888999999999999998433 3344445544433 223456788999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+||+++++|.+++.. ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 99999999999998843 35899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... ....++..|+|||.+.+..++.++|||||||++|+|++|..||...........+.-.. .
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-------------~ 232 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-------------T 232 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------------C
Confidence 43322 23467789999999988889999999999999999999999998765543322111000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+.+ ..+..++..+.++|.+||..||.+||++.+|++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 PEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 113345678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.38 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=188.6
Q ss_pred ceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEecc
Q 011995 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLF 261 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~ 261 (473)
.||+|+||.||+|...++.. ...+.++.............+.+|+.+++.++||||+++++++... ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTG-VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCC-cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEecCC
Confidence 59999999999997543322 2222334333333344567899999999999999999999998765 78999999999
Q ss_pred CCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC--
Q 011995 262 HGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD-- 338 (473)
Q Consensus 262 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-- 338 (473)
+|+|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999965322 235677888999999999999999998 9999999999999999999999999986432221
Q ss_pred --ccCcccccccCChhhhhc-------CCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 339 --ISNSSVAAANLSVETLER-------GLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 339 --~~~~~~t~~y~aPE~~~~-------~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--------~~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD--------QQV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh--------ccc
Confidence 123456789999999753 235789999999999999996 57788765443322211100 011
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
...++.+ ....+..+.+++..|| .+|.+||++.+|++.|.
T Consensus 228 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1122222 2234577888999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=303.70 Aligned_cols=247 Identities=20% Similarity=0.329 Sum_probs=201.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
.|+..+.||.|+||.||+|..... ...+++++............+.+|+.+++.+.|+||+++++++.++ ...++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRT---QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccC---CEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEE
Confidence 466668999999999999986543 3445566555444445567899999999999999999999998876 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 9999999999999843 35889999999999999999999998 9999999999999999999999999997664
Q ss_pred CCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 336 ETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 336 ~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.... ....++..|+|||.+.+..++.++|+|||||++|||++|..||...........+..
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------------- 215 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK----------------- 215 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-----------------
Confidence 4321 233567889999999888899999999999999999999999976554332211110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......+..++..+.+++.+||+.+|++||++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 01122345677889999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=300.24 Aligned_cols=248 Identities=20% Similarity=0.331 Sum_probs=199.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||.|+||.||+|...++. ..++++..... .....+.+|+++++.++|+||+++++++... ...|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~---~~~~~k~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETG---QVVAIKVVPVE---EDLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCC---cEEEEEEeecH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEE
Confidence 57888899999999999999976532 33344443322 1267899999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+++||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 75 l~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 75 IVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred EEEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhc
Confidence 999999999999998542 356899999999999999999999999 999999999999999999999999998876
Q ss_pred CCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.... .....++..|++||.+.+..++.++|||||||++|+|++|..||...........+.- ...
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-------------~~~ 216 (256)
T cd06612 150 TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPP 216 (256)
T ss_pred ccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc-------------CCC
Confidence 4432 2233567899999999888899999999999999999999999976543322111100 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+. ...+...+..+.+++.+||+.||.+|||+.+|++
T Consensus 217 ~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 1113345678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=314.45 Aligned_cols=254 Identities=13% Similarity=0.162 Sum_probs=194.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||.||++..... .+.+++|+.... ........+.+|+.++..++|+||+.+++++.++ +.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNT---GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE--NN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCC---CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--Ce
Confidence 4788899999999999999986543 345556655421 1223345688999999999999999999988766 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCcee
Confidence 99999999999999999542 346899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCc---cCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 333 HIPETDI---SNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 333 ~~~~~~~---~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
....... ....+|+.|||||++.. ..++.++|||||||++|||++|+.||......+....+... .
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~------~ 224 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH------K 224 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC------C
Confidence 6543221 22358899999999863 45788999999999999999999999876543332222100 0
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS--ERPTMRSIFEE 451 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~eil~~ 451 (473)
... .+. ......+..+.+++.+||..++. .|+++.++++.
T Consensus 225 ~~~------~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 EHF------QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred Ccc------cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 000 01123567889999998865443 37899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=307.43 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=203.6
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCccccee
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLG 243 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g 243 (473)
++.+++...+++|...+.||+|+||.||++...++ .+.+++++... .......+.+|+.++.++ +|+||+++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~---~~~~aik~~~~--~~~~~~~~~~e~~~l~~l~~h~ni~~~~~ 86 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKD---GSLAAVKILDP--ISDVDEEIEAEYNILQSLPNHPNVVKFYG 86 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCC---CCEEEEEEecc--cccHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence 45566677789999999999999999999986443 34444554432 223346778899999999 8999999999
Q ss_pred eeecCC---CCceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 244 FHARDG---SDQRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 244 ~~~~~~---~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
++.... .+..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~ 163 (291)
T cd06639 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTT 163 (291)
T ss_pred EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcC
Confidence 987532 24689999999999999988532 23456899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCC--ccCcccccccCChhhhhcCC-----CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 320 DFSAKLSGYGCAGHIPETD--ISNSSVAAANLSVETLERGL-----LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~--~~~~~~t~~y~aPE~~~~~~-----~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
++.+||+|||++....... .....++..|+|||.+.... ++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~ 243 (291)
T cd06639 164 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243 (291)
T ss_pred CCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence 9999999999987654332 22345678899999986432 6889999999999999999999998665433222
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+....+ +.+ ..+......+.++|.+||+.+|++||++.++++.
T Consensus 244 ~~~~~~~-------------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPRNPP-------------PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhcCCC-------------CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111000 000 0122345679999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=298.56 Aligned_cols=245 Identities=20% Similarity=0.370 Sum_probs=195.2
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+.||.|+||.||++...+ .+.+++|.............+.+|+++++++.|+||+++++++... ...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~----~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC----CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence 469999999999998654 2344455444333334567899999999999999999999998766 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCcc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 340 (473)
++++|.+++... ...+++..+..++.+++.+|+|||+++ ++||||+|+|||++.++.+||+|||++.........
T Consensus 75 ~~~~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 999999998543 336889999999999999999999999 999999999999999999999999998765422211
Q ss_pred ----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 341 ----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 341 ----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
....+..|+|||.+.++.++.++|||||||++|||++ |..||...........+... .
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-----------------~ 212 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-----------------Y 212 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-----------------C
Confidence 1223567999999988889999999999999999999 88999766543332222110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
....+...+.++.+++.+||..+|.+|||+.||++.|+
T Consensus 213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01123345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=300.91 Aligned_cols=253 Identities=18% Similarity=0.253 Sum_probs=202.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||.|+||.||++....+ ...+++++..... .....+.+..|+++++.++|+||+++++++........+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSD---GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCC---CCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 477889999999999999985443 3444555544332 334456788999999999999999999988765556789
Q ss_pred EEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 255 LIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLH-----EEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
++|||+++++|.+++... .....+++..+..++.|++.||.||| +.+ ++|+||+|+||+++.++.+||+||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecc
Confidence 999999999999998542 22457899999999999999999999 777 999999999999999999999999
Q ss_pred CCCcccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 329 GCAGHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 329 Gla~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
|++....... .....++..|++||.+.+..++.++||||||+++++|++|..||...........+. .
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~--- 224 (265)
T cd08217 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-------E--- 224 (265)
T ss_pred cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-------c---
Confidence 9998775443 234467889999999988889999999999999999999999998765332221111 0
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....++...+..+.+++.+||+.+|.+||++.+|++.
T Consensus 225 -------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 -------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00112344566889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=303.14 Aligned_cols=257 Identities=16% Similarity=0.303 Sum_probs=197.6
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
|++.+++++.....||+|+||.||+|...++. ..++++.... ......+.+.+|+.+++.++|+||+++++++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQ---VRIAIKEIPE-RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCC---cEEEEEEecC-CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 34556777777789999999999999865443 2333333222 2334556889999999999999999999998765
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-CCcEEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPI--DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-DFSAKL 325 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~vkl 325 (473)
+..++|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|
T Consensus 78 --~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l 150 (268)
T cd06624 78 --GFFKIFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKI 150 (268)
T ss_pred --CEEEEEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEE
Confidence 78999999999999999996432 234 78889999999999999999998 999999999999986 679999
Q ss_pred eccCCCcccCCCC--ccCcccccccCChhhhhcCC--CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 326 SGYGCAGHIPETD--ISNSSVAAANLSVETLERGL--LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 326 ~DFGla~~~~~~~--~~~~~~t~~y~aPE~~~~~~--~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
+|||++....... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||......... .+.....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~ 227 (268)
T cd06624 151 SDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMF 227 (268)
T ss_pred ecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhh
Confidence 9999987653322 22335678999999986644 788999999999999999999999654322111 1110000
Q ss_pred ccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....++.....++.+|+.+||+.+|.+|||+.+++..
T Consensus 228 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01112344566889999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=315.31 Aligned_cols=268 Identities=12% Similarity=0.176 Sum_probs=196.2
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC-
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG- 249 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~- 249 (473)
...++|...+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.+|+.++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRL---RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCC---CCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 4568899999999999999999985433 3444555443221 2233456789999999999999999999875432
Q ss_pred ---CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 250 ---SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 250 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
....|+++|++ +++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence 14578999988 779988873 235999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-hccccccc-
Q 011995 327 GYGCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-WSRPFLAD- 403 (473)
Q Consensus 327 DFGla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~- 403 (473)
|||++..... ......++..|+|||++.+ ..++.++|||||||++|||++|..||...........+. ........
T Consensus 161 Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 161 DFGLARQADD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CCccceecCC-CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999986543 2344578899999999876 468999999999999999999999998755433222111 00000000
Q ss_pred cccc-----ccccc--cccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRL-----SLIMD--PQLKG----RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~-----~~~~~--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+ ..... +.... .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000 00000 0001234567899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=304.87 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=193.6
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
|+..+.||.|+||.||+|...... ..++++.... ........+.+|+++++.++|+||+++++++... +..++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~---~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETG---VLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCC---eEEEEEEeCC-CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEE
Confidence 566688999999999999865443 2333333322 1234456788999999999999999999998776 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 81 IEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 9999999999887542 346899999999999999999999999 99999999999999999999999999875532
Q ss_pred C--CccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 337 T--DISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 337 ~--~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
. ......++..|+|||++. +..++.++|||||||++|||++|.+||...........+....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~----------- 224 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE----------- 224 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC-----------
Confidence 2 123346788999999984 3457889999999999999999999997655433221111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.+ ..+..++.++.+|+.+||+.||.+||++.++++.
T Consensus 225 --~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 --PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 1123455789999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=300.27 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=200.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||.|+||.||+|....+ .+.+++++...... .....+.+|++++++++||||+++++++... +.++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIAT---GELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCC---CCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEE
Confidence 5788889999999999999986443 23455555554322 2567889999999999999999999988765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++...
T Consensus 77 l~~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence 999999999999988542 246899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCC--ccCcccccccCChhhhhcC---CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERG---LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~---~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
.... .....++..|++||.+.+. .++.++|||||||++|||++|..||...........+....
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~----------- 220 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN----------- 220 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------
Confidence 4321 2334567889999999776 78999999999999999999999998765443322111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+.+ ......+.++.+|+.+||..+|.+|||+.+|+.
T Consensus 221 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 123456678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.01 Aligned_cols=259 Identities=21% Similarity=0.399 Sum_probs=201.5
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC----C
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS----D 251 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----~ 251 (473)
|.+.+.||+|+||.||+|.+..+......+++|+..... .....+++.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556689999999999999876555555666676655432 33446678999999999999999999998765321 1
Q ss_pred ceEEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS---DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
..++++||+.+|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478899999999988874321 2235789999999999999999999998 999999999999999999999999
Q ss_pred CCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccc
Q 011995 329 GCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 329 Gla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|+++...... .....++..|++||.+....++.++|||||||++|||++ |.+||...........+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 9988664322 122234578999999988889999999999999999999 8999976554332221110
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.... ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 01223457899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=322.79 Aligned_cols=243 Identities=19% Similarity=0.359 Sum_probs=196.0
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
-+||+|+||+||-|+..+ +...+ +++.+.. ..+..+-+..||.+.++++|.|||+++|.+..+ +++-|.||-
T Consensus 581 vVLGKGTYG~VYA~RD~~---tqvrI--aIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen--Gf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMD---TQVRI--AIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN--GFFKIFMEQ 653 (1226)
T ss_pred EEeecCceeEEEeecccc---ceeEE--EeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC--CeEEEEeec
Confidence 479999999999998444 43443 4444432 344556788999999999999999999998766 678889999
Q ss_pred ccCCChhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CCCcEEEeccCCCcccCC
Q 011995 260 LFHGSLDRLIYGRSDGPPI--DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~ 336 (473)
++||||.++|+... +++ .+.+...+..||++||.|||+.. |||||||-+||||+ -.|.+||+|||-++.+..
T Consensus 654 VPGGSLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred CCCCcHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 99999999997643 456 78889999999999999999998 99999999999997 459999999998876632
Q ss_pred --CCccCcccccccCChhhhhcCC--CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhhhccccccccccccccc
Q 011995 337 --TDISNSSVAAANLSVETLERGL--LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 337 --~~~~~~~~t~~y~aPE~~~~~~--~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 411 (473)
....++.||..|||||++..+. |+.++|||||||++.||.||++||......+.. ..+ .+. ..
T Consensus 729 inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV----Gmy--------Kv 796 (1226)
T KOG4279|consen 729 INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV----GMY--------KV 796 (1226)
T ss_pred CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh----cce--------ec
Confidence 2345678999999999996654 899999999999999999999999755433221 111 000 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ..+|...+.++..||.+|+..||.+||++.++|+.
T Consensus 797 H----P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 797 H----PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred C----CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2 23488999999999999999999999999999874
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=304.81 Aligned_cols=245 Identities=20% Similarity=0.333 Sum_probs=186.9
Q ss_pred cceeecCCceEEEEEECCCCee--eeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDAST--SKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||+|+||.||+|........ .....++++.... .....+.+.+|+.+++.++||||+++++++..+ ...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEEEE
Confidence 3689999999999986443211 1111122222222 223346788999999999999999999999875 6789999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc--------EEEeccC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS--------AKLSGYG 329 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------vkl~DFG 329 (473)
||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999999643 336899999999999999999999999 999999999999987764 6999999
Q ss_pred CCcccCCCCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcC-CCCCCCCChHHHHhHhhhccccccccccc
Q 011995 330 CAGHIPETDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTG-RKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~~~~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
++...... ....++..|+|||++.+. .++.++|||||||++|||++| ..||............. .
T Consensus 154 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-------~---- 220 (258)
T cd05078 154 ISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-------D---- 220 (258)
T ss_pred cccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-------c----
Confidence 88655332 234567889999999764 479999999999999999998 46665544332221111 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
...++.....++.+++.+||+.||++|||+++|++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00122234467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=299.00 Aligned_cols=251 Identities=18% Similarity=0.240 Sum_probs=199.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||+|++|.||++....+ .+.++++...... .....+.+.+|++++++++|+|++++++.+... ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTD---GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCC---CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEE
Confidence 478889999999999999986443 3445555554332 234456788999999999999999999877543 25689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ....+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEe
Confidence 999999999999998653 2446899999999999999999999999 999999999999999999999999998766
Q ss_pred CCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
... ......+++.|+|||++.+..++.++|||||||+++||++|+.||...+.......+.. + .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------~-~------ 218 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-------G-K------ 218 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------c-C------
Confidence 432 22334567899999999988899999999999999999999999976553322111110 0 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....+...+..+.+|+.+||+.||.+||++.++++.
T Consensus 219 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 ---LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011234566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=298.75 Aligned_cols=251 Identities=19% Similarity=0.255 Sum_probs=201.6
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||.|+||.||.+....+ +..++++...... .......+.+|++++++++|+||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTED---DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCC---CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEE
Confidence 477889999999999999885433 3344455444332 344567789999999999999999999999875 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 9999999999999996542 456899999999999999999999998 999999999999999999999999998766
Q ss_pred CCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..||......+....+...
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--------------- 216 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--------------- 216 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC---------------
Confidence 4332 23446789999999998888899999999999999999999999775543322211100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
... ..+...+.++.+++.+||..+|.+||++.++++.+
T Consensus 217 -~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 -NYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 000 11234567899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=305.36 Aligned_cols=261 Identities=19% Similarity=0.280 Sum_probs=201.9
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCccccee
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLG 243 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g 243 (473)
.++.++....+.|+..+.||.|+||.||+|..... ...+++++... .......+..|+.++.++ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~a~K~~~~--~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 80 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKT---GQLAAIKVMDV--TEDEEEEIKLEINMLKKYSHHRNIATYYG 80 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCC---CcEEEEEEEec--ChHHHHHHHHHHHHHHHhcCCCcEEEEee
Confidence 35556666678899999999999999999986543 23444554433 233456788999999998 7999999999
Q ss_pred eeecC----CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 244 FHARD----GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 244 ~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
++... ..+..|+||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~ 156 (282)
T cd06636 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE 156 (282)
T ss_pred ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 88542 236789999999999999998653 2445888999999999999999999999 999999999999999
Q ss_pred CCcEEEeccCCCcccCCC--CccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 320 DFSAKLSGYGCAGHIPET--DISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~--~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
++.++|+|||++...... ......++..|+|||.+. ...++.++|||||||++|||++|..||..........
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 999999999998765322 223346788999999985 3457889999999999999999999997654333222
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+.+.. .+. .....++.++.+||.+||+.||.+||++.||++
T Consensus 237 ~~~~~~-------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LIPRNP-------------PPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hHhhCC-------------CCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111100 000 012235578999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=302.45 Aligned_cols=248 Identities=19% Similarity=0.312 Sum_probs=195.3
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-----CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-----SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
+|...+.||.|+||.||+|...++ ..++++...... .......+.+|+++++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQG----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-- 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCC----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--
Confidence 477789999999999999975432 334444443322 122345688999999999999999999999766
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 7899999999999999999542 35889999999999999999999999 99999999999999999999999998
Q ss_pred CcccCCC--------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc
Q 011995 331 AGHIPET--------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 331 a~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
+...... ......++..|+|||++.+..++.++|||||||++|||++|..||...........+.-..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---- 224 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR---- 224 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc----
Confidence 8754211 1123456789999999998889999999999999999999999997654333221111000
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......+...+.++.+++.+||+.+|.+||++.++++
T Consensus 225 -----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -----------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001123345678899999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.71 Aligned_cols=252 Identities=21% Similarity=0.367 Sum_probs=197.4
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChh-hHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
|+..+.||+|+||+||++....+. ..+++|+......... .....+|+.++++++|+||+++++++... ...++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNG---QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTT---EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCC---eEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc--ccccc
Confidence 567799999999999999965543 4556666655432222 23346699999999999999999999875 88999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc-
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI- 334 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~- 334 (473)
||||+.+++|.+++. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred ccccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999999995 2346899999999999999999999999 999999999999999999999999998753
Q ss_pred -CCCCccCcccccccCChhhhh-cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 -PETDISNSSVAAANLSVETLE-RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 -~~~~~~~~~~t~~y~aPE~~~-~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.........++..|+|||++. +..++.++||||||+++|+|++|..||......................
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 221 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS-------- 221 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------
Confidence 223334557789999999998 7789999999999999999999999998763333322222111000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. .........+.+++.+||+.||++||++.++++
T Consensus 222 -~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 -SS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -HT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000112378999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=305.04 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=197.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|++.+.||.|+||.||+|....+ ...+++++.... .......+.+|++++++++|+||+++++++..+ ...+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKET---GLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCC---CcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEE
Confidence 5688889999999999999986543 234445554432 333456788999999999999999999998865 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhh
Confidence 999999999999998542 346899999999999999999999999 999999999999999999999999988655
Q ss_pred CCCC--ccCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
.... .....++..|++||.+.. ..++.++|||||||++|||++|..||...........+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--------- 224 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC---------
Confidence 3221 233457889999999853 346789999999999999999999997754433221111000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.+ ..+...+.++.+++.+||+.||.+||++.++++.
T Consensus 225 ----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 ----PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000 1133456788999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=299.71 Aligned_cols=247 Identities=22% Similarity=0.378 Sum_probs=196.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||++...+. .++++..... .....+.+|+.++.+++|+||+++++++.. +..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~ 74 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQ-----KVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLY 74 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCC-----ceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcE
Confidence 4688889999999999999875332 2334443321 234678899999999999999999998864 4579
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 75 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 75 IVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceec
Confidence 999999999999999654 2346899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
... ......+..|+|||.+.++.++.++|||||||++|||++ |..||...........+....
T Consensus 151 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 214 (254)
T cd05083 151 SMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------------- 214 (254)
T ss_pred ccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence 322 223344578999999988889999999999999999997 999998765544332222110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
....+..++..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 215 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 --RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 001123445788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=320.73 Aligned_cols=262 Identities=18% Similarity=0.244 Sum_probs=193.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
..+|.+.+.||+|+||.||++...+.. ..+.+++|.... ...+.+|+++|+.++|||||++++++... ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~-~~~~v~vK~~~~------~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDE-QRKKVIVKAVTG------GKTPGREIDILKTISHRAIINLIHAYRWK--STV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCc-cceeEEEEeccc------cccHHHHHHHHHhcCCCCccceeeeEeeC--CEE
Confidence 357999999999999999999764432 334444443321 13456899999999999999999988765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+|||++. ++|.+++. ....+++..++.++.||+.||.|||+++ ||||||||+|||++.++.++|+|||++..
T Consensus 162 ~lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999985 68888883 3456999999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH----HhHhhhcc--cc-cc
Q 011995 334 IPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE----RNLVKWSR--PF-LA 402 (473)
Q Consensus 334 ~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~----~~~~~~~~--~~-~~ 402 (473)
..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+...... ..++.... +. ..
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 54332 1245689999999999998999999999999999999999999976543211 11111000 00 00
Q ss_pred ccc--cccc---ccccccCCCC--C-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 403 DDC--RLSL---IMDPQLKGRF--P-----LKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 403 ~~~--~~~~---~~~~~l~~~~--~-----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... .+.. ......+..+ + ...+.++.+||.+||..||.+|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000 0000000000 0 1234678899999999999999999999875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=315.17 Aligned_cols=254 Identities=14% Similarity=0.161 Sum_probs=195.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||++..... .+.+++++.... ........+.+|+.++..++|+||+++++++.+. +.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE--NN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCC---CCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CE
Confidence 4688889999999999999987554 344455554321 1222334578899999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchhe
Confidence 99999999999999999642 346899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCC---ccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 333 HIPETD---ISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 333 ~~~~~~---~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
...... .....+|+.|+|||++. ...++.++|||||||++|||++|+.||...........+... .
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~------~ 224 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH------K 224 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC------C
Confidence 553222 12346899999999986 345889999999999999999999999876544433222110 0
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE--RPTMRSIFEE 451 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 451 (473)
... .. ......++.++.+|+.+|+..++.+ |+++.++++.
T Consensus 225 ~~~------~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERF------QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccc------cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 00 0112345688999999988665444 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=302.87 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=195.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||+|...++ .+.+++++.+... ......+.+|+.+++.++||||+++++++... +..+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~ 82 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNT---GELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLW 82 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCC---CcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEE
Confidence 4677779999999999999985443 3445566554432 23345678999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 99999999999999853 346899999999999999999999999 999999999999999999999999998755
Q ss_pred CCC--CccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
... ......++..|+|||++. ...++.++|||||||++|||++|..||................
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~----------- 225 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN----------- 225 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-----------
Confidence 322 123346788999999984 4558899999999999999999999986554332221111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+.... ...++..+.+++.+||+.||++||++.+|++
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 226 FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000100 1124467899999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=315.48 Aligned_cols=254 Identities=13% Similarity=0.155 Sum_probs=195.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||++..... .+.+++|+.... ........+.+|+.++..++|+||+.+++++.+. +.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHT---ERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE--NY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCC---CCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 4788899999999999999986543 344555554321 1222345578899999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|+||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecccee
Confidence 99999999999999999642 346899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCc---cCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 333 HIPETDI---SNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 333 ~~~~~~~---~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
....... ....+++.|+|||++.+ +.++.++|||||||++|||++|+.||......+....+... .
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~------~ 224 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH------E 224 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC------C
Confidence 6643322 22468899999999875 46789999999999999999999999876544332222110 0
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE--RPTMRSIFEE 451 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 451 (473)
... .+. .....++.++.+++.+||..++.+ |++++++++.
T Consensus 225 ~~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 000 011235678999999999866544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.78 Aligned_cols=240 Identities=16% Similarity=0.189 Sum_probs=185.0
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC---CCCCcccceeeeecCCCCceEEEE
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL---QHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
||+|+||+||+|+... ..+.+++|+..... .......+..|..++..+ +||||+.+++++... +..|+||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEE
Confidence 7999999999998543 33455566543221 122334456677777665 699999999988766 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence 99999999998853 346899999999999999999999999 999999999999999999999999998754322
Q ss_pred --CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 338 --DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 338 --~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
......+|..|+|||++.+. .++.++|||||||++|||++|..||......+....+..... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------~ 215 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--------------R 215 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--------------C
Confidence 22345789999999998765 489999999999999999999999987654443222211100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERP----TMRSIFE 450 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~eil~ 450 (473)
+. ....+.++.+|+.+||..||.+|| ++.++++
T Consensus 216 ~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00 112457889999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.30 Aligned_cols=247 Identities=18% Similarity=0.285 Sum_probs=195.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC--------hhhHhHHHHHHHHHhCCCCCcccceeeeec
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--------QGVKEFINDVNTLASLQHPNLCKLLGFHAR 247 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 247 (473)
+|.....||.|+||.||+|....+ .+.++++........ ...+.+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASS---GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCC---CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence 367779999999999999985432 334445544332211 123568899999999999999999999876
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
. +..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 78 ~--~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 78 A--DHLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred C--CccEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecc
Confidence 5 788999999999999999954 246889999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccCCCC--------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 328 YGCAGHIPETD--------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 328 FGla~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
||+++...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---- 225 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---- 225 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh----
Confidence 99987664221 112346788999999988889999999999999999999999998654332211110
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.... ..++...+..+.+++.+||+.||.+||++.+|++
T Consensus 226 ---------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ---------ENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------ccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0011 1223455688999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=310.31 Aligned_cols=263 Identities=18% Similarity=0.187 Sum_probs=190.7
Q ss_pred Ccceeec--CCceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 180 DRCISEG--LSSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 180 ~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
..+||+| +|++||++.... +++.+++|....... ......+.+|+++++.++||||+++++++..+ +..++|
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 77 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV 77 (327)
T ss_pred hhhccccccceEEEEEEeecc---cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence 4789999 678999998543 345555665554432 23345677899999999999999999999876 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++++||+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 78 TSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 99999999999985432 335899999999999999999999999 99999999999999999999999986543221
Q ss_pred CC---------ccCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhH-hhhcccccccc
Q 011995 337 TD---------ISNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL-VKWSRPFLADD 404 (473)
Q Consensus 337 ~~---------~~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~ 404 (473)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|..||........... .....+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 10 112245677999999976 3589999999999999999999999976443221110 00000000000
Q ss_pred c-----c-------------cccc---------cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 C-----R-------------LSLI---------MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ~-----~-------------~~~~---------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. . .... ........+....+..+.+|+.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0 0000 00000011223456789999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=302.50 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=200.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||++..... .+.++++.............+.+|++++++++||||+++++++... +..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPT---GKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCC---CcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEE
Confidence 3577779999999999999986532 3444555554443445567899999999999999999999998776 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchh
Confidence 9999999999999995432 578999999999999999999999 88 99999999999999999999999999876
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH--HHhHhhhccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE--ERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..........++..|++||.+.+..++.++||||||+++|+|++|..||....... ....... +.
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~~ 217 (265)
T cd06605 151 LVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-------------IV 217 (265)
T ss_pred hHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-------------Hh
Confidence 54332223567789999999998899999999999999999999999997543111 1111110 00
Q ss_pred ccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLK-AARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... ....+.. .+.++.++|.+||..||.+|||+.+++..
T Consensus 218 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 218 NEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 0011222 66789999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=308.43 Aligned_cols=262 Identities=18% Similarity=0.237 Sum_probs=185.5
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
..||+|+||.||+|+..+.. ..+.++++.... ......+.+|+++++.++||||+++++++........++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEG---TGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCC-ccceEEEEEecC---CCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 68999999999999865432 334444544332 12235678999999999999999999998765557889999998
Q ss_pred cCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee----CCCCcEEEeccCC
Q 011995 261 FHGSLDRLIYGR------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI----DKDFSAKLSGYGC 330 (473)
Q Consensus 261 ~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFGl 330 (473)
.+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 64 777776421 12235889999999999999999999999 9999999999999 5668999999999
Q ss_pred CcccCCC-----CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-------HhH---h
Q 011995 331 AGHIPET-----DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-------RNL---V 394 (473)
Q Consensus 331 a~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-------~~~---~ 394 (473)
++..... ......+|..|+|||++.+. .++.++|||||||++|||+||.+||........ ... .
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9866432 12334678899999998764 489999999999999999999999975432110 000 0
Q ss_pred h---------hcccc-cccccccc------cccccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 395 K---------WSRPF-LADDCRLS------LIMDPQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 395 ~---------~~~~~-~~~~~~~~------~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. |.... ........ ......+. ..........+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000 00000000 00000000 0001123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=306.28 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=197.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.+|...+.||+|+||.||+|....+ ...++++...... ....+.+.+|+.+++.++|+||+++++++... +..+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIAT---GQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCC---CCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEE
Confidence 5788889999999999999985432 3445555554332 23346688999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 99999999999999843 35889999999999999999999999 999999999999999999999999998765
Q ss_pred CCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.... .....+++.|++||.+.+..++.++|||||||++|+|++|..||...........+ .. .
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~---------~ 230 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT---------N 230 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------cc---------C
Confidence 4332 12345778999999999888999999999999999999999999765432211100 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.......+...+..+.+|+.+||..||++||++.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001123445677899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.10 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=197.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|....+ ++.+++++..... .....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRET---GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCC---CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEE
Confidence 4688889999999999999986543 3344455443222 223345678999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||++++.|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 76 HLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred EEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccccee
Confidence 999999999888877632 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCC--ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-hcccccc-------
Q 011995 334 IPETD--ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-WSRPFLA------- 402 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~~------- 402 (473)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+....+....+. .......
T Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 150 LTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 64432 223456788999999876 457899999999999999999999998765543322211 0000000
Q ss_pred cccccccccccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 403 DDCRLSLIMDPQLKGRF-----PLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..........+...... ....+..+.+|+.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000111111000 1134678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.82 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=201.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||.|+||+||+|...++ ...+++++............+.+|+++++.++|+||+++++.+... +..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPN---NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCC---CcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEE
Confidence 4788899999999999999986543 2344455554443344667899999999999999999999988765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+||+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 99999999999999965433356899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCc------cCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 335 PETDI------SNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 335 ~~~~~------~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
..... ....++..|++||.+... .++.++|+|||||++|||++|+.||............... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-----~---- 223 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-----D---- 223 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-----C----
Confidence 43221 223567899999999777 6899999999999999999999999765443221111100 0
Q ss_pred ccccccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 408 SLIMDPQLKGR-FPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+.+... .....+..+.+++.+||..||++||++.+|++
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 ----PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001000 01245688899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=315.41 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=194.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 253 (473)
..|++.+.||+||.+.||++...+... .++.+++......+....|.+|+.+|.+| .|.+||+|++|-..+ +.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~i---yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~l 435 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQI---YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYL 435 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcc---hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceE
Confidence 457788999999999999998655432 11223333345667788999999999999 699999999998776 899
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
||||||= ..+|..+|.++. .....| .++.+..|++.++.++|.++ |||.||||.|+|+-. |.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9999975 559999996543 223334 88899999999999999999 999999999999864 5899999999988
Q ss_pred cCCCCc----cCcccccccCChhhhhcC-----------CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 334 IPETDI----SNSSVAAANLSVETLERG-----------LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 334 ~~~~~~----~~~~~t~~y~aPE~~~~~-----------~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
+..+.. ...+||+.||+||.+... ..+.++||||||||||+|+.|++||...... |+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-------~a- 580 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-------IA- 580 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------HH-
Confidence 865533 345899999999998532 2567899999999999999999999753211 11
Q ss_pred cccccccccccccccccCCCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAA-RTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~-~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
++..+.+|.-.-.|+..-. .++.++++.||+.||.+||++.++|+.
T Consensus 581 -------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3444555544334443222 339999999999999999999999863
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=295.70 Aligned_cols=253 Identities=22% Similarity=0.418 Sum_probs=199.5
Q ss_pred cccCcceeecCCceEEEEEECCCC-eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDA-STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
|++.+.||.|+||.||++...+.. .....+++|+............+..|+.++..++|+||+++++++.+. +..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeEE
Confidence 345688999999999999976533 122444455544333333567899999999999999999999998776 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
+|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 79 i~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999999995432 122899999999999999999999999 9999999999999999999999999997665
Q ss_pred CCCccC---cccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 336 ETDISN---SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 336 ~~~~~~---~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
...... ..++..|++||.+.+..++.++|||||||+++||++ |.+||...........+.... .
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-------~----- 222 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-------R----- 222 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------C-----
Confidence 432211 235678999999988889999999999999999998 889987654433322221100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
...+...+.++.+++.+||..||.+|||+.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011223567899999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.44 Aligned_cols=250 Identities=19% Similarity=0.259 Sum_probs=194.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|++.+.||.|+||.||+|....+. +.+++++.... .....+.+.+|+.+++.++|+||+++++++..+ ...+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~---~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 85 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETG---ALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLW 85 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCC---ceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEE
Confidence 56888899999999999999865433 33444443322 334567788999999999999999999998766 6899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|..++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 86 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 86 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999998887542 345899999999999999999999998 999999999999999999999999988654
Q ss_pred CCC--CccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
... ......++..|+|||.+. ...++.++|||||||++|||++|..||.......... .+...
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~-------- 230 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKS-------- 230 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH--HHhcC--------
Confidence 322 123345678999999984 3446889999999999999999999997654332211 11000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..+. ...+..++.++.+++.+||..||++||++.++++
T Consensus 231 ---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 ---EPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 0113345577899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=310.05 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=203.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
+.|..-++||+||||.||-+..+ .++|.++.+....+ ....+..-.++|-.+|.+++.+.||.+--.|.+. +.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvr---aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVR---ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK--DA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEe---cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--Cc
Confidence 55788899999999999999844 35555555432211 1334555678899999999999999997666555 89
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|||+..|+||+|.-+|+... .+.|++..+..++.+|+.||++||... ||+||+||+|||||+.|+++|+|+|||.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence 999999999999999887653 467999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCc-cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 333 HIPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 333 ~~~~~~~-~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
.+..... ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||.....+....-++.. .+.
T Consensus 336 ei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr--~~~--------- 404 (591)
T KOG0986|consen 336 EIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR--TLE--------- 404 (591)
T ss_pred ecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH--Hhc---------
Confidence 9877654 4449999999999999999999999999999999999999999876544433212110 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMR 446 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 446 (473)
....++...++++.+|....|.+||++|.-.+
T Consensus 405 ---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 ---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 12245778889999999999999999997655
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=304.42 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=198.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|...++ .+.+++++..... .......+.+|+++++.++|+||+++++++... +..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKAT---GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCC---CcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEE
Confidence 4688889999999999999986543 3344444433322 333457789999999999999999999999775 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||++++.+..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 76 ~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 76 YLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 999999988777665532 345899999999999999999999999 99999999999999999999999999877
Q ss_pred cCCCC---ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc------
Q 011995 334 IPETD---ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD------ 403 (473)
Q Consensus 334 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 403 (473)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|++||...........+.........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 65432 2334567889999999888 7899999999999999999999999866543322211110000000
Q ss_pred --ccccc--ccccc----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 --DCRLS--LIMDP----QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 --~~~~~--~~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..... ...+. .....++..++.++.+||.+||..+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000 0011223345788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=328.73 Aligned_cols=274 Identities=15% Similarity=0.180 Sum_probs=189.0
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeE------------E--EEEEEecCCCChhhHhHHHHHHHHHhCCCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKK------------F--EATVTRLNPSSQGVKEFINDVNTLASLQHPN 237 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn 237 (473)
...++|++.+.||+|+||.||+|.++........ . .+..+...........+.+|+.+|.+++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999876432211000 0 0011111222334567889999999999999
Q ss_pred cccceeeeecCCCCceEEEEEeccCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 238 Iv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
||++++++... +..|+|+|++. ++|.+++..... ........+..|+.||+.||.|||+++ ||||||||+||
T Consensus 225 Iv~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 225 ILKIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred cCcEeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 99999999876 78899999984 577777643211 122345667889999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCC-CCCCChHHHH
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKN-LDSRHPKEER 391 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p-~~~~~~~~~~ 391 (473)
||+.++.+||+|||++..+.... .....+|..|+|||++.+..++.++|||||||++|||++|..+ |.........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999998764332 1235689999999999999999999999999999999998754 4332221111
Q ss_pred h---Hhhhccc----cccccccccccccc----ccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 392 N---LVKWSRP----FLADDCRLSLIMDP----QLKGRFP-----LKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 392 ~---~~~~~~~----~~~~~~~~~~~~~~----~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .+..... +......+...++. .....++ .....++.+++.+||+.||.+|||+.|+|..
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1 1111000 00000000000000 0000000 1234567889999999999999999999864
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=305.63 Aligned_cols=244 Identities=18% Similarity=0.305 Sum_probs=193.0
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
...||.|+||.||++....+ ...++++..... .....+.+.+|+.+++.++|+||+++++++... +..++||||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e~ 100 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHT---GKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVMEF 100 (292)
T ss_pred hhcccCCCCeEEEEEEECCC---CCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEeC
Confidence 36799999999999985433 334445544322 233456788999999999999999999998765 789999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC-
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD- 338 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 338 (473)
+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 101 LEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999998832 35899999999999999999999999 9999999999999999999999999987553221
Q ss_pred -ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCC
Q 011995 339 -ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417 (473)
Q Consensus 339 -~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 417 (473)
.....++..|+|||.+.+..++.++|||||||++|||++|..||...........+... ..+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-------------~~~~~~~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-------------LPPRVKD 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------CCCcccc
Confidence 12345788999999998888999999999999999999999999865543322221110 0111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 418 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....+..+.+++.+||..||.+|||+.++++.
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 12345678999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.22 Aligned_cols=246 Identities=19% Similarity=0.233 Sum_probs=199.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||++....+ .+.+++++..... .......+.+|++++++++||||+++++++... ..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--Ce
Confidence 4688889999999999999986543 3445555544321 223456788999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|.|||++.++.+||+|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 99999999999999998543 46899999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... .....+++.|++||.+.+..++.++||||||+++|+|++|..||...........+...
T Consensus 150 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 213 (290)
T cd05580 150 RVKGR-TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--------------- 213 (290)
T ss_pred ccCCC-CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence 76544 34456788999999998888899999999999999999999999765533222111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
...++...+..+.+++.+||..||.+|+ +++++++
T Consensus 214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0112334467889999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.62 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=198.6
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC--
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG-- 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~-- 249 (473)
.+++|+..+.||.|+||.||+|..... ...+++++... .......+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~~k~~~~--~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKT---GQLVAIKIMDI--IEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCC---CcEEEEEEEec--CchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 468899999999999999999986543 33444554443 233456789999999999 7999999999987642
Q ss_pred --CCceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 250 --SDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 250 --~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
...+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence 356899999999999999885422 2457899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCC--ccCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 327 GYGCAGHIPETD--ISNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 327 DFGla~~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|||++....... .....++..|+|||.+.. ..++.++|||||||++|+|++|..||...........+...
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 233 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-- 233 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc--
Confidence 999987653321 233457889999999854 24678999999999999999999999765433222111100
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..+.+ ..+...+.++.+|+.+||..||.+|||+.++++
T Consensus 234 -----------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 -----------PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----------CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00001 112345678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.69 Aligned_cols=251 Identities=19% Similarity=0.220 Sum_probs=198.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC--hhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||.||+|...+ ..+.+++|........ ...+.+..|++++..++|+||+++++++... ..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CE
Confidence 368888999999999999998654 3345555555443222 3456789999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhh
Confidence 99999999999999998643 3457899999999999999999999999 9999999999999999999999999886
Q ss_pred ccCCCC-------------------------------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCC
Q 011995 333 HIPETD-------------------------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKN 381 (473)
Q Consensus 333 ~~~~~~-------------------------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p 381 (473)
...... .....++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 542211 1123567889999999988899999999999999999999999
Q ss_pred CCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 011995 382 LDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT----MRSIFE 450 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~eil~ 450 (473)
|...........+.. ...........+..+.+++.+||+.||++||+ +.+++.
T Consensus 232 f~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 232 FKGSNRDETFSNILK----------------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCchHHHHHHHhc----------------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 987654332221110 00000001125688999999999999999999 777666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.55 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=191.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHH-HHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNT-LASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|++.+.||+|+||.||++.... .++.++++.............+..|+.+ ++.++|+||+++++++..+ ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcE
Confidence 478888999999999999998543 3455556655444333344566677775 5667999999999999765 679
Q ss_pred EEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
++||||++ |+|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999996 6888877542 2345789999999999999999999997 7 999999999999999999999999998
Q ss_pred cccCCCCc-cCcccccccCChhhhhc----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChH-HHHhHhhhccccccccc
Q 011995 332 GHIPETDI-SNSSVAAANLSVETLER----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK-EERNLVKWSRPFLADDC 405 (473)
Q Consensus 332 ~~~~~~~~-~~~~~t~~y~aPE~~~~----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 405 (473)
........ ....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... +....+. .
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~--- 222 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV------E--- 222 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH------h---
Confidence 76643322 23467889999998865 34688999999999999999999999653221 1110000 0
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+.+. ...++.++.+++.+||..+|.+||++.+|++
T Consensus 223 ----~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 ----EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000010 1234678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=295.50 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=196.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC----CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP----SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
+|+..+.||+|+||.||+|....+. ..++++...... .....+.+.+|+++++.++|+||+++++++... .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG---DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--D 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC---cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--C
Confidence 4677799999999999999875332 233344433321 233457789999999999999999999998765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence 89999999999999999854 235889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... .....++..|++||.+.... ++.++|+|||||++|+|++|+.||...........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------ 217 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------ 217 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc------------
Confidence 7654332 23456788899999997766 899999999999999999999999765432222111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....++..++..+.+++.+||+.+|.+||++.+++.
T Consensus 218 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 ----KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0001123445688899999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.91 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=199.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
+|+..+.||.|++|.||+|+...+ +..+++++............+.+|++++++++|+||+++++++... +..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTT---GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCC---CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEE
Confidence 578889999999999999996443 3455666665544444456788999999999999999999999876 78899
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 9999975 89888865443456899999999999999999999999 9999999999999999999999999987553
Q ss_pred CC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-hh-cccccccccccccc
Q 011995 336 ET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-KW-SRPFLADDCRLSLI 410 (473)
Q Consensus 336 ~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~ 410 (473)
.. ......++..|++||.+.+. .++.++|||||||++|+|++|..||.+....+....+ .. ..+.. . ....+
T Consensus 152 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~ 228 (284)
T cd07836 152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE-S--TWPGI 228 (284)
T ss_pred CCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh-h--hHHHH
Confidence 22 12334567889999998664 4789999999999999999999999876544332211 11 00000 0 00000
Q ss_pred cc-cccC-----------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 411 MD-PQLK-----------GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 411 ~~-~~l~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+ +.+. ..+....+..+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000 0111234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.04 Aligned_cols=245 Identities=20% Similarity=0.317 Sum_probs=194.1
Q ss_pred cCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
....||+|+||.||++.... ....+++++..... ....+.+.+|+.++..++||||+++++++..+ +..++|||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~e 98 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLME 98 (297)
T ss_pred hhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEEe
Confidence 34689999999999998543 23344555544332 23356788999999999999999999998765 78999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 338 (473)
|+++++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999988732 35899999999999999999999999 9999999999999999999999999987554322
Q ss_pred --ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccC
Q 011995 339 --ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416 (473)
Q Consensus 339 --~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 416 (473)
.....++..|+|||++.+..++.++|||||||++|||++|..||...........+.... ....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------~~~~- 237 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-------------PPKL- 237 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-------------CCCc-
Confidence 233467889999999988889999999999999999999999997655433322221100 0000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 417 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......+..+.+++.+||+.+|.+||++.+|++.
T Consensus 238 -~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 -KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0122345678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=299.14 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=198.0
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
|+..+.||+|+||.||+|....+ ...+++++............+.+|+.++.+++|+||+++++++..+ +..++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRT---QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCC---CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEE
Confidence 55668999999999999985443 3445555544443344556788999999999999999999998766 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999999999842 35899999999999999999999999 99999999999999999999999999876543
Q ss_pred CC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 337 TD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 337 ~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
.. .....++..|++||.+.+..++.++|||||||++|+|++|..||...........+...
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 216 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN----------------- 216 (277)
T ss_pred chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-----------------
Confidence 32 12335678899999998888899999999999999999999999765433222211100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....++..++.++.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011233456788999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=295.00 Aligned_cols=250 Identities=18% Similarity=0.240 Sum_probs=199.5
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||+|+||.||++...+ ....++++...... .......+.+|+++++.++|+||+++++++... +..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEE
Confidence 47788999999999999998644 33445555554332 334467789999999999999999999988755 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~ 333 (473)
+||||+++++|.+++... ....+++..+..++.+++.+|.|||+++ ++|+||+|+||+++.+ +.+||+|||++..
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred EEEecCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 999999999999999653 2445899999999999999999999999 9999999999999855 5689999999987
Q ss_pred cCCCCc-cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 334 IPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~~-~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
...... ....++..|+|||.+.+..++.++||||||+++|+|++|..||...........+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08220 152 LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-------------- 217 (256)
T ss_pred cCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC--------------
Confidence 654322 23456789999999988889999999999999999999999997765433222111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...++...+..+.+++.+||..||++|||+.++++.
T Consensus 218 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 ---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011233456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=297.76 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=197.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-----ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-----SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
+|+..+.||+|+||.||+|... .....+++++...... ......+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV---KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-- 75 (268)
T ss_pred CccccceecCcCceEEEEEEEc---CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--
Confidence 5788899999999999999843 3345566666553321 12356789999999999999999999998765
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYG 329 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFG 329 (473)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .+||+|||
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccc
Confidence 789999999999999999854 346899999999999999999999999 99999999999998775 59999999
Q ss_pred CCcccCCCCc------cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 330 CAGHIPETDI------SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 330 la~~~~~~~~------~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
++........ ....++..|+|||.+.+..++.++|||||||++++|++|..||...........+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----- 224 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA----- 224 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh-----
Confidence 9876643211 12356789999999988889999999999999999999999997543222111111000
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.......++...+.++.+++.+||..+|++||++.++++
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 --------SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112235566788999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.16 Aligned_cols=254 Identities=17% Similarity=0.189 Sum_probs=196.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||.||++..... .+.++++...... .......+.+|+++++.++|+||+++++.+..+ +.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKET---RQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCC---CcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CE
Confidence 4788889999999999999986543 3444455443321 123345788999999999999999999988765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 9999999999999999954 246899999999999999999999998 9999999999999999999999999886
Q ss_pred ccCCC-----------------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh
Q 011995 333 HIPET-----------------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 333 ~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 395 (473)
..... ......++..|+|||.+.+..++.++|||||||++|||++|..||.+....+....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 42100 0012345778999999988889999999999999999999999998655433222211
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
... ...+.. ....+.++.+++.+||+.||++||++.++++.|+.
T Consensus 230 ~~~-----------~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDD-----------IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcc-----------cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 000000 11355778999999999999999997777766665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=295.09 Aligned_cols=280 Identities=18% Similarity=0.174 Sum_probs=201.1
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCCCCCcccceeeee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQHPNLCKLLGFHA 246 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 246 (473)
+-++....|+....||+|+||.||+|.-.+... -.+.+++|...-... ...-....+|+.+++.++|||||.|..++.
T Consensus 18 ~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 18 ERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred hhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 334556678999999999999999996443322 123344443332222 223466889999999999999999999887
Q ss_pred cCCCCceEEEEEeccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC----
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYG--RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---- 320 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---- 320 (473)
.. ...++|++||.++ +|..+|+- ......++...+..|+.||+.|+.|||++. |+||||||.|||+..+
T Consensus 98 ~~-d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPER 172 (438)
T ss_pred cc-CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCcc
Confidence 64 3789999999977 88888743 233467899999999999999999999999 9999999999999877
Q ss_pred CcEEEeccCCCcccCCC-----CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHH-----
Q 011995 321 FSAKLSGYGCAGHIPET-----DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKE----- 389 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~-----~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~----- 389 (473)
|.|||+|||+++.+.+. .....++|++|.|||.+.|.. |+.+.|||++|||+.||+|-++.|.+...+.
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P 252 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP 252 (438)
T ss_pred CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence 99999999999987543 234568899999999998876 9999999999999999999999997654321
Q ss_pred ----HHhHhhhc--------cccccccccccc-ccccccCCCCC----------HHHHHHHHHHHHHhcccCCCCCCCHH
Q 011995 390 ----ERNLVKWS--------RPFLADDCRLSL-IMDPQLKGRFP----------LKAARTVADIALRCLQKEPSERPTMR 446 (473)
Q Consensus 390 ----~~~~~~~~--------~~~~~~~~~~~~-~~~~~l~~~~~----------~~~~~~l~~li~~cl~~dP~~RPt~~ 446 (473)
+.+.|... +|.+........ +.+-+.....+ ..-+....+|+.++|..||-+|.|++
T Consensus 253 fq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~ 332 (438)
T KOG0666|consen 253 FQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE 332 (438)
T ss_pred chHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH
Confidence 11111100 011110000000 00000000000 01123478999999999999999999
Q ss_pred HHHHHHH
Q 011995 447 SIFEELD 453 (473)
Q Consensus 447 eil~~L~ 453 (473)
+.++..=
T Consensus 333 qAleh~y 339 (438)
T KOG0666|consen 333 QALEHPY 339 (438)
T ss_pred HHhcccc
Confidence 9887643
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=294.73 Aligned_cols=250 Identities=18% Similarity=0.259 Sum_probs=200.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||+|+||.||.+....+ .+.++++..... .......++.+|+.+++.++|+||+++++++... +..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKED---GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCC---CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEE
Confidence 477889999999999999986443 344555554432 2334456889999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 999999999999988543 2345789999999999999999999998 999999999999999999999999999766
Q ss_pred CCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... ....++..|+|||++.+..++.++|||||||++++|++|..||......+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-------------- 217 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--------------
Confidence 44322 22356788999999988889999999999999999999999997655433222111000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....+...+.++.++|.+||+.+|++||++.+|++.
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 ---YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011233456789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.16 Aligned_cols=255 Identities=13% Similarity=0.241 Sum_probs=198.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC---------CCChhhHhHHHHHHHHHh-CCCCCcccceeee
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN---------PSSQGVKEFINDVNTLAS-LQHPNLCKLLGFH 245 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~ 245 (473)
+|+..+.||+|+||.||+|....+ ..+.++++..... .......++.+|+.++.+ ++|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 477789999999999999997652 1234444443322 122334567889998875 7999999999998
Q ss_pred ecCCCCceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcE
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
..+ +..++||||+++++|.+++... .....+++..+..++.|++.||.|||+ .+ ++|+||+|+|||++.++.+
T Consensus 79 ~~~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 79 LEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred ccC--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence 766 7899999999999999887432 234568999999999999999999996 56 9999999999999999999
Q ss_pred EEeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc
Q 011995 324 KLSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 324 kl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
+|+|||++...... ......++..|++||.+.+..++.++||||||+++|||++|..||...........+....
T Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---- 229 (269)
T cd08528 154 TITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV---- 229 (269)
T ss_pred EEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc----
Confidence 99999999776544 2234467889999999998889999999999999999999999997654433222111000
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
..+. .....+..+.+++.+||+.||++||++.|+..+|.
T Consensus 230 --------~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 --------YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000 01134578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=301.74 Aligned_cols=267 Identities=19% Similarity=0.235 Sum_probs=199.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||.|+||.||+|....+. +.++++..+... .......+.+|+.++.+++||||+++++++.....+..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTG---EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCC---cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 57888899999999999999975433 334444444332 22233467789999999999999999999876655789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+||||+. ++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++..
T Consensus 82 ~lv~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EEEehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceee
Confidence 99999996 5999888543 236899999999999999999999999 99999999999999999999999999886
Q ss_pred cCCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh--cccc------c-
Q 011995 334 IPET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW--SRPF------L- 401 (473)
Q Consensus 334 ~~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~------~- 401 (473)
.... ......++..|+|||.+.+.. ++.++||||||+++|||++|.+||...........+.. ..+. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 6443 223345678899999987644 68999999999999999999999987655443322210 0000 0
Q ss_pred ----ccccccccccccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 402 ----ADDCRLSLIMDPQLKGRFPLK-AARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 402 ----~~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.............+...++.. .+..+.++|.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000011111122223333 5778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.19 Aligned_cols=264 Identities=17% Similarity=0.203 Sum_probs=192.3
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||+|+||.||+|....+ ++.++++...... .......+.+|++++++++|+||+++++++.+. ...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~---g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCC---CcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceE
Confidence 477789999999999999986543 3344555544332 222345678899999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 76 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred EEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 9999996 5888877532 346899999999999999999999999 999999999999999999999999998765
Q ss_pred CCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChH-HHHhHhhhccccccccc--ccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPK-EERNLVKWSRPFLADDC--RLS 408 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~--~~~ 408 (473)
... ......++..|+|||.+.+.. ++.++|||||||++|||++|..||...... .....+........... ...
T Consensus 150 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 150 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence 332 223345678999999987654 789999999999999999998886433322 21111100000000000 000
Q ss_pred cccc----cccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 409 LIMD----PQLK-----GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 409 ~~~~----~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+ +... .......+.++.+++.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0000 0112245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=295.49 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=196.3
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...+.||+|+||.||+|....+ .+.+++++...... ......+.+|+++++.++|+||+++++++... +..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDT---GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCC---CcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEE
Confidence 477789999999999999986443 34455555554432 24567899999999999999999999988665 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccccc
Confidence 99999999999999853 345889999999999999999999999 999999999999999999999999998776
Q ss_pred CCCCc------cCcccccccCChhhhhcCC---CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 335 PETDI------SNSSVAAANLSVETLERGL---LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 335 ~~~~~------~~~~~t~~y~aPE~~~~~~---~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
..... ....++..|++||++.+.. ++.++||||||+++|||++|+.||............ ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~---~~------ 220 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH---VG------ 220 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH---Hh------
Confidence 43321 1235678999999998766 889999999999999999999999765322211100 00
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
....+.+.. ...++..+.+++.+||+.+|.+||++.+++.
T Consensus 221 ---~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 221 ---AGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---cCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111110 1234677889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.64 Aligned_cols=265 Identities=17% Similarity=0.248 Sum_probs=196.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|...++. +.+++++..... .....+.+.+|+++++.++|+||+++++++..+ ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETG---QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCC---CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeE
Confidence 46888899999999999999975432 334444433222 223456788999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|..+... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred EEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 999999999999887643 235899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCC--ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh-ccccccc------
Q 011995 334 IPETD--ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW-SRPFLAD------ 403 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~------ 403 (473)
..... .....++..|+|||++.+. .++.++|||||||++|||++|.+||......+....+.. ...+...
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 150 LAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred ccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 54322 2334567899999998653 478899999999999999999999976554332221111 0000000
Q ss_pred -ccccccccccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 -DCRLSLIMDPQLKG-----RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 -~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.........+.... .....++..+.+|+.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000000 001245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=295.49 Aligned_cols=250 Identities=18% Similarity=0.251 Sum_probs=199.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC----CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP----SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
.+|...+.||+|+||.||+|.... ..+.++++...... .......+.+|++++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 478889999999999999998543 34455565544321 23345678899999999999999999999876544
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
..+++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccc
Confidence 6789999999999999998532 35889999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC-----CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 331 AGHIPET-----DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 331 a~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
++..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------- 222 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---------- 222 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH----------
Confidence 8765321 1123457789999999988889999999999999999999999997654333221111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.......++...+..+.+++.+||+ ++..||++.+++.
T Consensus 223 ------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 ------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111123456677889999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=300.00 Aligned_cols=265 Identities=19% Similarity=0.270 Sum_probs=198.9
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|++.+.||+|+||.||+|....+ ++.+++++..... .......+.+|+.++++++|+||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRET---GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCC---CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeE
Confidence 477889999999999999986543 3444455544432 233456789999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 76 ~v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred EEeccc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 999999 99999998543 356999999999999999999999999 999999999999999999999999998876
Q ss_pred CCCC---ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh--ccc------ccc
Q 011995 335 PETD---ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW--SRP------FLA 402 (473)
Q Consensus 335 ~~~~---~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~------~~~ 402 (473)
.... .....++..|+|||.+.+.. ++.++|||||||+++||++|.++|...........+.. ..+ ...
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 5432 34456788999999986544 68999999999999999999988876654332221110 000 000
Q ss_pred cccccccccccccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 403 DDCRLSLIMDPQLK----GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 403 ~~~~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+......+..+... .....+.+..+.+++.+||..||.+||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 00112345889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=300.84 Aligned_cols=265 Identities=17% Similarity=0.225 Sum_probs=193.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|++|.||+|....+ .+.+++|.............+.+|+++++.++|+||+++++++.++ +..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLT---GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCC---CcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEE
Confidence 5788889999999999999985433 3445566554433333345677899999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+.+ +|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 80 lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred EEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 99999974 999988543 236899999999999999999999999 999999999999999999999999998654
Q ss_pred CCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChH-HHHhHhhhccccccccc-----
Q 011995 335 PET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK-EERNLVKWSRPFLADDC----- 405 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~----- 405 (473)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||...... +....+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 321 1223346788999999865 45889999999999999999999999765421 11111100000000000
Q ss_pred --------ccccccccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 --------RLSLIMDPQLKGRFP-LKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 --------~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.........+....+ .....++.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000000 011267889999999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=295.07 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=203.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||.|++|.||+|+..+ ..+.+++++............+.+|+..+.+++|+||+++++++... ...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEE
Confidence 468888999999999999998654 33455555555443334567899999999999999999999998766 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence 999999999999999543 568999999999999999999999 98 99999999999999999999999999887
Q ss_pred cCCCCcc--CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IPETDIS--NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~~~--~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
....... ...++..|+|||.+.+..++.++||||||+++|+|++|..||.............+..
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 216 (264)
T cd06623 150 LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------- 216 (264)
T ss_pred cccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------
Confidence 6543322 3456789999999998889999999999999999999999997764211111121111
Q ss_pred ccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLK-AARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... ....+.. .+..+.+++.+||..+|++||++.++++.
T Consensus 217 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 DGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 0111223 56889999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=297.73 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=196.9
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC---CCCcccceeeeecCCCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ---HPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~ 252 (473)
.|+..+.||+|+||.||+|....+ .+.+++++...........++.+|+.+++.++ |+|++++++++... ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPT---GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCC---CcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CE
Confidence 477779999999999999986433 34555665554444455677889999999996 99999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 9999999999999998843 26899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCC--ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 333 HIPETD--ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 333 ~~~~~~--~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... .....++..|+|||.+.++ .++.++|||||||++|+|++|..||...........+. .
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-------------~ 216 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-------------K 216 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-------------c
Confidence 664432 2334577889999998754 46899999999999999999999997654332211110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+.+.. ...+.++.+++.+||..||++||++.++++.
T Consensus 217 ~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 217 SKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00111111 1245789999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.03 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=205.0
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG 249 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 249 (473)
...+-+|+.+..||.|.||.||.|... .++...++|-+++.. .......+.+|+.++..+.|||+|++||+-...
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~---~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR- 1306 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNL---DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR- 1306 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecC---CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-
Confidence 345677889999999999999999844 444555555555543 344567889999999999999999999987765
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
+.++|.||||.+|+|.+.+. .+...++.....+..|++.|+.|||++| ||||||||+||||+.+|.+|++|||
T Consensus 1307 -ekv~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1307 -EKVYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred -HHHHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccc
Confidence 78999999999999999993 4556778888889999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC------CccCcccccccCChhhhhcCC---CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc
Q 011995 330 CAGHIPET------DISNSSVAAANLSVETLERGL---LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 330 la~~~~~~------~~~~~~~t~~y~aPE~~~~~~---~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
.|..+.+. ......||+.|||||++.+.. -..++||||+|||++||+||+.||...+.. |+.-+
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy 1452 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMY 1452 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHh
Confidence 99876443 124557899999999997643 457899999999999999999999765432 21111
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. +...-.+++|...+.+-.+|+..||+.||.+|.++.|+++.
T Consensus 1453 -----~----V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 -----H----VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----H----HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 11112234577899999999999999999999999877754
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=296.29 Aligned_cols=253 Identities=19% Similarity=0.326 Sum_probs=194.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC---------ChhhHhHHHHHHHHHhCCCCCcccceeeee
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS---------SQGVKEFINDVNTLASLQHPNLCKLLGFHA 246 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 246 (473)
+|...+.||.|+||.||+|....+ +..++++..+.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTT---GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCC---CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec
Confidence 467789999999999999985433 33444554432211 112346788999999999999999999987
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
.. +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 79 ~~--~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~ 150 (272)
T cd06629 79 TE--EYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKIS 150 (272)
T ss_pred cC--CceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEe
Confidence 65 7899999999999999998543 46899999999999999999999998 9999999999999999999999
Q ss_pred ccCCCcccCCC----CccCcccccccCChhhhhcCC--CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc
Q 011995 327 GYGCAGHIPET----DISNSSVAAANLSVETLERGL--LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 327 DFGla~~~~~~----~~~~~~~t~~y~aPE~~~~~~--~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
|||++...... ......++..|++||.+.... ++.++||||||+++|||++|..||.............
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----- 225 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG----- 225 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh-----
Confidence 99998765322 112335678999999987654 7899999999999999999999997544332211100
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.. . ....+.......++..+.+++.+||..||.+||++.+|++.
T Consensus 226 -~~--~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 -NK--R----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cc--c----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 0 01111111223456889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=301.26 Aligned_cols=259 Identities=14% Similarity=0.157 Sum_probs=185.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhh----------HhHHHHHHHHHhCCCCCcccceee
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV----------KEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
+.|.+.+.||+|+||.||+|...++....+.+++++.......... .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999997665333344444444333221111 112234445666789999999987
Q ss_pred eecCCC--CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc
Q 011995 245 HARDGS--DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322 (473)
Q Consensus 245 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 322 (473)
+..... ...++++|++. .++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 654321 13467777763 366666632 224678889999999999999999998 999999999999999999
Q ss_pred EEEeccCCCcccCCC---------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-Hh
Q 011995 323 AKLSGYGCAGHIPET---------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RN 392 (473)
Q Consensus 323 vkl~DFGla~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~ 392 (473)
++|+|||+++.+... ......+|+.|+|||++.+..++.++|||||||++|||++|..||........ ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999765321 11223688999999999999999999999999999999999999986632221 11
Q ss_pred H--hhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 393 L--VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 393 ~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
. ..+... +....+ .....+..+.+++..||..+|++||++.+|++.|+
T Consensus 245 ~~~~~~~~~----------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKR----------LHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHH----------hhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 111000 000000 01234578999999999999999999999998764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=287.16 Aligned_cols=252 Identities=16% Similarity=0.253 Sum_probs=203.5
Q ss_pred HhcccccC-cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeec--C
Q 011995 173 ACHNFFSD-RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHAR--D 248 (473)
Q Consensus 173 ~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~--~ 248 (473)
.+++|.+. .+||-|-.|.|-.+. +..++.++++|+.+ .....++|+++.-.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~---~k~T~ekfALKvL~------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCV---HKRTQEKFALKVLL------DSPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEE---eccchhhhHHHHHh------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 56777654 689999999999998 55567777777654 235567899987766 79999999998864 3
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC---CCCcEEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKL 325 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~vkl 325 (473)
+..++.+|||.|+||.|+..+..+ ....|++.++..|+.||..|+.|||+.+ |.||||||+|+|.. .|..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEe
Confidence 457889999999999999999765 4567999999999999999999999999 99999999999996 4567999
Q ss_pred eccCCCcccC-CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCCh----HHHHhHhhhcccc
Q 011995 326 SGYGCAGHIP-ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP----KEERNLVKWSRPF 400 (473)
Q Consensus 326 ~DFGla~~~~-~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~----~~~~~~~~~~~~~ 400 (473)
+|||+|+... .....+.+.|+.|.|||++...+|+...|+||+||++|-|++|.+||...+. ..+...|.-..-
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy- 284 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY- 284 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc-
Confidence 9999998765 4456777899999999999999999999999999999999999999965432 111111111000
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+...-...+++.+.++|+.+|..+|.+|.|+.+++..
T Consensus 285 -------------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 -------------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -------------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 01111135788999999999999999999999999864
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=300.18 Aligned_cols=267 Identities=15% Similarity=0.194 Sum_probs=194.4
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++++|...+.||+|+||.||+|....+ ...+++|+............+.+|+.+++.++|+||+++++++..+ +.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRIN---GQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCC---CcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--Ce
Confidence 357899999999999999999985433 3445566555443334445678999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|+||||+. ++|.+++... ...+.+..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence 999999995 6777776432 245788889999999999999999999 9999999999999999999999999987
Q ss_pred ccCCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc---
Q 011995 333 HIPET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR--- 406 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 406 (473)
..... ......++..|+|||.+.+. .++.++|||||||++|||++|..||.............|..........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 54322 12333568899999998654 4788999999999999999999999865543221111111000000000
Q ss_pred ---c----ccccccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 407 ---L----SLIMDPQLKGRF-----PLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 407 ---~----~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. ............ .......+.+++.+|+..||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 000000000000 0012467889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.72 Aligned_cols=264 Identities=18% Similarity=0.239 Sum_probs=194.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||.|++|.||+|+...+ ...++++...... .......+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLT---GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCC---CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEE
Confidence 578889999999999999986543 3344455444332 222345788999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred EEeeccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999995 6898888653 2456899999999999999999999999 999999999999999999999999998765
Q ss_pred CCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh-Hhhhccccccc-------
Q 011995 335 PET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN-LVKWSRPFLAD------- 403 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~------- 403 (473)
... ......++..|+|||.+.+.. ++.++|||||||++|||+||..||.......... ...+.......
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 151 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 332 223335678899999886644 6889999999999999999999997655433221 11111000000
Q ss_pred ----ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 ----DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...........+ .......+.++.++|.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 0011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=296.29 Aligned_cols=265 Identities=20% Similarity=0.229 Sum_probs=192.1
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~l 255 (473)
|...+.||+|+||.||+|....+ .+.++++...............+|+.++.++. |+||+++++++.+...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~---~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKT---GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCC---CcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 55678999999999999985433 33444554433222223344567999999985 999999999988764468999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+. |+|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||++....
T Consensus 78 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 999996 5888887542 246899999999999999999999999 999999999999999 999999999997664
Q ss_pred CCC-ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc----ccc---
Q 011995 336 ETD-ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD----DCR--- 406 (473)
Q Consensus 336 ~~~-~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~--- 406 (473)
... .....++..|+|||.+.. ..++.++|||||||++|||++|..||.+.+..+....+......... ...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 332 233456789999998754 45789999999999999999999999876654322211100000000 000
Q ss_pred cccccccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 407 LSLIMDPQLKG----RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 407 ~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......+.... ......+..+.++|.+||++||++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 0112457889999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=299.17 Aligned_cols=265 Identities=19% Similarity=0.241 Sum_probs=196.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC----ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS----SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
+|...+.||+|+||.||+|....+ ...++++..+.... ......+..|+++++.++|+||+++++++.+. +
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKET---GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--S 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCC---CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--C
Confidence 477778999999999999986543 33445555443321 22345677899999999999999999999875 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+ +|+|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||+|+|||++.++.++|+|||++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~ 149 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA 149 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceee
Confidence 899999999 899999995432 36999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc-ccccccc---
Q 011995 332 GHIPET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-RPFLADD--- 404 (473)
Q Consensus 332 ~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~--- 404 (473)
...... ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|...........+... .......
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 150 RSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 766443 2233355788999999865 45789999999999999999998888765543322221100 0000000
Q ss_pred -cccccccccccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 -CRLSLIMDPQLK-----GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 -~~~~~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
............ .......+..+.+++.+||..||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 01123456789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.78 Aligned_cols=246 Identities=19% Similarity=0.307 Sum_probs=194.6
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
|...+.||+|++|.||++....+ ...+++++.... .....+.+.+|+.+++.++|+||+++++++... +..++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v 94 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKST---GRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVV 94 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCC---CCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEE
Confidence 44448999999999999985433 234445544332 223456688999999999999999999988765 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
+||+.+++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999999999999854 35899999999999999999999999 99999999999999999999999998865533
Q ss_pred CC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 337 TD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 337 ~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
.. .....++..|+|||.+.+..++.++|||||||++|||++|..||...........+.... .+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-------------~~~ 234 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-------------PPK 234 (285)
T ss_pred CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-------------CCC
Confidence 21 123457889999999988889999999999999999999999997655433322221110 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. .+..++..+.+|+.+||..+|.+||++.++++
T Consensus 235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Cc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00 12235578999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=295.08 Aligned_cols=248 Identities=17% Similarity=0.237 Sum_probs=198.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+|+..+.||.|+||.||+|.... ..+.+++++..... .....+.+.+|++++++++||||+++++++.+. +..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeE
Confidence 57888999999999999998543 33455565554322 224567899999999999999999999988655 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++|+||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 9999999999999999543 46899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 334 IPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.... ......++..|++||.+.+..++.++|+||||+++|+|++|..||............... ..
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~--------- 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ----ET--------- 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh----cc---------
Confidence 6443 223446778999999998888999999999999999999999999876532111111100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTM--RSIF 449 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~eil 449 (473)
....++...+..+.+++.+||..||.+||++ .|++
T Consensus 217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112344556889999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.99 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=201.0
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
..+++|+....||.|+||.||+|..... ...+++++...... ....+.+|+++++.++|+||+++++++... .
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRAT---GKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVG--D 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccC---CcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--C
Confidence 3467788889999999999999986532 33445555543322 567789999999999999999999998876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchh
Confidence 8999999999999999996532 47999999999999999999999998 999999999999999999999999988
Q ss_pred cccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... .....++..|++||.+.+..++.++|||||||++|+|++|..||...........+.... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~--------~-- 233 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG--------I-- 233 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------C--
Confidence 6553321 123346788999999988889999999999999999999999997655433222111000 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+.. .....++..+.+|+.+||+.+|.+||++.++++
T Consensus 234 ---~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 234 ---PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 000 012235678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=300.49 Aligned_cols=269 Identities=18% Similarity=0.197 Sum_probs=198.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|..... +..+++|+...... ......+.+|+.++++++|+||+++++++.....+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTS---GEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCC---CcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 46788999999999999999986543 34455665554432 222345678999999999999999999987654467
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceee
Confidence 899999996 4888888542 356899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc-----
Q 011995 333 HIPET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD----- 404 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 404 (473)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...........+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 76433 2223345788999999865 457899999999999999999999998776554433222110000000
Q ss_pred ---cccccc-cccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 ---CRLSLI-MDPQLKGRF---PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ---~~~~~~-~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...... ........+ ....+..+.++|.+||+.||.+|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 000000000 01246778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=299.83 Aligned_cols=255 Identities=19% Similarity=0.268 Sum_probs=191.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...+.||+|+||.||++....+ ...++++.............+.+|+.++.++. |+||+++++++..+ ...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPS---GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCC---CCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEE
Confidence 445558899999999999986543 34455555444333455677899999999996 99999999988765 7789
Q ss_pred EEEEeccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 255 LIYERLFHGSLDRLIYG--RSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
++|||+.. +|.++... ......+++..+..++.|++.||+|||+. + ++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchh
Confidence 99999854 65544321 11235689999999999999999999975 6 999999999999999999999999998
Q ss_pred cccCCCC-ccCcccccccCChhhhhcC---CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERG---LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~---~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
....... .....++..|+|||.+.+. .++.++|||||||++|||++|..||......... .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~----~~----- 225 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LTQV----VK----- 225 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH-Hhhh----cC-----
Confidence 7654332 2334678899999999776 6899999999999999999999999764421110 0000 00
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+.+.......++.++.+|+.+||+.||++|||+.+|++.
T Consensus 226 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 --GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111112223466789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.79 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=199.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
+|...+.||+|++|.||++....+ .+.+++++...... .....+.+|+++++.++|+||+++++++..+ ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRT---GKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCC---CcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEE
Confidence 467779999999999999997543 23344444433222 3567899999999999999999999998776 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
++||+++++|.+++... ...+++..+..++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 75 VMEFCSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred EEecCCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 99999999999998543 256899999999999999999999998 9999999999999999999999999987765
Q ss_pred CCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 336 ETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 336 ~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
... .....++..|++||.+.+..++.++||||||+++|+|++|+.||............... ... .
T Consensus 150 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~-----~ 216 (253)
T cd05122 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--------GPP-----G 216 (253)
T ss_pred ccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--------CCC-----C
Confidence 443 23456778999999998888999999999999999999999999876443332221110 000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+. .....+..+.+++.+||+.||.+|||+.++++
T Consensus 217 ~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 LR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cC--cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 01123578999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=299.86 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=196.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||++....+ .+.++++..... .....+.+.+|+.+++.++||||+++++++... +..+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~ 92 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVAT---GQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVG--DELW 92 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCC---CCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEE
Confidence 6788889999999999999985432 234445544322 223356788999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 99999999999999843 24789999999999999999999999 999999999999999999999999988655
Q ss_pred CCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.... .....+++.|++||.+.+..++.++|||||||++|+|++|+.||...........+. . .
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~---------~ 230 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T---------N 230 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------c---------C
Confidence 4332 223356788999999988889999999999999999999999997654332211000 0 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.......+...+..+.+++.+||..+|.+||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001123455778999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=296.53 Aligned_cols=244 Identities=18% Similarity=0.218 Sum_probs=184.7
Q ss_pred ceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHH---hCCCCCcccceeeeecCCCCceEEE
Q 011995 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLA---SLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~---~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
.||+|+||.||++...++ .+.++++...... .......+.+|..++. ..+|+||+.+++++... +..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCC---CcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEE
Confidence 489999999999986443 3344455443321 1122233445544433 34799999999888765 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 999999999998853 346999999999999999999999999 99999999999999999999999999876544
Q ss_pred CCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 TDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 ~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......++..|+|||.+.+ ..++.++|||||||++|||++|..||............... . ..
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----------~----~~ 214 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----------L----TV 214 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-----------h----cC
Confidence 33344568899999999864 45899999999999999999999999754332211111100 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
...++...+.++.+++.+||..||.+|| ++.++++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1122445668899999999999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.48 Aligned_cols=248 Identities=22% Similarity=0.302 Sum_probs=194.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..|...+.||+|+||.||+|....+ ...+++++..... .......+.+|+++++.++||||+++++++... +.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRT---NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCC---CcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--Ce
Confidence 4477789999999999999986543 3344555544322 233446789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcce
Confidence 899999996 5777777432 346899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... ....++..|+|||.+. ...++.++||||||+++|||++|..||...........+.+..+
T Consensus 164 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 231 (307)
T cd06607 164 LVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS---------- 231 (307)
T ss_pred ecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC----------
Confidence 65432 2345678899999874 35688999999999999999999999977654332221111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.+ .....+..+.+++.+||..||++||++.+|+..
T Consensus 232 ---~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ---PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 122356789999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=295.82 Aligned_cols=267 Identities=17% Similarity=0.214 Sum_probs=194.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC--
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~-- 250 (473)
++|+..+.||+|+||.||+|....+ .+.+++++..... .......+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~---~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNT---GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCC---CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 4788889999999999999986543 3445555544432 222346788999999999 46999999998876421
Q ss_pred -CceEEEEEeccCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-CCcEEEe
Q 011995 251 -DQRMLIYERLFHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-DFSAKLS 326 (473)
Q Consensus 251 -~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~vkl~ 326 (473)
...|+||||+++ +|.+++..... ...+++..+..++.||+.||.|||+++ |+||||+|+||+++. ++.+||+
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEe
Confidence 237999999975 89888864322 346899999999999999999999999 999999999999998 8999999
Q ss_pred ccCCCcccCCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-hhcccccc
Q 011995 327 GYGCAGHIPET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-KWSRPFLA 402 (473)
Q Consensus 327 DFGla~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~ 402 (473)
|||++..+... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||...........+ ..... .
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~ 231 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT--P 231 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC--C
Confidence 99998765322 2233356788999998865 45789999999999999999999999876544332211 10000 0
Q ss_pred ccccccccc-------ccccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 403 DDCRLSLIM-------DPQLK----GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 403 ~~~~~~~~~-------~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......... .+... .......+..+.+||.+||..||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 00000 0001235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=289.94 Aligned_cols=250 Identities=19% Similarity=0.270 Sum_probs=196.6
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...+.||+|+||.||+|....+. ..++++...... .....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS---EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC---ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEE
Confidence 4778899999999999999975543 334455443321 223456788999999999999999999988765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~ 333 (473)
+|+||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+..
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151 (257)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchh
Confidence 999999999999998653 2346899999999999999999999998 99999999999999885 569999999876
Q ss_pred cCCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IPETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
...... ....++..|+|||.+.+..++.++|||||||+++||++|..||...........+. . .
T Consensus 152 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-----~------- 217 (257)
T cd08225 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--Q-----G------- 217 (257)
T ss_pred ccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh--c-----c-------
Confidence 643321 22357788999999988889999999999999999999999997654333221110 0 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.. .......+.++.+++.+||..+|++|||+.++++.
T Consensus 218 --~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 --YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 01122345789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=290.90 Aligned_cols=240 Identities=17% Similarity=0.237 Sum_probs=200.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...++||+|+||.|-+++ ...+++.+++|+.+... ....+..-+.|-.+|...+||.+..|.-.|... +.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~r---EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~--dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCR---EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ--DR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEe---ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC--ce
Confidence 455666999999999999998 66678888888765432 334455567789999999999999987667665 89
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|+||||..||.|.-+|. ....+++.....+..+|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||+.+
T Consensus 243 lCFVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence 999999999999998884 3456888888999999999999999999 9999999999999999999999999986
Q ss_pred cc--CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HI--PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.- ......+.+||+.|+|||++....|+.++|.|.+||++|||++|+.||...+-.....+|...
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------- 383 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------- 383 (516)
T ss_pred hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------
Confidence 43 233456789999999999999999999999999999999999999999876544444443211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 443 (473)
. -.||...++++..|+..+|.+||.+|.
T Consensus 384 ---d--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 ---D--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---h--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1 135778889999999999999999995
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=304.73 Aligned_cols=271 Identities=15% Similarity=0.208 Sum_probs=197.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---C
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG---S 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---~ 250 (473)
+++|++.+.||+|+||.||+|.... ++..+++|+............+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 5789999999999999999998543 334455555433233445567889999999999999999999876432 2
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++|+||+. ++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccc
Confidence 45799999996 48888773 235899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC-----ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 331 AGHIPETD-----ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 331 a~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
+....... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~-~~~ 231 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT-PSQ 231 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CCH
Confidence 87653221 122356889999998755 45889999999999999999999999765543322111000000 000
Q ss_pred cccccccccc---------cCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 011995 405 CRLSLIMDPQ---------LKGR-----FPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQE 456 (473)
Q Consensus 405 ~~~~~~~~~~---------l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~ 456 (473)
.....+.+.. .... .....+.++.+++.+||+.||++|||+.++++. |+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000000 0000 011346778999999999999999999999987 55544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=265.70 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=212.0
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhh-HhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...++||+|+||+||+|+ +..+...++.+..++....++. ....+||-+|+.+.|.|||++++....+ ..+-
T Consensus 3 ~ydkmekigegtygtvfkar---n~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd--kklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKAR---NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecc---cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeE
Confidence 45556899999999999998 5556677888888888665554 5688999999999999999999987655 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+|||+. +|..+... -.+.++.+.+..++.|+++||.|+|+++ +.|||+||.|+||+.+|++|++|||+++.+
T Consensus 78 lvfe~cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred EeHHHhhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc
Confidence 99999955 88888743 3456899999999999999999999999 999999999999999999999999999877
Q ss_pred CCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc-
Q 011995 335 PET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL- 409 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 409 (473)
.-. -++..++|.+|.+|.++.+.. |+...|+||-|||+.|+.. |++.|.+.+-.++...+-|......++.+...
T Consensus 152 gipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred CCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 533 345668899999999998765 8999999999999999985 88888888777776666665444333323222
Q ss_pred -ccccccCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 -IMDPQLKGRFPL---------KAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 -~~~~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.|=.....|+. .....-++++.+.|.-+|.+|.++++.++.
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 222222222332 334456799999999999999999988763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=291.36 Aligned_cols=243 Identities=19% Similarity=0.278 Sum_probs=192.7
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
||.|+||.||+++... ..+.+++++..... .....+.+.+|+.+++.++|+||+++++++.++ ...++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecC
Confidence 6899999999999654 23445555554332 223457799999999999999999999988765 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC-c
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD-I 339 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 339 (473)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 76 ~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc
Confidence 999999999543 35899999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCC
Q 011995 340 SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419 (473)
Q Consensus 340 ~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 419 (473)
....++..|++||.+.+..++.++|+||||+++|||++|..||............. +.+......+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------~~~~~~~~~~ 215 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND--------------ILKGNGKLEF 215 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH--------------HhccCCCCCC
Confidence 23466789999999988889999999999999999999999997655211111000 0000111123
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011995 420 PLKAARTVADIALRCLQKEPSERPT-----MRSIFE 450 (473)
Q Consensus 420 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~ 450 (473)
+...+.++.+++.+||+.||.+||+ +.|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 4444688999999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.91 Aligned_cols=267 Identities=14% Similarity=0.190 Sum_probs=197.3
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC--
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG-- 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-- 249 (473)
..++|+..+.||+|+||.||+|.... ..+.+++|..... ........+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 45789999999999999999998543 3344455544322 23334567788999999999999999999876432
Q ss_pred --CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 250 --SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 250 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
....|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 135799999995 588887732 2888999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccCCCCc-cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh--ccc-----
Q 011995 328 YGCAGHIPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW--SRP----- 399 (473)
Q Consensus 328 FGla~~~~~~~~-~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~----- 399 (473)
||++........ ....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. ..+
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999986644322 234567899999999998999999999999999999999999987654332211100 000
Q ss_pred ---------ccccc-----ccccccccc----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 ---------FLADD-----CRLSLIMDP----QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ---------~~~~~-----~~~~~~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.... ..+..+... ......+...+..+.+++.+||+.||.+|||+.|+|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000000000 00001122346778999999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.24 Aligned_cols=252 Identities=18% Similarity=0.254 Sum_probs=207.8
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
.....|.+.+.||+|.|+.|..|+... +...+++|++.... .......+.+|+++|..++|||||+++++....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-- 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-- 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--
Confidence 345788899999999999999998543 44555565544332 333445589999999999999999999998776
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
..+|+||||+.+|.+++++... ..+.+..+..++.|+.++++|||+++ |||||||++||||+.+.++||+|||+
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccc
Confidence 8999999999999999999543 34566888999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC-CccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPET-DISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~-~~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+.++... ...+.+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++.+..+....+...
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g----------- 270 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG----------- 270 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-----------
Confidence 9988654 3467799999999999998876 58999999999999999999999987655433222110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
+-.++.-.+.++.++|+++|..+|.+|+++.++++.-
T Consensus 271 -------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 271 -------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -------eecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 0122455667889999999999999999999998753
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.12 Aligned_cols=263 Identities=17% Similarity=0.217 Sum_probs=194.6
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
|+..+.||.|++|.||+|....+ +..+++++...... ......+.+|+++++.++|+||+++++++.+. +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCC---CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEE
Confidence 56678999999999999986543 34455555544332 22346788999999999999999999998765 88999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||++ ++|.+++.... ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 76 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred EEeccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 999995 68999885432 246899999999999999999999998 9999999999999999999999999987553
Q ss_pred CC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhH-hhhcccccccc-------
Q 011995 336 ET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL-VKWSRPFLADD------- 404 (473)
Q Consensus 336 ~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~------- 404 (473)
.. ......++..|+|||++.+. .++.++|||||||++|||++|.+||........... ..+........
T Consensus 151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 22 12333557889999988654 478899999999999999999999987654332211 11110000000
Q ss_pred c----ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 405 C----RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 405 ~----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. .......... .......+..+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000 0112234578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=299.16 Aligned_cols=266 Identities=20% Similarity=0.311 Sum_probs=194.9
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHh--CCCCCcccceeeeecCC--CCceEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLAS--LQHPNLCKLLGFHARDG--SDQRMLI 256 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~~--~~~~~lV 256 (473)
.+||+|.||.||+|.+.+.. +|||+.. .+..+.|.+|-+|.+. +.|+||++++++-.... .-.++||
T Consensus 216 eli~~Grfg~V~KaqL~~~~-----VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLDNRL-----VAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred HHhhcCccceeehhhccCce-----eEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 77999999999999987744 2344332 3456778888777765 48999999998654331 2489999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG------PFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+||.+.|+|.++|.. ..++|....+|+..+++||+|||+.. +|+|+|||||..||||..|+++.|+|||+
T Consensus 287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999954 46999999999999999999999654 46899999999999999999999999999
Q ss_pred CcccCCC----CccCcccccccCChhhhhcCC-CC-----CcCCchHHHHHHHHHHcCCCCCC-CCChHHHHhHhh--hc
Q 011995 331 AGHIPET----DISNSSVAAANLSVETLERGL-LT-----PKSNVWSFGIVLLELLTGRKNLD-SRHPKEERNLVK--WS 397 (473)
Q Consensus 331 a~~~~~~----~~~~~~~t~~y~aPE~~~~~~-~s-----~~sDvwSlGvvl~elltG~~p~~-~~~~~~~~~~~~--~~ 397 (473)
|..+... +....+||.+|||||++.+.. +. .+.||||+|.|||||+++..-+. +..+..+.-+-. -.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9877433 445578999999999997743 22 36899999999999999765543 211111110000 00
Q ss_pred ccccccccccccccccccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPL-----KAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
.|.+.+ ....++....+..++. ....-+++.+..||..|++.|.|+.-+.+.+.++......
T Consensus 443 hPt~e~--mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEE--MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHH--HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111 1111112222222222 3456789999999999999999999999999988765544
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=298.41 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=190.5
Q ss_pred cceeec--CCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEG--LSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
..||+| +||+||++.. ...++.+++++..... .....+.+.+|+.+++.++||||+++++++... +..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARH---TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEE---cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEE
Confidence 456666 9999999984 3344566676665543 233457788999999999999999999999875 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 9999999999886532 345899999999999999999999998 999999999999999999999999754322111
Q ss_pred C---------ccCcccccccCChhhhhcC--CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc--
Q 011995 338 D---------ISNSSVAAANLSVETLERG--LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD-- 404 (473)
Q Consensus 338 ~---------~~~~~~t~~y~aPE~~~~~--~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 404 (473)
. .....++..|++||++.+. .++.++|||||||++|||++|..||................++...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 0 0111234679999999764 47899999999999999999999997654332211110000000000
Q ss_pred ----------------------cc-----cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 ----------------------CR-----LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ----------------------~~-----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.. ........+.......++..+.+|+.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 000111111222234567889999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=287.13 Aligned_cols=251 Identities=20% Similarity=0.264 Sum_probs=202.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|++.+.||+|+||.||++....+ .+.++++...... .......+.+|+++++.++|+||+++++++... ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSD---NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCC---CCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEE
Confidence 477789999999999999985443 3344455444322 233456788999999999999999999988765 7899
Q ss_pred EEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999999999885522 2356899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
..........++..|++||.+.+..++.++|+||||+++|||++|+.||...........+..
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------- 215 (256)
T cd08530 153 LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR----------------- 215 (256)
T ss_pred hccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------
Confidence 765543445678899999999888899999999999999999999999987654332221110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......+...+.++.+++.+||..+|++||++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00111234566889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=295.33 Aligned_cols=268 Identities=17% Similarity=0.220 Sum_probs=194.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|+..+.||+|+||.||+|.... ..+.++++...... .......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 3578999999999999999998544 34555566554432 2222345678999999999999999999886542
Q ss_pred ---CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 250 ---SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 250 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
....++||||+. ++|.+.+... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEEC
Confidence 135699999995 5888887432 346899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCC------ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 327 GYGCAGHIPETD------ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 327 DFGla~~~~~~~------~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|||++....... .....++..|+|||.+.+.. ++.++||||||+++|||++|..||...........+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999987653321 12335678899999986654 78899999999999999999999987665444333322111
Q ss_pred ccccc-----cccccccccccCCC----C-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 400 FLADD-----CRLSLIMDPQLKGR----F-----PLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 400 ~~~~~-----~~~~~~~~~~l~~~----~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..... ........-..... . +...+..+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 00000000000000 0 1112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=291.95 Aligned_cols=245 Identities=19% Similarity=0.270 Sum_probs=189.9
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
||+|+||+||++....+ ++.+++++..... .......+.+|+++++.++||||+++++++... +..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKAT---GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCC---CcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecC
Confidence 68999999999985443 3445555544321 222345667899999999999999999988765 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-Cc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET-DI 339 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~~ 339 (473)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc
Confidence 9999999986542 246899999999999999999999999 999999999999999999999999998765432 22
Q ss_pred cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCC
Q 011995 340 SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419 (473)
Q Consensus 340 ~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 419 (473)
....++..|++||.+.+..++.++|||||||++|+|++|+.||...........+... .. .....+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------~~~~~~ 217 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TL------------EMAVEY 217 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--cc------------cccccC
Confidence 3345678999999998888999999999999999999999999765431111111100 00 001112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 420 PLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 420 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
+...+..+.+++.+||+.||.+|| ++.+++.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 334567899999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=285.30 Aligned_cols=251 Identities=21% Similarity=0.352 Sum_probs=201.3
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...+.||+|++|.||+|....+ .+.+++++..... .......+.+|++++++++|+||+++++++........+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDT---GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 467779999999999999986542 3444455544332 234567889999999999999999999988765336789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|+||+++++|.+++... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 999999999999999543 27999999999999999999999998 999999999999999999999999998877
Q ss_pred CCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.... .....++..|++||.+.+..++.++||||||+++++|++|..||......... ... +
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~--------------~ 216 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-LYK--------------I 216 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHh--------------c
Confidence 5543 23456778999999998888999999999999999999999999876511111 000 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
........++...+..+.+++.+||..||.+||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 217 GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0011112234455788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.24 Aligned_cols=265 Identities=19% Similarity=0.248 Sum_probs=196.7
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
|++.+.||+|+||.||+|...++ .+.+++++..... .......+.+|+++++.++|+|++++++++........++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKT---GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCC---CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 56678999999999999986553 3444555554432 2333467889999999999999999999987653468999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+++ +|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 78 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred Eeccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 9999975 898888543 246899999999999999999999999 9999999999999999999999999987664
Q ss_pred CCC---ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc--cccc
Q 011995 336 ETD---ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC--RLSL 409 (473)
Q Consensus 336 ~~~---~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 409 (473)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|..||...........+........... ....
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 432 233456788999998765 4578999999999999999999999987665443322211100000000 0000
Q ss_pred -----------ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 410 -----------IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 410 -----------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....+...+...++..+.+++.+||..+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000001111113678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.03 Aligned_cols=267 Identities=17% Similarity=0.230 Sum_probs=197.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
..++|+..+.||+|+||.||+|....+ ...++++..... ........+.+|+.++.++ +|+||+++++++.....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRT---KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCC---CeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 456788889999999999999986533 233334433211 1233445678899999999 99999999999876544
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++||||+. ++|..++... .+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccc
Confidence 67899999996 5999888432 6889999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCC-------ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc
Q 011995 331 AGHIPETD-------ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 331 a~~~~~~~-------~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
+....... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 87654322 123356789999998755 4578999999999999999999999987655443332221111000
Q ss_pred cc-----------cccccccc---cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 403 DD-----------CRLSLIMD---PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 403 ~~-----------~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.. ..+..+.. ..+. ......+.++.++|.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 00000000 0000 0112256789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=292.88 Aligned_cols=266 Identities=17% Similarity=0.217 Sum_probs=193.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|++|.||+|....+ .+.++++...... .......+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCC---CcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeE
Confidence 5788889999999999999986443 3344455444332 223346788999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-CCcEEEeccCCCc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-DFSAKLSGYGCAG 332 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~ 332 (473)
++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.
T Consensus 77 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~ 151 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (294)
T ss_pred EEEEeccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccc
Confidence 99999995 5888877543 2334688899999999999999999998 999999999999985 5679999999987
Q ss_pred ccCCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-h-hccccccc---c
Q 011995 333 HIPET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-K-WSRPFLAD---D 404 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~-~~~~~~~~---~ 404 (473)
..... ......++..|++||++.+. .++.++|||||||++|+|+||.+||...........+ . +..+.... .
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 152 AFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred ccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 55322 22334567899999998764 5789999999999999999999999876543332211 1 00000000 0
Q ss_pred ccccccc--ccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 405 CRLSLIM--DPQLKG----RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 405 ~~~~~~~--~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..+.... .+.... ......+.++.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000000 012234677899999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=295.67 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=194.6
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|...+.||+|+||.||++....+ ...+++++..... .......+.+|+++++.++|+|++++++++..+ +..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRT---NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCC---CcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEE
Confidence 66668999999999999986543 2344455444321 223446788999999999999999999998776 7889
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 102 lv~e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 102 LVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred EEEeCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 9999996 588777743 2346899999999999999999999999 999999999999999999999999988654
Q ss_pred CCCCccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
.. .....++..|+|||.+. .+.++.++|||||||++|||++|..||...........+....
T Consensus 176 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~------------- 240 (317)
T cd06635 176 SP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------- 240 (317)
T ss_pred CC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcc-------------
Confidence 33 23446778999999974 4568899999999999999999999997654333221111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.........+..+.+++.+||+.+|.+||++.++++.+..+.
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000012234567899999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=289.74 Aligned_cols=244 Identities=18% Similarity=0.227 Sum_probs=185.3
Q ss_pred ceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHH---HHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDV---NTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei---~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
.||+|+||.||++...+ ..+.++++...... .......+..|. .+++...||||+.+++++... +..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEE
Confidence 48999999999998543 33445555544321 112222233443 344556899999999988765 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 76 ~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 999999999998843 346999999999999999999999998 99999999999999999999999999876654
Q ss_pred CCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 337 TDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 337 ~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
.......++..|+|||.+.++ .++.++|||||||++|||++|..||............. . .....
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~----------~~~~~--- 215 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M----------TLTMA--- 215 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H----------hhccC---
Confidence 444455788999999999754 58999999999999999999999997653222111110 0 00001
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+.++.+++.+||..+|.+|| ++.++++.
T Consensus 216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112334568899999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=299.02 Aligned_cols=272 Identities=17% Similarity=0.242 Sum_probs=199.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC--
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-- 250 (473)
.++|...+.||+|+||+||+|.... +.+.+++|..... ........+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4578889999999999999998543 3445555544332 123345667889999999999999999998765321
Q ss_pred -CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 251 -DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 251 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCc
Confidence 35899999995 689888843 346999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc-cc------
Q 011995 330 CAGHIPET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-RP------ 399 (473)
Q Consensus 330 la~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~------ 399 (473)
++...... ......++..|+|||.+.. ..++.++|||||||++|+|++|++||.+.+.......+... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 154 LARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 99766433 1233456789999998865 46899999999999999999999999776433222211100 00
Q ss_pred -ccccccc------cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 011995 400 -FLADDCR------LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQE 456 (473)
Q Consensus 400 -~~~~~~~------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~ 456 (473)
+...... .....++... .....++.++.+++.+||+.||++|||+.++++. |..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000000 0000000000 0112456788999999999999999999999987 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=289.05 Aligned_cols=262 Identities=20% Similarity=0.244 Sum_probs=196.3
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
|...+.||.|++|.||+|....+ .+.++++...... .......+.+|++++++++|+||+++++++... +..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLT---GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCC---CcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEE
Confidence 45668999999999999986433 3444455443322 223456788999999999999999999998765 88999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
|+||+.+ +|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+....
T Consensus 76 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 76 VFEFMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFG 149 (283)
T ss_pred EEeccCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence 9999965 888888543 257899999999999999999999999 9999999999999999999999999987664
Q ss_pred CCC--ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc--ccc------ccc-
Q 011995 336 ETD--ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--RPF------LAD- 403 (473)
Q Consensus 336 ~~~--~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~------~~~- 403 (473)
... .....++..|++||.+.+. .++.++||||||+++|+|++|+.||...+..+....+... .+. ...
T Consensus 150 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 150 SPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred CCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 432 2234567889999999776 6899999999999999999999999776654332221100 000 000
Q ss_pred ----ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 ----DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
............ .......+.++.+||.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000000 0112346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=291.95 Aligned_cols=242 Identities=20% Similarity=0.329 Sum_probs=192.4
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
..||+|+||.||++....+ ...+++++.... .......+.+|+.+++.++|+||+++++++... +..++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~---~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSS---GKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCC---CeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecC
Confidence 6799999999999986543 334445444322 233456789999999999999999999998776 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC--
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD-- 338 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-- 338 (473)
++++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 100 EGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc
Confidence 99999998732 35899999999999999999999999 9999999999999999999999999886553322
Q ss_pred ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCC
Q 011995 339 ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418 (473)
Q Consensus 339 ~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 418 (473)
.....++..|++||.+.+..++.++|+|||||++|||++|..||...........+....+ +.+.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-------------~~~~-- 237 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-------------PKLK-- 237 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-------------cccC--
Confidence 2234567899999999888899999999999999999999999986554433222211100 0000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 419 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
....++..+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01234567889999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=295.86 Aligned_cols=270 Identities=17% Similarity=0.227 Sum_probs=193.5
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.|...+.||+|+||.||+|..... .....+++++..... .......+.+|+.++..++||||+++++++.+......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 367778999999999999996542 134455566554421 12334667899999999999999999999987655789
Q ss_pred EEEEEeccCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC----CCcEEEec
Q 011995 254 MLIYERLFHGSLDRLIYGRS--DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK----DFSAKLSG 327 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~----~~~vkl~D 327 (473)
++||||+.+ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999965 6766663221 2236899999999999999999999999 999999999999999 89999999
Q ss_pred cCCCcccCCCC-----ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHH-------HHh--
Q 011995 328 YGCAGHIPETD-----ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-------ERN-- 392 (473)
Q Consensus 328 FGla~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~-------~~~-- 392 (473)
||++....... .....++..|+|||.+.+. .++.++|||||||+++||++|++||....... ...
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 99987654321 1233567889999988764 47899999999999999999999997654322 000
Q ss_pred -Hhhh-ccc------ccccccccccccccccCCCCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 393 -LVKW-SRP------FLADDCRLSLIMDPQLKGRFP---------L--KAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 393 -~~~~-~~~------~~~~~~~~~~~~~~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
++.. ..+ ............+......++ . ..+.++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 000 000000000000000000011 1 34567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=298.70 Aligned_cols=268 Identities=16% Similarity=0.207 Sum_probs=197.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecC--CC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARD--GS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~ 250 (473)
.++|+..+.||+|+||.||+|....+ +..+++++..... .......+.+|+.+|+.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRS---GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCC---CCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 36899999999999999999985443 3445555443322 233456788899999999999999999987643 23
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred ceEEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccc
Confidence 57899999995 689988843 345899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCc------cCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc--cccc
Q 011995 331 AGHIPETDI------SNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--RPFL 401 (473)
Q Consensus 331 a~~~~~~~~------~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~~ 401 (473)
+........ ....++..|++||.+.+ ..++.++|||||||++|||++|+.||...........+... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 876533211 23367789999999865 45889999999999999999999999876544332211100 0000
Q ss_pred c--c---ccccccccc-cccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 A--D---DCRLSLIMD-PQLKGR-----FPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~--~---~~~~~~~~~-~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. . ...+....+ ...... +....+.++.+++.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0 000000000 000000 112356889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=287.23 Aligned_cols=242 Identities=19% Similarity=0.253 Sum_probs=191.2
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
||.|+||.||++...++ ++.+++++..... .......+.+|++++++++|+||+++++.+... ...|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCC---CCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecC
Confidence 68999999999996543 3444555443321 124456789999999999999999999988765 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC---
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET--- 337 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~--- 337 (473)
++++|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 999999998543 26899999999999999999999999 999999999999999999999999998755332
Q ss_pred -------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 338 -------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 338 -------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
......++..|++||.+....++.++||||||+++|||++|..||...........+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK------------ 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------
Confidence 1223356788999999988889999999999999999999999998765443322221100
Q ss_pred cccccCCCCCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 411 MDPQLKGRFPLK--AARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 411 ~~~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
. .++.. .+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 218 ----~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 ----I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 01111 3678899999999999999999955555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=290.95 Aligned_cols=269 Identities=19% Similarity=0.204 Sum_probs=197.5
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC-
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG- 249 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~- 249 (473)
...++|++.+.||+|+||.||+|....+. +.+++++.+... .......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTG---ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCC---cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 45678999999999999999999975433 344555554432 2233456788999999999999999999886542
Q ss_pred -------CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc
Q 011995 250 -------SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322 (473)
Q Consensus 250 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 322 (473)
...+++|+||+++ +|.+.+... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence 2378999999976 777777432 346899999999999999999999999 999999999999999999
Q ss_pred EEEeccCCCcccCCCC---ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc-
Q 011995 323 AKLSGYGCAGHIPETD---ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS- 397 (473)
Q Consensus 323 vkl~DFGla~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~- 397 (473)
+||+|||++....... ......+..|++||.+.+. .++.++|||||||++|||++|++||...........+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999987664332 1223457789999988654 4789999999999999999999999876544433222211
Q ss_pred -ccc------cccccccc-----cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 398 -RPF------LADDCRLS-----LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 398 -~~~------~~~~~~~~-----~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+. +....... .......... ....+..+.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000000 0000000000 1124678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.71 Aligned_cols=276 Identities=18% Similarity=0.253 Sum_probs=209.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC----CC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG----SD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~ 251 (473)
.|...+.||+|+||.||+|+ +..++..+|+|..+........+...+|+++|++++|+|||+++++-.+.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgr---nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGR---NKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeec---ccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 45666899999999999998 666778888887776666667788999999999999999999998766554 46
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC--CCC--cEEEec
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID--KDF--SAKLSG 327 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~--~vkl~D 327 (473)
...+|||||.+|||...|.+-.+...|++.+.+.++.++..||.|||+++ ||||||||.||++- .+| ..||+|
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeec
Confidence 77899999999999999977656667999999999999999999999999 99999999999983 334 479999
Q ss_pred cCCCcccCCCC-ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 328 YGCAGHIPETD-ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 328 FGla~~~~~~~-~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
||.|+.+..+. ..+.+||..|++||.+.. ..|+..+|.|||||++|+++||..||..........-+.|....-...+
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99999887654 466799999999999985 7899999999999999999999999965432211111112111111110
Q ss_pred cccccccccc------------CCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhhcc
Q 011995 406 RLSLIMDPQL------------KGRFPLKAARTVADIALRCLQKEPSERP--TMRSIFEELDRQESR 458 (473)
Q Consensus 406 ~~~~~~~~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~eil~~L~~l~~~ 458 (473)
. .....+.. ...........+-.++..+|..+|.+|- ...+....+..+...
T Consensus 248 v-~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 V-AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred e-eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0 00011100 1111233445566778888888999998 777777777766543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.06 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=214.7
Q ss_pred CcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 180 DRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
.+.||.|+||+||+|.|-- +......+++|++..........++++|+.+|.+++|||+++|+|+|... .+.||++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlvtq 777 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLVTQ 777 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHHHH
Confidence 3899999999999998743 33344456777777666777789999999999999999999999999764 5889999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 338 (473)
||+.|.|.|+++. +...+.....+.|..||++||.|||.+. +|||||...|||+..-..+||.|||+++......
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999965 4456888999999999999999999999 9999999999999999999999999999875442
Q ss_pred --ccCc--ccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 339 --ISNS--SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 339 --~~~~--~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
+... ...+.|||-|.+....|+.++|||||||++||++| |..||.+....+..++.+ .+.++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~geRL------ 919 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGERL------ 919 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------ccccC------
Confidence 2222 33578999999999999999999999999999998 999999877666544332 22222
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
..|..++.++..++.+||..|+..||+++++..++.++...
T Consensus 920 ----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 920 ----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 23778899999999999999999999999999999987653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=298.61 Aligned_cols=272 Identities=17% Similarity=0.223 Sum_probs=202.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---CC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG---SD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---~~ 251 (473)
+|.+.+.||.|+||.||+|+..+. ...+++++..... .....+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRT---GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCC---CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 477889999999999999986443 3444454443322 2344577899999999999999999999987652 23
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||.|||++.++.++|+|||++
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred ceEEEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCce
Confidence 6899999997 589888843 237999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-----ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc-
Q 011995 332 GHIPETD-----ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD- 404 (473)
Q Consensus 332 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 404 (473)
....... .....++..|+|||.+.+. .++.++|||||||++|+|++|.+||......+....+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8764432 3344668899999999887 78999999999999999999999998776544333221110000000
Q ss_pred ------cccccccc---cccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhc
Q 011995 405 ------CRLSLIMD---PQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQES 457 (473)
Q Consensus 405 ------~~~~~~~~---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~~ 457 (473)
........ .... .......+..+.+++.+||+.||.+||++.+++.. |+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000 0000 00112356788999999999999999999999985 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=282.01 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=201.3
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|...+.||+|+||.||++....+ ...+++++..... .......+.+|+++++.++|+|++++++.+... +..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSD---GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCC---CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEE
Confidence 477789999999999999996542 3445555554432 234567789999999999999999999988766 7899
Q ss_pred EEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+|+||+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 9999999999999986532 2467999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..... .....+++.|++||.+.+..++.++||||||+++++|++|..||.............. .
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~-------- 218 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------G-------- 218 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc------C--------
Confidence 64432 2234567889999999888899999999999999999999999976653332211100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....+...+..+.+++.+||..+|++|||+.++++.
T Consensus 219 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 219 ---QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011233455788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=293.04 Aligned_cols=267 Identities=18% Similarity=0.197 Sum_probs=193.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|...+.||+|+||.||+|....+. ..+++++..... .......+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTG---RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCC---cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 578999999999999999999865432 334455443332 2222356789999999999999999999876532
Q ss_pred ---CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 250 ---SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 250 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
...+++|+||+.+ +|...+.. ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEC
Confidence 1357999999965 77777643 2446999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCCc-------------cCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 327 GYGCAGHIPETDI-------------SNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 327 DFGla~~~~~~~~-------------~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
|||++........ ....++..|+|||.+.+. .++.++|||||||++|||++|.+||.+........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999876532211 122456789999988654 47899999999999999999999998766544333
Q ss_pred Hhhhc-ccccccc----ccccccc--------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 393 LVKWS-RPFLADD----CRLSLIM--------DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 393 ~~~~~-~~~~~~~----~~~~~~~--------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+... ....... ..+.... .+.+... .......+.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 22110 0000000 0000000 0000000 0123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=289.99 Aligned_cols=260 Identities=19% Similarity=0.245 Sum_probs=188.4
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
+.+|.|+++.||++.. ..+.+++++.... ........+.+|+++++.++|+||+++++++... +..+++|||
T Consensus 8 ~~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~ 80 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPL 80 (314)
T ss_pred HhhcCCceEEEEEecC-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEec
Confidence 4445555555555542 3455566665544 2445567899999999999999999999998766 789999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC-
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD- 338 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 338 (473)
+++|+|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 81 MAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred cCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 99999999996532 345889999999999999999999999 9999999999999999999999999886543221
Q ss_pred --------ccCcccccccCChhhhhcC--CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhhhccccccc----
Q 011995 339 --------ISNSSVAAANLSVETLERG--LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVKWSRPFLAD---- 403 (473)
Q Consensus 339 --------~~~~~~t~~y~aPE~~~~~--~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~---- 403 (473)
.....++..|+|||++... .++.++|||||||++|||++|..||......... ..+.-..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 1223456789999998663 4889999999999999999999999865433221 111100000000
Q ss_pred ---cccccc----cccc----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 ---DCRLSL----IMDP----QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ---~~~~~~----~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...... ..++ ..........+.++.+|+.+||..||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0000 01111234566789999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=283.43 Aligned_cols=253 Identities=16% Similarity=0.217 Sum_probs=192.9
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|.+.+.||+|+||.||++.............++..... .......++.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 477789999999999999986543221111111111111 1223345677899999999999999999998765 6789
Q ss_pred EEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceee
Confidence 999999999999988542 23457899999999999999999999999 999999999999975 5699999999876
Q ss_pred cCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..... .....++..|++||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~---------------- 218 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV---------------- 218 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----------------
Confidence 54322 223456789999999988888999999999999999999999997544322211110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ......+...+.++.+++.+||..||++||++.++++.
T Consensus 219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0 00111244566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.03 Aligned_cols=278 Identities=18% Similarity=0.247 Sum_probs=199.8
Q ss_pred CHHHHHHH----hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCccc
Q 011995 166 PLDEVAAA----CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCK 240 (473)
Q Consensus 166 ~~~el~~~----~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~ 240 (473)
..+|+..+ .++|...+.||+|+||.||+|.... .+..+++++..... .......+.+|+.+++.++|+||++
T Consensus 2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 78 (342)
T cd07879 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78 (342)
T ss_pred chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccc
Confidence 34455544 3789999999999999999998543 23444555443321 2233456889999999999999999
Q ss_pred ceeeeecCCC----CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 241 LLGFHARDGS----DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 241 l~g~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
+++++..... ..+++|+||+.. +|..++ +..+++..+..++.|++.||+|||+++ |+||||||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIl 149 (342)
T cd07879 79 LLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLA 149 (342)
T ss_pred hhheecccccCCCCceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 9998865421 356999999954 777665 235889999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh
Q 011995 317 IDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 395 (473)
++.++.+||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+.
T Consensus 150 l~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 150 VNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred ECCCCCEEEeeCCCCcCCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999876532 2234466788999999876 458899999999999999999999998765433322221
Q ss_pred hccccccc-------ccccccccc--cc-cCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 011995 396 WSRPFLAD-------DCRLSLIMD--PQ-LKGRF---PLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQE 456 (473)
Q Consensus 396 ~~~~~~~~-------~~~~~~~~~--~~-l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~ 456 (473)
........ ......... +. ....+ ....+..+.+|+.+||+.||.+||++.+++.. ++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 11000000 000000000 00 00000 11345678999999999999999999999955 66554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=290.15 Aligned_cols=257 Identities=18% Similarity=0.237 Sum_probs=197.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
+|+..+.||+|+||.||+++...+....+.+++++.+... .......+.+|++++.++ +|+||+++++.+..+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 4677899999999999999865444444555566544221 123346688999999999 699999999888665 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++|+|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 88999999999999999853 245899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCc---cCcccccccCChhhhhcCC--CCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhHhhhccccccccc
Q 011995 332 GHIPETDI---SNSSVAAANLSVETLERGL--LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSRPFLADDC 405 (473)
Q Consensus 332 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~--~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 405 (473)
..+..... ....++..|++||.+.+.. .+.++||||||+++|||++|..||........ ..+... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~-- 227 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR---ILKS-- 227 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH---HHcc--
Confidence 76543321 2235678999999987765 78899999999999999999999964322111 111100 0000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
. ...+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 228 ------~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ------K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ------C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 112334557889999999999999999998888777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.12 Aligned_cols=254 Identities=21% Similarity=0.346 Sum_probs=191.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||.|+||.||+|...+. .+.++++.............+..|+.++.+.. |+||+++++++.++ ..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKT---GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCC---CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--Ce
Confidence 35678889999999999999997543 34445555543333344566778888777774 99999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.++||||+. ++|.+++... ...+++..+..++.|++.||+|||+. + |+||||+|+||+++.++.+||+|||++
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred EEEEeeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccc
Confidence 999999984 5777776442 33789999999999999999999974 6 999999999999999999999999998
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCC----CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGL----LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~----~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
..+.... .....++..|+|||.+.+.. ++.++||||||+++|||++|..||......... +.... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~----~~~-- 235 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKIL----QEE-- 235 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH-HHHHh----cCC--
Confidence 7654322 22335678899999987553 788999999999999999999999753322111 11100 000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
.+... ....++.++.+|+.+||..||.+||++.++++.-
T Consensus 236 -----~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 -----PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -----CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00000 0113457789999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=287.36 Aligned_cols=264 Identities=19% Similarity=0.270 Sum_probs=192.5
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~l 255 (473)
|.+.+.||+|+||+||+|+..+.. +.++++...............+|+..+.+++ |+||+++++++..+ +..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG---ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC---cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEE
Confidence 566789999999999999975542 3333443322222223334567999999998 99999999998775 88999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+ +|+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 76 v~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~ 150 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR 150 (283)
T ss_pred EEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence 99999 889998886532 356899999999999999999999999 9999999999999999999999999997664
Q ss_pred CCC-ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-hhcccccccc----cccc
Q 011995 336 ETD-ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-KWSRPFLADD----CRLS 408 (473)
Q Consensus 336 ~~~-~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~----~~~~ 408 (473)
... .....++..|+|||++.. ..++.++||||||++++||++|++||...........+ .+......+. ..+.
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 151 SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 432 233456789999998854 45789999999999999999999999766543322211 1100000000 0000
Q ss_pred cccccccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 409 LIMDPQLK-------GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 409 ~~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+..+. .......+.++.+|+.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0001122577999999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=291.17 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=193.6
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|...+.||+|+||.||+|+...+. ..++++..... ........+.+|+++++.++|+|++++++++... ...+
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 91 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 91 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCC---cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeE
Confidence 556688999999999999965432 33444444332 2333456788999999999999999999998775 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+. |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++...
T Consensus 92 lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence 9999996 6888777432 345899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
... ....++..|+|||.+. ...++.++|||||||++|||++|..||...........+. .. .
T Consensus 166 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~------~----- 230 (308)
T cd06634 166 APA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--QN------E----- 230 (308)
T ss_pred cCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh--hc------C-----
Confidence 432 2345678999999985 3457889999999999999999999987654332221111 00 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.+. ......+..+.+||.+||..+|.+||++.++++...-+.
T Consensus 231 ~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 231 SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000 012245677899999999999999999999997754333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.40 Aligned_cols=275 Identities=14% Similarity=0.182 Sum_probs=201.1
Q ss_pred CCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccce
Q 011995 164 NFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLL 242 (473)
Q Consensus 164 ~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~ 242 (473)
.....++..++++|...+.||+|+||.||+|.... .++.+++|+..... .....+.+.+|+.++.+++|+||++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~ 82 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence 34556777889999999999999999999998543 33455555443221 223346688999999999999999999
Q ss_pred eeeecCC----CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC
Q 011995 243 GFHARDG----SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318 (473)
Q Consensus 243 g~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~ 318 (473)
+++.... ....+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~ 154 (345)
T cd07877 83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 154 (345)
T ss_pred eeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEc
Confidence 9876431 13478888877 7899888743 35899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeccCCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc
Q 011995 319 KDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 319 ~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 397 (473)
.++.+||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...
T Consensus 155 ~~~~~kl~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 155 EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CCCCEEEecccccccccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999999876532 2234466889999999866 46889999999999999999999999765543322211110
Q ss_pred cc--------cccccc--c----cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 398 RP--------FLADDC--R----LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 398 ~~--------~~~~~~--~----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.. .+.... . +......... ......+.++.+||.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000 0 0000000000 0011245678999999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=288.48 Aligned_cols=247 Identities=20% Similarity=0.283 Sum_probs=198.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~ 251 (473)
++|...+.||.|+||.||+|....+ +..+++++.... ........+.+|++++++++ |+||+++++++..+ +
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCC---CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--c
Confidence 4788889999999999999986543 344555554432 12334567889999999998 99999999988765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccc
Confidence 899999999999999999543 36999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCc----------------------cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH
Q 011995 332 GHIPETDI----------------------SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE 389 (473)
Q Consensus 332 ~~~~~~~~----------------------~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~ 389 (473)
........ ....++..|++||.+.+..++.++||||||+++++|++|+.||.......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 76543221 12345788999999988889999999999999999999999998765332
Q ss_pred HHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 011995 390 ERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM----RSIFE 450 (473)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~eil~ 450 (473)
....+. .....++...+..+.+|+.+||+.||.+||++ +++++
T Consensus 230 ~~~~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKIL------------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHH------------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 221111 00112234446789999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.18 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=191.2
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|...+.||+|+||.||+|+...+ +..+++++..... .......+.+|+++++.++|+|++++++++.+. +..|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~---~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHT---NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCC---CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEE
Confidence 55567899999999999985433 3444555544321 233446788999999999999999999998876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+. |+|.+++... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 98 lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred EEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 9999995 5787777432 346899999999999999999999999 999999999999999999999999988654
Q ss_pred CCCCccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
.. .....++..|+|||++. ...++.++|||||||++|||++|..||...........+....
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~------------- 236 (313)
T cd06633 172 SP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND------------- 236 (313)
T ss_pred CC--CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------
Confidence 22 23456788999999984 4568899999999999999999999997765433322111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.. .....+..+.+|+.+||+.+|.+||++.+++..
T Consensus 237 ~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 012334678999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=280.39 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=198.1
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+|+..+.||+|++|.||++...... +.++++...... .......+.+|++++.+++|+|++++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG---DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC---cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEE
Confidence 4777899999999999999865432 334444443332 224567899999999999999999999998765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+.+++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceec
Confidence 999999999999998543 46899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... ....++..|++||...+..++.++|||+||+++|+|++|..||............. .
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------~---------- 213 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------Q---------- 213 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------c----------
Confidence 54332 23466789999999988888999999999999999999999997654322111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....++...+..+.+++.+||..+|++||++.+++.
T Consensus 214 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 -DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0011223455688999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=288.55 Aligned_cols=253 Identities=19% Similarity=0.263 Sum_probs=194.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
+|+..+.||.|+||.||++....+...+..+++++..... .....+.+.+|+.++.++ +|+||+.+++++..+ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 4778899999999999999865433445556666554321 223346788999999999 699999999888765 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 889999999999999998543 45889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCc---cCcccccccCChhhhhcC--CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhhhccccccccc
Q 011995 332 GHIPETDI---SNSSVAAANLSVETLERG--LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVKWSRPFLADDC 405 (473)
Q Consensus 332 ~~~~~~~~---~~~~~t~~y~aPE~~~~~--~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 405 (473)
........ ....++..|++||.+.+. .++.++||||||+++|+|++|..||......... ..... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~-- 227 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---ILKS-- 227 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH---hhcc--
Confidence 76543221 234578899999998653 4678999999999999999999999643221111 11110 0000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
. ..++...+..+.+++.+||+.||++|| ++.+++..
T Consensus 228 ------~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ------E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 112344567889999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=284.32 Aligned_cols=246 Identities=20% Similarity=0.179 Sum_probs=186.2
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHH-HhCCCCCcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTL-ASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
+.||.|+||.||+|..... ++.+++++..... .......+..|..++ ...+|+||+++++++... +..++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCC---CCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEE
Confidence 5689999999999986443 3344555443221 112223445555544 445899999999998765 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence 99999999999853 246899999999999999999999999 99999999999999999999999999876533
Q ss_pred CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCC
Q 011995 338 DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417 (473)
Q Consensus 338 ~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 417 (473)
.....++..|++||.+.+..++.++||||||+++|||++|..||...........+..... ....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI--------------NWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--------------CCCC
Confidence 2234567889999999888889999999999999999999999987654432222111000 0011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 418 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
.....++..+.+++.+||+.||++||++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 112245688999999999999999997765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=284.56 Aligned_cols=265 Identities=17% Similarity=0.199 Sum_probs=194.3
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhC---CCCCcccceeeeecCCC--
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASL---QHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~-- 250 (473)
|++.+.||+|+||.||+|.... ..+.+++++.+.... ......+.+|+.++.++ .|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 5667899999999999999754 234555665554332 22235567788877766 59999999999876521
Q ss_pred -CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 251 -DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 251 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccC
Confidence 23899999996 48988885432 346899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh-cccccccc---
Q 011995 330 CAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW-SRPFLADD--- 404 (473)
Q Consensus 330 la~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~--- 404 (473)
++....... .....++..|+|||++.+..++.++|||||||++|||++|.+||......+....+.. ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 987764332 2333567889999999988899999999999999999999999987654433222110 00000000
Q ss_pred ------cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 405 ------CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 405 ------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
........... .......+..+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred Ccccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 1112245678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.23 Aligned_cols=264 Identities=19% Similarity=0.284 Sum_probs=192.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC----
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS---- 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~---- 250 (473)
.+|...+.||.|+||.||+|.... +.+.+++++..... ....+.+.+|+++++.++||||+++++++...+.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 678889999999999999998543 33444555444332 2445678899999999999999999987665422
Q ss_pred --------CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CCC
Q 011995 251 --------DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDF 321 (473)
Q Consensus 251 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~ 321 (473)
...++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCc
Confidence 35789999996 589888732 35899999999999999999999999 99999999999997 456
Q ss_pred cEEEeccCCCcccCCCC-----ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh
Q 011995 322 SAKLSGYGCAGHIPETD-----ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 395 (473)
.+||+|||++....... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 78999999987653221 122356788999998754 457889999999999999999999998776544433322
Q ss_pred hcccccccccc--c----ccccc-cccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 396 WSRPFLADDCR--L----SLIMD-PQLKG-----RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 396 ~~~~~~~~~~~--~----~~~~~-~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+....... . ..... ..... .+....+.++.+|+.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 22111110000 0 00000 00000 011235578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=284.17 Aligned_cols=252 Identities=18% Similarity=0.181 Sum_probs=190.7
Q ss_pred CHHHHHHHhcccccCcce--eecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccce
Q 011995 166 PLDEVAAACHNFFSDRCI--SEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLL 242 (473)
Q Consensus 166 ~~~el~~~~~~f~~~~~l--G~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~ 242 (473)
+..++....++|.+.+.+ |+|+||.||++....+ ...+++++...... .. .|+.....+ +|+||++++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~k~~~~~~~----~~--~e~~~~~~~~~h~~iv~~~ 75 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPT---QKLFVQKIIKAKNF----NA--IEPMVHQLMKDNPNFIKLY 75 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCC---CcEEEEEEEehhhc----ch--hhHHHHHHhhcCCCEEEEE
Confidence 345666677888887777 9999999999985443 34444444432111 11 122222222 799999999
Q ss_pred eeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-
Q 011995 243 GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF- 321 (473)
Q Consensus 243 g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~- 321 (473)
+++... +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 76 ~~~~~~--~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 76 YSVTTL--KGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKD 147 (267)
T ss_pred EEEecC--CeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCC
Confidence 998876 7899999999999999999543 37999999999999999999999999 99999999999999988
Q ss_pred cEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 322 SAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
.++|+|||++...... ....++..|+|||++.+..++.++|||||||++|||++|..||....... .....+....
T Consensus 148 ~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~- 223 (267)
T PHA03390 148 RIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ- 223 (267)
T ss_pred eEEEecCccceecCCC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-
Confidence 9999999998765432 23457889999999998889999999999999999999999997543221 1111111000
Q ss_pred ccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-MRSIFE 450 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~ 450 (473)
.. ........+..+.+|+.+||+.||.+||+ ++++++
T Consensus 224 ----------~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ----------QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----------cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 00123356788999999999999999996 688874
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=280.85 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=202.3
Q ss_pred CCCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCc
Q 011995 160 GTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNL 238 (473)
Q Consensus 160 ~~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnI 238 (473)
.....|+-+.|+.. ..||.|.||+|++-. ....++.+|||.++........++++.|.+...+- +.|||
T Consensus 56 ~~~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~---hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~I 125 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDL-------GEIGNGAFGTVNKML---HKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNI 125 (361)
T ss_pred ccccccccchHHHH-------HHhcCCcchhhhhhh---cCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHH
Confidence 34555777777665 889999999999997 45567788888888777777788899999876655 79999
Q ss_pred ccceeeeecCCCCceEEEEEeccCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR--SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 239 v~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
|++||.+..+ +..|+.||+|+ .||+.+...- .....+++..+-.|+...+.||.||...- .|||||+||+|||
T Consensus 126 VkfyGa~F~E--GdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNIL 200 (361)
T KOG1006|consen 126 VKFYGALFSE--GDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNIL 200 (361)
T ss_pred HHHhhhhhcC--CceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheE
Confidence 9999998876 66799999994 4776543210 12346889999999999999999998876 5999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCC-CccCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH-HHh
Q 011995 317 IDKDFSAKLSGYGCAGHIPET-DISNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-ERN 392 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~-~~~ 392 (473)
|+..|.+||||||++..+... ..+...|...|||||.+.. ..|+.+|||||||++|||+.||..||.+-+... +..
T Consensus 201 ldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 201 LDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred EecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 999999999999998765433 2234467789999999943 348999999999999999999999998765422 111
Q ss_pred HhhhcccccccccccccccccccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLK-GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+-...+ |.+. ..-..+.+..+..||..||.+|-..||.+.++++
T Consensus 281 ~Vv~gdp-------------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 281 QVVIGDP-------------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHcCCC-------------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1111111 0111 0112457788999999999999999999998875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=294.51 Aligned_cols=264 Identities=18% Similarity=0.196 Sum_probs=190.9
Q ss_pred cccc-cCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh-------------hhHhHHHHHHHHHhCCCCCccc
Q 011995 175 HNFF-SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ-------------GVKEFINDVNTLASLQHPNLCK 240 (473)
Q Consensus 175 ~~f~-~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~Ei~~l~~l~HpnIv~ 240 (473)
++|. ..+.||.|+||+||+|.... ..+.+++++........ ....+.+|+++++.++|+||++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 3454 34779999999999998543 23444555544322111 1125789999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 241 l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
+++++... +..++||||+. |+|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+||+++.+
T Consensus 85 ~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 85 LVDVYVEG--DFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSK 155 (335)
T ss_pred eeEEEecC--CcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCC
Confidence 99998765 78999999996 699998843 345899999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCC----------------CCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 321 FSAKLSGYGCAGHIPE----------------TDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~----------------~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
+.++|+|||++..... .......++..|+|||.+.+. .++.++|||||||++|||++|.+||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999876541 111223456789999998764 36899999999999999999999998
Q ss_pred CCChHHHHhHhh-hccccccccc----ccc--cccccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 384 SRHPKEERNLVK-WSRPFLADDC----RLS--LIMDPQLKG---RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 384 ~~~~~~~~~~~~-~~~~~~~~~~----~~~--~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....+....+. .......... .+. ......... ......+.++.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 776544322221 1000000000 000 000000000 011234577899999999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=293.05 Aligned_cols=269 Identities=15% Similarity=0.220 Sum_probs=197.8
Q ss_pred HHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 170 VAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 170 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
+...+++|+..+.||.|+||.||+|.... ..+.+++|..... ......+.+.+|++++..++||||+++++++...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 34567899999999999999999998543 3344445543322 2233456788999999999999999999988654
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
+ ...++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.++|+||
T Consensus 82 ~-~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 82 L-EDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred C-CcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcc
Confidence 3 6789999998 5689888842 35788899999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-hcccc------
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-WSRPF------ 400 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~------ 400 (473)
|++...... .....++..|++||.+.+ ..++.++|||||||++|||++|..||...........+. +....
T Consensus 153 g~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 153 GLARIQDPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccccccCCC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 998755332 233456788999998866 568999999999999999999999997765432221111 00000
Q ss_pred -cccccccccccccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 401 -LADDCRLSLIMDPQLKGRFP-----LKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 401 -~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........+..-......+ ..++..+.++|.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000001111 1345789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.95 Aligned_cols=258 Identities=20% Similarity=0.299 Sum_probs=212.3
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeec
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHAR 247 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 247 (473)
.+..-++.|++...||.|.+|.||+++..+ +....++|++.. .....+++..|..+|+.. .|||++.++|++.-
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~--~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDP--TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecC--CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 333345678888999999999999998443 333444554443 344557788899999887 79999999999864
Q ss_pred ---CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 248 ---DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 248 ---~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
.+.+++|||||||.+||..|++.... +..+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 23589999999999999999997654 788999999999999999999999998 99999999999999999999
Q ss_pred EeccCCCcccCCC--CccCcccccccCChhhhhcC-----CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc
Q 011995 325 LSGYGCAGHIPET--DISNSSVAAANLSVETLERG-----LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 325 l~DFGla~~~~~~--~~~~~~~t~~y~aPE~~~~~-----~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 397 (473)
|+|||++..+..+ ...+..||+.|||||++... .|+.++|+||||++..||.-|.+|+.+.++......+.
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-- 241 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-- 241 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--
Confidence 9999999877554 44567899999999998543 37789999999999999999999999887765443221
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
-+|...-.-+...+.++-+||..||.+|..+||++.++|+
T Consensus 242 -------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 -------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 2333333347889999999999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.90 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=208.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeee--eEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTS--KKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
++..+.+.||+|.||.||+|.+....... ..+.++++.+. ......+.+..|+++|+.+ .|+||+.++|+|...
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~- 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD- 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC-
Confidence 34455579999999999999875433321 23445555544 3445678899999999999 699999999999874
Q ss_pred CCceEEEEEeccCCChhhhhhcCC-----CC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRS-----DG--------PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
+.+++|+||+..|+|.++|+... .. ..++....+.++.||+.|++||++.. +|||||...|||
T Consensus 375 -~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 375 -GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred -CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 78999999999999999997654 00 23888999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCCccCc---c--cccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHH
Q 011995 317 IDKDFSAKLSGYGCAGHIPETDISNS---S--VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~~~~~---~--~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~ 390 (473)
+..+..+||+|||+++.......... . ....|||||.+....|+.++|||||||+|||++| |..||.+......
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 99999999999999997655443321 2 2456999999999999999999999999999998 8999987332221
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
. .+ ++.++.++ ..|..+..++.+++..||+.+|++||++.++.+.|+.+.
T Consensus 531 l--~~----~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 L--LE----FLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred H--HH----HHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1 11 22333222 237778899999999999999999999999999999854
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.13 Aligned_cols=270 Identities=23% Similarity=0.349 Sum_probs=221.3
Q ss_pred HHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEec--CCCChhhHhHHHHHHHHHhCCCCCcccceeee
Q 011995 168 DEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRL--NPSSQGVKEFINDVNTLASLQHPNLCKLLGFH 245 (473)
Q Consensus 168 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 245 (473)
.||.....+++..-++-+|+||.||+|.|++...-.+..++-+|.. +.++-....++.|..++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4555556678888899999999999998876543222222222222 23444556788999999999999999999999
Q ss_pred ecCCCCceEEEEEeccCCChhhhhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIY-----GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
.++. +..+.+|.++.-|+|..+|. .......++-.+...++.|++.|++|||.++ |||.||...|++||+.
T Consensus 357 ie~~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 357 IEDY-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred eecc-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 78889999999999999997 2233456777888999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCcc----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhh
Q 011995 321 FSAKLSGYGCAGHIPETDIS----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~~----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 395 (473)
..+||+|-.+++.+...++. +......||++|.+....|+.++|||||||++|||+| |+.||...++.+...
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--- 509 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--- 509 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH---
Confidence 99999999999887655543 2234578999999999999999999999999999987 999999888877665
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
++.++.++.. |.+++++++.++..||..+|++||++++++.-|.++...
T Consensus 510 ----ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 ----YLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ----HHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 3445555443 778999999999999999999999999999999987643
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=282.54 Aligned_cols=262 Identities=18% Similarity=0.243 Sum_probs=195.5
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
|+..+.||+|+||.||+|+..++ ...+++++..... .......+..|+.+++.++|+||+++++++... +..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKT---GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCC---CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEE
Confidence 45568899999999999986543 3445555554432 233346788999999999999999999998765 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 76 v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~ 149 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG 149 (282)
T ss_pred EecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence 999997 59999996432 46899999999999999999999999 9999999999999999999999999987664
Q ss_pred CCC--ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-hccc-------cccc-
Q 011995 336 ETD--ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-WSRP-------FLAD- 403 (473)
Q Consensus 336 ~~~--~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~~-------~~~~- 403 (473)
... ......+..|+|||.+.+. .++.++|||||||++|||++|.+||...........+. .... ....
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 150 IPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred CCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 332 2333456789999998776 78999999999999999999999997765433222111 0000 0000
Q ss_pred ---ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 ---DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ---~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...............+ ...+..+.+++.+||..||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000111 123678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.55 Aligned_cols=254 Identities=19% Similarity=0.287 Sum_probs=195.3
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC--
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD-- 248 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-- 248 (473)
.+-.++|+....||+||||.||+++ +.-.+..+|+|.+.++.+......+.+|+.+|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVR---NKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVR---NKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEe---ecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 4556678888999999999999998 66677888888888887677778899999999999999999987543211
Q ss_pred ---------------------------------------------------------------------------C----
Q 011995 249 ---------------------------------------------------------------------------G---- 249 (473)
Q Consensus 249 ---------------------------------------------------------------------------~---- 249 (473)
+
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ----------------------------C--------CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 011995 250 ----------------------------S--------DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293 (473)
Q Consensus 250 ----------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 293 (473)
+ ..+||-||||+...|.+++..+.... ......+++.+|+.|
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEG 709 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHH
Confidence 0 13788899999988888885543111 357778999999999
Q ss_pred HHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC--------------------CCCccCcccccccCChhh
Q 011995 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP--------------------ETDISNSSVAAANLSVET 353 (473)
Q Consensus 294 L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~--------------------~~~~~~~~~t~~y~aPE~ 353 (473)
|.|+|++| ||||||||.||+|+++..|||+|||+|+... ..+.+..+||.-|+|||.
T Consensus 710 LaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999999 9999999999999999999999999998721 012345678999999999
Q ss_pred hhcCC---CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccC--CCCCHHHHHHHH
Q 011995 354 LERGL---LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK--GRFPLKAARTVA 428 (473)
Q Consensus 354 ~~~~~---~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~ 428 (473)
+.+.. |+.|+|||||||||+||+. ||... ++....+.- +.+..+. ..|.......-+
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~-------------LR~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTN-------------LRKGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHh-------------cccCCCCCCcccccccchHHH
Confidence 97655 9999999999999999986 45432 222222211 1111111 123333445567
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 011995 429 DIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 429 ~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+|.++++.||++||||.|+|+
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8999999999999999999986
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=292.85 Aligned_cols=266 Identities=15% Similarity=0.204 Sum_probs=195.6
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|...+.||+|+||.||+|....+ +..+++|+..... .......+.+|+++|+.++|+||+++++++..+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRT---GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCC---CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3567899999999999999999985433 3445555443221 23334568899999999999999999998865421
Q ss_pred ----CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 251 ----DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 251 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
...++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 2468999998 7799888742 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh-hhccc-----
Q 011995 327 GYGCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV-KWSRP----- 399 (473)
Q Consensus 327 DFGla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~----- 399 (473)
|||++..... ......+++.|++||.+.+ ..++.++|||||||++|+|++|..||...........+ .....
T Consensus 161 dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 161 DFGLARQTDS-EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred eccccccccc-CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999876533 2234466889999999876 35889999999999999999999999876543221111 10000
Q ss_pred ---ccccc-cc----cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 400 ---FLADD-CR----LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 400 ---~~~~~-~~----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..... .. +.......+ ..+...++..+.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 00 000000000 0111245567899999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=275.22 Aligned_cols=267 Identities=18% Similarity=0.239 Sum_probs=204.0
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh-hhHhHHHHHHHHHhCCCCCcccceeeeecC------
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARD------ 248 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------ 248 (473)
.|+...+||+|.||.||+|+. ..++++++++++....... --...++|+++|..+.|+|++.++++|...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~---~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARS---KNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhh---cCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 455558899999999999984 4455666665554433333 335678999999999999999999988542
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
....+||||++|++ +|..+|.. ....++..++.+++.++..||.|+|... |+|||+|+.|+||+.+|.+||+||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 12458999999977 89988843 2367899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccC------CCCccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 329 GCAGHIP------ETDISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 329 Gla~~~~------~~~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
|+++.+. ...+++.++|.+|.+||.+.+.. |++..|||+-|||+.||+||.+.+.+........++......+
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9997653 23466778899999999998765 9999999999999999999999999888777776664221111
Q ss_pred c--------ccccccccc-ccccCCCC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 A--------DDCRLSLIM-DPQLKGRF--------PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~--------~~~~~~~~~-~~~l~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .-.....+. .|-..+.+ +..-..+..+++..++..||.+|+++.+++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1 111111111 11111111 11223478899999999999999999998864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=273.96 Aligned_cols=265 Identities=16% Similarity=0.291 Sum_probs=206.1
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCccccee
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLG 243 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g 243 (473)
-.++|+-..|+ ..||+|+|+.|-.++ +..+++.++||++... ....+.++.+|++++.++ .|+||+.|++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv---~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLie 143 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCV---SIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIE 143 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeee---eeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHH
Confidence 45677777765 789999999999997 6667788888876644 456678899999999999 6999999999
Q ss_pred eeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---
Q 011995 244 FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD--- 320 (473)
Q Consensus 244 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--- 320 (473)
||+++ ..+|||||-|.||+|..+|+++ ..|++.++.+++.+|+.||.|||.+| |.||||||+|||-..-
T Consensus 144 fFEdd--~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 144 FFEDD--TRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKV 215 (463)
T ss_pred Hhccc--ceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCc
Confidence 99887 8899999999999999999654 35899999999999999999999999 9999999999998644
Q ss_pred CcEEEeccCCCcccCC---------CCccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCC
Q 011995 321 FSAKLSGYGCAGHIPE---------TDISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRH 386 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~---------~~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~ 386 (473)
--+|||||.+..-+.. .+..+.+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||.+.-
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 3489999988754421 1234567788999999872 2358999999999999999999999997754
Q ss_pred hHHHHhHhhhccccccccc---cccccccccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 387 PKEERNLVKWSRPFLADDC---RLSLIMDPQL--KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..+ .-|.+......+ .+..+.+... ++.-...++.+..+++..+|..|+.+|.++.+++.
T Consensus 296 g~d----CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 296 GAD----CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCc----CCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 322 112221111111 1111111111 11123468899999999999999999999999987
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=293.44 Aligned_cols=267 Identities=15% Similarity=0.198 Sum_probs=196.4
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|...+.||+|+||.||+|....+ ...+++++.... ........+.+|+.+++.++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCC---CcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 4567899999999999999999986543 334445543322 123344667889999999999999999987765421
Q ss_pred ----CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 251 ----DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 251 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
...++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEc
Confidence 2489999998 6799998843 46999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc-
Q 011995 327 GYGCAGHIPETDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD- 404 (473)
Q Consensus 327 DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 404 (473)
|||++...... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.-......+.
T Consensus 161 dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 161 DFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99998765432 3344667889999998653 57899999999999999999999998765443322111000000000
Q ss_pred ------cccccc---cccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 405 ------CRLSLI---MDPQLKGRF---PLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 405 ------~~~~~~---~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...... ........+ ....+..+.+++.+||..||.+|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 000000000 1124678999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=289.39 Aligned_cols=267 Identities=16% Similarity=0.188 Sum_probs=191.6
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhC-CCCCcccceeeeecC--CCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARD--GSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~--~~~ 251 (473)
+|...+.||+|+||.||++...... ..+.++++...... .....+.+.+|++++.++ +|+||+++++++... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4777899999999999999965431 13445555444321 223356788999999999 599999999875432 224
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 6788889885 689988843 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC------ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 332 GHIPETD------ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 332 ~~~~~~~------~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
....... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+........ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~ 231 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD-E 231 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC-H
Confidence 7653221 123467889999998866 4589999999999999999999999987654332221111000000 0
Q ss_pred cccccccc-----------cccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 CRLSLIMD-----------PQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ~~~~~~~~-----------~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....+.. .... .......+..+.+|+.+||+.||.+|||+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 0000 00111235789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=274.83 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=189.4
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
||.|+||.||++...+. ...+++++..... .......+..|+++++.++|+||+++++.+..+ ...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCC---CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecC
Confidence 68999999999986542 3445555544332 223456889999999999999999999988765 7899999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC--C
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET--D 338 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~--~ 338 (473)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 76 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCc
Confidence 999999999543 36899999999999999999999998 999999999999999999999999998776443 2
Q ss_pred ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCC
Q 011995 339 ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418 (473)
Q Consensus 339 ~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 418 (473)
.....++..|++||...+..++.++|+||||+++|+|++|..||...........+... ...
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------------~~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD------------------PLR 211 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC------------------CCC
Confidence 33446678999999998888899999999999999999999999765542222111110 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011995 419 FPLKAARTVADIALRCLQKEPSERPTMRS 447 (473)
Q Consensus 419 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 447 (473)
++...+..+.+++.+||..||++||++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 23344678899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=280.14 Aligned_cols=259 Identities=19% Similarity=0.306 Sum_probs=196.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC--CCCCcccceeeeecCC--
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL--QHPNLCKLLGFHARDG-- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~g~~~~~~-- 249 (473)
.......+.||+|.||.||+|.|++..++ ||+. +....+.+.+|.+|...+ +|+||+.+++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VA-----VKiF----~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVA-----VKIF----SSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceE-----EEEe----cccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 34556668999999999999999987643 3332 234456788888887764 9999999987543322
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCceeecCCCCCceeeCCCCcEE
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH-----EEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
-.++|||.+|.++|||+|+|.. .+++-...++++..+|.||+||| .+|+|.|.|||||..|||+..++.+-
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 2479999999999999999943 46999999999999999999999 46788999999999999999999999
Q ss_pred EeccCCCcccCCC------CccCcccccccCChhhhhcCC----C--CCcCCchHHHHHHHHHHcC----------CCCC
Q 011995 325 LSGYGCAGHIPET------DISNSSVAAANLSVETLERGL----L--TPKSNVWSFGIVLLELLTG----------RKNL 382 (473)
Q Consensus 325 l~DFGla~~~~~~------~~~~~~~t~~y~aPE~~~~~~----~--s~~sDvwSlGvvl~elltG----------~~p~ 382 (473)
|+|+|||....+. ..+..+||-.|||||++.... + -..+||||||+|+||+..+ ++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999765433 234568999999999985532 1 2368999999999999853 4566
Q ss_pred CCCChHH-----HHhHhhhcccccccccccccccccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 383 DSRHPKE-----ERNLVKWSRPFLADDCRLSLIMDPQLKGRF-PLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 383 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.+..+.+ ++..+. ..-..|.+...+ ...+...+.++++.||..+|..|.|+-.|-+.|.++.
T Consensus 437 yd~Vp~DPs~eeMrkVVC------------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVC------------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCCCCCHHHHhccee------------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 5432211 111110 011122222222 3467788999999999999999999999999999887
Q ss_pred c
Q 011995 457 S 457 (473)
Q Consensus 457 ~ 457 (473)
+
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 4
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.60 Aligned_cols=148 Identities=21% Similarity=0.252 Sum_probs=126.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|.+.+.||+|+||.||+|.... ..+.+++|+.+... .......+.+|+.++..++|+||+++++++... +
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--N 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--C
Confidence 3678899999999999999998653 33455666654322 233456788999999999999999999888765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+||||||+.+++|.+++.. ...+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 89999999999999999854 235889999999999999999999998 999999999999999999999999987
Q ss_pred c
Q 011995 332 G 332 (473)
Q Consensus 332 ~ 332 (473)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.63 Aligned_cols=245 Identities=17% Similarity=0.252 Sum_probs=198.4
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
.+.||+|.||+||-|+.+. +++.+++|++... .......++++|+.||..++||.||.|.-.|++. +.+++|||
T Consensus 569 devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~--ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecc---cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEEEeh
Confidence 4789999999999998544 5566667765433 2344457899999999999999999998888776 88999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---CcEEEeccCCCcccC
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---FSAKLSGYGCAGHIP 335 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~ 335 (473)
-+ +|++.++|... +.++|++...+.++.||+.||.|||.++ |||+||||+|||+... -.+||||||+|+++.
T Consensus 644 Kl-~GDMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 644 KL-HGDMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred hh-cchHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 99 56777777554 4567999999999999999999999999 9999999999999643 579999999999998
Q ss_pred CCCcc-CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 336 ETDIS-NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 336 ~~~~~-~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
+.... ..+||+.|+|||+++...|...-||||.|||+|.-++|..||....+.. +.|+-+. ++.|.
T Consensus 719 EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAa-----------FMyPp 785 (888)
T KOG4236|consen 719 EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAA-----------FMYPP 785 (888)
T ss_pred hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccc-----------cccCC
Confidence 77654 5589999999999999999999999999999999999999997644322 2222111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
- -..+++..+.+||..+|+..-.+|-|..+.+.
T Consensus 786 ~---PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 N---PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred C---chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 0 13577888999999999999999999887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=295.94 Aligned_cols=241 Identities=18% Similarity=0.241 Sum_probs=193.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 252 (473)
++.|.....+|.|+|+.|-++.. ..+...++++++... ..+-.+|+.++... +||||+++++.+.+. .+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~---~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCES---SPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDG--KE 390 (612)
T ss_pred chhhccccccCCCCccceeeeec---cccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCC--ce
Confidence 56788888899999999999984 444455556655432 23344677666666 799999999998765 88
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee-CCCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI-DKDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~vkl~DFGla 331 (473)
.|+|||++.++-|.+.+.... .+. ..+..|+.+|+.++.|||++| ||||||||+|||+ +..++++|+|||.+
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 999999999999888885433 222 778889999999999999999 9999999999999 68899999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
...... ..+.+.|..|.|||++....|++++||||||++||+|++|+.||.......+ +.
T Consensus 464 ~~~~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e--i~----------------- 523 (612)
T KOG0603|consen 464 SELERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE--IH----------------- 523 (612)
T ss_pred hhCchh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH--HH-----------------
Confidence 877554 4556788999999999988999999999999999999999999976543311 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..-..+.+...++..+++|+.+||+.||.+|++|.+++..
T Consensus 524 ~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 524 TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 0111223347788999999999999999999999999764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.12 Aligned_cols=254 Identities=16% Similarity=0.157 Sum_probs=201.3
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHA 246 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 246 (473)
++....++|.+.++||+|+||.|..+++. .+.+.+|.|+...- .......-|..|-++|...+.+.|+.++-.|.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k---~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHK---STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEee---ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34444688999999999999999999854 45566666554321 12233456889999999999999999987777
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
++ .++|||||||+||+|..++.. ...+++..+..++.+|+-||.-||+.| +|||||||+|||||..|++||+
T Consensus 146 D~--~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 DE--RYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred Cc--cceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence 66 899999999999999999943 237999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCC---ccCcccccccCChhhhh----c-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 327 GYGCAGHIPETD---ISNSSVAAANLSVETLE----R-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 327 DFGla~~~~~~~---~~~~~~t~~y~aPE~~~----~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
|||.+-.+..+. ....+|||.|++||+++ + +.|+..+|+||+||++|||+.|..||......+....|.
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm--- 294 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM--- 294 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh---
Confidence 999776665332 24568999999999994 2 569999999999999999999999997665444433332
Q ss_pred cccccccccccccccccCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFP--LKAARTVADIALRCLQKEPSERPT---MRSIFE 450 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~eil~ 450 (473)
+-.-.-.|| ..++.++.+||.+.+. +|+.|.. ++++-.
T Consensus 295 -------------~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 -------------NHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred -------------chhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 111111233 4588999999998874 6888887 777654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=282.40 Aligned_cols=256 Identities=18% Similarity=0.253 Sum_probs=198.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC------ChhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS------SQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
++|-..++||+|||+.||+|. +....+.+++++-.++.. ....+...+|..|.+.|.||.||++|+|+.-+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAF---Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAF---DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred HHHHHHHHhccccHHHHHHhc---ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 446667899999999999998 555566677777766542 22345678899999999999999999999876
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAKL 325 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vkl 325 (473)
. +.+|-|+|||+|.+|+-+|.. ...+++.++..|+.||+.||.||....+ +|||-||||.||||-. -|.+||
T Consensus 540 t-dsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 T-DSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred c-ccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEe
Confidence 4 789999999999999999843 4468999999999999999999999875 5999999999999943 488999
Q ss_pred eccCCCcccCCCCc---------cCcccccccCChhhhhcC----CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 326 SGYGCAGHIPETDI---------SNSSVAAANLSVETLERG----LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 326 ~DFGla~~~~~~~~---------~~~~~t~~y~aPE~~~~~----~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
.||||++++....+ +...||.||++||.+.-+ ..+.++||||+|||+|..+.|+.||...... .+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH
Confidence 99999998865433 234678999999988433 4788999999999999999999999754322 22
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+.......... .+.-.--..++.++.+||++||++.-++|....++..
T Consensus 693 ILqeNTIlkAt----------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQENTILKAT----------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhhchhcce----------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22221110000 0000112356788999999999999999998877654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=276.71 Aligned_cols=241 Identities=19% Similarity=0.240 Sum_probs=195.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
.+|....+||+|+||.|.+|.-++ +...+++++.+... ....++--+.|-.+|... +-|.++.++.++.+- +
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm--D 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--D 423 (683)
T ss_pred cccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--h
Confidence 467777999999999999996433 33445555443321 223334445677777766 578999999988876 8
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+||||+.||+|--++++ -+.+.+..+..+|.+|+-||-|||+++ ||+||||.+|||||.+|.+||+|||+.
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred heeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence 89999999999999888854 345788889999999999999999999 999999999999999999999999998
Q ss_pred ccc--CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHI--PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
+.- ......+.+||+.|+|||++....|+..+|+|||||+||||+.|++||++.++.+....|...
T Consensus 498 KEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------ 565 (683)
T KOG0696|consen 498 KENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------ 565 (683)
T ss_pred cccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc------------
Confidence 643 333445679999999999999999999999999999999999999999998877765544311
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 444 (473)
. -.||...+.++.+++...|.+.|.+|..
T Consensus 566 ----n--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 ----N--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----c--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1 1357888899999999999999999954
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=274.22 Aligned_cols=267 Identities=14% Similarity=0.173 Sum_probs=197.6
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC--CC----Ccccceeee
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ--HP----NLCKLLGFH 245 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--Hp----nIv~l~g~~ 245 (473)
..+++|.+...+|+|+||.|-.+..+.. ...+++|++ +.-....+..+-|+++|.++. .| -+|.+.+|+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~---~~~vAlKIi--k~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRET---KEHVALKII--KNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCC---CceehHHHH--HHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 3478999999999999999999985443 333334433 333344566678999999993 22 356777777
Q ss_pred ecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC------
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK------ 319 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~------ 319 (473)
... ++.|||+|.+ |-|+.++|..+ ...+++...+..++.|++++++|||+.+ ++|.||||+|||+..
T Consensus 161 dyr--ghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 161 DYR--GHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hcc--CceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 655 8899999998 66999999654 4567999999999999999999999999 999999999999831
Q ss_pred --------------CCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCC
Q 011995 320 --------------DFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSR 385 (473)
Q Consensus 320 --------------~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~ 385 (473)
+..++|+|||.|+.-.+.. +..+.|..|.|||++.+-.++..+||||+||||+||+||...|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 2348999999998664433 5667899999999999999999999999999999999999999887
Q ss_pred ChHHHHhHhhhccc--------------ccccc----------cccccccccccC----CCCCHHHHHHHHHHHHHhccc
Q 011995 386 HPKEERNLVKWSRP--------------FLADD----------CRLSLIMDPQLK----GRFPLKAARTVADIALRCLQK 437 (473)
Q Consensus 386 ~~~~~~~~~~~~~~--------------~~~~~----------~~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~ 437 (473)
+..+.....+.... +...+ .......++... -........++.+|+.+||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 76553332221100 00000 000000000000 011234566799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 011995 438 EPSERPTMRSIFEE 451 (473)
Q Consensus 438 dP~~RPt~~eil~~ 451 (473)
||.+|+|+.|+|+.
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=269.63 Aligned_cols=220 Identities=20% Similarity=0.206 Sum_probs=172.8
Q ss_pred cCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEeccCCCh
Q 011995 186 GLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265 (473)
Q Consensus 186 G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL 265 (473)
|.+|.||++.... +.+.+++|..+.. ..+.+|...+....||||+++++++... +..++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~------~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKS------SEYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecch------hhhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 8999999998543 4455556655432 1234555566666899999999998765 789999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCcccc
Q 011995 266 DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA 345 (473)
Q Consensus 266 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t 345 (473)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||++...... .....++
T Consensus 73 ~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~ 145 (237)
T cd05576 73 WSHISKF---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVE 145 (237)
T ss_pred HHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcC
Confidence 9998543 35899999999999999999999999 999999999999999999999999987655432 2334456
Q ss_pred cccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHH
Q 011995 346 AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAAR 425 (473)
Q Consensus 346 ~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 425 (473)
..|+|||.+.+..++.++||||+||++|||++|..|+....... . . .....++...+.
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~-------~----------~~~~~~~~~~~~ 203 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----N-------T----------HTTLNIPEWVSE 203 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----c-------c----------ccccCCcccCCH
Confidence 78999999988889999999999999999999998875321100 0 0 000012344567
Q ss_pred HHHHHHHHhcccCCCCCCCH
Q 011995 426 TVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 426 ~l~~li~~cl~~dP~~RPt~ 445 (473)
.+.+++.+||+.||++||++
T Consensus 204 ~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHccCCHHHhcCC
Confidence 89999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=280.68 Aligned_cols=243 Identities=16% Similarity=0.246 Sum_probs=202.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.+++....||-||||.|-+........ .+++|+.+.. ......+.+..|-.||..++.|.||++|--|.++ ..
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~---~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKA---TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccch---HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hh
Confidence 445555789999999999998765543 2333332221 2344567788999999999999999999877665 88
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|++||-|-||.|...|+. .+.|+..+...++.+++.|++|||+++ ||+|||||+|+||+.+|-+||.|||+|+
T Consensus 495 vYmLmEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hhhhHHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence 9999999999999999954 457999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 333 HIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 333 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
.+.... ..+++||+.|.|||++.+..-+.++|.|+||+++|||++|.+||.+.++....++|......
T Consensus 569 ki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------- 637 (732)
T KOG0614|consen 569 KIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------- 637 (732)
T ss_pred HhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence 886654 45679999999999999999999999999999999999999999999988877665422110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 444 (473)
-.+|..+...+.++|.++...+|.+|.-
T Consensus 638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 -----IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1246667788899999999999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.12 Aligned_cols=264 Identities=15% Similarity=0.159 Sum_probs=165.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCC-eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeee----ec
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDA-STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFH----AR 247 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~----~~ 247 (473)
..++|...+.||+|+||.||+|++.++. .....+++|. ..... ..+.+..| .+....+.+++.++..+ ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~--~~~~~-~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK--ATEYG-AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEE--ecccc-hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999976541 1133344443 22111 11111111 12222233333322211 11
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCC
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDG-----------------PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 310 (473)
.....++|||||+.+++|.+++...... .......+..++.||+.||+|||+++ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 2337899999999999999998543210 01123446689999999999999999 999999
Q ss_pred CCCceeeCC-CCcEEEeccCCCcccCCC---CccCcccccccCChhhhhcC----------------------CCCCcCC
Q 011995 311 STANIQIDK-DFSAKLSGYGCAGHIPET---DISNSSVAAANLSVETLERG----------------------LLTPKSN 364 (473)
Q Consensus 311 kp~NILl~~-~~~vkl~DFGla~~~~~~---~~~~~~~t~~y~aPE~~~~~----------------------~~s~~sD 364 (473)
||+|||++. ++.+||+|||+++.+... ......+++.|||||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 589999999999765322 12345678999999976432 2345679
Q ss_pred chHHHHHHHHHHcCCCCCCCCChHHHHh-------HhhhcccccccccccccccccccCCCC--CHHHHHHHHHHHHHhc
Q 011995 365 VWSFGIVLLELLTGRKNLDSRHPKEERN-------LVKWSRPFLADDCRLSLIMDPQLKGRF--PLKAARTVADIALRCL 435 (473)
Q Consensus 365 vwSlGvvl~elltG~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl 435 (473)
||||||++|||+++..++.......... ...|...... ...+.+...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-------RASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-------ccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999776654321111000 0111110000 0000000000 0112234568999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 011995 436 QKEPSERPTMRSIFEE 451 (473)
Q Consensus 436 ~~dP~~RPt~~eil~~ 451 (473)
+.||.+|||+.++|+.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=254.22 Aligned_cols=238 Identities=21% Similarity=0.273 Sum_probs=187.0
Q ss_pred CCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEeccCCChh
Q 011995 187 LSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266 (473)
Q Consensus 187 ~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~ 266 (473)
+||.||+|...++ ...+++++..........+.+.+|++.+++++|+||+++++++... ...++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKT---GKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 5899999997652 2344455544333222268899999999999999999999998775 7899999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-CccCcccc
Q 011995 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET-DISNSSVA 345 (473)
Q Consensus 267 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~t 345 (473)
+++... ..+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||.+...... ......++
T Consensus 76 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKKR---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCC
Confidence 998543 23899999999999999999999998 999999999999999999999999999876544 23445677
Q ss_pred cccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCC-CCHHHH
Q 011995 346 AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR-FPLKAA 424 (473)
Q Consensus 346 ~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~ 424 (473)
..|++||.+.+..++.++|||+||+++++|++|..||......... ..+.. .. ..... .....+
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--~~~~~----~~---------~~~~~~~~~~~~ 214 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL--FKKIG----KP---------KPPFPPPEWKIS 214 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHh----cc---------CCCCccccccCC
Confidence 8999999998888999999999999999999999999763222211 11100 00 00000 000155
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 425 RTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 425 ~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.++.+++.+||..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 78999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=261.45 Aligned_cols=268 Identities=16% Similarity=0.254 Sum_probs=199.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEec-CCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC---C
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRL-NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS---D 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~---~ 251 (473)
+.+..+.||-|+||+||..+. ...++.++.+.... ...-...+.+.+|+++|.-++|.|++..+++..-..- .
T Consensus 54 Di~PDRPIGYGAFGVVWsVTD---PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTD---PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cCCCCCcccccceeEEEeccC---CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 445569999999999999984 33444444433221 1233345789999999999999999999887654321 3
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
++|+|.|+| ..+|..+| .....++...++-+++||++||.|||+.+ |.||||||.|+|++.+..+||||||++
T Consensus 131 EiYV~TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 131 ELYVLTELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccc
Confidence 578888988 45888888 34567899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc--ccccc---
Q 011995 332 GHIPETD---ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--RPFLA--- 402 (473)
Q Consensus 332 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~~~--- 402 (473)
+.....+ ++..++|..|.|||.+.|.. |+.+.||||.|||+.||+.++..|....+.+..+++... .|..+
T Consensus 204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 8775443 34557899999999998765 999999999999999999999999888887776665311 11111
Q ss_pred ---cccccccccccccCCCC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 403 ---DDCRLSLIMDPQLKGRF--------PLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 403 ---~~~~~~~~~~~~l~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
++.+...+..+.-...+ +.....+...+...++..||.+|.+..+.+..+.
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111111111111 2234456778889999999999999999887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=247.78 Aligned_cols=262 Identities=16% Similarity=0.203 Sum_probs=193.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 252 (473)
.++|++.+++|+|-++.||.|..-.+. .++.+++ ++ ....+.+.+|+.||..+. |||||+|+++..+..+..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~---eK~ViKi--LK--PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNN---EKCVIKI--LK--PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCC---ceEEEee--ec--hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 478999999999999999999743322 2222332 22 234578999999999996 999999999998887788
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla 331 (473)
..||+||+++.+...+. +.|+...+..++.+++.||.|||++| |+|||+||.|++||.. ..++|+|||+|
T Consensus 110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchH
Confidence 99999999998876654 35788889999999999999999999 9999999999999865 67999999999
Q ss_pred cccCCCCccCc-ccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCC-CCChHHHHhHhhh----------cc
Q 011995 332 GHIPETDISNS-SVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLD-SRHPKEERNLVKW----------SR 398 (473)
Q Consensus 332 ~~~~~~~~~~~-~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~-~~~~~~~~~~~~~----------~~ 398 (473)
.+.......+. +.+..|--||.+... .|+..-|+|||||+|..|+..+.||- +.+..++...+.. ..
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 98876654444 445666789998664 48999999999999999999888874 3333333222210 00
Q ss_pred cc-cccccccccccccccCCCC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 399 PF-LADDCRLSLIMDPQLKGRF--------PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 399 ~~-~~~~~~~~~~~~~~l~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+ +.-+.....++....+..+ ..-.++++.+|+.++|..|..+|+|+.|.+..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00 0011111111111111111 12245889999999999999999999998863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=278.39 Aligned_cols=264 Identities=11% Similarity=0.141 Sum_probs=179.4
Q ss_pred HhcccccCcceeecCCceEEEEEECCCC-------------eeeeEEEEEEEecCCCChhh--------------HhHHH
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDA-------------STSKKFEATVTRLNPSSQGV--------------KEFIN 225 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~--------------~~~~~ 225 (473)
..++|.+.++||+|+||+||+|.+.... ...+.+++|..... ..... +....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~-~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD-RQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEeccc-chhhHHHHHhhhhhhhcccchhHH
Confidence 3678999999999999999999752211 11123334433221 11111 23345
Q ss_pred HHHHHHhCCCCCc-----ccceeeeecC------CCCceEEEEEeccCCChhhhhhcCCC--------------------
Q 011995 226 DVNTLASLQHPNL-----CKLLGFHARD------GSDQRMLIYERLFHGSLDRLIYGRSD-------------------- 274 (473)
Q Consensus 226 Ei~~l~~l~HpnI-----v~l~g~~~~~------~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------- 274 (473)
|+.++.+++|.++ +++++||... ..+..+|||||+.+++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777788876654 6777877542 12568999999999999999864211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc-c--CcccccccCC
Q 011995 275 -GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI-S--NSSVAAANLS 350 (473)
Q Consensus 275 -~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~--~~~~t~~y~a 350 (473)
...++|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ . ...+++.|++
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 123567889999999999999999999 99999999999999999999999999876533211 1 1234789999
Q ss_pred hhhhhcCC--------------------C--CCcCCchHHHHHHHHHHcCCC-CCCCCChHHH------HhHhhhccccc
Q 011995 351 VETLERGL--------------------L--TPKSNVWSFGIVLLELLTGRK-NLDSRHPKEE------RNLVKWSRPFL 401 (473)
Q Consensus 351 PE~~~~~~--------------------~--s~~sDvwSlGvvl~elltG~~-p~~~~~~~~~------~~~~~~~~~~~ 401 (473)
||.+.... + ..+.||||+||++|+|++|.. ||........ .....|..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--- 455 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--- 455 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---
Confidence 99875432 1 124799999999999999875 6654321111 01111110
Q ss_pred ccccccccccccccCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEP---SERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~eil~~ 451 (473)
.......-......+....+|+.+||..+| .+|+|+.|+|++
T Consensus 456 --------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 --------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000111111123456889999999999866 689999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=244.39 Aligned_cols=200 Identities=21% Similarity=0.278 Sum_probs=164.2
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceEEEEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
...||+|++|.|-+-++ ...+...++|.++.....+..++.++|+.+..+. .+|.+|.+||..... ...++.||
T Consensus 51 i~elGrGayG~vekmrh---~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIcME 125 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRH---IQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWICME 125 (282)
T ss_pred hhhhcCCccchhhheee---ccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEeHH
Confidence 37899999999888774 3345555666555555677788899999987765 799999999988766 68999999
Q ss_pred eccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 259 RLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 259 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
.|+. ||+.+..+. ..+..+++..+-+|+..+..||.|||++- .+||||+||+||||+.+|.+|+||||++..+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9954 887665331 34678999999999999999999999987 6999999999999999999999999999877554
Q ss_pred CccC-cccccccCChhhhhcC----CCCCcCCchHHHHHHHHHHcCCCCCCCCCh
Q 011995 338 DISN-SSVAAANLSVETLERG----LLTPKSNVWSFGIVLLELLTGRKNLDSRHP 387 (473)
Q Consensus 338 ~~~~-~~~t~~y~aPE~~~~~----~~s~~sDvwSlGvvl~elltG~~p~~~~~~ 387 (473)
-..+ ..|.-.|||||.+..+ .|+.++||||||+.+.||.+++.||+....
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 3333 4566789999998543 589999999999999999999999986543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-31 Score=257.52 Aligned_cols=268 Identities=18% Similarity=0.274 Sum_probs=194.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-----C---CCcccceeee
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-----H---PNLCKLLGFH 245 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----H---pnIv~l~g~~ 245 (473)
.++|.+.++||.|.|++||+|. +....+.+|+||.+ ......+..+.||++|++++ | .+||+|+++|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLaw---Dtq~~r~VAlKVvK--SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAW---DTQNKRYVALKVVK--SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred CceEEEEEeccccccceeEEEe---eccCCeEEEEEEEe--hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 3678899999999999999998 44444555566554 34455677889999999983 2 3799999998
Q ss_pred ecCC--CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---
Q 011995 246 ARDG--SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD--- 320 (473)
Q Consensus 246 ~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--- 320 (473)
...| +.++|||+|++ |-+|..+|... ....++...++.|++||+.||.|||..+ .|||.||||+||||..+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~ 227 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEID 227 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccc
Confidence 7643 46899999999 66888888654 3455899999999999999999999998 79999999999997211
Q ss_pred --------C-----------------------------------------------------------------------
Q 011995 321 --------F----------------------------------------------------------------------- 321 (473)
Q Consensus 321 --------~----------------------------------------------------------------------- 321 (473)
+
T Consensus 228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~ 307 (590)
T KOG1290|consen 228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP 307 (590)
T ss_pred hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 011995 322 -------------------------------------------------------------------------------- 321 (473)
Q Consensus 322 -------------------------------------------------------------------------------- 321 (473)
T Consensus 308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~ 387 (590)
T KOG1290|consen 308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP 387 (590)
T ss_pred CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence
Q ss_pred ----cEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCCh----HHH--H
Q 011995 322 ----SAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP----KEE--R 391 (473)
Q Consensus 322 ----~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~----~~~--~ 391 (473)
.+||+|||-|+.+.. .++....|..|.|||++.+..|+..+||||++|+++||+||...|+.... .++ .
T Consensus 388 ~~di~vKIaDlGNACW~~k-hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 388 ECDIRVKIADLGNACWVHK-HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred ccceeEEEeeccchhhhhh-hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 023333333332211 12233446789999999999999999999999999999999999964321 111 1
Q ss_pred h-Hhh--------------hccccccccccccccccc---cc------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011995 392 N-LVK--------------WSRPFLADDCRLSLIMDP---QL------KGRFPLKAARTVADIALRCLQKEPSERPTMRS 447 (473)
Q Consensus 392 ~-~~~--------------~~~~~~~~~~~~~~~~~~---~l------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 447 (473)
. +++ +.+-+......+..+-.- .+ ...|+.+...++.+|+.-||+.+|++||||.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1 111 223333333333322111 11 12467888999999999999999999999999
Q ss_pred HHHH
Q 011995 448 IFEE 451 (473)
Q Consensus 448 il~~ 451 (473)
+|+.
T Consensus 547 cl~h 550 (590)
T KOG1290|consen 547 CLKH 550 (590)
T ss_pred HhcC
Confidence 9853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=273.25 Aligned_cols=240 Identities=18% Similarity=0.229 Sum_probs=183.1
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|...+.||-|+||.|.+++--|. ...++.|..+..+ .......++.|-+||.....+.||+||-.|.+. +++|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT---~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk--dnLY 705 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDT---RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLY 705 (1034)
T ss_pred eEEEeeecccccceeEEEeecch---hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC--CceE
Confidence 55667899999999999974433 3334444333221 233446678899999999999999998777665 8999
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||++||++-.+|.+. +-|.+..+..++.++.+|+++.|..| +|||||||+|||||.+|.+||.||||++-+
T Consensus 706 FVMdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 999999999999988643 35888888889999999999999999 999999999999999999999999997533
Q ss_pred C---------CCC-----------------------------------ccCcccccccCChhhhhcCCCCCcCCchHHHH
Q 011995 335 P---------ETD-----------------------------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGI 370 (473)
Q Consensus 335 ~---------~~~-----------------------------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGv 370 (473)
. +++ ....+||+.|+|||++....|+..+|+||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1 000 01336789999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHh-HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011995 371 VLLELLTGRKNLDSRHPKEERN-LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443 (473)
Q Consensus 371 vl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 443 (473)
|||||+.|++||....+.+... ++.|.. + +.-.+..+++.++.++|.++. -+++.|.
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~nw~~-~--------------l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVINWRN-F--------------LHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeeehhh-c--------------cccccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999999998766655433 233322 1 111224566777888876543 3556664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=278.96 Aligned_cols=242 Identities=19% Similarity=0.272 Sum_probs=181.6
Q ss_pred cccCcceeecCCce-EEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceE
Q 011995 177 FFSDRCISEGLSSV-MYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 177 f~~~~~lG~G~~g~-Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 254 (473)
|...+++|.|+.|+ ||+|.+.+.. |+||++-. ....-..+||..|+.- .|||||++|+ .+.+..++|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~-------VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGRE-------VAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCce-------ehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEE
Confidence 44557789999986 9999987764 55555532 2234457999999988 7999999954 555558999
Q ss_pred EEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---C--CcEEEecc
Q 011995 255 LIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---D--FSAKLSGY 328 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~--~~vkl~DF 328 (473)
|+.|.|.. +|.+++... .+.....-.....++.|++.||++||+-+ ||||||||.||||+. + ..++|+||
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccc
Confidence 99999955 999999653 11111111445778899999999999988 999999999999965 3 57999999
Q ss_pred CCCcccCCCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcC-CCCCCCCChHHHHhHhhhcccccc
Q 011995 329 GCAGHIPETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTG-RKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 329 Gla~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
|+++.+..+. ..+..||-+|+|||.+....-+.++||||||||+|+.++| ..||.+....+.. ++ .
T Consensus 656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-Il-------~ 727 (903)
T KOG1027|consen 656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-IL-------T 727 (903)
T ss_pred ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-hh-------c
Confidence 9998875442 3456789999999999999889999999999999999886 8999865332221 11 1
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
....+..+.. ... .++.+||.+|+..||..||++.+||.
T Consensus 728 ~~~~L~~L~~-------~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 728 GNYTLVHLEP-------LPD--CEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred Cccceeeecc-------Cch--HHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111111100 111 18899999999999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.76 Aligned_cols=250 Identities=18% Similarity=0.283 Sum_probs=194.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|...++||+|+|+.|..+.+.. +...+++|+++.. ...+...-+..|-.+..+. +||.+|-|+.+|.++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-- 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-- 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc--
Confidence 4678888999999999999998544 4456666665433 3444556667787777776 799999999998877
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
..+++|.||++||+|--++.+ ...+++..+..+..+|..||.|||++| ||+||||.+|||||..|.+||.|||.
T Consensus 324 srlffvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred ceEEEEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccch
Confidence 789999999999999666643 346999999999999999999999999 99999999999999999999999998
Q ss_pred Cccc--CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHI--PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~--~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
.+.- +....++.+||+.|+|||.+.+..|+..+|+|+|||+++||+.|+.||+.-...... ...++..+.
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d--------~ntedylfq 469 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD--------MNTEDYLFQ 469 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc--------cchhHHHHH
Confidence 8653 233456779999999999999999999999999999999999999999632110000 000111122
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 444 (473)
.++..++ .+|...+-.+..+++.-|.+||.+|..
T Consensus 470 vilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 470 VILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 2222222 235566677788899999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=261.40 Aligned_cols=267 Identities=18% Similarity=0.220 Sum_probs=207.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC------CCCcccceeeeec
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ------HPNLCKLLGFHAR 247 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~g~~~~ 247 (473)
-..|.+....|.|-|++|.+|.. ...+..+|+++++.+ +...+.=+.|++||.+|+ --|+++|+-.|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D---~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARD---QARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccc---cCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 45688888899999999999984 333346666666643 344566678999999995 2378888877765
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEe
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLS 326 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~ 326 (473)
. +++|||+|-+ ..+|.++|........|....+..++.|+.-||..|..-+ |+|.||||+|||+++. ..+|||
T Consensus 506 k--nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 506 K--NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred c--ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence 5 8999999987 5599999977666667888999999999999999999998 9999999999999876 668999
Q ss_pred ccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc---------
Q 011995 327 GYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--------- 397 (473)
Q Consensus 327 DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------- 397 (473)
|||.|..+..+..+...++.-|.|||++.|-.|+...|+||.||.||||+||+..|.+....++..+.+-.
T Consensus 580 DfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 580 DFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 99999999888888888899999999999999999999999999999999999999998776655443200
Q ss_pred ------cccccccccccc----------------cccc------ccCC--CC---CHHHHHHHHHHHHHhcccCCCCCCC
Q 011995 398 ------RPFLADDCRLSL----------------IMDP------QLKG--RF---PLKAARTVADIALRCLQKEPSERPT 444 (473)
Q Consensus 398 ------~~~~~~~~~~~~----------------~~~~------~l~~--~~---~~~~~~~l~~li~~cl~~dP~~RPt 444 (473)
..+...++.+.. .+.| .+.. .+ .......+.+|+..||..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 000111110000 0111 0000 11 2356678899999999999999999
Q ss_pred HHHHHHH
Q 011995 445 MRSIFEE 451 (473)
Q Consensus 445 ~~eil~~ 451 (473)
..+.|+.
T Consensus 740 ~nqAL~H 746 (752)
T KOG0670|consen 740 VNQALKH 746 (752)
T ss_pred HHHHhcC
Confidence 9998863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=268.67 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=206.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+....+|.|+||.||+++ +....+..+++++++... ....-+..|+-+++.++|+|||.++|-+... +.++
T Consensus 15 ddyellqrvgsgTygdvyKaR---d~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklw 88 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKAR---DKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLW 88 (829)
T ss_pred cchhheeeecCCcccchhhhc---ccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhh--cCcE
Confidence 567777999999999999998 566667777888777643 3456677899999999999999999988876 8899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
++||||.+|+|.+..+ ..+++++.++..+.++.++||+|||+++ -+|||||-.|||++..|.+|++|||.+..+
T Consensus 89 icMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh
Confidence 9999999999999874 3457999999999999999999999999 899999999999999999999999998766
Q ss_pred CCC--CccCcccccccCChhhh---hcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETL---ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~---~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
... ....+.||+.|||||+- ..+.|...+|||++|+...|+---++|....++.....+.... .
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-----------~ 231 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-----------G 231 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-----------C
Confidence 433 33567899999999986 4567999999999999999999999987766655443322111 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+.+++ ....+..+.+|++.||.++|.+||+++.+|+
T Consensus 232 ~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11122222 4567788999999999999999999998775
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-29 Score=228.20 Aligned_cols=211 Identities=27% Similarity=0.470 Sum_probs=177.2
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEeccC
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFH 262 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~ 262 (473)
||+|.+|.||++...+ ..+.+.+|+............+.+|++.++.+.|++|+++++++... ...++++||+.+
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 6899999999998654 23344455444332222457899999999999999999999998765 789999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-CCcEEEeccCCCcccCCCC--c
Q 011995 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-DFSAKLSGYGCAGHIPETD--I 339 (473)
Q Consensus 263 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~--~ 339 (473)
++|.+++.... ..+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+....... .
T Consensus 76 ~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 76 GSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchh
Confidence 99999985431 46899999999999999999999999 999999999999999 8999999999987665442 3
Q ss_pred cCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCC
Q 011995 340 SNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418 (473)
Q Consensus 340 ~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 418 (473)
........|++||.+... .++.++|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 445567899999999877 788999999999999999
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 419 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
..+.+++..|+..||++||++.++++.|
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=258.22 Aligned_cols=199 Identities=19% Similarity=0.215 Sum_probs=167.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC---CC----ChhhHhHHHHHHHHHhCC---CCCccccee
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN---PS----SQGVKEFINDVNTLASLQ---HPNLCKLLG 243 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~Ei~~l~~l~---HpnIv~l~g 243 (473)
..+|.....||+|+||.|+.|.++.+. ..+.+|.+... .. ....-.+-.||+||..++ |+||+++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~---~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENN---YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred cccceeeeeccccccceEEEeeecccc---eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 346888899999999999999976653 22222222111 01 111234667999999997 999999999
Q ss_pred eeecCCCCceEEEEEec-cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc
Q 011995 244 FHARDGSDQRMLIYERL-FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322 (473)
Q Consensus 244 ~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 322 (473)
||+++ +++||+||-. ++.+|+++|. -.+.+++..+..|+.||+.|+++||+.+ |||||||-+||.++.+|.
T Consensus 637 fFEdd--d~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 637 FFEDD--DYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF 708 (772)
T ss_pred eeecC--CeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence 99887 8999999975 4569999994 3457999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCCcccCCCCccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCC
Q 011995 323 AKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 323 vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
+||+|||.+....+.....++||..|.|||++.|..| +..-|||++|++||-++..+.||.
T Consensus 709 ~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999888888889999999999999999887 567999999999999999998885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=239.72 Aligned_cols=264 Identities=16% Similarity=0.229 Sum_probs=191.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC----
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG---- 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---- 249 (473)
.+|...+.+|.|.- .|..+. +......++++..... ......++..+|..++..+.|+||++++.++.-..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~---D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAF---DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeecccCCCCc-eEEecc---hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 45666688888888 555554 3333344334333222 23444577789999999999999999999886432
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
....|+||||| .++|...+.- .++-.++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence 24689999999 4599888852 3677899999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-------------
Q 011995 330 CAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK------------- 395 (473)
Q Consensus 330 la~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~------------- 395 (473)
+|+..... ..+..++|..|.|||++.+-.|...+||||+||++.||++|...|.+.+-.++...+.
T Consensus 164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 99876555 4566688999999999998889999999999999999999999998765433222111
Q ss_pred ---hccccccccc-----ccc-cccccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 396 ---WSRPFLADDC-----RLS-LIMDPQLKG--RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 396 ---~~~~~~~~~~-----~~~-~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
-++.+..... ... .+.|..... ..+......+++++.+||..||++|.+++++|+.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000000 000 000111110 0112334568899999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=223.96 Aligned_cols=198 Identities=21% Similarity=0.303 Sum_probs=164.1
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
|...+.||.|++|.||++...++ .+.++++.............+.+|++.+..++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGT---GELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCC---CcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEE
Confidence 45668899999999999987652 2344444444322222567889999999999999999999998765 789999
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
+||+++++|.+++.... ..+++..+..++.+++.+|.|||+.+ ++|+||++.||+++.++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 76 MEYCEGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred EeccCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 99999999999985432 12889999999999999999999998 99999999999999999999999999887654
Q ss_pred C---CccCcccccccCChhhh-hcCCCCCcCCchHHHHHHHHHHcCCCCCCC
Q 011995 337 T---DISNSSVAAANLSVETL-ERGLLTPKSNVWSFGIVLLELLTGRKNLDS 384 (473)
Q Consensus 337 ~---~~~~~~~t~~y~aPE~~-~~~~~s~~sDvwSlGvvl~elltG~~p~~~ 384 (473)
. ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3 22334567889999998 666688899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=232.65 Aligned_cols=268 Identities=17% Similarity=0.232 Sum_probs=190.7
Q ss_pred HHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecC
Q 011995 170 VAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARD 248 (473)
Q Consensus 170 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 248 (473)
+....+.|...++||+|+|++||++++.........++++.+... .....+.+|+++|..+ .+.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t---s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT---SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc---cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 334557788999999999999999986553223344445444433 2336688999999999 699999999988665
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEec
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSG 327 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~D 327 (473)
+..++|+||+++....+++. .++...+..+++.++.||.++|..| ||||||||+|+|.+.. +.-.|+|
T Consensus 108 --d~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 108 --DQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred --CeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 89999999999999988873 2678999999999999999999999 9999999999999854 7788999
Q ss_pred cCCCccc-----------------CC--C---------------C------------ccCcccccccCChhhhhcC-CCC
Q 011995 328 YGCAGHI-----------------PE--T---------------D------------ISNSSVAAANLSVETLERG-LLT 360 (473)
Q Consensus 328 FGla~~~-----------------~~--~---------------~------------~~~~~~t~~y~aPE~~~~~-~~s 360 (473)
||+|... .. . . .....||++|.|||++... ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9998611 00 0 0 0123578999999998654 478
Q ss_pred CcCCchHHHHHHHHHHcCCCCCCCCChH--HHHhHh-------------------hhcccc---cccc-cccccc-cccc
Q 011995 361 PKSNVWSFGIVLLELLTGRKNLDSRHPK--EERNLV-------------------KWSRPF---LADD-CRLSLI-MDPQ 414 (473)
Q Consensus 361 ~~sDvwSlGvvl~elltG~~p~~~~~~~--~~~~~~-------------------~~~~~~---~~~~-~~~~~~-~~~~ 414 (473)
.++||||.|||++.+++++.||-..... ...+++ .|.... +... .....+ ....
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 9999999999999999999998543211 001111 011000 0000 000000 0000
Q ss_pred -------c-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 415 -------L-KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 415 -------l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ........+..+.+|+.+|+..||.+|.|+++.|+.
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 011122334578899999999999999999998863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=219.02 Aligned_cols=255 Identities=15% Similarity=0.244 Sum_probs=182.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
..+.|.+.+.||+|.||.+-++.++.... .++++.........++|.+|..---.| .|.||+.-|+..... .+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t-----~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d 95 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKT-----RIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SD 95 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCce-----EEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-Cc
Confidence 34678888999999999999998765433 244444555556678899998765555 689999888654433 37
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee-C-CCCcEEEeccC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI-D-KDFSAKLSGYG 329 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl-~-~~~~vkl~DFG 329 (473)
.+++++||++-|+|..-+.. ..+.+....+++.|+++||.|+|+++ +||||||.+|||| + +...+||||||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred eEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 88999999999999887733 34788999999999999999999999 9999999999999 3 34589999999
Q ss_pred CCcccCCCCccCcccccccCChhhhhcC-----CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH--HhHhhhcccccc
Q 011995 330 CAGHIPETDISNSSVAAANLSVETLERG-----LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLA 402 (473)
Q Consensus 330 la~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~ 402 (473)
+.+..... ......+..|-+||..... ...+.+|||.||++++.++||.+||.....+.. -....|...
T Consensus 169 ~t~k~g~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r--- 244 (378)
T KOG1345|consen 169 LTRKVGTT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR--- 244 (378)
T ss_pred cccccCce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc---
Confidence 87654221 1112235678899987432 257889999999999999999999974332221 112222211
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
..+.++..|. -.++.+..+.++-|..++++|--..++-+...
T Consensus 245 --------k~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 245 --------KNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred --------cCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1122222221 23466778889999999999954444444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=267.16 Aligned_cols=195 Identities=19% Similarity=0.203 Sum_probs=140.5
Q ss_pred hCCC-CCcccceeeeecCC-----CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 011995 232 SLQH-PNLCKLLGFHARDG-----SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQA 305 (473)
Q Consensus 232 ~l~H-pnIv~l~g~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i 305 (473)
.++| .||+.++++|.... .+.+++++||+ +++|.++|.. ....+++..++.++.||+.||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 58888888772211 14677888987 6699999953 2356999999999999999999999999 9
Q ss_pred eecCCCCCceeeCC-------------------CCcEEEeccCCCcccCCC------------------CccCccccccc
Q 011995 306 MYNEFSTANIQIDK-------------------DFSAKLSGYGCAGHIPET------------------DISNSSVAAAN 348 (473)
Q Consensus 306 vHrDlkp~NILl~~-------------------~~~vkl~DFGla~~~~~~------------------~~~~~~~t~~y 348 (473)
|||||||+||||+. ++.+||+|||+++..... ......+|++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 455667777776542110 00113468889
Q ss_pred CChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHH
Q 011995 349 LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVA 428 (473)
Q Consensus 349 ~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 428 (473)
||||++.+..++.++|||||||+||||++|.+|+...... ...+... ...+. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~------------~~~~~-----~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHR------------VLPPQ-----ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHh------------hcChh-----hhhcCHHHH
Confidence 9999999999999999999999999999998887532111 0000000 00000 011123456
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 011995 429 DIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 429 ~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+++.+||++||.+||++.||++.
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 88999999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=210.27 Aligned_cols=170 Identities=21% Similarity=0.211 Sum_probs=129.1
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCc
Q 011995 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNS 342 (473)
Q Consensus 263 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 342 (473)
|+|.+++..+ +..+++..+..|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ..
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---~~ 64 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---QS 64 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc---cC
Confidence 6899999542 456999999999999999999999986 999999999999999 9998765432 23
Q ss_pred ccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHH
Q 011995 343 SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLK 422 (473)
Q Consensus 343 ~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 422 (473)
.+++.|||||++.+..++.++|||||||++|||++|+.||.......... ..+....... .+.. ...+..
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~--------~~~~-~~~~~~ 134 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL-EILLNGMPAD--------DPRD-RSNLES 134 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH-HHHHHHhccC--------Cccc-cccHHH
Confidence 67899999999999999999999999999999999999997543221110 0000000000 0000 011223
Q ss_pred HHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 423 AAR--TVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 423 ~~~--~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
... ++.+++.+||..||.+||++.++++.+..+..+
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 333 699999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-24 Score=213.04 Aligned_cols=261 Identities=17% Similarity=0.164 Sum_probs=195.5
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC----CCcccceeeeecCCCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH----PNLCKLLGFHARDGSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~g~~~~~~~~ 251 (473)
+|.+.+.||+|+||.||.+...... .+.+++++.......... .+..|+.++..+.. .++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCc
Confidence 7999999999999999999855443 344555555543222222 78889999999873 57888887763 1226
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-----CcEEEe
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-----FSAKLS 326 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~vkl~ 326 (473)
..|+||+.+ |.+|.++..... ...++..+.+.|+.|++.+|++||+.| +|||||||.|++++.. ..+.|.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEE
Confidence 789999988 779999875443 578999999999999999999999999 9999999999999754 469999
Q ss_pred ccCCCc--ccCCCC----------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh
Q 011995 327 GYGCAG--HIPETD----------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394 (473)
Q Consensus 327 DFGla~--~~~~~~----------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 394 (473)
|||+++ .+.... .....||..|.++.+..+...+.+.|+||++.++.||+.|..||............
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 321111 12345899999999999999999999999999999999999999765432221111
Q ss_pred h-hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 395 K-WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 395 ~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
. ...... ... +.......+.++...+-..+...+|....+...|+......
T Consensus 250 ~~~~~~~~---------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 250 EKDPRKLL---------TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHhhhhc---------ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1 000000 000 12233466777777777799999999999999998876654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=205.14 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=194.5
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEec
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
.+|.+...|..|+|+|.++....+...+.- ......+.|..|.-.|+-+.||||+.++|.|... .++.++..||
T Consensus 196 tkl~e~hsgelwrgrwqgndivakil~vr~----~t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq~m 269 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGNDIVAKILNVRE----VTARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQYM 269 (448)
T ss_pred hhhccCCCcccccccccCcchhhhhhhhhh----cchhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeeeec
Confidence 568889999999999998876544333221 1334456788999999999999999999999776 7889999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCcc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 340 (473)
+.|||+..|+.. .+..++-.++.+++.+|++|++|||+..+. |----|....|+||++.+++|+ ++-+++.. ...
T Consensus 270 p~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris-mad~kfsf--qe~ 344 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS-MADTKFSF--QEV 344 (448)
T ss_pred cchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee-cccceeee--ecc
Confidence 999999999764 344567789999999999999999999842 3344788999999999988874 22122111 112
Q ss_pred CcccccccCChhhhhcCCC---CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCC
Q 011995 341 NSSVAAANLSVETLERGLL---TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417 (473)
Q Consensus 341 ~~~~t~~y~aPE~~~~~~~---s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 417 (473)
.....+.||+||.++...- -.++|+|||++++|||.|.+.||.+..+.+..-.+. -..++.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----------------leglrv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----------------LEGLRV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh----------------hccccc
Confidence 3344689999999987653 357999999999999999999998877666443322 123444
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 418 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.+|...+..+..++.-|+..||.+||.+..|+-.|+++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 567888899999999999999999999999999998863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=202.26 Aligned_cols=261 Identities=14% Similarity=0.137 Sum_probs=196.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 253 (473)
-+|.++++||+|.||+++.|+ +......+|+|....+ ....++..|....+.| ..++|...|-|-.+. -+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~---Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG--~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGK---NLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG--KYN 99 (449)
T ss_pred ccceeccccccCcceeeeccc---ccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeecccc--chh
Confidence 378999999999999999997 5555556666655433 3446788888888888 578888887444332 667
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-----CcEEEecc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-----FSAKLSGY 328 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~vkl~DF 328 (473)
.||+|++ |-||+|++.- -+..|+..+++.+|.|++.-++|+|+++ +|+|||||+|+||..- ..+.|+||
T Consensus 100 iLVidLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEec
Confidence 8999998 7799888743 3567999999999999999999999999 9999999999999643 35899999
Q ss_pred CCCcccCCC---------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 329 GCAGHIPET---------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 329 Gla~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|+.+... ......||..||+-....+...+.+.|+-+||-|++++|.|..||.+.......+..+..
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI-- 251 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI-- 251 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh--
Confidence 999866332 234568999999999999999999999999999999999999999876433322221110
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
...........+..+.+.++...+...-..+-.+-|..+-+...+..+..+.
T Consensus 252 --------Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 252 --------GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred --------ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 0000000011123455677777777777888899999988888887766544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=212.06 Aligned_cols=178 Identities=13% Similarity=0.117 Sum_probs=129.1
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC----CCChhhHhHHHHHHHHHhCCCCCcccceee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN----PSSQGVKEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
.+....++|...+.||+|+||+||+|.+.... ...+++|++... ........|.+|+++|..++|+|++..+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDP--GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCC--CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 33455678999999999999999999865321 122344443321 122345678999999999999999964322
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCC-CCCceeeCCCCcE
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-STANIQIDKDFSA 323 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~v 323 (473)
+ +..||||||+++++|.. +. ... ...++.+++.+|.|||+++ |+|||| ||+|||++.++.+
T Consensus 90 ~-----~~~~LVmE~~~G~~L~~-~~--~~~-------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 90 T-----GKDGLVRGWTEGVPLHL-AR--PHG-------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred c-----CCcEEEEEccCCCCHHH-hC--ccc-------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence 1 35799999999999963 21 111 1467889999999999999 999999 9999999999999
Q ss_pred EEeccCCCcccCCCC----------ccCcccccccCChhhhhcCC------CCCcCCch
Q 011995 324 KLSGYGCAGHIPETD----------ISNSSVAAANLSVETLERGL------LTPKSNVW 366 (473)
Q Consensus 324 kl~DFGla~~~~~~~----------~~~~~~t~~y~aPE~~~~~~------~s~~sDvw 366 (473)
||+|||+++.+.... ..+..+++.|++||++.... .+..+|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999998664322 23445677899999885432 23446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=191.01 Aligned_cols=260 Identities=12% Similarity=0.058 Sum_probs=195.2
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC-CCcccceeeeecCCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH-PNLCKLLGFHARDGSD 251 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~ 251 (473)
..++|...+.||.|+||.+|.|.. ...+..+|+|+... .....++..|..+...+++ ..|..+..|..+. +
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~---i~~ge~VAiK~Es~---~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~--~ 84 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGIS---ITSGEEVAIKLESS---KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEK--D 84 (341)
T ss_pred eccceEEEEeecCCchhheeeeee---ccCCceEEEEeecc---cCCCcchhHHHHHHHHhccCCCCchhhhhcccc--c
Confidence 357899999999999999999983 44456666776553 3345678889999999965 4555555555443 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---CcEEEecc
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---FSAKLSGY 328 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DF 328 (473)
.-.||||++ |.||++++.- -...++..+++-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.++||
T Consensus 85 ynvlVMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred cceeeeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEec
Confidence 778999998 7799998843 3456899999999999999999999999 9999999999999643 56899999
Q ss_pred CCCcccCC---------CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 329 GCAGHIPE---------TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 329 Gla~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+++.+.. ....+..||..|.+-....+-..+.+.|+-|+|.+|.++..|..||.+.......+..+..
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI-- 236 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI-- 236 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH--
Confidence 99976532 2234568899999999888888899999999999999999999999987654433322211
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
....-...........+.++...+..|-..--++-|...-+-+.+.-+.
T Consensus 237 --------~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 237 --------SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred --------HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 0000000111223445677888888998888888888877777666443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-22 Score=196.50 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=190.7
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh--hhHhHHHHHHHHHhCCCC-CcccceeeeecCCCCce
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHP-NLCKLLGFHARDGSDQR 253 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~~ 253 (473)
|.....||.|+||.||++... +.+++++........ ....+.+|+.++..+.|+ +|+++++++... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEE
Confidence 566688999999999999865 333344433332222 467899999999999988 799999988544 457
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccCCCc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGCAG 332 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~ 332 (473)
+++++|+.++++.+++........+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||++.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 999999999999977743211126889999999999999999999999 99999999999999988 79999999987
Q ss_pred ccCCCC--------ccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCCh----HHHHhHhhhc
Q 011995 333 HIPETD--------ISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHP----KEERNLVKWS 397 (473)
Q Consensus 333 ~~~~~~--------~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~----~~~~~~~~~~ 397 (473)
...... .....++..|++||.+.+ ..++...|+|++|++++++++|..||..... ......+. .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~ 229 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL-E 229 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH-h
Confidence 554332 355678999999999987 5788999999999999999999999876553 11111111 0
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... . .................+.+++..|+..+|..|.++.+....
T Consensus 230 ~~~-----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPT-----P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCC-----c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000 0 000000000012334678899999999999999998887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-24 Score=226.24 Aligned_cols=255 Identities=18% Similarity=0.197 Sum_probs=181.9
Q ss_pred cCcceeecCCceEEEEEECCCCe--eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 179 SDRCISEGLSSVMYRASFGDDAS--TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
..+++|.|.+|.|+......... ..+.+.++.+...........+..|+.+-..++|+|++..+..+.+. ....-+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchhh
Confidence 45789999999777776433222 11222211001111112223367788888899999999888776654 333444
Q ss_pred EEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 257 YERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 257 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
||||+. +|..++... ..+....+-.++.|++.|+.|||+.| |.|||||++|+++..+|.+||+|||.+..+..
T Consensus 400 mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999999 999998432 35888899999999999999999999 99999999999999999999999999876532
Q ss_pred C------CccCcccccccCChhhhhcCCCCC-cCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 337 T------DISNSSVAAANLSVETLERGLLTP-KSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 337 ~------~~~~~~~t~~y~aPE~~~~~~~s~-~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
. ......|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+...... .......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------~~~~~~~- 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------NYSDQRN- 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------ccccccc-
Confidence 2 234567889999999999999986 4899999999999999999997654332211000 0000000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...-........+...+.+|.++|+.||.+|.|+++|++.
T Consensus 546 --~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 --IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000011233556778899999999999999999999863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=203.28 Aligned_cols=229 Identities=17% Similarity=0.200 Sum_probs=182.6
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh-hhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ-GVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+|.|.||.|+.+.--.+..+.+.++.++........ .......|..++..++ ||.+|+++..+..+ ...+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhhc
Confidence 789999999987644455555666666544332111 1124556888888886 99999998877766 7889999999
Q ss_pred cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCcc
Q 011995 261 FHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS 340 (473)
Q Consensus 261 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 340 (473)
.+|+|...+. ....+++.....+...++-+++++|..+ |+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 80 rgg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred ccchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988883 4557888888999999999999999999 999999999999999999999999999877544333
Q ss_pred CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCC
Q 011995 341 NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFP 420 (473)
Q Consensus 341 ~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 420 (473)
+||..|||||++. ....++|.||||++++||+||..||.. +....+... .-.+|
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~------------------~~~~p 207 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA------------------ELEMP 207 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh------------------ccCCc
Confidence 8999999999998 467899999999999999999999987 222222111 11247
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 011995 421 LKAARTVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 421 ~~~~~~l~~li~~cl~~dP~~RPt~ 445 (473)
...+..+.+++.+++..+|..|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 7888999999999999999999765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-22 Score=210.39 Aligned_cols=245 Identities=18% Similarity=0.214 Sum_probs=173.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChh---hHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG---VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
+|...+.||++.|=.|.+|+.+.+...+ ||.......-. ..+.+.|++ ...++|||.+++.-+-..+ ..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVv-----KVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~--kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVV-----KVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD--KA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEE-----EEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh--HH
Confidence 5667789999999999999876665432 22222222222 334444555 5556999999987665444 56
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|||-+|..+ +|+|.|. ..+-+...+.+.|+.|++.||..+|..+ |+|||||.+||||+.-..+.|+||...+
T Consensus 96 AylvRqyvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHHHHHHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 6788888855 9999883 3445788889999999999999999999 9999999999999999999999997654
Q ss_pred cc--CCCCc-------cCcccccccCChhhhhcC-----------CCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHH
Q 011995 333 HI--PETDI-------SNSSVAAANLSVETLERG-----------LLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEER 391 (473)
Q Consensus 333 ~~--~~~~~-------~~~~~t~~y~aPE~~~~~-----------~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~ 391 (473)
.. +.++. .+...-.+|+|||.+... ..+++.||||+||++.||++ |+++|.-.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------ 242 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------ 242 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------
Confidence 33 22221 122334689999998542 16789999999999999987 78888532
Q ss_pred hHhhhccc-ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 392 NLVKWSRP-FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 392 ~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
++..+... .......+..+.| ..+++++..|++.||++|.++++.|+.-.
T Consensus 243 QL~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 QLLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111110 0000111222222 35789999999999999999999998743
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=170.99 Aligned_cols=182 Identities=15% Similarity=0.053 Sum_probs=132.6
Q ss_pred cCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhH-----hHHHHHHHHHhCC-CCCcccceeeeecCCCCc
Q 011995 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVK-----EFINDVNTLASLQ-HPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 252 (473)
....|++|+||+||.+.-.+.. +....+.......+ .+.+|+++|.++. |++|++++++ +.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k-------~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~ 72 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERK-------FVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DG 72 (218)
T ss_pred cceeecCCCcceEEEeecCCce-------eeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cC
Confidence 3478999999999977532211 22233333333333 5789999999995 5889999875 24
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCC-CCCceeeCCCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-STANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~vkl~DFGla 331 (473)
.+++|||+.|.+|...+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++
T Consensus 73 ~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A 139 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLA 139 (218)
T ss_pred EEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCc
Confidence 6899999999998654411 11357789999999999999 999999 799999999999999999999
Q ss_pred cccCCCCc-----c----------CcccccccCChhhhhcC-CCC-CcCCchHHHHHHHHHHcCCCCCCCCC
Q 011995 332 GHIPETDI-----S----------NSSVAAANLSVETLERG-LLT-PKSNVWSFGIVLLELLTGRKNLDSRH 386 (473)
Q Consensus 332 ~~~~~~~~-----~----------~~~~t~~y~aPE~~~~~-~~s-~~sDvwSlGvvl~elltG~~p~~~~~ 386 (473)
........ . -...++.|++|+...-- ..+ .+.+.++-|+.+|.++||..+..+..
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 85543221 0 01236778888765322 233 56788899999999999998876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=181.86 Aligned_cols=237 Identities=19% Similarity=0.294 Sum_probs=151.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCC----------CCccccee
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQH----------PNLCKLLG 243 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~H----------pnIv~l~g 243 (473)
.+..+..||.|+|+.||.++. ..+...+++++..... .....+++++|.-....+.+ -.++..++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d---~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTD---VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEE---TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEEccccccCCceEEEEEEE---ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 455668999999999999994 4455667777766554 34456777777765555432 12222222
Q ss_pred eeecC----------CCC-----ceEEEEEeccCCChhhhhhc---C-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 011995 244 FHARD----------GSD-----QRMLIYERLFHGSLDRLIYG---R-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQ 304 (473)
Q Consensus 244 ~~~~~----------~~~-----~~~lV~E~~~~gsL~~~l~~---~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ 304 (473)
..... +.. +.+++|+-+ .++|.+++.. . .....+....++.+..|+++.+++||..|
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--- 165 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--- 165 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---
Confidence 22111 001 346778877 5688887632 1 11223456677788899999999999999
Q ss_pred eeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcC--------CCCCcCCchHHHHHHHHHH
Q 011995 305 AMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERG--------LLTPKSNVWSFGIVLLELL 376 (473)
Q Consensus 305 ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~s~~sDvwSlGvvl~ell 376 (473)
+||+||+|+|++++.+|.+.|+||+........... ...+..|.+||..... .++.+.|.|+||+++|.|+
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999999866544332222 4455789999977432 4788999999999999999
Q ss_pred cCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011995 377 TGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442 (473)
Q Consensus 377 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 442 (473)
+|..||.......... | .-..+. +.++.+..||..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~---~------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE---W------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG---G------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc---c------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998653221110 0 111234 788999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-21 Score=176.87 Aligned_cols=174 Identities=11% Similarity=0.054 Sum_probs=128.6
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHh------HHHHHHHHHhCCCCCcccceee
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKE------FINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
..++|...+.||.|+||.||..... ...+++|+.+-.. ....... +.+|+..+.++.|++|..+.++
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~-----~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD-----YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC-----CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4688999999999999999996432 2334455554322 1222222 5799999999999999999988
Q ss_pred eecCC------CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC
Q 011995 245 HARDG------SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318 (473)
Q Consensus 245 ~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~ 318 (473)
+.... ....+|||||++|.+|.++.. ++. ....+++.+|..||..+ ++|||+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEe
Confidence 65432 135899999999999988741 222 34569999999999999 99999999999999
Q ss_pred CCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHH
Q 011995 319 KDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELL 376 (473)
Q Consensus 319 ~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ell 376 (473)
.+| ++|+|||........... ..++....+..++|+|+||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH----------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987655322111 11333444668999999999887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.4e-21 Score=181.95 Aligned_cols=196 Identities=17% Similarity=0.257 Sum_probs=141.0
Q ss_pred CCCCcccceeeeecC-------------------------CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHH
Q 011995 234 QHPNLCKLLGFHARD-------------------------GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIAL 288 (473)
Q Consensus 234 ~HpnIv~l~g~~~~~-------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 288 (473)
.|||||+++++|.+. ....+|+||..++. +|..++..+ ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 599999999887543 12468999988865 899998443 466778888999
Q ss_pred HHHHHHHHhhhcCCCceeecCCCCCceee--CCC--CcEEEeccCCCcccCC--------CCccCcccccccCChhhhhc
Q 011995 289 CAAQGLTFLHEEGPFQAMYNEFSTANIQI--DKD--FSAKLSGYGCAGHIPE--------TDISNSSVAAANLSVETLER 356 (473)
Q Consensus 289 ~i~~~L~yLH~~~~~~ivHrDlkp~NILl--~~~--~~vkl~DFGla~~~~~--------~~~~~~~~t~~y~aPE~~~~ 356 (473)
|++.|+.|||.++ |.|||+|.+|||| |.| -.+.|+|||++---.. .......|....||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 344 3578999998632211 11222345567899999854
Q ss_pred CC------CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHH
Q 011995 357 GL------LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADI 430 (473)
Q Consensus 357 ~~------~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 430 (473)
-. --.++|.|+.|.+.||+++...||.+....... .- ....-.-|. .+..++..++++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~r-----------~Yqe~qLPa----lp~~vpp~~rql 489 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-TR-----------TYQESQLPA----LPSRVPPVARQL 489 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-hh-----------hhhhhhCCC----CcccCChHHHHH
Confidence 22 135899999999999999999999763322110 00 011111122 255667889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 011995 431 ALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 431 i~~cl~~dP~~RPt~~eil~~L~ 453 (473)
+...|+.||++|++..=....|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999998765544443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=169.83 Aligned_cols=140 Identities=12% Similarity=0.086 Sum_probs=104.4
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-Chh-------h-----------------HhHHHHHHHHHhCC
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-SQG-------V-----------------KEFINDVNTLASLQ 234 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~-------~-----------------~~~~~Ei~~l~~l~ 234 (473)
...||+|+||.||+|... .++.+++|+.+.... ... . .....|++++.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 368999999999999854 345566666654311 000 1 12235999999998
Q ss_pred CCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceeecCCCCC
Q 011995 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL-HEEGPFQAMYNEFSTA 313 (473)
Q Consensus 235 HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivHrDlkp~ 313 (473)
++++.....+.. ...+|||||++++++...+. ....+++..+..++.|++.+|.|| |+.+ |+||||||+
T Consensus 78 ~~~v~~p~~~~~----~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~ 147 (190)
T cd05147 78 TAGIPCPEPILL----KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY 147 (190)
T ss_pred HCCCCCCcEEEe----cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 887754433322 22389999998887765432 234688999999999999999999 6888 999999999
Q ss_pred ceeeCCCCcEEEeccCCCccc
Q 011995 314 NIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 314 NILl~~~~~vkl~DFGla~~~ 334 (473)
|||++ ++.++|+|||++...
T Consensus 148 NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HEEEE-CCcEEEEEccccccC
Confidence 99998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-22 Score=195.47 Aligned_cols=170 Identities=16% Similarity=0.223 Sum_probs=129.8
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
++||.|++|...+|.+||.++......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 378899999999999999876666778899999999999999999 77 999999999999999999999999998
Q ss_pred cccCCCC--------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccc
Q 011995 332 GHIPETD--------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 332 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
....... .+...+|.+||+||.+.+..|+.++|||+||++|+||+. -...+.-..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------------- 467 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---------------- 467 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------------
Confidence 7664332 355688999999999999999999999999999999997 222221100
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS 447 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 447 (473)
.+..+-+..+.+.+..+. ++-..|+.+++...|.+||++.+
T Consensus 468 ---t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 468 ---TLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---hhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 011111111111111111 23358999999999999994443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=185.32 Aligned_cols=217 Identities=23% Similarity=0.338 Sum_probs=165.8
Q ss_pred HHhCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecC
Q 011995 230 LASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNE 309 (473)
Q Consensus 230 l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 309 (473)
|+.+.|.|+.+++|.+.+. ...++|.+||.-|+|.|.+.. ....++|.....++++|+.||+|||..- -..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence 4568999999999999887 789999999999999999964 4567999999999999999999999876 239999
Q ss_pred CCCCceeeCCCCcEEEeccCCCcccCCC----CccCcccccccCChhhhhcCC-------CCCcCCchHHHHHHHHHHcC
Q 011995 310 FSTANIQIDKDFSAKLSGYGCAGHIPET----DISNSSVAAANLSVETLERGL-------LTPKSNVWSFGIVLLELLTG 378 (473)
Q Consensus 310 lkp~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~~t~~y~aPE~~~~~~-------~s~~sDvwSlGvvl~elltG 378 (473)
++..|+++|....+||+|||+....... ......-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766431 111122346789999997642 46779999999999999999
Q ss_pred CCCCCCCChHHH-HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 379 RKNLDSRHPKEE-RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 379 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
..||........ .+++.+... + ......|.+.. .....+++..++..||..+|..||++.+|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~----~--~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK----G--GSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh----c--CCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999987443222 223322111 0 00111111110 01344578999999999999999999999999998887
Q ss_pred ccC
Q 011995 458 RKS 460 (473)
Q Consensus 458 ~~~ 460 (473)
...
T Consensus 227 ~~~ 229 (484)
T KOG1023|consen 227 GGS 229 (484)
T ss_pred ccc
Confidence 654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=163.17 Aligned_cols=142 Identities=14% Similarity=0.147 Sum_probs=107.0
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC--------------------hh-----hHhHHHHHHHHHhCC
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--------------------QG-----VKEFINDVNTLASLQ 234 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~-----~~~~~~Ei~~l~~l~ 234 (473)
.+.||+|+||.||+|... .+..+++|+.+..... .. ...+.+|.+.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 478999999999999854 3455566665543210 00 122357899999999
Q ss_pred CCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCC
Q 011995 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTA 313 (473)
Q Consensus 235 HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~ 313 (473)
|+++.....+... ..+|||||++++++...+. ....++......++.|++.+|.+||+ .+ |+||||||+
T Consensus 78 ~~~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~ 147 (190)
T cd05145 78 EAGVPVPEPILLK----KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEY 147 (190)
T ss_pred hCCCCCceEEEec----CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChh
Confidence 9988655544332 2489999998886544321 12357788999999999999999999 88 999999999
Q ss_pred ceeeCCCCcEEEeccCCCcccCC
Q 011995 314 NIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 314 NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|||++ ++.++|+|||++.....
T Consensus 148 NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE-CCCEEEEEcccceecCC
Confidence 99999 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=160.98 Aligned_cols=138 Identities=14% Similarity=0.095 Sum_probs=102.6
Q ss_pred ccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-----CCCCcccceeeeecCCC-C
Q 011995 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-----QHPNLCKLLGFHARDGS-D 251 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~g~~~~~~~-~ 251 (473)
.....||+|+||.||. +.++. .+ ++|+..... ....+.+.+|+.+++.+ .||||++++|++.++.+ .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~---~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDA---QR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred CCcceecCCCceEEEE--CCCCc---Ce-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 4458899999999995 33221 12 355555432 23456799999999999 57999999999987632 2
Q ss_pred c-eEEEEEe--ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCceeecCCCCCceeeCC----CCcE
Q 011995 252 Q-RMLIYER--LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGL-TFLHEEGPFQAMYNEFSTANIQIDK----DFSA 323 (473)
Q Consensus 252 ~-~~lV~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~~~~ivHrDlkp~NILl~~----~~~v 323 (473)
. +.+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++. ++.+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcE
Confidence 3 3378999 5579999999431 35555 35678888888 9999999 999999999999974 3479
Q ss_pred EEeccCCC
Q 011995 324 KLSGYGCA 331 (473)
Q Consensus 324 kl~DFGla 331 (473)
+|+||+.+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=189.51 Aligned_cols=253 Identities=16% Similarity=0.163 Sum_probs=175.2
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC---CCCcccceeee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ---HPNLCKLLGFH 245 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~ 245 (473)
+++-....|.+.+.||+|+||.||+|...+ ++.+++|+.+-.. .+. |.-=.+++.+|+ -+.|..+...+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~----~~~~alK~e~P~~--~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN----GKLVALKVEKPPN--PWE--FYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC----CcEEEEEeecCCC--cee--eeehHHHHHhhchhhhcchHHHHHHH
Confidence 344445678899999999999999998554 5666676654321 121 111122333333 22344444443
Q ss_pred ecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-------
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID------- 318 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~------- 318 (473)
... +.-+||+||.+.|+|.+++. ....++|..++.+..|++..+++||..+ |||+||||+|+||.
T Consensus 764 ~~~--~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 764 VFQ--NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred ccC--CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence 333 56789999999999999994 5567999999999999999999999999 99999999999993
Q ss_pred CCCcEEEeccCCCccc---CCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh
Q 011995 319 KDFSAKLSGYGCAGHI---PET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394 (473)
Q Consensus 319 ~~~~vkl~DFGla~~~---~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 394 (473)
....++|+|||.+-.+ ... .....+.|-.+-.+|...|..|++..|.|+|+-+++.||.|+.- +
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q----- 903 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E----- 903 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H-----
Confidence 2345899999988543 222 44556778889999999999999999999999999999998641 0
Q ss_pred hhcccccccccccccccccccCCCCCHHHHHH-HHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAART-VADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
.| ....+ .++.. ++.....+ ..+|+..+|..|-..=|...+|...|++...++..
T Consensus 904 ~~-----~g~~~---~~~~~----~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 904 VK-----NGSSW---MVKTN----FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred hc-----CCcce---ecccc----chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 00 00000 01111 12222222 33566777775555557888888888877655443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=158.32 Aligned_cols=135 Identities=12% Similarity=0.145 Sum_probs=106.3
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--C-----hhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--S-----QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+.||+|++|.||+|.+.+... .+|+...... . .....+.+|++++..+.|++|.....++... +..
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~-----~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKA-----VIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENF 74 (211)
T ss_pred cccccCceEEEEEEeeCCCce-----EEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCC
Confidence 579999999999998744332 2333222111 0 1124578899999999999988777676554 677
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||++|++|.+++... .+ .+..++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 8999999999999998432 12 78899999999999999999 99999999999999 78899999998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=180.63 Aligned_cols=147 Identities=11% Similarity=0.136 Sum_probs=113.6
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
......|...+.||+|+||+||+|.+.+.....+....+..+... .......+.+|++++..++|++++....++...
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 334455667799999999999999876654433322211111111 112235688999999999999999877776654
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
...++||||+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ .++.++|+||
T Consensus 409 --~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 409 --EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred --CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 56789999999999999883 45789999999999999999 9999999999999 5778999999
Q ss_pred CCCccc
Q 011995 329 GCAGHI 334 (473)
Q Consensus 329 Gla~~~ 334 (473)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-18 Score=182.67 Aligned_cols=137 Identities=19% Similarity=0.222 Sum_probs=108.0
Q ss_pred HHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCC--------C---------CccCcccccccCChhh
Q 011995 291 AQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE--------T---------DISNSSVAAANLSVET 353 (473)
Q Consensus 291 ~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~--------~---------~~~~~~~t~~y~aPE~ 353 (473)
+.+++|||+.+ |+|||+||+|.||+.-|.+|+.|||+++.... . .....++|+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 67899999999 99999999999999999999999999864311 0 1235588999999999
Q ss_pred hhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHH
Q 011995 354 LERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALR 433 (473)
Q Consensus 354 ~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~ 433 (473)
+....|+..+|+|++|+|+||.+-|..||.+..+.+.+..+- .++.....- ......++++++.+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------sd~i~wpE~---------dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------SDDIEWPEE---------DEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------hhhcccccc---------CcCCCHHHHHHHHH
Confidence 999999999999999999999999999999987766543221 111000000 12334789999999
Q ss_pred hcccCCCCCCCH
Q 011995 434 CLQKEPSERPTM 445 (473)
Q Consensus 434 cl~~dP~~RPt~ 445 (473)
+|+.+|..|.-.
T Consensus 295 LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 295 LLRQNPLCRLGT 306 (1205)
T ss_pred HHHhChHhhccc
Confidence 999999999643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=150.95 Aligned_cols=131 Identities=15% Similarity=0.184 Sum_probs=99.8
Q ss_pred ceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CC-----hhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SS-----QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.||+|+||.||+|.+.+.. +.+|+..... .. ....++.+|++++..++|+++.....++... +..+
T Consensus 1 ~ig~G~~~~vy~~~~~~~~-----~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLK-----AVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKT 73 (199)
T ss_pred CCCCCceEEEEEeecCCcc-----EEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCE
Confidence 4899999999999854422 2333322211 11 1135678899999999988766555454444 5678
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||++|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999999998873311 0 78999999999999999 99999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7e-17 Score=152.44 Aligned_cols=145 Identities=15% Similarity=0.122 Sum_probs=105.9
Q ss_pred ccccCcceeecCCceEEEEE-ECCCCeeeeEEEEEEEecCCCC-------------------h----hhHhHHHHHHHHH
Q 011995 176 NFFSDRCISEGLSSVMYRAS-FGDDASTSKKFEATVTRLNPSS-------------------Q----GVKEFINDVNTLA 231 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~~~~~~~~~~~~~~~~~-------------------~----~~~~~~~Ei~~l~ 231 (473)
-|.+.+.||+|+||.||+|. ... .+..+++|+.+..... . ....+.+|+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 47888999999999999997 221 2344556655533110 0 1123568999999
Q ss_pred hCCCCC--cccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecC
Q 011995 232 SLQHPN--LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNE 309 (473)
Q Consensus 232 ~l~Hpn--Iv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrD 309 (473)
++.+.+ +.+++++ ...+|||||+++++|...+.. ...+.......++.|++.+|.+||..+ .|+|||
T Consensus 106 ~L~~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 106 RLYEAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHHhcCCCCCeeeEe------cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 997633 3334332 234899999999888765422 234566677899999999999999997 499999
Q ss_pred CCCCceeeCCCCcEEEeccCCCcccC
Q 011995 310 FSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 310 lkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
|||+||+++ ++.++|+|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=145.56 Aligned_cols=148 Identities=15% Similarity=0.079 Sum_probs=108.8
Q ss_pred HHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC---------------------hhhHhHHH
Q 011995 167 LDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS---------------------QGVKEFIN 225 (473)
Q Consensus 167 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~ 225 (473)
+.++......|...+.||+|+||.||++...+ +..+++|+.+..... .....+..
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPD----GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQK 82 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCC----CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHH
Confidence 34555554458888999999999999998642 344556654432100 01123677
Q ss_pred HHHHHHhCCCCC--cccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 011995 226 DVNTLASLQHPN--LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPF 303 (473)
Q Consensus 226 Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~ 303 (473)
|+.++..+.|.+ +...++. ...++||||+++++|..+... .....++.+++.++.++|..+
T Consensus 83 E~~~l~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g-- 145 (198)
T cd05144 83 EFAALKALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG-- 145 (198)
T ss_pred HHHHHHHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--
Confidence 899999998874 3444331 345899999999998765420 235678899999999999998
Q ss_pred ceeecCCCCCceeeCCCCcEEEeccCCCcccCC
Q 011995 304 QAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 304 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 336 (473)
|+|+||||+||+++.++.++|+|||++.....
T Consensus 146 -i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 146 -IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.5e-15 Score=141.14 Aligned_cols=143 Identities=13% Similarity=0.097 Sum_probs=102.1
Q ss_pred ccee-ecCCceEEEEEECCCCeeeeEEEEE-----EEecC--CCChhhHhHHHHHHHHHhCCCCCc--ccceeeeecCCC
Q 011995 181 RCIS-EGLSSVMYRASFGDDASTSKKFEAT-----VTRLN--PSSQGVKEFINDVNTLASLQHPNL--CKLLGFHARDGS 250 (473)
Q Consensus 181 ~~lG-~G~~g~Vy~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~~ 250 (473)
..|| .||.|+||.+...+...+.+.+... +.+.. ........+.+|++++..+.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 6687 8999999999876544333333210 10100 011234567899999999998875 667766544321
Q ss_pred C--ceEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEec
Q 011995 251 D--QRMLIYERLFH-GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 251 ~--~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
. ..++||||+++ .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+|+||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 1 23599999997 689888743 235543 3578999999999999 99999999999999999999999
Q ss_pred cCCCccc
Q 011995 328 YGCAGHI 334 (473)
Q Consensus 328 FGla~~~ 334 (473)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.2e-15 Score=127.49 Aligned_cols=134 Identities=19% Similarity=0.189 Sum_probs=105.4
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC--CCcccceeeeecCCCCceEEEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH--PNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~~~lV~ 257 (473)
.+.||+|.++.||++...+ +.+.+|... .... ...+.+|+.++..++| .++++++++.... +..+++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-----~~~~iK~~~--~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-----EDYVLKINP--SREK-GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC-----CeEEEEecC--CCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEE
Confidence 4789999999999998644 223333332 2222 4678899999999976 5888888776544 6789999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
||+.++.+..+ +......++.+++.+|++||......++|+|++|.|||++..+.++++|||.+..
T Consensus 73 e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99988777543 4567788899999999999986433499999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-16 Score=167.69 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=182.2
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCc
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 252 (473)
|...+-||+|.|+.|-......+.. . .++.+.... +......+..|..+-..+. |.|++.+++..... +.
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~--~--~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~ 95 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPE--S--SSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RS 95 (601)
T ss_pred ccccccccccccchhhhhhhcCCCc--c--eeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC--cc
Confidence 4444679999999998876433322 1 233333322 2333455566888877786 99999999987655 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCceeecCCCCCceeeCCCC-cEEEeccCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH-EEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGC 330 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGl 330 (473)
.+++++|..++++.+-+.. .+....+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+
T Consensus 96 ~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchh
Confidence 8999999999999888731 12224556677889999999999999 887 99999999999999999 999999999
Q ss_pred CcccCC-CC----ccCccc-ccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 331 AGHIPE-TD----ISNSSV-AAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 331 a~~~~~-~~----~~~~~~-t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|..+.. .. ....++ ++.|+|||...+. ...+..|+||.|+++.-+++|..||......... ...|. ..
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~----~~ 246 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWK----SN 246 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeec----cc
Confidence 987755 22 123466 8999999999874 4578899999999999999999999765443311 11111 00
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ................+++.+++..+|..|.+.+++...
T Consensus 247 ~--------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 247 K--------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred c--------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0 000011133455677889999999999999998877543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.7e-15 Score=132.90 Aligned_cols=138 Identities=15% Similarity=0.115 Sum_probs=92.7
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--ChhhHh---------------------HHHHHHHHHhCCCC
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--SQGVKE---------------------FINDVNTLASLQHP 236 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---------------------~~~Ei~~l~~l~Hp 236 (473)
.+.||+|+||.||+|...+ ...+++|+.+.... ...... ...|...+..+.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~----~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDGD----GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECCC----CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 4789999999999998652 23455655443211 111111 13566666666443
Q ss_pred C--cccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCC
Q 011995 237 N--LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTA 313 (473)
Q Consensus 237 n--Iv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~ 313 (473)
. +.+++++ ...++||||++++.+........ ... .....++.+++.++.++|. .+ |+|+||||+
T Consensus 78 ~~~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~ 144 (187)
T cd05119 78 GVPVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEY 144 (187)
T ss_pred CCCCCceEec------CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChh
Confidence 3 3344332 24589999999855432111100 011 5678899999999999999 88 999999999
Q ss_pred ceeeCCCCcEEEeccCCCcccC
Q 011995 314 NIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 314 NILl~~~~~vkl~DFGla~~~~ 335 (473)
||+++ ++.++|+|||.+....
T Consensus 145 Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hEEEE-CCcEEEEECccccccc
Confidence 99999 8999999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.7e-13 Score=136.82 Aligned_cols=248 Identities=17% Similarity=0.195 Sum_probs=176.6
Q ss_pred ccccCcceee--cCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 176 NFFSDRCISE--GLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 176 ~f~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
.|.....+|. |.+|.||.+.... ......++++.-.... .......=.+|+.....+ .|+|.++.+..+... +
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~ 191 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--G 191 (524)
T ss_pred hcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC--C
Confidence 4666688999 9999999997522 3344555555433332 222233345677777777 599999977776554 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEe
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQ----GLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLS 326 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~ 326 (473)
..++-+|++ +.+|..+.+.. ...++......+..+..+ ||.++|..+ ++|-|+||.||++..+ ...++.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 888889988 46888887542 334667777778888888 999999999 9999999999999999 889999
Q ss_pred ccCCCcccCCCCccCc-------ccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 327 GYGCAGHIPETDISNS-------SVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 327 DFGla~~~~~~~~~~~-------~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|||+...+........ -+...|++||..+ +.++..+|+|++|.++++..+|......... ..|..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~- 337 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ- 337 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc-
Confidence 9999887765543222 3456899999874 4689999999999999999998776543311 11211
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. ...+...|....+.++...+..+++.++-.|++++.++.
T Consensus 338 ---~r-------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ---LR-------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---cc-------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 011222334445566677999999999999999887653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.9e-14 Score=131.67 Aligned_cols=204 Identities=18% Similarity=0.228 Sum_probs=141.7
Q ss_pred HHHHHhCCCCCcccceeeeecCC---CCceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 011995 227 VNTLASLQHPNLCKLLGFHARDG---SDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGP 302 (473)
Q Consensus 227 i~~l~~l~HpnIv~l~g~~~~~~---~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ 302 (473)
+.-|-.+-|-|||+++.|+.+.. .....++.|||..|+|..+|.+.. ....+....-.+|+.||+.||.|||+-.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 44555667999999999886532 245788999999999999996532 34567888889999999999999999875
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCcccCC------CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHH
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE------TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELL 376 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~------~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ell 376 (473)
+|+|+++..+.|++..+|-+||.----...... .......+-++|.+||.-.....+.++|||+||...+||.
T Consensus 198 -piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 -PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred -ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 599999999999999999999853211111000 0111223457899999877777788999999999999998
Q ss_pred cCCCCCCCCChHHH-HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 377 TGRKNLDSRHPKEE-RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 377 tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
-+..--........ ...+.. .+..+-+ ..-++++..|++-.|..||+|++++-..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~---------~i~~len------------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIAN---------VIIGLEN------------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhhhhhh---------heeeccC------------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 77653221111100 000000 0000001 1124788999999999999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.6e-12 Score=130.11 Aligned_cols=143 Identities=15% Similarity=0.118 Sum_probs=95.2
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChh---------------------------------------h
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG---------------------------------------V 220 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------~ 220 (473)
.+.||.|++|.||+|++.++ +.+++|+.+-...... .
T Consensus 122 ~~plasaSigQVh~A~l~~G----~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDG----KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred CcceeeeehhheEEEEecCC----CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 36899999999999998765 3455666543211000 0
Q ss_pred HhHHHHHHHHHhC----CCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHH
Q 011995 221 KEFINDVNTLASL----QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQ-GLT 295 (473)
Q Consensus 221 ~~~~~Ei~~l~~l----~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~ 295 (473)
-.|.+|...+.++ +|.+-+.+-.++.+.. ...+|||||++|++|.++...... .+ .+..++..++. .+.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLN 271 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHH
Confidence 1244555555555 2333333333332221 457899999999999887643211 12 23456666665 468
Q ss_pred HhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 296 FLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 296 yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
.+|..| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 889998 9999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.3e-12 Score=111.18 Aligned_cols=130 Identities=18% Similarity=0.156 Sum_probs=91.1
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcc-cceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC-KLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~lV~E~ 259 (473)
+.|+.|.++.||++...+ ..+.+|+.. ........+.+|+.++..+.+.+++ +++.+. . ...++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~~-----~~~~lK~~~--~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVAN-----KKYVVRIPG--NGTELLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEECC-----eEEEEEeCC--CCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEe
Confidence 568899999999998542 233344332 2221234567899999998665554 444432 2 345799999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG--PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+++.++.+.. .....++.+++.+|+.||..+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 73 i~G~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCcccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9998875431 111345678999999999987 22359999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-12 Score=131.74 Aligned_cols=252 Identities=16% Similarity=0.082 Sum_probs=169.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.+.+|.....||.|.|+.|+....+.. ...+++++-.... ........-..|+.+...+ .|.+++..+.-+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~--~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-- 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPE--GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-- 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCC--CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--
Confidence 345688888999999999999875422 2223322221111 1111112224566666665 577888766555444
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEeccC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYG 329 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFG 329 (473)
...|+-.|||+++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||
T Consensus 339 r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccc
Confidence 5677899999999887665 22345788889999999999999999998 9999999999999886 888999999
Q ss_pred CCcccCCCCccCcccccccC--ChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 330 CAGHIPETDISNSSVAAANL--SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~~~~~~~~~~~t~~y~--aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
++..+..... ....+.+++ +++......+..+.|++|||.-+.|.++|...-.... .|..
T Consensus 413 ~~t~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--------- 474 (524)
T KOG0601|consen 413 CWTRLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--------- 474 (524)
T ss_pred cccccceecc-cccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee---------
Confidence 9865322111 112233444 5556666778999999999999999999876433211 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
+...... . .......+..+...++..++..||.+.++....+...
T Consensus 475 --i~~~~~p-~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 475 --IRSGDTP-N-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --eeccccc-C-CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000000 0 1122377888899999999999999998877665443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-10 Score=120.18 Aligned_cols=147 Identities=16% Similarity=0.235 Sum_probs=112.7
Q ss_pred hhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 011995 218 QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297 (473)
Q Consensus 218 ~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yL 297 (473)
.......+-++.|+.++||||++++..+..+ ...|||.|-+ --|..++.. +....+...+.||+.||.||
T Consensus 51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV--~Pl~~~lk~------l~~~~v~~Gl~qIl~AL~FL 120 (690)
T KOG1243|consen 51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERV--RPLETVLKE------LGKEEVCLGLFQILAALSFL 120 (690)
T ss_pred hhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeecc--ccHHHHHHH------hHHHHHHHHHHHHHHHHHHH
Confidence 3345567788999999999999999988766 6899999987 356666633 23567778899999999999
Q ss_pred hhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHH
Q 011995 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLEL 375 (473)
Q Consensus 298 H~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~el 375 (473)
|+.+ .++|++|..+.|+++..|..||++|-++........ .....-..|..|+.+.... ...|.|.|||+++|+
T Consensus 121 ~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el 196 (690)
T KOG1243|consen 121 NDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEEL 196 (690)
T ss_pred hccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHH
Confidence 9777 599999999999999999999999987754432221 1111223456666653322 457999999999999
Q ss_pred HcC
Q 011995 376 LTG 378 (473)
Q Consensus 376 ltG 378 (473)
+.|
T Consensus 197 ~ng 199 (690)
T KOG1243|consen 197 FNG 199 (690)
T ss_pred hCc
Confidence 999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.9e-12 Score=136.87 Aligned_cols=245 Identities=18% Similarity=0.204 Sum_probs=163.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
+.|.+.+-+-+|.++.++.+.-. ..+..+..++..+.. .....+.+..+-.++-..+||.++...--+.. ...
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa---~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP 878 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPA---GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSP 878 (1205)
T ss_pred ccceecccccCCCCcccccCCcc---ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCC
Confidence 44555566677777777766422 122222222222111 11123334444444444566777655433222 267
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.+||++|+.+++|...|+.. +..+..........+.++++|||... ++|+|++|.|+|+..++..++.|||...
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred cchhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 89999999999999988543 24555556666777889999999997 9999999999999999999999998432
Q ss_pred ccC-------C----------------------CC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCC
Q 011995 333 HIP-------E----------------------TD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGR 379 (473)
Q Consensus 333 ~~~-------~----------------------~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~ 379 (473)
... . .+ .....+|+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 110 0 00 11235688999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHhHhh-hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011995 380 KNLDSRHPKEERNLVK-WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMR 446 (473)
Q Consensus 380 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 446 (473)
+||..........-+. ...+|. .-+...+.++.+++...+..++.+|..+.
T Consensus 1033 pp~na~tpq~~f~ni~~~~~~~p----------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWP----------------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhhhccccCCCCCC----------------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 9998766554332111 000100 01445667888999999999999998765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.2e-11 Score=125.59 Aligned_cols=148 Identities=11% Similarity=0.150 Sum_probs=90.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC---------------------------------hhh
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS---------------------------------QGV 220 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~ 220 (473)
...|+. +.||+|++|.||+|++.++ ++.+++|+.+-.... +..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~---G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDN---GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCC---CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 345666 7899999999999998762 345666666532100 011
Q ss_pred H------hHHHHHHHHHhCC----CCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCC---CCCHHHHHHHH
Q 011995 221 K------EFINDVNTLASLQ----HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP---PIDWNTRVKIA 287 (473)
Q Consensus 221 ~------~~~~Ei~~l~~l~----HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---~l~~~~~~~i~ 287 (473)
+ .|.+|...+.+++ +.+.+.+-.++.+- ....+|||||++|+.+.++-.-...+. .+....+..++
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 1 2344444444442 33333333333321 145689999999999987431111111 12222233333
Q ss_pred HHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC----cEEEeccCCCcccCC
Q 011995 288 LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF----SAKLSGYGCAGHIPE 336 (473)
Q Consensus 288 ~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~~~ 336 (473)
.| ++..| ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 274 ~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 34577 99999999999999888 999999999877643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.7e-10 Score=99.86 Aligned_cols=149 Identities=15% Similarity=0.118 Sum_probs=104.3
Q ss_pred cCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEE
Q 011995 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV 256 (473)
....|-+|+-+.|+++.+.+.....|....|..+... ..-...+-.+|+.+|.+++--.|.--.-++.+. ..-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCeEE
Confidence 4478899999999999988776555554444444332 122345678899999998644443322244443 445689
Q ss_pred EEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC---cEEEeccCCCc
Q 011995 257 YERLFH-GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF---SAKLSGYGCAG 332 (473)
Q Consensus 257 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~ 332 (473)
|||+++ .++.+++...-.. .........++..|-..|.-||..+ |||+||..+||+|..++ .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 999976 3778887653222 2333344788889999999999999 99999999999996543 46899999985
Q ss_pred c
Q 011995 333 H 333 (473)
Q Consensus 333 ~ 333 (473)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-09 Score=105.24 Aligned_cols=264 Identities=17% Similarity=0.203 Sum_probs=160.9
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceee-----eecCCCCce
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGF-----HARDGSDQR 253 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~-----~~~~~~~~~ 253 (473)
++.||+|+-+.+|-.---.+. ..|+.. ........+ -++.|... .||-+-.-+.| +-.+.+...
T Consensus 16 gr~LgqGgea~ly~l~e~~d~------VAKIYh-~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQ------VAKIYH-APPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CccccCCccceeeecchhhch------hheeec-CCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 478999999999964211111 123332 222222222 22233333 56533321111 111111235
Q ss_pred EEEEEeccCCChhhhhh----cCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 254 MLIYERLFHGSLDRLIY----GRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~----~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
-++|..+.+..--..++ ++...+...|...+++++.++.+.+-||.+| .+-+|+.++|+|+++++.|.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccc
Confidence 67777776643222222 2334566899999999999999999999999 8889999999999999999999876
Q ss_pred CCcccC-CCCccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcC-CCCCCCCChH------HHHhHhhh
Q 011995 330 CAGHIP-ETDISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTG-RKNLDSRHPK------EERNLVKW 396 (473)
Q Consensus 330 la~~~~-~~~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG-~~p~~~~~~~------~~~~~~~~ 396 (473)
...... .......++...|.+||.-. +-.-+...|.|.|||++++|+.| +.||.+.... .+..+...
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 544432 22345567889999999865 23346789999999999999876 9999764311 11111110
Q ss_pred cccccccccccccccccccCCCCCH-HHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhhhcccC
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPL-KAARTVADIALRCLQK--EPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~--dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
...+..+ ..... .+ ....+|. -...++..+..+|+.. ++.-|||++-++..|..++....
T Consensus 243 ~f~ya~~-~~~g~--~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASD-QRRGL--KP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechh-ccCCC--CC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 0000000 00000 00 1112232 3457788888999865 46689999999999998876543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=100.09 Aligned_cols=137 Identities=14% Similarity=0.164 Sum_probs=95.2
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh--hhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
..+++|+-+.+|.+.+-+.....|...-|-.+...-.+ ...+-.+|..+|.++.--.|.--+=|..+. +...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCEEEEE
Confidence 46789999999999775544332222222222211111 124457899999988654444333233444 66789999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|++|-.|.+.+... ...++..+-.-+.-||..+ |||+||.++||++..++ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888432 3567777778889999999 99999999999998775 89999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.6e-10 Score=103.54 Aligned_cols=145 Identities=15% Similarity=0.171 Sum_probs=104.0
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCC--CcccceeeeecCC-CCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHP--NLCKLLGFHARDG-SDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~~-~~~~~lV~ 257 (473)
+.|+.|.++.||++...+ ++.+.+|+............+..|++++..+.+. ++.+++.+..... .+..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~----g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC----CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998654 1233344333222112456789999999999763 4566776654321 13568999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG------------------------------------ 301 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------ 301 (473)
||++|.++.+.+.. ..++......++.+++.+|.+||+..
T Consensus 80 e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 80 ERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 99999888776521 34677788888888888888888521
Q ss_pred -----------------CCceeecCCCCCceeeCC--CCcEEEeccCCCcc
Q 011995 302 -----------------PFQAMYNEFSTANIQIDK--DFSAKLSGYGCAGH 333 (473)
Q Consensus 302 -----------------~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~ 333 (473)
+..++|+|+.+.|||++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.2e-09 Score=99.18 Aligned_cols=141 Identities=13% Similarity=0.092 Sum_probs=94.2
Q ss_pred CcceeecCCceEEEEEECCCC---eeeeEEEEEEEecCC-----C----------------ChhhHhHH----HHHHHHH
Q 011995 180 DRCISEGLSSVMYRASFGDDA---STSKKFEATVTRLNP-----S----------------SQGVKEFI----NDVNTLA 231 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~---~~~~~~~~~~~~~~~-----~----------------~~~~~~~~----~Ei~~l~ 231 (473)
...||.|--+.||.|.-.++. .....+++|+.+... . ......+. +|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 367999999999999744310 012344455543321 0 01122233 7999999
Q ss_pred hCCC--CCcccceeeeecCCCCceEEEEEeccCCChhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceee
Q 011995 232 SLQH--PNLCKLLGFHARDGSDQRMLIYERLFHGSLDR-LIYGRSDGPPIDWNTRVKIALCAAQGLTFL-HEEGPFQAMY 307 (473)
Q Consensus 232 ~l~H--pnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH 307 (473)
++.. -++...+++ ...+|||||+.+..+.. .+. ...++......+..+++.+|..| |..+ |||
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9843 455566643 23579999997654422 221 12345556778889999999999 7888 999
Q ss_pred cCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 308 NEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 308 rDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||++.|||++ ++.+.|+|||.+...
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999997 467999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.8e-08 Score=97.01 Aligned_cols=218 Identities=17% Similarity=0.236 Sum_probs=143.7
Q ss_pred CceEEEEEECCCCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCCCCCcccceeeeecC--CCCceEEEEEeccC-C
Q 011995 188 SSVMYRASFGDDASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQHPNLCKLLGFHARD--GSDQRMLIYERLFH-G 263 (473)
Q Consensus 188 ~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~~~lV~E~~~~-g 263 (473)
..+-|++...-+ +.. +..+|++.. .+.......-++.++++.|.|||++.+++... +...++|||+|+++ +
T Consensus 289 ~~Ttyk~~s~~D---G~~--YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVD---GNA--YVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccC---Cce--eeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 356788874333 333 333444211 11112233557899999999999999887632 23678999999876 5
Q ss_pred ChhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 264 SLDRLIYGRS------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 264 sL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
+|.++..... .+..+++..++.++.|+..||.++|+.| +.-+-|.+.+||++.+.+++|+..|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccce
Confidence 7877765432 2234678899999999999999999999 888999999999999999999988877
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..+..+.. |.++. -.+-|.=-||.+++.|.||..--...+......+.
T Consensus 441 Dvl~~d~~------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~----------------- 488 (655)
T KOG3741|consen 441 DVLQEDPT------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT----------------- 488 (655)
T ss_pred eeecCCCC------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH-----------------
Confidence 65544320 11111 23568889999999999996532111111110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
.+....+.++++++......++.+ -+..+++..+
T Consensus 489 ------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 489 ------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 113355667777777777777775 5666666544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.2e-08 Score=88.80 Aligned_cols=141 Identities=14% Similarity=0.080 Sum_probs=95.6
Q ss_pred CceEEEEEECCCCeeeeEEEEEEEecCCC------ChhhHhHHHHHHHHHhCCCC--CcccceeeeecCC--CCceEEEE
Q 011995 188 SSVMYRASFGDDASTSKKFEATVTRLNPS------SQGVKEFINDVNTLASLQHP--NLCKLLGFHARDG--SDQRMLIY 257 (473)
Q Consensus 188 ~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~~--~~~~~lV~ 257 (473)
-|.+|.+.........+.+.++....... .-......+|...+..+..- .+.+.+++..... ....+||+
T Consensus 17 R~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lit 96 (206)
T PF06293_consen 17 RRGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLIT 96 (206)
T ss_pred CceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEE
Confidence 34566666544333444443432211111 12345678888888877433 3445555554421 13458999
Q ss_pred EeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC---cEEEeccCCCcc
Q 011995 258 ERLFHG-SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF---SAKLSGYGCAGH 333 (473)
Q Consensus 258 E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~ 333 (473)
|++++. +|.+++.... .++......++.+++..+.-||..| |+|+|+++.|||++.++ .+.++||+.++.
T Consensus 97 e~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 97 EALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999874 7999885421 2566778899999999999999999 99999999999999887 899999997764
Q ss_pred c
Q 011995 334 I 334 (473)
Q Consensus 334 ~ 334 (473)
.
T Consensus 171 ~ 171 (206)
T PF06293_consen 171 R 171 (206)
T ss_pred C
Confidence 3
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1e-07 Score=91.33 Aligned_cols=108 Identities=14% Similarity=0.106 Sum_probs=81.0
Q ss_pred hHHHHHHHHHhCCCCCc--ccceeeeecCC---CCceEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 011995 222 EFINDVNTLASLQHPNL--CKLLGFHARDG---SDQRMLIYERLFHG-SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLT 295 (473)
Q Consensus 222 ~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~---~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~ 295 (473)
.+.+|...+.++..-+| ...++|..... ...-+||+|++++. +|.+++.... ....+...+..++.+++..+.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHH
Confidence 37789998888843333 34444543211 23578999999876 8988874321 234566778899999999999
Q ss_pred HhhhcCCCceeecCCCCCceeeCC-------CCcEEEeccCCCcc
Q 011995 296 FLHEEGPFQAMYNEFSTANIQIDK-------DFSAKLSGYGCAGH 333 (473)
Q Consensus 296 yLH~~~~~~ivHrDlkp~NILl~~-------~~~vkl~DFGla~~ 333 (473)
-||..| |+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 153 ~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999 999999999999975 46899999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=85.79 Aligned_cols=154 Identities=11% Similarity=0.068 Sum_probs=102.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC--cccceeeee---cC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN--LCKLLGFHA---RD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~---~~ 248 (473)
...+...---|+||.+-|++..+.+...-.|.-.-.+.+.-.-.-....|.+|+..|.++..-+ +.+.. ++. ..
T Consensus 17 ~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~ 95 (216)
T PRK09902 17 EGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE 95 (216)
T ss_pred CCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence 3444444445789999999987765521111111001110001346788999999999985332 34444 322 12
Q ss_pred CCCceEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc--EEE
Q 011995 249 GSDQRMLIYERLFH-GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS--AKL 325 (473)
Q Consensus 249 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--vkl 325 (473)
..-.-+||+|-+++ -+|.+++... .-.+.+...+..++.+|+..|.-||+.+ +.|+|+.+.|||++.++. +++
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEE
Confidence 22346899997754 4898888442 2235677888899999999999999999 999999999999986666 999
Q ss_pred eccCCCc
Q 011995 326 SGYGCAG 332 (473)
Q Consensus 326 ~DFGla~ 332 (473)
+||--++
T Consensus 172 IDlEk~r 178 (216)
T PRK09902 172 LDLEKSR 178 (216)
T ss_pred EEhhccc
Confidence 9997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.3e-09 Score=109.79 Aligned_cols=145 Identities=17% Similarity=0.222 Sum_probs=102.5
Q ss_pred HHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-C-----ccC-----cccccccCChhhhhcC
Q 011995 289 CAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET-D-----ISN-----SSVAAANLSVETLERG 357 (473)
Q Consensus 289 ~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~-----~~~-----~~~t~~y~aPE~~~~~ 357 (473)
+++.|+.|+|... .+||+.|.|++|.++.++..||+.|+.+...... + +.. ......|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3448999999987 6999999999999999999999999987654331 1 111 1223679999999988
Q ss_pred CCCCcCCchHHHHHHHHHH-cCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcc
Q 011995 358 LLTPKSNVWSFGIVLLELL-TGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQ 436 (473)
Q Consensus 358 ~~s~~sDvwSlGvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~ 436 (473)
..+.++|+||+||++|-+. .|..-+..........+. .. .+..-...+..+++.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-----~~---------~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-----RN---------LLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-----hc---------ccccccccccccCcHHHHHHHHHHhc
Confidence 8899999999999999998 455544433211111100 00 00011112245677889999999999
Q ss_pred cCCCCCCCHHHHH
Q 011995 437 KEPSERPTMRSIF 449 (473)
Q Consensus 437 ~dP~~RPt~~eil 449 (473)
.+...||++.+++
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.5e-07 Score=86.52 Aligned_cols=135 Identities=17% Similarity=0.097 Sum_probs=93.8
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC---------------------ChhhHhHHHHHHHHHhCCC
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS---------------------SQGVKEFINDVNTLASLQH 235 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~Ei~~l~~l~H 235 (473)
..++..||-|--+.||.|....+. ++++|+-+.... .-......+|.++|.+|.-
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~----~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGR----KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECCCCC----EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 445689999999999999865433 333444333210 1112345789999999965
Q ss_pred C--CcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCC
Q 011995 236 P--NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTA 313 (473)
Q Consensus 236 p--nIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~ 313 (473)
. .+.+.+++ +..++||||++|-.|...- ++......++..|+.-+.-+-..| |||+|++.-
T Consensus 169 ~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSef 231 (304)
T COG0478 169 EGVKVPKPIAW------NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEF 231 (304)
T ss_pred cCCCCCCcccc------ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence 5 67777654 4567999999886664322 223444555666666666666777 999999999
Q ss_pred ceeeCCCCcEEEeccCCCc
Q 011995 314 NIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 314 NILl~~~~~vkl~DFGla~ 332 (473)
|||++++|.+.++||--+.
T Consensus 232 NIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred eEEEecCCCEEEEeCcccc
Confidence 9999999999999995443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.4e-07 Score=83.86 Aligned_cols=98 Identities=16% Similarity=0.167 Sum_probs=65.0
Q ss_pred hHHHHHHHHHhCCCC--CcccceeeeecCCCCceEEEEEecc--CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-
Q 011995 222 EFINDVNTLASLQHP--NLCKLLGFHARDGSDQRMLIYERLF--HGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF- 296 (473)
Q Consensus 222 ~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~y- 296 (473)
...+|.+.|.++..- ++.+++++. ..+|||||++ |..+..+.... ++......++.+++..+..
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~------~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN------RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE------TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe------CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHH
Confidence 457899999999765 456665442 2379999998 55554433211 1134456777888886655
Q ss_pred hhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 297 LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+|..| |||+||.+.|||++++ .+.|+|||.+...
T Consensus 123 ~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 123 LHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 57888 9999999999999988 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.4e-07 Score=96.90 Aligned_cols=181 Identities=13% Similarity=0.074 Sum_probs=130.1
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC-cccceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN-LCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~~~lV~E~ 259 (473)
+.+++|+++.+|+.+-. +.+.+..+++.. .....-++++|.+++||| .+..++-+ +.++..++++++
T Consensus 248 h~fvK~altknpKkRpt----aeklL~h~fvs~------~l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i 315 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPT----AEKLLQHPFVSQ------TLSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRI 315 (829)
T ss_pred HHHHHHHhcCCCccCCC----hhhheeceeecc------chhhHHHHHHHHHccCCCCcccccccC--Ccccccchhhhh
Confidence 56789999999998622 222222333321 155667899999999999 55554433 334788999999
Q ss_pred ccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC
Q 011995 260 LFHG-SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338 (473)
Q Consensus 260 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 338 (473)
+.++ +-.... ......+...+...+.+.-+.+++|||+.. -+|+| |||..+ +..+..||+....+....
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9877 222111 112233455566677778889999999975 58998 887766 688999999887765543
Q ss_pred -ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 339 -ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 339 -~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
.....+++.+++||+...+.+....|+|++|+-..+|--|.+|-.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 345578899999999999999999999999998888888877654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-05 Score=75.62 Aligned_cols=138 Identities=12% Similarity=0.115 Sum_probs=77.1
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC--cccceeeeecCCCCceEEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN--LCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~~~lV~E 258 (473)
..||.|..+.||+.. ++. +.+++.. .......+.+|.+++..+..-. +.+.+++.... +...+|||
T Consensus 7 ~~i~~G~t~~~y~~~--~~~-----~VlR~~~---~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGK-----WMLKLYN---PGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEec--CCC-----EEEEeCC---CCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--Ceeeeeee
Confidence 678999999999842 221 1122222 2223455789999999986433 35666666444 55788999
Q ss_pred eccCCC-hhhhh---------------------hcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHhhh-cCCC
Q 011995 259 RLFHGS-LDRLI---------------------YGRSDGPPIDWNTRVK-IAL----------CAAQ-GLTFLHE-EGPF 303 (473)
Q Consensus 259 ~~~~gs-L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~i~~-~L~yLH~-~~~~ 303 (473)
+++|.. +...+ +.- .-.......... +.. .+.. ...+|.. ...+
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 998863 22111 110 000111111000 000 0011 1122211 1123
Q ss_pred ceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 304 QAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 304 ~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 579999999999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.7e-06 Score=75.66 Aligned_cols=104 Identities=25% Similarity=0.128 Sum_probs=80.9
Q ss_pred HHHHHHHHhCCC-CCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 011995 224 INDVNTLASLQH-PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGP 302 (473)
Q Consensus 224 ~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ 302 (473)
..|.-+|..+.+ +++.+++|+|- . ++|.||...+++......-......+|..+.+||.+++..+.+|+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG-----~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG-----R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC-----C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888888866 69999999992 2 5789999877664321000112246899999999999999999988554
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
-.+.-.|++++|+-++++|.+|++|...+..
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 4588899999999999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-05 Score=73.40 Aligned_cols=68 Identities=15% Similarity=0.130 Sum_probs=53.7
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...+|||||++|..|.++.. ++. .++..+.+++.-||..| ++|+|..|.|++++.++ ++++||+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~ 180 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQG 180 (229)
T ss_pred eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcc
Confidence 35678999999988876541 222 34556778899999999 99999999999999665 89999986
Q ss_pred Ccc
Q 011995 331 AGH 333 (473)
Q Consensus 331 a~~ 333 (473)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.3e-05 Score=73.23 Aligned_cols=140 Identities=16% Similarity=0.143 Sum_probs=77.8
Q ss_pred ceeecCC-ceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceEEEEEe
Q 011995 182 CISEGLS-SVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 182 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
.|..|.+ ..||+....+. . +.++...... ...+.+|++++..+. +--+.+++++.... +..++|||+
T Consensus 5 ~~~~g~~~~~v~~~~~~~~-----~--~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~ 73 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNP-----G--LYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSA 73 (244)
T ss_pred ecCCCCCcCeEEEEcCCCC-----c--EEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEe
Confidence 3445555 77999864321 1 2222222211 346778999998883 33455677666543 567899999
Q ss_pred ccCCChhhhh-------------------hcCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHh
Q 011995 260 LFHGSLDRLI-------------------YGRSD-GPPIDWN--TRVKIAL--------------------CAAQGLTFL 297 (473)
Q Consensus 260 ~~~gsL~~~l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------~i~~~L~yL 297 (473)
++|.+|.... +.... ...+... ....... .+...+..|
T Consensus 74 i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 153 (244)
T cd05150 74 VPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL 153 (244)
T ss_pred eCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence 9988776432 11100 1111100 0000000 011112222
Q ss_pred hh----cCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 298 HE----EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 298 H~----~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
-. ..++.++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 11 123459999999999999998888999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.2e-05 Score=70.81 Aligned_cols=144 Identities=19% Similarity=0.222 Sum_probs=79.6
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCC--CcccceeeeecCC-CCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHP--NLCKLLGFHARDG-SDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~~-~~~~~lV~ 257 (473)
+.|+.|..+.||+....++ .+.+|+.. .. .....+.+|..+++.+... .+.+++.+..... ....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~~-----~~vlK~~~--~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDG-----RYVLKFYR--PP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETTS-----EEEEEEES--SH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCc-----EEEEEEeC--CC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999986553 22233322 12 4567788999999888533 3456665443321 23468999
Q ss_pred EeccCCChhh----------------hh---hcC-CCCCCCCHHHH---------HHH------------HHHHHH-HHH
Q 011995 258 ERLFHGSLDR----------------LI---YGR-SDGPPIDWNTR---------VKI------------ALCAAQ-GLT 295 (473)
Q Consensus 258 E~~~~gsL~~----------------~l---~~~-~~~~~l~~~~~---------~~i------------~~~i~~-~L~ 295 (473)
+++++..+.. .+ +.. .....+.+... ... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 11 111 01111111110 000 111222 333
Q ss_pred Hhhhc----CCCceeecCCCCCceeeC-CCCcEEEeccCCCc
Q 011995 296 FLHEE----GPFQAMYNEFSTANIQID-KDFSAKLSGYGCAG 332 (473)
Q Consensus 296 yLH~~----~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~ 332 (473)
.++.. .+..++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33321 334699999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.2e-05 Score=82.63 Aligned_cols=153 Identities=13% Similarity=0.114 Sum_probs=87.5
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCc--ccceeeeecCC-CCceEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNL--CKLLGFHARDG-SDQRML 255 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnI--v~l~g~~~~~~-~~~~~l 255 (473)
...|+.|.++.+|+..+.++... ..+.+++............+.+|+++|+.+. |.+| .+++.+|.+.. .+..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~-~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSV-KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcc-eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 46788999999999876543211 2222222221111123356889999999995 6665 67777775431 135789
Q ss_pred EEEeccCCChhhh-----------------------hhcCCC--------CCCCCH--HHHHHHHH--------------
Q 011995 256 IYERLFHGSLDRL-----------------------IYGRSD--------GPPIDW--NTRVKIAL-------------- 288 (473)
Q Consensus 256 V~E~~~~gsL~~~-----------------------l~~~~~--------~~~l~~--~~~~~i~~-------------- 288 (473)
||||++|..+.+. ||.-.. +.+..+ ..+..|..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 9999987643211 111100 001111 11211111
Q ss_pred -HHHHHHHHhhhcCC--------CceeecCCCCCceeeCCC-C-cEEEeccCCCcc
Q 011995 289 -CAAQGLTFLHEEGP--------FQAMYNEFSTANIQIDKD-F-SAKLSGYGCAGH 333 (473)
Q Consensus 289 -~i~~~L~yLH~~~~--------~~ivHrDlkp~NILl~~~-~-~vkl~DFGla~~ 333 (473)
.+...+.+|..+-+ +.+||+|+++.|||++.+ + .+-|.||.++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334566654332 249999999999999853 3 357999998754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00012 Score=68.11 Aligned_cols=153 Identities=16% Similarity=0.147 Sum_probs=93.3
Q ss_pred CCHHHHHHHhcccccCcc---eeecCCceEEEEEECCCCeeeeEEEEEEEecCCC------------------ChhhH--
Q 011995 165 FPLDEVAAACHNFFSDRC---ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS------------------SQGVK-- 221 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~---lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~-- 221 (473)
.+++.|........+... |..|--+.||+|.-.+ ...+++++.+.... ....+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~----~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD----GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC----CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 455666666666655554 4455666799986432 23334444433211 00111
Q ss_pred ---hHHHHHHHHHhCC--CCCcccceeeeecCCCCceEEEEEeccCCCh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 011995 222 ---EFINDVNTLASLQ--HPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDGPPIDWNTRVKIALCAAQGLT 295 (473)
Q Consensus 222 ---~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~ 295 (473)
-..+|+..|.++. +-.+.+-+++. .-.|||||+....+ .-.| ....+.......+..++++.+.
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~ 180 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMR 180 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHH
Confidence 1245777777763 44455555543 23699999854311 1111 1222333356777888888888
Q ss_pred Hhhh-cCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 296 FLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 296 yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
-|-. .+ +||+||+.-|||+. ++.+.|+|||-|....
T Consensus 181 ~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 181 RLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 8877 55 99999999999999 8899999999776543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.7e-05 Score=67.05 Aligned_cols=129 Identities=16% Similarity=0.183 Sum_probs=85.2
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
.+.|++|++|.||+|.+.+. .+++++-+ .+.....+..|.++|..+.--++.+=+-++ +.-++.|||
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-----~~a~Kvrr---~ds~r~~l~kEakiLeil~g~~~~p~vy~y-----g~~~i~me~ 93 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-----EVALKVRR---RDSPRRNLEKEAKILEILAGEGVTPEVYFY-----GEDFIRMEY 93 (201)
T ss_pred hhhhhcccccEEEEeeccCc-----eEEEEEec---CCcchhhHHHHHHHHHHhhhcCCCceEEEe-----chhhhhhhh
Confidence 37899999999999988765 23345444 334467888999999999877665433222 223466999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCC-CCceeeCCCCcEEEeccCCCccc
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS-TANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk-p~NILl~~~~~vkl~DFGla~~~ 334 (473)
+.|-.|.++-... +-.+ ...++..---|-..| |-|+.|. |...+|-.++.+.|+||..|++-
T Consensus 94 i~G~~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9888887765211 2223 334444444455666 8888886 44444444558999999988743
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.1e-05 Score=79.71 Aligned_cols=79 Identities=20% Similarity=0.210 Sum_probs=55.9
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
....|+|||++|..+.+...... ..++...+.....++ -+..+-..| ++|.|..|.||+++.+|.+.+.|||+
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~--f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRA--FLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHH--HHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcc
Confidence 56789999999999988853222 234533333332222 233333456 99999999999999999999999999
Q ss_pred CcccCC
Q 011995 331 AGHIPE 336 (473)
Q Consensus 331 a~~~~~ 336 (473)
...+..
T Consensus 312 ~g~l~~ 317 (517)
T COG0661 312 VGRLDP 317 (517)
T ss_pred eecCCH
Confidence 877653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0002 Score=65.51 Aligned_cols=135 Identities=13% Similarity=0.148 Sum_probs=86.8
Q ss_pred cCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---------------CChhhHhHHHHHHHHHhCC------CCC
Q 011995 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---------------SSQGVKEFINDVNTLASLQ------HPN 237 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~Ei~~l~~l~------Hpn 237 (473)
....||+|+.-.||.-- ++... .+||.+... ......+..+|+.-...+. +.+
T Consensus 5 ~~~~i~~G~~R~cy~HP--~dp~~----cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~ 78 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP--DDPNL----CIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH 78 (199)
T ss_pred CCcccccCCCceEEECC--CCCCe----EEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence 34789999999999753 22211 144433222 0123466677776666555 788
Q ss_pred cccceeeeecCCCCceEEEEEeccC------CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCC
Q 011995 238 LCKLLGFHARDGSDQRMLIYERLFH------GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS 311 (473)
Q Consensus 238 Iv~l~g~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 311 (473)
|.+++|+..++ ....+|+|.+.+ -+|.+++.. ..++. ..... +-.-..||-+++ |+.+|++
T Consensus 79 i~r~~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~ 145 (199)
T PF10707_consen 79 IPRFYGFVETN--LGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLN 145 (199)
T ss_pred cccEeEEEecC--CceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCC
Confidence 99999999887 677899998633 257777732 23554 33333 334457777887 9999999
Q ss_pred CCceeeCCC--C--cEEEec-cCCCc
Q 011995 312 TANIQIDKD--F--SAKLSG-YGCAG 332 (473)
Q Consensus 312 p~NILl~~~--~--~vkl~D-FGla~ 332 (473)
|.||++..+ + .+.|+| ||...
T Consensus 146 ~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred cccEEEEecCCCceEEEEEeCCCCcc
Confidence 999999533 2 477777 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00012 Score=69.08 Aligned_cols=32 Identities=16% Similarity=0.382 Sum_probs=26.6
Q ss_pred CCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 302 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++.++|+|+.+.|||++.++..-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34589999999999999776677999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.3e-05 Score=84.96 Aligned_cols=198 Identities=17% Similarity=0.217 Sum_probs=136.4
Q ss_pred HHHHHHHHHhCCCCCcccceeeeecCCCCc--eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 011995 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQ--RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300 (473)
Q Consensus 223 ~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~--~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 300 (473)
..-|+..+..+.|+|++.+++|....-... ..+.-+++..-++...+. .-..++..+...+..++..||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345677788889999999998876542111 223347777778877773 345688899999999999999999998
Q ss_pred CCCceeecCCCCC---ceeeCCCCcEEEe--ccCCCcccCCCCccCc-ccccccCChhhhhcCCCCC--cCCchHHHHHH
Q 011995 301 GPFQAMYNEFSTA---NIQIDKDFSAKLS--GYGCAGHIPETDISNS-SVAAANLSVETLERGLLTP--KSNVWSFGIVL 372 (473)
Q Consensus 301 ~~~~ivHrDlkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~-~~t~~y~aPE~~~~~~~s~--~sDvwSlGvvl 372 (473)
. ..|.-+..+ +...+..+.+.++ ||+............. ..+..+.++|......+.. ..|+|.+|..+
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6 666655555 4445666777777 8988877654433322 3445677888776555444 47999999999
Q ss_pred HHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 373 LELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 373 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
..+..|..+-....... .++ +........+...+|+..++++|+++.+++...
T Consensus 383 ~~~~~~~~i~~~~~~~~-------------------~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPV-------------------SLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccchh-------------------hhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99998865432211000 000 111112567889999999999999999998765
Q ss_pred H
Q 011995 453 D 453 (473)
Q Consensus 453 ~ 453 (473)
-
T Consensus 436 f 436 (1351)
T KOG1035|consen 436 F 436 (1351)
T ss_pred h
Confidence 4
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00012 Score=76.17 Aligned_cols=141 Identities=15% Similarity=0.061 Sum_probs=85.6
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh------------------------------hhH------hHH
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ------------------------------GVK------EFI 224 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~------~~~ 224 (473)
..||..+.|.||+|++.++. .+++||-+-.-... ..+ .|.
T Consensus 167 ~piaaASlaQVhrA~L~~G~----~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~ 242 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGE----DVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT 242 (538)
T ss_pred chhhhcchhheEEEEecCCC----EEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence 68999999999999998843 34455433221110 011 133
Q ss_pred HHHHHHHhC----CCCC------cccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 011995 225 NDVNTLASL----QHPN------LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGL 294 (473)
Q Consensus 225 ~Ei~~l~~l----~Hpn------Iv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L 294 (473)
+|.+...++ .|-+ |.+++-.+ .....|+||||+|.-+.|.-.-. ...++...+..-+.++..
T Consensus 243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~-- 314 (538)
T KOG1235|consen 243 KEAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYL-- 314 (538)
T ss_pred HHHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHH--
Confidence 344333333 3545 33343222 15689999999999887664322 223555544444443322
Q ss_pred HHhhhcCCCceeecCCCCCceeeC----CCCcEEEeccCCCcccCC
Q 011995 295 TFLHEEGPFQAMYNEFSTANIQID----KDFSAKLSGYGCAGHIPE 336 (473)
Q Consensus 295 ~yLH~~~~~~ivHrDlkp~NILl~----~~~~vkl~DFGla~~~~~ 336 (473)
.-+-..| ++|+|=.|.||++. .++.+.+.|||+...+..
T Consensus 315 ~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2223345 99999999999998 367899999999876643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00034 Score=63.59 Aligned_cols=128 Identities=13% Similarity=0.226 Sum_probs=88.0
Q ss_pred cccccCcceeecCC-ceEEEEEECCCCeeeeEEEEEEEec---CCC----------C-------hhhHhHHHHHHHHHhC
Q 011995 175 HNFFSDRCISEGLS-SVMYRASFGDDASTSKKFEATVTRL---NPS----------S-------QGVKEFINDVNTLASL 233 (473)
Q Consensus 175 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~~---~~~----------~-------~~~~~~~~Ei~~l~~l 233 (473)
.+++..+.||.|.- |.||++...+. .+++|+.+. ... . ....-|..|.....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-----~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-----IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-----EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 67888899999999 99999987665 444555111 100 0 1123577888877776
Q ss_pred ---CCCCc--ccceeeeecCC----------------CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 011995 234 ---QHPNL--CKLLGFHARDG----------------SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQ 292 (473)
Q Consensus 234 ---~HpnI--v~l~g~~~~~~----------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~ 292 (473)
.+.++ |+++||..-.. .....||.||++... .+ ...-+.+|.+
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~ 175 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLR 175 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHH
Confidence 45566 99999974331 123467888765532 11 2234567788
Q ss_pred HHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 293 ~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 176 dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 899999999 999999999987 4589999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00054 Score=67.06 Aligned_cols=78 Identities=18% Similarity=0.180 Sum_probs=52.4
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC---CCcccceeeeecCC-CCceEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH---PNLCKLLGFHARDG-SDQRML 255 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~g~~~~~~-~~~~~l 255 (473)
...||.|..+.||+....++.. .+|+.+ .......+.+|.+.|+.+.- -.+.++++++.... .+..+|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~-----~~k~~~---~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNP-----MPLMAR---SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCCCE-----EEEEec---ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3679999999999986544431 123221 11123578899999998843 35778888775421 255799
Q ss_pred EEEeccCCCh
Q 011995 256 IYERLFHGSL 265 (473)
Q Consensus 256 V~E~~~~gsL 265 (473)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999988765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00065 Score=63.91 Aligned_cols=30 Identities=27% Similarity=0.332 Sum_probs=26.2
Q ss_pred CceeecCCCCCceeeCC-CCcEEEeccCCCc
Q 011995 303 FQAMYNEFSTANIQIDK-DFSAKLSGYGCAG 332 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~-~~~vkl~DFGla~ 332 (473)
..++|+|+.+.|||++. ++.+.|+||-.+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 45999999999999998 5789999997664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0016 Score=63.50 Aligned_cols=155 Identities=14% Similarity=0.080 Sum_probs=84.6
Q ss_pred HHHHHhccccc-----CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC--cccc
Q 011995 169 EVAAACHNFFS-----DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN--LCKL 241 (473)
Q Consensus 169 el~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l 241 (473)
++....+.|.. .+.|..|....+|+....++. +.+++.. . .....+..|++++..+.+.+ +.++
T Consensus 3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~~~~-----~vLr~~~--~--~~~~~~~~e~~~l~~L~~~g~~vp~~ 73 (296)
T cd05153 3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTDSGR-----YVLTLFE--K--VSAEELPFFLALLDHLAERGLPVPRP 73 (296)
T ss_pred HHHHHHHHcCCCchhheecccCccccceEEEEeCCCc-----EEEEEcC--C--CChHhccHHHHHHHHHHHCCCCCCcc
Confidence 44454455543 356777777899998654332 2233322 1 23456777888888874332 4444
Q ss_pred eeee----ecCCCCceEEEEEeccCCChhh----h----------hhcCCC--------CCCCCHHHHH----------H
Q 011995 242 LGFH----ARDGSDQRMLIYERLFHGSLDR----L----------IYGRSD--------GPPIDWNTRV----------K 285 (473)
Q Consensus 242 ~g~~----~~~~~~~~~lV~E~~~~gsL~~----~----------l~~~~~--------~~~l~~~~~~----------~ 285 (473)
+... .....+..++|++|++|..+.. . ++.... .....|.... .
T Consensus 74 i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 153 (296)
T cd05153 74 IADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAE 153 (296)
T ss_pred ccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHH
Confidence 3311 0011245689999998876532 0 111000 0111222211 0
Q ss_pred HHHHHHHHHHHhhhc----CCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 286 IALCAAQGLTFLHEE----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 286 i~~~i~~~L~yLH~~----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
....+...+.++... -+..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 154 DRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 111223344554431 12359999999999999998778899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00098 Score=63.70 Aligned_cols=137 Identities=16% Similarity=0.173 Sum_probs=72.4
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhh-HhHHHHHHHHHhCCCCCcc-cceeeeecCCCCceEEEEEec
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQHPNLC-KLLGFHARDGSDQRMLIYERL 260 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~lV~E~~ 260 (473)
+..|-.+.+|+....+ +.+.+++ ........ -...+|..+++.+....++ +++++. . -++||||+
T Consensus 4 ~~~G~tn~~y~~~~~~-----~~~vlR~--~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i 70 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPG-----ISFVWRP--QSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWL 70 (256)
T ss_pred CCCcCcCCeEEEEeCC-----ccEEEee--CCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEec
Confidence 4567778899886322 2222222 11111111 2457899999998654443 444332 1 26899999
Q ss_pred cCCChhhh-----------------hhcCC-CCCCCCHHHH-HHHHHHH---------HHHHHHhhhc-----CCCceee
Q 011995 261 FHGSLDRL-----------------IYGRS-DGPPIDWNTR-VKIALCA---------AQGLTFLHEE-----GPFQAMY 307 (473)
Q Consensus 261 ~~gsL~~~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------~~~L~yLH~~-----~~~~ivH 307 (473)
+|..+... ||... ...+++.... ..+..++ ...+..+-.. .++.++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 88765421 11111 1122222211 1111111 1112222111 1235899
Q ss_pred cCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 308 NEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 308 rDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+|+.+.||++++++ +.|+||..+..
T Consensus 151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 151 MDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCCcCcEEEeCCC-CEEEeccccCc
Confidence 99999999999887 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.008 Score=59.09 Aligned_cols=160 Identities=13% Similarity=0.090 Sum_probs=86.6
Q ss_pred CCHHHHHHHhcccccC-----cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC--
Q 011995 165 FPLDEVAAACHNFFSD-----RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN-- 237 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~-----~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-- 237 (473)
.+.++|......|... +.++.|....+|+....++. +.+++.... .....+..|++++..|....
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~-----~vLK~~~~~---~~~~~i~~e~~~l~~L~~~g~p 78 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGR-----YILTLYEKR---VKAEELPFFLALTTHLAARGLP 78 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCc-----EEEEEecCC---CCHHHHHHHHHHHHHHHHCCCC
Confidence 4557777776667543 45667777889998643332 223332211 12345566777777774222
Q ss_pred cccceeee----ecCCCCceEEEEEeccCCChhh--------------hhhcCCCC--C-------CCCHHHHH------
Q 011995 238 LCKLLGFH----ARDGSDQRMLIYERLFHGSLDR--------------LIYGRSDG--P-------PIDWNTRV------ 284 (473)
Q Consensus 238 Iv~l~g~~----~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~--~-------~l~~~~~~------ 284 (473)
+.+++... .....+..++|++|++|..+.. .++....+ . .-.|....
T Consensus 79 vp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (307)
T TIGR00938 79 VPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEA 158 (307)
T ss_pred CCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhc
Confidence 34443311 1111256789999998855421 01111110 0 01121110
Q ss_pred ------HHHHHHHHHHHHhhh----cCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 285 ------KIALCAAQGLTFLHE----EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 285 ------~i~~~i~~~L~yLH~----~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.....+...++++.. ..+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 159 ~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 159 APQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011123344555542 223469999999999999998877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.26 E-value=3.7e-05 Score=86.37 Aligned_cols=160 Identities=10% Similarity=-0.010 Sum_probs=115.9
Q ss_pred HHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 011995 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEG 301 (473)
Q Consensus 223 ~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 301 (473)
...|...++...|+++.....-.........+.+++|+.+|.+.+.|.+.. ..+.++..-+.....+.+....-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555666678998887765444444567789999999999999986532 2334444444444444355555555433
Q ss_pred C--CceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-C-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc
Q 011995 302 P--FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET-D-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377 (473)
Q Consensus 302 ~--~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt 377 (473)
. -..+|+++|+.|.+|..+..+|++++|+.+..... . .....+++.|+.++..+.-.++.++|+|..|+.+|++.-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 1 13689999999999999999999999999843322 1 233466778999999988889999999999999999998
Q ss_pred CCCCC
Q 011995 378 GRKNL 382 (473)
Q Consensus 378 G~~p~ 382 (473)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 88776
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0033 Score=61.61 Aligned_cols=31 Identities=19% Similarity=0.193 Sum_probs=26.9
Q ss_pred CCceeecCCCCCceeeCCC----CcEEEeccCCCc
Q 011995 302 PFQAMYNEFSTANIQIDKD----FSAKLSGYGCAG 332 (473)
Q Consensus 302 ~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~ 332 (473)
+..++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4469999999999999985 889999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.018 Score=56.82 Aligned_cols=30 Identities=10% Similarity=0.065 Sum_probs=25.8
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
..+||+|+.+.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 359999999999999977666899999764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0092 Score=60.50 Aligned_cols=77 Identities=14% Similarity=0.164 Sum_probs=47.5
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEE----ecCCC--ChhhHhHHHHHHHHHhCC---CCCcccceeeeecCCCC
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVT----RLNPS--SQGVKEFINDVNTLASLQ---HPNLCKLLGFHARDGSD 251 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~ 251 (473)
+.||.|.+..||++...++. +.+.+|.- +.... .....++..|.+.|..+. -.++.+++.+. . +
T Consensus 32 ~elggGn~N~VyrV~~~~g~---~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~ 104 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGG---KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--E 104 (401)
T ss_pred eEcCCCceEEEEEEEeCCCC---eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--C
Confidence 57899999999999876542 11112221 11101 123456777888888762 24566776542 2 5
Q ss_pred ceEEEEEeccCCC
Q 011995 252 QRMLIYERLFHGS 264 (473)
Q Consensus 252 ~~~lV~E~~~~gs 264 (473)
..++||||+++..
T Consensus 105 ~~~lVME~L~~~~ 117 (401)
T PRK09550 105 LAVTVMEDLSDHK 117 (401)
T ss_pred CCEEEEecCCCcc
Confidence 5789999997643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.024 Score=54.77 Aligned_cols=31 Identities=19% Similarity=0.183 Sum_probs=25.6
Q ss_pred CceeecCCCCCceeeCCCCc-EEEeccCCCcc
Q 011995 303 FQAMYNEFSTANIQIDKDFS-AKLSGYGCAGH 333 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~-vkl~DFGla~~ 333 (473)
+.++|+|+.+.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997554 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.023 Score=56.86 Aligned_cols=144 Identities=13% Similarity=0.197 Sum_probs=77.0
Q ss_pred cceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcc-cceeeeecCCCCceEEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC-KLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~lV~E 258 (473)
..|-.|-...+|+..+.++.. ..+.+.+++.. ......-.-.+|+.++..+..-++. ++++++. . . .|+|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g--~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~-~---g--~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYG--EGVELFFDRDDEIRTFECMSRHGQGPRLLGRFP-N---G--RVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEcc--CCCCeeechHHHHHHHHHHHHcCCCCceEEEEC-C---c--eEEE
Confidence 345457778899987643221 12333333222 1222222336799999988544444 5555542 2 1 5899
Q ss_pred eccCCChhhh-----------------hhcCC-CCC--CCCHHHHHHHHHHH-----------------HHHHHHh----
Q 011995 259 RLFHGSLDRL-----------------IYGRS-DGP--PIDWNTRVKIALCA-----------------AQGLTFL---- 297 (473)
Q Consensus 259 ~~~~gsL~~~-----------------l~~~~-~~~--~l~~~~~~~i~~~i-----------------~~~L~yL---- 297 (473)
|+++.+|... +|... ... ...|..+..+..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987676421 11111 011 12233333333222 1111122
Q ss_pred hh-cCCCceeecCCCCCceeeCC-CCcEEEeccCCCc
Q 011995 298 HE-EGPFQAMYNEFSTANIQIDK-DFSAKLSGYGCAG 332 (473)
Q Consensus 298 H~-~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~ 332 (473)
.. ..+..++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 21 12335899999999999986 4789999998765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.029 Score=55.01 Aligned_cols=32 Identities=13% Similarity=0.081 Sum_probs=28.5
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+.++|+|+.+.||+++.++-+=|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 47999999999999999888999999988653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0025 Score=65.02 Aligned_cols=166 Identities=24% Similarity=0.361 Sum_probs=93.6
Q ss_pred hHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 011995 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299 (473)
Q Consensus 220 ~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~ 299 (473)
..++......++.+.|+|+...+.+..... ....+|+|++ +.||++.+..+. +-.. +++ .
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~-~~Sled~~~~~~----l~~~----------s~~----~ 85 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHY-TMSLEDILKTGN----LKDE----------SLL----A 85 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhh-ccchHHHHHhcc----cchh----------hhc----c
Confidence 356777888999999999999998765543 5588899998 669999884321 1100 111 1
Q ss_pred cCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCC
Q 011995 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGR 379 (473)
Q Consensus 300 ~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~ 379 (473)
++ +.| -|++ +++| .+.... |- ...+++||||+|.++.|+.-|.
T Consensus 86 ~~---~~~-----~~~~-------~~td----~~~t~~-------------~~-----~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 86 HG---VLH-----LNII-------YITD----HFLTKY-------------PS-----PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred cc---cce-----ehhh-------hccc----cccccC-------------CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence 11 222 1222 2222 000000 00 0124999999999999999998
Q ss_pred CCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 011995 380 KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448 (473)
Q Consensus 380 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 448 (473)
.-+......+....+. .+..++.....+.-.. .+...+...+.++...|+-..|..||...++
T Consensus 129 ~l~~~~~~s~~l~~i~---k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 129 SLEAELTESEYLEILL---KYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHHHHH---HhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 7665443333222221 1111111111000000 1233556677889999999999988765443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.027 Score=56.08 Aligned_cols=78 Identities=12% Similarity=0.149 Sum_probs=43.3
Q ss_pred ceeecCCceEEEEEECCCC-eeeeEEEEEEEec-C-CCChhhHhHHHHHHHHHhCC--CC-CcccceeeeecCCCCceEE
Q 011995 182 CISEGLSSVMYRASFGDDA-STSKKFEATVTRL-N-PSSQGVKEFINDVNTLASLQ--HP-NLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~-~-~~~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~g~~~~~~~~~~~l 255 (473)
.||.|....||++...++. ....+.+....+. . .-.-...+..-|.+.|+... -| .+.++|.| +. +...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~--e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DT--EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cc--cccee
Confidence 5799999999999864331 2222222222222 1 11233455566777777653 34 45556433 33 55679
Q ss_pred EEEeccCC
Q 011995 256 IYERLFHG 263 (473)
Q Consensus 256 V~E~~~~g 263 (473)
|||+++..
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.01 Score=57.49 Aligned_cols=131 Identities=15% Similarity=0.064 Sum_probs=85.9
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-----------------CCChh----hHhHHHHHHHHHhCC-
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-----------------PSSQG----VKEFINDVNTLASLQ- 234 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~Ei~~l~~l~- 234 (473)
+..++.||-|--+-||.+...++... ++|+-++. .+..| +-...+|+..|+.|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~----~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPL----ILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhccccccccccceEEEecCCCCch----hHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 56789999999999999986544321 12222211 01111 123467888888884
Q ss_pred CC-CcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCC
Q 011995 235 HP-NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTA 313 (473)
Q Consensus 235 Hp-nIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~ 313 (473)
|. -+.+.+++ +..++|||++.+-.|...-+- .+..+ +...+..-|--|-.+| +||+|+.-=
T Consensus 170 ~gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEF 231 (465)
T KOG2268|consen 170 RGFPVPKPIDH------NRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEF 231 (465)
T ss_pred cCCCCCCcccc------cceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC---ceecccchh
Confidence 32 24444443 456899999988877654311 12233 3334444566677888 999999999
Q ss_pred ceeeCCCCcEEEeccC
Q 011995 314 NIQIDKDFSAKLSGYG 329 (473)
Q Consensus 314 NILl~~~~~vkl~DFG 329 (473)
||++++++.++++||-
T Consensus 232 Nimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFP 247 (465)
T ss_pred eeEEecCCCEEEeech
Confidence 9999999999999995
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.044 Score=53.20 Aligned_cols=73 Identities=23% Similarity=0.288 Sum_probs=41.0
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC---CCCcccceeeeecCCCCceEEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ---HPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~lV 256 (473)
.+.|+.|....+|+..- ++ +.+-+|+.. ......|..|.+-|+.|. --.+.+++++.... +.-+||
T Consensus 22 ~~~v~GG~i~~a~~~~~-~~----~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-DG----GSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEET-TS-----EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEE
T ss_pred eEecCCCChhheEEEEC-CC----ccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEE
Confidence 36788888999999862 21 233355443 233456788888888873 34566788776655 455899
Q ss_pred EEeccCC
Q 011995 257 YERLFHG 263 (473)
Q Consensus 257 ~E~~~~g 263 (473)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.02 Score=56.32 Aligned_cols=73 Identities=12% Similarity=0.035 Sum_probs=57.1
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...|++|++. |++|.- + ....|.+...++.+.+..++-+..+- +.-|||+.-.||||+ +|++.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 5566777764 444432 2 12468899999999888888777765 599999999999999 99999999999
Q ss_pred Cccc
Q 011995 331 AGHI 334 (473)
Q Consensus 331 a~~~ 334 (473)
++.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9854
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.15 Score=50.60 Aligned_cols=144 Identities=13% Similarity=0.122 Sum_probs=89.0
Q ss_pred ccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCCh---h----------------h-HhHHHHHHHHHhCCCC
Q 011995 178 FSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQ---G----------------V-KEFINDVNTLASLQHP 236 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~---~----------------~-~~~~~Ei~~l~~l~Hp 236 (473)
.+..+|..|--+.||.++-.++.. +.|.+.--+..+..-.. + + --...|+.-|.+++.-
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344788999999999998665544 33433333322221100 0 0 1124577777777654
Q ss_pred CcccceeeeecCCCCceEEEEEeccCCCh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 237 NLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 237 nIv~l~g~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
.|.----+.. ...+|||+|+..... .-.| ....++...+..+-.+++.-+.-|.+.+ .+||.||.--|+
T Consensus 227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL 296 (520)
T ss_pred CCCCCCceee----ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence 4321111111 234799999843221 1111 2335666677788888888888888887 699999999999
Q ss_pred eeCCCCcEEEeccCCCc
Q 011995 316 QIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~ 332 (473)
|+.. |.+.|+|-+-+.
T Consensus 297 Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSV 312 (520)
T ss_pred eEEC-CEEEEEEccccc
Confidence 8864 588999987554
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.12 Score=51.42 Aligned_cols=30 Identities=7% Similarity=0.145 Sum_probs=25.6
Q ss_pred CceeecCCCCCceeeCC-CCcEEEeccCCCc
Q 011995 303 FQAMYNEFSTANIQIDK-DFSAKLSGYGCAG 332 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~-~~~vkl~DFGla~ 332 (473)
..++|+|+.+.|||+++ ++.++++||..|.
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 35899999999999975 5789999998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.025 Score=52.25 Aligned_cols=29 Identities=34% Similarity=0.424 Sum_probs=20.6
Q ss_pred ceeecCCCCCceee-CCCCcEEEeccCCCc
Q 011995 304 QAMYNEFSTANIQI-DKDFSAKLSGYGCAG 332 (473)
Q Consensus 304 ~ivHrDlkp~NILl-~~~~~vkl~DFGla~ 332 (473)
.++|+|+.+.|||+ +.++.++++||-.+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999997664
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.49 Score=46.86 Aligned_cols=159 Identities=18% Similarity=0.181 Sum_probs=86.2
Q ss_pred CCHHHHHHHhcccccC-----cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC--
Q 011995 165 FPLDEVAAACHNFFSD-----RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN-- 237 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~-----~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-- 237 (473)
+.-.++..+...|..+ ..|.+ .-..||+....++.. .+++.+. . ....++.-|++.|..+.-..
T Consensus 11 ~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-----iLki~~~--~-~~~~~i~~el~~l~~La~~~i~ 81 (331)
T COG2334 11 LTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-----ILKIYRP--G-WTRAEIPFELALLQHLAERGIP 81 (331)
T ss_pred cChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-----EEEEecC--C-CCHHHHHHHHHHHHHHHHcCCC
Confidence 3444555554444322 34444 456688887655543 2333332 2 45567778888888873222
Q ss_pred -ccc---ceeeeecCCCC--ceEEEEEeccCCChhh-h--------------hhcC----C--C---CCCCCHHH-----
Q 011995 238 -LCK---LLGFHARDGSD--QRMLIYERLFHGSLDR-L--------------IYGR----S--D---GPPIDWNT----- 282 (473)
Q Consensus 238 -Iv~---l~g~~~~~~~~--~~~lV~E~~~~gsL~~-~--------------l~~~----~--~---~~~l~~~~----- 282 (473)
.++ +-|-....-.. ..+-|++|++|..+.. . |+.. . . .....|..
T Consensus 82 v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~ 161 (331)
T COG2334 82 VPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRA 161 (331)
T ss_pred CCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchh
Confidence 222 11211111113 7788899999887762 1 1110 0 0 11233431
Q ss_pred --------HHHHHHHHHHHHHHhhhcC----CC---ceeecCCCCCceeeCCCCc-EEEeccCCCc
Q 011995 283 --------RVKIALCAAQGLTFLHEEG----PF---QAMYNEFSTANIQIDKDFS-AKLSGYGCAG 332 (473)
Q Consensus 283 --------~~~i~~~i~~~L~yLH~~~----~~---~ivHrDlkp~NILl~~~~~-vkl~DFGla~ 332 (473)
......++...+..+.+.- +. .+||+|+.+.|||++.+.. +.++|||-+.
T Consensus 162 ~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 162 LLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 0112334444455444433 22 2999999999999998874 8999999765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.29 Score=49.70 Aligned_cols=77 Identities=9% Similarity=0.026 Sum_probs=43.7
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--ChhhHhHHHHHHHHHhCC---CCCcccceeeeecCCCCceEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--SQGVKEFINDVNTLASLQ---HPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~l 255 (473)
+.||.|....||+....++. .+.+.+....+.... .....+-..|.+.|..+. ..++.+++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~~~~s-vVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de----d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSSSGS-FVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR----TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEcCCcc-EEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC----CCCEE
Confidence 67899999999998753221 111111111111111 123344455666666653 247778887764 44678
Q ss_pred EEEeccC
Q 011995 256 IYERLFH 262 (473)
Q Consensus 256 V~E~~~~ 262 (473)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.25 Score=50.12 Aligned_cols=78 Identities=17% Similarity=0.175 Sum_probs=44.5
Q ss_pred cceeecCCceEEEEEECCCCe---eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcc-cceeeeecCCCCceEEE
Q 011995 181 RCISEGLSSVMYRASFGDDAS---TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC-KLLGFHARDGSDQRMLI 256 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~lV 256 (473)
..|..|-...+|++...++.. ..+.+.+.+ ........-.-.+|++++..+...++. ++++.+. -++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~--~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK--SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEe--ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------CEEE
Confidence 455568888999998654321 111121111 111222222335789999999665555 4555442 2599
Q ss_pred EEeccCCChh
Q 011995 257 YERLFHGSLD 266 (473)
Q Consensus 257 ~E~~~~gsL~ 266 (473)
+||++|-.|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999987764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.78 E-value=1.3 Score=43.88 Aligned_cols=29 Identities=14% Similarity=0.132 Sum_probs=23.9
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
..+||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3589999999999995 4 578999997653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.1 Score=52.69 Aligned_cols=78 Identities=15% Similarity=0.148 Sum_probs=45.4
Q ss_pred cceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCC-ChhhHhHHHHHHHHHhCC--CC-CcccceeeeecCCCCceEE
Q 011995 181 RCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPS-SQGVKEFINDVNTLASLQ--HP-NLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~--Hp-nIv~l~g~~~~~~~~~~~l 255 (473)
+.||.|.-..||++.... ......+.+....+...+ .-...+..-|.+.|+.+. -| .+.++|.| +. +...+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~--e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS--VMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc--HHhhH
Confidence 578999999999998642 222222222222332211 334566667778887763 34 45556543 33 56678
Q ss_pred EEEeccC
Q 011995 256 IYERLFH 262 (473)
Q Consensus 256 V~E~~~~ 262 (473)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.2 Score=46.17 Aligned_cols=125 Identities=20% Similarity=0.207 Sum_probs=78.8
Q ss_pred hHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 011995 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299 (473)
Q Consensus 220 ~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~ 299 (473)
..-|..+..++.+++ .|+++.. ++.-.+-+++|+|..... ... .++..=+..|.-.|+
T Consensus 102 ~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------------~~~-N~i~agi~~L~~fH~ 159 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------------NFS-NFITAGIKDLMDFHS 159 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------------chh-HHHHHhHHHHHHhhc
Confidence 345678888888775 3777752 233567789998844211 111 122222467888895
Q ss_pred cCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCC
Q 011995 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGR 379 (473)
Q Consensus 300 ~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~ 379 (473)
.+ .+.+|+|-.|+||+-|..|.+||.|-+.--. + +..|.- + .....+.++.+-+|=.-+++++..+
T Consensus 160 ~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~--------~V~~vN-~--~Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 160 EN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N--------QVNMVN-I--EYESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred cC-CCeecCCCChhheeecCCCCEEecChhhhhh--h--------eeeEEe-e--eccccChHHHHHHHHHHHHHHHHHH
Confidence 43 2599999999999999999999999874311 0 111111 1 1223567777777777777777654
Q ss_pred C
Q 011995 380 K 380 (473)
Q Consensus 380 ~ 380 (473)
.
T Consensus 226 ~ 226 (308)
T PF07387_consen 226 R 226 (308)
T ss_pred h
Confidence 4
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.34 Score=48.70 Aligned_cols=62 Identities=13% Similarity=0.002 Sum_probs=44.5
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~ 318 (473)
....|+-+|+.|.++..++... ..++..+.+++.-.+.++-.+--.. ..+|.|+.|.||++-
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~----~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWK----SQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhhcc----cChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 3456777889899999888432 3455566777776677765554433 299999999999994
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.23 E-value=1.6 Score=40.66 Aligned_cols=46 Identities=24% Similarity=0.379 Sum_probs=31.5
Q ss_pred hhHhHHHHHHHHHhCCCC---CcccceeeeecCCCCceEEEEEeccCCChh
Q 011995 219 GVKEFINDVNTLASLQHP---NLCKLLGFHARDGSDQRMLIYERLFHGSLD 266 (473)
Q Consensus 219 ~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~~~~~~~~~lV~E~~~~gsL~ 266 (473)
...-|..|+.-|..+.-- ++.+++.+ ....++.|+||||++-|.++
T Consensus 51 ~~~~f~AEa~gL~~la~s~ti~VP~vi~~--G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 51 QLSMFTAEADGLELLARSNTITVPKVIAV--GASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred hHHHHHHHHHHHHHHHhcCCccccceEEe--cCCCCeeEEEEeeccCCCCC
Confidence 345678888877777443 44555433 33448899999999987775
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.90 E-value=1.5 Score=50.40 Aligned_cols=30 Identities=33% Similarity=0.388 Sum_probs=25.2
Q ss_pred ceeecCCCCCceeeCCCC--cEE-EeccCCCcc
Q 011995 304 QAMYNEFSTANIQIDKDF--SAK-LSGYGCAGH 333 (473)
Q Consensus 304 ~ivHrDlkp~NILl~~~~--~vk-l~DFGla~~ 333 (473)
.+||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 599999999999999875 454 999997754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.68 E-value=1.5 Score=45.48 Aligned_cols=29 Identities=17% Similarity=0.246 Sum_probs=23.9
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
..++|+|+-+.|||.+.++ ++++||-.|.
T Consensus 284 ~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCCC-EEEEeecccc
Confidence 4589999999999987554 9999997654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.072 Score=57.71 Aligned_cols=40 Identities=13% Similarity=0.174 Sum_probs=19.4
Q ss_pred CCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCCCh
Q 011995 35 EPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPSS 78 (473)
Q Consensus 35 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~~ 78 (473)
.+.+..|+|+|.+|+++.+++.|+.|| |++|+ +.|.+|.+
T Consensus 470 ~LdLs~N~lsg~iP~~l~~L~~L~~L~---Ls~N~-l~g~iP~~ 509 (623)
T PLN03150 470 VLDLSYNSFNGSIPESLGQLTSLRILN---LNGNS-LSGRVPAA 509 (623)
T ss_pred EEECCCCCCCCCCchHHhcCCCCCEEE---CcCCc-ccccCChH
Confidence 344444444444444444444444444 44444 44555544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 473 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-27 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-25 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-21 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-05 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 473 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-81 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-79 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-70 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-41 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-31 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-30 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-28 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-28 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-27 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-26 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-26 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-25 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-25 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-23 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-22 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-22 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-21 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-21 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-21 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-18 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-17 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-17 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-17 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-17 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-17 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-17 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-16 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-16 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-16 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-16 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-16 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 7e-16 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-15 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-15 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-15 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-15 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-15 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-15 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 7e-15 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-15 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-14 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-14 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-14 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-14 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-14 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-14 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-14 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-14 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-14 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-14 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-13 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-13 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-13 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-13 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-13 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-13 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 8e-13 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-12 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-12 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-12 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-12 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-12 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-12 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 8e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-11 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-11 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-11 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-11 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-11 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-11 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-11 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-11 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-10 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-10 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-10 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-10 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-10 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-10 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-10 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-09 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-09 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-09 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-09 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-09 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-09 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-09 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-09 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-09 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-08 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-08 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-08 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-08 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-08 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-08 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-08 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-08 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-07 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-07 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-07 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-07 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-07 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-05 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-05 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-05 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-04 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-04 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-04 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-04 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-04 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-04 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-04 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 8e-04 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-04 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-81
Identities = 76/320 (23%), Positives = 141/320 (44%), Gaps = 43/320 (13%)
Query: 159 TGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFG-------DDASTSKKFEATVT 211
+F E+ +NF D + M FG ++ V
Sbjct: 9 DTRFHSFSFYELKNVTNNF--DERPISVGGNKMGEGGFGVVYKGYVNNT------TVAVK 60
Query: 212 RLNP-----SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD 266
+L + + ++F ++ +A QH NL +LLGF + D L+Y + +GSL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYVYMPNGSLL 118
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
+ PP+ W+ R KIA AA G+ FLHE ++ + +ANI +D+ F+AK+S
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKIS 175
Query: 327 GYGCAGHIPETDISNSS--VA-----AANLSVETLE--RGLLTPKSNVWSFGIVLLELLT 377
+G A + + + + A E RG +TPKS+++SFG+VLLE++T
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAP------EALRGEITPKSDIYSFGVVLLEIIT 229
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQK 437
G +D + L+ ++ + +D ++ + + +A +CL +
Sbjct: 230 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286
Query: 438 EPSERPTMRSIFEELDRQES 457
+ ++RP ++ + + L +
Sbjct: 287 KKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-79
Identities = 89/323 (27%), Positives = 156/323 (48%), Gaps = 22/323 (6%)
Query: 136 SFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRAS 195
+ T S S +P PL ++ A +NF I G+ +Y+
Sbjct: 4 KYSKATNSINDALSSSYLVPFES----YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV 59
Query: 196 FGDDASTSKKFEATVTRLNPSS-QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254
D A + + R P S QG++EF ++ TL+ +HP+L L+GF ++ +
Sbjct: 60 LRDGA------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER--NEMI 111
Query: 255 LIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTA 313
LIY+ + +G+L R +YG + W R++I + AA+GL +LH ++ + +
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSI 168
Query: 314 NIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN----LSVETLERGLLTPKSNVWSFG 369
NI +D++F K++ +G + E D ++ S + E +G LT KS+V+SFG
Sbjct: 169 NILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228
Query: 370 IVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVAD 429
+VL E+L R + P+E NL +W+ + +L I+DP L + ++ R D
Sbjct: 229 VVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-QLEQIVDPNLADKIRPESLRKFGD 287
Query: 430 IALRCLQKEPSERPTMRSIFEEL 452
A++CL +RP+M + +L
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 2e-70
Identities = 83/305 (27%), Positives = 148/305 (48%), Gaps = 19/305 (6%)
Query: 153 PLPPTGTGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTR 212
P G L+ F L E+ A NF + + G +Y+ D V R
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT------LVAVKR 61
Query: 213 LNP-SSQGVK-EFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIY 270
L +QG + +F +V ++ H NL +L GF +R+L+Y + +GS+ +
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP--TERLLVYPYMANGSVASCLR 119
Query: 271 GRSDG-PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
R + PP+DW R +IAL +A+GL +LH+ + ++ + ANI +D++F A + +G
Sbjct: 120 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 330 CAGHIPETDISNSSVAAAN----LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSR 385
A + D ++ + A ++ E L G + K++V+ +G++LLEL+TG++ D
Sbjct: 180 LAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238
Query: 386 HPKEER--NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
+ L+ W + L + +L ++D L+G + + + +AL C Q P ERP
Sbjct: 239 RLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297
Query: 444 TMRSI 448
M +
Sbjct: 298 KMSEV 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-41
Identities = 48/322 (14%), Positives = 105/322 (32%), Gaps = 42/322 (13%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE 222
+ + + + G +++A ++ V + +
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-------YVAVKIFPIQDKQSWQ 64
Query: 223 FINDVNTLASLQHPNLCKLLGF--HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDW 280
+V +L ++H N+ + +G LI GSL + + W
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSW 120
Query: 281 NTRVKIALCAAQGLTFLHEEGPFQAMYNE-------FSTANIQIDKDFSAKLSGYGCAGH 333
N IA A+GL +LHE+ P ++ + N+ + + +A ++ +G A
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA-- 178
Query: 334 IPETDISNSSVAAANLSV--------ETLERGLL-----TPKSNVWSFGIVLLELLTGRK 380
+ S + V E LE + + ++++ G+VL EL +
Sbjct: 179 --LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 381 NLDSRHPKEERNLVK--WSRPFLAD--DCRLSLIMDPQLKGRFPLKAA-RTVADIALRCL 435
D + + P L D + + P L+ + A + + C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 436 QKEPSERPTMRSIFEELDRQES 457
+ R + + E + + +
Sbjct: 297 DHDAEARLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 61/341 (17%), Positives = 114/341 (33%), Gaps = 53/341 (15%)
Query: 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI 224
E + N I G +Y+ S + K F S + FI
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF---------SFANRQNFI 53
Query: 225 N--DVNTLASLQHPNLCKLLGFHAR---DGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
N ++ + ++H N+ + + R DG + +L+ E +GSL + + + D
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SD 109
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYN------EFSTANIQIDKDFSAKLS--GYGCA 331
W + ++A +GL +LH E P Y + ++ N+ + D + +S G
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 332 GHIPETDISNSSVAAANLSV--------ETLERGL-------LTPKSNVWSFGIVLLELL 376
AA V E LE + + ++++ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 377 TGRKNLDSRHPKEERNL----VKWSRPFLADDCRLSLIMD--PQLKGRFPL--KAARTVA 428
+L E + + P D L P+ + A R++
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 429 DIALRCLQKEPSERPTMRSIFEELDR----QESRKSSSSTV 465
+ C ++ R T + E + E KS S T
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 43/280 (15%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLL 242
+ G V+ +A + K+ E S K FI ++ L+ + HPN+ KL
Sbjct: 16 VGRGAFGVVCKAKWRAKDVAIKQIE--------SESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 243 GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGP 302
G + L+ E GSL +++G P + L +QG+ +LH P
Sbjct: 68 GA----CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 303 FQAMYNEFSTANIQIDKDFS-AKLSGYGCAGHIPETDISNSSVA----AANLSVETLERG 357
++ + N+ + + K+ +G A DI AA ++ E E
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 358 LLTPKSNVWSFGIVLLELLTGR---KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414
+ K +V+S+GI+L E++T R + + + +RP L +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL------PKP 232
Query: 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
++ + RC K+PS+RP+M I + +
Sbjct: 233 IE------------SLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+ ++ V EF+ +V + L+HPN+ +G A ++ E L GSL RL++
Sbjct: 72 DFHAERVNEFLREVAIMKRLRHPNIVLFMG--AVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333
+D R+ +A A+G+ +LH P ++ + N+ +DK ++ K+ +G +
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
Query: 334 IPETDISNSSVA--AANLSVETLERGLLTPKSNVWSFGIVLLELLTGR---KNLDSR--- 385
T +S+ S A ++ E L KS+V+SFG++L EL T + NL+
Sbjct: 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248
Query: 386 HPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445
+ R + + +PQ+ A I C EP +RP+
Sbjct: 249 AAVGFKCK----RLEIPRNL------NPQV------------AAIIEGCWTNEPWKRPSF 286
Query: 446 RSIFEELDR 454
+I + L
Sbjct: 287 ATIMDLLRP 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 47/279 (16%), Positives = 96/279 (34%), Gaps = 54/279 (19%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ + + F+ +V + L+HPN+ K +G +D + I E + G+L +I +
Sbjct: 44 IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGII--K 99
Query: 273 SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSG 327
S W+ RV A A G+ +LH ++ N + ++ + ++
Sbjct: 100 SMDSQYPWSQRVSFAKDIASGMAYLHSMN--------IIHRDLNSHNCLVRENKNVVVAD 151
Query: 328 YGCAGHIPETDISNSSVAAANLSV----------------ETLERGLLTPKSNVWSFGIV 371
+G A + + + + E + K +V+SFGIV
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211
Query: 372 LLELLTGRK---NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVA 428
L E++ + R N+ + + +C P
Sbjct: 212 LCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC------PPSF------------F 253
Query: 429 DIALRCLQKEPSERPTMRSIFEELDRQESRKSSSSTVRR 467
I +RC +P +RP+ + L+ + +
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 44/287 (15%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
I G +YRA + D K SQ ++ + A L+HPN+
Sbjct: 13 EIIGIGGFGKVYRAFWIGDEVAVKAARHD--PDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L G L+ E G L+R++ G+ I + V A+ A+G+ +LH+E
Sbjct: 71 LRG--VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDE 124
Query: 301 GPFQAMYNEFSTANIQIDKDFS--------AKLSGYGCAGHIPETDISNSSVAAANLSVE 352
++ + ++NI I + K++ +G A T +++ A A ++ E
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184
Query: 353 TLERGLLTPKSNVWSFGIVLLELLTGR---KNLDSR---HPKEERNLVKWSRPFLADDCR 406
+ + + S+VWS+G++L ELLTG + +D + L + C
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL----ALPIPSTC- 239
Query: 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
A + C +P RP+ +I ++L
Sbjct: 240 -----PEPF------------AKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 53/283 (18%), Positives = 110/283 (38%), Gaps = 44/283 (15%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLL 242
++E S +++ + + K + + S++ ++F + L HPN+ +L
Sbjct: 18 LNENHSGELWKGRWQGNDIVVKVLKVR----DWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 243 GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGP 302
G + LI + +GSL +++ +D + VK AL A+G+ FLH P
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA--AANLSVETLER---G 357
+ ++ ++ ID+D +A++S + A ++ E L++
Sbjct: 133 -LIPRHALNSRSVMIDEDMTARISMADVK-----FSFQSPGRMYAPAWVAPEALQKKPED 186
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE------ERNLVKWSRPFLADDCRLSLIM 411
+++WSF ++L EL+T E L RP +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTIPPGI------ 236
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
P + + + C+ ++P++RP I L++
Sbjct: 237 SPHV------------SKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 49/254 (19%), Positives = 103/254 (40%), Gaps = 39/254 (15%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
P+ Q ++ F N+V L +H N+ +G+ Q ++ + SL + +
Sbjct: 58 APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHL--HA 112
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333
+ + IA A+G+ +LH + ++ + + NI + +D + K+ +G A
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
Query: 334 IPETDISNSSVAAAN----LSVETLERGLLTP---KSNVWSFGIVLLELLTGRKNLDSRH 386
S+ + ++ E + P +S+V++FGIVL EL+TG+ + +
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229
Query: 387 PKE------ERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440
++ R + + +C ++K + CL+K+
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNC------PKRMK------------RLMAECLKKKRD 271
Query: 441 ERPTMRSIFEELDR 454
ERP+ I E++
Sbjct: 272 ERPSFPRILAEIEE 285
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 55/289 (19%), Positives = 109/289 (37%), Gaps = 46/289 (15%)
Query: 183 ISEGLSSVMYRASFGDDAST--SKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHPNLC 239
I +G ++++ D S K + +EF +V +++L HPN+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL G + ++ E + G L + ++ PI W+ ++++ L A G+ ++
Sbjct: 87 KLYGL----MHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN 140
Query: 300 EGPFQAMYNEFSTANIQIDK-----DFSAKLSGYGCAGHIPETDISNSSVAAANLS---- 350
+ P ++ + + NI + AK++ +G + + S N
Sbjct: 141 QNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAP 195
Query: 351 -VETLERGLLTPKSNVWSFGIVLLELLTGR---KNLDSRHPKEERNLV-KWSRPFLADDC 405
E T K++ +SF ++L +LTG K + + RP + +DC
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255
Query: 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
P+L ++ C +P +RP I +EL
Sbjct: 256 ------PPRL------------RNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/256 (18%), Positives = 93/256 (36%), Gaps = 53/256 (20%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+F+ + L HPN+ +L+G + ++ E + G + R++G
Sbjct: 152 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGDFLT--FLRTEG 207
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
+ T +++ AA G+ +L + + N + + K+S +G
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKC--------CIHRDLAARNCLVTEKNVLKISDFGM 259
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ + + +S + V E L G + +S+VWSFGI+L E +
Sbjct: 260 SREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
N +R F+ R + P V + +C E
Sbjct: 319 LSNQQTRE-------------FVEKGGR----LPC------PELCPDAVFRLMEQCWAYE 355
Query: 439 PSERPTMRSIFEELDR 454
P +RP+ +I++EL
Sbjct: 356 PGQRPSFSTIYQELQS 371
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 48/302 (15%), Positives = 98/302 (32%), Gaps = 42/302 (13%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN--DVNTLASLQHPN 237
+ I +G ++ + + K F + + ++ ++H N
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEKVAVKVF---------FTTEEASWFRETEIYQTVLMRHEN 92
Query: 238 LCKLLG--FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLT 295
+ + Q LI + +GSL + +D + +K+A + GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLC 148
Query: 296 FLHEEGPFQAMYNE-----FSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLS 350
LH E + NI + K+ + ++ G A + +N N
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VKFISDTNEVDIPPNTR 206
Query: 351 V--------ETLERGLLTP------KSNVWSFGIVLLELLTGRKNLDSRHP-KEERNLVK 395
V E L+ L ++++SFG++L E+ + + + +
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
Query: 396 WSRPFLADDCRLSLIMD--PQLKGRFPLKAA-RTVADIALRCLQKEPSERPTMRSIFEEL 452
S P D + I P R+ R + + C P+ R T + + L
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 453 DR 454
+
Sbjct: 327 AK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 57/314 (18%)
Query: 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN--DVNTLASLQHPNLC 239
I +G ++R + + K F SS+ + + ++ L+H N+
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIF---------SSREERSWFREAEIYQTVMLRHENIL 99
Query: 240 KLLG--FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+ Q L+ + HGSL + + +K+AL A GL L
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHL 155
Query: 298 HEEGPFQAMYNEFS-----TANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV- 351
H E + + NI + K+ + ++ G A + +++ A N V
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVG 213
Query: 352 -------ETLERGLLTP------KSNVWSFGIVLLELLTGRKNLDSRHPKEE---RNLVK 395
E L+ + ++++++ G+V E+ R ++ H + +LV
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVP 272
Query: 396 WSRPF-------LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
R ++ P A R +A I C + R T I
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNI---PNRWQSCE--ALRVMAKIMRECWYANGAARLTALRI 327
Query: 449 ---FEELDRQESRK 459
+L +QE K
Sbjct: 328 KKTLSQLSQQEGIK 341
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 40/266 (15%), Positives = 87/266 (32%), Gaps = 40/266 (15%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+ +K F +V +H N+ +G A +I +L ++ R
Sbjct: 67 RDNEDQLKAFKREVMAYRQTRHENVVLFMG--ACMSPPHLAIITSLCKGRTLYSVV--RD 122
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333
+D N +IA +G+ +LH +G ++ + + N+ D ++ +G
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSI 178
Query: 334 IPETDISNSS----------------VAAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377
+ ++ + S+V++ G + EL
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQK 437
++ + + W + + +L + + ++DI L C
Sbjct: 239 REWPFKTQPAEA----IIWQ---MGTGMKPNLS---------QIGMGKEISDILLFCWAF 282
Query: 438 EPSERPTMRSIFEELDRQESRKSSSS 463
E ERPT + + L++ R S
Sbjct: 283 EQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 59/314 (18%), Positives = 106/314 (33%), Gaps = 68/314 (21%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN--DVNTLASLQHPNL 238
C+ +G ++R S+ + K F SS+ K + ++ L+H N+
Sbjct: 14 ECVGKGRYGEVWRGSWQGENVAVKIF---------SSRDEKSWFRETELYNTVMLRHENI 64
Query: 239 CKLLG--FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ +R S Q LI GSL + +D + ++I L A GL
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAH 120
Query: 297 LHEEGPFQAMYNE-----FSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV 351
LH E + NI + K+ ++ G A + + +N N V
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVGNNPRV 178
Query: 352 --------ETLERGLLTP------KSNVWSFGIVLLELLTGRK-------------NLDS 384
E L+ + + ++W+FG+VL E+ ++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 385 RHPKEE--RNLV--KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440
P E R +V RP + + + ++A + C + PS
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTL-------------TSLAKLMKECWYQNPS 285
Query: 441 ERPTMRSIFEELDR 454
R T I + L +
Sbjct: 286 ARLTALRIKKTLTK 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 50/259 (19%), Positives = 91/259 (35%), Gaps = 38/259 (14%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+ + ++ L +L H N+ K G DG + LI E L GSL Y
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPK 118
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGY 328
+ I+ ++K A+ +G+ +L + + N+ ++ + K+ +
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLGSRQ--------YVHRDLAARNVLVESEHQVKIGDF 170
Query: 329 GCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382
G I + + V E L + S+VWSFG+ L ELLT +
Sbjct: 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230
Query: 383 DSRHPKEERNLVKWSRP-------FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
+ + L + RL P P V + +C
Sbjct: 231 SPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL-----PC-----PPNCPDEVYQLMRKCW 280
Query: 436 QKEPSERPTMRSIFEELDR 454
+ +PS R + +++ E +
Sbjct: 281 EFQPSNRTSFQNLIEGFEA 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 53/255 (20%), Positives = 98/255 (38%), Gaps = 33/255 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ + +++F ++ L SLQH N+ K G G LI E L +GSL Y +
Sbjct: 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHK 108
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
ID ++ +G+ +L + + +T NI ++ + K+ +G
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTKR--------YIHRDLATRNILVENENRVKIGDFGL 160
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSR 385
+P+ + E+L + S+VWSFG+VL EL T + S+
Sbjct: 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSK 218
Query: 386 HPKEERNLVKWSRPFLADDCR--LSLIMD----PQLKGRFPLKAARTVADIALRCLQKEP 439
P E + + + L+ + P+ P + I C
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-----PDGCPDEIYMIMTECWNNNV 273
Query: 440 SERPTMRSIFEELDR 454
++RP+ R + +D+
Sbjct: 274 NQRPSFRDLALRVDQ 288
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-17
Identities = 49/258 (18%), Positives = 95/258 (36%), Gaps = 54/258 (20%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ S EF + T+ L HP L K G +++ ++ E + +G L Y R
Sbjct: 40 IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPIYIVTEYISNGCLLN--YLR 95
Query: 273 SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSG 327
S G ++ + +++ +G+ FL F + N +D+D K+S
Sbjct: 96 SHGKGLEPSQLLEMCYDVCEGMAFLESHQ--------FIHRDLAARNCLVDRDLCVKVSD 147
Query: 328 YGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT----- 377
+G ++ + +S V E + KS+VW+FGI++ E+ +
Sbjct: 148 FGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
Query: 378 --GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
N + ++ R + P A+ T+ I C
Sbjct: 206 YDLYTNSEVVL-------------KVSQGHR----LYR------PHLASDTIYQIMYSCW 242
Query: 436 QKEPSERPTMRSIFEELD 453
+ P +RPT + + ++
Sbjct: 243 HELPEKRPTFQQLLSSIE 260
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 56/260 (21%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ P S V+ F+ + N + +LQH L KL ++ +I E + GSL L + +
Sbjct: 220 MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI---YIITEFMAKGSL--LDFLK 274
Query: 273 S-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
S +G + + A+G+ F+ + + ANI + K++
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--------YIHRDLRAANILVSASLVCKIA 326
Query: 327 GYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT---- 377
+G A I + + + A + E + G T KS+VWSFGI+L+E++T
Sbjct: 327 DFGLARVIEDNEYTARE--GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
Query: 378 ---GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRC 434
G N + L R M P + +I +RC
Sbjct: 385 PYPGMSNPEVIR-------------ALERGYR----MPR------PENCPEELYNIMMRC 421
Query: 435 LQKEPSERPTMRSIFEELDR 454
+ P ERPT I LD
Sbjct: 422 WKNRPEERPTFEYIQSVLDD 441
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 56/252 (22%), Positives = 98/252 (38%), Gaps = 40/252 (15%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
L P + + F+ + + L+H L +L + + ++ E + GSL + +
Sbjct: 216 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLD--FLK 270
Query: 273 S-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
G + V +A A G+ ++ + ANI + ++ K++
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMN--------YVHRDLRAANILVGENLVCKVA 322
Query: 327 GYGCAGHIPE---TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382
+G A I + T + + E G T KS+VWSFGI+L EL T GR
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
+E + V+ R M P + ++ D+ +C +KEP ER
Sbjct: 383 PGMVNREVLDQVE-------RGYR----MPC------PPECPESLHDLMCQCWRKEPEER 425
Query: 443 PTMRSIFEELDR 454
PT + L+
Sbjct: 426 PTFEYLQAFLED 437
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 51/259 (19%), Positives = 94/259 (36%), Gaps = 52/259 (20%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
V +F+ + + HPN+ LLG +++ + HG L + R+
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRN--FIRN 120
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGY 328
+ + L A+G+ +L + F + N +D+ F+ K++ +
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKK--------FVHRDLAARNCMLDEKFTVKVADF 172
Query: 329 GCAGHIPETDI-SNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT----- 377
G A + + + S + A L V E+L+ T KS+VWSFG++L EL+T
Sbjct: 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
Query: 378 --GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
D +L RL Q P + ++ L+C
Sbjct: 233 YPDVNTFDITV-------------YLLQGRRL-----LQ-----PEYCPDPLYEVMLKCW 269
Query: 436 QKEPSERPTMRSIFEELDR 454
+ RP+ + +
Sbjct: 270 HPKAEMRPSFSELVSRISA 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 53/255 (20%), Positives = 98/255 (38%), Gaps = 33/255 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ + +++F ++ L SLQH N+ K G G LI E L +GSL Y +
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHK 139
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
ID ++ +G+ +L + + +T NI ++ + K+ +G
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLGTKR--------YIHRDLATRNILVENENRVKIGDFGL 191
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSR 385
+P+ + E+L + S+VWSFG+VL EL T + S+
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--KSK 249
Query: 386 HPKEERNLVKWSRPFLADDCR--LSLIMD----PQLKGRFPLKAARTVADIALRCLQKEP 439
P E + + + L+ + P+ P + I C
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-----PDGCPDEIYMIMTECWNNNV 304
Query: 440 SERPTMRSIFEELDR 454
++RP+ R + +D+
Sbjct: 305 NQRPSFRDLALRVDQ 319
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 48/254 (18%), Positives = 91/254 (35%), Gaps = 32/254 (12%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
++F ++ L +L + K G G L+ E L G L + +
Sbjct: 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHR 121
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
+D + + + +G+ +L + NI ++ + K++ +G
Sbjct: 122 ARLDASRLLLYSSQICKGMEYLGSRR--------CVHRDLAARNILVESEAHVKIADFGL 173
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDS 384
A +P + E+L + + +S+VWSFG+VL EL T K+
Sbjct: 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--C 231
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMD----PQLKGRFPLKAARTVADIALRCLQKEPS 440
E ++ R A L L+ + P P V ++ C P
Sbjct: 232 SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA-----PPACPAEVHELMKLCWAPSPQ 286
Query: 441 ERPTMRSIFEELDR 454
+RP+ ++ +LD
Sbjct: 287 DRPSFSALGPQLDM 300
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 45/265 (16%), Positives = 94/265 (35%), Gaps = 57/265 (21%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ S EFI + + +L H L +L G + +I E + +G L Y R
Sbjct: 56 IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLN--YLR 111
Query: 273 SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSG 327
+++ + + +L + F + N ++ K+S
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--------FLHRDLAARNCLVNDQGVVKVSD 163
Query: 328 YGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT----- 377
+G + ++ + + ++S + V E L + KS++W+FG+++ E+ +
Sbjct: 164 FGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
Query: 378 --GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
N ++ +A R + P A+ V I C
Sbjct: 222 YERFTNSETAE-------------HIAQGLR----LYR------PHLASEKVYTIMYSCW 258
Query: 436 QKEPSERPTMRSIFEELD---RQES 457
++ ERPT + + + +ES
Sbjct: 259 HEKADERPTFKILLSNILDVMDEES 283
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 60/259 (23%), Positives = 104/259 (40%), Gaps = 52/259 (20%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
Q V+ F+ + + L HPN+ L+G ++ + HG L + + RS
Sbjct: 60 ITEMQQVEAFLREGLLMRGLNHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQ--FIRS 116
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGY 328
+ L A+G+ +L E +F + N +D+ F+ K++ +
Sbjct: 117 PQRNPTVKDLISFGLQVARGMEYLAE--------QKFVHRDLAARNCMLDESFTVKVADF 168
Query: 329 GCAGHIPETDI-SNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKN 381
G A I + + S A L V E+L+ T KS+VWSFG++L ELLT G
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
Query: 382 LDSRHPKEERNLVKW----SRPFLADDCRLSL--IMDPQLKGRFPLKAARTVADIALRCL 435
P + + + +P + C SL +M +C
Sbjct: 229 YRHIDPFDLTHFLAQGRRLPQP---EYCPDSLYQVM--------------------QQCW 265
Query: 436 QKEPSERPTMRSIFEELDR 454
+ +P+ RPT R + E+++
Sbjct: 266 EADPAVRPTFRVLVGEVEQ 284
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 48/259 (18%), Positives = 91/259 (35%), Gaps = 54/259 (20%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ + ++FI + + L HP L +L G L+ E + HG L Y R
Sbjct: 40 IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVTEFMEHGCLSD--YLR 95
Query: 273 SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSG 327
+ T + + L +G+ +L E + N + ++ K+S
Sbjct: 96 TQRGLFAAETLLGMCLDVCEGMAYLEEAC--------VIHRDLAARNCLVGENQVIKVSD 147
Query: 328 YGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT----- 377
+G + + ++S+ V E + KS+VWSFG+++ E+ +
Sbjct: 148 FGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
Query: 378 --GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
R N + ++ RL + P A+ V I C
Sbjct: 206 YENRSNSEVVE-------------DISTGFRL-----YK-----PRLASTHVYQIMNHCW 242
Query: 436 QKEPSERPTMRSIFEELDR 454
++ P +RP + +L
Sbjct: 243 RERPEDRPAFSRLLRQLAE 261
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 52/254 (20%), Positives = 102/254 (40%), Gaps = 43/254 (16%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
L + V+EF+ + + ++HPNL +LLG R+ +I E + +G+L Y R
Sbjct: 253 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLD--YLR 308
Query: 273 S-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
+ + + +A + + +L ++ F + N + ++ K++
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLEKKN--------FIHRNLAARNCLVGENHLVKVA 360
Query: 327 GYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRK 380
+G + + D + A A + E+L + KS+VW+FG++L E+ T G
Sbjct: 361 DFGLSRLM-TGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418
Query: 381 NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440
+ L++ D R M+ P V ++ C Q PS
Sbjct: 419 PYPGIDLSQVYELLE-------KDYR----MER------PEGCPEKVYELMRACWQWNPS 461
Query: 441 ERPTMRSIFEELDR 454
+RP+ I + +
Sbjct: 462 DRPSFAEIHQAFET 475
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 47/258 (18%), Positives = 91/258 (35%), Gaps = 59/258 (22%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S ++F+ + T+ HP++ KL+G + +I E G L + +
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRS--FLQVRK 110
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
+D + + A + L +L + F + N+ + + KL +G
Sbjct: 111 YSLDLASLILYAYQLSTALAYLESKR--------FVHRDIAARNVLVSSNDCVKLGDFGL 162
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ ++ ++ +S L + E++ T S+VW FG+ + E+L G
Sbjct: 163 SRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSL--IMDPQLKGRFPLKAARTVADIALRCLQ 436
KN D E + P +C +L +M +C
Sbjct: 221 VKNNDVIGRIENGERL--PMP---PNCPPTLYSLM--------------------TKCWA 255
Query: 437 KEPSERPTMRSIFEELDR 454
+PS RP + +L
Sbjct: 256 YDPSRRPRFTELKAQLST 273
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 55/246 (22%), Positives = 96/246 (39%), Gaps = 46/246 (18%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPID 279
+ F+ + + + L+H NL +LLG + ++ E + GSL + Y RS +
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSL--VDYLRSRGRSVLG 287
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGCAGHI 334
+ +K +L + + +L F + N+ + +D AK+S +G
Sbjct: 288 GDCLLKFSLDVCEAMEYLEGNN--------FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 335 PETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPK 388
+S+ L V E L + KS+VWSFGI+L E+ + GR K
Sbjct: 340 ------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393
Query: 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
+ V+ + MD P V D+ C + + RPT +
Sbjct: 394 DVVPRVE-------KGYK----MDA------PDGCPPAVYDVMKNCWHLDAATRPTFLQL 436
Query: 449 FEELDR 454
E+L+
Sbjct: 437 REQLEH 442
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 47/258 (18%), Positives = 96/258 (37%), Gaps = 52/258 (20%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+ + +F+ + + H N+ +L G ++ M+I E + +G+LD+ + R
Sbjct: 84 GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDK--FLRE 139
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGY 328
V + A G+ +L + + NI ++ + K+S +
Sbjct: 140 KDGEFSVLQLVGMLRGIAAGMKYLANMN--------YVHRDLAARNILVNSNLVCKVSDF 191
Query: 329 GCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT------ 377
G + + + + + + + + E + T S+VWSFGIV+ E++T
Sbjct: 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
Query: 378 -GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQ 436
N + + D RL P P+ + + ++C Q
Sbjct: 252 WELSNHEVMK-------------AINDGFRL-----PT-----PMDCPSAIYQLMMQCWQ 288
Query: 437 KEPSERPTMRSIFEELDR 454
+E + RP I LD+
Sbjct: 289 QERARRPKFADIVSILDK 306
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 55/259 (21%), Positives = 91/259 (35%), Gaps = 40/259 (15%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+ Q + +++ L +L H ++ K G G+ L+ E + GSL + S
Sbjct: 71 DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS 130
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGY 328
I + A +G+ +LH + + + N+ +D D K+ +
Sbjct: 131 ----IGLAQLLLFAQQICEGMAYLHAQH--------YIHRDLAARNVLLDNDRLVKIGDF 178
Query: 329 GCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382
G A +PE + V E L+ S+VWSFG+ L ELLT +
Sbjct: 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238
Query: 383 DSRHPKEERNLVKWSRP-------FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
E + + L RL P+ P K V + C
Sbjct: 239 SPPTKFLELIGIAQGQMTVLRLTELLERGERL-----PR-----PDKCPAEVYHLMKNCW 288
Query: 436 QKEPSERPTMRSIFEELDR 454
+ E S RPT ++ L
Sbjct: 289 ETEASFRPTFENLIPILKT 307
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 56/260 (21%), Positives = 96/260 (36%), Gaps = 56/260 (21%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
L S F+ + N + LQH L +L ++ +I E + +GSL + +
Sbjct: 45 LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVD--FLK 99
Query: 273 S-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
+ G + N + +A A+G+ F+ E + ANI + S K++
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERN--------YIHRDLRAANILVSDTLSCKIA 151
Query: 327 GYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT---- 377
+G A I + + + A + E + G T KS+VWSFGI+L E++T
Sbjct: 152 DFGLARLIEDNEYTAREGA--KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 378 ---GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRC 434
G N + L R M P + + C
Sbjct: 210 PYPGMTNPEVIQ-------------NLERGYR----MVR------PDNCPEELYQLMRLC 246
Query: 435 LQKEPSERPTMRSIFEELDR 454
++ P +RPT + L+
Sbjct: 247 WKERPEDRPTFDYLRSVLED 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 53/251 (21%), Positives = 94/251 (37%), Gaps = 38/251 (15%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
L P + + F+ + + L+H L +L + + ++ E + GSL + +
Sbjct: 299 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLD--FLK 353
Query: 273 S-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
G + V +A A G+ ++ + ANI + ++ K++
Sbjct: 354 GETGKYLRLPQLVDMAAQIASGMAYVERMN--------YVHRDLRAANILVGENLVCKVA 405
Query: 327 GYGCAGHIPE---TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383
+G A I + T + + E G T KS+VWSFGI+L EL T +
Sbjct: 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
Query: 384 SRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
E + R M P + ++ D+ +C +KEP ERP
Sbjct: 466 PGMVNRE------VLDQVERGYR----MPC------PPECPESLHDLMCQCWRKEPEERP 509
Query: 444 TMRSIFEELDR 454
T + L+
Sbjct: 510 TFEYLQAFLED 520
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 51/259 (19%), Positives = 94/259 (36%), Gaps = 52/259 (20%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
V +F+ + + HPN+ LLG +++ + HG L + R+
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRN--FIRN 184
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGY 328
+ + L A+G+ FL +F + N +D+ F+ K++ +
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLAS--------KKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 329 GCAGHIPETDISNS-SVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT----- 377
G A + + + + + A L V E+L+ T KS+VWSFG++L EL+T
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
Query: 378 --GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
D +L RL Q P + ++ L+C
Sbjct: 297 YPDVNTFDITV-------------YLLQGRRL-----LQ-----PEYCPDPLYEVMLKCW 333
Query: 436 QKEPSERPTMRSIFEELDR 454
+ RP+ + +
Sbjct: 334 HPKAEMRPSFSELVSRISA 352
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 52/273 (19%), Positives = 99/273 (36%), Gaps = 42/273 (15%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
Q + + + + SL H ++ +LLG L+ + L GSL +
Sbjct: 51 EDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSLLD--HV 105
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
R + + + A+G+ +L E G + N+ + +++
Sbjct: 106 RQHRGALGPQLLLNWGVQIAKGMYYLEEHG--------MVHRNLAARNVLLKSPSQVQVA 157
Query: 327 GYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRK 380
+G A +P D + A + E++ G T +S+VWS+G+ + EL+T G +
Sbjct: 158 DFGVADLLPPDDKQLLY-SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 381 NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440
E +L++ RL Q P V + ++C + +
Sbjct: 217 PYAGLRLAEVPDLLE-------KGERL-----AQ-----PQICTIDVYMVMVKCWMIDEN 259
Query: 441 ERPTMRSIFEELDRQESRKSSSSTVRRASVEGF 473
RPT + + E R ++R S G
Sbjct: 260 IRPTFKELANEFTRMARDPPRYLVIKRESGPGI 292
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 50/250 (20%), Positives = 96/250 (38%), Gaps = 42/250 (16%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG LI + + G L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLD--YVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
I + + A+G+ +L + + N+ + K++ +G
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDRR--------LVHRDLAARNVLVKTPQHVKITDFGL 163
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDS 384
A + + + + + E++ + T +S+VWS+G+ + EL+T G K D
Sbjct: 164 AKLLGAEEKEYHA-EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
E ++++ RL PQ P V I +C + RP
Sbjct: 223 IPASEISSILE-------KGERL-----PQ-----PPICTIDVYMIMRKCWMIDADSRPK 265
Query: 445 MRSIFEELDR 454
R + E +
Sbjct: 266 FRELIIEFSK 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 47/256 (18%), Positives = 96/256 (37%), Gaps = 52/256 (20%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ + ++F+++ + + HPN+ +L G R M++ E + +GSLD + R+
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDT--FLRTHD 145
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
V + G+ +L + G + + N+ +D + K+S +G
Sbjct: 146 GQFTIMQLVGMLRGVGAGMRYLSDLG--------YVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ + + + + + + E + + S+VWSFG+V+ E+L
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
N D + + RL P P+ + + L C K+
Sbjct: 258 MTNRDVIS-------------SVEEGYRL-----PA-----PMGCPHALHQLMLDCWHKD 294
Query: 439 PSERPTMRSIFEELDR 454
++RP I LD
Sbjct: 295 RAQRPRFSQIVSVLDA 310
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 48/280 (17%), Positives = 87/280 (31%), Gaps = 72/280 (25%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ F + ++ L H +L G D+ +L+ E + GSLD Y + +
Sbjct: 52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--GDENILVQEFVKFGSLDT--YLKKNK 107
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFS-------- 322
I+ ++++A A + FL E NI + ++
Sbjct: 108 NCINILWKLEVAKQLAAAMHFLEENT--------LIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 323 AKLSGYGCAGHIPETDISNSSV------AAANLSVETLERGLLTPKSNVWSFGIVLLELL 376
KLS G + + DI + N L ++ WSFG L E+
Sbjct: 160 IKLSDPGISITVLPKDILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEIC 212
Query: 377 T-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVAD 429
+ + E+R+ + P L+ ++
Sbjct: 213 SGGDKPLSALDSQRKLQFYEDRHQL--PAP---KAAELANLI------------------ 249
Query: 430 IALRCLQKEPSERPTMRSIFEELDR--QESRKSSSSTVRR 467
C+ EP RP+ R+I +L+ S
Sbjct: 250 --NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHH 287
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 55/269 (20%), Positives = 100/269 (37%), Gaps = 55/269 (20%)
Query: 209 TVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR---MLIYERLFHGSL 265
T+ N S + ++EF+++ + HPN+ +LLG S M+I + +G L
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 266 D---RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQI 317
+ I T +K + A G+ +L F + N +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--------RNFLHRDLAARNCML 180
Query: 318 DKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVL 372
D + ++ +G + I D A + V E+L + T KS+VW+FG+ +
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQG-RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
Query: 373 LELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAAR 425
E+ T G +N + +L RL Q P
Sbjct: 240 WEIATRGMTPYPGVQNHEMYD-------------YLLHGHRL-----KQ-----PEDCLD 276
Query: 426 TVADIALRCLQKEPSERPTMRSIFEELDR 454
+ +I C + +P +RPT + +L++
Sbjct: 277 ELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 52/270 (19%), Positives = 99/270 (36%), Gaps = 56/270 (20%)
Query: 209 TVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR----MLIYERLFHGS 264
+ +S ++EF+ + + HP++ KL+G R + R M+I + HG
Sbjct: 58 MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 265 LD---RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQ 316
L + + T V+ + A G+ +L F + N
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--------RNFIHRDLAARNCM 169
Query: 317 IDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIV 371
+ +D + ++ +G + I D A+ L V E+L L T S+VW+FG+
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQG-CASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 372 LLELLT-GRKNLDSRHPKEERNLVKW----SRPFLADDCRLSL--IMDPQLKGRFPLKAA 424
+ E++T G+ E N + +P +C + +M
Sbjct: 229 MWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP---PECMEEVYDLM------------- 272
Query: 425 RTVADIALRCLQKEPSERPTMRSIFEELDR 454
+C +P +RP+ + EL+
Sbjct: 273 -------YQCWSADPKQRPSFTCLRMELEN 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 51/256 (19%), Positives = 97/256 (37%), Gaps = 52/256 (20%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ + ++F+ + + + HPN+ +L G + S M++ E + +GSLD + R
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
V + A G+ +L + G + + NI I+ + K+S +G
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMG--------YVHRDLAARNILINSNLVCKVSDFGL 193
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ + + + + + E + T S+VWS+GIVL E+++
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
N D + + RL P P+ + + L C QK+
Sbjct: 254 MSNQDVIK-------------AVDEGYRL-----PP-----PMDCPAALYQLMLDCWQKD 290
Query: 439 PSERPTMRSIFEELDR 454
+ RP I LD+
Sbjct: 291 RNNRPKFEQIVSILDK 306
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 43/267 (16%)
Query: 213 LNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
L + V+EF+ + + ++HPNL +LLG R+ +I E + +G+L Y R
Sbjct: 46 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--FYIITEFMTYGNLLD--YLR 101
Query: 273 SDGP-PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
+ + +A + + +L ++ F + N + ++ K++
Sbjct: 102 ECNRQEVSAVVLLYMATQISSAMEYLEKKN--------FIHRDLAARNCLVGENHLVKVA 153
Query: 327 GYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRK 380
+G + + D + A A + E+L + KS+VW+FG++L E+ T G
Sbjct: 154 DFGLSRLM-TGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
Query: 381 NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPS 440
+ L++ D R+ + P V ++ C Q PS
Sbjct: 212 PYPGIDLSQVYELLE-------KDYRM-----ER-----PEGCPEKVYELMRACWQWNPS 254
Query: 441 ERPTMRSIFEELDRQESRKSSSSTVRR 467
+RP+ I + + S S V +
Sbjct: 255 DRPSFAEIHQAFETMFQESSISDEVEK 281
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 47/250 (18%), Positives = 94/250 (37%), Gaps = 40/250 (16%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ + +FI +VN + SL H NL +L G + ++ E GSL R
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLD--RLRKHQ 115
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
T + A+ A+G+ +L + F + N+ + K+ +G
Sbjct: 116 GHFLLGTLSRYAVQVAEGMGYLESKR--------FIHRDLAARNLLLATRDLVKIGDFGL 167
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDS 384
+P+ D + E+L+ + S+ W FG+ L E+ T G++
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
+ + + + RL P+ P + + ++ ++C +P +RPT
Sbjct: 228 LNGSQILHKIDKEGE------RL-----PR-----PEDCPQDIYNVMVQCWAHKPEDRPT 271
Query: 445 MRSIFEELDR 454
++ + L
Sbjct: 272 FVALRDFLLE 281
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 61/273 (22%), Positives = 101/273 (36%), Gaps = 74/273 (27%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
S + EF+N+ + + ++ +LLG ++ ++I E + G L Y RS
Sbjct: 66 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDL--KSYLRS 121
Query: 274 DGPPIDWNTR---------VKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDK 319
P + N +++A A G+ +L+ N+F + N + +
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--------NKFVHRDLAARNCMVAE 173
Query: 320 DFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLE 374
DF+ K+ +G I ETD L V E+L+ G+ T S+VWSFG+VL E
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGKGL-LPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232
Query: 375 LLT-------GRKNLDSRHPKEERNLVK----WSRPFLADDCRLSL--IMDPQLKGRFPL 421
+ T G N ++ V +P D+C L +M
Sbjct: 233 IATLAEQPYQGLSN------EQVLRFVMEGGLLDKP---DNCPDMLFELM---------- 273
Query: 422 KAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
C Q P RP+ I +
Sbjct: 274 ----------RMCWQYNPKMRPSFLEIISSIKE 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 47/256 (18%), Positives = 89/256 (34%), Gaps = 55/256 (21%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ ++F+++ + +L HP++ KL+G + +I E +G L Y +
Sbjct: 53 TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGH--YLERNK 107
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
+ T V +L + + +L + NI + KL +G
Sbjct: 108 NSLKVLTLVLYSLQICKAMAYLESIN--------CVHRDIAVRNILVASPECVKLGDFGL 159
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ +I + D +S L + E++ T S+VW F + + E+L+
Sbjct: 160 SRYIEDEDYYKAS--VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
+N D L RL P+ P + + RC +
Sbjct: 218 LENKDVIG-------------VLEKGDRL-----PK-----PDLCPPVLYTLMTRCWDYD 254
Query: 439 PSERPTMRSIFEELDR 454
PS+RP + L
Sbjct: 255 PSDRPRFTELVCSLSD 270
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 37/256 (14%), Positives = 88/256 (34%), Gaps = 53/256 (20%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+E + + + L +P + +L+G ++ ML+ E G L + +
Sbjct: 50 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEALMLVMEMAGGGPLHK--FLVGKR 104
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
I + ++ + G+ +L E+ F + N+ + AK+S +G
Sbjct: 105 EEIPVSNVAELLHQVSMGMKYLEEKN--------FVHRDLAARNVLLVNRHYAKISDFGL 156
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ + D ++ +A + E + + +S+VWS+G+ + E L+
Sbjct: 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
K + F+ R+ P + + + C +
Sbjct: 217 MKGPEVMA-------------FIEQGKRM-----EC-----PPECPPELYALMSDCWIYK 253
Query: 439 PSERPTMRSIFEELDR 454
+RP ++ + +
Sbjct: 254 WEDRPDFLTVEQRMRA 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 47/260 (18%), Positives = 92/260 (35%), Gaps = 55/260 (21%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYG 271
+ S ++F+ + T+ HP++ KL+G + +I E G L +
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRS--FL 481
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLS 326
+ +D + + A + L +L + F + N+ + + KL
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKR--------FVHRDIAARNVLVSSNDCVKLG 533
Query: 327 GYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT---- 377
+G + ++ ++ +S L + E++ T S+VW FG+ + E+L
Sbjct: 534 DFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591
Query: 378 ---GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRC 434
G KN D + + RL P P T+ + +C
Sbjct: 592 PFQGVKNNDVIG-------------RIENGERL-----PM-----PPNCPPTLYSLMTKC 628
Query: 435 LQKEPSERPTMRSIFEELDR 454
+PS RP + +L
Sbjct: 629 WAYDPSRRPRFTELKAQLST 648
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 51/262 (19%), Positives = 91/262 (34%), Gaps = 44/262 (16%)
Query: 215 PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY-ERLFHGSLDRLI-YGR 272
++ + I +++ L L HPN+ K D + I E G L R+I + +
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE---LNIVLELADAGDLSRMIKHFK 127
Query: 273 SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332
I T K + L +H M+ + AN+ I KL G
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 184
Query: 333 HIPETDISNSSVAAAN--------LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDS 384
+S AA+ +S E + KS++WS G +L E+ +
Sbjct: 185 FF------SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ----- 233
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF-PLKAAR---TVADIALRCLQKEPS 440
PF D L + + + PL + + + C+ +P
Sbjct: 234 -------------SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 280
Query: 441 ERPTMRSIFEELDRQESRKSSS 462
+RP + +++ R + +SS
Sbjct: 281 KRPDVTYVYDVAKRMHACTASS 302
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 53/246 (21%), Positives = 93/246 (37%), Gaps = 46/246 (18%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPID 279
+ F+ + + + L+H NL +LLG + ++ E + GSL Y RS +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVD--YLRSRGRSVLG 115
Query: 280 WNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGCAGHI 334
+ +K +L + + +L F + N+ + +D AK+S +G
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNN--------FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167
Query: 335 PETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPK 388
T L V E L + KS+VWSFGI+L E+ + GR K
Sbjct: 168 SSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221
Query: 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
+ V+ + MD P V ++ C + + RP+ +
Sbjct: 222 DVVPRVE-------KGYK----MDA------PDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264
Query: 449 FEELDR 454
E+L+
Sbjct: 265 REQLEH 270
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 43/246 (17%), Positives = 82/246 (33%), Gaps = 51/246 (20%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML--IYERLFHGSLDRLI--YG 271
+ + F + L LQHPN+ + ++ + + E + G+L + +
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 272 RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGYGC 330
+ +GL FLH P ++ + NI I S K+ G
Sbjct: 125 -----VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGL 178
Query: 331 AGHIPETDISNSSVAAANLSV---------ETLERGLLTPKSNVWSFGIVLLELLTGRKN 381
A + +V E E +V++FG+ +LE+ T
Sbjct: 179 ATLKRASFAK---------AVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATS--- 225
Query: 382 LDSRHP-KEERNLVKWSRPFLADDCRLSL--IMDPQLKGRFPLKAARTVADIALRCLQKE 438
+P E +N + R + S + P++K +I C+++
Sbjct: 226 ---EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK------------EIIEGCIRQN 270
Query: 439 PSERPT 444
ER +
Sbjct: 271 KDERYS 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 34/237 (14%), Positives = 71/237 (29%), Gaps = 30/237 (12%)
Query: 216 SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD 274
+ + +V + + QHP +L G + + L SL + +
Sbjct: 96 GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG---ILYLQTELCGPSLQQHC--EAW 150
Query: 275 GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334
G + L LH +G ++ + ANI + KL +G +
Sbjct: 151 GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207
Query: 335 PETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393
++ E L+ ++V+S G+ +LE+
Sbjct: 208 GTAGAGEVQEGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACN--------------- 251
Query: 394 VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
P + + L F + + + + L+ +P R T ++
Sbjct: 252 --MELPHGGEG--WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 50/250 (20%), Positives = 96/250 (38%), Gaps = 42/250 (16%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S + KE +++ +AS+ +P++C+LLG LI + + G L Y R
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLD--YVREHK 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
I + + A+G+ +L + + N+ + K++ +G
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDRR--------LVHRDLAARNVLVKTPQHVKITDFGL 163
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDS 384
A + + + + E++ + T +S+VWS+G+ + EL+T G K D
Sbjct: 164 AKLLGAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
E ++++ RL PQ P V I ++C + RP
Sbjct: 223 IPASEISSILE-------KGERL-----PQ-----PPICTIDVYMIMVKCWMIDADSRPK 265
Query: 445 MRSIFEELDR 454
R + E +
Sbjct: 266 FRELIIEFSK 275
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 37/256 (14%), Positives = 87/256 (33%), Gaps = 53/256 (20%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+E + + + L +P + +L+G + ML+ E G L + +
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHK--FLVGKR 430
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
I + ++ + G+ +L E+ F + N+ + AK+S +G
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKN--------FVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ + D ++ +A + E + + +S+VWS+G+ + E L+
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
K + F+ R+ P + + + C +
Sbjct: 543 MKGPEVMA-------------FIEQGKRM-----EC-----PPECPPELYALMSDCWIYK 579
Query: 439 PSERPTMRSIFEELDR 454
+RP ++ + +
Sbjct: 580 WEDRPDFLTVEQRMRA 595
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 53/272 (19%), Positives = 94/272 (34%), Gaps = 71/272 (26%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S ++F + L LQH ++ + G ++++E + HG L+R + RS G
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--RPLLMVFEYMRHGDLNR--FLRSHG 138
Query: 276 PPIDWNTR--------------VKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQ 316
P + +A A G+ +L F +T N
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--------LHFVHRDLATRNCL 190
Query: 317 IDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIV 371
+ + K+ +G + I TD L + E++ T +S+VWSFG+V
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 372 LLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL--IMDPQLKGRFPLK 422
L E+ T N ++ + + RP C + IM
Sbjct: 250 LWEIFTYGKQPWYQLSNTEAIDCITQGREL--ERP---RACPPEVYAIM----------- 293
Query: 423 AARTVADIALRCLQKEPSERPTMRSIFEELDR 454
C Q+EP +R +++ + L
Sbjct: 294 ---------RGCWQREPQQRHSIKDVHARLQA 316
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 51/267 (19%), Positives = 87/267 (32%), Gaps = 62/267 (23%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR-LIYGR 272
S Q +F+ + ++ H N+ + +G + R ++ E + G L L R
Sbjct: 71 VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--RFILMELMAGGDLKSFLRETR 128
Query: 273 ---SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANI---QIDKDF 321
S + + +A A G +L E N F + N
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEE--------NHFIHRDIAARNCLLTCPGPGR 180
Query: 322 SAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELL 376
AK+ +G A I A L V E G+ T K++ WSFG++L E+
Sbjct: 181 VAKIGDFGMARDIYRASYYRKG-GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
Query: 377 T-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL--IMDPQLKGRFPLKAARTV 427
+ + N + + P +C + IM
Sbjct: 240 SLGYMPYPSKSNQEVLEFVTSGGRMD--PP---KNCPGPVYRIM---------------- 278
Query: 428 ADIALRCLQKEPSERPTMRSIFEELDR 454
+C Q +P +RP I E ++
Sbjct: 279 ----TQCWQHQPEDRPNFAIILERIEY 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 51/311 (16%), Positives = 95/311 (30%), Gaps = 83/311 (26%)
Query: 181 RCISEGLSSVMYRASFGD-----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH 235
+C+ G FG + + RL ++ + +V LA L+H
Sbjct: 11 QCLGRG--------GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 62
Query: 236 PNLCKLLGFHARDGSDQRMLIYERLFH----------GSLDRLIYGRSDGPPIDWNTRVK 285
P + + + +++ + +L + GR + + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 286 IALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI-PET 337
I L A+ + FLH +G P +NI D K+ +G + +
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKP----------SNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 338 DISNSSVAAANLSVETLERGLLTP---------------KSNVWSFGIVLLELLTGRKNL 382
+ + T + G T K +++S G++L ELL
Sbjct: 173 EEQTVLTPMPAYARHTGQVG--TKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----- 225
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFP---LKAARTVADIALRCLQKEP 439
PF R+ + D + +FP + + L P
Sbjct: 226 ----------------PFSTQMERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSP 268
Query: 440 SERPTMRSIFE 450
ERP +I E
Sbjct: 269 MERPEAINIIE 279
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 53/273 (19%), Positives = 98/273 (35%), Gaps = 72/273 (26%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ K+F + L +LQH ++ K G D ++++E + HG L++ + R+ G
Sbjct: 57 TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNK--FLRAHG 112
Query: 276 PPIDWNTR---------------VKIALCAAQGLTFLHEEGPFQAMYNEF-----STANI 315
P + IA A G+ +L F +T N
Sbjct: 113 PDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--------QHFVHRDLATRNC 164
Query: 316 QIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGI 370
+ + K+ +G + + TD L + E++ T +S+VWSFG+
Sbjct: 165 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM-LPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 371 VLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL--IMDPQLKGRFPL 421
+L E+ T N + + ++ RP C + +M
Sbjct: 224 ILWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERP---RVCPKEVYDVM---------- 268
Query: 422 KAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
L C Q+EP +R ++ I++ L
Sbjct: 269 ----------LGCWQREPQQRLNIKEIYKILHA 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 34/270 (12%), Positives = 72/270 (26%), Gaps = 54/270 (20%)
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI-----YGRSDGPP 277
FI + + Q + ++ R +Y +L + +
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHSSTHKSL 208
Query: 278 IDWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGC 330
+ R+++ L + L LH G P +I +D+ L+G+
Sbjct: 209 -VHHARLQLTLQVIRLLASLHHYGLVHTYLRP----------VDIVLDQRGGVFLTGFEH 257
Query: 331 A---GHIPETDISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNL 382
G + I + L L+T + W+ G+ + +
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--- 314
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER 442
P D + P + V + L+ +R
Sbjct: 315 ---------------LPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDR 355
Query: 443 PTMRSIFEELDRQESRKSSSSTVRRASVEG 472
E + ++ R S+ + +G
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQTDG 385
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 60/272 (22%), Positives = 102/272 (37%), Gaps = 65/272 (23%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYG 271
+ + + + + I+++ + + +H N+ LLG +DG +I E G+L + L
Sbjct: 112 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQAR 169
Query: 272 RSDGPPIDWNTR------------VKIALCAAQGLTFLHEEGPFQAMYNEF-----STAN 314
R G +N V A A+G+ +L + + N
Sbjct: 170 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--------KKCIHRDLAARN 221
Query: 315 IQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFG 369
+ + +D K++ +G A I D + L V E L + T +S+VWSFG
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR-LPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 370 IVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLK 422
++L E+ T G L K L + R MD P
Sbjct: 281 VLLWEIFTLGGSPYPGVPV---------EELFK----LLKEGHR----MDK------PSN 317
Query: 423 AARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ + C PS+RPT + + E+LDR
Sbjct: 318 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 38/245 (15%), Positives = 79/245 (32%), Gaps = 41/245 (16%)
Query: 221 KEFINDVNTLASLQHPNLCKLLG-FHARDGSDQRMLIYERLFH-------------GSLD 266
++ +V LA L H N+ G + D + G+L+
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326
+ I R G +D +++ +G+ ++H + + + +NI + K+
Sbjct: 109 QWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164
Query: 327 GYGCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSR 385
+G + S +S E + + ++++ G++L ELL
Sbjct: 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD----- 219
Query: 386 HPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445
E + + D + F K + + L K+P +RP
Sbjct: 220 TAFETSKF-------------FTDLRDGIISDIFDKKE----KTLLQKLLSKKPEDRPNT 262
Query: 446 RSIFE 450
I
Sbjct: 263 SEILR 267
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 51/267 (19%), Positives = 87/267 (32%), Gaps = 62/267 (23%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDR-LIYGR 272
S Q +F+ + ++ H N+ + +G + R ++ E + G L L R
Sbjct: 112 VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLRETR 169
Query: 273 ---SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANI---QIDKDF 321
S + + +A A G +L E N F + N
Sbjct: 170 PRPSQPSSLAMLDLLHVARDIACGCQYLEE--------NHFIHRDIAARNCLLTCPGPGR 221
Query: 322 SAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELL 376
AK+ +G A I A L V E G+ T K++ WSFG++L E+
Sbjct: 222 VAKIGDFGMARDIYRAGYYRKG-GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 377 T-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL--IMDPQLKGRFPLKAARTV 427
+ + N + + P +C + IM
Sbjct: 281 SLGYMPYPSKSNQEVLEFVTSGGRMD--PP---KNCPGPVYRIM---------------- 319
Query: 428 ADIALRCLQKEPSERPTMRSIFEELDR 454
+C Q +P +RP I E ++
Sbjct: 320 ----TQCWQHQPEDRPNFAIILERIEY 342
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 53/272 (19%), Positives = 98/272 (36%), Gaps = 65/272 (23%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSL------- 265
+ + + + + ++++ + + +H N+ LLG +DG +I E G+L
Sbjct: 78 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRAR 135
Query: 266 ------DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STAN 314
R + + V A+G+ +L + + N
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--------QKCIHRDLAARN 187
Query: 315 IQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFG 369
+ + ++ K++ +G A I D + L V E L + T +S+VWSFG
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGR-LPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 370 IVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLK 422
+++ E+ T G L K L + R MD P
Sbjct: 247 VLMWEIFTLGGSPYPGIPV---------EELFK----LLKEGHR----MDK------PAN 283
Query: 423 AARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ + C PS+RPT + + E+LDR
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 55/274 (20%), Positives = 101/274 (36%), Gaps = 42/274 (15%)
Query: 195 SFGD-----DASTSKKF---EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLG-FH 245
S+G S K E + + + + +++VN L L+HPN+ +
Sbjct: 18 SYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 246 ARDGSDQRMLIY-ERLFHGSLDRLI-YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPF 303
D ++ + I E G L +I G + +D +++ L H
Sbjct: 76 --DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 304 QA--MYNEFSTANIQIDKDFSAKLSGYGCAGHI-PETDISNSSVAAAN-LSVETLERGLL 359
++ + AN+ +D + KL +G A + +T + + V +S E + R
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
KS++WS G +L EL PF A + +G+F
Sbjct: 194 NEKSDIWSLGCLLYELCALM------------------PPFTAFS--QKELAGKIREGKF 233
Query: 420 ---PLKAARTVADIALRCLQKEPSERPTMRSIFE 450
P + + + +I R L + RP++ I E
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 8e-12
Identities = 58/285 (20%), Positives = 107/285 (37%), Gaps = 74/285 (25%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-------- 265
N S +++ +++ N L + HP++ KL G ++DG +LI E +GSL
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESR 121
Query: 266 -------------DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-- 310
+ D + + A +QG+ +L E +
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--------MKLVH 173
Query: 311 ---STANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPK 362
+ NI + + K+S +G + + E D + V E+L + T +
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGR-IPVKWMAIESLFDHIYTTQ 232
Query: 363 SNVWSFGIVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415
S+VWSFG++L E++T G L L R M+
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPP---------ERLFN----LLKTGHR----MER-- 273
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR--QESR 458
P + + + L+C ++EP +RP I ++L++ + R
Sbjct: 274 ----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR 314
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 41/256 (16%), Positives = 85/256 (33%), Gaps = 54/256 (21%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
E + + N + L +P + +++G + ML+ E G L++ Y +
Sbjct: 58 DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNK--YLQQ-N 111
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STANIQIDKDFSAKLSGYGC 330
+ +++ + G+ +L E F + N+ + AK+S +G
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYLEESN--------FVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 331 AGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFGIVLLELLT-------G 378
+ + + + V E + + KS+VWSFG+++ E + G
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
Query: 379 RKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
K + E+ R+ P R + D+ C +
Sbjct: 224 MKGSEVTAMLEKGE-------------RM-----GC-----PAGCPREMYDLMNLCWTYD 260
Query: 439 PSERPTMRSIFEELDR 454
RP ++ L
Sbjct: 261 VENRPGFAAVELRLRN 276
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 54/274 (19%), Positives = 90/274 (32%), Gaps = 72/274 (26%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+EF ++ A LQHPN+ LLG +D +I+ HG L +
Sbjct: 50 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHE--FLVM 105
Query: 274 DGPPIDWNTR---------------VKIALCAAQGLTFLHEEGPFQAMYNEF-----STA 313
P D + V + A G+ +L + +T
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--------HHVVHKDLATR 157
Query: 314 NIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSF 368
N+ + + K+S G + D + L + E + G + S++WS+
Sbjct: 158 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL-LPIRWMAPEAIMYGKFSIDSDIWSY 216
Query: 369 GIVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL--IMDPQLKGRF 419
G+VL E+ + G N D R ++ P DDC + +M
Sbjct: 217 GVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL--PCP---DDCPAWVYALM-------- 263
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
+ C + PS RP + I L
Sbjct: 264 ------------IECWNEFPSRRPRFKDIHSRLR 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 54/299 (18%), Positives = 103/299 (34%), Gaps = 69/299 (23%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEA--TVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
+ I G SS +++ + K+ A V +Q + + N++ L LQ +
Sbjct: 15 KQIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 239 C--KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+L + +DQ + + + L+ + + ID R + +
Sbjct: 70 KIIRLYDYEI---TDQYIYMVMECGNIDLNSWL--KKKKS-IDPWERKSYWKNMLEAVHT 123
Query: 297 LHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS---NSSV-- 344
+H+ G P AN I KL +G A + S +S V
Sbjct: 124 IHQHGIVHSDLKP----------ANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 345 ----------AAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394
++ + ++PKS+VWS G +L + G
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-------KT------- 218
Query: 395 KWSRPFLADD---CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
PF +L I+DP + FP + + D+ CL+++P +R ++ +
Sbjct: 219 ----PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 61/358 (17%), Positives = 119/358 (33%), Gaps = 70/358 (19%)
Query: 123 PHTQSAASLKATGSFKSGTASGPLFASGPLPLPPTGTGTLRNFPLDEVAAACHNFFS-DR 181
H S+ + K A+ P T + +E + +S +
Sbjct: 3 HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK 62
Query: 182 CISEGLSSVMYRASFGDDASTSKKFEA--TVTRLNPSSQGVKEFINDVNTLASLQHPNL- 238
I G SS +++ + K+ A V +Q + + N++ L LQ +
Sbjct: 63 QIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 239 -CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+L + +DQ + + + L+ + + ID R + + +
Sbjct: 118 IIRLYDYEI---TDQYIYMVMECGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 171
Query: 298 HEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP--ETDISNSSVA--- 345
H+ G P AN I KL +G A + T + S
Sbjct: 172 HQHGIVHSDLKP----------ANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 346 ----------AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395
++ + ++PKS+VWS G +L + G+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--------------- 265
Query: 396 WSRPF---LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
PF + +L I+DP + FP + + D+ CL+++P +R ++ +
Sbjct: 266 ---PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 54/267 (20%), Positives = 94/267 (35%), Gaps = 54/267 (20%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ + ++++ ++ L QH N+ LLG G ++I E +G L L + R
Sbjct: 87 TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDL--LNFLR 142
Query: 273 SDGPPIDWNTR-------------VKIALCAAQGLTFLHEEGPFQAMYNEF-----STAN 314
++ + + + AQG+ FL + N
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--------KNCIHRDVAARN 194
Query: 315 IQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFG 369
+ + AK+ +G A I A L V E++ + T +S+VWS+G
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR-LPVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 370 IVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVA 428
I+L E+ + G + K + D + M P A + +
Sbjct: 254 ILLWEIFSLGLNPYPGILVNSK--FYK----LVKDGYQ----MAQ------PAFAPKNIY 297
Query: 429 DIALRCLQKEPSERPTMRSIFEELDRQ 455
I C EP+ RPT + I L Q
Sbjct: 298 SIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 45/249 (18%), Positives = 90/249 (36%), Gaps = 55/249 (22%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY-ERLFHGSLDRLIYGRSD 274
S+ + ++ L+H N+ + LG + +G + I+ E++ GSL L+ RS
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF---IKIFMEQVPGGSLSALL--RSK 113
Query: 275 GPPIDWNTRVKIALCAAQ---GLTFLHEEG-------PFQAMYNEFSTANIQID-KDFSA 323
P+ N + I Q GL +LH+ N+ I+
Sbjct: 114 WGPLKDNEQT-IGFYTKQILEGLKYLHDNQIVHRDIKG----------DNVLINTYSGVL 162
Query: 324 KLSGYGCAGHIPETDISNSSVAA-----ANLSVETLERGLLTPKSNVWSFGIVLLELLTG 378
K+S +G + + + + A ++ RG +++WS G ++E+ TG
Sbjct: 163 KISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATG 221
Query: 379 RKNLDSRHPKEERNLVKWS---RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
+ P + P A + + ++ P + L+C
Sbjct: 222 ------KPP--------FYELGEPQAA----MFKVGMFKVHPEIPESMSAEAKAFILKCF 263
Query: 436 QKEPSERPT 444
+ +P +R
Sbjct: 264 EPDPDKRAC 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 53/272 (19%), Positives = 98/272 (36%), Gaps = 65/272 (23%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSL------- 265
+ + + + + ++++ + + +H N+ LLG +DG +I E G+L
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRAR 181
Query: 266 ------DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STAN 314
R + + V A+G+ +L + + N
Sbjct: 182 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--------QKCIHRDLAARN 233
Query: 315 IQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFG 369
+ + ++ K++ +G A I D + L V E L + T +S+VWSFG
Sbjct: 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGR-LPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 370 IVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLK 422
+++ E+ T G L K L + R MD P
Sbjct: 293 VLMWEIFTLGGSPYPGIPV---------EELFK----LLKEGHR----MDK------PAN 329
Query: 423 AARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ + C PS+RPT + + E+LDR
Sbjct: 330 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 49/260 (18%), Positives = 78/260 (30%), Gaps = 63/260 (24%)
Query: 227 VNTLASLQHPNLCKLLGFHARDGSDQRMLIY-ERLFHGSLDRLI--YGRSDGPPIDWNTR 283
+ A L P + L G + I+ E L GSL +LI G +
Sbjct: 101 LVACAGLSSPRIVPLYGAVR---EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 157
Query: 284 VKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKD-FSAKLSGYGCAGHIP 335
A +GL +LH N+ + D A L +G A +
Sbjct: 158 -----QALEGLEYLHTRRILHGDVKA----------DNVLLSSDGSRAALCDFGHALCLQ 202
Query: 336 ETDISNSSVAAANL-------SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
+ S + + + E + K ++WS ++L +L G
Sbjct: 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC--------- 253
Query: 389 EERNLVKWSRPFLADDCRLSLIM----DPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
P+ R L + +P P A A L+KEP R +
Sbjct: 254 ---------HPW-TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
Query: 445 ----MRSIFEELDRQESRKS 460
R + + L KS
Sbjct: 304 AMELRRKVGKALQEVGGLKS 323
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 51/270 (18%), Positives = 92/270 (34%), Gaps = 56/270 (20%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR 272
+ + ++++ L+ L H N+ LLG G ++I E +G L L + R
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDL--LNFLR 119
Query: 273 SDGPPIDWNTR-----------------VKIALCAAQGLTFLHEEGPFQAMYNEF----- 310
+ + + A+G+ FL
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--------KNCIHRDL 171
Query: 311 STANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN----LSVETLERGLLTPKSNVW 366
+ NI + K+ +G A I A ++ E++ + T +S+VW
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 367 SFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAAR 425
S+GI L EL + G + K + + R M P A
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSK--FYK----MIKEGFR----MLS------PEHAPA 275
Query: 426 TVADIALRCLQKEPSERPTMRSIFEELDRQ 455
+ DI C +P +RPT + I + +++Q
Sbjct: 276 EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 52/270 (19%), Positives = 92/270 (34%), Gaps = 59/270 (21%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSL------- 265
+ + ++++ L + H N+ LLG + G M+I E G+L
Sbjct: 68 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSK 126
Query: 266 ------DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STAN 314
++ + + + A+G+ FL + + N
Sbjct: 127 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--------RKCIHRDLAARN 178
Query: 315 IQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPKSNVWSFG 369
I + + K+ +G A I + A L + ET+ + T +S+VWSFG
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR-LPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 370 IVLLELLT-GRKNLDSRHP----KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAA 424
++L E+ + G P K + + L + R M P
Sbjct: 238 VLLWEIFSLGAS------PYPGVKIDEEFCR----RLKEGTR----MRA------PDYTT 277
Query: 425 RTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ L C EPS+RPT + E L
Sbjct: 278 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 37/261 (14%), Positives = 77/261 (29%), Gaps = 44/261 (16%)
Query: 218 QGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL----DRLIYGRS 273
+ FI + + Q + ++ R +Y +L + L+ S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHSS 198
Query: 274 DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA-- 331
+ + R+++ L + L LH G ++ +I +D+ L+G+
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 332 -GHIPETDISNSSVA------AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDS 384
G + +S A +S R L+T + W+ G+V+ +
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD----- 310
Query: 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
P D + P + V + L+ +R
Sbjct: 311 -------------LPITKDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLL 353
Query: 445 MRSI-----FEELDRQESRKS 460
+E+L + S
Sbjct: 354 PLQAMETPEYEQLRTELSAAL 374
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 54/299 (18%), Positives = 104/299 (34%), Gaps = 69/299 (23%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEA--TVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
+ I G SS +++ + K+ A V +Q + + N++ L LQ +
Sbjct: 34 KQIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 239 --CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+L + +DQ + + + L+ + + ID R + +
Sbjct: 89 KIIRLYDYEI---TDQYIYMVMECGNIDLNSWL--KKKKS-IDPWERKSYWKNMLEAVHT 142
Query: 297 LHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDIS---NSSV-- 344
+H+ G P AN I KL +G A + S +S V
Sbjct: 143 IHQHGIVHSDLKP----------ANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 345 ----------AAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394
++ + ++PKS+VWS G +L + G+
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--------------- 236
Query: 395 KWSRPFLADD---CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
PF +L I+DP + FP + + D+ CL+++P +R ++ +
Sbjct: 237 ---TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 58/267 (21%), Positives = 103/267 (38%), Gaps = 49/267 (18%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY---ERLFHGSLDRL 268
L + I ++ L P + G DG I E + GSLD++
Sbjct: 67 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQV 121
Query: 269 IYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328
+ I K+++ +GLT+L E+ + M+ + +NI ++ KL +
Sbjct: 122 L---KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 329 GCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGR-------- 379
G +G + ++ ++NS V + +S E L+ + +S++WS G+ L+E+ GR
Sbjct: 177 GVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 380 -----------KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD----------PQL-KG 417
+ + P R + F D I + P+L G
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
Query: 418 RFPLKAARTVADIALRCLQKEPSERPT 444
F L+ V +CL K P+ER
Sbjct: 296 VFSLEFQDFVN----KCLIKNPAERAD 318
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 47/255 (18%), Positives = 97/255 (38%), Gaps = 57/255 (22%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLGFHARD-GSDQRM--LIYERLFHGSLDRLIYGRSDGP 276
+K F +V+ + L H N+ ++ D + L+ E + +L I S GP
Sbjct: 55 LKRFEREVHNSSQLSHQNIVSMI-----DVDEEDDCYYLVMEYIEGPTLSEYI--ESHGP 107
Query: 277 PIDWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYG 329
+ +T + G+ H+ P NI ID + + K+ +G
Sbjct: 108 -LSVDTAINFTNQILDGIKHAHDMRIVHRDIKP----------QNILIDSNKTLKIFDFG 156
Query: 330 CAGHIPETDISNSSVA---AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRH 386
A + ET ++ ++ S E + ++++S GIVL E+L G
Sbjct: 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------- 209
Query: 387 PKEERNLVKWSRPFLADDCRLSLIM------DPQLKGRFPLKAARTVADIALRCLQKEPS 440
PF + +S+ + P + ++++++ LR +K+ +
Sbjct: 210 -----------PPFNGETA-VSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKA 257
Query: 441 ERP-TMRSIFEELDR 454
R T++ + ++L
Sbjct: 258 NRYKTIQEMKDDLSS 272
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 76/281 (27%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-------- 265
S+ +F + +A +PN+ KLLG A L++E + +G L
Sbjct: 88 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMS 145
Query: 266 -------------DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-- 310
R PP+ ++ IA A G+ +L E +F
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--------RKFVH 197
Query: 311 ---STANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPK 362
+T N + ++ K++ +G + +I D + A + + E++ T +
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA-IPIRWMPPESIFYNRYTTE 256
Query: 363 SNVWSFGIVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL--IMDP 413
S+VW++G+VL E+ + G + + + + N++ + P ++C L L +M
Sbjct: 257 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--ACP---ENCPLELYNLM-- 309
Query: 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
C K P++RP+ SI L R
Sbjct: 310 ------------------RLCWSKLPADRPSFCSIHRILQR 332
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 61/271 (22%), Positives = 104/271 (38%), Gaps = 43/271 (15%)
Query: 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241
I +G +++ D T K + L + +++ ++ L+ P + K
Sbjct: 29 KIGKGSFGEVFKGI---DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
G + +D + +I E L GS L+ P+D I +GL +LH E
Sbjct: 86 YGSYLKD--TKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK 139
Query: 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV--------ET 353
++ + AN+ + + KL+ +G AG + +T N V E
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------QIKRNTFVGTPFWMAPEV 190
Query: 354 LERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413
+++ K+++WS GI +EL G HP + L+ + P P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------P 237
Query: 414 QLKGRFPLKAARTVADIALRCLQKEPSERPT 444
L+G + V CL KEPS RPT
Sbjct: 238 TLEGNYSKPLKEFVE----ACLNKEPSFRPT 264
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 49/251 (19%)
Query: 212 RLNPSSQGVKEFINDVN-TLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI- 269
R +SQ K + D++ ++ ++ P G R+G + E L SLD+
Sbjct: 41 RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVWICME-LMDTSLDKFYK 97
Query: 270 YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329
G I + KIA+ + L LH + ++ + +N+ I+ K+ +G
Sbjct: 98 QVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG 155
Query: 330 CAGHIPETDISNSSVAAANLSVETL-----ER--GLLTP-----KSNVWSFGIVLLELLT 377
+G++ + A ++ ER L KS++WS GI ++EL
Sbjct: 156 ISGYL-----VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD---PQLK-GRFPLKAARTVADIALR 433
R P W PF L +++ PQL +F + + +
Sbjct: 209 L------RFP-----YDSWGTPFQQ----LKQVVEEPSPQLPADKFSAEFVDFTS----Q 249
Query: 434 CLQKEPSERPT 444
CL+K ERPT
Sbjct: 250 CLKKNSKERPT 260
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 54/317 (17%), Positives = 109/317 (34%), Gaps = 67/317 (21%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTL-ASLQHPNLCKL 241
+ G +++ T R + + + K + D++ + S P + +
Sbjct: 33 MGSGTCGQVWKMR---FRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 242 LGFHARDGSDQRMLIY---ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
G + ++ E L ++L + PI K+ + + L +L
Sbjct: 90 FGTFITNTD-----VFIAME-LMGTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSV------AAANLSVE 352
E+ ++ + +NI +D+ KL +G +G + + + S A +
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 353 TLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412
+ +++VWS GI L+EL TG+ + F L+ ++
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----------DFEV----LTKVLQ 244
Query: 413 ---PQLKG--RFPLKAARTVADIALRCLQKEPSERPT-------------------MRSI 448
P L G F V CL K+ +RP + S
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVK----DCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASW 300
Query: 449 FEE-LDRQESRKSSSST 464
F++ + + ES +S S+
Sbjct: 301 FKDVMAKTESPRSGPSS 317
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 50/242 (20%), Positives = 98/242 (40%), Gaps = 35/242 (14%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
SS+ +E +V LA+++HPN+ + +GS ++ + G L + I G
Sbjct: 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGS--LYIVMDYCEGGDLFKRIN-AQKG 119
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
+ + + L +H+ ++ + + NI + KD + +L +G A +
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 336 ET-DISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393
T +++ + + LS E E KS++W+ G VL EL T +
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK-------------- 222
Query: 394 VKWSRPFLADDCR--LSLIMDPQLKGRF---PLKAARTVADIALRCLQKEPSERPTMRSI 448
F A + + I+ G F L + + + + ++ P +RP++ SI
Sbjct: 223 ----HAFEAGSMKNLVLKII----SGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
Query: 449 FE 450
E
Sbjct: 275 LE 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 45/268 (16%), Positives = 78/268 (29%), Gaps = 53/268 (19%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI-YGRSDGPPI 278
V +++ HPN+ D ++ ++ + +GS LI DG
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 279 DWNTRVKIAL-C--AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
IA + L ++H G ++ ++I I D LSG +
Sbjct: 128 LA-----IAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 336 ETDI-SNSSVAAANLSV--------ETLERGLL--TPKSNVWSFGIVLLELLTGRKNLDS 384
SV E L++ L KS+++S GI EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239
Query: 385 RHP-KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIAL----------- 432
+ + + P L D + R + + +
Sbjct: 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299
Query: 433 ----------------RCLQKEPSERPT 444
+CLQ+ P RP+
Sbjct: 300 HPYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 54/278 (19%), Positives = 93/278 (33%), Gaps = 67/278 (24%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSL------- 265
S + ++++ + L H N+ LLG G LI+E +G L
Sbjct: 86 KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSK 143
Query: 266 -------------DRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-- 310
+ + D + + + A A+G+ FL
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--------KSCVH 195
Query: 311 ---STANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-----ETLERGLLTPK 362
+ N+ + K+ +G A I A L V E+L G+ T K
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR-LPVKWMAPESLFEGIYTIK 254
Query: 363 SNVWSFGIVLLELLT-GRKNLDSRHP----KEERNLVKWSRPFLADDCRLSLIMDPQLKG 417
S+VWS+GI+L E+ + G +P + N K + + + MD
Sbjct: 255 SDVWSYGILLWEIFSLG------VNPYPGIPVDANFYK----LIQNGFK----MDQ---- 296
Query: 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455
P A + I C + +RP+ ++ L Q
Sbjct: 297 --PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 44/303 (14%), Positives = 100/303 (33%), Gaps = 51/303 (16%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASL 233
++ + + EG S + + + R+ Q +E + +
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVE---GLHDGHFY--ALKRILCHEQQDREEAQREADMHRLF 83
Query: 234 QHPNLCKLLG-FHARDGSDQRMLI----YERLFHGSL-DRLIYGRSDGPPIDWNTRVKIA 287
HPN+ +L+ G+ + ++R G+L + + + G + + + +
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKR---GTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 288 LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAA 347
L +GL +H +G + + NI + + L G S A
Sbjct: 141 LGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN--QACIHVEGSRQAL 195
Query: 348 NLSVETLERG----------------LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER 391
L +R ++ +++VWS G VL ++ G P +
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG------EGPYDMV 249
Query: 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451
S ++L + QL + + + + + +P +RP + + +
Sbjct: 250 FQKGDS---------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
Query: 452 LDR 454
L+
Sbjct: 301 LEA 303
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 29/260 (11%), Positives = 53/260 (20%), Gaps = 41/260 (15%)
Query: 223 FINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI----YGRSDGPPI 278
+ + +A P +L +L+ L+ L +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRGDE 191
Query: 279 DWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
+ + L +G P N+ I D L
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTP----------DNLFIMPDGRLMLGDVSAL 241
Query: 332 GHIPETDISNSSVAAANLS---VETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388
+ +S + T N W G+ + + P
Sbjct: 242 WKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL------FLPF 293
Query: 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI 448
L + L V + R L + R
Sbjct: 294 GLVTP---GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
Query: 449 -----FEELDRQESRKSSSS 463
F +L + S S+
Sbjct: 351 METPEFLQLQNEISSSLSTG 370
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 41/229 (17%), Positives = 70/229 (30%), Gaps = 52/229 (22%)
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHG-SLDRLIYGRSDGPPIDWNTRVKIALC 289
LQ P++ + H D ++ + RL +G L ++ R GP + V I
Sbjct: 89 GRLQEPHV---VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGP-LAPPRAVAIVRQ 142
Query: 290 AAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNS 342
L H G P NI + D A L +G A + ++
Sbjct: 143 IGSALDAAHAAGATHRDVKP----------ENILVSADDFAYLVDFGIASATTDEKLTQL 192
Query: 343 SVA---AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399
++ E T ++++++ VL E LTG P
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS------------------PP 234
Query: 400 FLADDCRLSLIM-----DPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
+ D LS++ + R + K P +R
Sbjct: 235 YQGDQ--LSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 53/258 (20%), Positives = 89/258 (34%), Gaps = 59/258 (22%)
Query: 212 RLNPSSQGVKEFINDVNT-LASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI- 269
R + K+ + D++ + S P + + G R+G + E L S D+
Sbjct: 56 RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG--DCWICME-LMSTSFDKFYK 112
Query: 270 -YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG--------PFQAMYNEFSTANIQIDKD 320
I KI L + L L E P +NI +D+
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP----------SNILLDRS 162
Query: 321 FSAKLSGYGCAGHIPETDISNSSVAAAN-------LSVETLERGLLTP----KSNVWSFG 369
+ KL +G +G + S+A ++ E ++ +S+VWS G
Sbjct: 163 GNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
Query: 370 IVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD---PQLKGRFPLKAART 426
I L EL TGR + F L+ ++ PQL + + +
Sbjct: 217 ITLYELATGRFPYPKWNS-----------VFDQ----LTQVVKGDPPQLSNSEEREFSPS 261
Query: 427 VADIALRCLQKEPSERPT 444
+ CL K+ S+RP
Sbjct: 262 FINFVNLCLTKDESKRPK 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 57/278 (20%), Positives = 106/278 (38%), Gaps = 33/278 (11%)
Query: 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241
I G ++V+ A A +K L + E + ++ ++ HPN+
Sbjct: 22 VIGSGATAVVQAAY---CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWN--TRVKIA-LC--AAQGLTF 296
D+ L+ + L GS+ +I IA + +GL +
Sbjct: 79 YTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV----- 351
LH+ G ++ + NI + +D S +++ +G + + + V
Sbjct: 137 LHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-GDITRNKVRKTFVGTPCW 192
Query: 352 ---ETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHP-KEERNLVKWSRPFLADDCR 406
E +E+ K+++WSFGI +EL TG P K ++ P L +
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
D ++ ++ K+ R + CLQK+P +RPT
Sbjct: 253 -----DKEMLKKYG-KSFR---KMISLCLQKDPEKRPT 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 50/275 (18%), Positives = 97/275 (35%), Gaps = 48/275 (17%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ EG +Y+A T + + ++E I +++ + P++ K
Sbjct: 35 EKLGEGSYGSVYKAI---HKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVK 88
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
G + ++ ++ E GS+ +I R + + I +GL +LH
Sbjct: 89 YYGSYFKN--TDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV--------E 352
++ + NI ++ + AKL+ +G AG + +T +A N + E
Sbjct: 145 R---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT------MAKRNTVIGTPFWMAPE 195
Query: 353 TLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV---KWSRPFLADDCRLSL 409
++ +++WS GI +E+ G+ HP R + P S
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMIPTNPPPTFRKPELWS- 252
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
D +CL K P +R T
Sbjct: 253 ---DNFT------------DFVKQCLVKSPEQRAT 272
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 52/285 (18%), Positives = 98/285 (34%), Gaps = 94/285 (32%)
Query: 214 NPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLD------ 266
S ++F ++ L L HPN+ LLG G L E HG+L
Sbjct: 63 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKS 120
Query: 267 -------RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF-----STAN 314
S + + A A+G+ +L ++ F + N
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--------FIHRDLAARN 172
Query: 315 IQIDKDFSAKLSGYGCA-----------GHIPETDISNSSVAAANLSV-----ETLERGL 358
I + +++ AK++ +G + G +P V E+L +
Sbjct: 173 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLP---------------VRWMAIESLNYSV 217
Query: 359 LTPKSNVWSFGIVLLELLT-------GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL-- 409
T S+VWS+G++L E+++ G + + ++ +P +C +
Sbjct: 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE--KP---LNCDDEVYD 272
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+M +C +++P ERP+ I L+R
Sbjct: 273 LM--------------------RQCWREKPYERPSFAQILVSLNR 297
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 48/238 (20%), Positives = 96/238 (40%), Gaps = 41/238 (17%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
++++I ++ LA+ HP + KLLG + D + ++ E G++D ++ +
Sbjct: 60 LEDYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIM--LELDRGL- 114
Query: 280 WNTRVKIAL-C--AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
T +I + C + L FLH + ++ + N+ + + +L+ +G + +
Sbjct: 115 --TEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169
Query: 337 TDI-SNSSV------AAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE 389
T +S + A + ET++ K+++WS GI L+E+ +P
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM- 228
Query: 390 ERNLV---KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
R L+ K P L + S + + D L K P RP+
Sbjct: 229 -RVLLKIAKSDPPTLLTPSKWS----VEFR------------DFLKIALDKNPETRPS 269
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 59/273 (21%), Positives = 108/273 (39%), Gaps = 44/273 (16%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLC 239
I +G S +Y A D +T ++ + ++N Q KE I N++ + ++PN+
Sbjct: 26 EKIGQGASGTVYTAM---DVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L + D+ ++ E L GSL ++ +D + Q L FLH
Sbjct: 81 NYLDSYLVG--DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS 134
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV-------- 351
++ + + NI + D S KL+ +G I S++ V
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAP 185
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
E + R PK ++WS GI+ +E++ G + +P L+ +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------------ 233
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
P+L+ P K + D RCL+ + +R +
Sbjct: 234 -PELQN--PEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 41/217 (18%), Positives = 75/217 (34%), Gaps = 32/217 (14%)
Query: 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMY 307
S + E+ + + + + A+G+ FL + ++
Sbjct: 160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 216
Query: 308 NEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN----LSVETLERGLLTPKS 363
+ + NI + + K+ +G A I + A ++ ET+ + T +S
Sbjct: 217 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 276
Query: 364 NVWSFGIVLLELLT-GRKNLDSRHP----KEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
+VWSFG++L E+ + G P K + + L + R M
Sbjct: 277 DVWSFGVLLWEIFSLGAS------PYPGVKIDEEFCR----RLKEGTR----MRA----- 317
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455
P + L C EPS+RPT + E L
Sbjct: 318 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 37/274 (13%), Positives = 78/274 (28%), Gaps = 71/274 (25%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRMLIY-ERLFHGSL-D 266
+ S + + +V A L QH ++ + A D MLI E GSL D
Sbjct: 44 SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD---HMLIQNEYCNGGSLAD 100
Query: 267 RLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDK 319
+ + L +GL ++H P +NI I +
Sbjct: 101 AISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP----------SNIFISR 150
Query: 320 DFSAKLSGYGCAGHIPETDISNSSVA----AANLSVETLERGLLTP-------------- 361
+ ++ + +S +E G
Sbjct: 151 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEG--DSRFLANEVLQENYTH 208
Query: 362 --KSNVWSFGIVLLELLTGR---KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416
K+++++ + ++ +N D H + + P + LS +
Sbjct: 209 LPKADIFALALTVVCAAGAEPLPRNGDQWH-----EIRQGRLPRIPQV--LS----QEFT 257
Query: 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
++ + +P RP+ ++ +
Sbjct: 258 ------------ELLKVMIHPDPERRPSAMALVK 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 42/264 (15%), Positives = 75/264 (28%), Gaps = 41/264 (15%)
Query: 227 VNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKI 286
L L H N+ KL + ++LI E GSL ++ S+ + + + +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 287 ALCAAQGLTFLHEEG-------PFQAMYNEFSTANI----QIDKDFSAKLSGYGCAGHIP 335
G+ L E G P NI D KL+ +G A +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKP----------GNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 336 ETDISNSSV-----AA----ANLSVETLERGLLTPKSNVWSFGIVLLELLTG----RKNL 382
+ + S + + ++WS G+ TG R
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 383 DSRHPKEERNLVKWSRP-------FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
R KE + +P A++ + D + + + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 436 QKEPSERPTMRSIFEELDRQESRK 459
+ + + F E R
Sbjct: 288 EADQEKCWGFDQFFAETSDILHRG 311
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 54/273 (19%), Positives = 109/273 (39%), Gaps = 46/273 (16%)
Query: 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFI-NDVNTLASLQHPNLCK 240
I EG + ++ A + + ++ V ++ Q +E + N+V + QH N+ +
Sbjct: 52 KIGEGSTGIVCLAR---EKHSGRQ--VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
+ + ++ ++ E L G+L ++ ++ + Q L +LH +
Sbjct: 107 MYKSYLVG--EELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV--------E 352
G ++ + + +I + D KLS +G I + S+ V E
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL------VGTPYWMAPE 211
Query: 353 TLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP-KEERNLVKWSRPFLADDCRLSLIM 411
+ R L + ++WS GI+++E++ G S P + + L P L + ++S
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS--- 268
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPT 444
P L+ D R L ++P ER T
Sbjct: 269 -PVLR------------DFLERMLVRDPQERAT 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 40/277 (14%), Positives = 83/277 (29%), Gaps = 69/277 (24%)
Query: 212 RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFH--------- 262
++ + + + +++V LASL H + + + + + +
Sbjct: 38 KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC 97
Query: 263 --GSLDRLIYGRSDGPPIDWNTRVKIALCAAQ---GLTFLHEEG-------PFQAMYNEF 310
G+L LI S+ R + Q L+++H +G P
Sbjct: 98 ENGTLYDLI--HSENLNQQ---RDEYWRLFRQILEALSYIHSQGIIHRDLKP-------- 144
Query: 311 STANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETL---------------- 354
NI ID+ + K+ +G A ++ + +
Sbjct: 145 --MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202
Query: 355 -ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413
G K +++S GI+ E++ V + R I P
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIYP--------FSTGMERVN-----ILKKLRSVSIEFP 249
Query: 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
F + I + +P++RP R++
Sbjct: 250 P---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 35/220 (15%), Positives = 68/220 (30%), Gaps = 43/220 (19%)
Query: 229 TLASLQHPNLCKLLGFHARDGSDQRMLIY---ERLFHGSLDRLIYGRSDGPPIDWNTRVK 285
LA + HP++ ++ F + Y E + SL R + +
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIA 186
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA 345
L L++LH G +YN+ NI + ++ KL G I +
Sbjct: 187 YLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLY 238
Query: 346 --AANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403
+ E + R T +++++ G L L + R+
Sbjct: 239 GTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------- 283
Query: 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP 443
+ + LK + + R + +P +R
Sbjct: 284 ------LPEDDP----VLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 42/264 (15%), Positives = 75/264 (28%), Gaps = 41/264 (15%)
Query: 227 VNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKI 286
L L H N+ KL + ++LI E GSL ++ S+ + + + +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 287 ALCAAQGLTFLHEEG-------PFQAMYNEFSTANI----QIDKDFSAKLSGYGCAGHIP 335
G+ L E G P NI D KL+ +G A +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKP----------GNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 336 ETDISNSSV-----AA----ANLSVETLERGLLTPKSNVWSFGIVLLELLTG----RKNL 382
+ + S + + ++WS G+ TG R
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 383 DSRHPKEERNLVKWSRP-------FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCL 435
R KE + +P A++ + D + + + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 436 QKEPSERPTMRSIFEELDRQESRK 459
+ + + F E R
Sbjct: 288 EADQEKCWGFDQFFAETSDILHRM 311
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 55/334 (16%), Positives = 107/334 (32%), Gaps = 58/334 (17%)
Query: 149 SGPLPLPPTGTGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEA 208
+GP L +F V R ++EG + +Y A D + +++
Sbjct: 2 AGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQ---DVGSGREY-- 56
Query: 209 TVTRLN-PSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHA-----RDGSDQRMLIYERLF 261
+ RL + + I +V + L HPN+ + + D L+ L
Sbjct: 57 ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 262 HGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321
G L + P+ +T +KI + + +H + P + + N+ +
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII-HRDLKVENLLLSNQG 175
Query: 322 SAKLSGYG-CAGHIPETDISNSSVAAANLSVETLERGLL----------------TPKSN 364
+ KL +G D S S+ A + E K +
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 365 VWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAA 424
+W+ G +L L +HP E+ ++ I + G++ +
Sbjct: 236 IWALGCILYLLCFR------QHPFEDGAKLR--------------I----VNGKYSIPPH 271
Query: 425 ----RTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ LQ P ER ++ + +L
Sbjct: 272 DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 51/243 (20%)
Query: 220 VKEFINDVNTLASLQHPNLCKLL--GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPP 277
F + A+L HP + + G ++ E + +L ++ ++GP
Sbjct: 56 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGP- 112
Query: 278 IDWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGC 330
+ +++ A Q L F H+ G P ANI I + K+ +G
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKP----------ANIMISATNAVKVMDFGI 162
Query: 331 AGHIPETDIS---NSSV--AAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSR 385
A I ++ S ++V A LS E + +S+V+S G VL E+LTG
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------ 216
Query: 386 HPKEERNLVKWSRPFLADDCRLSLIM-----DPQLKGRFPLKAARTVADIALRCLQKEPS 440
PF D +S+ DP + + + L+ L K P
Sbjct: 217 ------------PPFTGDS-PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPE 263
Query: 441 ERP 443
R
Sbjct: 264 NRY 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 46/310 (14%), Positives = 91/310 (29%), Gaps = 44/310 (14%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEF---INDVNTLASLQHP 236
+ EG + +Y A+ GD K + + P++ EF + L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQH 127
Query: 237 NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI--YGRSDGPPIDWNTRVKIALCAAQGL 294
K H + +L+ E +G+L I Y + + + A+ +
Sbjct: 128 MFMKFYSAH--LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 295 TFLHEEG-------PFQAMY-NEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAA 346
+H+ P + N F + + D L G + I ++
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--IDMKLFPKGTIFT 243
Query: 347 AN------LSVETLERGLLTPKSNVWSFGIVLLELLTGR--KNLDSRHPKEERNLVK--W 396
A VE L + + + + +L G K + + L +
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
Query: 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS-------IF 449
+ + L + D+ + L+K + T + I
Sbjct: 304 HLDMWNEFFHVMLNIPDCHH--------LPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355
Query: 450 EELDRQESRK 459
L+ + SRK
Sbjct: 356 LLLECKRSRK 365
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 50/249 (20%), Positives = 90/249 (36%), Gaps = 38/249 (15%)
Query: 213 LNPSSQGVKEFINDVNTLASL-QHPNLCKLLG----FHARDGSDQRMLIYERLFHGSLDR 267
++ + +E ++N L H N+ G + DQ L+ E GS+
Sbjct: 57 MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 268 LIYGRSDGPPIDWNTRVKIA-LC--AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324
LI IA +C +GL+ LH+ ++ + N+ + ++ K
Sbjct: 117 LIKNTKGNTL----KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 325 LSGYGCAGHIPETDI-SNSSV------AAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377
L +G + + T N+ + A ++ + KS++WS GI +E+
Sbjct: 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQK 437
G L HP L+ + P+LK + K ++ CL K
Sbjct: 230 GAPPLCDMHPMRALFLIPRNPA-------------PRLKSK---KWSKKFQSFIESCLVK 273
Query: 438 EPSERPTMR 446
S+RP
Sbjct: 274 NHSQRPATE 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 38/215 (17%), Positives = 65/215 (30%), Gaps = 60/215 (27%)
Query: 262 HGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTAN 314
+L + R + + I + A+ + FLH +G P +N
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP----------SN 194
Query: 315 IQIDKDFSAKLSGYGCA-GHIPETDISNSSVAAANLSVETLERGLLTP------------ 361
I D K+ +G + + + T + G T
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG--TKLYMSPEQIHGNN 252
Query: 362 ---KSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
K +++S G++L ELL F R+ +I D + +
Sbjct: 253 YSHKVDIFSLGLILFELLY---------------------SFSTQMERVRIITDVR-NLK 290
Query: 419 FPLKAAR---TVADIALRCLQKEPSERPTMRSIFE 450
FPL + + L P+ERP I E
Sbjct: 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 7e-06
Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 36/236 (15%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLG-FHARDGSDQRM-LIYERLFHGSLDRLIYGRSDGPP 277
+ +V + L+HPN+ +L G FH R+ LI E G++ R + +
Sbjct: 53 EHQLRREVEIQSHLRHPNILRLYGYFH----DATRVYLILEYAPLGTVYREL--QKLSKF 106
Query: 278 IDWNTRVKIA-LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPE 336
+ T I L A L++ H + ++ + N+ + K++ +G + H P
Sbjct: 107 DEQRTATYITELANA--LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161
Query: 337 TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396
+ ++ L E +E + K ++WS G++ E L G P
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KP--------- 205
Query: 397 SRPFLADDCRLSLIMDPQLKG--RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
PF A+ + FP D+ R L+ PS+RP +R + E
Sbjct: 206 --PFEANT--YQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 65/383 (16%), Positives = 115/383 (30%), Gaps = 138/383 (36%)
Query: 176 NFFSD-RC--ISEGLSSVMYRASFGDDASTSKKFEATVTRL-----NPSSQGVKEFINDV 227
F + C + + S++ + D SK + RL + + V++F+ +V
Sbjct: 28 AFVDNFDCKDVQDMPKSILSKEEI-DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 228 NTLASLQHPN---LCKLLGFHARDGS-DQRMLIYERLFHGSLDRLIYGRSDGPPI-DWN- 281
L+ N L + R S RM I +R DRL +D +N
Sbjct: 87 -----LR-INYKFLMSPIKTEQRQPSMMTRMYIEQR------DRL---YNDNQVFAKYNV 131
Query: 282 TR------VKIALCAAQ-------------GLTFL----------HEEGPFQAMY----N 308
+R ++ AL + G T++ + F+ + N
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 309 EFSTANI---------QIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV----ETLE 355
S + QID +++++ A L + E
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDH-------SSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 356 RGLLTPKSNVWS------FGI---VLLELLTGRKN----LDSRHPKEERNLVKWSRPFLA 402
LL NV + F + +L L T K L + L S
Sbjct: 245 NCLLV-LLNVQNAKAWNAFNLSCKIL--LTTRFKQVTDFLSAATTTHIS-LDHHSMTLTP 300
Query: 403 DDCR--LSLIMD-------PQLKGRFPLK----AAR--------------------TVAD 429
D+ + L +D ++ P + A T+ +
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 430 IALRCLQKEPSERPTMRSIFEEL 452
+L L EP+E R +F+ L
Sbjct: 361 SSLNVL--EPAE---YRKMFDRL 378
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 38/240 (15%), Positives = 72/240 (30%), Gaps = 55/240 (22%)
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAA 291
S +HPN+ + + + E L +L + + + +
Sbjct: 74 SDEHPNVIRYFCTE--KDRQFQYIAIE-LCAATLQEYVEQKDFAHLGL--EPITLLQQTT 128
Query: 292 QGLTFLHEEG-------PFQAMYNEFSTANIQI-----DKDFSAKLSGYGCAGHIPETDI 339
GL LH P NI I A +S +G +
Sbjct: 129 SGLAHLHSLNIVHRDLKP----------HNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 340 SNSSVAAAN-----LSVETLERGL---LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER 391
S S + ++ E L T +++S G V +++ H
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-----GSH----- 228
Query: 392 NLVKWSRPFLADDCRLSLIM--DPQLKGRFPLKAARTVA-DIALRCLQKEPSERPTMRSI 448
PF R + I+ L P K +A ++ + + +P +RP+ + +
Sbjct: 229 -------PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 42/257 (16%), Positives = 78/257 (30%), Gaps = 62/257 (24%)
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCA 290
S HPN+ + D + E L + +L L+ ++ + +
Sbjct: 64 ESDDHPNVIRYYCSETTD--RFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 291 ----AQGLTFLHEEG-------P----FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
A G+ LH P + + F+ ++ +S +G +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILV-STSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 336 ETDISNSS-----------VAAANL--SVETLERGLLTPKSNVWSFGIVLLELLTGRKNL 382
S + A L S + LT +++S G V +L+ K
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-- 237
Query: 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIAL---------R 433
PF R S I ++G F L + + D +L +
Sbjct: 238 ---------------HPFGDKYSRESNI----IRGIFSLDEMKCLHDRSLIAEATDLISQ 278
Query: 434 CLQKEPSERPTMRSIFE 450
+ +P +RPT +
Sbjct: 279 MIDHDPLKRPTAMKVLR 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 51/247 (20%), Positives = 87/247 (35%), Gaps = 57/247 (23%)
Query: 215 PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD 274
S++ ++ I +V L L+HPN + G + R+ L+ E + D +
Sbjct: 93 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASD--LLEVHK 148
Query: 275 GPPIDWNTRVKIA-LC--AAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
P V+IA + A QGL +LH ++ + NI + + KL +G A
Sbjct: 149 KPL----QEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 201
Query: 332 GHI--------------PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377
+ PE + ++ G K +VWS GI +EL
Sbjct: 202 SIMAPANSFVGTPYWMAPEV-------------ILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQK 437
+ L + + + + P L+ + + CLQK
Sbjct: 249 RKPPLFNMNAMSALYHIAQNES-------------PALQSG---HWSEYFRNFVDSCLQK 292
Query: 438 EPSERPT 444
P +RPT
Sbjct: 293 IPQDRPT 299
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 37/268 (13%), Positives = 69/268 (25%), Gaps = 78/268 (29%)
Query: 220 VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHG-SLDRLIYGRSDGPPI 278
++E ++ L+ + P + ++L L+ G SL + D P
Sbjct: 75 LQETLSRTLRLSRIDKPGVARVLDVVHTRA---GGLVVAEWIRGGSLQEVA----DTSP- 126
Query: 279 DWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
++ A H G P + +++ D L+
Sbjct: 127 SPVGAIRAMQSLAAAADAAHRAGVALSIDHP----------SRVRVSIDGDVVLAYPATM 176
Query: 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER 391
P+ ++ G L LL R
Sbjct: 177 PD-------------------------ANPQDDIRGIGASLYALLVNR------------ 199
Query: 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADI-------ALRCLQKEPSERP- 443
P R L + P++ A DI A R +Q + R
Sbjct: 200 ------WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA 253
Query: 444 -TMRSIFEELDRQESRKSSSSTVRRASV 470
T+ ++ ++ R + A V
Sbjct: 254 STLLNLMQQATAVADRTEVLGPIDEAPV 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 32/94 (34%)
Query: 361 PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK----WSRPFLADDCRLSLIMDPQLK 416
+ VWS GI+L +++ G P E + + R ++ +C+ LI
Sbjct: 228 RSAAVWSLGILLYDMVCG------DIPFEHDEEIIRGQVFFRQRVSSECQ-HLIR----- 275
Query: 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
CL PS+RPT I
Sbjct: 276 ----------------WCLALRPSDRPTFEEIQN 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 40/227 (17%), Positives = 83/227 (36%), Gaps = 32/227 (14%)
Query: 227 VNTLASLQHPNLCKLLG-FHARDGSDQRM-LIYERLFHGSLDRLIYGRSDGPPIDWNTRV 284
+ + L+HPN+ ++ FH +R+ L+ E G L + + + G + +
Sbjct: 65 IEIQSHLRHPNILRMYNYFH----DRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSAT 118
Query: 285 KIA-LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSS 343
+ L A L + HE ++ + N+ + K++ +G + H P
Sbjct: 119 FMEELADA--LHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 344 VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403
L E +E K ++W G++ E L G P + + + R +
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP------PFDSPSHTETHRRIVNV 227
Query: 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
D + + K D+ + L+ P +R ++ + E
Sbjct: 228 DLKFPPFLSDGSK------------DLISKLLRYHPPQRLPLKGVME 262
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 54/255 (21%), Positives = 89/255 (34%), Gaps = 65/255 (25%)
Query: 215 PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM--LIYERLFHGSL-DRLIYG 271
+ + +V L L HPN+ KL F D+ L+ E G L D +I
Sbjct: 65 KQKTDKESLLREVQLLKQLDHPNIMKLYEFF----EDKGYFYLVGEVYTGGELFDEIISR 120
Query: 272 RSDGPPIDWNTRVKIALCAAQ---GLTFLHEEG-------PFQAMYNE---FSTANIQID 318
+ + V A Q G+T++H+ P E +
Sbjct: 121 KR-------FSEVDAARIIRQVLSGITYMHKNKIVHRDLKP------ENLLLESK----S 163
Query: 319 KDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLT 377
KD + ++ +G + H + + A ++ E L K +VWS G++L LL+
Sbjct: 164 KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLS 222
Query: 378 GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR--FPLKAARTVADIA---- 431
G PF + I+ KG+ F L + V++ A
Sbjct: 223 GC------------------PPFNGAN--EYDILKKVEKGKYTFELPQWKKVSESAKDLI 262
Query: 432 LRCLQKEPSERPTMR 446
+ L PS R + R
Sbjct: 263 RKMLTYVPSMRISAR 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 50/276 (18%), Positives = 79/276 (28%), Gaps = 70/276 (25%)
Query: 227 VNTLASLQHPNLCKLL----GFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNT 282
+ + L HPN+ G +D +L E G L + + + +
Sbjct: 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 283 RVKIALCAAQGLTFLHEEG-------PFQAMYNEFSTANIQIDKDFSA---KLSGYGCAG 332
+ + L +LHE P NI + K+ G A
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKP----------ENIVLQPGPQRLIHKIIDLGYAK 172
Query: 333 HIPETDISNSSV-----AAANLSVETLERGLLTPKSNVWSFGIVLLELLTGR-------- 379
+ + ++ V A E LE+ T + WSFG + E +TG
Sbjct: 173 ELDQGELCTEFVGTLQYLAP----ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
Query: 380 -----------KNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVA 428
N + VK+S L LS I+ +L+
Sbjct: 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSS-VLPTPNHLSGILAGKLE---RWLQCM--- 281
Query: 429 DIALRCLQKEPSERPTMRSI-----FEELDRQESRK 459
L +R T F+ LD S K
Sbjct: 282 ------LMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 54/262 (20%), Positives = 91/262 (34%), Gaps = 67/262 (25%)
Query: 209 TVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM--LIYERLFHGSL- 265
+ + + S+ + + +V L L HPN+ KL F D+R L+ E G L
Sbjct: 69 IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF----EDKRNYYLVMECYKGGELF 124
Query: 266 DRLI----YGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG-------PFQAMYNE---FS 311
D +I + D I +K L +T+LH+ P E
Sbjct: 125 DEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLHKHNIVHRDLKP------ENLLLE 170
Query: 312 TANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGI 370
+ +KD K+ +G + + A ++ E L + K +VWS G+
Sbjct: 171 SK----EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY-DEKCDVWSIGV 225
Query: 371 VLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR--FPLKAARTVA 428
+L LL G PF I+ KG+ F + V+
Sbjct: 226 ILFILLAGY------------------PPFGGQT--DQEILRKVEKGKYTFDSPEWKNVS 265
Query: 429 DIA----LRCLQKEPSERPTMR 446
+ A + LQ + R + +
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQ 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 32/94 (34%)
Query: 361 PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK----WSRPFLADDCRLSLIMDPQLK 416
+ VWS GI+L +++ G P E + ++ DC +LI
Sbjct: 218 LPATVWSLGILLYDMVCG------DIPFERDQEILEAELHFPAHVSPDCC-ALIR----- 265
Query: 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
RCL +PS RP++ I
Sbjct: 266 ----------------RCLAPKPSSRPSLEEILL 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 47/262 (17%), Positives = 87/262 (33%), Gaps = 67/262 (25%)
Query: 209 TVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM--LIYERLFHGSL- 265
+ +E N+++ L SL HPN+ KL D++ L+ E G L
Sbjct: 79 YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF----EDKKYFYLVTEFYEGGELF 134
Query: 266 DRLI-YGRSDGPPIDWNTRVKIALCAAQ---GLTFLHEEG-------PFQAMYNE---FS 311
+++I + A Q G+ +LH+ P E
Sbjct: 135 EQIINRHK--------FDECDAANIMKQILSGICYLHKHNIVHRDIKP------ENILLE 180
Query: 312 TANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERGLLTPKSNVWSFGI 370
+ + K+ +G + + + A ++ E L++ K +VWS G+
Sbjct: 181 NK----NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGV 235
Query: 371 VLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR--FPLKAARTVA 428
++ LL G PF + I+ KG+ F + ++
Sbjct: 236 IMYILLCG------------------YPPFGGQN--DQDIIKKVEKGKYYFDFNDWKNIS 275
Query: 429 DIA----LRCLQKEPSERPTMR 446
D A L + ++R T
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAE 297
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 473 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.27 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.23 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.83 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.8 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.69 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.49 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.27 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 94.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 93.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.46 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.9 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.06 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 87.82 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 86.79 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.0 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 83.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 81.86 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 81.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 80.5 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 80.29 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=437.74 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=211.0
Q ss_pred ccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+++..+.||+|+||+||+|.+.+. ....+.+|+|+..........++|.+|+.+|++++|||||+++|+|.++ +.+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--QPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--CEE
Confidence 455668999999999999998542 2334555555554444445568899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
+||||||++|+|.++|..+.. ...++|..++.|+.||+.||+|||+++ ||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 999999999999999965321 246899999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhh
Q 011995 321 FSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 395 (473)
+.+||+|||+++.....+ .....+|+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+....+.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998764332 234578999999999999999999999999999999998 899998876654433322
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
. +. ....+..++.++.+|+.+||+.||++||||.||++.|+.+.
T Consensus 262 ~-------~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 262 N-------RQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp T-------TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred c-------CC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 10 11224566788999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=437.25 Aligned_cols=262 Identities=21% Similarity=0.360 Sum_probs=214.1
Q ss_pred cccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||+|++.+.. .....+|+|+... ......++|.+|+++|++++|||||+++|+|.+. +.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CE
Confidence 57888899999999999999976432 2344555555432 2445567899999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRS----------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 322 (473)
+|||||||++|+|.++|+... ....++|..++.|+.||+.||+|||+++ ||||||||+||||+.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence 999999999999999996532 2457999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhc
Q 011995 323 AKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 323 vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 397 (473)
+||+|||+++....... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+....+...
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987644332 23457899999999999999999999999999999999 89999887665543333211
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
. ....|..++.++.+|+.+||+.||++|||+.+|++.|+++.+..
T Consensus 247 ~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 247 R-----------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp C-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred C-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 0 01224556788999999999999999999999999999887543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-56 Score=437.41 Aligned_cols=261 Identities=20% Similarity=0.348 Sum_probs=209.0
Q ss_pred cccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|...+.||+|+||.||+|++.+. ......+|+|+... ......++|.+|+++|++++|||||+++|+|.+. +.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG--RP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 5677789999999999999998642 23445556665542 2445567899999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSD------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
+|||||||++|+|.++|+.... ..+++|..++.|+.||+.||+|||+++ ||||||||+||||+.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCC
Confidence 9999999999999999975421 246999999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhh
Q 011995 321 FSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 395 (473)
+.+||+|||+++....... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+....+.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987644322 34568999999999999999999999999999999999 899998876655433332
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
... +...|..++.++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 275 ~g~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 QGR-----------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HTC-----------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCC-----------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 110 1122455678899999999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-56 Score=433.41 Aligned_cols=258 Identities=18% Similarity=0.340 Sum_probs=205.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|...+.||+|+||+||+|++.++ +++|+++.. ......+.|.+|+.+|++++|||||+++|++.. +.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~~------vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHGD------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNL 106 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSSE------EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc------EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeE
Confidence 4567779999999999999986542 355555433 344556789999999999999999999999854 568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|||||||++|+|.++|+.. ...++|..+..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.
T Consensus 107 ~iVmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999999999643 356999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCC----CccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 334 IPET----DISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 334 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
.... .....+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+.............
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~--------- 252 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR--------- 252 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT---------
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc---------
Confidence 6432 2345589999999999964 35899999999999999999999999876544332211100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
....+.+ ...+..++.++.+|+.+||+.||++||||.||++.|+.+...
T Consensus 253 --~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 253 --GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp --TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred --CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0011111 123456678899999999999999999999999999988643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=436.25 Aligned_cols=249 Identities=19% Similarity=0.303 Sum_probs=210.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
..|+..+.||+|+||+||+|+... +++.+|+|++.... ....+.+.+|+.+|+.++|||||++++++.++ +.+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 458889999999999999999544 45667777776543 23456789999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||||||++|+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 148 ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 99999999999999954 35999999999999999999999999 999999999999999999999999999877
Q ss_pred CCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+....+....+....+
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------- 287 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------- 287 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-------------
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-------------
Confidence 543 34567899999999999999999999999999999999999999988776555443322110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+. ...+..++.++.+||.+||++||++|||+.|+++.
T Consensus 288 ~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 288 PR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01 11234567899999999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=442.53 Aligned_cols=249 Identities=19% Similarity=0.315 Sum_probs=211.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+.|+..+.||+|+||.||+|+... +++.+|+|++.... ....+.+.+|+.+|+.++|||||++++++.++ +.+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEE
Confidence 459999999999999999999544 45667777776543 33456789999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||||||++|+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 225 iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 99999999999999953 35999999999999999999999999 999999999999999999999999999876
Q ss_pred CCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.........+....+
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------- 364 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------- 364 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------------
T ss_pred CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-------------
Confidence 543 34567899999999999999999999999999999999999999988776655444322111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.+ ..+..++.++.+||.+||++||++|||+.|+|+.
T Consensus 365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 1133567889999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=436.00 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=206.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|++.+.||+|+||+||+|+... +++.+|+|++.... .....+.+.+|+.+|++++|||||++++++.++ +.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN--GS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred ccceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CE
Confidence 3689999999999999999998543 45677788776543 344567899999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|||||||++|+|.++|..+ ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccce
Confidence 99999999999999999654 3456899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.+.... ....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+....+....
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------------ 241 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS------------ 241 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------------
T ss_pred eecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------
Confidence 775432 234579999999999999999999999999999999999999998876655443332110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ...+..++.++.+||.+||++||++|||+.|+++.
T Consensus 242 ----~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 ----F-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----C-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01234566889999999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=435.70 Aligned_cols=266 Identities=20% Similarity=0.301 Sum_probs=217.7
Q ss_pred HHhcccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC-CCcccceeeeecC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH-PNLCKLLGFHARD 248 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~ 248 (473)
.-.++|+..+.||+|+||.||+|.+.+. ..+.+.+++|+..........+.|.+|+++|.++.| ||||+++|+|...
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 3457899999999999999999987543 345667777766554455556789999999999965 8999999998764
Q ss_pred CCCceEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
+ +.+|||||||++|+|.++|+... ....++|..+..++.||+.||+|||+++ ||||||||+||
T Consensus 141 ~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 141 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp T-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred C-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 3 57899999999999999996532 1345899999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHH
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~ 390 (473)
||+.++.+||+|||+|+.+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+.
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654322 34467899999999999999999999999999999998 9999987653332
Q ss_pred H-hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 391 R-NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 391 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
. ..+. .+ .+...|..++.++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 297 ~~~~i~-------~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 FCRRLK-------EG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHH-------HT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH-------cC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1 1111 11 11123455678899999999999999999999999999998654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-56 Score=431.21 Aligned_cols=246 Identities=17% Similarity=0.212 Sum_probs=209.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||+||+|+... +++.+|+|++.... .....+.+.+|+++|++++|||||++++++.++ +.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CE
Confidence 579999999999999999998544 45677777765321 233457789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+|||||||++|+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 99999999999999999543 46999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCC----CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 333 HIPET----DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 333 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
.+... ...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+....+....
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---------- 250 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE---------- 250 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 76432 2345689999999999999999999999999999999999999998876655443332111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIF 449 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 449 (473)
..++..++.++.+||.+||++||++|||++|++
T Consensus 251 --------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 --------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 123445678899999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=431.17 Aligned_cols=255 Identities=18% Similarity=0.175 Sum_probs=208.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+.|...++||+|+||.||+|+... +++.+|+|+++.. ..+.+|+.+|+.++|||||++++++.++ +.+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~------~~~~~E~~il~~l~HpnIV~l~~~~~~~--~~~ 125 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAVREG--PWV 125 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETT------TCCTHHHHTTTTCCCTTBCCEEEEEEET--TEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHH------HhHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 3578888999999999999999544 4566777777643 2235799999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccCCCc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGCAG 332 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~ 332 (473)
|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 9999999999999999643 46999999999999999999999999 99999999999999987 59999999998
Q ss_pred ccCCCC-------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 333 HIPETD-------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 333 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
.+.... ....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.........+....+
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------ 273 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP------ 273 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC------
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC------
Confidence 764332 1234799999999999999999999999999999999999999987654433222211110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
....++..++.++.+||.+||++||.+|||+.||++.|.+......
T Consensus 274 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 274 ---------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ---------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0012345667899999999999999999999999999987765443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=421.98 Aligned_cols=249 Identities=18% Similarity=0.227 Sum_probs=200.0
Q ss_pred ccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecC--CCCceE
Q 011995 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARD--GSDQRM 254 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~~~ 254 (473)
...+.||+|+||+||+|.+... ...+++|+..... .....+.|.+|+++|++++|||||++++++.+. +...+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCC---CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 5567899999999999996543 3455666554332 344567799999999999999999999998652 235689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~ 333 (473)
||||||++|+|.++|.. ...+++..+..|+.||+.||+|||++++ +||||||||+||||+ .++.+||+|||+|+.
T Consensus 106 lvmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999999964 3469999999999999999999999873 499999999999997 479999999999987
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhhhcccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.........+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....... ..+...
T Consensus 182 ~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~--------------- 245 (290)
T 3fpq_A 182 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--------------- 245 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT---------------
T ss_pred CCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC---------------
Confidence 66655667789999999998865 6999999999999999999999999765443321 111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....++...+.++.+||.+||++||++|||+.|+++
T Consensus 246 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 -VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001112334568999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=411.03 Aligned_cols=247 Identities=17% Similarity=0.256 Sum_probs=193.8
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||+||+|.. ..+++.+|+|+..... .......+.+|+++|+.++|||||++++++.++ +.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYH---TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEEC---TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred eCeEEEEEEecCcCeEEEEEEE---CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CE
Confidence 6899999999999999999984 3455677777765432 334456799999999999999999999999876 88
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+||||||+ +|+|.+++..+ ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred EEEEEeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCe
Confidence 99999999 68999998643 46999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC-ccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPETD-ISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
...... ..+.+||+.|||||++.+..+ +.++|||||||++|||+||+.||.+.........+....
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------ 228 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------ 228 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence 765443 345689999999999988876 589999999999999999999998766554333332111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++..++.++.+|+.+||+.||++|||++|+++.
T Consensus 229 ------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 ------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11244566889999999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=421.46 Aligned_cols=250 Identities=17% Similarity=0.220 Sum_probs=202.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|++.+.||+|+||+||+|+...+..+.+.+|+|+..... .......+.+|+++|++++|||||++++++.++ +.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 57999999999999999999875555556677777765332 222345688999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999999643 46999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
.... ...+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+....
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------------- 242 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK------------- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 5332 3456689999999999999999999999999999999999999999877655444332111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTM-----RSIFE 450 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 450 (473)
..++..++.++.+||.+||++||++|||+ +|+++
T Consensus 243 -----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 -----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 12344567889999999999999999984 56664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=414.62 Aligned_cols=273 Identities=16% Similarity=0.207 Sum_probs=196.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC--Cc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS--DQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~--~~ 252 (473)
.+|...+.||+|+||+||+|++.+ ..+|+|+. .........+..|+..+.+++|||||+++|+|.+++. ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g-----~~VAvK~l--~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRG-----EEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT-----EEEEEEEE--CGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-----EEEEEEEE--CccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 467788999999999999999753 34455544 3222222233456666678899999999999986532 25
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceeecCCCCCceeeCCCCcEEEec
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG-----PFQAMYNEFSTANIQIDKDFSAKLSG 327 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivHrDlkp~NILl~~~~~vkl~D 327 (473)
+|||||||++|+|.++|+.. .++|..+.+++.|++.||+|||+++ .++||||||||+||||+.++.+||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 79999999999999999643 5999999999999999999999871 22399999999999999999999999
Q ss_pred cCCCcccCCCC------ccCcccccccCChhhhhcC------CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh
Q 011995 328 YGCAGHIPETD------ISNSSVAAANLSVETLERG------LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 328 FGla~~~~~~~------~~~~~~t~~y~aPE~~~~~------~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 395 (473)
||+++...... .....||+.|||||++.+. .++.++|||||||++|||+||.+||.......... ..
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~ 230 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YD 230 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hh
Confidence 99998764332 1234789999999999764 36779999999999999999988775432211000 00
Q ss_pred hc--ccccccc--cccccccccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 396 WS--RPFLADD--CRLSLIMDPQLKGRF-PLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 396 ~~--~~~~~~~--~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
+. .+..... .......++.+...+ ...+...+.+|+.+||+.||++||||.||++.|+++.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 00 0000000 000011122222111 2356778999999999999999999999999999987654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=405.16 Aligned_cols=252 Identities=18% Similarity=0.267 Sum_probs=192.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS--- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~--- 250 (473)
.++|+..+.||+|+||+||+|+... +++.+|+|++.........+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred chhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 3579999999999999999998543 3466778877766555566789999999999999999999999875431
Q ss_pred -------CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcE
Q 011995 251 -------DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 251 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
..+|||||||++|+|.+++.........++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcE
Confidence 247999999999999999976544445677888999999999999999999 9999999999999999999
Q ss_pred EEeccCCCcccCCCC--------------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH
Q 011995 324 KLSGYGCAGHIPETD--------------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE 389 (473)
Q Consensus 324 kl~DFGla~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~ 389 (473)
||+|||+|+.+.... ....+||+.|||||++.+..|+.++|||||||++|||++ ||.... +
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~ 232 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E 232 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H
Confidence 999999998764332 123479999999999999999999999999999999996 775421 1
Q ss_pred HHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 390 ERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
....+... .+.... ......++.+.+||.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~-------------~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDV-------------RNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-------------HTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-------------hcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111100 000000 012234466789999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=406.70 Aligned_cols=268 Identities=14% Similarity=0.182 Sum_probs=206.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecC----
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARD---- 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~---- 248 (473)
.++|++.+.||+|+||+||+|+... +++.+|+|++.... .....+.+.+|+++|+.++|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 3579999999999999999999543 45667777765433 233456789999999999999999999987642
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
..+.+|||||||+ |+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeec
Confidence 2367899999995 689999953 457999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCC------CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 329 GCAGHIPET------DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 329 Gla~~~~~~------~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
|+|+.+... ...+.+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..+....+.......
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876322 23456899999999998875 46999999999999999999999999887766655443211100
Q ss_pred cccc-------ccccc---cccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDC-------RLSLI---MDPQLKGR---FPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~-------~~~~~---~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.... ..... ..+..... .....+.++.+||.+||++||.+|||+.|+|+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 00000000 012346789999999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=393.15 Aligned_cols=265 Identities=16% Similarity=0.172 Sum_probs=199.1
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
...+.|++.+.||+|+||+||+|+...+..+.+.+|+|+.... ....++.+|+++|..+ +|||||++++++.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-- 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-- 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--
Confidence 4567899999999999999999986544445667777655432 2345688999999998 699999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEeccC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYG 329 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFG 329 (473)
+.+|||||||++|+|.+++. .+++..+..++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 89999999999999999982 3899999999999999999999999 9999999999999877 899999999
Q ss_pred CCcccCCC------------------------------CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcC
Q 011995 330 CAGHIPET------------------------------DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTG 378 (473)
Q Consensus 330 la~~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG 378 (473)
+|+..... .....+||++|||||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99754322 12344799999999999775 489999999999999999999
Q ss_pred CCCCCCCCh-HHHHhHhhh----------cccccc----cc----ccccc---------cccccc---------CCCCCH
Q 011995 379 RKNLDSRHP-KEERNLVKW----------SRPFLA----DD----CRLSL---------IMDPQL---------KGRFPL 421 (473)
Q Consensus 379 ~~p~~~~~~-~~~~~~~~~----------~~~~~~----~~----~~~~~---------~~~~~l---------~~~~~~ 421 (473)
+.||..... .+....+.. ...+.. .. ..... ...+.+ ......
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 999965443 222221110 000000 00 00000 000000 001122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 422 KAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 422 ~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.++.++.+|+.+||+.||.+|+|++|+|+
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 45678999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=414.02 Aligned_cols=251 Identities=17% Similarity=0.207 Sum_probs=203.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhH---hHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVK---EFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
.++|++.+.||+|+||.||+|+... +++.+|+|++.... ...... ....++.+++.++|||||++++++.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 3789999999999999999999544 45677777765321 111222 233456777888999999999999876
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
+.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+||
T Consensus 265 --~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 265 --DKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred --CEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccc
Confidence 8999999999999999999643 46999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
|+|+.+......+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+........+....
T Consensus 337 GlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---------- 406 (689)
T 3v5w_A 337 GLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 406 (689)
T ss_dssp TTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH----------
T ss_pred ceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh----------
Confidence 9999887777777899999999999965 57999999999999999999999999764322221111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~ 450 (473)
.. ....++..++.++.+||.+||++||.+|++ ++||++
T Consensus 407 ---~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 ---LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---HH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---cC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00 011235567789999999999999999998 677765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=410.24 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=210.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|++.+.||+|+||.||+|.... +++.+|+|++... .....+.+.+|+.+|+.++|||||++++++.++ +.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence 4789999999999999999999554 4456677766543 233456789999999999999999999999876 899
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC--CcEEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD--FSAKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~vkl~DFGla 331 (473)
|||||||+||+|.++|.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 230 ~iv~E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp EEEEECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred EEEEeecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence 999999999999999953 2346999999999999999999999999 9999999999999854 89999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
+.+.... ....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+....+....+.....
T Consensus 305 ~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~----------- 373 (573)
T 3uto_A 305 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------- 373 (573)
T ss_dssp EECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-----------
T ss_pred eEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC-----------
Confidence 8875443 3456899999999999999999999999999999999999999998776665444432111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.......++.++.+||.+||+.||.+|||+.|+|++
T Consensus 374 ---~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111123456889999999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=373.89 Aligned_cols=283 Identities=29% Similarity=0.527 Sum_probs=230.0
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceee
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
+++.++...+++|...+.||+|+||.||+|.+.++ ..+++|+... ......+.+.+|+.+++.++||||++++++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG----AKVALKRRTP-ESSQGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTC----CEEEEEECCS-CCSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCC----CEEEEEEecc-cChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45556667789999999999999999999986432 3444444332 234456789999999999999999999999
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcE
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
+... +..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 104 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 104 CDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178 (321)
T ss_dssp CCCT--TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCE
T ss_pred EcCC--CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCE
Confidence 8765 789999999999999999965322 346999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 324 KLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 324 kl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
||+|||++....... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.............|...
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 258 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence 999999997653221 2234578999999999999999999999999999999999999987655444444444322
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.. ....+..+.++.+...++...+..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 259 ~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 259 SH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 21 12234455666666677889999999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=370.34 Aligned_cols=268 Identities=18% Similarity=0.326 Sum_probs=216.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|.+.+.||+|+||.||+|.+..+......+++|+..........+.+.+|+.+++.++||||+++++++.+. +..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--RLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--GCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--Ccc
Confidence 467889999999999999999986655555556677666544555667899999999999999999999999765 788
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 126 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999543 346999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
...... ....+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---------- 270 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG---------- 270 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT----------
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC----------
Confidence 643321 22244678999999999999999999999999999999 99999877655443322211
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCCccc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSSTV 465 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~~ 465 (473)
.....+..++..+.+|+.+||..||.+|||+.+|++.|+.+.....+....
T Consensus 271 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~ 321 (325)
T 3kul_A 271 -------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT 321 (325)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred -------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence 011123456688999999999999999999999999999998766654443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=370.19 Aligned_cols=293 Identities=27% Similarity=0.509 Sum_probs=232.2
Q ss_pred CCCCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCc
Q 011995 159 TGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238 (473)
Q Consensus 159 ~~~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI 238 (473)
.+....+++.++....++|...+.||+|+||.||+|...+ ...+++|+............+.+|++++..++||||
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 89 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS----SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC----CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc
Confidence 3456679999999999999999999999999999997543 334455554433333344578999999999999999
Q ss_pred ccceeeeecCCCCceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee
Q 011995 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317 (473)
Q Consensus 239 v~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl 317 (473)
+++++++... ...++||||+++|+|.+++.... ....+++..+..++.|++.||.|||++..++|+||||||+|||+
T Consensus 90 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 90 LRLRGFCMTP--TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp CCCCEEECCS--SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred cceEEEEecC--CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 9999999766 77899999999999999997643 23469999999999999999999999911129999999999999
Q ss_pred CCCCcEEEeccCCCcccCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCCh--HHHHh
Q 011995 318 DKDFSAKLSGYGCAGHIPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP--KEERN 392 (473)
Q Consensus 318 ~~~~~vkl~DFGla~~~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~--~~~~~ 392 (473)
+.++.+||+|||++....... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 999999999999998764332 2334589999999999998899999999999999999999999963211 11111
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...|...... ......+.+..+...++...+..+.+++.+||+.||.+|||+.+|++.|+...-.
T Consensus 248 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 248 LLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp HHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 2233332222 2244556666677778889999999999999999999999999999999975443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=375.38 Aligned_cols=263 Identities=19% Similarity=0.341 Sum_probs=214.2
Q ss_pred hcccccCcceeecCCceEEEEEECC----CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 248 (473)
.++|...+.||+|+||.||+|.+.. .......+++|+............+.+|+.+|+.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 4689999999999999999998632 22344555666554443445567899999999999 899999999999765
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
+.+|+||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 234 (370)
T 2psq_A 160 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 234 (370)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred --CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence 789999999999999999975421 245899999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHH
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~ 390 (473)
||+.++.+||+|||+++...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999998664332 223356788999999999999999999999999999999 9999987654443
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+... .....+..++.++.+++.+||+.||.+|||+.||++.|+++...
T Consensus 315 ~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 FKLLKEG-----------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHHHHTT-----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcC-----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 3222111 01122445668899999999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=372.18 Aligned_cols=275 Identities=19% Similarity=0.290 Sum_probs=221.4
Q ss_pred CCCHHHHHHHhcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCccc
Q 011995 164 NFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCK 240 (473)
Q Consensus 164 ~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~ 240 (473)
.+...+.....++|...+.||+|+||.||+|.+.+ +....+.+++|+..........+.+.+|++++.++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 35566666678899999999999999999998654 44566777777776554555567899999999999 8999999
Q ss_pred ceeeeecCCCCceEEEEEeccCCChhhhhhcCCC----------------------------------------------
Q 011995 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD---------------------------------------------- 274 (473)
Q Consensus 241 l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------- 274 (473)
+++++...+ ...++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 91 LLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEEEECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 999987653 568999999999999999975432
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCC
Q 011995 275 -----------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337 (473)
Q Consensus 275 -----------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 337 (473)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999999 999999999999999999999999999866432
Q ss_pred C----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 338 D----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 338 ~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
. .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+............ .
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------~--------- 311 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK------E--------- 311 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH------H---------
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH------c---------
Confidence 2 233466789999999999999999999999999999998 9999987653332111100 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
......+..++.++.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus 312 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 312 -GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 001112344567899999999999999999999999999988753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=361.59 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=206.4
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|++.+.||+|+||+||+|...+ ..+++|+..... .......+.+|++++++++||||+++++++...
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHG-----SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-- 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-----EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred CChhHceeeeEeecCCCeEEEEEEECC-----CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--
Confidence 345789999999999999999998643 334556554433 334456789999999999999999999999765
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++||||+++|+|.+++........+++..+..++.||+.||+|||++++ +|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCC
Confidence 6789999999999999999654323348999999999999999999999873 399999999999999999999999999
Q ss_pred CcccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+....... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------- 255 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC---------- 255 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC----------
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------
Confidence 97654332 234578999999999999999999999999999999999999998876555433322111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
....++..++..+.+||.+||+.||.+|||+.+|++.|+.+.+..
T Consensus 256 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 ------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 011224456688999999999999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=362.59 Aligned_cols=261 Identities=18% Similarity=0.298 Sum_probs=209.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||+||+|....+. +.+++|+.. .......+.+.+|++++..++||||+++++++.++ ...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~---~~va~K~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETG---EVMVMKELI-RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEES-CCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCC---cEEEEEEec-cCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Cee
Confidence 467889999999999999999975533 344444432 23455667899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp EEEEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 9999999999999999653 456999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCc----------------cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc
Q 011995 334 IPETDI----------------SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 334 ~~~~~~----------------~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 397 (473)
...... ....+|+.|+|||.+.+..++.++|||||||++|||++|..||............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--- 234 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--- 234 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---
Confidence 643221 1456899999999999999999999999999999999999998754322110000
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
......+ ..++..++..+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 235 --------~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 235 --------NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp --------CHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --------hhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0000011 11233455778999999999999999999999999998876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=355.65 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=206.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||+||+|.... ..+.+++|+..... ....+.+.+|+.+++.++||||+++++++... +..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEE
Confidence 3679999999999999999998433 34556666655432 23356788999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 9999999999999999543 4899999999999999999999999 99999999999999999999999999877
Q ss_pred cCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 334 IPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..... .....+|+.|+|||.+.+..++.++|||||||++|||++|..||...........+....
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------------- 232 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------- 232 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-------------
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 64332 344578999999999999999999999999999999999999998776544333221110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......+..++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 233 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 233 --TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00011234566889999999999999999999999873
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=358.32 Aligned_cols=282 Identities=16% Similarity=0.217 Sum_probs=216.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||+||+|....+ .+.+++|+..........+.+.+|++++++++||||+++++++........
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKT---GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCC---CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 35799999999999999999996543 345566665543333446778899999999999999999999987655688
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee----CCCCcEEEeccC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI----DKDFSAKLSGYG 329 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFG 329 (473)
++||||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 999999999999999976544455999999999999999999999999 9999999999999 788889999999
Q ss_pred CCcccCCCC-ccCcccccccCChhhhh--------cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhH---hhh
Q 011995 330 CAGHIPETD-ISNSSVAAANLSVETLE--------RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNL---VKW 396 (473)
Q Consensus 330 la~~~~~~~-~~~~~~t~~y~aPE~~~--------~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~---~~~ 396 (473)
++....... .....+|+.|+|||++. +..++.++|||||||++|||++|+.||........ ... +..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 998765443 34557899999999986 46789999999999999999999999965432211 111 110
Q ss_pred cccc-----ccc--ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 397 SRPF-----LAD--DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 397 ~~~~-----~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
..+. ... ...+....+......+....+..+.+|+.+||+.||++|||+.|+++...+...++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~ 313 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNS 313 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC----
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCc
Confidence 0000 000 0000000011122245678899999999999999999999999999999987766654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=368.87 Aligned_cols=263 Identities=19% Similarity=0.339 Sum_probs=203.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|++.........+++|+..........+.|.+|+.++.+++||||+++++++... +..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--Cce
Confidence 357999999999999999999865333344555666655444455567899999999999999999999999765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999643 456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...........+...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~---------- 266 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG---------- 266 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT----------
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 643321 12234678999999999999999999999999999998 99999876654433322111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
.....+..++..+.+++.+||+.||.+||++.+|++.|+++.....
T Consensus 267 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 267 -------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp -------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred -------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 0011133456789999999999999999999999999999875543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=353.64 Aligned_cols=283 Identities=26% Similarity=0.437 Sum_probs=223.1
Q ss_pred CCcCCCHHHHHHHhcccccC------cceeecCCceEEEEEECCCCeeeeEEEEEEEecC---CCChhhHhHHHHHHHHH
Q 011995 161 TLRNFPLDEVAAACHNFFSD------RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLA 231 (473)
Q Consensus 161 ~~~~~~~~el~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~Ei~~l~ 231 (473)
....|++.++..++++|... +.||+|+||.||+|...+ ..+++|+.... ......+.+.+|+.+++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-----TTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSS-----CEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECC-----ceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 45669999999999999877 899999999999998533 33445544332 12344677999999999
Q ss_pred hCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCC
Q 011995 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS 311 (473)
Q Consensus 232 ~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 311 (473)
.++||||+++++++... +..++||||+++|+|.+++........+++..+..++.|++.||.|||+++ |+|||||
T Consensus 86 ~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk 160 (307)
T 2nru_A 86 KCQHENLVELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK 160 (307)
T ss_dssp HCCCTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred hcCCCCeEEEEEEEecC--CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 99999999999999765 789999999999999999975444567999999999999999999999999 9999999
Q ss_pred CCceeeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCCh
Q 011995 312 TANIQIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP 387 (473)
Q Consensus 312 p~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~ 387 (473)
|+|||++.++.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|||++|..||.....
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 999999999999999999987654321 233467899999998865 589999999999999999999999976543
Q ss_pred HHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
......+. .........+....+..+ ...+...+..+.+++.+||+.||.+|||+.+|++.|+++..
T Consensus 240 ~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 240 PQLLLDIK--EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSBTTHHH--HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHH--HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22111110 000011111222233322 23467788999999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=362.92 Aligned_cols=249 Identities=18% Similarity=0.294 Sum_probs=208.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||+|+||.||+|.... +++.+++|+..... .....+.+.+|+.+|+.++||||+++++++... +.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CE
Confidence 5689999999999999999998543 34556666665432 334567789999999999999999999999776 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EEEEEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 99999999999999999543 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCC-CccCcccccccCChhhhhcCCCC-CcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPET-DISNSSVAAANLSVETLERGLLT-PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~s-~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ......+|+.|+|||++.+..+. .++|||||||++|||++|+.||.+.........+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------ 230 (328)
T 3fe3_A 163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK------------ 230 (328)
T ss_dssp GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 66443 33456889999999999888765 78999999999999999999998876655443332111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++...+.++.+|+.+||..||.+|||+.|+++.
T Consensus 231 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01234456789999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=365.08 Aligned_cols=272 Identities=15% Similarity=0.205 Sum_probs=204.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC--CC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--SD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~ 251 (473)
.++|+..+.||+|+||+||+|.+.+ +.+++|+.. ........+.+|+.++.+++|||||++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLN-----EYVAVKIFP--IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETT-----EEEEEEEEC--GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEECC-----CEEEEEEee--cCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 4689999999999999999998653 344555543 23344456677999999999999999999988653 23
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCceeecCCCCCceeeCCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE----------GPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------~~~~ivHrDlkp~NILl~~~~ 321 (473)
.+++||||+++|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred eEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence 479999999999999999543 499999999999999999999998 8 99999999999999999
Q ss_pred cEEEeccCCCcccCCCC----ccCcccccccCChhhhhcC-----CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHh
Q 011995 322 SAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERG-----LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERN 392 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~-----~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~ 392 (473)
.+||+|||+++...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+........
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 99999999997664332 2335789999999999763 35668899999999999999999997654321111
Q ss_pred Hhhhcccccccccc----cccccccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 393 LVKWSRPFLADDCR----LSLIMDPQLKGRF-PLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 393 ~~~~~~~~~~~~~~----~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
.............. ......+.+...+ ....+.++.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11000000000000 0001111111111 2356678999999999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=347.47 Aligned_cols=255 Identities=18% Similarity=0.330 Sum_probs=209.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|...++. .+++|+. .......+.+.+|++++++++||||+++++++.+. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKD----KVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 80 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTE----EEEEEEE--CTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred hhhceeeheecCCCccEEEEEEecCCC----eEEEEEe--cccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cce
Confidence 357888999999999999999975432 3444444 33444557899999999999999999999999765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEEEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccc
Confidence 9999999999999999543 346899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~------------ 223 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------------ 223 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------------
T ss_pred ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC------------
Confidence 64432 233455678999999999999999999999999999999 99999876655433322211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.....+...+..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 224 -----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00111333467899999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=363.35 Aligned_cols=266 Identities=21% Similarity=0.353 Sum_probs=218.0
Q ss_pred hcccccCcceeecCCceEEEEEECC----CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD----DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 248 (473)
.++|.+.+.||+|+||.||+|.... .......+++|+............+.+|++++..+ +|||||++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999998632 22344566666665554555668899999999999 999999999999766
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 148 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 148 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred --CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 789999999999999999975431 246999999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHH
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~ 390 (473)
||+.++.+||+|||++....... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998764432 233456789999999999999999999999999999999 9999987765543
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
...+.... ....+..++.++.+|+.+||+.||.+|||+.+|++.|+++....+.
T Consensus 303 ~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 303 FKLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHTTC-----------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 33222110 1112334567899999999999999999999999999998765543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=352.29 Aligned_cols=260 Identities=18% Similarity=0.314 Sum_probs=202.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|....+......+++++..........+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Ccc
Confidence 46899999999999999999997655444455555555443444556789999999999999999999999843 578
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999999643 346899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~----------- 234 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----------
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-----------
Confidence 644321 22345678999999999999999999999999999996 999998765544332221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...++..++..+.+++.+||..||.+|||+.++++.|+++...
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0112345568899999999999999999999999999988653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=358.17 Aligned_cols=279 Identities=19% Similarity=0.255 Sum_probs=209.2
Q ss_pred hcccccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||+||+|++.. +....+.+++|+... ......+.+.+|++++.+++||||+++++++...+...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 4678999999999999999998642 233455666665542 23445578999999999999999999999987654467
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999653 335899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 333 HIPETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 333 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
...... .....++..|+|||.+.+..++.++|||||||++|||++|..||.................... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH-HHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh-HHHH
Confidence 764332 1223456779999999999999999999999999999999999865322111100000000000 0000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
............+..++.++.+|+.+||+.||.+|||+.+|++.|+++..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0011111122234566789999999999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=354.23 Aligned_cols=261 Identities=20% Similarity=0.307 Sum_probs=212.9
Q ss_pred cCCCHHHHHHHhcc----------cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHh
Q 011995 163 RNFPLDEVAAACHN----------FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLAS 232 (473)
Q Consensus 163 ~~~~~~el~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 232 (473)
..++++++..+++. |...+.||+|+||.||+|....+ ++.+++|+.... .....+.+.+|+.+++.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~---g~~vavK~~~~~-~~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS---GRQVAVKMMDLR-KQQRRELLFNEVVIMRD 98 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEETT-TCCSHHHHHHHHHHHTT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCC---CcEEEEEEEecc-chhHHHHHHHHHHHHHh
Confidence 34889999988864 66778999999999999986533 345566665543 23445778999999999
Q ss_pred CCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCC
Q 011995 233 LQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312 (473)
Q Consensus 233 l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp 312 (473)
++||||+++++++... +..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 99 l~h~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 169 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS 169 (321)
T ss_dssp CCCTTBCCEEEEEEET--TEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CCCCCcceEEEEEEEC--CEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 9999999999999876 789999999999999999843 35999999999999999999999999 99999999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE 390 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~ 390 (473)
+|||++.++.+||+|||++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999998776443 23445789999999999999999999999999999999999999987665443
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+.... .+.+ ......+..+.+++.+||+.||.+|||+.++++.
T Consensus 250 ~~~~~~~~-------------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRDSP-------------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHSS-------------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCC-------------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 32221110 0011 1123456789999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=370.98 Aligned_cols=259 Identities=19% Similarity=0.338 Sum_probs=211.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|.+..+. ..+++|+............|.+|+.+|+.++|||||++++++... +..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADN---TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTC---CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCC---eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCc
Confidence 457888899999999999999976432 344555544333344456799999999999999999999999765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... +..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 188 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 9999999999999999642 345899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCcc----CcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETDIS----NSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~~----~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... ...++..|+|||.+.++.++.++|||||||++|||++ |..||...........+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~----------- 331 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG----------- 331 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-----------
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 5433221 1234678999999999999999999999999999998 99999887655443332211
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
.....+..++..+.+|+.+||+.||++|||+.+|++.|+++.++.
T Consensus 332 ------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 332 ------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 011123445678999999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=365.63 Aligned_cols=264 Identities=19% Similarity=0.301 Sum_probs=212.6
Q ss_pred hcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|.+.+ +....+.+++|+............+.+|+.++.+++|||||++++++... .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--L 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--C
Confidence 3678999999999999999999765 23345566666654444555667899999999999999999999998765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC---cEE
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS----DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF---SAK 324 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~vk 324 (473)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 7899999999999999996532 2246899999999999999999999999 99999999999999554 599
Q ss_pred EeccCCCcccCC----CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPE----TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~----~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||+++.... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~- 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG- 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999975422 12233456889999999999999999999999999999998 999998876554433332110
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
....+..++..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus 304 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 304 ----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ----------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 01123345678999999999999999999999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.97 Aligned_cols=268 Identities=22% Similarity=0.331 Sum_probs=215.9
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
....++|...+.||+|+||.||+|...+.. ...+.+++|+............+.+|+.++..++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344688999999999999999999875422 344566666655444445567899999999999999999999999765
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceee
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSD---------------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMY 307 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH 307 (473)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+|
T Consensus 123 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 123 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred --CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 789999999999999999965321 257999999999999999999999999 999
Q ss_pred cCCCCCceeeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCC
Q 011995 308 NEFSTANIQIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNL 382 (473)
Q Consensus 308 rDlkp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~ 382 (473)
|||||+|||++.++.+||+|||++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999987653322 223456789999999999999999999999999999999 99999
Q ss_pred CCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 383 DSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
.+....+....+.... ...++..++..+.+++.+||+.||.+|||+.+|++.|+++..+..
T Consensus 278 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGN-----------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHHHHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChHHHHHHHhCCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 8766544332221100 011234556789999999999999999999999999999886554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.52 Aligned_cols=253 Identities=17% Similarity=0.209 Sum_probs=206.8
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-----hhhHhHHHHHHHHHhCCCCCcccceeeeec
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-----QGVKEFINDVNTLASLQHPNLCKLLGFHAR 247 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 247 (473)
..+.|.+.+.||+|+||.||+|.... ++..+++|+....... ...+.+.+|+.+|..++||||+++++++.+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 35679999999999999999998654 3455666666544321 135678999999999999999999999977
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC----cE
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF----SA 323 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~v 323 (473)
. ..+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 87 ~--~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 87 R--TDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp S--SEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCE
T ss_pred C--CEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCE
Confidence 6 789999999999999999943 346999999999999999999999999 99999999999998776 79
Q ss_pred EEeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc
Q 011995 324 KLSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 324 kl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
||+|||++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+......
T Consensus 159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-- 236 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD-- 236 (361)
T ss_dssp EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--
T ss_pred EEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--
Confidence 99999999876543 334567899999999999989999999999999999999999999887655543333211000
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
....+....+..+.+||.+||..||.+|||+.|+++
T Consensus 237 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 ------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011234578999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=359.50 Aligned_cols=259 Identities=19% Similarity=0.342 Sum_probs=205.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||+||+|.+..+.. ...++++|..+........+.+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---C
Confidence 3679999999999999999999754432 22334444443333445667899999999999999999999999763 5
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++|+||+.+|+|.+++... ...+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 78999999999999999653 356999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 333 HIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 333 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
....... ....+|..|+|||.+.+..++.++|||||||++|||++ |..||...........+....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------- 236 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------- 236 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---------
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC---------
Confidence 6643321 23345779999999999999999999999999999999 999998766544333332111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
....+..++.++.+++.+||+.||.+||++.+|++.|+++..
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111234456789999999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.84 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=196.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC---ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS---SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||+|.+.+ ..+++|+...... ....+.+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIG-----DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-- 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETT-----EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred hhheeeeeeeccCCCeEEEEEEEcC-----CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--
Confidence 3678999999999999999998653 3344555443321 23457789999999999999999999999765
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC--------CCc
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK--------DFS 322 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~--------~~~ 322 (473)
+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+++..+|+||||||+|||++. ++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred CceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 78899999999999999983 346999999999999999999999998555889999999999986 678
Q ss_pred EEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc
Q 011995 323 AKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 323 vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
+||+|||++............+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+...
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----- 229 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN----- 229 (271)
T ss_dssp EEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-----
T ss_pred eEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-----
Confidence 999999999877655555667899999999999999999999999999999999999999876654433222111
Q ss_pred cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 403 DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 403 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
......+..++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 230 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122445568899999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=352.69 Aligned_cols=264 Identities=18% Similarity=0.258 Sum_probs=209.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|++.+.||+|+||.||+|.... ....+++|+..... .....+.+.+|+.++..++||||+++++++... +
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--D 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--S
T ss_pred hccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--C
Confidence 3579999999999999999998543 34556666654432 334457899999999999999999999998766 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 899999999999999999543 36999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 332 GHIPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 332 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.+..............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 228 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS---------- 228 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC----------
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc----------
Confidence 8764332 233468999999999999999999999999999999999999998766543321111000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhcccCC
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-TMRSIFEELDRQESRKSS 461 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~l~~~~~~ 461 (473)
.+.....+...++..+.+++.+||..||.+|| +++++.+.|+.+......
T Consensus 229 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 229 ---VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp ---CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred ---CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 00000111234557899999999999999998 999999999987755443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=346.45 Aligned_cols=255 Identities=18% Similarity=0.332 Sum_probs=208.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|...++. .+++|+.. .......++.+|++++.+++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQY----DVAVKMIK--EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPI 78 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTE----EEEEEEEC--BTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSE
T ss_pred hhheeeeeeeccCCCceEEEEEecCce----eEEEEEec--cCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccC--Cce
Confidence 467999999999999999999876532 24444443 3334457799999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred EEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCcccee
Confidence 9999999999999999543 345899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------- 223 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence 654432 23345677999999999889999999999999999999 9999987665544332221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus 224 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 -------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011233457899999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=352.97 Aligned_cols=263 Identities=22% Similarity=0.382 Sum_probs=214.6
Q ss_pred hcccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|..... ......+++|+..........+.+.+|+.+++.++||||+++++++... +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD--G 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--C
Confidence 56899999999999999999986322 2344556666655444455567899999999999999999999998765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD---------------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 310 (473)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 89999999999999999975432 234899999999999999999999999 999999
Q ss_pred CCCceeeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCC
Q 011995 311 STANIQIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSR 385 (473)
Q Consensus 311 kp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~ 385 (473)
||+|||++.++.+||+|||++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998664332 123356788999999999889999999999999999999 99999876
Q ss_pred ChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 386 HPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
........+.... ....+..++..+.+++.+||+.||.+|||+.+|++.|+++..+
T Consensus 257 ~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPERLFNLLKTGH-----------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGGGHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHhhcCC-----------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 6544333222110 1112345568899999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=347.69 Aligned_cols=256 Identities=16% Similarity=0.272 Sum_probs=207.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|.+.++. .+++|+. .......+++.+|++++..++||||+++++++.+. ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 94 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQY----DVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPI 94 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTE----EEEEEEE--CTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCC----eEEEEEe--cCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC--CCe
Confidence 468889999999999999999876532 2344443 33444557899999999999999999999999765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccc
Confidence 9999999999999999642 346999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...........+....
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----------- 238 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 238 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-----------
Confidence 64432 223345678999999999999999999999999999998 999998776554433322110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
....+...+..+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus 239 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 239 ------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 01113334578999999999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.27 Aligned_cols=266 Identities=19% Similarity=0.309 Sum_probs=214.4
Q ss_pred hcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|...+.||+|+||.||+|.+.. +....+.+++|+..........+.+.+|+.++.++ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-- 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--
Confidence 4689999999999999999998633 23355666677665444445567899999999999 999999999999766
Q ss_pred CceEEEEEeccCCChhhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSD---------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 788999999999999999965432 235899999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHH
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~ 390 (473)
|++.++.+||+|||++........ ....+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999987654322 23356778999999999999999999999999999999 9999987653322
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
...... . ......+...+..+.+++.+||+.||.+|||+.+|++.|+++..+..
T Consensus 257 ~~~~~~------~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 FYKMIK------E----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHH------H----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHhc------c----------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 111100 0 00111133456789999999999999999999999999999876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=355.25 Aligned_cols=252 Identities=15% Similarity=0.165 Sum_probs=205.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+.. ........+.+|+.+++.++||||+++++++.+. +..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~a~K~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHESFESM--EEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEC--CCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCC---CcEEEEEEEe--cCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEE
Confidence 46899999999999999999986543 3455555544 3344556788999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC--CCcEEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK--DFSAKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~vkl~DFGla 331 (473)
++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 77 VMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999999999999953 2346999999999999999999999999 999999999999987 789999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
....... .....+|+.|+|||++.+..++.++|||||||++|||++|..||...........+........
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 223 (321)
T 1tki_A 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------- 223 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------
T ss_pred eECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC--------
Confidence 8775433 2345688999999999988899999999999999999999999988765544333221110000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .....++.++.+|+.+||..||.+|||+.|+++.
T Consensus 224 --~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 --E----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --H----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --h----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0012346789999999999999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=357.06 Aligned_cols=259 Identities=18% Similarity=0.308 Sum_probs=208.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|.+..+.. ...++++++............+.+|+.++..++||||+++++++.. ...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---Ccc
Confidence 578888999999999999999754433 3334455554444444556778899999999999999999999853 578
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999999643 346899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------- 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--------- 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------
Confidence 64332 233456779999999999999999999999999999999 9999987665544333322110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+..++.++.+++.+||..||.+|||+.++++.|+++...
T Consensus 236 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 236 --------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011223445678999999999999999999999999987643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=348.67 Aligned_cols=263 Identities=19% Similarity=0.336 Sum_probs=207.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
..+|...+.||+|+||+||+|.+.++......+++++..........+.+.+|+.++++++||||+++++++...+ +..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC-Cce
Confidence 3568888999999999999999765544444445555444344455678999999999999999999999876543 678
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999964 3456899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCC------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 334 IPETD------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 334 ~~~~~------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
..... .....+|+.|+|||.+.+..++.++|||||||++|||++ |.+||...........+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-------- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC--------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC--------
Confidence 64332 223456678999999999999999999999999999999 667776654433222221100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
....+..++..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00113334578999999999999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=358.02 Aligned_cols=249 Identities=17% Similarity=0.241 Sum_probs=206.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||.||+|.... +++.+++|+..... .......+.+|+.+|..++||||+++++++.+. +
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--S
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--C
Confidence 4689999999999999999998654 34556666654321 223456788999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccch
Confidence 89999999999999999854 246899999999999999999999999 999999999999999999999999999
Q ss_pred cccCC--CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPE--TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
+.... ......++|+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------- 221 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------- 221 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred hhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 76432 23345688999999999999999999999999999999999999998766544333222110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++...+.++.+||.+||+.||.+|| ++.+|++.
T Consensus 222 -------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 113445668899999999999999999 89999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=363.38 Aligned_cols=264 Identities=19% Similarity=0.339 Sum_probs=202.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
..|...+.||+|+||.||+|.+.+.......+++|+..........+.|.+|+.++++++||||+++++++.... +..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS-SCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-CCeE
Confidence 346777899999999999998754433334444554443344556788999999999999999999999876542 6789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 168 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999999964 3456899999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCc------cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 335 PETDI------SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 335 ~~~~~------~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
..... ....+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+....+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--------- 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------- 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC---------
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC---------
Confidence 43221 23345678999999999999999999999999999999 788887654433222221100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
....+..++..+.+++.+||+.||.+|||+.+|++.|+++......
T Consensus 314 --------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 314 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0011334567899999999999999999999999999998765543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=358.11 Aligned_cols=264 Identities=19% Similarity=0.287 Sum_probs=208.3
Q ss_pred hcccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|...+.||+|+||.||+|..... ......+++|+............+.+|+.++.++ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence 47899999999999999999986332 2244556666665444445567899999999999 999999999999775
Q ss_pred CceEEEEEeccCCChhhhhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDG--------------------PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEF 310 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDl 310 (473)
+..++||||+++|+|.+++...... ..+++..+..++.||+.||+|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 7899999999999999999754321 34899999999999999999999999 999999
Q ss_pred CCCceeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCC
Q 011995 311 STANIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSR 385 (473)
Q Consensus 311 kp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~ 385 (473)
||+|||++.++.+||+|||++........ ....+|+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999986643321 23355778999999999999999999999999999998 99999876
Q ss_pred ChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 386 HPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.......... ........+..++.++.+|+.+||..||.+|||+.+|++.|+.+...
T Consensus 279 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVDANFYKLI----------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSHHHHHHH----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcHHHHHHHH----------------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5332211110 00011122344568899999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=352.77 Aligned_cols=253 Identities=17% Similarity=0.217 Sum_probs=205.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-----hhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-----QGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
.++|...+.||+|+||.||+|.... ++..+++|+....... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4679999999999999999998654 3345566665543221 2357799999999999999999999999875
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC----cEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF----SAK 324 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~vk 324 (473)
...++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 87 --~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 87 --TDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp --SEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEE
T ss_pred --CEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEE
Confidence 789999999999999999943 356999999999999999999999999 99999999999999887 799
Q ss_pred EeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 325 LSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 325 l~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|+|||++...... ......+|+.|+|||++.+..++.++|||||||++|||++|..||.+.........+......
T Consensus 159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 235 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--- 235 (326)
T ss_dssp ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC---
T ss_pred EEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC---
Confidence 9999999876433 334567899999999999889999999999999999999999999876654433322211100
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....+....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 236 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000112345788999999999999999999999973
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.90 Aligned_cols=252 Identities=18% Similarity=0.206 Sum_probs=200.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|.... ..+.+++|+..........+.+.+|+.+++.++||||+++++++.+. +..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeE
Confidence 4689999999999999999998654 34556677666554444557889999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccce
Confidence 999999999999999843 346999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCC----CccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPET----DISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~----~~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+... ......+|+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...|...
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~--------- 224 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK--------- 224 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT---------
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc---------
Confidence 5322 2235578999999999987775 77899999999999999999999765432211 1111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 225 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -----KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000123456788999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=343.64 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=209.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||+|+||.||+|.+.+ ..+++|+..... .....+.+.+|+.++++++||||+++++++.+.....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQG-----NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETT-----EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEECC-----eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 3578889999999999999999742 345566665543 3345577999999999999999999999998765578
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++. .|+||||||+|||++.++.++|+|||++.
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eEeeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEecccee
Confidence 89999999999999999753 23468999999999999999999999763 39999999999999999999999998875
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCC---cCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTP---KSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~---~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
.... ....+|+.|+|||.+.+..++. ++|||||||++|||++|+.||...........+...
T Consensus 162 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 226 (271)
T 3kmu_A 162 SFQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE------------ 226 (271)
T ss_dssp TTSC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS------------
T ss_pred eecc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc------------
Confidence 5322 3456789999999998765544 799999999999999999999876654432221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
.....++..++.++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ----GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11112244566889999999999999999999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=357.84 Aligned_cols=255 Identities=16% Similarity=0.208 Sum_probs=207.6
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|...+.||+|+||.||+|.... +...+++|+..... .....+.+.+|+.+++.++|||||++++++.+.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-- 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-- 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--
Confidence 346789999999999999999998644 34566677665543 334457789999999999999999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---CcEEEec
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---FSAKLSG 327 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~vkl~D 327 (473)
+..|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEee
Confidence 789999999999999999853 346899999999999999999999999 9999999999999865 4599999
Q ss_pred cCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 328 YGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 328 FGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
||++....... .....+|+.|+|||++.+..++.++|||||||++|||++|.+||.+.........+......
T Consensus 175 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------ 248 (362)
T 2bdw_A 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------ 248 (362)
T ss_dssp CTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred cCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 99998765432 34567899999999999989999999999999999999999999876654433322211100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
........++.++.+||.+||+.||.+|||+.++++.
T Consensus 249 --------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 --------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000112456789999999999999999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.64 Aligned_cols=271 Identities=21% Similarity=0.371 Sum_probs=199.2
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
..++|...+.||+|+||.||+|....+......+++|+..... .....+.+.+|+++++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3567999999999999999999865544333345555544332 345567899999999999999999999998765211
Q ss_pred ----ceEEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 252 ----QRMLIYERLFHGSLDRLIYGRS---DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 252 ----~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 2389999999999999985432 2236899999999999999999999999 99999999999999999999
Q ss_pred EeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||++........ ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~- 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN- 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-
Confidence 999999987644322 23345678999999999999999999999999999999 999998766544333221110
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCCc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSS 463 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~ 463 (473)
....+..++.++.+|+.+||+.||.+|||+.++++.|+++.......+
T Consensus 257 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 257 ----------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred ----------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 011234456789999999999999999999999999999887665443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=346.70 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=211.1
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
.|...+.||+|+||+||+|.+.++......+++|+..........+.+.+|+.+++.++||||+++++++...+ ...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEE
Confidence 45566899999999999999766655555666666654444456678999999999999999999999987652 44589
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+.+|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999964 3456899999999999999999999999 9999999999999999999999999997654
Q ss_pred CC------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcC-CCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 336 ET------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTG-RKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 336 ~~------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
.. ......++..|+|||.+.+..++.++|||||||++|||++| .+||...........+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---------- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC----------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC----------
Confidence 32 22334667899999999999999999999999999999995 55555544433332222111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
....+..++..+.+++.+||+.||.+|||+.++++.|+++.+....
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111334557899999999999999999999999999998766543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=350.80 Aligned_cols=273 Identities=19% Similarity=0.282 Sum_probs=209.4
Q ss_pred cccccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
+.|+..+.||+|+||.||+|.+.. +....+.+++|+............+.+|+.++..++||||+++++++...+...+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458888999999999999998643 3345677777776655445556789999999999999999999999987766779
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999999543 345999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc--ccc
Q 011995 334 IPETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD--DCR 406 (473)
Q Consensus 334 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 406 (473)
..... .....+|..|+|||.+.+..++.++|||||||++|||++|..|+......... ...+.... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK----MIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH----HHCSCCGGGHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh----ccCCcccccCHHH
Confidence 65432 22345677899999999999999999999999999999999986532111100 00000000 000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
+............+..++..+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111122234566789999999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=353.98 Aligned_cols=276 Identities=21% Similarity=0.289 Sum_probs=215.3
Q ss_pred cccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 177 FFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
|+..+.||+|+||+||++.+.. +....+.+++|+............+.+|+++++.++||||+++++++.+.+...+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 4888999999999999997643 334567777777765545556778999999999999999999999998866678999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999543 4999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 336 ETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 336 ~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
... .....++..|+|||.+.+..++.++|||||||++|||++|..||....... .....+...... ...+...
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~ 263 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMT-VLRLTEL 263 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHH-HHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchh-HHHHHHH
Confidence 432 123456778999999999899999999999999999999999997532211 111111000000 0011111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
.........+..++.++.+|+.+||+.||.+|||+.+|++.|+.+.++...
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 122222233556678999999999999999999999999999998766543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=366.44 Aligned_cols=255 Identities=16% Similarity=0.186 Sum_probs=206.8
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|+..+.||+|+||+||+|.... +++.+++|+..... .......+.+|+.+++.++|||||++++++.+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-- 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--
Confidence 346789999999999999999998543 34566666665443 233456789999999999999999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC---CCCcEEEec
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSG 327 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~vkl~D 327 (473)
+..|+||||+.+|+|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~D 156 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLAD 156 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred CEEEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEcc
Confidence 7899999999999999998653 46999999999999999999999999 99999999999998 468899999
Q ss_pred cCCCcccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 328 YGCAGHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 328 FGla~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
||++....... .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+......
T Consensus 157 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----- 231 (444)
T 3soa_A 157 FGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD----- 231 (444)
T ss_dssp CSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----
T ss_pred CceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----
Confidence 99998765432 24567899999999999989999999999999999999999999887655544333211100
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
........++.++.+|+.+||+.||.+|||+.|+++.
T Consensus 232 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 ---------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0001123456889999999999999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=345.16 Aligned_cols=259 Identities=18% Similarity=0.313 Sum_probs=209.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|.+.++......+++|+..........+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCC
Confidence 46899999999999999999987665555555666655544344566789999999999999999999999854 456
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 8999999999999999642 346899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...........+....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~----------- 231 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD----------- 231 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-----------
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-----------
Confidence 64432 223355788999999999999999999999999999998 999997655444332221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
....+..++..+.+++.+||..||.+|||+.++++.|+++..
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 001133455789999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=347.81 Aligned_cols=251 Identities=18% Similarity=0.243 Sum_probs=197.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-------------------------ChhhHhHHHHHH
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-------------------------SQGVKEFINDVN 228 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~Ei~ 228 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+...... ....+.+.+|++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEND---NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTT---TEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCC---CcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 46899999999999999999986543 34555665543321 112356899999
Q ss_pred HHHhCCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeec
Q 011995 229 TLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYN 308 (473)
Q Consensus 229 ~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHr 308 (473)
+++.++||||+++++++.+......++||||+++++|.+++. ...+++..+..++.||+.||+|||+++ |+||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 161 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHR 161 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 999999999999999998755578999999999999988762 346999999999999999999999999 9999
Q ss_pred CCCCCceeeCCCCcEEEeccCCCcccCCCC--ccCcccccccCChhhhhcCC---CCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 309 EFSTANIQIDKDFSAKLSGYGCAGHIPETD--ISNSSVAAANLSVETLERGL---LTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 309 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
||||+|||++.++.+||+|||++....... .....+|+.|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998765432 24457899999999997655 3778999999999999999999998
Q ss_pred CCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 384 SRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..........+..... .......++.++.+|+.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLHSKIKSQAL----------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHHHHHHHCCC----------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHHHhcccC----------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 7654433222211100 00001234578999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=372.66 Aligned_cols=260 Identities=18% Similarity=0.309 Sum_probs=213.3
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|...+.||+|+||.||+|.+... ...+++ |.+.......+.|.+|+.+|++++|||||+++++|... ..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vav--K~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 290 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKY---SLTVAV--KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PP 290 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGG---TEEEEE--EECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCC---CeEEEE--EEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cc
Confidence 356788889999999999999997542 233444 44444444578899999999999999999999999765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.+|||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccce
Confidence 99999999999999999753 2456899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 333 HIPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 333 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------ 434 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 434 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT------------
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 7654332 22345678999999999999999999999999999999 9999987665443322211
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
......+..++..+.+||.+||+.||.+|||+.+|++.|+.+....+
T Consensus 435 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 435 -----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 11112244566889999999999999999999999999999875543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=348.19 Aligned_cols=269 Identities=17% Similarity=0.249 Sum_probs=193.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|... .+++.+++|+............+.+|+.+++.++||||+++++++..+ +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK---TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKL 78 (317)
T ss_dssp ---------------CEEEEEECS---SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC---CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeE
Confidence 467888999999999999999843 345666777776655455567889999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 254 MLIYERLFHGSLDRLIYGRS---DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
++||||++ |+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999997 59998885421 2245899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc--
Q 011995 331 AGHIPET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC-- 405 (473)
Q Consensus 331 a~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 405 (473)
+...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+...........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 9876432 23445789999999999764 589999999999999999999999988776554433211100000000
Q ss_pred cccc--cccccc------------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSL--IMDPQL------------KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~--~~~~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.... ...+.+ ........+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 000000 001112345789999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=355.23 Aligned_cols=263 Identities=12% Similarity=0.084 Sum_probs=207.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||+|+||.||+|.... ..+.+++|+..... ....+.+|+.+++.+ +||||+++++++... +.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecC--Cc
Confidence 4679999999999999999998543 34566677665432 235688999999999 999999999998876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc-----EEEec
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS-----AKLSG 327 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----vkl~D 327 (473)
.++||||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred cEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 99999999 99999999653 357999999999999999999999999 999999999999998887 99999
Q ss_pred cCCCcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 328 YGCAGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 328 FGla~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
||++..+.... .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+..............
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 99998664332 235578999999999999999999999999999999999999998754332222111100
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
.. .... ....+ ....+ ++.+++..||..||.+||++.+|++.|+++..+...
T Consensus 234 ~~-----~~~~-~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 234 DT-----KRAT-PIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HH-----HHHS-CHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hh-----hccC-CHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 0000 00000 11233 899999999999999999999999999988776543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=352.27 Aligned_cols=274 Identities=19% Similarity=0.300 Sum_probs=219.3
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccc
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKL 241 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l 241 (473)
+...+.....++|...+.||+|+||.||+|.+.+ +....+.+++|+..........+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 4455555567899999999999999999998643 33456777777766554455567899999999999 79999999
Q ss_pred eeeeecCCCCceEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeec
Q 011995 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYN 308 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHr 308 (473)
++++...+ ...++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||
T Consensus 97 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 97 LGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 99987653 568999999999999999965432 123899999999999999999999999 9999
Q ss_pred CCCCCceeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCC
Q 011995 309 EFSTANIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLD 383 (473)
Q Consensus 309 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~ 383 (473)
||||+|||++.++.+||+|||++........ ....+|+.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986643321 23456789999999999999999999999999999998 999997
Q ss_pred CCChHHHHh-HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 384 SRHPKEERN-LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 384 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
......... .+... .....+...+..+.+++.+||+.||.+|||+.+|++.|+.+.+..
T Consensus 253 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 253 GVKIDEEFCRRLKEG-----------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp TCCCSHHHHHHHHHT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHhccC-----------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 754332211 11100 001123345678999999999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=369.24 Aligned_cols=258 Identities=23% Similarity=0.395 Sum_probs=211.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|...+.||+|+||.||+|.+.++ ..+++|+ +.......+.|.+|+.+|+.++|||||++++++. . +.
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~vavK~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~--~~ 256 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKH----TKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K--EP 256 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTT----EEEEEEE--ECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S--SS
T ss_pred chHHeEEEEEcccCCceEEEEEEECCc----cEEEEEE--ecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C--Cc
Confidence 456888999999999999999997643 2344444 4434455788999999999999999999999985 2 67
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 89999999999999999643 2235889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 333 HIPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 333 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... ....++..|+|||++....++.++|||||||++|||++ |+.||.+....+....+...
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~----------- 401 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----------- 401 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-----------
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 7644321 23345678999999999999999999999999999999 99999877655433322211
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
.....+..++.++.+||.+||..||.+|||+.+|++.|+.+.....
T Consensus 402 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 402 ------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 0011234566889999999999999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=351.98 Aligned_cols=259 Identities=19% Similarity=0.338 Sum_probs=206.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|.+..+.. ...+++++.............+.+|+.++..++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---C
Confidence 3679999999999999999999754432 33344455554444555678899999999999999999999999763 4
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++|+||+.+|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 88999999999999999653 346999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 333 HIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 333 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------- 236 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------- 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---------
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 764322 123345678999999999999999999999999999999 999998766554333322111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
....+..++.++.+|+.+||+.||.+|||+.|+++.|+++..
T Consensus 237 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 --------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111234456789999999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=350.32 Aligned_cols=265 Identities=19% Similarity=0.338 Sum_probs=213.4
Q ss_pred hcccccCcceeecCCceEEEEEECCC----CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDD----ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 248 (473)
.++|...+.||+|+||.||+|...+. ......+++|+............+.+|++++..+ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46899999999999999999987532 2344555566555444445567899999999999 999999999999765
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSD-------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 114 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 114 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp --SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred --CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 789999999999999999975431 235899999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHH
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEE 390 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~ 390 (473)
|++.++.+||+|||++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 99999999999999998765432 223355788999999998889999999999999999999 9999987665443
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
...+.... ....+..++..+.+++.+||+.||.+|||+.+|++.|+++.....
T Consensus 269 ~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 269 FKLLKEGH-----------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhcCC-----------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 32221110 011234456789999999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=351.36 Aligned_cols=253 Identities=17% Similarity=0.249 Sum_probs=201.2
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC--
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-- 250 (473)
..++|+..+.||+|+||.||+|+... .++.+++|+..........+.+.+|+.+|++++|||||++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45789999999999999999999653 3456677777665555667889999999999999999999998865421
Q ss_pred -----------------------------------------------------CceEEEEEeccCCChhhhhhcCCCCCC
Q 011995 251 -----------------------------------------------------DQRMLIYERLFHGSLDRLIYGRSDGPP 277 (473)
Q Consensus 251 -----------------------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~ 277 (473)
...++||||+++|+|.+++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 138999999999999999977655556
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC--------------ccCcc
Q 011995 278 IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD--------------ISNSS 343 (473)
Q Consensus 278 l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--------------~~~~~ 343 (473)
..+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 788889999999999999999999 9999999999999999999999999998765432 23346
Q ss_pred cccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHH
Q 011995 344 VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKA 423 (473)
Q Consensus 344 ~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 423 (473)
+|+.|+|||.+.+..++.++|||||||++|||++|..|+.. ......... .... .......
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~-------------~~~~-~~~~~~~ 298 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVR-------------NLKF-PLLFTQK 298 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHH-------------TTCC-CHHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhh-------------ccCC-CcccccC
Confidence 89999999999999999999999999999999998766421 111111000 0000 0012345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 424 ARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 424 ~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+.++.+|+.+||+.||.+|||+.|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 577899999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=349.35 Aligned_cols=265 Identities=18% Similarity=0.320 Sum_probs=207.5
Q ss_pred cccccCcceeecCCceEEEEEECCCC-eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA-STSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|...+.||+|+||.||+|.+.... .....+++|+............+.+|+.++..++||||+++++++... +..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--CCc
Confidence 46777899999999999999865432 234455566655444445566799999999999999999999998765 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999643 356999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~---------- 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---------- 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC----------
Confidence 643321 12244678999999999999999999999999999999 99999876554433222110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCCc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSS 463 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~ 463 (473)
.....+..++..+.+++.+||+.||.+||++.+|++.|+++.......+
T Consensus 267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 0011133456789999999999999999999999999999876555433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=364.91 Aligned_cols=254 Identities=20% Similarity=0.332 Sum_probs=206.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|.+.+ ..+++|+.... ...+.|.+|+.+|++++|||||++++++.... ...
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 262 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGL 262 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----EEEEEEEESSC---TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCE
T ss_pred hHHeEEEeeecCcCCeeEEEEEecC-----CeEEEEEeCCc---hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cce
Confidence 4678889999999999999998753 24455554432 25678999999999999999999999987652 478
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 263 ~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 9999999999999999754 2334799999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.. +
T Consensus 339 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-------~-------- 402 (450)
T 1k9a_A 339 ASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------G-------- 402 (450)
T ss_dssp CC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-------T--------
T ss_pred ccccc-cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------C--------
Confidence 53322 23356789999999999999999999999999999998 9999987654433222211 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.....+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11122445678899999999999999999999999999988643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.01 Aligned_cols=248 Identities=19% Similarity=0.264 Sum_probs=201.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||+|+...+ .+.+++|+..... .......+.+|+.++..+ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-- 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-- 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCC---CCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Confidence 57899999999999999999996543 4556666655321 223346688999999988 799999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+.+||||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccc
Confidence 7899999999999999999543 46999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++..... .....++|+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 240 (353)
T 3txo_A 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------- 240 (353)
T ss_dssp CBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred eeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 9864322 3345578999999999998889999999999999999999999998876655443332111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM------RSIFE 450 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~eil~ 450 (473)
..++...+.++.+|+.+||+.||.+||++ .+|++
T Consensus 241 --------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 --------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11244456789999999999999999998 67765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.99 Aligned_cols=254 Identities=17% Similarity=0.253 Sum_probs=201.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC----CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN----PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 249 (473)
.+.|+..+.||+|+||+||+|....+ .+.+++|+.... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRET---GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD- 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCC---CCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-
Confidence 46799999999999999999986543 455666665432 1122457789999999999999999999999876
Q ss_pred CCceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc---EEE
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS---AKL 325 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---vkl 325 (473)
+..|+||||+++|+|.+++.... .+..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||
T Consensus 99 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 99 -GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp -TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEE
T ss_pred -CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEE
Confidence 78999999999999988875432 2346899999999999999999999999 999999999999986654 999
Q ss_pred eccCCCcccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 326 SGYGCAGHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 326 ~DFGla~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
+|||++....... .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+........+......
T Consensus 175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~---- 250 (351)
T 3c0i_A 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK---- 250 (351)
T ss_dssp CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCC----
T ss_pred ecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCC----
Confidence 9999998765433 2345789999999999998999999999999999999999999987432111111110000
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..+.. ...++.++.+||.+||+.||.+|||+.++++
T Consensus 251 -------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -------MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -------CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 1134578999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.88 Aligned_cols=258 Identities=19% Similarity=0.346 Sum_probs=196.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||+|+||.||+|.+.++ +++|+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSSE------EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred ccceeeeeEecCCCCeEEEEEEEcCc------eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---Cc
Confidence 45788899999999999999985432 4455555443 34456779999999999999999999997643 56
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred cEEEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 8999999999999999954 3456999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCC----CccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 333 HIPET----DISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 333 ~~~~~----~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
..... ......+|+.|+|||.+. +..++.++|||||||++|||++|+.||.................
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------ 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS------ 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS------
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc------
Confidence 65321 223456899999999986 56688899999999999999999999987654432211110000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
..+.+ ......++..+.+|+.+||..||.+|||+.+|++.|+++..
T Consensus 243 -----~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 -----LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----CCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----cCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00000 11233456889999999999999999999999999998865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=355.58 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=211.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCC--eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDA--STSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|...+.||+|+||.||+|...... ...+.+++++..........+.+.+|+.++..+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--
Confidence 468999999999999999999975433 234556666665444445567899999999999 899999999999765
Q ss_pred CceEEEEEeccCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRS-----------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
+..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 78999999999999999986421 1346899999999999999999999999 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHh
Q 011995 320 DFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLV 394 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~ 394 (473)
++.+||+|||++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 9999999999998654322 123455778999999999999999999999999999998 99999875433322111
Q ss_pred hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.. . ......+...+..+.+++.+||+.||.+|||+.+|++.|+++...
T Consensus 280 ~~------~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 280 VK------D----------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HH------H----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hh------c----------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 00 0 001111333457899999999999999999999999999987653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=344.34 Aligned_cols=262 Identities=18% Similarity=0.303 Sum_probs=215.4
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|...+.||+|+||.||+|..... ...+++|+. .......+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 83 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PP 83 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGG---TEEEEEEEE--CSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred cccceeEEeecCCCCceeEEEeEecCC---CEEEEEEec--CcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CC
Confidence 467899999999999999999986543 344445444 34445667899999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999999654 3456999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 333 HIPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 333 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~----------- 228 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----------- 228 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-----------
Confidence 7654332 23345678999999999999999999999999999999 99999876654433322211
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCC
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~ 462 (473)
.....+..++..+.+|+.+||..||.+|||+.++++.|+.+......+
T Consensus 229 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~ 276 (288)
T 3kfa_A 229 ------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276 (288)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 111123455688999999999999999999999999999988765443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.38 Aligned_cols=247 Identities=18% Similarity=0.252 Sum_probs=205.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||.||+|....+ ++.+++|+..... .....+.+.+|+.++..++||||+++++++.+. .
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--Q 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT---CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCC---CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--C
Confidence 46899999999999999999986543 4556666654321 123356778999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcc
Confidence 899999999999999999643 46899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------- 219 (318)
T 1fot_A 154 KYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------- 219 (318)
T ss_dssp EECSS-CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------------
T ss_pred eecCC-ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 87643 2345678999999999999999999999999999999999999998766544333221110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
..++...+.++.+++.+||..||.+|| ++++|++
T Consensus 220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112445568899999999999999999 8888885
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=362.27 Aligned_cols=280 Identities=16% Similarity=0.205 Sum_probs=215.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+..........+.+.+|++++++++||||+++++++...+....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKT---GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCC---CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 35799999999999999999996543 345566665543333445778899999999999999999999987655688
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee----CCCCcEEEeccC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI----DKDFSAKLSGYG 329 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFG 329 (473)
++||||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 999999999999999965444445999999999999999999999999 9999999999999 778889999999
Q ss_pred CCcccCCCC-ccCcccccccCChhhhhc--------CCCCCcCCchHHHHHHHHHHcCCCCCCCCChH----HHHhHhhh
Q 011995 330 CAGHIPETD-ISNSSVAAANLSVETLER--------GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK----EERNLVKW 396 (473)
Q Consensus 330 la~~~~~~~-~~~~~~t~~y~aPE~~~~--------~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~----~~~~~~~~ 396 (473)
++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +....+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 998765443 345578999999999875 45788999999999999999999999643221 11111111
Q ss_pred cccccc-------cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 397 SRPFLA-------DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 397 ~~~~~~-------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
..+... ....+.-..+......+.......+.+++.+||+.||++||++.++++.++++..+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 110000 000000000111222345788899999999999999999999999999999887653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.29 Aligned_cols=264 Identities=13% Similarity=0.113 Sum_probs=208.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+.... .....+.+|+.++..+ +|+|++++++++... ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~---~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~ 80 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LH 80 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTT---TEEEEEEEEECC---TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCC---CcEEEEEEeccC---CccHHHHHHHHHHHHHhcCCCCCeEEeecCCC--ce
Confidence 45799999999999999999985433 355666655432 3345788999999999 899999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc-----EEEec
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS-----AKLSG 327 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----vkl~D 327 (473)
.++||||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred eEEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 99999999 99999999653 346999999999999999999999999 999999999999987766 99999
Q ss_pred cCCCcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 328 YGCAGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 328 FGla~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
||++....... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||................
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 99998664332 234568899999999999999999999999999999999999998754322211111000
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
...... .. +. ....++.++.+++.+||+.||.+||++.+|++.|+++..+...
T Consensus 235 ~~~~~~-~~-----~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 235 EKKQST-PL-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHS-CH-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhccCc-cH-----HH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 000000 00 00 0123457899999999999999999999999999998876554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=349.40 Aligned_cols=251 Identities=18% Similarity=0.211 Sum_probs=197.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||++....+...++.+++|+..... .......+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 468999999999999999999875444455667777665432 223446688999999999999999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred CEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 7899999999999999999542 35899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------- 237 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK---------- 237 (327)
T ss_dssp C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----------
T ss_pred ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----------
Confidence 8764322 2344578999999999999899999999999999999999999998766544332221110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
..++...+.++.+|+.+||..||.+|| ++.++++
T Consensus 238 --------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 --------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 012344568899999999999999999 7788876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=350.56 Aligned_cols=267 Identities=20% Similarity=0.330 Sum_probs=213.9
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHA 246 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 246 (473)
+.....++|...+.||+|+||.||+|...+ .....+.+++|+............+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 334456789999999999999999998542 123445555665544334445567899999999999999999999987
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRS-------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~ 319 (473)
.. +..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 99 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 99 QG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred cC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 65 78899999999999999986421 1245799999999999999999999999 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHh
Q 011995 320 DFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLV 394 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~ 394 (473)
++.+||+|||++........ ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 99999999999976643321 23355788999999999999999999999999999999 89999876654433222
Q ss_pred hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
.... ....+..++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 254 ~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGG-----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCC-----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1100 001233556789999999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=377.26 Aligned_cols=254 Identities=16% Similarity=0.271 Sum_probs=204.8
Q ss_pred ceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEecc
Q 011995 182 CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLF 261 (473)
Q Consensus 182 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~~~ 261 (473)
.||+|+||.||+|.+.... ....+++|+.+........+.|.+|+++|+.++|||||++++++.. +.++|||||++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~ 418 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAG 418 (613)
T ss_dssp EEEECSSSEEEEEEEECSS-CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCT
T ss_pred EEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCC
Confidence 7999999999999875332 2344555555444445567889999999999999999999999865 46899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc--
Q 011995 262 HGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI-- 339 (473)
Q Consensus 262 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 339 (473)
+|+|.+++.. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.......
T Consensus 419 ~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 419 GGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp TCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred CCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999999954 3456999999999999999999999999 99999999999999999999999999987643321
Q ss_pred ---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccccc
Q 011995 340 ---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415 (473)
Q Consensus 340 ---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 415 (473)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+... .
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-----------------~ 556 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----------------K 556 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-----------------C
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 12234578999999999999999999999999999998 99999887655543333211 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 416 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
...++..++.++.+||.+||..||++||++.+|++.|+.+....+.
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 1123445678899999999999999999999999999987655443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.07 Aligned_cols=254 Identities=19% Similarity=0.320 Sum_probs=208.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||.||+|...++ ..+++|+. .......+.+.+|++++..++||||+++++++... +..+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~----~~vaiK~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APIC 79 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEE--CTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCE
T ss_pred hheeeeeEecCCCceeEEEEEecCC----CeEEEEEc--cccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeE
Confidence 5788899999999999999997543 23444444 33334457899999999999999999999999765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp EEECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EEEeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccc
Confidence 999999999999999653 346899999999999999999999999 999999999999999999999999999866
Q ss_pred CCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~------------ 222 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------ 222 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC------------
Confidence 4322 223455678999999999999999999999999999999 899998766544332221100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
....+...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 223 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 -----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0111334457899999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=343.67 Aligned_cols=268 Identities=19% Similarity=0.347 Sum_probs=207.6
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|...+.||+|+||.||+|.+..+......+++|+..... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34577889999999999999999876655566666677665443 33445779999999999999999999999876532
Q ss_pred C---ceEEEEEeccCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 251 D---QRMLIYERLFHGSLDRLIYGR---SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 251 ~---~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
. ..++||||+++|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 2 469999999999999998432 23457999999999999999999999999 99999999999999999999
Q ss_pred EeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH- 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-
Confidence 99999998664332 123355778999999999999999999999999999999 999998765544332221100
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
....+..++..+.+++.+||..||.+|||+.+|++.|+++....
T Consensus 267 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 267 ----------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ----------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01123445678999999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=362.21 Aligned_cols=251 Identities=15% Similarity=0.230 Sum_probs=190.9
Q ss_pred hcccccC-cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHh-CCCCCcccceeeeec--CC
Q 011995 174 CHNFFSD-RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLAS-LQHPNLCKLLGFHAR--DG 249 (473)
Q Consensus 174 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~--~~ 249 (473)
.++|... +.||+|+||+||+|.... +.+.+++|+... ...+.+|++++.+ .+||||+++++++.. .+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 4567665 689999999999998654 345556665541 2567789988754 589999999998864 22
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEEEe
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAKLS 326 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vkl~ 326 (473)
...+||||||+++|+|.+++... ....+++..+..|+.||+.||.|||+++ |+||||||+|||++. ++.+||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEE
Confidence 36789999999999999999653 2346999999999999999999999999 999999999999997 7899999
Q ss_pred ccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH----HhHhhhccccc
Q 011995 327 GYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE----RNLVKWSRPFL 401 (473)
Q Consensus 327 DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~----~~~~~~~~~~~ 401 (473)
|||+++..... .....++|+.|+|||++.+..++.++|||||||++|||++|..||........ ...+....
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~--- 283 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--- 283 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC---
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc---
Confidence 99999876433 23456789999999999999999999999999999999999999976543210 11111000
Q ss_pred ccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..+.......++.++.+||.+||+.||.+|||+.+|++.
T Consensus 284 -----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 -----------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000001123456889999999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=340.97 Aligned_cols=265 Identities=15% Similarity=0.185 Sum_probs=200.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||+||+|....+ .+.+++|+..... .......+.+|+.++++++||||+++++++.++ +..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTT---CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCC---CceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEE
Confidence 5789999999999999999986543 4556677666543 334457788999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 77 ~lv~e~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEEEECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999975 66665543 2356999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCC-CCCChHHHHhHhhhcccccccc--ccc
Q 011995 334 IPET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNL-DSRHPKEERNLVKWSRPFLADD--CRL 407 (473)
Q Consensus 334 ~~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~--~~~ 407 (473)
.... ......+|+.|+|||++.+.. ++.++|||||||++|||++|..|| ...........+.......... ...
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred cCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 6432 234457799999999997766 899999999999999999888775 4433333222221100000000 000
Q ss_pred cccc---------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 408 SLIM---------DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 408 ~~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.... ............+.++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 000011123356788999999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=357.84 Aligned_cols=252 Identities=17% Similarity=0.269 Sum_probs=197.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||+|+...+ .+.+++|+.... ........+.+|..++.++ +|||||++++++.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-- 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-- 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCC---CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--
Confidence 46899999999999999999997654 355666666543 2333446688999999887 899999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+.+||||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGl 199 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 199 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecce
Confidence 7899999999999999998543 46999999999999999999999999 99999999999999999999999999
Q ss_pred CcccC--CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIP--ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~--~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++... .......++|+.|+|||++.+..++.++|||||||++|||++|+.||............. ......
T Consensus 200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~-------~~~~~~ 272 (396)
T 4dc2_A 200 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-------EDYLFQ 272 (396)
T ss_dssp CBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC-------HHHHHH
T ss_pred eeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh-------HHHHHH
Confidence 98632 223455689999999999999999999999999999999999999996432211100000 000000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 445 (473)
.+... ...++...+.++.+||.+||+.||.+||++
T Consensus 273 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00011 112355567889999999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=352.72 Aligned_cols=279 Identities=19% Similarity=0.237 Sum_probs=212.6
Q ss_pred CCCCcCCCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC----
Q 011995 159 TGTLRNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ---- 234 (473)
Q Consensus 159 ~~~~~~~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---- 234 (473)
......+++.+.....++|.+.+.||+|+||+||+|....+ .+.+++|+.. ........+..|+.++..+.
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~--~~~~~~~~~~~e~~~l~~l~~~~~ 93 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDN---KKYYAVKVVR--NIKKYTRSAKIEADILKKIQNDDI 93 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEC--SCHHHHHHHHHHHHHHHHTCCCST
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCC---CeEEEEEEec--cchhhhhhhHHHHHHHHHhcccCC
Confidence 44455566666666788999999999999999999996543 3445555543 33445567888999999996
Q ss_pred -CCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCC
Q 011995 235 -HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTA 313 (473)
Q Consensus 235 -HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~ 313 (473)
||||+++++++... +..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~--~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 166 (360)
T 3llt_A 94 NNNNIVKYHGKFMYY--DHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPE 166 (360)
T ss_dssp TGGGBCCEEEEEEET--TEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred CCCCeecccceeeEC--CeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcc
Confidence 99999999999876 7899999999 899999997543 345999999999999999999999999 999999999
Q ss_pred ceeeCC-------------------------CCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHH
Q 011995 314 NIQIDK-------------------------DFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSF 368 (473)
Q Consensus 314 NILl~~-------------------------~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSl 368 (473)
|||++. ++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 999975 78999999999986543 2345678999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc--------ccccccccccCCCCC--------------------
Q 011995 369 GIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC--------RLSLIMDPQLKGRFP-------------------- 420 (473)
Q Consensus 369 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~~~~-------------------- 420 (473)
||++|||++|+.||......+....+........... .........+...++
T Consensus 246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 325 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence 9999999999999988766554433322111100000 000000000000000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 421 LKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 421 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......+.+|+.+||+.||.+|||+.|+|+
T Consensus 326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 326 IIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 111267889999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.82 Aligned_cols=257 Identities=20% Similarity=0.343 Sum_probs=202.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChh------hHhHHHHHHHHHhCCCCCcccceeeeec
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG------VKEFINDVNTLASLQHPNLCKLLGFHAR 247 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 247 (473)
.++|+..+.||+|+||.||+|....+ .+.+++|+......... .+.+.+|+.++++++||||+++++++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKD---KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTT---CCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hccceehhccccCCceeEEEEEEcCC---ceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 36788899999999999999996543 34455665544322211 1678999999999999999999999854
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc-----
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS----- 322 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~----- 322 (473)
. .++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++. +|+||||||+|||++.++.
T Consensus 95 ~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 95 P----PRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp T----TEEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCC
T ss_pred C----CeEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCcee
Confidence 3 37999999999999988643 4579999999999999999999999873 3999999999999988776
Q ss_pred EEEeccCCCcccCCCCccCcccccccCChhhhh--cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc
Q 011995 323 AKLSGYGCAGHIPETDISNSSVAAANLSVETLE--RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 323 vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~--~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
+||+|||++..... ......+|+.|+|||.+. ...++.++|||||||++|||++|+.||..............
T Consensus 168 ~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---- 242 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI---- 242 (287)
T ss_dssp EEECCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH----
T ss_pred EEeCCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH----
Confidence 99999999975533 334567899999999983 44578999999999999999999999976543332111110
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
........++..++..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 243 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 ----------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011111223445668899999999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.43 Aligned_cols=247 Identities=14% Similarity=0.189 Sum_probs=205.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+..... .....+.+.+|+.+|..++||||+++++++.+. .
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--S 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT---CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCC---CCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--C
Confidence 36899999999999999999996543 3455666654321 223456788999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a 188 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccc
Confidence 899999999999999999643 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
...... .....+|+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 189 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------- 254 (350)
T 1rdq_E 189 KRVKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------- 254 (350)
T ss_dssp EECSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred eeccCC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 876433 345678999999999999999999999999999999999999998766554433222110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFE 450 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~ 450 (473)
..++...+.++.++|.+||+.||.+||+ +++|++
T Consensus 255 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 -----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1124455688999999999999999998 888875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.46 Aligned_cols=251 Identities=16% Similarity=0.264 Sum_probs=203.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|.+.+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.+|..++|||||++++++.+. +
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--E 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTT---CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCC---CCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence 36799999999999999999986543 4556666654321 223456788999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a 162 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIA 162 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEecccee
Confidence 89999999999999999954 346999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC-CccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 332 GHIPET-DISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 332 ~~~~~~-~~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------- 234 (384)
T 4fr4_A 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-------- 234 (384)
T ss_dssp EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--------
T ss_pred eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--------
Confidence 876443 3456689999999999964 4589999999999999999999999976443322222211000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-MRSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~ 450 (473)
....++..++..+.+||.+||+.||.+||+ +.+|++
T Consensus 235 -------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 -------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 001234456688999999999999999998 777664
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=356.13 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=205.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+.... .......+.+|+.+|..++||||+++++++.+. ...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~---~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKAT---GRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCC---CCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEE
Confidence 56899999999999999999986543 344555555432 223456789999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC--CCcEEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK--DFSAKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~vkl~DFGla 331 (473)
++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 124 ~lv~E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp EEEEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccc
Confidence 999999999999999853 2346999999999999999999999999 999999999999974 478999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
....... .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.....
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 267 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW----------- 267 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred eecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 8775443 2344789999999999998999999999999999999999999988765443332221100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........++.++.+||.+||+.||.+|||+.++++.
T Consensus 268 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 ---EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111123456889999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=364.43 Aligned_cols=257 Identities=21% Similarity=0.374 Sum_probs=205.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|.+.++. . +++|.+.......+.|.+|+.+|++++||||+++++++.. +..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~--vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~ 253 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTT----R--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 253 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTE----E--EEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCc----e--EEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cce
Confidence 467888899999999999999986532 2 3444444434456789999999999999999999999854 568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++... .+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 9999999999999999532 2345899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+...
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------------ 397 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------ 397 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 654322 22345678999999999999999999999999999999 99999887655433322211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
.....+..++..+.+||.+||+.||++|||+.+|++.|+.+.....
T Consensus 398 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 398 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0111244566889999999999999999999999999999875543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=343.80 Aligned_cols=255 Identities=23% Similarity=0.380 Sum_probs=197.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||+|.+.+ +.+++|+ +. .....+.+.+|+.++++++||||+++++++. +..+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~--~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~ 75 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRA-----KDVAIKQ--IE-SESERKAFIVELRQLSRVNHPNIVKLYGACL----NPVC 75 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT-----EEEEEEE--CS-STTHHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTE
T ss_pred hHeeeeeEeecCCCceEEEEEECC-----eeEEEEE--ec-ChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcE
Confidence 578889999999999999998653 3334443 33 2345678999999999999999999999875 3479
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh---cCCCceeecCCCCCceeeCCCCc-EEEeccCC
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE---EGPFQAMYNEFSTANIQIDKDFS-AKLSGYGC 330 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~---~~~~~ivHrDlkp~NILl~~~~~-vkl~DFGl 330 (473)
+||||+++|+|.+++........+++..+..++.|++.||+|||+ ++ |+||||||+|||++.++. +||+|||+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccc
Confidence 999999999999999765444458899999999999999999999 66 999999999999998876 79999999
Q ss_pred CcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 331 AGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 331 a~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
+...... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......... +.|... ..
T Consensus 153 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~---~~------ 220 (307)
T 2eva_A 153 ACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVH---NG------ 220 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHH---TT------
T ss_pred ccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHh---cC------
Confidence 9765432 23446899999999999999999999999999999999999999764332211 111000 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
.....+..++..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 221 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 221 ----TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ----CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ----CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0111233456789999999999999999999999999998875543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=344.56 Aligned_cols=265 Identities=15% Similarity=0.214 Sum_probs=199.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||+||+|...+ ++.+++|+..... .......+.+|+++++.++||||+++++++.+. ..
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ----GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT----SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SC
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC----CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CE
Confidence 5789999999999999999998644 3445566554432 233456788999999999999999999998765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++ +|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCce
Confidence 9999999974 888888543 346999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc-ccccccc----
Q 011995 333 HIPET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-RPFLADD---- 404 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~---- 404 (473)
..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+... .......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 76432 3344578999999999976 45899999999999999999999999876554433322110 0000000
Q ss_pred cccccc-------cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 405 CRLSLI-------MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 405 ~~~~~~-------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...... .............+.++.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 0000000011234578899999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.48 Aligned_cols=264 Identities=20% Similarity=0.339 Sum_probs=208.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|...+.||+|+||.||+|....+... ..++++...........+.+.+|++++.++ +||||+++++++... +..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEE-EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcc-cceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cce
Confidence 6788999999999999999986543321 122344444333445567799999999999 999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCC
Confidence 99999999999999996532 2346999999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcc
Q 011995 321 FSAKLSGYGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 398 (473)
+.+||+|||++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+...
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~- 257 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 257 (327)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-
Confidence 999999999987543221 223355788999999998889999999999999999998 99999877654433222110
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
.....+..++..+.+|+.+||..||.+|||+.++++.|+++..++..
T Consensus 258 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 258 ----------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp ----------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred ----------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 01112345568899999999999999999999999999998877654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=342.47 Aligned_cols=253 Identities=18% Similarity=0.254 Sum_probs=200.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|....+ ...+++|+..........+.+.+|+++++.++||||+++++++.+. ...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSS---GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTT---CCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred hhheeecceeccCCCeEEEEEEEccC---CceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC--CeE
Confidence 46799999999999999999986543 3455566665544455568899999999999999999999999765 789
Q ss_pred EEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee---CCCCcEEEeccC
Q 011995 254 MLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---DKDFSAKLSGYG 329 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFG 329 (473)
++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 9999999999999988542 12356999999999999999999999999 9999999999999 456889999999
Q ss_pred CCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 330 CAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 330 la~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++....... .....+++.|+|||.+. ..++.++|||||||++|||++|+.||.+.........+.+..+.....
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 247 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE---- 247 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-----
T ss_pred cceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc----
Confidence 998764432 34457889999999985 568999999999999999999999998876555443333221111000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 248 -----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 -----------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1113577889999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=355.76 Aligned_cols=249 Identities=20% Similarity=0.308 Sum_probs=204.4
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARD 248 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 248 (473)
...++|...+.||+|+||.||+|+...+ ++.+++|+..... .......+..|..++..+ +||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTT---TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCC---CCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 4567899999999999999999997543 3556666654321 123456678899999887 999999999999876
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 91 --~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 91 --ENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred --CEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEC
Confidence 7899999999999999999542 36899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCC--CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 329 GCAGHIPE--TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 329 Gla~~~~~--~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
|+++.... ......++|+.|+|||++.+..++.++|||||||++|||++|..||.+.........+....
T Consensus 163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------- 234 (345)
T 1xjd_A 163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------- 234 (345)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred hhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence 99986432 23455688999999999999999999999999999999999999998776554433332111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMR-SIF 449 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil 449 (473)
..++...+.++.+||.+||+.||.+||++. +|+
T Consensus 235 ----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 112344568899999999999999999997 665
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=345.58 Aligned_cols=262 Identities=19% Similarity=0.280 Sum_probs=200.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCe--e--eeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDAS--T--SKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 249 (473)
.++|...+.||+|+||+||+|....... . ...+++|+... ......+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG-GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc-ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-
Confidence 3678899999999999999998654321 1 23344444322 2334457799999999999999999999999765
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc-------
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS------- 322 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~------- 322 (473)
+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 -~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 -DENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp -TCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred -CCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccc
Confidence 7789999999999999999653 334899999999999999999999999 999999999999998877
Q ss_pred -EEEeccCCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcC-CCCCCCCChHHHHhHhhhccc
Q 011995 323 -AKLSGYGCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTG-RKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 323 -vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~ 399 (473)
+||+|||++...... ....+++.|+|||.+.+ ..++.++|||||||++|||++| .+||............... .
T Consensus 159 ~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~-~ 235 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-H 235 (289)
T ss_dssp EEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-C
T ss_pred eeeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc-C
Confidence 999999998765332 23457889999999987 6689999999999999999995 5555544433322211110 0
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCCcc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSST 464 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~ 464 (473)
.++...+.++.+|+.+||+.||.+|||+.++++.|+++.....+...
T Consensus 236 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~ 282 (289)
T 4fvq_A 236 ------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282 (289)
T ss_dssp ------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence 01122245688999999999999999999999999999887666544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.98 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=203.3
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
..++|+..+.||+|+||.||+|....+. ..+++|+..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSK---FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-- 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCC---cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--
Confidence 3578999999999999999999865543 344555543221 122346788999999999999999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCE
T ss_pred CEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccc
Confidence 7899999999999999998543 45899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 331 AGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 331 a~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
+............+++.|+|||.+.+..++.++||||||+++|||++|..||...........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 223 (279)
T 3fdn_A 156 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------ 223 (279)
T ss_dssp ESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------
T ss_pred cccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------
Confidence 87766555566688999999999999999999999999999999999999998766554433332111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
..++...+..+.+|+.+||+.||.+|||+.||++.-
T Consensus 224 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 224 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 112334567889999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=352.22 Aligned_cols=250 Identities=18% Similarity=0.220 Sum_probs=205.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
..++|...+.||+|+||.||+|.... +.+.+++|+..... .......+..|..++..+ +||||+++++++.+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~- 93 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM- 93 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-
Confidence 35789999999999999999998543 55667777765421 223456788999999988 899999999998876
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 -~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 94 -DRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred -CEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCC
Confidence 7899999999999999999542 35999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCC--CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 330 CAGHIPE--TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~~~--~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+....
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 237 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------- 237 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence 9986432 23345688999999999999999999999999999999999999998776554433222110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 451 (473)
..++...+.++.+||.+||..||.+||+ +++|++.
T Consensus 238 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234456688999999999999999995 5777653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.99 Aligned_cols=259 Identities=19% Similarity=0.282 Sum_probs=197.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHh--CCCCCcccceeeeecC--C
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLAS--LQHPNLCKLLGFHARD--G 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~--~ 249 (473)
.++|...+.||+|+||+||+|.+.+ +.+++|+... .....+.+|.+++.. ++||||+++++++... .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQG-----ENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETT-----EEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEeeccCCCcEEEEEEECC-----EEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 5689999999999999999998632 3445555432 344566677777776 7999999999987643 2
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceeecCCCCCceeeCCCC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH--------EEGPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivHrDlkp~NILl~~~~ 321 (473)
....++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +.+ |+||||||+|||++.++
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTS
T ss_pred CceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCC
Confidence 2568999999999999999932 36999999999999999999999 777 99999999999999999
Q ss_pred cEEEeccCCCcccCCCC------ccCcccccccCChhhhhcC------CCCCcCCchHHHHHHHHHHcC----------C
Q 011995 322 SAKLSGYGCAGHIPETD------ISNSSVAAANLSVETLERG------LLTPKSNVWSFGIVLLELLTG----------R 379 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~~------~~~~~~t~~y~aPE~~~~~------~~s~~sDvwSlGvvl~elltG----------~ 379 (473)
.+||+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999997653322 1234789999999999876 345789999999999999999 8
Q ss_pred CCCCCCChHHHH-hHhhhcccccccccccccccccccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 380 KNLDSRHPKEER-NLVKWSRPFLADDCRLSLIMDPQLK-GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 380 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.||......... ...... .... ...+.+. ..++...+..+.+|+.+||+.||.+|||+.+|++.|++++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKV--VCVD------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHH--HTTS------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccccccCCCCcchhhhhHH--Hhcc------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 888553221110 000000 0000 0011111 1123467889999999999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=358.59 Aligned_cols=275 Identities=14% Similarity=0.135 Sum_probs=205.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCe--eeeEEEEEEEecCCCC----------hhhHhHHHHHHHHHhCCCCCcccc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDAS--TSKKFEATVTRLNPSS----------QGVKEFINDVNTLASLQHPNLCKL 241 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~HpnIv~l 241 (473)
.++|.+.+.||+|+||.||+|.+..+.. ..+.+++|+....... .....+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 5689999999999999999999866432 2355666665543210 001234456667778889999999
Q ss_pred eeeeecCC--CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-
Q 011995 242 LGFHARDG--SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID- 318 (473)
Q Consensus 242 ~g~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~- 318 (473)
++++.... ....+|||||+ +++|.+++... ...+++..+..|+.||+.||+|||+++ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99987642 24589999999 99999999653 356999999999999999999999999 99999999999999
Q ss_pred -CCCcEEEeccCCCcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChH
Q 011995 319 -KDFSAKLSGYGCAGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388 (473)
Q Consensus 319 -~~~~vkl~DFGla~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~ 388 (473)
.++.+||+|||+++.+.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999997654221 12345899999999999999999999999999999999999999853322
Q ss_pred HHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 389 EERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
......... .. ...+..+.++.+. ...++.++.+|+..||..||.+||++.+|++.|+++......
T Consensus 268 ~~~~~~~~~--~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 268 PKYVRDSKI--RY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHHHHHHH--HH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHH--Hh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 211111000 00 0011112222111 123457899999999999999999999999999998766544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.49 Aligned_cols=259 Identities=15% Similarity=0.270 Sum_probs=209.2
Q ss_pred cccccCc-ceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDR-CISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|.+.. .||+|+||.||+|.+.... ....+++|+..........+.+.+|++++..++||||+++++++.. +..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCC-CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CCc
Confidence 4566655 9999999999999865322 2345556666554455567889999999999999999999999843 568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999999953 3456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...........+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~---------- 229 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---------- 229 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT----------
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC----------
Confidence 64332 122345788999999998889999999999999999998 99999876654433222211
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
....++..++.++.+++.+||..||.+||++.++++.|+.+....
T Consensus 230 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 230 -------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 011224456688999999999999999999999999999876443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=339.08 Aligned_cols=264 Identities=17% Similarity=0.264 Sum_probs=198.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|.... .+.+++|+..... .......+.+|+.+++.++||||+++++++... +..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNY----GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT----SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred ccchhhhhcccCCCEEEEEEEcCC----CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeE
Confidence 578899999999999999998632 3445566554432 222346788999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 76 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp EEEEECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred EEEEEecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 999999975 999988543 356899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc-ccccccc-cccc
Q 011995 334 IPET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-RPFLADD-CRLS 408 (473)
Q Consensus 334 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~ 408 (473)
.... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+... ....... ....
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 5432 23445779999999999764 5899999999999999999999999887655443322110 0000000 0000
Q ss_pred c--cccccc-------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 409 L--IMDPQL-------KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 409 ~--~~~~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. ..++.. ...+....+.++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000000 01122345688999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.40 Aligned_cols=257 Identities=14% Similarity=0.141 Sum_probs=206.7
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHA 246 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 246 (473)
++....++|+..+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.++..++|||||++++++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCC---CcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3344568899999999999999999996543 3455666654311 1223356889999999999999999999998
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
+. ..+||||||+++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+
T Consensus 140 ~~--~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 140 DD--RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp CS--SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EC--CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 76 7899999999999999999542 4899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCCC---ccCcccccccCChhhhhcCC----CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 327 GYGCAGHIPETD---ISNSSVAAANLSVETLERGL----LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 327 DFGla~~~~~~~---~~~~~~t~~y~aPE~~~~~~----~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|||+++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+.....
T Consensus 211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred ccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 999998765442 23568999999999997765 78999999999999999999999988766554433321100
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE--RPTMRSIFEE 451 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 451 (473)
. +.......++.++.+||.+||..+|.+ ||+++||++.
T Consensus 291 ~--------------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 S--------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H--------------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c--------------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 000001235688999999999999988 9999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=337.04 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=207.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|...++ ..+++|+. .......+.+.+|+++++.++||||+++++++.. +..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 82 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPI 82 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEE--CTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCC----cEEEEEEe--cCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCc
Confidence 46788999999999999999987543 23444443 3334456789999999999999999999998853 568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999999999999999532 1236899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------------ 226 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------------ 226 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc------------
Confidence 654332 23345678999999998889999999999999999999 99999876654433222111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
.....+..++..+.+++.+||..||++|||+.+|++.|+++....
T Consensus 227 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 227 -----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 001123345678999999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=349.76 Aligned_cols=252 Identities=17% Similarity=0.260 Sum_probs=198.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||+|+...+ .+.+++|+..... .......+.+|+.++.++ +||||+++++++.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-- 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-- 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred hhheEEEEEEEecCCeEEEEEEECCC---CCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--
Confidence 36799999999999999999996543 4566677665432 334456788999999988 899999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 156 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccc
Confidence 7899999999999999999542 36999999999999999999999999 99999999999999999999999999
Q ss_pred CcccC--CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIP--ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~--~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++... .......++|+.|+|||++.+..++.++|||||||++|||++|+.||.............. .....
T Consensus 157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-------~~~~~ 229 (345)
T 3a8x_A 157 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE-------DYLFQ 229 (345)
T ss_dssp CBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CH-------HHHHH
T ss_pred cccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccH-------HHHHH
Confidence 98642 2234456889999999999999999999999999999999999999965321110000000 00000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 445 (473)
.+.... ..++...+.++.+|+.+||+.||.+||++
T Consensus 230 ~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 230 VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000111 12344567889999999999999999995
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=365.61 Aligned_cols=248 Identities=17% Similarity=0.238 Sum_probs=196.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||.||+|.... .+..+++|+.... ........+.+|+.++..++||||+++++++... +
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--D 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--T
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--C
Confidence 4689999999999999999998544 3455666665532 2334456788999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
.++|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ ||||||||+||||+.++.+||+|||+
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCC
Confidence 89999999999999999854 3468999999999999999999998 88 99999999999999999999999999
Q ss_pred CcccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 365 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------- 365 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 9864322 3345688999999999999999999999999999999999999998776554433332111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
..++...+.++.+||.+||+.||.+|| ++.|+++
T Consensus 366 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 --------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112444568899999999999999999 9999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=350.51 Aligned_cols=251 Identities=17% Similarity=0.224 Sum_probs=188.0
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|+..+.||+|+||.||+|....+ .+.+++|+.... ...+.+.+|++++.+++||||+++++++... +.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 122 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGT---QKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TE 122 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCC---CcEEEEEEeccc---hhHHHHHHHHHHHHhCCCCCCcceeeeEecC--Ce
Confidence 467899999999999999999997543 344556655432 2346688999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFG 329 (473)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 123 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EEEEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCc
Confidence 9999999999999999953 346899999999999999999999999 999999999999975 8899999999
Q ss_pred CCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhHhhhccccccccccc
Q 011995 330 CAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 407 (473)
++....... .....+|+.|+|||++.+..++.++|||||||++|||++|..||........ ...+... .
T Consensus 197 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~------~--- 267 (349)
T 2w4o_A 197 LSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC------E--- 267 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT------C---
T ss_pred cccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC------C---
Confidence 998764432 2345789999999999998999999999999999999999999976554331 1111100 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......+....+.++.+|+.+||+.||.+|||+.++++.
T Consensus 268 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 -----YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111223456789999999999999999999999873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=355.92 Aligned_cols=248 Identities=17% Similarity=0.245 Sum_probs=201.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|.+.+.||+|+||.||+|....+ ...+++|+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKT---QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCC---CCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--C
Confidence 36899999999999999999996443 3455666554321 123346788999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+ +|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s 155 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS 155 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred EEEEEEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccc
Confidence 899999999 78999988543 46999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... .....+|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........ .
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~ 219 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------K 219 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------C
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------H
Confidence 8765443 345678999999999988776 689999999999999999999997643222110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.. ....++...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 220 i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 220 VNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 0112344566889999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.72 Aligned_cols=271 Identities=17% Similarity=0.193 Sum_probs=202.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC----CChhhHhHHHHHHHHHhCC---CCCcccceeee
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP----SSQGVKEFINDVNTLASLQ---HPNLCKLLGFH 245 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~ 245 (473)
..++|+..+.||+|+||+||+|... ...+.+++|+..... .......+.+|+.+++.++ ||||+++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT---TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4678999999999999999999843 344566666655432 1222356778888877774 99999999998
Q ss_pred ecCCCC---ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc
Q 011995 246 ARDGSD---QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS 322 (473)
Q Consensus 246 ~~~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 322 (473)
.....+ ..++||||+. |+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCC
Confidence 765322 5799999996 59999996542 345999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 323 AKLSGYGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 323 vkl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
+||+|||++....... .....+|+.|+|||++.+..++.++|||||||++|||++|++||.+.........+.......
T Consensus 159 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 159 VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999998765432 344578999999999999999999999999999999999999998877655443332111000
Q ss_pred ccccccc------cccccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDCRLS------LIMDPQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~------~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....... ....+... .......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 00000000 00112456788999999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=365.79 Aligned_cols=261 Identities=14% Similarity=0.160 Sum_probs=207.9
Q ss_pred HHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeee
Q 011995 168 DEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFH 245 (473)
Q Consensus 168 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 245 (473)
.++....++|+..+.||+|+||+||+|+...+ .+.+++|+..... .......+.+|+.++..++||||+++++++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCC---CcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34445578999999999999999999997654 3455666654311 122234588999999999999999999999
Q ss_pred ecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEE
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl 325 (473)
.+. +.+|||||||++|+|.+++... ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||
T Consensus 144 ~~~--~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 144 QDD--NNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp ECS--SEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred eeC--CEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEE
Confidence 876 7899999999999999999642 356999999999999999999999999 999999999999999999999
Q ss_pred eccCCCcccCCCC---ccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc
Q 011995 326 SGYGCAGHIPETD---ISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 326 ~DFGla~~~~~~~---~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 397 (473)
+|||+++...... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+....+...
T Consensus 217 ~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred cchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 9999997664432 23357899999999997 456899999999999999999999999887665544333211
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSE--RPTMRSIFEE 451 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 451 (473)
.. . ..-+ .....++.++.+||.+||..+|.+ |++++|+++.
T Consensus 297 ~~------~---~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KE------R---FQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HH------H---CCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cc------c---ccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00 0 0000 011235688999999999888888 9999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.28 Aligned_cols=267 Identities=20% Similarity=0.290 Sum_probs=206.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|....+ ...+++|+............+.+|+.+++.++||||+++++++..+ +..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT---CCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCC---CcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEE
Confidence 36799999999999999999996543 3556666666554555667899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.
T Consensus 107 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 180 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEEEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence 9999999999999999543 3589999999999999999999996 7 9999999999999999999999999997
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc-------------
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP------------- 399 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~------------- 399 (473)
...........+|+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 6544444556789999999999999999999999999999999999999987665443222110000
Q ss_pred ------cccc-------ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 ------FLAD-------DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ------~~~~-------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+..+ ...+..+.............+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 000000000111111122356789999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=349.17 Aligned_cols=285 Identities=18% Similarity=0.250 Sum_probs=212.1
Q ss_pred hcccccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|.+.. +....+.+++|+.... .....+.+.+|++++++++|+||+++++++...+...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 3678999999999999999998643 2334556666655432 3344567899999999999999999999988665578
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999999999999642 235899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 333 HIPETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 333 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
...... .....++..|+|||.+.+..++.++|||||||++|||++|..||.......... ..+... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~-~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERD-VPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC-----CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccc-cccHHHH
Confidence 764332 123356778999999999889999999999999999999999987533221110 000000 0000011
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCCcccc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSSTVR 466 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~~~ 466 (473)
............+..++..+.+|+.+||+.||.+|||+.+|++.|+.+..........+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 312 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----------
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccc
Confidence 11112222223355667889999999999999999999999999999876665544433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=354.89 Aligned_cols=268 Identities=14% Similarity=0.215 Sum_probs=197.0
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDG 249 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~ 249 (473)
...++|+..+.||+|+||.||+|....+ ++.+++|+.... ........+.+|+.++..+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRT---GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTT---CCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCC---CCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 3567899999999999999999985443 445556655332 23445677889999999997 999999999998765
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...+|+|||||+ |+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCc
Confidence 568999999996 699999854 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC-----------------------CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCC
Q 011995 330 CAGHIPET-----------------------DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSR 385 (473)
Q Consensus 330 la~~~~~~-----------------------~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~ 385 (473)
+++.+... .....++|++|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99765321 1234578999999999976 56899999999999999999999999987
Q ss_pred ChHHHHhHhhhccccccccccccccc------------------ccccCCCC------------CHHHHHHHHHHHHHhc
Q 011995 386 HPKEERNLVKWSRPFLADDCRLSLIM------------------DPQLKGRF------------PLKAARTVADIALRCL 435 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~~------------~~~~~~~l~~li~~cl 435 (473)
........+......... ..+..+. .......+ ...++.++.+|+.+||
T Consensus 235 ~~~~~~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SHHHHHHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 765554433211000000 0000000 00000000 1134578999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 011995 436 QKEPSERPTMRSIFEE 451 (473)
Q Consensus 436 ~~dP~~RPt~~eil~~ 451 (473)
+.||.+|||+.|+++.
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=369.17 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=209.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|.+.++. .+++|+. .......+.|.+|+++|++++|+|||++++++.. +..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~vavK~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~ 336 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTT----RVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 336 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTE----EEEEEEE--CTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCc----eEEEEEe--CCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccc
Confidence 467888899999999999999986532 2444444 3333446789999999999999999999999854 568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+|||||+.+|+|.++|... ....+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 337 ~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999999542 2345899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+...
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~------------ 480 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------ 480 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 65332 123345678999999999999999999999999999999 99999887655443322211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
.....+..++..+.+||.+||+.||++|||+.+|++.|+.+.....
T Consensus 481 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 481 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 0111234566889999999999999999999999999999875443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.38 Aligned_cols=253 Identities=17% Similarity=0.203 Sum_probs=205.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-----hhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-----QGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+....... ...+.+.+|+.++..++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCC---CeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 46799999999999999999996543 345566665543221 1357799999999999999999999999766
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC----cEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF----SAK 324 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~vk 324 (473)
...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 88 --TDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp --SEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred --CEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEE
Confidence 789999999999999999954 346899999999999999999999999 99999999999999887 799
Q ss_pred EeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 325 LSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 325 l~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|+|||++...... ......+|+.|+|||.+.+..++.++|||||||++|||++|..||.+....+....+......
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--- 236 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--- 236 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC---
T ss_pred EccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc---
Confidence 9999999876543 234557899999999999999999999999999999999999999876654433322211000
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.++. +....+..+.+|+.+||..||.+|||+.++++.
T Consensus 237 -------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 -------FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -------CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -------cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 012345778999999999999999999999873
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=348.48 Aligned_cols=261 Identities=16% Similarity=0.164 Sum_probs=201.4
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC----CCChhhHhHHHHHHHHHhCCCCCcccceee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN----PSSQGVKEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
++....++|...+.||+|+||.||+|....+ .+.+++|+.... ......+.+.+|+.+++.++||||++++++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTT---CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCC---CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 3456678899999999999999999986543 344556655432 133456789999999999999999999999
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCC-------------------------------------CCCCCCHHHHHHHH
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRS-------------------------------------DGPPIDWNTRVKIA 287 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~ 287 (473)
+.+. +..++||||+++|+|.+++.... ....+++..+..++
T Consensus 97 ~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 97 YEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp EECS--SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred hccC--CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 9876 78999999999999999884210 01124677888999
Q ss_pred HHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC--cEEEeccCCCcccCCC------CccCcccccccCChhhhhc--C
Q 011995 288 LCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF--SAKLSGYGCAGHIPET------DISNSSVAAANLSVETLER--G 357 (473)
Q Consensus 288 ~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~--~vkl~DFGla~~~~~~------~~~~~~~t~~y~aPE~~~~--~ 357 (473)
.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..+... ......+|+.|+|||++.+ .
T Consensus 175 ~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 99999999999999 99999999999998776 8999999999765321 1234578899999999975 6
Q ss_pred CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhccc
Q 011995 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQK 437 (473)
Q Consensus 358 ~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~ 437 (473)
.++.++|||||||++|||++|+.||......+....+....... ........+..+.+|+.+||+.
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF--------------ENPNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT--------------TSGGGGGSCHHHHHHHHHHSCS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc--------------CCcccccCCHHHHHHHHHHcCC
Confidence 78999999999999999999999998776554433222111000 0001123567899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 011995 438 EPSERPTMRSIFEE 451 (473)
Q Consensus 438 dP~~RPt~~eil~~ 451 (473)
||.+|||+.++++.
T Consensus 318 ~p~~Rps~~~~l~h 331 (345)
T 3hko_A 318 NVDERFDAMRALQH 331 (345)
T ss_dssp CTTTSCCHHHHHHS
T ss_pred ChhHCCCHHHHhcC
Confidence 99999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=342.25 Aligned_cols=268 Identities=13% Similarity=0.098 Sum_probs=205.3
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|+..+.||+|+||.||+|....+ .+.+++|+.... .....+.+|+.++..++|++++..++++...+ +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~---~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG-DY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTT---TEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET-TE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCC---CceEEEEeeccc---ccchHHHHHHHHHHHhcCCCCCCeeeeecCCC-Cc
Confidence 457899999999999999999985443 345566654433 22356889999999999999888887775543 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee---CCCCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---DKDFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFG 329 (473)
.++||||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred eEEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 89999999 99999999642 346999999999999999999999999 9999999999999 788999999999
Q ss_pred CCcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc
Q 011995 330 CAGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 330 la~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
++....... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||..................
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 998764332 13457889999999999999999999999999999999999999765432211111100000
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCCc
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSS 463 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~ 463 (473)
... .. .......++.++.+|+.+||+.||++|||+.+|++.|+++..+.+.+.
T Consensus 234 -----~~~----~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 234 -----KMS----TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp -----HHH----SC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred -----ccc----ch-hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 000 00 000012335789999999999999999999999999999987776543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.30 Aligned_cols=262 Identities=20% Similarity=0.249 Sum_probs=199.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC-
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~- 250 (473)
.++|+..+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRD---HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCC---CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 46799999999999999999985443 4556666665432 23345678999999999999999999999876422
Q ss_pred -CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 251 -DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 251 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCS
T ss_pred CcccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeecc
Confidence 2359999999999999999543 36899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 330 CAGHIPETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 330 la~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
++....... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.+.................
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 238 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--- 238 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC---
Confidence 998664321 223467999999999999999999999999999999999999998766544322111100000
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhhhcc
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-MRSIFEELDRQESR 458 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~L~~l~~~ 458 (473)
+ ......++.++.+|+.+||+.||.+||+ ++++.+.|.++...
T Consensus 239 --------~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 239 --------P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp --------H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred --------c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0 0001235678999999999999999996 55555667665443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=352.83 Aligned_cols=248 Identities=16% Similarity=0.185 Sum_probs=195.4
Q ss_pred ccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEE
Q 011995 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~ 257 (473)
...+.||+|+||.||+|....+ +..+++|+.... .....+.+.+|+++|.+++||||+++++++... +..+|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~---g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 165 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVM 165 (373)
T ss_dssp EEEEECC-----CEEEEEETTT---CCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCC---CcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEE
Confidence 3357899999999999986543 345556655433 224567899999999999999999999999876 7899999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee--CCCCcEEEeccCCCcccC
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI--DKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl--~~~~~vkl~DFGla~~~~ 335 (473)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 166 E~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp ECCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 999999999988543 346899999999999999999999999 9999999999999 567899999999998765
Q ss_pred CCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccc
Q 011995 336 ETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQ 414 (473)
Q Consensus 336 ~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (473)
... .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..... .
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------~-------- 306 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW------D-------- 306 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------C--------
T ss_pred CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------C--------
Confidence 433 3345789999999999988899999999999999999999999988765543332211100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+.......++.++.+||.+||+.||.+|||+.|+++
T Consensus 307 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000011234578999999999999999999999997
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=361.37 Aligned_cols=248 Identities=18% Similarity=0.268 Sum_probs=204.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|.... +++.+++|+..... .......+.+|+.+++.++||||+++++++... +
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 3679999999999999999998653 34556666654321 122356789999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a 163 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS 163 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccch
Confidence 89999999999999999953 346999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... ....++|+.|+|||++.+..+ +.++|||||||++|||++|..||.+.........+....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 232 (476)
T 2y94_A 164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------- 232 (476)
T ss_dssp EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------
T ss_pred hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 8765433 345678999999999988765 689999999999999999999998766544332221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
...+...+.++.+|+.+||+.||.+|||+.+|++
T Consensus 233 -------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 -------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0113345578999999999999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=344.60 Aligned_cols=264 Identities=19% Similarity=0.303 Sum_probs=207.1
Q ss_pred hcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|.+.+ +......+++|+............+.+|+.++++++||||+++++++... .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--L 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--C
Confidence 4678999999999999999998643 23344556666654444555667899999999999999999999998765 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEE
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD----GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAK 324 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vk 324 (473)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 78999999999999999975431 245899999999999999999999999 999999999999984 45699
Q ss_pred EeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG- 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-
Confidence 99999987543221 223456789999999999999999999999999999998 999998766544332222110
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
....+..++..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 263 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 263 ----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 01113345678999999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.06 Aligned_cols=266 Identities=15% Similarity=0.192 Sum_probs=197.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|+..+.||+|+||+||+|.... +.+.+++|+..... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 5789999999999999999998544 34556666655332 3344677899999999999999999999986542
Q ss_pred -CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 250 -SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 250 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
...+||||||+++ +|.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEE
Confidence 2467999999966 57776632 3899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc--c------
Q 011995 329 GCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR--P------ 399 (473)
Q Consensus 329 Gla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--~------ 399 (473)
|+++..... ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... +
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 209 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp CCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred EeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 999876543 2345688999999999999999999999999999999999999999877655433321100 0
Q ss_pred --------ccccc-----cccccccccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 --------FLADD-----CRLSLIMDPQLKG---RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 --------~~~~~-----~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.... ..+.......+.. ......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 0012236789999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.14 Aligned_cols=249 Identities=19% Similarity=0.200 Sum_probs=194.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHH-HHhCCCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNT-LASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||+|+...+ .+.+++|+..... .......+.+|..+ ++.++||||+++++++.+.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-- 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-- 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTT---CCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS--
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCC---CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--
Confidence 46899999999999999999996543 3556666665432 22334566777776 5678999999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~ 185 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL 185 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred CEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcc
Confidence 789999999999999999954 236899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCC--CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPE--TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~--~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++.... ......++|+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+....
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 255 (373)
T 2r5t_A 186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------- 255 (373)
T ss_dssp CGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC----------
T ss_pred ccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Confidence 986432 23455688999999999999999999999999999999999999998766554433222110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++..++..+.+||.+||+.||.+||++.+.+++
T Consensus 256 --------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 256 --------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp --------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred --------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 01233456789999999999999999998644433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=335.36 Aligned_cols=253 Identities=16% Similarity=0.216 Sum_probs=205.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|....+ +..+++|+..... .......+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCC---CceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CE
Confidence 57899999999999999999986543 3455666665432 334457788999999999999999999999765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc---EEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS---AKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---vkl~DFG 329 (473)
.++||||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 89999999999998888543 45899999999999999999999999 999999999999986655 9999999
Q ss_pred CCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 330 CAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 330 la~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 225 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-------- 225 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--------
Confidence 997665433 24457899999999999999999999999999999999999999877655443333211100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
........++.++.+|+.+||+.||.+|||+.|+++.
T Consensus 226 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0001122455789999999999999999999999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=343.67 Aligned_cols=267 Identities=16% Similarity=0.255 Sum_probs=201.0
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC--CCCCcccceeeee
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL--QHPNLCKLLGFHA 246 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l--~HpnIv~l~g~~~ 246 (473)
.-....++|+..+.||+|+||.||+|.+.+ +.+++|+... .....+.+|.+++..+ +||||+++++++.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRG-----EKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccccccceEEEeEeecCCCeEEEEEEECC-----ceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 333456789999999999999999998652 4455555432 2334555666666655 9999999999987
Q ss_pred cCCC--CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------CCCceeecCCCCCcee
Q 011995 247 RDGS--DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE--------GPFQAMYNEFSTANIQ 316 (473)
Q Consensus 247 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~~~~ivHrDlkp~NIL 316 (473)
.... ...++||||+++|+|.+++... .+++..+..++.|++.||+|||++ + |+||||||+|||
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil 174 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL 174 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence 6532 5789999999999999999543 589999999999999999999998 7 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCCc------cCcccccccCChhhhhcCCCCCc------CCchHHHHHHHHHHcC------
Q 011995 317 IDKDFSAKLSGYGCAGHIPETDI------SNSSVAAANLSVETLERGLLTPK------SNVWSFGIVLLELLTG------ 378 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~~------~~~~~t~~y~aPE~~~~~~~s~~------sDvwSlGvvl~elltG------ 378 (473)
++.++.+||+|||++........ ....+|+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 99999999999999976643321 24478999999999988776665 9999999999999999
Q ss_pred ----CCCCCCCChHHH--HhHhhhcccccccccccccccccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 379 ----RKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDPQLKGRF-PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 379 ----~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+.||........ ....... ......+.+...+ ...++.++.+|+.+||+.||.+|||+.+|++.
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIV---------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccccHhhhcCCCCchhhhHHHH---------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 666644321110 0000000 0000111111111 23778899999999999999999999999999
Q ss_pred HHhhhcccC
Q 011995 452 LDRQESRKS 460 (473)
Q Consensus 452 L~~l~~~~~ 460 (473)
|+++.....
T Consensus 326 L~~l~~~~~ 334 (337)
T 3mdy_A 326 LAKMSESQD 334 (337)
T ss_dssp HHHHHHTTT
T ss_pred HHHHHhhcc
Confidence 999886543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.52 Aligned_cols=258 Identities=15% Similarity=0.278 Sum_probs=207.8
Q ss_pred hcccccCc-ceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDR-CISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+ .||+|+||.||+|.+... ...+.+++|+..... .....+.+.+|+.++..++||||+++++++. . +
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~--~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A--E 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S--S
T ss_pred chhhhhccCccccccCeeeEeeeecCC-CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C--C
Confidence 46787777 999999999999965432 345666666665432 3344678999999999999999999999983 3 6
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 789999999999999999653 45899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccc
Q 011995 332 GHIPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 332 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
........ ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...........+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------- 237 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------- 237 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence 87643321 22345678999999998889999999999999999999 999998766544333222110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...++..++..+.+++.+||+.||.+||++.+|++.|+++...
T Consensus 238 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 238 ----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1112445668899999999999999999999999999988654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=339.13 Aligned_cols=266 Identities=13% Similarity=0.100 Sum_probs=207.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+..... ....+.+|+.++..++|++++..++++...+ ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT---TEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEET-TEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCC---CcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCC-Cce
Confidence 57899999999999999999985433 3556666655432 2356889999999999999888887775543 788
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee---CCCCcEEEeccCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---DKDFSAKLSGYGC 330 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGl 330 (473)
++||||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 9999999 89999999632 346999999999999999999999999 9999999999999 4789999999999
Q ss_pred CcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 331 AGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 331 a~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
+....... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 232 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-- 232 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH--
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc--
Confidence 98764432 2345788999999999999999999999999999999999999986432211111100000
Q ss_pred ccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCC
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~ 462 (473)
. .... ..+. ....++.++.+++.+||+.||.+|||+.+|++.|+++..+...+
T Consensus 233 -~--~~~~-~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 233 -K--KMST-PIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp -H--HHHS-CHHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -c--ccCC-chHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 0 0000 0000 01234578999999999999999999999999999988776653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=351.04 Aligned_cols=252 Identities=15% Similarity=0.157 Sum_probs=189.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||+||++.... +.+.+++|+... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 91 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 91 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEES--STTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEec--CccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEE
Confidence 4579999999999999999999653 344555665543 233346788999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc--EEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS--AKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--vkl~DFGla 331 (473)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 92 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 9999999999999998542 35999999999999999999999999 999999999999987765 999999999
Q ss_pred cccCCC-CccCcccccccCChhhhhcCCCCCc-CCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhhhcccccccccccc
Q 011995 332 GHIPET-DISNSSVAAANLSVETLERGLLTPK-SNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVKWSRPFLADDCRLS 408 (473)
Q Consensus 332 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~-sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 408 (473)
+..... ......+|+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ..+..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~------------ 233 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR------------ 233 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH------------
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH------------
Confidence 754322 3345578999999999988887655 89999999999999999999764432111 11110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+............++.++.+||.+||+.||.+|||+.|+++.
T Consensus 234 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 234 -ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000000000112345788999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=337.00 Aligned_cols=249 Identities=18% Similarity=0.253 Sum_probs=205.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|....+. ..+++|+..... .......+.+|++++..++||||+++++++.+. +
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNK---FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--K 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCC---cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--C
Confidence 468999999999999999999865433 344555543321 122346788999999999999999999999865 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 161 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS 161 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccccc
Confidence 899999999999999999543 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
............+++.|+|||.+.+..++.++||||||+++|||++|..||...........+...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------- 227 (284)
T 2vgo_A 162 VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------------- 227 (284)
T ss_dssp EECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------
T ss_pred ccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--------------
Confidence 776555555667899999999999989999999999999999999999999876544432222110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+ ..++...+..+.+++.+||+.||.+|||+.++++.
T Consensus 228 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0 11234456789999999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.93 Aligned_cols=267 Identities=20% Similarity=0.228 Sum_probs=199.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||+||+|....+ ++.+++|+..... .....+.+.+|+.++.+++||||+++++++... +.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDT---GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCC---CcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC--Ce
Confidence 36799999999999999999996543 3455555544332 223356788999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence 9999999999999988843 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc-c-------
Q 011995 333 HIPET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF-L------- 401 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~------- 401 (473)
..... ......+|..|+|||.+.+ ..++.++|||||||++|||++|..||.+.........+...... .
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 151 LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 76432 2234578899999999976 56899999999999999999999999887665544333211000 0
Q ss_pred ccccccccccccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRF-----PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...........+...... ...++..+.+|+.+||+.||.+|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000000 12456779999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=335.96 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=208.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+.|...+.||+|+||.||+|.... ..+.+++|+..........+.+.+|+.++..++||||+++++++... ...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEE
Confidence 468888999999999999998543 34556677766655556678899999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceec
Confidence 99999999999999842 46999999999999999999999999 999999999999999999999999999776
Q ss_pred CCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.... .....+++.|+|||.+.+..++.++|||||||++|||++|..||...........+.... .
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~ 236 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-------------P 236 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------C
T ss_pred CccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-------------C
Confidence 5432 234568899999999999999999999999999999999999998765544332221100 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
+ .++..++..+.+|+.+||..||.+|||+.++++..-
T Consensus 237 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 237 P----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp C----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred C----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1 112344578999999999999999999999998644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=347.80 Aligned_cols=265 Identities=17% Similarity=0.224 Sum_probs=196.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|...+.||+|+||+||+|....+ .+.+++|+............+.+|+.+++.++||||+++++++... +..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLT---DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCC---CcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEE
Confidence 5789999999999999999986543 3455666665444434444667899999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||++ |+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 77 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp EEEECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred EEecccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 9999996 5999888653 346899999999999999999999999 999999999999999999999999998765
Q ss_pred CCC--CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc-----
Q 011995 335 PET--DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR----- 406 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 406 (473)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+............
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 432 2334577999999999976 56899999999999999999999999987765544433211100000000
Q ss_pred ---cccccccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 407 ---LSLIMDPQLKG----RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 407 ---~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......+.... ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000 001235678899999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=357.67 Aligned_cols=261 Identities=16% Similarity=0.177 Sum_probs=206.0
Q ss_pred HHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceee
Q 011995 167 LDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 167 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
+.++....++|+..+.||+|+||.||+|+... +++.+++|+..... .......+.+|+.++..++||||++++++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 34444557899999999999999999999654 34556666654321 12234568899999999999999999999
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
+.+. +.+||||||+++|+|.+++... +..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+|
T Consensus 130 ~~~~--~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 130 FQDE--NYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EECS--SEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred EeeC--CEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEE
Confidence 9876 7899999999999999999642 346999999999999999999999999 99999999999999999999
Q ss_pred EeccCCCcccCCCCc---cCcccccccCChhhhh-------cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh
Q 011995 325 LSGYGCAGHIPETDI---SNSSVAAANLSVETLE-------RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394 (473)
Q Consensus 325 l~DFGla~~~~~~~~---~~~~~t~~y~aPE~~~-------~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 394 (473)
|+|||++........ ...++|+.|+|||++. +..++.++|||||||++|||++|+.||......+....+
T Consensus 203 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 282 (412)
T 2vd5_A 203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282 (412)
T ss_dssp ECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999987654322 3457899999999997 356899999999999999999999999887665543332
Q ss_pred hhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 011995 395 KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER---PTMRSIFEE 451 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~eil~~ 451 (473)
...... ..-+ .++..++.++.+||.+||. +|.+| |+++||++.
T Consensus 283 ~~~~~~---------~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 283 VHYKEH---------LSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HTHHHH---------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HhcccC---------cCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 211000 0000 0123456889999999999 99998 589998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=349.01 Aligned_cols=268 Identities=14% Similarity=0.136 Sum_probs=199.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCCh----------hhHhHHHHHHHHHhCCCCCccccee
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ----------GVKEFINDVNTLASLQHPNLCKLLG 243 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~Ei~~l~~l~HpnIv~l~g 243 (473)
.++|...+.||+|+||.||+|...........+++|+........ ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999986544455566666665432210 1234678889999999999999999
Q ss_pred eeecC--CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC
Q 011995 244 FHARD--GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 244 ~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 321 (473)
++... +....++||||+ +++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 98762 237899999999 99999999543 27999999999999999999999999 99999999999998877
Q ss_pred --cEEEeccCCCcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH
Q 011995 322 --SAKLSGYGCAGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE 390 (473)
Q Consensus 322 --~vkl~DFGla~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~ 390 (473)
.+||+|||+++.+.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999997653221 1344788999999999999999999999999999999999999964322111
Q ss_pred --HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 391 --RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 391 --~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
............. ....... ...++.++.+++.+||..||.+|||+.+|++.|+.+..
T Consensus 269 ~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLLDELPQ------SVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHTTTH------HHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhcccccH------HHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111100000000 0000000 11345789999999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=345.33 Aligned_cols=278 Identities=19% Similarity=0.259 Sum_probs=209.1
Q ss_pred hcccccCcceeecCCceEEEEEECC-CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD-DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|.+.. +...++.+++|+... ......+.+.+|+++++.++||||+++++++...+...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 4578889999999999999998643 233455666665543 24455678999999999999999999999987765568
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 89999999999999999653 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 333 HIPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 333 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
....... ....++..|+|||.+.+..++.++|||||||++|||++|..||......... ..............+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR-MIGNDKQGQMIVFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH-HHCTTCCTHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH-hhccccchhhhHHHH
Confidence 7654321 2234567899999999888999999999999999999999988643111100 000000000000000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+........+..++.++.+++.+||..||.+|||+.+|++.|+++..+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 011111111122445678899999999999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=339.66 Aligned_cols=261 Identities=18% Similarity=0.291 Sum_probs=201.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||+||+|.+.........+++|+.... ......+.+.+|+.++..++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 46799999999999999999986543333333444444332 1345567899999999999999999999998753
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 488999999999999999643 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccc
Q 011995 332 GHIPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 332 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------- 241 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG------- 241 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-------
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC-------
Confidence 87644321 23355678999999998889999999999999999999 999998776544332221110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.....+..++.++.+++.+||..||.+|||+.++++.|+++...
T Consensus 242 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00111334568899999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.97 Aligned_cols=252 Identities=17% Similarity=0.192 Sum_probs=202.0
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|...+.||+|+||.||+|....+. ..+++++.... .....+.+.+|+++++.++||||+++++++.+. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~a~k~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTR---IRRAAKKIPKY-FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TD 80 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGG-GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCC---cEEEEEeehhh-ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Ce
Confidence 3567999999999999999999965543 33444444332 223457889999999999999999999999865 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee---CCCCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---DKDFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFG 329 (473)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999999999998854 345899999999999999999999999 9999999999999 788999999999
Q ss_pred CCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 330 CAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 330 la~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++...... ......+|+.|+|||.+.+. ++.++|||||||++|||++|..||......+....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 228 (277)
T 3f3z_A 155 LAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE----- 228 (277)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH-----
T ss_pred cceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 99876543 33455789999999998654 899999999999999999999999876655433322211100000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....++..+.+|+.+||+.||.+|||+.++++.
T Consensus 229 ---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 ---------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001345789999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=345.04 Aligned_cols=246 Identities=15% Similarity=0.159 Sum_probs=191.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||+||+|....+ .+.+++|+..... .......+..|+..+..+ +|+||+++++++.+. +
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKED---GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--G 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTT---SCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--T
T ss_pred hhheeeeheeccCCCeEEEEEEECCC---CeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--C
Confidence 36899999999999999999997643 3445566544332 233344566666666665 999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceee
Confidence 899999999 77999888653 346999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
....... .....+|+.|+|||++.+ .++.++|||||||++|||++|..++....... .+..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~--------------- 266 (311)
T 3p1a_A 205 VELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ--QLRQ--------------- 266 (311)
T ss_dssp EECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH--HHTT---------------
T ss_pred eecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--HHhc---------------
Confidence 7764433 234468999999999875 78999999999999999999977665422111 0000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......++..++.++.+|+.+||+.||++|||+.|+++
T Consensus 267 --~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 267 --GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00001112235678999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=348.11 Aligned_cols=245 Identities=16% Similarity=0.240 Sum_probs=201.1
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-------ChhhHhHHHHHHHHHhCCCCCcccceee
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-------SQGVKEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
...++|...+.||+|+||.||+|....+ .+.+++|+...... ......+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEK---NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTT---TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCC---CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3467899999999999999999985443 45566666654321 1234578899999999999999999999
Q ss_pred eecCCCCceEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcE
Q 011995 245 HARDGSDQRMLIYERLFHG-SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
+.+. +..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 98 ~~~~--~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 169 (335)
T 3dls_A 98 FENQ--GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTI 169 (335)
T ss_dssp EECS--SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred EeeC--CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcE
Confidence 9866 7899999999777 99999854 346999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCCcccCCCC-ccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 324 KLSGYGCAGHIPETD-ISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 324 kl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
||+|||++....... .....+|+.|+|||++.+..+ +.++|||||||++|||++|..||....... .
T Consensus 170 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~------ 238 (335)
T 3dls_A 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----E------ 238 (335)
T ss_dssp EECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----T------
T ss_pred EEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----h------
Confidence 999999998765443 334578999999999988776 789999999999999999999996521100 0
Q ss_pred ccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... ..+..++.++.+|+.+||+.||.+|||+.++++.
T Consensus 239 -------~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 -------AAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------TCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------hcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0122355789999999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.14 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=200.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
+.|...+.||+|+||.||+|.... ..+.+++|+...... ....+.+.+|+++++.++||||+++++++... +.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--Ce
Confidence 558888999999999999998543 334566666654322 23346789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+. |+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred EEEEEecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 999999996 6888887532 346999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
.... .....+|+.|+|||++. ++.++.++|||||||++|||++|..||...........+....
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~----------- 269 (348)
T 1u5q_A 203 IMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------- 269 (348)
T ss_dssp SSSS--BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred ecCC--CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------
Confidence 7643 24457899999999985 4678999999999999999999999998766544322111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
.+.+ .+...+..+.+|+.+||+.||.+|||+.++++..
T Consensus 270 --~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 270 --SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp --CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred --CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0001 1223457889999999999999999999998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.85 Aligned_cols=260 Identities=16% Similarity=0.157 Sum_probs=198.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+..... .....+.+.+|+.++..++||||+++++++..+ +
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVR---ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--G 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTT---TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--T
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCC---CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--C
Confidence 57899999999999999999986543 3455565554321 223347789999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred eEEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccC
Confidence 899999999999999999543 46899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 332 GHIPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 332 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+....+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 252 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP--------- 252 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCC---------
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCC---------
Confidence 7664432 2344678999999999988899999999999999999999999987544322221111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhccc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-TMRSIFEELDRQESRK 459 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~l~~~~ 459 (473)
....++..++.++.+++.+||..||.+|| +++++++.|+.+....
T Consensus 253 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 ------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00112334557899999999999999999 9999999999876544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.50 Aligned_cols=266 Identities=15% Similarity=0.179 Sum_probs=193.8
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
..++|...+.||+|+||+||+|....+ .+.+++|+..... .......+.+|+.+++.++||||+++++++... +
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVT---NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--H 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTT---TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET--T
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCC---CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC--C
Confidence 357899999999999999999985443 4555666655433 233356788999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee-----CCCCcEEEe
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI-----DKDFSAKLS 326 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl-----~~~~~vkl~ 326 (473)
..++||||++ |+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEEEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence 8999999997 5999999643 35999999999999999999999999 9999999999999 455669999
Q ss_pred ccCCCcccCCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 327 GYGCAGHIPET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 327 DFGla~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|||++...... ......+|+.|+|||++.+.. ++.++|||||||++|||++|..||...........+.........
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp CTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 99999765422 234456799999999998754 899999999999999999999999887655443322111000000
Q ss_pred ccc------------cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 DCR------------LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ~~~------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
... ........+...++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 00000000000111225678899999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.00 Aligned_cols=249 Identities=19% Similarity=0.321 Sum_probs=195.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCC--CCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQH--PNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~ 250 (473)
.++|++.+.||+|+||.||++...+ ...+++|+..... .......+.+|+.+|..++| +||+++++++...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTT----SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCC----CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--
Confidence 4679999999999999999998543 3456666665543 34455788999999999976 9999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++||| +.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred CEEEEEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccc
Confidence 78999999 5588999999653 46899999999999999999999999 99999999999997 57899999999
Q ss_pred CcccCCCC----ccCcccccccCChhhhhc-----------CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh
Q 011995 331 AGHIPETD----ISNSSVAAANLSVETLER-----------GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 331 a~~~~~~~----~~~~~~t~~y~aPE~~~~-----------~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 395 (473)
+....... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---- 229 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 229 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----
Confidence 98764332 234578999999999975 66889999999999999999999999764332111
Q ss_pred hcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 396 WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+..+.++.....++...+.++.+|+.+||+.||.+|||+.++++.
T Consensus 230 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 -----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 011111222223344445788999999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.93 Aligned_cols=267 Identities=16% Similarity=0.179 Sum_probs=185.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|++.+.||+|+||+||+|.... +.+.+++|+.... ......+.+.+|+.+|+.++|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 3689999999999999999998543 4456666655433 23344578899999999999999999999985432
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...+|+||||+ +|+|.+++.. ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccc
Confidence 25789999998 5799999854 346999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC-----------------------------CccCcccccccCChhhh-hcCCCCCcCCchHHHHHHHHHHc--
Q 011995 330 CAGHIPET-----------------------------DISNSSVAAANLSVETL-ERGLLTPKSNVWSFGIVLLELLT-- 377 (473)
Q Consensus 330 la~~~~~~-----------------------------~~~~~~~t~~y~aPE~~-~~~~~s~~sDvwSlGvvl~ellt-- 377 (473)
+++..... .....++|++|+|||++ .+..++.++|||||||++|||++
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 99876421 12344679999999987 45669999999999999999999
Q ss_pred ---------CCCCCCCCChH--------------------HHHhHhhh-c-ccccc------cc--cc----cccccccc
Q 011995 378 ---------GRKNLDSRHPK--------------------EERNLVKW-S-RPFLA------DD--CR----LSLIMDPQ 414 (473)
Q Consensus 378 ---------G~~p~~~~~~~--------------------~~~~~~~~-~-~~~~~------~~--~~----~~~~~~~~ 414 (473)
|.++|.+.... .....+.. . .+... .. .. +.......
T Consensus 282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (458)
T 3rp9_A 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361 (458)
T ss_dssp TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence 67777654310 00000000 0 00000 00 00 00000000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 415 LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 415 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+... ....+.++.+|+.+||+.||.+|||+.|+|+.
T Consensus 362 ~~~~-~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 362 LAER-FPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGGG-STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHH-CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111 12346889999999999999999999999984
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=333.26 Aligned_cols=253 Identities=17% Similarity=0.193 Sum_probs=203.4
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|+..+.||+|+||.||+|....+ .+.+++|+..........+.+.+|+.+++.++||||+++++++.+. +.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTT---CCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCC---CcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CE
Confidence 357899999999999999999986543 3455666665544445567899999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 8999999999999999843 346899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCC----CccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 333 HIPET----DISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 333 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
..... ......+++.|+|||.+.+..+ +.++|||||||++|||++|..||......... ...|....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~------- 225 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKK------- 225 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTC-------
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcc-------
Confidence 65322 1234568899999999987665 77899999999999999999999865432211 11111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 -------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0000123456788999999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=348.63 Aligned_cols=269 Identities=18% Similarity=0.171 Sum_probs=202.4
Q ss_pred hcccccCcceeec--CCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEG--LSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
.++|++.+.||+| +||.||+|.... .++.+++|+..... .......+.+|+.+++.++|||||++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-- 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--
Confidence 4689999999999 999999999654 34556677665543 334456788999999999999999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccc
Confidence 7899999999999999999654 2346999999999999999999999999 99999999999999999999999998
Q ss_pred CcccCCC---------CccCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-hcc
Q 011995 331 AGHIPET---------DISNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-WSR 398 (473)
Q Consensus 331 a~~~~~~---------~~~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~ 398 (473)
+...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+. ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 7543211 1223467889999999987 578999999999999999999999998755433221110 000
Q ss_pred cccccccc------------------ccccc---------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 399 PFLADDCR------------------LSLIM---------DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 399 ~~~~~~~~------------------~~~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+...+... ..... .......++..++..+.+||.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000000 00000 0000011344567889999999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=350.48 Aligned_cols=248 Identities=20% Similarity=0.325 Sum_probs=195.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCC--CCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQ--HPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~ 251 (473)
.+|.+.+.||+|+||.||+|...+ ...+++|+..... .......+.+|+.+|..++ |+|||++++++... +
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--Q 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred CceEEEEEEccCCCeEEEEEEcCC----CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--C
Confidence 469999999999999999998543 4456677665543 3445678999999999996 59999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+||||| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred EEEEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 8999999 5688999999653 36899999999999999999999999 99999999999996 579999999999
Q ss_pred cccCCCC----ccCcccccccCChhhhhc-----------CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 332 GHIPETD----ISNSSVAAANLSVETLER-----------GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 332 ~~~~~~~----~~~~~~t~~y~aPE~~~~-----------~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
..+.... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......... +
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~--- 277 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-L--- 277 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-H---
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-H---
Confidence 8764332 234578999999999975 36889999999999999999999999765332111 0
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..+.++.....++...+.++.+||.+||+.||.+|||+.|+++.
T Consensus 278 -----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 -----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 01111111122233345789999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=369.78 Aligned_cols=251 Identities=16% Similarity=0.296 Sum_probs=203.7
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
+.||+|+||.||+|.+... ...+.+++|+..... .....+++.+|+++|.+++|||||++++++.. +..+|||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcCC-CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEc
Confidence 5799999999999976433 345666677665432 23345789999999999999999999999864 468999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCC-
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD- 338 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 338 (473)
+++|+|.+++.. ...+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+....
T Consensus 451 ~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 451 AELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp CTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred cCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 999999999954 346899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 339 ----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 339 ----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+....
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------------- 589 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--------------- 589 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------------
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 122345678999999999999999999999999999998 999998876655443332110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...++..++.++.+||.+||+.||++||++.+|++.|+++...
T Consensus 590 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1122445668899999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=347.52 Aligned_cols=252 Identities=17% Similarity=0.270 Sum_probs=198.8
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
..++|+..+.||+|+||.||+|....+ .+.+++|+..... ..+.+|++++.++ +||||+++++++.+. +
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~-----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~ 89 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSK-----RDPTEEIEILLRYGQHPNIITLKDVYDDG--K 89 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEETTT-----CCCHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCC---CCEEEEEEEEccc-----CChHHHHHHHHHhcCCCCcCeEEEEEEcC--C
Confidence 467899999999999999999996543 4566666664322 3456799999888 799999999999765 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC----CcEEEec
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD----FSAKLSG 327 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~vkl~D 327 (473)
..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+..+ +.+||+|
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 899999999999999999543 46999999999999999999999999 9999999999998433 3599999
Q ss_pred cCCCcccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 328 YGCAGHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 328 FGla~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
||++...... ......+|+.|+|||++.+..++.++|||||||++|||++|..||..........+..... .+
T Consensus 164 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~- 238 (342)
T 2qr7_A 164 FGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SG- 238 (342)
T ss_dssp CTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HC-
T ss_pred CCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cC-
Confidence 9999876433 2345578999999999988888999999999999999999999997643211111111100 00
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+...+...++.++.+|+.+||..||.+|||+.++++.
T Consensus 239 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 239 ------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011112234567889999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=331.87 Aligned_cols=260 Identities=17% Similarity=0.244 Sum_probs=204.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-----ChhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-----SQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCC---CCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 36799999999999999999996543 34455665544321 12357799999999999999999999999875
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC----cEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF----SAK 324 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~vk 324 (473)
...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 81 --TDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp --SEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEE
T ss_pred --CeEEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceE
Confidence 789999999999999999954 346899999999999999999999999 99999999999998877 899
Q ss_pred EeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 325 LSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 325 l~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|+|||++...... ......+++.|+|||.+.+..++.++||||||+++|||++|..||...........+.....
T Consensus 153 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 228 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY---- 228 (283)
T ss_dssp ECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----
T ss_pred EEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc----
Confidence 9999999876433 23445688999999999988999999999999999999999999987665443322221100
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhcc
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE--ELDRQESR 458 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~--~L~~l~~~ 458 (473)
..........+..+.+|+.+||..||.+|||+.++++ .++.+..+
T Consensus 229 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 229 ----------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp ----------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred ----------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0000001234577899999999999999999999997 45555443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.61 Aligned_cols=265 Identities=19% Similarity=0.233 Sum_probs=198.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|.+.+.||+|+||.||+|....+ ++.+++|+..... .......+.+|+.+++.++||||+++++++... +
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLD---GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--N 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTT---CCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred ccceEEEEeecCCCCceEEEEEEcCC---CceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence 45799999999999999999986443 3455566655422 334567789999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 899999999999999998532 12456899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+....... .....+++.|+|||.+.+..++.++|||||||++|||++|..||.+....... ..... .
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~----~------ 251 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKI----E------ 251 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHHH----H------
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHHh----h------
Confidence 87664332 23446789999999999989999999999999999999999999754321111 11100 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
............+.++.+++.+||..||.+|||+.+|++.|+++.....
T Consensus 252 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 252 ---QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0000000123455789999999999999999999999999999876544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.25 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=198.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|...+ ..+++|+.. . ....+.+.+|+.++..++||||+++++++.... +..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~--~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 90 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIK--N-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGL 90 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-----EEEEEEECC--C-CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred hhhceEEeEEecCCCceEEEEEEcC-----CEEEEEEec--c-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-Cce
Confidence 4689999999999999999998642 334444433 2 234577999999999999999999999876542 578
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccc
Confidence 99999999999999995431 223789999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 167 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---------------- 229 (278)
T 1byg_A 167 ASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------------- 229 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----------------
T ss_pred ccccc-cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----------------
Confidence 54322 23356789999999999999999999999999999998 9999987654332222110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
......+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 230 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 230 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 001122345568899999999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.15 Aligned_cols=255 Identities=17% Similarity=0.231 Sum_probs=203.3
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeec-----
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR----- 247 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----- 247 (473)
..++|+..+.||+|+||.||+|....+ .+.+++|+.... ...+.+|++++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRID---GKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTT---CCEEEEEEEECC-----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hccccceeeeeccCCceEEEEEEEcCC---CeEEEEEEeccc-----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 456899999999999999999997533 344555555432 2567899999999999999999998754
Q ss_pred ---------CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC
Q 011995 248 ---------DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318 (473)
Q Consensus 248 ---------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~ 318 (473)
......++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLV 156 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEc
Confidence 1124589999999999999999653 2356999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc
Q 011995 319 KDFSAKLSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 319 ~~~~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 397 (473)
.++.+||+|||++...... ......+++.|+|||.+.+..++.++|||||||++|||++|..|+.... .....
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~- 230 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFTD- 230 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHHH-
T ss_pred CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHHH-
Confidence 9999999999999876543 2344578899999999999999999999999999999999998874211 10000
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
+.+.. ++...+..+.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus 231 ------------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 231 ------------LRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ------------HHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ------------hhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 00011 1223456789999999999999999999999999998765543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=345.49 Aligned_cols=265 Identities=14% Similarity=0.195 Sum_probs=198.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC--
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-- 250 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+..... .....+.+.+|+.+|+.++||||+++++++...+.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRT---GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTT---CCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCC---CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 46799999999999999999986443 3455555543322 33345678999999999999999999999876421
Q ss_pred --CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 251 --DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 251 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred cCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEee
Confidence 3569999999 8899999854 35899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc---
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD--- 404 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 404 (473)
|+++.... ......+|++|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..........
T Consensus 173 g~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 173 GLARQADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp TTCEECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccccccc-ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99987643 3455678999999999987 679999999999999999999999998876655433322110000000
Q ss_pred -----c------ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 -----C------RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 -----~------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .+.......+ ..+....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 0000000011 11223556889999999999999999999999883
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.09 Aligned_cols=249 Identities=17% Similarity=0.273 Sum_probs=205.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|...++ .+.+++|+.... ......+.+.+|+.+++.++||||+++++++... +
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--D 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred ccceEEEEEEeecCCEEEEEEEECCC---CceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--C
Confidence 46799999999999999999996543 344556655433 2334567789999999999999999999999865 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCc
Confidence 89999999999999998854 246899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 231 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE----------- 231 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred eecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-----------
Confidence 776422 2334568899999999998889999999999999999999999998766544332221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++...+..+.+++.+||+.||.+|||+.++++.
T Consensus 232 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01233455788999999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.13 Aligned_cols=249 Identities=17% Similarity=0.273 Sum_probs=205.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||++...++ .+.+++|+.... ......+.+.+|+.+++.++|+||+++++++.+. +
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADT---KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--D 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCC---CCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--C
Confidence 46899999999999999999996553 345556655433 2334567789999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCc
Confidence 89999999999999998854 246899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 257 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE----------- 257 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----------
T ss_pred eecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-----------
Confidence 876432 2334578899999999999889999999999999999999999998765544332221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++..++..+.+|+.+||+.||.+|||+.++++.
T Consensus 258 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 -------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01233445788999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=369.66 Aligned_cols=260 Identities=18% Similarity=0.313 Sum_probs=210.9
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|...+.||+|+||.||+|.+.........+++++..........+.+.+|+.++++++||||+++++++.+ +.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 346799999999999999999998655444455555555444444556789999999999999999999999843 56
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 89999999999999999643 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 333 HIPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 333 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+....
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~---------- 609 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---------- 609 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC----------
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------
Confidence 7644322 22345678999999999999999999999999999997 999998776554333222110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
...++..++..+.+|+.+||..||.+|||+.+|++.|+.+..
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011234556889999999999999999999999999998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.74 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=205.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|.... +++.+++|+..... .......+.+|+.+|..++|||||++++++.+. +
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--D 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--C
Confidence 4679999999999999999999654 34556666654321 223346688999999999999999999998876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+||||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccc
Confidence 8999999999999999996542 345999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... +
T Consensus 334 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~------------i 401 (576)
T 2acx_A 334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL------------V 401 (576)
T ss_dssp EECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH------------H
T ss_pred eecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH------------h
Confidence 8775443 34568999999999999888999999999999999999999999875422111111000 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
. .....++...+.++.+||.+||+.||.+|| ++.||++.
T Consensus 402 ~--~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 402 K--EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp H--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred h--cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 001123445678899999999999999999 78888753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.48 Aligned_cols=267 Identities=18% Similarity=0.255 Sum_probs=200.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|....+ ++.+++|+..... .....+.+.+|+.+++.++||||+++++++... +.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDT---GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTT---CCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCC---CceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CE
Confidence 46899999999999999999996543 3455566554433 233356688999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCce
Confidence 9999999999999888743 345999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc-ccc-------c
Q 011995 333 HIPET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-RPF-------L 401 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~-------~ 401 (473)
..... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ... .
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 66432 23445788999999999775 6899999999999999999999999887655433222100 000 0
Q ss_pred ccccccccccccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ADDCRLSLIMDPQLKGRF-----PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...........+.+.... ...++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000111111111111 12456889999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=334.34 Aligned_cols=251 Identities=20% Similarity=0.337 Sum_probs=182.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
..++|...+.||+|+||.||+|....+ ++.+++|+..... .......+.+|+.++..++||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHT---GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-- 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--
T ss_pred ccccceeeeeecCCCceEEEEEEEccC---CceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--
Confidence 357899999999999999999986432 3445566554321 122346789999999999999999999999875
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 7899999999999999999643 356899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
+...... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||...........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------- 224 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-------------- 224 (278)
T ss_dssp CEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--------------
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--------------
Confidence 9866432 223456789999999999888999999999999999999999999765432211100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.... ...+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 225 --~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 225 --VLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --hhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0000 01233456789999999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=346.27 Aligned_cols=269 Identities=17% Similarity=0.214 Sum_probs=205.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-----eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCccc---------
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-----TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK--------- 240 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~--------- 240 (473)
++|...+.||+|+||.||+|....+.. ..+.+++|+.... ..+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 689999999999999999999764311 2455566665422 56889999999999999988
Q ss_pred ------ceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCc
Q 011995 241 ------LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTAN 314 (473)
Q Consensus 241 ------l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~N 314 (473)
+++++... ....++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 56666553 37889999999 99999999653 2356999999999999999999999999 9999999999
Q ss_pred eeeCCCC--cEEEeccCCCcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 315 IQIDKDF--SAKLSGYGCAGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 315 ILl~~~~--~vkl~DFGla~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
||++.++ .+||+|||++..+.... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 89999999997664321 133478899999999999899999999999999999999999998
Q ss_pred CCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCC
Q 011995 384 SRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~ 462 (473)
........ .......+... ...+.+... ....++.++.+|+.+||..||.+|||+.+|++.|+++.......
T Consensus 270 ~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLPNTED-IMKQKQKFVDK---PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTTCHHH-HHHHHHHHHHS---CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcCHHH-HHHHHHhccCC---hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 65321111 11100000000 000000000 01234578999999999999999999999999999998776543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.58 Aligned_cols=253 Identities=16% Similarity=0.222 Sum_probs=203.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|...+.||+|+||.||+|.... .++.+++|+..... ......+.+|+.++..++||||+++++++.+. +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYEST--TH 80 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccC--CE
Confidence 34679999999999999999998653 33455666655332 22345688999999999999999999999765 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee---CCCCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---DKDFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFG 329 (473)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 99999999999999998543 35899999999999999999999999 9999999999999 788999999999
Q ss_pred CCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 330 CAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 330 la~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
++............+++.|+|||.+.+..++.++|||||||++|||++|..||...........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------- 224 (304)
T 2jam_A 155 LSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY---------- 224 (304)
T ss_dssp TTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC----------
T ss_pred cceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 9987655444455789999999999988899999999999999999999999987665443322221100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....+...++..+.+|+.+||..||.+|||+.++++.
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 ----EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111233456889999999999999999999999873
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.79 Aligned_cols=272 Identities=18% Similarity=0.283 Sum_probs=195.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHH--HHhCCCCCcccceeeeec---C
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNT--LASLQHPNLCKLLGFHAR---D 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~--l~~l~HpnIv~l~g~~~~---~ 248 (473)
.++|+..+.||+|+||.||+|+..+ +.+++|+... .....+..|.++ +..++|+||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDE-----RPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETT-----EEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEECC-----eEEEEEEeec----cchhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 4689999999999999999998643 4455665542 223444555555 445899999999975532 2
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCceeecCCCCCceeeCC
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE---------GPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~---------~~~~ivHrDlkp~NILl~~ 319 (473)
+...+++||||+++|+|.+++... .+++..+..++.||+.||.|||+. + |+||||||+|||++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKN 155 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECT
T ss_pred CCceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcC
Confidence 334678999999999999999543 358999999999999999999999 8 999999999999999
Q ss_pred CCcEEEeccCCCcccCCCC----------ccCcccccccCChhhhhc-------CCCCCcCCchHHHHHHHHHHcCCCCC
Q 011995 320 DFSAKLSGYGCAGHIPETD----------ISNSSVAAANLSVETLER-------GLLTPKSNVWSFGIVLLELLTGRKNL 382 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~----------~~~~~~t~~y~aPE~~~~-------~~~s~~sDvwSlGvvl~elltG~~p~ 382 (473)
++.+||+|||++..+.... .....+|+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999999997664321 123468999999999976 34667899999999999999997766
Q ss_pred CCCChHHHHh-Hh---hhccccccccc--ccccccccccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 011995 383 DSRHPKEERN-LV---KWSRPFLADDC--RLSLIMDPQLKGRF--PLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454 (473)
Q Consensus 383 ~~~~~~~~~~-~~---~~~~~~~~~~~--~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 454 (473)
.......... .. ....+...+.. .......+.+...+ ...++.++.+||.+||+.||++|||+.|+++.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 4332211000 00 00000000000 00000111111111 23577789999999999999999999999999999
Q ss_pred hhcccCC
Q 011995 455 QESRKSS 461 (473)
Q Consensus 455 l~~~~~~ 461 (473)
+...-..
T Consensus 316 ll~~~~~ 322 (336)
T 3g2f_A 316 LMMIWER 322 (336)
T ss_dssp HHHCCCC
T ss_pred HHHHHHh
Confidence 8755443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.77 Aligned_cols=264 Identities=18% Similarity=0.223 Sum_probs=207.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|....+ .+.+++|+..... .....+.+.+|+.++++++||||+++++++.......
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT---CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCC---CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 46899999999999999999986543 3455566655443 3345677899999999999999999999886544478
Q ss_pred eEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCC--CceeecCCCCCceeeCCCCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGP--FQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~--~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+. .+|+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999999996432 23458999999999999999999999861 239999999999999999999999999
Q ss_pred CCcccCCCCc--cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 330 CAGHIPETDI--SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~~~~~~--~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
++........ ....++..|+|||.+.+..++.++|||||||++|||++|..||...........+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--------- 232 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--------- 232 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc---------
Confidence 9876643321 23467899999999999899999999999999999999999998765443322221100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
...++..++.++.+++.+||+.||.+|||+.+|++.+...+.
T Consensus 233 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 233 --------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 011233456889999999999999999999999987765443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.72 Aligned_cols=270 Identities=17% Similarity=0.218 Sum_probs=197.5
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC----ChhhHhHHHHHHHHHhCCCCCcccceeeee
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS----SQGVKEFINDVNTLASLQHPNLCKLLGFHA 246 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 246 (473)
....++|...+.||+|+||.||+|.... +++.+++|+...... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG 82 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence 3446789999999999999999998543 344555665543221 122356889999999999999999999987
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
.. ...++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 83 ~~--~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 83 HK--SNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp CT--TCCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eC--CceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence 65 789999999975 89888854 3456889999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCC--CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc--cccc
Q 011995 327 GYGCAGHIPET--DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS--RPFL 401 (473)
Q Consensus 327 DFGla~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~~ 401 (473)
|||++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+... .+..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999876433 23455789999999999764 4889999999999999999999999887655443322111 0000
Q ss_pred ---ccccccccccccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ---ADDCRLSLIMDPQLKGRF-----PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ---~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.+.............. ...++.++.+||.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000000000001 13456789999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=333.56 Aligned_cols=252 Identities=18% Similarity=0.211 Sum_probs=199.0
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecC--CCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD--GSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~ 252 (473)
.|...+.||+|+||.||+|....+. ..+++++.... ........+.+|+.+++.++||||+++++++... +...
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~---~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCc---eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3677789999999999999865543 34445554433 2344567789999999999999999999988652 2356
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla 331 (473)
+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+. +|+||||||+|||++ .++.+||+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 89999999999999999542 468999999999999999999999863 399999999999998 7899999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
............+++.|+|||.+. +.++.++|||||||++|+|++|+.||............... .
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------~------- 245 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS------G------- 245 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT------T-------
T ss_pred ccccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc------c-------
Confidence 876655555667899999999886 45899999999999999999999999875443322111000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....++...+.++.+|+.+||+.||.+|||+.++++
T Consensus 246 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 --VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000112233467999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=351.47 Aligned_cols=254 Identities=15% Similarity=0.245 Sum_probs=191.1
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-------CChhhHhHHHHHHHHHhCCCCCcccceee
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-------SSQGVKEFINDVNTLASLQHPNLCKLLGF 244 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 244 (473)
...++|...+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.+|++++||||++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTT---CCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCC---CcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4568899999999999999999986543 4556666654321 12223468899999999999999999999
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---C
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---F 321 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~ 321 (473)
+.. +..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.+ +
T Consensus 209 ~~~---~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 209 FDA---EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp EES---SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSC
T ss_pred Eec---CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcc
Confidence 854 468999999999999998843 356999999999999999999999999 9999999999999754 4
Q ss_pred cEEEeccCCCcccCCCC-ccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhHhhh
Q 011995 322 SAKLSGYGCAGHIPETD-ISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKW 396 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~ 396 (473)
.+||+|||+++...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|..||........ ...+..
T Consensus 280 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 280 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp CEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred eEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 59999999998775443 345578999999999853 5678899999999999999999999976433211 111110
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... .........++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 360 ~~~--------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 GKY--------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TCC--------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC--------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 00000012346789999999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=357.03 Aligned_cols=252 Identities=18% Similarity=0.242 Sum_probs=199.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.+.|+..+.||+|+||+||+|..... ...+++|+..... .......+.+|+.+++.++|||||++++++.+. ..
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTT---CCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCC---CcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CE
Confidence 45799999999999999999996543 3455566655432 233457789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFG 329 (473)
.|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 99999999999999988543 45899999999999999999999999 999999999999976 4559999999
Q ss_pred CCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 330 CAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 330 la~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++...... ......+|+.|+|||++. ..++.++|||||||++|+|++|.+||.+....+....+........
T Consensus 185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 257 (494)
T 3lij_A 185 LSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD------ 257 (494)
T ss_dssp TCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred CCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 99876543 334567899999999986 4699999999999999999999999988766554433322111000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
......++..+.+||.+||+.||.+|||+.++++.
T Consensus 258 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 --------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp --------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00012456789999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=358.04 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=206.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|.... ..+.+++|+..... .......+.+|+.++++++|||||++++++.+. .
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--G 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred cCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence 4679999999999999999998543 34566677665442 234567899999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee---CCCCcEEEecc
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---DKDFSAKLSGY 328 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DF 328 (473)
..++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 89999999999999999854 346999999999999999999999999 9999999999999 56789999999
Q ss_pred CCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 329 GCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 329 Gla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
|++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+....+.......
T Consensus 174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 246 (484)
T 3nyv_A 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF------ 246 (484)
T ss_dssp THHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred eeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 9998765432 344578999999999876 69999999999999999999999998876655443332211000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.......++.++.+||.+||+.||.+|||+.++++.
T Consensus 247 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 --------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000123456889999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=357.92 Aligned_cols=253 Identities=17% Similarity=0.242 Sum_probs=202.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC------------ChhhHhHHHHHHHHHhCCCCCccc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS------------SQGVKEFINDVNTLASLQHPNLCK 240 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~Ei~~l~~l~HpnIv~ 240 (473)
..++|...+.||+|+||+||+|....+ ...+++|+...... ....+.+.+|+.+|+.++|||||+
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNG---HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTT---CCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccceEEEeEecccCCeEEEEEEECCC---CcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 457899999999999999999996543 34455555543221 133567899999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 241 l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
+++++.+. ..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 111 ~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 111 LFDVFEDK--KYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENK 182 (504)
T ss_dssp EEEEEECS--SEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESST
T ss_pred EEEEEEcC--CEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecC
Confidence 99999876 7899999999999999988543 45999999999999999999999999 9999999999999877
Q ss_pred C---cEEEeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 321 F---SAKLSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 321 ~---~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
+ .+||+|||++...... ......+|+.|+|||++. +.++.++|||||||++|+|++|..||.+....+....+..
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 5 6999999999876543 334567899999999986 4689999999999999999999999998776554443332
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
........ ....++.++.+|+.+||+.||.+|||+.|+++.
T Consensus 262 ~~~~~~~~--------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GKYYFDFN--------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCCCHH--------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCcc--------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 21100000 012345789999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=344.49 Aligned_cols=248 Identities=17% Similarity=0.247 Sum_probs=175.8
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceEEEEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~lV~E 258 (473)
.+.||+|+||.||+|....+ .+.+++|+... .....+.+|+.++..+. ||||+++++++.+. ...|+|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKS---NQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTT---CCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCC---CCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEE
Confidence 47899999999999996543 34555665532 34567889999999997 99999999999866 78999999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC---cEEEeccCCCcccC
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF---SAKLSGYGCAGHIP 335 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~~ 335 (473)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 87 LLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999999653 46999999999999999999999999 99999999999997665 89999999998664
Q ss_pred CC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 336 ET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 336 ~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
.. ......+|+.|+|||++.+..++.++|||||||++|||++|..||.............. ....+...
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---------~~~~i~~~ 231 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE---------IMKKIKKG 231 (325)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH---------HHHHHTTT
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH---------HHHHHHcC
Confidence 33 23445779999999999999999999999999999999999999976543210000000 00000000
Q ss_pred c--cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 414 Q--LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 414 ~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ........++.++.+|+.+||+.||.+|||+.++++.
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0 0001112456889999999999999999999999854
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=343.26 Aligned_cols=257 Identities=14% Similarity=0.146 Sum_probs=203.5
Q ss_pred HhcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC---CCCcccceeeeec
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ---HPNLCKLLGFHAR 247 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~ 247 (473)
..++|...+.||+|+||+||+|.+.+ +....+.+++|+... ....++.+|++++..++ |+||+.+++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45789999999999999999996433 233456666666542 23567888888888887 9999999999987
Q ss_pred CCCCceEEEEEeccCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC------
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGR--SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK------ 319 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~------ 319 (473)
. +..||||||+++|+|.+++... .....+++..+..|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 139 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 Q--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp S--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred C--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 6 7889999999999999999642 13456999999999999999999999999 999999999999998
Q ss_pred -----CCcEEEeccCCCcccC----CCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH
Q 011995 320 -----DFSAKLSGYGCAGHIP----ETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE 390 (473)
Q Consensus 320 -----~~~vkl~DFGla~~~~----~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~ 390 (473)
++.+||+|||+++.+. ........+|+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 8999999999996543 223345678999999999999999999999999999999999999985432110
Q ss_pred HhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhcccC
Q 011995 391 RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSER-PTMRSIFEELDRQESRKS 460 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~eil~~L~~l~~~~~ 460 (473)
| .+ ...+. .+ .....+.+++..||..+|.+| |++.++.+.|+++.....
T Consensus 293 -----~---------~~----~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 -----C---------KP----EGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -----E---------EE----CSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----e---------ee----chhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 00 00011 11 125678899999999999999 679999999998776543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.01 Aligned_cols=261 Identities=15% Similarity=0.212 Sum_probs=205.6
Q ss_pred HHHHHHhcccccC-cceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhC-CCCCcccceee
Q 011995 168 DEVAAACHNFFSD-RCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASL-QHPNLCKLLGF 244 (473)
Q Consensus 168 ~el~~~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~ 244 (473)
+......+.|... +.||+|+||.||+|....+ .+.+++|+.... ........+.+|+.++..+ +||||++++++
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKST---GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCC---CCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444556678776 8999999999999986543 345556655433 2334467889999999999 56999999999
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CC
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DF 321 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~ 321 (473)
+... ...++||||+.+|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++
T Consensus 98 ~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 98 YENT--SEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EECS--SEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred EEeC--CeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence 9766 7899999999999999998543 3457999999999999999999999999 999999999999987 78
Q ss_pred cEEEeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc
Q 011995 322 SAKLSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
.+||+|||++...... ......+|+.|+|||++.+..++.++|||||||++|||++|..||...........+.....
T Consensus 172 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~- 250 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV- 250 (327)
T ss_dssp CEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred cEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc-
Confidence 9999999999876543 23445789999999999999999999999999999999999999988765544332221110
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........++..+.+|+.+||+.||.+|||+.++++.
T Consensus 251 -------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 -------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 01111123456789999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=356.84 Aligned_cols=253 Identities=18% Similarity=0.248 Sum_probs=203.6
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
..++|.+.+.||+|+||+||+|.... +.+.+++|+..... .......+.+|+++|++++|||||++++++.+. .
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--S 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--C
Confidence 35689999999999999999998643 34556666654321 233457789999999999999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC---CCCcEEEecc
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGY 328 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DF 328 (473)
..++||||+.+|+|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred EEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEEC
Confidence 899999999999999988543 46999999999999999999999999 99999999999995 4567999999
Q ss_pred CCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 329 GCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 329 Gla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
|++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+....+.......
T Consensus 169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 241 (486)
T 3mwu_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------ 241 (486)
T ss_dssp SCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------
T ss_pred CcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 999876443 3345578999999999875 58999999999999999999999998876655443332111000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.......++.++.+||.+||+.||.+|||+.++++.
T Consensus 242 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 --------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000123456789999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.86 Aligned_cols=258 Identities=17% Similarity=0.261 Sum_probs=198.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|...+. +++++.... ......+.+.+|+.++++++|+||+++++++... ..
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~~------~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESSS------EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--SC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcCe------EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--Cc
Confidence 56899999999999999999987542 334444433 2334456788999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999954 2346899999999999999999999999 99999999999998 6799999999987
Q ss_pred ccCC-------CCccCcccccccCChhhhhc---------CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 333 HIPE-------TDISNSSVAAANLSVETLER---------GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 333 ~~~~-------~~~~~~~~t~~y~aPE~~~~---------~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
.... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 5421 12233457899999999964 3478899999999999999999999987665443322211
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
. ..+.. ....++.++.+++.+||..||.+|||+.+|++.|+++..+...
T Consensus 258 ~-------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 258 G-------------MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp T-------------CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred C-------------CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 00000 0112446789999999999999999999999999998876544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=334.94 Aligned_cols=259 Identities=18% Similarity=0.315 Sum_probs=192.9
Q ss_pred ccccc-CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCc
Q 011995 175 HNFFS-DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 252 (473)
+.|.+ .+.||+|+||.||+|.. ....+.+++|+.... .......+.+|++++.++ +||||+++++++.+. +.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCIN---LITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEEC---SSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred eeEEecCceecCCceEEEEEEEE---cCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CE
Confidence 56776 47899999999999984 334556667766543 234467789999999985 799999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc---EEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS---AKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---vkl~DFG 329 (473)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 99999999999999999643 36899999999999999999999999 999999999999988765 9999999
Q ss_pred CCcccCCC---------CccCcccccccCChhhhhc-----CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh
Q 011995 330 CAGHIPET---------DISNSSVAAANLSVETLER-----GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK 395 (473)
Q Consensus 330 la~~~~~~---------~~~~~~~t~~y~aPE~~~~-----~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 395 (473)
++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---- 235 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG---- 235 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC----
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc----
Confidence 98765321 1223458899999999975 45889999999999999999999999765422100
Q ss_pred hcccccc---cccccccccccccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 396 WSRPFLA---DDCRLSLIMDPQLKGRFP----LKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 396 ~~~~~~~---~~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
|...... .......+..... .++ ..++.++.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000 0000000000000 112 1345789999999999999999999999873
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.15 Aligned_cols=259 Identities=17% Similarity=0.285 Sum_probs=206.5
Q ss_pred HHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-------hhhHhHHHHHHHHHhC-CCCCc
Q 011995 167 LDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-------QGVKEFINDVNTLASL-QHPNL 238 (473)
Q Consensus 167 ~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~Ei~~l~~l-~HpnI 238 (473)
........++|...+.||+|+||.||+|....+ ++.+++|+.+..... ...+.+.+|+.++.++ +||||
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 162 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT---GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCC---CcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 344556678899999999999999999997533 345667766654321 1245678999999999 89999
Q ss_pred ccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC
Q 011995 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID 318 (473)
Q Consensus 239 v~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~ 318 (473)
+++++++... ...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 163 v~~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 163 ITLIDSYESS--SFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLD 234 (365)
T ss_dssp CCEEEEEEBS--SEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred eEEEEEEeeC--CEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999998765 789999999999999999954 246999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeccCCCcccCCC-CccCcccccccCChhhhhcC------CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH
Q 011995 319 KDFSAKLSGYGCAGHIPET-DISNSSVAAANLSVETLERG------LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER 391 (473)
Q Consensus 319 ~~~~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~------~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~ 391 (473)
.++.+||+|||++..+... ......+|+.|+|||++.+. .++.++|||||||++|||++|..||.........
T Consensus 235 ~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 314 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML 314 (365)
T ss_dssp TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999999876543 33456789999999998643 5789999999999999999999999876554433
Q ss_pred hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..+....... ..+. ....+..+.+|+.+||+.||.+|||+.++++
T Consensus 315 ~~i~~~~~~~---------~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMIMEGQYQF---------SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHTCCCC---------CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhCCCCC---------CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2221110000 0000 0123467899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.46 Aligned_cols=252 Identities=14% Similarity=0.254 Sum_probs=196.7
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
+|.....||+|+||.||+|....+ ...+++|+.... .....+.+.+|+.+++.++||||+++++++... +..++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 96 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSN---QVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKI 96 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTT---CCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCC---CeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEE
Confidence 344456999999999999986543 344455554433 334457789999999999999999999999876 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-CCcEEEeccCCCccc
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-DFSAKLSGYGCAGHI 334 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~ 334 (473)
||||+++++|.+++........+++..+..++.|++.||.|||+++ |+|+||||+|||++. ++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999976544456789999999999999999999999 999999999999987 899999999999776
Q ss_pred CCCC--ccCcccccccCChhhhhcCC--CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETD--ISNSSVAAANLSVETLERGL--LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~--~~~~~~t~~y~aPE~~~~~~--~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.... .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||.............. . .
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~--------~- 241 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG---M--------F- 241 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH---H--------H-
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc---c--------c-
Confidence 4322 23457889999999997654 78999999999999999999999975433221110000 0 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.....++...+.++.+|+.+||+.||.+|||+.++++.
T Consensus 242 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 ---KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01112244556889999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.57 Aligned_cols=264 Identities=14% Similarity=0.135 Sum_probs=203.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|.+.+.||+|+||.||+|....+ .+.+++|+..... ...++.+|++++..++|.+++..+.++... .+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~-~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVE-GDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTT---CCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEE-TTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCC---CcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEee-CCEE
Confidence 46899999999999999999986433 3456666655432 235688999999999876555554444333 2788
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee---CCCCcEEEeccCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---DKDFSAKLSGYGC 330 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGl 330 (473)
+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+|||+
T Consensus 79 ~lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9999999 99999999642 346999999999999999999999999 9999999999999 5889999999999
Q ss_pred CcccCCCCc---------cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc
Q 011995 331 AGHIPETDI---------SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401 (473)
Q Consensus 331 a~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 401 (473)
++.+..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~- 231 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 231 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-
Confidence 987643321 2557899999999999999999999999999999999999999875442222221111000
Q ss_pred ccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 402 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
....... . +...++.++.+|+..||+.||.+||++.+|++.|+++..+..
T Consensus 232 ----~~~~~~~-~----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 232 ----KVATSIE-A----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp ----HHHSCHH-H----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----cccccHH-H----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 0000000 0 012335789999999999999999999999999999865543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.40 Aligned_cols=254 Identities=17% Similarity=0.256 Sum_probs=203.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|...+.||+|+||.||+|+... +++.+++|+..... .......+.+|+.+|..++||||+++++++.+. .
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--T 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--C
Confidence 3678888999999999999999654 34556666654321 223356788999999999999999999998776 7
Q ss_pred ceEEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
.+|+||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecce
Confidence 8999999999999999986542 2456999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhHhhhccccccccccc
Q 011995 331 AGHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSRPFLADDCRL 407 (473)
Q Consensus 331 a~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 407 (473)
+..+.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...
T Consensus 336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~----------- 404 (543)
T 3c4z_A 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----------- 404 (543)
T ss_dssp CEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH-----------
T ss_pred eeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH-----------
Confidence 98765433 2345899999999999999999999999999999999999999976532111 111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM-----RSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 450 (473)
+... ...++..++..+.+||.+||+.||.+||++ .+|++
T Consensus 405 --i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 405 --VLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --Hhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0000 012344567889999999999999999975 66654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.66 Aligned_cols=269 Identities=14% Similarity=0.187 Sum_probs=201.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|+..+.||+|+||.||+|....+ ++.+++|+..... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKT---GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTT---CCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCC---CCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 46899999999999999999996543 3455565544332 2334567889999999999999999999987642
Q ss_pred ---CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 250 ---SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 250 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
.+..++||||+.+ +|.+.+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEc
Confidence 2568999999975 777777543 346999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCC------CCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 327 GYGCAGHIPE------TDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 327 DFGla~~~~~------~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|||++..+.. .......+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999976532 122445678999999999764 589999999999999999999999998776554443321111
Q ss_pred cccccc-----ccc--ccccc--ccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 FLADDC-----RLS--LIMDP--QLKGRFPL-----KAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ~~~~~~-----~~~--~~~~~--~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...... ... ..... ........ ..+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000 000 00000 00000000 124668899999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=335.54 Aligned_cols=261 Identities=16% Similarity=0.199 Sum_probs=199.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|....+ .+.+++|+.. ....+.+.+|+.++..++ ||||+++++++.......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILK----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEC----SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCC---CcEEEEEEec----ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 36799999999999999999986443 3455555543 233577899999999997 999999999998755578
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla 331 (473)
.++||||+.+++|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 108 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 999999999999999883 3889999999999999999999999 99999999999999776 8999999999
Q ss_pred cccCCC-CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH-HHhHhh----------hcc
Q 011995 332 GHIPET-DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-ERNLVK----------WSR 398 (473)
Q Consensus 332 ~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~-~~~~~~----------~~~ 398 (473)
...... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||....... ....+. +..
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 876443 3345578899999999977 668999999999999999999999995543321 111110 000
Q ss_pred cc-cccccccccc--------cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 399 PF-LADDCRLSLI--------MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 399 ~~-~~~~~~~~~~--------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. .........+ .........+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000000000 0001111123346788999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.86 Aligned_cols=250 Identities=19% Similarity=0.304 Sum_probs=198.7
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
..++|+..+.||+|+||.||+|....+ ++.+++|+.... .....+.+|+.++..++||||+++++++... +.
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKET---GQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN--TD 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTT---CCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCC---CCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CE
Confidence 356799999999999999999986543 344556655432 2457789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 99 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEEEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccch
Confidence 9999999999999999853 2346899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 333 HIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ......+++.|+|||.+.+..++.++|||||||++|||++|..||...........+....
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 241 (314)
T 3com_A 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP------------ 241 (314)
T ss_dssp ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC------------
Confidence 66443 2234567899999999999889999999999999999999999998765543322211100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+. ...+...+..+.+|+.+||..||.+|||+.++++
T Consensus 242 -~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 242 -PPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -Ccc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 0113345678999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=334.81 Aligned_cols=271 Identities=17% Similarity=0.280 Sum_probs=207.1
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHh--CCCCCcccce
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLAS--LQHPNLCKLL 242 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~ 242 (473)
.++.--....++|...+.||+|+||.||+|... ++.+++|+.. ......+.+|++++.. ++||||++++
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~----~~~~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-----GEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEC----GGGHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-----CccEEEEEeC----chhHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 334344455678999999999999999999864 2344555543 2345678889999988 7999999999
Q ss_pred eeeecCCC--CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceeecCCCC
Q 011995 243 GFHARDGS--DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH--------EEGPFQAMYNEFST 312 (473)
Q Consensus 243 g~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivHrDlkp 312 (473)
+++..... ...++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+ |+||||||
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp 175 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKS 175 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSG
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCH
Confidence 99877532 2789999999999999999542 5899999999999999999999 777 99999999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCCC------ccCcccccccCChhhhhcCC------CCCcCCchHHHHHHHHHHcC--
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPETD------ISNSSVAAANLSVETLERGL------LTPKSNVWSFGIVLLELLTG-- 378 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~~------~~~~~~t~~y~aPE~~~~~~------~s~~sDvwSlGvvl~elltG-- 378 (473)
+|||++.++.+||+|||++....... .....+|+.|+|||.+.+.. ++.++|||||||++|||++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence 99999999999999999997664332 23447889999999997753 33689999999999999999
Q ss_pred --------CCCCCCCChHHH--HhHhhhcccccccccccccccccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011995 379 --------RKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDPQLKGR-FPLKAARTVADIALRCLQKEPSERPTMRS 447 (473)
Q Consensus 379 --------~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~e 447 (473)
+.||........ ...... .. .....+.+... ....+...+.+|+.+||+.||++|||+.+
T Consensus 256 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKV---VC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHH---HT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCCcccccccCccccCcCcccHHHHHHH---HH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence 778865422110 000000 00 00011111111 12367788999999999999999999999
Q ss_pred HHHHHHhhhcccC
Q 011995 448 IFEELDRQESRKS 460 (473)
Q Consensus 448 il~~L~~l~~~~~ 460 (473)
|++.|+++....+
T Consensus 327 i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 327 IKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 9999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.01 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=200.0
Q ss_pred CHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceee
Q 011995 166 PLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGF 244 (473)
Q Consensus 166 ~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~ 244 (473)
.+.++....++|+..+.||+|+||.||+|....+ .+.+++|+... .......+.+|+.++.++ +||||++++++
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKT---GQLAAIKVMDV--TGDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEC--CSSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCC---CCeEEEEEEec--CcccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 3334445578899999999999999999996543 34455555543 233457889999999999 89999999999
Q ss_pred eecCC----CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 245 HARDG----SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 245 ~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
+.... .+..++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCC
Confidence 87642 36889999999999999999653 2356899999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCC--CccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhH
Q 011995 321 FSAKLSGYGCAGHIPET--DISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~--~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~ 393 (473)
+.+||+|||++...... ......+++.|+|||++. +..++.++|||||||++|||++|..||...........
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245 (326)
T ss_dssp CCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 99999999998766432 223456889999999986 55689999999999999999999999987665443322
Q ss_pred hhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 394 VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+.... .+.+ ....++..+.+|+.+||..||.+|||+.++++
T Consensus 246 ~~~~~-------------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNP-------------APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSC-------------CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCc-------------cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 21100 0000 12234578999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=369.15 Aligned_cols=249 Identities=18% Similarity=0.222 Sum_probs=206.0
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
..++|+..+.||+|+||.||+|.... +.+.+++|+..... .....+.+..|..+|..+ +|+||+.+++++.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~- 414 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM- 414 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-
Confidence 45789999999999999999999654 34556666655321 233456788999999988 799999999988765
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
+.+||||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||
T Consensus 415 -~~~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 415 -DRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCT
T ss_pred -CEEEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecc
Confidence 7899999999999999999643 36999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCC--CCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 330 CAGHIPE--TDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 330 la~~~~~--~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
+++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------- 558 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------- 558 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence 9986432 23455689999999999999999999999999999999999999998876655443332110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM-----RSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 450 (473)
..++...+.++.+||.+||+.||.+||++ +||++
T Consensus 559 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 12345567889999999999999999997 66664
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=335.50 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=184.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|...+.||+|+||.||+|... ...+.+++|+............+.+|+.++..++||||+++++++... +..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCA---PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--DEL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS--SCE
T ss_pred hhhhhhhheeccccceEEEEEEEC---CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--CCc
Confidence 568999999999999999999843 233455555444333344567789999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhc-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 254 MLIYERLFHGSLDRLIYG-----RSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
++||||+++++|.+++.. ......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999853 112456899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCC-------ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc
Q 011995 329 GCAGHIPETD-------ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400 (473)
Q Consensus 329 Gla~~~~~~~-------~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 400 (473)
|++....... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||................+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987653221 123467899999999876 56899999999999999999999999876544332211110000
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. ......++. .....+.++.+++.+||+.||.+|||+.++++
T Consensus 246 ~----~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 S----LETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C----TTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c----cccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 000011111 12234578899999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=353.75 Aligned_cols=253 Identities=15% Similarity=0.195 Sum_probs=191.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHH---HHHHhCCCCCcccce------
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDV---NTLASLQHPNLCKLL------ 242 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei---~~l~~l~HpnIv~l~------ 242 (473)
.++|...+.||+|+||.||+|... ..++.+++|+.... ......+.+.+|+ .+|+.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQ---ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC----CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEEC---CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 467888999999999999999853 33456667766543 2344567889999 555566899999998
Q ss_pred -eeeecCCC----------C-----ceEEEEEeccCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 011995 243 -GFHARDGS----------D-----QRMLIYERLFHGSLDRLIYGRS----DGPPIDWNTRVKIALCAAQGLTFLHEEGP 302 (473)
Q Consensus 243 -g~~~~~~~----------~-----~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ 302 (473)
+++...+. + ..||||||+ +|+|.+++.... ....+++..+..|+.||+.||+|||+++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 55544311 1 378999999 689999996421 1123446888999999999999999999
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcC-----------CCCCcCCchHHHHH
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERG-----------LLTPKSNVWSFGIV 371 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~s~~sDvwSlGvv 371 (473)
|+||||||+||||+.++.+||+|||+++.... ......+ +.|+|||++.+. .++.++|||||||+
T Consensus 227 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999999999986433 2344456 999999999887 79999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-
Q 011995 372 LLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE- 450 (473)
Q Consensus 372 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~- 450 (473)
+|||++|+.||...........+ .. ....++.++.+||.+||+.||.+|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~----------------~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWI----------------FR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCSGGG----------------GS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccchhhh----------------hh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999764422211100 00 01234578999999999999999999999996
Q ss_pred -HHHhhhc
Q 011995 451 -ELDRQES 457 (473)
Q Consensus 451 -~L~~l~~ 457 (473)
.++.+..
T Consensus 361 p~f~~~~~ 368 (377)
T 3byv_A 361 PEYEQLRT 368 (377)
T ss_dssp HHHHHHHH
T ss_pred hHHHHHHH
Confidence 4555543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=330.24 Aligned_cols=249 Identities=16% Similarity=0.203 Sum_probs=198.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
..++|...+.||+|+||.||+|....+ .+.+++|+.... ........+.+|+.++..+ +||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-- 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLD---GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-- 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCC---CceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--
Confidence 457899999999999999999996533 345566665543 2345567889999999999 999999999999876
Q ss_pred CceEEEEEeccCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---------
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSD-GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD--------- 320 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--------- 320 (473)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccc
Confidence 789999999999999999964311 246899999999999999999999999 9999999999999844
Q ss_pred ----------CcEEEeccCCCcccCCCCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHH
Q 011995 321 ----------FSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE 389 (473)
Q Consensus 321 ----------~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~ 389 (473)
..+||+|||++...... ....+|+.|+|||.+.+. .++.++|||||||++|||++|.+++.......
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 238 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH
T ss_pred cccccccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH
Confidence 47999999999876543 234689999999999766 56689999999999999999998775432211
Q ss_pred HHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 390 ERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. +... ....++..++..+.+|+.+||+.||.+|||+.++++.
T Consensus 239 ~--~~~~------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 E--IRQG------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H--HHTT------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H--HHcC------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 1100 0011233456789999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=340.93 Aligned_cols=263 Identities=16% Similarity=0.231 Sum_probs=189.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeec-----
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHAR----- 247 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~----- 247 (473)
..+|+..+.||+|+||.||+|....+ .+.+++|+.... .......+.+|+.++.++. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTT---CCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCC---CcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 45899999999999999999996543 344555544322 3344577899999999996 9999999999852
Q ss_pred -CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 248 -DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 248 -~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
.....+++||||+. |+|.+++........+++..+..++.||+.||.|||++++ +|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEe
Confidence 22245899999995 7999988653344579999999999999999999999863 39999999999999999999999
Q ss_pred ccCCCcccCCCCc--------------cCcccccccCChhhh---hcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH
Q 011995 327 GYGCAGHIPETDI--------------SNSSVAAANLSVETL---ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE 389 (473)
Q Consensus 327 DFGla~~~~~~~~--------------~~~~~t~~y~aPE~~---~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~ 389 (473)
|||++........ ....+|+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 9999987643221 134578999999998 56668899999999999999999999997543221
Q ss_pred HHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCCC
Q 011995 390 ERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSS 462 (473)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~ 462 (473)
. .... .........+..+.+|+.+||+.||.+|||+.|+++.|+.+.......
T Consensus 261 ~---~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 261 I---VNGK-----------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred h---hcCc-----------------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 1 0000 000001122345789999999999999999999999999988665543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.06 Aligned_cols=253 Identities=15% Similarity=0.193 Sum_probs=199.4
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 249 (473)
..++|.+.+.||+|+||.||+|.... ....+++|+..... .......+.+|+.+++.++||||+++++++....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 35789999999999999999998543 33455566554321 2344577999999999999999999999986555
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
....++||||+.++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg 154 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALG 154 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccc
Confidence 57899999999876 77777543 3456999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC----CccCcccccccCChhhhhcCC--CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 330 CAGHIPET----DISNSSVAAANLSVETLERGL--LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 330 la~~~~~~----~~~~~~~t~~y~aPE~~~~~~--~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
++...... ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||...........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~----- 229 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS----- 229 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-----
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-----
Confidence 99766422 123446889999999997644 3779999999999999999999998766544333222110
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++..++..+.+|+.+||..||.+|||+.++++.
T Consensus 230 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 -------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01233455788999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=350.87 Aligned_cols=266 Identities=17% Similarity=0.173 Sum_probs=195.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC----
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG---- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---- 249 (473)
..+|...+.||+|+||.||+|.+..+ ++.+++|+.... ...+.+|+++|+.++|||||++++++...+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDS---GELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEECC-----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCC---CcEEEEEEeccc-----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34688999999999999999997543 344555554322 223457999999999999999999886432
Q ss_pred CCceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC-CcEEEec
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSG 327 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~vkl~D 327 (473)
...+++||||+++ +|.+.+... .....+++..+..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence 1247799999975 666655321 13457999999999999999999999999 9999999999999965 6789999
Q ss_pred cCCCcccCCC-CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc--cccc-
Q 011995 328 YGCAGHIPET-DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR--PFLA- 402 (473)
Q Consensus 328 FGla~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--~~~~- 402 (473)
||+++.+... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+.... +...
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999876433 23455789999999999765 68999999999999999999999998876544332221110 0000
Q ss_pred ---cccccccccccccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 403 ---DDCRLSLIMDPQLK-----GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 403 ---~~~~~~~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........-+.+. ..++...+.++.+||.+||+.||.+|||+.|+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000000011111 01233456889999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=337.42 Aligned_cols=265 Identities=15% Similarity=0.204 Sum_probs=202.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC--CCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD--GSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 251 (473)
.++|...+.||+|+||.||++....+ .+.+++|+.... .....+.+.+|+++++.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTT---CCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCC---CcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 46899999999999999999986433 345556654432 344567889999999999999999999998632 225
Q ss_pred ceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
..++||||+.+|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence 789999999999999988642 12457999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC-----------ccCcccccccCChhhhhcCC---CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 331 AGHIPETD-----------ISNSSVAAANLSVETLERGL---LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 331 a~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~---~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
+....... .....+|+.|+|||.+.+.. ++.++|||||||++|||++|+.||..............
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 87653211 11234588999999987554 68999999999999999999999953111000000000
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
. ...........+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 261 -----~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 261 -----Q----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -----H----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -----h----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0 000011123456789999999999999999999999999998875443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.77 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=201.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC---CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
.++|...+.||+|+||.||+|....+....+.+++|+..... .......+.+|+++|..+ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 468999999999999999999975434445666666654321 223446678899999999 799999999998776
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
+..+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -ceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence 7899999999999999999643 36899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC---CccCcccccccCChhhhhcC--CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 330 CAGHIPET---DISNSSVAAANLSVETLERG--LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 330 la~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
+++.+... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. ....
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~-- 280 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILK-- 280 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHH--
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhc--
Confidence 99765332 22345789999999999863 478999999999999999999999975432211111100 0000
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEEL 452 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~L 452 (473)
....++...+..+.+||.+||..||.+|| ++.++++..
T Consensus 281 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 ----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01122445567899999999999999999 999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=339.73 Aligned_cols=267 Identities=13% Similarity=0.176 Sum_probs=202.9
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
..++|+..+.||+|+||.||+|....+ ...+++|+............+.+|++++.+++||||+++++++....
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCC---CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 356899999999999999999985543 34556666554344445578899999999999999999999986542
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
....++||||+. |+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCc
Confidence 246899999996 599998854 35999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC-----ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 330 CAGHIPETD-----ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 330 la~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.........
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 998664321 234578999999998765 44899999999999999999999999887655543332210000000
Q ss_pred cccccccc---------ccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 404 DCRLSLIM---------DPQLKGR-----FPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 404 ~~~~~~~~---------~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .+..+. ....... +....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 E-DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp H-HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 0000000 112346789999999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.99 Aligned_cols=199 Identities=19% Similarity=0.240 Sum_probs=163.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC--
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-- 250 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+..... .....+.+.+|+.+|+.++|+||+++++++...+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNT---EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTT---TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCC---CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 56899999999999999999986543 4556666654332 33445788999999999999999999999876432
Q ss_pred -CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 251 -DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 251 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCC
Confidence 56899999985 699999954 346999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC------------------------ccCcccccccCChhhh-hcCCCCCcCCchHHHHHHHHHHcCCCCC
Q 011995 330 CAGHIPETD------------------------ISNSSVAAANLSVETL-ERGLLTPKSNVWSFGIVLLELLTGRKNL 382 (473)
Q Consensus 330 la~~~~~~~------------------------~~~~~~t~~y~aPE~~-~~~~~s~~sDvwSlGvvl~elltG~~p~ 382 (473)
+++...... ....++|++|+|||++ ....++.++|||||||++|||++|..||
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 998764321 2455789999999987 4556999999999999999999854443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=343.80 Aligned_cols=265 Identities=16% Similarity=0.150 Sum_probs=201.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC------CCCCcccceeeeec
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL------QHPNLCKLLGFHAR 247 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~g~~~~ 247 (473)
..+|+..+.||+|+||.||+|..... .+.+++|+.. ........+.+|+.++..+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~---~~~vAvK~~~--~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKV---HQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTT---TEEEEEEEEC--SCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCC---CcEEEEEEEC--CccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 45799999999999999999986543 3445555543 3444556788899988887 57799999999987
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc--EEE
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS--AKL 325 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--vkl 325 (473)
. ...++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++. +||
T Consensus 171 ~--~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 171 R--NHICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp T--TEEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEE
T ss_pred C--CeEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEE
Confidence 6 78999999995 6999988654 2345999999999999999999999999 999999999999999887 999
Q ss_pred eccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc------
Q 011995 326 SGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP------ 399 (473)
Q Consensus 326 ~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~------ 399 (473)
+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|.+||.+....+....+.....
T Consensus 244 ~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 244 IDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CCCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eecccceecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99999976543 33456789999999999999999999999999999999999999988766544332211000
Q ss_pred ---------cccccc-----ccccc-----------------cccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCC
Q 011995 400 ---------FLADDC-----RLSLI-----------------MDPQLKG----RFPLKAARTVADIALRCLQKEPSERPT 444 (473)
Q Consensus 400 ---------~~~~~~-----~~~~~-----------------~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt 444 (473)
+..... ....+ ..+.... .+....+..+.+||.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 000000 00000 0000000 011123577899999999999999999
Q ss_pred HHHHHHH
Q 011995 445 MRSIFEE 451 (473)
Q Consensus 445 ~~eil~~ 451 (473)
+.|+|+.
T Consensus 403 a~e~L~H 409 (429)
T 3kvw_A 403 PGQALRH 409 (429)
T ss_dssp HHHHHTS
T ss_pred HHHHhCC
Confidence 9999973
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=329.00 Aligned_cols=249 Identities=17% Similarity=0.280 Sum_probs=195.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|.+.+.||+|+||.||+|....+ ++.+++|+..... .......+.+|+.+++.++||||+++++++... +
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLT---GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--T 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred eccEEEEeeecCCCCeEEEEEEECCC---CceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--C
Confidence 46799999999999999999986532 3445566554321 223456788999999999999999999999776 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS 158 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred eEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccc
Confidence 899999999999999999543 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
....... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 228 (276)
T 2h6d_A 159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---------- 228 (276)
T ss_dssp GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------
Confidence 8765433 234467899999999987765 6899999999999999999999987654443322221100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.++...+..+.+++.+||+.||.+|||+.++++.
T Consensus 229 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1133345788999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=338.36 Aligned_cols=266 Identities=14% Similarity=0.164 Sum_probs=194.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|...+.||+|+||.||+|.... ..+.+++|+..... .......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 4689999999999999999998544 34556666665432 3344567889999999999999999999987642
Q ss_pred -CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 250 -SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 250 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
....|+||||++ |+|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEe
Confidence 137899999996 478888842 4899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccc-------
Q 011995 329 GCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF------- 400 (473)
Q Consensus 329 Gla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------- 400 (473)
|++....... .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+.........+......
T Consensus 172 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 172 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp CC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9998764432 34457899999999999989999999999999999999999999887654433222110000
Q ss_pred ---------cccc-----cccccccccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 401 ---------LADD-----CRLSLIMDPQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 401 ---------~~~~-----~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.... ..+......... .......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 000000000000 00112347789999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=346.30 Aligned_cols=266 Identities=15% Similarity=0.146 Sum_probs=194.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS--- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~--- 250 (473)
..+|...+.||+|+||+||+|....+.. +++++.... .....+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~----~aikk~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE----VAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE----EEEEEEECC-----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe----EEEEEEecC-----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 3579999999999999999999755432 334433221 1223479999999999999999999865421
Q ss_pred -CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CCCcEEEecc
Q 011995 251 -DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGY 328 (473)
Q Consensus 251 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DF 328 (473)
..+++||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 237899999977544333321123457999999999999999999999999 99999999999999 7899999999
Q ss_pred CCCcccCCC-CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc-c-ccc---
Q 011995 329 GCAGHIPET-DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS-R-PFL--- 401 (473)
Q Consensus 329 Gla~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~-~~~--- 401 (473)
|+++..... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+... . +..
T Consensus 187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999876433 33455789999999999765 4899999999999999999999999987655443322110 0 000
Q ss_pred ---cc---ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 ---AD---DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 ---~~---~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.. ...+..+....+...++...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 000000000111111233466889999999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=345.36 Aligned_cols=268 Identities=16% Similarity=0.227 Sum_probs=198.5
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC-
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG- 249 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~- 249 (473)
....++|...+.||+|+||+||+|.... +++.+++|+.... .....+|+++|+.++|||||++++++...+
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQD-----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECC-----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecC-----cchHHHHHHHHHHcCCCCccchhheeeecCc
Confidence 4456789999999999999999998544 3455666655432 223447999999999999999999986532
Q ss_pred -----------------------------------CCceEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHH
Q 011995 250 -----------------------------------SDQRMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQG 293 (473)
Q Consensus 250 -----------------------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~ 293 (473)
...+++||||++ |+|.+.+... .....+++..+..++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 234889999997 5887776431 134579999999999999999
Q ss_pred HHHhhhcCCCceeecCCCCCceeeC-CCCcEEEeccCCCcccCCC-CccCcccccccCChhhhhcCC-CCCcCCchHHHH
Q 011995 294 LTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGYGCAGHIPET-DISNSSVAAANLSVETLERGL-LTPKSNVWSFGI 370 (473)
Q Consensus 294 L~yLH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGv 370 (473)
|.|||+++ |+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||.+.+.. ++.++|||||||
T Consensus 154 L~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 154 VGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999999 99999999999997 6899999999999876433 334557789999999987754 899999999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHhHhhhcc--cccc---------cccccccccccccCCCCCHHHHHHHHHHHHHhcccCC
Q 011995 371 VLLELLTGRKNLDSRHPKEERNLVKWSR--PFLA---------DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEP 439 (473)
Q Consensus 371 vl~elltG~~p~~~~~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP 439 (473)
++|||++|+.||.+....+....+.... +... .......+........++...+.++.+|+.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999876655433221100 0000 0000000011111111344567889999999999999
Q ss_pred CCCCCHHHHHH
Q 011995 440 SERPTMRSIFE 450 (473)
Q Consensus 440 ~~RPt~~eil~ 450 (473)
.+|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.38 Aligned_cols=266 Identities=18% Similarity=0.222 Sum_probs=200.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC--------CCCcccceeee
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ--------HPNLCKLLGFH 245 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~g~~ 245 (473)
.++|.+.+.||+|+||+||+|+...+ .+.+++|+.. ......+.+.+|+.+++.++ |+||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~--~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQG---KKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEC--SCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCC---CeEEEEEEEe--cCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 46799999999999999999986543 3445555543 34455678899999999985 78899999988
Q ss_pred ecC--CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCC-
Q 011995 246 ARD--GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDF- 321 (473)
Q Consensus 246 ~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~- 321 (473)
... .....||||||+ +++|.+.+... ....+++..+..++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccch
Confidence 732 236799999999 66776666543 235699999999999999999999998 8 99999999999999775
Q ss_pred ------------------------------------------------cEEEeccCCCcccCCCCccCcccccccCChhh
Q 011995 322 ------------------------------------------------SAKLSGYGCAGHIPETDISNSSVAAANLSVET 353 (473)
Q Consensus 322 ------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~ 353 (473)
.+||+|||++..... ......+|+.|+|||+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-CSCSCCSCGGGCCHHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-cCccCCCCCcccCChh
Confidence 799999999987643 3445678999999999
Q ss_pred hhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH------HHhHh-hh--------------cccccccccccccccc
Q 011995 354 LERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE------ERNLV-KW--------------SRPFLADDCRLSLIMD 412 (473)
Q Consensus 354 ~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~------~~~~~-~~--------------~~~~~~~~~~~~~~~~ 412 (473)
+.+..++.++|||||||++|||++|+.||....... ....+ .. ...+.........+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997654211 11111 10 0000111101111000
Q ss_pred cc---------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQ---------LKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. -...++...+..+.+||.+||+.||.+|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 011245678889999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=338.88 Aligned_cols=276 Identities=15% Similarity=0.153 Sum_probs=199.9
Q ss_pred CHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC----------hhhHhHHHHHHHHHhCCC
Q 011995 166 PLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----------QGVKEFINDVNTLASLQH 235 (473)
Q Consensus 166 ~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~H 235 (473)
...++....++|...+.||+|+||.||+|...+ +..+++|+....... ...+.+.+|+.++.+++|
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 88 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC
Confidence 356788889999999999999999999998543 344555554332211 123778999999999999
Q ss_pred CCcccceeeeecC---CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCC
Q 011995 236 PNLCKLLGFHARD---GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312 (473)
Q Consensus 236 pnIv~l~g~~~~~---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp 312 (473)
|||+++++++... .....|+||||+. |+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||
T Consensus 89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 162 (362)
T 3pg1_A 89 PNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHP 162 (362)
T ss_dssp TTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred cCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCCh
Confidence 9999999998653 2246899999997 688888864 3456999999999999999999999999 99999999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCC-CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPET-DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE 390 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~ 390 (473)
+|||++.++.+||+|||++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp GGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999999765433 2334577899999999977 6689999999999999999999999988765443
Q ss_pred HhHhhh-cc-ccccc-----ccccccccccc---cC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 391 RNLVKW-SR-PFLAD-----DCRLSLIMDPQ---LK----GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 391 ~~~~~~-~~-~~~~~-----~~~~~~~~~~~---l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+.. .. +...+ ........... .. .......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 332211 00 00000 00000000000 00 00122345779999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.16 Aligned_cols=265 Identities=15% Similarity=0.193 Sum_probs=185.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+..... .......+.+|+.+|+.++||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKT---GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTT---TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCC---CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 47899999999999999999985443 3455555543322 2334577889999999999999999999986531
Q ss_pred -CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 250 -SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 250 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
....++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp GCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-
T ss_pred cCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeec
Confidence 25689999999 7899998843 46999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
|+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+........ ...+
T Consensus 177 G~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~-~~~~ 254 (367)
T 2fst_X 177 GLARHTAD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC-HHHH
T ss_pred cccccccc-cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-HHHH
Confidence 99987543 2345678999999999977 6789999999999999999999999988776554433321100000 0000
Q ss_pred ccc--------cc--ccc-CCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLI--------MD--PQL-KGR---FPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~--------~~--~~l-~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..+ .. +.. ... .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 00 000 000 011345788999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.58 Aligned_cols=259 Identities=19% Similarity=0.224 Sum_probs=187.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHh-HHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|....+ ++.+++|+............ +.++...++.++||||+++++++... +.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCC---CeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CC
Confidence 46899999999999999999986443 35566666554433333333 44455568888999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 253 RMLIYERLFHGSLDRLIYGR-SDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
.++||||++ |+|.+++... .....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCC
Confidence 999999996 5887776431 1345799999999999999999999998 8 99999999999999999999999999
Q ss_pred CcccCCCCc-cCcccccccCChhhh----hcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 331 AGHIPETDI-SNSSVAAANLSVETL----ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 331 a~~~~~~~~-~~~~~t~~y~aPE~~----~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
+........ ....+|+.|+|||.+ .+..++.++|||||||++|||++|+.||................
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------- 229 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE------- 229 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-------
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-------
Confidence 987654432 334788999999996 45568899999999999999999999998643322111110000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE--ELDRQE 456 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~--~L~~l~ 456 (473)
..........+.++.+|+.+||+.||.+|||+.|+++ .++...
T Consensus 230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 230 --------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp --------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred --------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 0000012245678999999999999999999999998 444433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=335.80 Aligned_cols=280 Identities=14% Similarity=0.142 Sum_probs=195.4
Q ss_pred HHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeec
Q 011995 168 DEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247 (473)
Q Consensus 168 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 247 (473)
.+.....++|...+.||+|+||.||+|....+ +..+++|+... .......+.+|+..+..++||||+++++++..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~--~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKST---GMSVAIKKVIQ--DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTT---CCEEEEEEEEC--CTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCC---CCEEEEEEEec--CccccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 45667789999999999999999999996543 34455554432 23334567788889999999999999999875
Q ss_pred CCC-----CceEEEEEeccCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCceeecCCCCCceeeCC
Q 011995 248 DGS-----DQRMLIYERLFHGSLDRLIYG-RSDGPPIDWNTRVKIALCAAQGLTFLH--EEGPFQAMYNEFSTANIQIDK 319 (473)
Q Consensus 248 ~~~-----~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~~~~ivHrDlkp~NILl~~ 319 (473)
.+. ...++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 321 237899999976 55444322 123456899999999999999999999 888 999999999999996
Q ss_pred -CCcEEEeccCCCcccCCCC-ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 320 -DFSAKLSGYGCAGHIPETD-ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 320 -~~~vkl~DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
++.+||+|||++....... .....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+..
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 8999999999998775443 33457899999999996654 89999999999999999999999988766544333211
Q ss_pred ccccc---------ccccccccccc-----cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 011995 397 SRPFL---------ADDCRLSLIMD-----PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQE 456 (473)
Q Consensus 397 ~~~~~---------~~~~~~~~~~~-----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~ 456 (473)
..... ........... ...........+.++.+|+.+||+.||.+|||+.|+++. |+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 10000 00000000000 000111223467889999999999999999999999974 44443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.13 Aligned_cols=266 Identities=15% Similarity=0.167 Sum_probs=203.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChh--------------hHhHHHHHHHHHhCCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQG--------------VKEFINDVNTLASLQHPN 237 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~--------------~~~~~~Ei~~l~~l~Hpn 237 (473)
.++|...+.||+|+||.||+|.. .++.+++|+..... .... ...+.+|+.++.+++|||
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 46899999999999999999986 23455565554321 1111 178999999999999999
Q ss_pred cccceeeeecCCCCceEEEEEeccCCChhhh------hhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCC
Q 011995 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRL------IYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEF 310 (473)
Q Consensus 238 Iv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDl 310 (473)
|+++++++.+. +..++||||+++|+|.++ +... ....+++..+..++.|++.||.|||+ .+ |+||||
T Consensus 105 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl 178 (348)
T 2pml_X 105 CLTCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV 178 (348)
T ss_dssp BCCCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred cceEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence 99999999876 789999999999999998 5331 25679999999999999999999999 88 999999
Q ss_pred CCCceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcC-CCCC-cCCchHHHHHHHHHHcCCCCCCCCCh-
Q 011995 311 STANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERG-LLTP-KSNVWSFGIVLLELLTGRKNLDSRHP- 387 (473)
Q Consensus 311 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~-~~s~-~sDvwSlGvvl~elltG~~p~~~~~~- 387 (473)
||+|||++.++.+||+|||++............++..|+|||.+.+. .++. ++|||||||++|||++|..||.....
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred ChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999999987765555666789999999999877 5665 99999999999999999999987654
Q ss_pred HHHHhHhhhcccccccc-cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 388 KEERNLVKWSRPFLADD-CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......+.......... ..................++.++.+|+.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 33222221111000000 0000000000000112345688999999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=325.99 Aligned_cols=253 Identities=18% Similarity=0.264 Sum_probs=203.5
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--------ChhhHhHHHHHHHHHhCC-CCCccccee
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--------SQGVKEFINDVNTLASLQ-HPNLCKLLG 243 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~Ei~~l~~l~-HpnIv~l~g 243 (473)
..++|...+.||+|+||.||+|....+ ++.+++|+...... ....+.+.+|+.++.++. ||||+++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCc---CceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 457899999999999999999996543 35566776654421 122456889999999995 999999999
Q ss_pred eeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcE
Q 011995 244 FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSA 323 (473)
Q Consensus 244 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~v 323 (473)
++... ...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+
T Consensus 92 ~~~~~--~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 92 TYETN--TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred eeccC--CeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcE
Confidence 99765 789999999999999999954 246899999999999999999999999 9999999999999999999
Q ss_pred EEeccCCCcccCCC-CccCcccccccCChhhhh------cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh
Q 011995 324 KLSGYGCAGHIPET-DISNSSVAAANLSVETLE------RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396 (473)
Q Consensus 324 kl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~------~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 396 (473)
||+|||++...... ......+++.|+|||++. ...++.++|||||||++|||++|..||...........+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 99999999876443 334457889999999985 34688999999999999999999999987655443322211
Q ss_pred cccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
... .........++..+.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNY--------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCC--------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCc--------------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 100 0000112345678999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=332.39 Aligned_cols=252 Identities=15% Similarity=0.259 Sum_probs=193.4
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-------CChhhHhHHHHHHHHHhCCCCCcccceeee
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-------SSQGVKEFINDVNTLASLQHPNLCKLLGFH 245 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 245 (473)
..++|...+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+++++.++||||+++++++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCC---CcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 457899999999999999999986543 3455566554321 122345688999999999999999999998
Q ss_pred ecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc---
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS--- 322 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--- 322 (473)
... ..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~---~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~ 155 (322)
T 2ycf_A 85 DAE---DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 155 (322)
T ss_dssp ESS---SEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCC
T ss_pred cCC---ceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCe
Confidence 653 48999999999999999843 456999999999999999999999999 999999999999987654
Q ss_pred EEEeccCCCcccCCCCc-cCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhHhhhc
Q 011995 323 AKLSGYGCAGHIPETDI-SNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWS 397 (473)
Q Consensus 323 vkl~DFGla~~~~~~~~-~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~ 397 (473)
+||+|||++........ ....+|+.|+|||++. ...++.++|||||||++|||++|..||........ ...+...
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 156 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp EEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred EEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 99999999987654322 2346789999999974 45689999999999999999999999976433211 1111100
Q ss_pred ccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. .. ..+. ....++..+.+|+.+||..||.+|||+.++++
T Consensus 236 ~--------~~--~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 K--------YN--FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C--------CC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c--------cc--cCch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 00 0000 01234578999999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.42 Aligned_cols=251 Identities=19% Similarity=0.263 Sum_probs=196.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|++.+.||+|+||.||+|....+ .+.+++|+.... .......+.+|+.++..++||||+++++++... +..
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 91 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKET---GALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKL 91 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTT---CCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CE
T ss_pred ccceeecceeccCCCeEEEEEEEcCC---CcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeE
Confidence 46799999999999999999997543 234445544332 334467889999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp EEEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999988542 345999999999999999999999999 99999999999999999999999998754
Q ss_pred cCCC--CccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 334 IPET--DISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 334 ~~~~--~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
.... ......+++.|+|||.+. +..++.++|||||||++|||++|..||...........+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 239 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP------- 239 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------
T ss_pred ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-------
Confidence 3211 123446789999999984 56689999999999999999999999987665443221111000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
+. ...+..++..+.+++.+||..||.+|||+.++++
T Consensus 240 ------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 ------PT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------CC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------cc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0113345678999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=341.27 Aligned_cols=270 Identities=16% Similarity=0.193 Sum_probs=182.6
Q ss_pred hccccc-CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFS-DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.+.|+. +++||+|+||+||+|.+.+.. ..+.+++|+... ......+.+|+.+|+.++|||||++++++.......
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSS-CCCCEEEEECSS---SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCC-CCeEEEEEEECC---CCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345665 468999999999999976432 234455554432 223457889999999999999999999997655578
Q ss_pred eEEEEEeccCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee----CCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGR------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI----DKDFS 322 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~ 322 (473)
.+|||||+. |+|.+++... .....+++..+..|+.||+.||.|||+++ |+||||||+|||| +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 999999996 5888777421 12235999999999999999999999999 9999999999999 67799
Q ss_pred EEEeccCCCcccCCC-----CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChH--------
Q 011995 323 AKLSGYGCAGHIPET-----DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPK-------- 388 (473)
Q Consensus 323 vkl~DFGla~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~-------- 388 (473)
+||+|||+++..... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999876432 22445789999999999874 4899999999999999999999999765432
Q ss_pred -HHHh-Hhhhc-cccccccccccc----------ccccccCC--------CCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011995 389 -EERN-LVKWS-RPFLADDCRLSL----------IMDPQLKG--------RFPLKAARTVADIALRCLQKEPSERPTMRS 447 (473)
Q Consensus 389 -~~~~-~~~~~-~~~~~~~~~~~~----------~~~~~l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 447 (473)
.... +.... .+....-..+.. ........ ......+..+.+||.+||+.||.+|||+.|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111 11000 000000000000 00000000 000112567889999999999999999999
Q ss_pred HHHH
Q 011995 448 IFEE 451 (473)
Q Consensus 448 il~~ 451 (473)
+|+.
T Consensus 331 ~L~h 334 (405)
T 3rgf_A 331 AMQD 334 (405)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=345.09 Aligned_cols=257 Identities=15% Similarity=0.106 Sum_probs=182.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--ChhhHhHHHHHHHHHhC--CCCCcccce-------e
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--SQGVKEFINDVNTLASL--QHPNLCKLL-------G 243 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Ei~~l~~l--~HpnIv~l~-------g 243 (473)
.+|...+.||+|+||.||+|....+ .+.+++|+...... ......+.+|+.++..+ +||||++++ +
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVER---LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCC---CceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 4688889999999999999996543 45666777665432 23456677885444444 699988754 4
Q ss_pred eeecCCC---------------CceEEEEEeccCCChhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCC
Q 011995 244 FHARDGS---------------DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTR------VKIALCAAQGLTFLHEEGP 302 (473)
Q Consensus 244 ~~~~~~~---------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~yLH~~~~ 302 (473)
++...+. ..+||||||++ |+|.+++... +..+.+..+ ..++.||+.||+|||+++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 4433321 34899999998 8999999653 223455566 788899999999999999
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCC
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRK 380 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~ 380 (473)
||||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp --EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred --CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998764322 24556799999999987 679999999999999999999999
Q ss_pred CCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 381 NLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 381 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
||......... .|... .................++..+.+|+.+||+.||++|||+.++++
T Consensus 292 Pf~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKG---SWKRP------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTT---CCCBC------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCccccc---chhhh------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99876432211 01100 000001111111112356788999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=337.60 Aligned_cols=267 Identities=17% Similarity=0.209 Sum_probs=200.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---C
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG---S 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---~ 250 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+............+.+|+.+++.++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPT---GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCC---CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 46899999999999999999986543 34555665543334445677889999999999999999999876531 3
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++||||+. |+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999996 699998854 35899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC------------ccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhc
Q 011995 331 AGHIPETD------------ISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397 (473)
Q Consensus 331 a~~~~~~~------------~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 397 (473)
+....... .....+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 98664221 123467899999998865 67899999999999999999999999887654433322110
Q ss_pred ccccccccccccccc----------cccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 398 RPFLADDCRLSLIMD----------PQLK----GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~----------~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
............+.. +... ......++.++.+|+.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000000 0000 00112456788999999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=327.68 Aligned_cols=266 Identities=16% Similarity=0.189 Sum_probs=203.0
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC------cccceeeeec
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN------LCKLLGFHAR 247 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~~ 247 (473)
.++|++.+.||+|+||.||+|.... ...+.+++|+.. ........+.+|+.++..++|++ ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVK--NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEC--SSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEe--cCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 4689999999999999999998632 123444555443 33445677889999999987654 9999999887
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC--------
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-------- 319 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-------- 319 (473)
. +..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 89 ~--~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 89 H--GHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp T--TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred C--CcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence 6 7899999999 88999999654 2346899999999999999999999999 999999999999987
Q ss_pred -----------CCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChH
Q 011995 320 -----------DFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388 (473)
Q Consensus 320 -----------~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~ 388 (473)
++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred CccccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 66899999999976543 334557899999999999989999999999999999999999999887665
Q ss_pred HHHhHhhhcccccccc----cc---------------------ccccccc-ccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011995 389 EERNLVKWSRPFLADD----CR---------------------LSLIMDP-QLKGRFPLKAARTVADIALRCLQKEPSER 442 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~----~~---------------------~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~~dP~~R 442 (473)
+....+.......... .. ......+ ..........+.++.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 5433322111000000 00 0000000 00011234567889999999999999999
Q ss_pred CCHHHHHHH
Q 011995 443 PTMRSIFEE 451 (473)
Q Consensus 443 Pt~~eil~~ 451 (473)
||+.|+++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=326.85 Aligned_cols=273 Identities=18% Similarity=0.239 Sum_probs=203.5
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhC---CCCCcccceeeeec
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASL---QHPNLCKLLGFHAR 247 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~ 247 (473)
...++|...+.||+|+||.||+|..... .++.+++|+..... .......+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3467899999999999999999986421 22344555544322 222345677888887776 89999999999862
Q ss_pred ---CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 248 ---DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 248 ---~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
......++||||+. |+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEE
Confidence 12367899999997 69999986542 345899999999999999999999999 99999999999999999999
Q ss_pred EeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc-
Q 011995 325 LSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA- 402 (473)
Q Consensus 325 l~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 402 (473)
|+|||++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||.+.........+........
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred EecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 9999999876433 23445778999999999999999999999999999999999999988765544332211000000
Q ss_pred ccc----cc-ccc---cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 403 DDC----RL-SLI---MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 403 ~~~----~~-~~~---~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... .. ... ........+...++..+.+|+.+||..||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00 000 00000112234566889999999999999999999999953
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=326.06 Aligned_cols=253 Identities=17% Similarity=0.293 Sum_probs=192.1
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC----
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD---- 248 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~---- 248 (473)
..++|+..+.||+|+||.||+|....+ .+.+++|+... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCC---CeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 457899999999999999999986543 33444554432 334567889999999999999999999987652
Q ss_pred -------CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC
Q 011995 249 -------GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 249 -------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 321 (473)
.....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESR 153 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTS
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCC
Confidence 135789999999999999999643 346788999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCCcccCCC----------------CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCC
Q 011995 322 SAKLSGYGCAGHIPET----------------DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDS 384 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~----------------~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~ 384 (473)
.+||+|||++...... ......+++.|+|||++.+. .++.++|||||||++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 9999999999765421 12344678999999999764 68999999999999999998 5543
Q ss_pred CChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 385 RHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
... .......... ....+...++...+..+.+++.+||+.||.+|||+.++++.
T Consensus 231 ~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 231 GME--RVNILKKLRS-----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHH--HHHHHHHHHS-----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chh--HHHHHHhccc-----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 211 1111110000 01112223345566788999999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.19 Aligned_cols=265 Identities=15% Similarity=0.193 Sum_probs=197.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC-
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD- 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~- 251 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRS---GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCC---CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 46899999999999999999986543 4556666655432 333457789999999999999999999998765311
Q ss_pred ---ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 252 ---QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 252 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
..++||||+. ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECST
T ss_pred cceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEec
Confidence 2499999996 68888872 24899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc---
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD--- 404 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 404 (473)
|++..... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..........
T Consensus 189 g~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 189 GLARHADA-EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp TCC---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred Cccccccc-CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 99986543 3345578999999999987 678999999999999999999999998876554433221100000000
Q ss_pred ----ccccc---ccccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 ----CRLSL---IMDPQLKG---RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ----~~~~~---~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..... ........ .+....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 00000000 0112346889999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=329.23 Aligned_cols=266 Identities=18% Similarity=0.284 Sum_probs=194.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC-----
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD----- 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~----- 248 (473)
.++|...+.||+|+||.||+|..... .+.+++|+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDC---DKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTT---TEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCC---CeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 46789999999999999999996543 345556655433 344567889999999999999999999987432
Q ss_pred -------CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CC
Q 011995 249 -------GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KD 320 (473)
Q Consensus 249 -------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~ 320 (473)
.....++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++ .+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTED 157 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCC
Confidence 2267899999997 699999842 46899999999999999999999999 99999999999997 56
Q ss_pred CcEEEeccCCCcccCCC-----CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHh
Q 011995 321 FSAKLSGYGCAGHIPET-----DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV 394 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 394 (473)
+.+||+|||++...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 79999999999876422 2233456889999999866 67899999999999999999999999887765443333
Q ss_pred hhcccccccccccc------c-----cccccc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 395 KWSRPFLADDCRLS------L-----IMDPQL-KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 395 ~~~~~~~~~~~~~~------~-----~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....+......... . ...+.. ...+...++.++.+|+.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 22111111000000 0 000000 000112356889999999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=331.53 Aligned_cols=246 Identities=19% Similarity=0.279 Sum_probs=192.3
Q ss_pred HHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-----hhhHhHHHHHHHHHhC----CCCCcccc
Q 011995 171 AAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-----QGVKEFINDVNTLASL----QHPNLCKL 241 (473)
Q Consensus 171 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~Ei~~l~~l----~HpnIv~l 241 (473)
....++|...+.||+|+||.||+|.... ..+.+++|+....... .....+.+|+.++.++ +|+||+++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3456789999999999999999998543 3345556655433211 2334577899999999 89999999
Q ss_pred eeeeecCCCCceEEEEEe-ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-C
Q 011995 242 LGFHARDGSDQRMLIYER-LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-K 319 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~ 319 (473)
++++... +..++|||| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 104 ~~~~~~~--~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 104 LDWFETQ--EGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR 175 (312)
T ss_dssp EEEC-------CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred EEEEecC--CeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence 9998765 788999999 7899999999643 35899999999999999999999999 99999999999999 8
Q ss_pred CCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCC-CcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 320 DFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLT-PKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s-~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
++.+||+|||++............++..|+|||++.+..+. .++|||||||++|||++|+.||..... ....
T Consensus 176 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~-- 248 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILEA-- 248 (312)
T ss_dssp TTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHT--
T ss_pred CCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hhhh--
Confidence 89999999999988766666667889999999999877764 589999999999999999999975311 0100
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...++..++..+.+|+.+||+.||++|||+.++++.
T Consensus 249 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 -----------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001233456788999999999999999999999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.85 Aligned_cols=253 Identities=18% Similarity=0.254 Sum_probs=201.8
Q ss_pred HHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 172 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...++|.+.+.||+|+||.||+|....+ .+.+++|+..... .......+.+|+.++++++||||+++++++...
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRIT---QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-- 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCC---CcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--
Confidence 3457899999999999999999986533 3455566654432 334567899999999999999999999999765
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC---CcEEEec
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---FSAKLSG 327 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~vkl~D 327 (473)
...++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.+ +.+||+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~D 167 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred CeEEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEec
Confidence 7899999999999999988543 35899999999999999999999999 9999999999999754 4799999
Q ss_pred cCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 328 YGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 328 FGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
||++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~ 240 (287)
T 2wei_A 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY------A 240 (287)
T ss_dssp TTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------C
T ss_pred cCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------C
Confidence 99998664432 234467899999999865 489999999999999999999999987665443322211100 0
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. + . .....++.++.+++.+||..||.+|||+.++++
T Consensus 241 ~----~--~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F----D--L--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C----C--S--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----C--c--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0 0 001234578999999999999999999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.13 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=178.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHH-HHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVN-TLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+...........++..|+. +++.++||||+++++++... +.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTT---TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCC---CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--Cc
Confidence 36788889999999999999996543 35566666655444445566677776 67778999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 253 RMLIYERLFHGSLDRLIYG--RSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
.++||||+.+ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999975 88777642 11245689999999999999999999998 8 9999999999999999999999999
Q ss_pred CCcccCCCCc-cCcccccccCChhhh----hcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 330 CAGHIPETDI-SNSSVAAANLSVETL----ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 330 la~~~~~~~~-~~~~~t~~y~aPE~~----~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
++........ ....+++.|+|||++ .+..++.++|||||||++|||++|+.||......... .. ...
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~---~~~--- 243 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--LT---QVV--- 243 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------C---CCC---
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--HH---HHh---
Confidence 9987644322 334788999999998 4566899999999999999999999999764321110 00 000
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
....+.+.......++..+.+|+.+||..||.+|||+.+|++.
T Consensus 244 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 ----KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ----CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0001111111223456789999999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=328.89 Aligned_cols=264 Identities=16% Similarity=0.205 Sum_probs=197.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC--
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-- 250 (473)
.++|...+.||+|+||.||+|....+ ++.+++|+..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRS---GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCC---CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 46799999999999999999986543 3555666554432 23345678999999999999999999999876521
Q ss_pred --CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 251 --DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 251 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
...++||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECST
T ss_pred cceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeec
Confidence 23599999996 68888772 24899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc------
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL------ 401 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~------ 401 (473)
|++...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.......
T Consensus 171 g~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 171 GLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TCTTC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccccCCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 999865432 344578999999999977 678999999999999999999999998876544332221100000
Q ss_pred --cccc------ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 402 --ADDC------RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 402 --~~~~------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.+.. .+.......+ .......+.++.+|+.+||..||.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0000000001 11223567889999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=332.16 Aligned_cols=256 Identities=15% Similarity=0.191 Sum_probs=172.4
Q ss_pred HhcccccC-cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHH-HHHHhCCCCCcccceeeeecC--
Q 011995 173 ACHNFFSD-RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDV-NTLASLQHPNLCKLLGFHARD-- 248 (473)
Q Consensus 173 ~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei-~~l~~l~HpnIv~l~g~~~~~-- 248 (473)
..++|.+. +.||+|+||.||+|....+ .+.+++|+... . ....+|+ ..+..+.||||+++++++...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~--~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRT---GQKCALKLLYD--S----PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEES--S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCC---CCEEEEEEecC--c----HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 36788885 4699999999999996543 34555665542 1 2223333 345667999999999998752
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAKL 325 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vkl 325 (473)
+....++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred CCceEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEE
Confidence 225589999999999999999754 2356999999999999999999999999 999999999999976 456999
Q ss_pred eccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 326 SGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 326 ~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
+|||++............+|+.|+|||++.+..++.++|||||||++|||++|..||.............. .+
T Consensus 173 ~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~---- 245 (336)
T 3fhr_A 173 TDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RI---- 245 (336)
T ss_dssp CCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred eccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hh----
Confidence 99999987765555666789999999999888899999999999999999999999976543221100000 00
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..............++.++.+|+.+||+.||.+|||+.++++.
T Consensus 246 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 246 ---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000011111123456889999999999999999999999983
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=332.31 Aligned_cols=265 Identities=17% Similarity=0.163 Sum_probs=200.0
Q ss_pred HhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CC-----Ccccceeeee
Q 011995 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HP-----NLCKLLGFHA 246 (473)
Q Consensus 173 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~l~g~~~ 246 (473)
..++|...+.||+|+||+||+|....+ .+.+++|+.. .......++.+|+.++..++ |+ +|+.+++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVE---QEWVAIKIIK--NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT---TEEEEEEEEC--SSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCC---CcEEEEEEEe--ccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 467899999999999999999986543 3445555543 33445577888999998885 55 4899999988
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh--cCCCceeecCCCCCceeeC--CCCc
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE--EGPFQAMYNEFSTANIQID--KDFS 322 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~--~~~~~ivHrDlkp~NILl~--~~~~ 322 (473)
.. +..+|||||+. |+|.+++.... ...+++..+..++.|++.||.|||. .+ ||||||||+||||+ .++.
T Consensus 127 ~~--~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 127 FR--NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp ET--TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCC
T ss_pred cC--CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCc
Confidence 76 78999999995 59999996542 3458999999999999999999994 56 99999999999995 5788
Q ss_pred EEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc
Q 011995 323 AKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA 402 (473)
Q Consensus 323 vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 402 (473)
+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+........
T Consensus 200 ~kL~DFG~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EEECCCTTCEETTC-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEEeccCceeccc-ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999999987643 33456789999999999999999999999999999999999999998766554333221100000
Q ss_pred c-----ccc----cccccc-----------------cc--------------------cCCCCCHHHHHHHHHHHHHhcc
Q 011995 403 D-----DCR----LSLIMD-----------------PQ--------------------LKGRFPLKAARTVADIALRCLQ 436 (473)
Q Consensus 403 ~-----~~~----~~~~~~-----------------~~--------------------l~~~~~~~~~~~l~~li~~cl~ 436 (473)
. ... +..+.+ +. -..........++.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 0 000 000000 00 0001123345689999999999
Q ss_pred cCCCCCCCHHHHHH
Q 011995 437 KEPSERPTMRSIFE 450 (473)
Q Consensus 437 ~dP~~RPt~~eil~ 450 (473)
.||++|||+.|+|+
T Consensus 359 ~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 359 YDPKTRIQPYYALQ 372 (382)
T ss_dssp SCTTTSCCHHHHTT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=326.95 Aligned_cols=271 Identities=13% Similarity=0.136 Sum_probs=202.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC------cccceeeeec
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN------LCKLLGFHAR 247 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~~ 247 (473)
.++|.+.+.||+|+||.||+|...... ...+++|+. .........+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~vavK~~--~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKII--RNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT--TEEEEEEEE--CSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCC--ceEEEEEEE--cccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 468999999999999999999865432 134445544 333445677889999999997766 8888888877
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee----------
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI---------- 317 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl---------- 317 (473)
. +..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 94 ~--~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 94 H--GHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp T--TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred C--CeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence 6 7899999999 66777777543 2346999999999999999999999999 9999999999999
Q ss_pred ---------CCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChH
Q 011995 318 ---------DKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPK 388 (473)
Q Consensus 318 ---------~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~ 388 (473)
+.++.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999976533 334567899999999999999999999999999999999999999887655
Q ss_pred HHHhHhhhcccccccc-----cccccc--------------------ccc-ccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011995 389 EERNLVKWSRPFLADD-----CRLSLI--------------------MDP-QLKGRFPLKAARTVADIALRCLQKEPSER 442 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~-----~~~~~~--------------------~~~-~l~~~~~~~~~~~l~~li~~cl~~dP~~R 442 (473)
.....+.......... ...... ..+ ..........+.++.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 4333222111000000 000000 000 00001123456789999999999999999
Q ss_pred CCHHHHHHH--HHhhh
Q 011995 443 PTMRSIFEE--LDRQE 456 (473)
Q Consensus 443 Pt~~eil~~--L~~l~ 456 (473)
||+.|+++. +..+.
T Consensus 326 pt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLT 341 (355)
T ss_dssp CCHHHHTTSGGGGGCC
T ss_pred cCHHHHhcChhhcCCC
Confidence 999999853 44444
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=330.64 Aligned_cols=267 Identities=18% Similarity=0.229 Sum_probs=198.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-----------CCCcccce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-----------HPNLCKLL 242 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~ 242 (473)
.++|...+.||+|+||.||+|....+ .+.+++|+.. ........+.+|+.++.+++ |+||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEC--SCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCC---CcEEEEEEec--CCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 35799999999999999999986443 3445555543 33445677889999999886 89999999
Q ss_pred eeeecCC--CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeC-
Q 011995 243 GFHARDG--SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQID- 318 (473)
Q Consensus 243 g~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~- 318 (473)
+++...+ ....++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEI 167 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEec
Confidence 9987642 23789999999 889999996542 34599999999999999999999998 8 99999999999994
Q ss_pred -----CCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHH----
Q 011995 319 -----KDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE---- 389 (473)
Q Consensus 319 -----~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~---- 389 (473)
..+.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCCCcCcceEEEcccccccccCC-CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 445899999999976643 3345578999999999999999999999999999999999999997654211
Q ss_pred --H-HhHhhhcc--------------ccccccccccccccc---------ccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011995 390 --E-RNLVKWSR--------------PFLADDCRLSLIMDP---------QLKGRFPLKAARTVADIALRCLQKEPSERP 443 (473)
Q Consensus 390 --~-~~~~~~~~--------------~~~~~~~~~~~~~~~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 443 (473)
. ..++.... .+.........+... .-...++...+.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1 11111000 000000000000000 001134678889999999999999999999
Q ss_pred CHHHHHHH
Q 011995 444 TMRSIFEE 451 (473)
Q Consensus 444 t~~eil~~ 451 (473)
|+.|+++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=332.96 Aligned_cols=248 Identities=18% Similarity=0.228 Sum_probs=200.3
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-----hhhHhHHHHHHHHHhCC--CCCcccc
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-----QGVKEFINDVNTLASLQ--HPNLCKL 241 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~--HpnIv~l 241 (473)
+.....++|...+.||+|+||.||+|....+ .+.+++|+....... .....+.+|+.++.+++ |+||+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTT---TEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCC---CcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3344567899999999999999999986543 355566665543211 13356788999999996 5999999
Q ss_pred eeeeecCCCCceEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-C
Q 011995 242 LGFHARDGSDQRMLIYERLFH-GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-K 319 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~ 319 (473)
++++... +..++||||+.+ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .
T Consensus 114 ~~~~~~~--~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 114 LDWFERP--DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEEECS--SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred EEEEecC--CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence 9999876 789999999976 899999854 346899999999999999999999999 99999999999999 7
Q ss_pred CCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 320 DFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 320 ~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
++.+||+|||++............+|+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .... .
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~-~ 259 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIRG-Q 259 (320)
T ss_dssp TTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHC-C
T ss_pred CCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhcc-c
Confidence 8999999999998876666666788999999999987775 6889999999999999999999965311 1100 0
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .++..++.++.+|+.+||+.||.+|||+.+|++.
T Consensus 260 ~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 V------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0122345789999999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=324.84 Aligned_cols=259 Identities=18% Similarity=0.293 Sum_probs=197.7
Q ss_pred CCHHHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCC--CCCcccc
Q 011995 165 FPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQ--HPNLCKL 241 (473)
Q Consensus 165 ~~~~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~--HpnIv~l 241 (473)
+.++.+....++|...+.||+|+||.||++...+ ...+++|+..... .......+.+|+.++.+++ |+||+++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC----CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence 3334444456789999999999999999998543 3455666665543 3445678899999999997 5999999
Q ss_pred eeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC
Q 011995 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF 321 (473)
Q Consensus 242 ~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 321 (473)
++++... ...++||| +.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. +
T Consensus 94 ~~~~~~~--~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~ 163 (313)
T 3cek_A 94 YDYEITD--QYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-G 163 (313)
T ss_dssp EEEEECS--SEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-T
T ss_pred EEEeecC--CEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-C
Confidence 9999876 78999999 5688999999643 46899999999999999999999999 999999999999964 8
Q ss_pred cEEEeccCCCcccCCCC----ccCcccccccCChhhhhc-----------CCCCCcCCchHHHHHHHHHHcCCCCCCCCC
Q 011995 322 SAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLER-----------GLLTPKSNVWSFGIVLLELLTGRKNLDSRH 386 (473)
Q Consensus 322 ~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~-----------~~~s~~sDvwSlGvvl~elltG~~p~~~~~ 386 (473)
.+||+|||++....... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 99999999998764332 123467899999999875 468889999999999999999999997654
Q ss_pred hHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 011995 387 PKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 452 (473)
...... . .+.++.....++...+.++.+|+.+||..||.+||++.++++.-
T Consensus 244 ~~~~~~-~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 244 NQISKL-H--------------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp SHHHHH-H--------------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHH-H--------------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 322110 0 01111111222333457899999999999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=348.39 Aligned_cols=275 Identities=17% Similarity=0.189 Sum_probs=206.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeec----CC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR----DG 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~ 249 (473)
.++|++.+.||+|+||.||+|.... .+..+++|+............+.+|++++.+++||||+++++++.. ..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3689999999999999999998543 3344555554443445556789999999999999999999998754 12
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCc---EEEe
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFS---AKLS 326 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---vkl~ 326 (473)
.+..++||||+++|+|.+++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence 3678999999999999999976554557999999999999999999999999 999999999999987654 9999
Q ss_pred ccCCCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 327 GYGCAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 327 DFGla~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
|||++....... .....+++.|+|||.+.+..++.++|||||||++|||++|..||....... .|.........
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~ 241 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSN 241 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC----
T ss_pred ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccc
Confidence 999998765443 344578999999999999999999999999999999999999997653322 11111100000
Q ss_pred -----------ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhhhccc
Q 011995 406 -----------RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS-----IFEELDRQESRK 459 (473)
Q Consensus 406 -----------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-----il~~L~~l~~~~ 459 (473)
.............+....+..+.+|+.+||..||.+|||+.+ +.+.++.+.+..
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000000011122345568899999999999999999999988 667777766544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.58 Aligned_cols=251 Identities=19% Similarity=0.291 Sum_probs=177.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHh-HHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
.++|+..+.||+|+||.||+|....+ .+.+++|+...........+ +.++..++..++||||+++++++... +.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTT---CCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hccccccceeeecCCeeEEEEEEecC---CeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--Cc
Confidence 56889999999999999999997543 34556666654433333333 44455678888999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.++||||+ ++.+..++.. ....+++..+..++.|++.||.|||++ + |+|+||||+|||++.++.+||+|||++
T Consensus 99 ~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999 5555555432 234689999999999999999999995 8 999999999999999999999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH-HhHhhhcccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSRPFLADD 404 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~ 404 (473)
....... .....+++.|+|||++. ...++.++|||||||++|||++|+.||........ ...+....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------ 246 (318)
T 2dyl_A 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE------ 246 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC------
T ss_pred hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC------
Confidence 7664332 23457889999999994 45688999999999999999999999986433221 11111000
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+.+. ....++.++.+|+.+||+.||.+|||+.+|++
T Consensus 247 -------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 -------PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -------CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00000 01234578999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.81 Aligned_cols=248 Identities=16% Similarity=0.226 Sum_probs=182.6
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCceE
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 254 (473)
.|...+.||+|+||+||.+...+ ++.+++|+... ...+.+.+|+.+|.++ +|||||++++++.+. ...+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~----g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~ 85 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQ----GRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLY 85 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESS----SSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEEC----CeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CeEE
Confidence 45566889999999997654332 34555655442 2345678999999986 899999999988765 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC----------
Q 011995 255 LIYERLFHGSLDRLIYGRSDGP----PIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD---------- 320 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---------- 320 (473)
|||||+. |+|.+++....... ...+..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccC
Confidence 9999995 69999996542211 1133356789999999999999999 9999999999999654
Q ss_pred ---CcEEEeccCCCcccCCCC------ccCcccccccCChhhhhc-------CCCCCcCCchHHHHHHHHHHc-CCCCCC
Q 011995 321 ---FSAKLSGYGCAGHIPETD------ISNSSVAAANLSVETLER-------GLLTPKSNVWSFGIVLLELLT-GRKNLD 383 (473)
Q Consensus 321 ---~~vkl~DFGla~~~~~~~------~~~~~~t~~y~aPE~~~~-------~~~s~~sDvwSlGvvl~ellt-G~~p~~ 383 (473)
+.+||+|||++....... .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 489999999998765432 224478999999999976 568999999999999999999 999997
Q ss_pred CCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 384 SRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
....... .+..... .. +.........++.++.+||.+||+.||.+|||+.+|++
T Consensus 242 ~~~~~~~-~i~~~~~-------~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 242 DKYSRES-NIIRGIF-------SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp STTTHHH-HHHHTCC-------CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhHH-HHhcCCC-------Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 6543332 1111110 00 01111124567889999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=328.19 Aligned_cols=246 Identities=14% Similarity=0.198 Sum_probs=181.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 252 (473)
..+|...+.||+|+||+||.....+ .+.+++|+.. . .....+.+|+.+|+.+ +|||||++++++.+. ..
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~----~~~vAvK~~~--~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~ 92 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFD----NRDVAVKRIL--P--ECFSFADREVQLLRESDEHPNVIRYFCTEKDR--QF 92 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESS----SSEEEEEEEC--T--TTEEECHHHHHHHHHSCCCTTBCCEEEEEEET--TE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeC----CeEEEEEEEC--H--HHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CE
Confidence 4578889999999999955433222 2334454442 2 2234577899999999 899999999998766 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-----CCcEEEec
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-----DFSAKLSG 327 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~vkl~D 327 (473)
.||||||+. |+|.+++.... ..+.+..+..++.||+.||.|||+++ |+||||||+||||+. ...+||+|
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred EEEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 999999995 69999996532 33455567799999999999999999 999999999999953 34688999
Q ss_pred cCCCcccCCC-----CccCcccccccCChhhhh---cCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcc
Q 011995 328 YGCAGHIPET-----DISNSSVAAANLSVETLE---RGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 328 FGla~~~~~~-----~~~~~~~t~~y~aPE~~~---~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 398 (473)
||++...... ......+|+.|+|||++. ...++.++|||||||++|||++ |..||...............
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~- 245 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC- 245 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC-
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC-
Confidence 9999876432 223457899999999997 4567889999999999999999 99999765433322111100
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
... .. ......+..+.+||.+||+.||.+|||+.+|++
T Consensus 246 -------~~~-----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 -------SLD-----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------CCT-----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------Ccc-----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 00 112355677899999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=310.76 Aligned_cols=235 Identities=12% Similarity=0.103 Sum_probs=181.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||.||+|..... .+.+++|+...... ....+.+.+|+.++..++||||+++++++... +.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTAL---DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTT---TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCC---CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--Cc
Confidence 5799999999999999999996543 35556666554322 33457899999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|+||||+++++|.+++.. + .....+..|+.|++.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~---~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT---S--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT---C--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred EEEEEEecCCCCHHHHHhc---C--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---
Confidence 9999999999999999932 1 355678899999999999999999 9999999999999999999998554
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
|++ .++.++|||||||++|||++|+.||.+........ .........
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~-------- 221 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQ-------- 221 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSC--------
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccC--------
Confidence 333 36889999999999999999999998754322110 000000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
......+...++.++.+|+.+||+.||.+| |+.|+++.|+++....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000001123456789999999999999999 9999999999877543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=347.27 Aligned_cols=244 Identities=17% Similarity=0.220 Sum_probs=191.6
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC--
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD-- 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~-- 251 (473)
.++|.+.+.||+|+||.||+|..... ..+.+++|+............+.+|+.++.+++|||||++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 37899999999999999999986431 23444555443333445567789999999999999999999999875321
Q ss_pred -ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 252 -QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 252 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
..||||||+++++|.+++.. .+++..+..|+.||+.||.|||+++ ||||||||+|||++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 16999999999999987732 6999999999999999999999999 9999999999999986 899999999
Q ss_pred CcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 331 AGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 331 a~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
+...... ....+|+.|+|||++.++. +.++|||||||++|||++|.+||.+..... +.
T Consensus 228 a~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~-------- 285 (681)
T 2pzi_A 228 VSRINSF--GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP-------- 285 (681)
T ss_dssp CEETTCC--SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC--------
T ss_pred chhcccC--CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------cc--------
Confidence 9876443 4557899999999997764 889999999999999999998876421000 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERP-TMRSIFEELDRQ 455 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~l 455 (473)
........+..+.+||.+||+.||.+|| +++++.+.|..+
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000123457789999999999999999 577777777754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=305.56 Aligned_cols=231 Identities=17% Similarity=0.247 Sum_probs=177.4
Q ss_pred hcccccC-cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHH-HhCCCCCcccceeeeec--CC
Q 011995 174 CHNFFSD-RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTL-ASLQHPNLCKLLGFHAR--DG 249 (473)
Q Consensus 174 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~--~~ 249 (473)
.++|... +.||+|+||.||+|....+ .+.+++|+... ...+.+|+.++ +.++||||+++++++.. .+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCC---CcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 4567776 7899999999999986443 44556665532 35677899988 55699999999999865 22
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEEEe
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAKLS 326 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vkl~ 326 (473)
....++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CceEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEe
Confidence 36789999999999999999764 3346999999999999999999999999 999999999999998 7899999
Q ss_pred ccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 327 GYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 327 DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
|||++.... +..++.++|||||||++|||++|..||............
T Consensus 163 Dfg~a~~~~--------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~------------ 210 (299)
T 3m2w_A 163 DFGFAKETT--------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 210 (299)
T ss_dssp CCTTCEECT--------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS------------
T ss_pred ccccccccc--------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH------------
Confidence 999986542 234678899999999999999999999765432211000
Q ss_pred cccccccccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 407 LSLIMDPQLKGRFP----LKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 407 ~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
...+.... ..++ ..++.++.+|+.+||+.||.+|||+.|+++.
T Consensus 211 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 211 KTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 0111 2356889999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.60 Aligned_cols=246 Identities=15% Similarity=0.154 Sum_probs=180.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCC-CCccccee-------
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQH-PNLCKLLG------- 243 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g------- 243 (473)
+.+|...++||+|+||+||+|....+ +..+++|+..... .....+.+.+|+.++..++| .|...+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~---g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCC---CCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 34677889999999999999996543 3466677666432 23346789999999999987 32221111
Q ss_pred --e------------eecCC---CCceEEEEEeccCCChhhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 011995 244 --F------------HARDG---SDQRMLIYERLFHGSLDRLIYG----RSDGPPIDWNTRVKIALCAAQGLTFLHEEGP 302 (473)
Q Consensus 244 --~------------~~~~~---~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ 302 (473)
. +.... ...++++|+++ +++|.+++.. ......+++..+..++.||+.||+|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 1 11110 13467777765 6899988841 122446889999999999999999999999
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhh----------hcCCCCCcCCchHHHHHH
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETL----------ERGLLTPKSNVWSFGIVL 372 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~s~~sDvwSlGvvl 372 (473)
||||||||+||||+.++.+||+|||+++..... .....+ +.|+|||++ .+..++.++|||||||++
T Consensus 232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred --cccCCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999998765433 344566 999999999 444578899999999999
Q ss_pred HHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 373 LELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 373 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
|||++|+.||.......... .+... ...++.++.+||.+||+.||.+||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~----------------~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSE----------------WIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSG----------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhHH----------------HHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999997654322111 00000 1123478999999999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=310.60 Aligned_cols=245 Identities=9% Similarity=0.036 Sum_probs=181.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-------CChhhHhHHHHHHHHHhCC---------CCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-------SSQGVKEFINDVNTLASLQ---------HPN 237 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~---------Hpn 237 (473)
.++|+..+.||+|+||.||+|+.. ++.+++|+..... .....+.+.+|+.+++.++ |||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD-----HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET-----TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEeC-----CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 467899999999999999999862 2556677666542 2233477899999999886 555
Q ss_pred ccccee-----------------eeecC-----------CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHH
Q 011995 238 LCKLLG-----------------FHARD-----------GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC 289 (473)
Q Consensus 238 Iv~l~g-----------------~~~~~-----------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ 289 (473)
||++++ ++.+. +....||||||+++|++.+.+.. ..+++..+..++.|
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQ 169 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHH
Confidence 555554 43320 13789999999999977776632 45899999999999
Q ss_pred HHHHHHHhh-hcCCCceeecCCCCCceeeCCCC--------------------cEEEeccCCCcccCCCCccCccccccc
Q 011995 290 AAQGLTFLH-EEGPFQAMYNEFSTANIQIDKDF--------------------SAKLSGYGCAGHIPETDISNSSVAAAN 348 (473)
Q Consensus 290 i~~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~t~~y 348 (473)
|+.||+||| +++ ||||||||+||||+.++ .+||+|||+++..... ...+|+.|
T Consensus 170 i~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y 243 (336)
T 2vuw_A 170 LTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCT
T ss_pred HHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecc
Confidence 999999999 899 99999999999999887 8999999999876432 44789999
Q ss_pred CChhhhhcCCCCCcCCchHHHHH-HHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHH
Q 011995 349 LSVETLERGLLTPKSNVWSFGIV-LLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTV 427 (473)
Q Consensus 349 ~aPE~~~~~~~s~~sDvwSlGvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 427 (473)
||||++.+.. +.++|||||+++ .+++++|..||...... ....... . . ...............++.++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~---~-~----~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKM---L-K----QMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHH---H-H----TCCCSSCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhh---h-h----hhccCcccchhhhhhcCHHH
Confidence 9999998766 889999998777 77888999988431000 0000000 0 0 00000011111245788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHH
Q 011995 428 ADIALRCLQKEPSERPTMRSIF 449 (473)
Q Consensus 428 ~~li~~cl~~dP~~RPt~~eil 449 (473)
.+||.+||++| |+.|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999977 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-31 Score=281.35 Aligned_cols=184 Identities=16% Similarity=0.115 Sum_probs=125.1
Q ss_pred eeecCCceEEEEEECCCCeeeeEEEEEEEecCC---------CChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCc
Q 011995 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNP---------SSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 183 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 252 (473)
++.|++|.+..++ ....+..+++|++.... .....++|.+|+++|+++ .|+||+++++++.++ ..
T Consensus 242 ~~~~~~~~h~~~r---r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSR---RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QS 316 (569)
T ss_dssp -C--------CCE---EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SE
T ss_pred cccCCcccccccc---cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CE
Confidence 3445555444332 22234455666665432 123346799999999999 799999999999876 88
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.||||||++|++|.++|.. ..+++.. +|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+
T Consensus 317 ~yLVMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIV 387 (569)
T ss_dssp EEEEEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred EEEEEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCe
Confidence 9999999999999999954 3456654 58899999999999999 9999999999999999999999999998
Q ss_pred ccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCC
Q 011995 333 HIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKN 381 (473)
Q Consensus 333 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p 381 (473)
..... ...+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 388 ~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 388 TTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 76543 2345588999999999865 467889999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-28 Score=255.72 Aligned_cols=183 Identities=14% Similarity=0.103 Sum_probs=139.1
Q ss_pred ccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-C------hhhHhHHHHHHHHHhCCCCCcccceeeeecCCC
Q 011995 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-S------QGVKEFINDVNTLASLQHPNLCKLLGFHARDGS 250 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 250 (473)
...+.||+|+||.||+|.+.+... +++....... . ...+.+.+|+++|++++||||+++..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~-----~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-- 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDV-----IIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-- 411 (540)
T ss_dssp ---------CCEEEEEEECSSCEE-----EEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--
T ss_pred CCCCEEeeCCCEEEEEEEECCCeE-----EEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--
Confidence 345789999999999996544322 2333222211 1 1135589999999999999999666666554
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
+..||||||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred CccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 667999999999999999843 5689999999999999999 999999999999999 999999999
Q ss_pred CcccCCCCc---------cCcccccccCChhhhhc--CCCCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 331 AGHIPETDI---------SNSSVAAANLSVETLER--GLLTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 331 a~~~~~~~~---------~~~~~t~~y~aPE~~~~--~~~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
++....... ....+|+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 988754321 24578999999999977 557888999999999999888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=201.30 Aligned_cols=163 Identities=12% Similarity=0.103 Sum_probs=122.9
Q ss_pred HHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-----------------hhhHhHHHHHHHHHh
Q 011995 170 VAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-----------------QGVKEFINDVNTLAS 232 (473)
Q Consensus 170 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~Ei~~l~~ 232 (473)
+......|...+.||+|+||.||+|... .+..+++|+.+..... .....+.+|+.+|.+
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeC----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 3344455677799999999999999972 2345556665432110 134668999999999
Q ss_pred CCCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCC
Q 011995 233 LQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312 (473)
Q Consensus 233 l~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp 312 (473)
++ | +++.+++.. +..|+||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||
T Consensus 161 l~--~-~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp 221 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW---EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQ 221 (282)
T ss_dssp TT--T-SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred cc--C-CCcCeEEec---cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCH
Confidence 99 5 777776543 45699999999999988 411 224579999999999999999 99999999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhc----------CCCCCcCCchH
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER----------GLLTPKSNVWS 367 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~----------~~~s~~sDvwS 367 (473)
+|||++ ++.+||+|||+++. +..|+|||++.. ..|+..+|+|.
T Consensus 222 ~NILl~-~~~vkl~DFG~a~~-----------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSVE-----------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCEE-----------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred HHEEEE-CCcEEEEECCCCeE-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999 99999999999864 345788998754 34556666664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.3e-19 Score=168.32 Aligned_cols=138 Identities=14% Similarity=0.048 Sum_probs=101.5
Q ss_pred cccCcceeecCCceEEEEEECCCCeeeeE--EEEEEEecCCCC-----------------------hhhHhHHHHHHHHH
Q 011995 177 FFSDRCISEGLSSVMYRASFGDDASTSKK--FEATVTRLNPSS-----------------------QGVKEFINDVNTLA 231 (473)
Q Consensus 177 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~--~~~~~~~~~~~~-----------------------~~~~~~~~Ei~~l~ 231 (473)
|...+.||+|+||.||+|.... .+.. +++|+.+..... .....+.+|+.+|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 5677899999999999998621 2234 566664432110 01135789999999
Q ss_pred hCCCCCc--ccceeeeecCCCCceEEEEEeccC-C----ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCC
Q 011995 232 SLQHPNL--CKLLGFHARDGSDQRMLIYERLFH-G----SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH-EEGPF 303 (473)
Q Consensus 232 ~l~HpnI--v~l~g~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~ 303 (473)
++.|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +.+
T Consensus 126 ~l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g-- 191 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE-- 191 (258)
T ss_dssp HHHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--
T ss_pred HHHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9988865 333321 356899999942 4 66665421 224567889999999999999 888
Q ss_pred ceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 304 QAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 304 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||||||||+|||++. .++|+|||++...
T Consensus 192 -ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 -LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp -EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred -EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.6e-16 Score=155.54 Aligned_cols=138 Identities=10% Similarity=0.077 Sum_probs=93.8
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-------------ChhhHhH--------HHHHHHHHhCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-------------SQGVKEF--------INDVNTLASLQ 234 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~--------~~Ei~~l~~l~ 234 (473)
-|.+.+.||.|+||.||+|...+ ++.+|+|+.+.... ....... .+|...|.++.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~----G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK----GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT----CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC----CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999998543 45567776553210 0001112 24555555554
Q ss_pred CCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCc
Q 011995 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTAN 314 (473)
Q Consensus 235 HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~N 314 (473)
+.++.-..-+.. ...+|||||+++++|.++.. . .....++.|++.+|.|||..| ||||||||.|
T Consensus 172 ~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N 235 (397)
T 4gyi_A 172 EEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFN 235 (397)
T ss_dssp HTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred hcCCCCCeeeec----cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 433321111111 22479999999988876541 1 124578899999999999999 9999999999
Q ss_pred eeeCCCC----------cEEEeccCCCcc
Q 011995 315 IQIDKDF----------SAKLSGYGCAGH 333 (473)
Q Consensus 315 ILl~~~~----------~vkl~DFGla~~ 333 (473)
||+++++ .+.|+||+-+..
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEEeCCCCcccccccccceEEEEeCCccc
Confidence 9998776 389999986543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=8.3e-12 Score=118.35 Aligned_cols=148 Identities=11% Similarity=0.062 Sum_probs=108.2
Q ss_pred HHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeec
Q 011995 169 EVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHAR 247 (473)
Q Consensus 169 el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~ 247 (473)
.+.....+|.....++.|+++.||++...+ ..+.+|+..... ......+.+|+++++.+. +..+.++++++..
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~~-----~~~vlK~~~~~~-~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGEN-----ENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECSS-----CEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECCC-----CcEEEEeCCccc-CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 345566788888889989999999997332 233344443211 122346889999999984 6677889888876
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE--------------------------- 300 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------------------------- 300 (473)
. +..|+||||++|.+|.+.+.. ......++.+++.+|..||+.
T Consensus 82 ~--~~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 82 D--GWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp T--TEEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred C--CceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 5 678999999999999876411 122347888999999999981
Q ss_pred -----------------------------CCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 301 -----------------------------GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 301 -----------------------------~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++.++|+|+++.|||++.+..+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11349999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=109.90 Aligned_cols=139 Identities=11% Similarity=0.074 Sum_probs=93.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC--cccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN--LCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~ 251 (473)
..+|....+.+.|..+.||++...++. .+.+|+... . ....+.+|+.+++.+.+.+ +.+++++.... +
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~----~~vlK~~~~--~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~ 88 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRP----VLFVKTDLS--G--ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--G 88 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSC----CEEEEEECS--C--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--S
T ss_pred cCCCceEecccCCCCceEEEEecCCCC----eEEEEeCCc--c--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--C
Confidence 334444333345666999999754332 233444322 1 3356889999999986545 44577776554 5
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG------------------------------ 301 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------ 301 (473)
..++||||++|.+|. .. . .. ...++.+++..|..||...
T Consensus 89 ~~~~v~e~i~G~~l~--~~--~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SS--H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp CEEEEEECCSSEETT--TS--C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred CCEEEEEecCCcccC--cC--c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 689999999998884 21 1 11 2356777888888888643
Q ss_pred -------------------------CCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 302 -------------------------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 302 -------------------------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998877678999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.4e-10 Score=112.47 Aligned_cols=145 Identities=9% Similarity=0.054 Sum_probs=101.0
Q ss_pred cCcceeecCCceEEEEEECCCCeeeeEEEEEEEe--cCCCChhhHhHHHHHHHHHhCC--CCCcccceeeeecCCC-Cce
Q 011995 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTR--LNPSSQGVKEFINDVNTLASLQ--HPNLCKLLGFHARDGS-DQR 253 (473)
Q Consensus 179 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~-~~~ 253 (473)
..+.|+.|.++.||+....+. .+.+++.. ..........+.+|+.+++.+. +..+.+++.++.+... +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~-----~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQ-----TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSC-----EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEECCc-----eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 346789999999999975432 22233222 1111123457889999999996 4557788887754321 357
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG-------------------------------- 301 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------------------------------- 301 (473)
|+||||++|..+.+.. ...++...+..++.+++..|..||...
T Consensus 117 ~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 8999999998875422 123678888999999999999999731
Q ss_pred -----------------------CCceeecCCCCCceeeCCCCc--EEEeccCCCcc
Q 011995 302 -----------------------PFQAMYNEFSTANIQIDKDFS--AKLSGYGCAGH 333 (473)
Q Consensus 302 -----------------------~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~ 333 (473)
+..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=2.5e-09 Score=103.56 Aligned_cols=187 Identities=17% Similarity=0.179 Sum_probs=117.4
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCC--cccceeeeecCC-CCceEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPN--LCKLLGFHARDG-SDQRML 255 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~g~~~~~~-~~~~~l 255 (473)
.+.++.|.+..||+.. +. +.+++.. .......+.+|+++|+.+. +.. +.+++.+....+ ....|+
T Consensus 25 i~~~~~G~~n~v~~v~---~~-----~vlR~~~---~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RD-----FIFKFPK---HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST---TS-----EEEEEES---SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC---CE-----EEEEecC---CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 3568999999999873 21 2233322 2234567899999998883 333 334443332221 123588
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG---------------------------------- 301 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---------------------------------- 301 (473)
||++++|.+|.+... ..++...+..++.+++..|..||+..
T Consensus 94 vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp EEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred EEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 999999988875432 13677788888888888888888611
Q ss_pred ---------------------CCceeecCCCCCceeeCC--CCcEEEeccCCCcccCCC-CccCcccccccCChhhhhc-
Q 011995 302 ---------------------PFQAMYNEFSTANIQIDK--DFSAKLSGYGCAGHIPET-DISNSSVAAANLSVETLER- 356 (473)
Q Consensus 302 ---------------------~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~- 356 (473)
++.++|+|+++.|||++. +..+.|+||+.+...... +............++....
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 245899999999999998 556889999987653211 1000000000023332211
Q ss_pred ----CCC---------CCcCCchHHHHHHHHHHcCCCCC
Q 011995 357 ----GLL---------TPKSNVWSFGIVLLELLTGRKNL 382 (473)
Q Consensus 357 ----~~~---------s~~sDvwSlGvvl~elltG~~p~ 382 (473)
+.. ..-.+.|+++.++|++.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 11257899999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.9e-06 Score=82.07 Aligned_cols=136 Identities=14% Similarity=0.139 Sum_probs=89.7
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCC---CcccceeeeecCCCCceEEEE
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHP---NLCKLLGFHARDGSDQRMLIY 257 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~~~~~~~~~lV~ 257 (473)
..++.|....||+. +.. +.+++- ........+.+|.++|..+.+. .+.+++.++... .+..++||
T Consensus 25 ~~l~~G~~n~v~~v---g~~-----~VlR~~---~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGD-----WVFRFP---KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE---TTT-----EEEEEE---SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEE
T ss_pred eecCCCcceeEEEE---CCE-----EEEEec---CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEE
Confidence 56788888899988 222 123321 2233456789999999999653 245666665422 35678999
Q ss_pred EeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------
Q 011995 258 ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE------------------------------------- 300 (473)
Q Consensus 258 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------------------------- 300 (473)
||++|..|.+.... .++......++.+++..|..||+.
T Consensus 93 e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 93 RKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp ECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred eccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 99999888763211 234455555555555555555542
Q ss_pred --------------------CCCceeecCCCCCceeeCC---CCc-EEEeccCCCcc
Q 011995 301 --------------------GPFQAMYNEFSTANIQIDK---DFS-AKLSGYGCAGH 333 (473)
Q Consensus 301 --------------------~~~~ivHrDlkp~NILl~~---~~~-vkl~DFGla~~ 333 (473)
.++.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 355 58999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4.3e-06 Score=78.99 Aligned_cols=136 Identities=16% Similarity=0.071 Sum_probs=89.9
Q ss_pred ceeecCCc-eEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceEEEEEe
Q 011995 182 CISEGLSS-VMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 182 ~lG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
.+..|..| .||+.....+. ..+.+|+.. ......+.+|..+|+.+. +--+.++++++.+. +..++|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~---~~~~lk~~~----~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNA---PELFLKHGK----GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTC---CCEEEEEEE----THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCC---eEEEEEECC----CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEe
Confidence 45556665 69987643332 222244332 223466889999999884 32356778887765 678999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG-------------------------------------- 301 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------------------------------------- 301 (473)
++|.++.+..... ......++.+++..|.-||...
T Consensus 102 l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 102 IPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9998877655221 1223445566666666666421
Q ss_pred -----------------CCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 302 -----------------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 302 -----------------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12479999999999999887778999997753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.2e-05 Score=79.17 Aligned_cols=87 Identities=10% Similarity=0.024 Sum_probs=49.8
Q ss_pred cce-eecCCceEEEEEEC---CCCeeeeEEEEEEEecCCC--ChhhHhHHHHHHHHHhCC-C--CCcccceeeeecCC-C
Q 011995 181 RCI-SEGLSSVMYRASFG---DDASTSKKFEATVTRLNPS--SQGVKEFINDVNTLASLQ-H--PNLCKLLGFHARDG-S 250 (473)
Q Consensus 181 ~~l-G~G~~g~Vy~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~-H--pnIv~l~g~~~~~~-~ 250 (473)
+.| +.|....+|+.... ++......+.+++...... ......+.+|+.+++.+. + -.+.+++.++.+.. .
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 556 77888899988643 1110123333333221100 001356788999998884 2 34667777664431 1
Q ss_pred CceEEEEEeccCCChhh
Q 011995 251 DQRMLIYERLFHGSLDR 267 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~ 267 (473)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999998877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=0.00011 Score=73.47 Aligned_cols=77 Identities=10% Similarity=0.069 Sum_probs=44.0
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC------CChhhHhHHHHHHHHHhCCC--CCc-ccceeeeecCCC
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP------SSQGVKEFINDVNTLASLQH--PNL-CKLLGFHARDGS 250 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~Ei~~l~~l~H--pnI-v~l~g~~~~~~~ 250 (473)
.+.||.|.++.||++....+ .+.+.+|...... .......+..|.++|..+.. +.. .+++.+ +.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~---~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~-- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEH---DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT-- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--
T ss_pred EEECCCCceEEEEEEEECCC---CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC--
Confidence 35789999999999964322 2233343322110 01123456789999888742 333 355543 22
Q ss_pred CceEEEEEeccCC
Q 011995 251 DQRMLIYERLFHG 263 (473)
Q Consensus 251 ~~~~lV~E~~~~g 263 (473)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 4568999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00012 Score=71.32 Aligned_cols=31 Identities=6% Similarity=0.056 Sum_probs=27.1
Q ss_pred CCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 302 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3459999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0006 Score=65.84 Aligned_cols=138 Identities=12% Similarity=0.048 Sum_probs=85.1
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC---CCCcccceeeeecCCCCceEEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ---HPNLCKLLGFHARDGSDQRMLI 256 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~lV 256 (473)
.+.|+.|....+|+....+ ..+.+|+... .....+..|.+.|+.+. ...+.+++.++... +..++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~-----~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEV-----QTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEESSS-----CEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEE
T ss_pred eEEeCCccceeeeEEEECC-----CeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEE
Confidence 3578999999999987422 2233443331 23466889999998883 35677888777654 678999
Q ss_pred EEeccCCChhh-----------hhhcCCCCC-------------------CCCHHHHH---HHH----------------
Q 011995 257 YERLFHGSLDR-----------LIYGRSDGP-------------------PIDWNTRV---KIA---------------- 287 (473)
Q Consensus 257 ~E~~~~gsL~~-----------~l~~~~~~~-------------------~l~~~~~~---~i~---------------- 287 (473)
|||+++..+.. .|+...... .-+|.... ++.
T Consensus 110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~ 189 (312)
T 3jr1_A 110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI 189 (312)
T ss_dssp EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 99999876521 122221100 11454321 111
Q ss_pred HHHHHH-HHHhhh-cCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 288 LCAAQG-LTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 288 ~~i~~~-L~yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
..++.. ...|.. ..++.+||+|+.+.||+++.++ +.|+||.
T Consensus 190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 112212 223432 2246799999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0013 Score=66.23 Aligned_cols=75 Identities=11% Similarity=-0.014 Sum_probs=44.2
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCcccCCC-CccCcc--cccccCChhhhhcCC---CCCcCCchHHHHHHHHHH
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET-DISNSS--VAAANLSVETLERGL---LTPKSNVWSFGIVLLELL 376 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~--~t~~y~aPE~~~~~~---~s~~sDvwSlGvvl~ell 376 (473)
..++|+|+++.|||++.++ +.|+||+.+..-... +..... ....|++++...... .....++..+...+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3599999999999999876 999999987643211 111111 013355555442111 111234456777777776
Q ss_pred cC
Q 011995 377 TG 378 (473)
Q Consensus 377 tG 378 (473)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0017 Score=61.59 Aligned_cols=79 Identities=13% Similarity=0.054 Sum_probs=49.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCC---CcccceeeeecCCCCc
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHP---NLCKLLGFHARDGSDQ 252 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~~~~~~~ 252 (473)
.......+|.|..+.||+..+.++.. +.+|+... ........|.+|...|+.+.-- -+.+++++ + .
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~----~~vK~~~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~----~ 84 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTP----LFVKALPD-DAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D----D 84 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCE----EEEEECCT-TCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E----T
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCE----EEEEEeCC-CCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c----C
Confidence 34556789999999999999877643 22332221 1222234578899999988422 23444443 1 2
Q ss_pred eEEEEEeccCCCh
Q 011995 253 RMLIYERLFHGSL 265 (473)
Q Consensus 253 ~~lV~E~~~~gsL 265 (473)
-++||||++++..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 3789999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0015 Score=63.02 Aligned_cols=159 Identities=12% Similarity=0.043 Sum_probs=86.0
Q ss_pred CCCHHHHHHHhcccccC-----cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC-
Q 011995 164 NFPLDEVAAACHNFFSD-----RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN- 237 (473)
Q Consensus 164 ~~~~~el~~~~~~f~~~-----~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn- 237 (473)
.++.+++......|... +.|+.|....+|+....++. +.+++.... .....+..|+.++..+....
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~-----~vlk~~~~~---~~~~~l~~e~~~l~~L~~~g~ 77 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-----LILTLYEKR---VEKNDLPFFLGLMQHLAAKGL 77 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-----EEEEEECC------CCHHHHHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCcc-----EEEEEeCCC---CCHHHHHHHHHHHHHHHHCCC
Confidence 46778888887778653 34566777899998765432 223333221 12345667888887773222
Q ss_pred -cccceee------eecCCCCceEEEEEeccCCChhh--------------hhhcCC-C--CC---CC---CHHHHHH--
Q 011995 238 -LCKLLGF------HARDGSDQRMLIYERLFHGSLDR--------------LIYGRS-D--GP---PI---DWNTRVK-- 285 (473)
Q Consensus 238 -Iv~l~g~------~~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~-~--~~---~l---~~~~~~~-- 285 (473)
+.+++.. .... +..++||+|++|..+.. .++... . .. .. .|.....
T Consensus 78 ~vP~~~~~~~g~~~~~~~--g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~ 155 (322)
T 2ppq_A 78 SCPLPLPRKDGELLGELS--GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS 155 (322)
T ss_dssp CCCCBCCBTTCCSCEEET--TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred CCCcccCCCCCCEEEEEC--CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence 2333321 1111 45689999998865421 111110 0 00 01 2322111
Q ss_pred ----------HHHHHHHHHHHhhhc----CCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 286 ----------IALCAAQGLTFLHEE----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 286 ----------i~~~i~~~L~yLH~~----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+...+...+++++.. .+..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011134455555532 23459999999999999987666899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0017 Score=63.01 Aligned_cols=32 Identities=9% Similarity=0.053 Sum_probs=27.2
Q ss_pred CCceeecCCCCCceeeCCC----CcEEEeccCCCcc
Q 011995 302 PFQAMYNEFSTANIQIDKD----FSAKLSGYGCAGH 333 (473)
Q Consensus 302 ~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~ 333 (473)
+..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6799999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0017 Score=62.13 Aligned_cols=31 Identities=16% Similarity=0.154 Sum_probs=25.4
Q ss_pred CCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 302 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5566789999987753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.012 Score=56.61 Aligned_cols=159 Identities=11% Similarity=0.114 Sum_probs=84.0
Q ss_pred CCCHHHHHHHhccccc-----CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCC--
Q 011995 164 NFPLDEVAAACHNFFS-----DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHP-- 236 (473)
Q Consensus 164 ~~~~~el~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hp-- 236 (473)
.++.+++......|.. ...|+ |....||+....++ +.+.+|+.. ........+..|..++..+...
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g----~~~vlK~~~--~~~~~~~~~~~E~~~~~~L~~~g~ 82 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDR----RRFVVKFYR--PERWTADQILEEHQFALQLVNDEV 82 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTC----CCEEEEEEC--TTTSCHHHHHHHHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCC----CEEEEEEcC--CCCCCHHHHHHHHHHHHHHHHcCC
Confidence 3666777766666643 23466 77889998864333 222344332 2222345677788888877422
Q ss_pred Ccccceee-----eecCCCCceEEEEEeccCCChhh----h----------hhcC----C--CCCCCCHHHH----HHHH
Q 011995 237 NLCKLLGF-----HARDGSDQRMLIYERLFHGSLDR----L----------IYGR----S--DGPPIDWNTR----VKIA 287 (473)
Q Consensus 237 nIv~l~g~-----~~~~~~~~~~lV~E~~~~gsL~~----~----------l~~~----~--~~~~l~~~~~----~~i~ 287 (473)
.+.+++.. ... .+..++||+|++|..+.. . ++.. . ....+++... ..++
T Consensus 83 ~vp~~~~~~g~~~~~~--~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l 160 (328)
T 1zyl_A 83 PVAAPVAFNGQTLLNH--QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLF 160 (328)
T ss_dssp SBCCCCCBTTBSCEEE--TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHH
T ss_pred eecceeecCCcEEEEE--CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHH
Confidence 23444432 111 245678999998754320 0 1110 0 0112232211 0010
Q ss_pred ---------------HHHHHHHHHhhh----cCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 288 ---------------LCAAQGLTFLHE----EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 288 ---------------~~i~~~L~yLH~----~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
..+...++.+.. ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 161 EDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011112223222 1234589999999999999 4 899999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0026 Score=64.28 Aligned_cols=76 Identities=16% Similarity=0.181 Sum_probs=45.2
Q ss_pred cceeecCCceEEEEEECCCCe----eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCc-ccceeeeecCCCCceEE
Q 011995 181 RCISEGLSSVMYRASFGDDAS----TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL-CKLLGFHARDGSDQRML 255 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~~~l 255 (473)
..|+.|....||+....++.. ....+.+++... ......+.+|..++..+...++ .++++++. + .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~---~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~----~--g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFS----G--GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----T--EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC---CCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC----C--CE
Confidence 567788889999998754211 122333443321 1112566789999988853334 56766542 1 28
Q ss_pred EEEeccCCCh
Q 011995 256 IYERLFHGSL 265 (473)
Q Consensus 256 V~E~~~~gsL 265 (473)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999976444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0042 Score=63.22 Aligned_cols=74 Identities=14% Similarity=0.122 Sum_probs=42.1
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCc-ccceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL-CKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~~~lV~E~ 259 (473)
..|+.|-...+|+....+. ...+.+++... .........+|..++..+...++ .++++++ . + .+||||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~---~~~~vLRi~g~--~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~--~--G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSK---QAKYLIRLYGP--KTDEIINREREKKISCILYNKNIAKKIYVFF--T--N--GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTT---TEEEEEEEECC---CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--T--T--EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCC---CceEEEEECCC--ChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--C--C--eEEEEe
Confidence 5677788889999986541 12222333321 11111122589999999865555 4676665 2 2 259999
Q ss_pred ccCCCh
Q 011995 260 LFHGSL 265 (473)
Q Consensus 260 ~~~gsL 265 (473)
++|..|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.005 Score=60.98 Aligned_cols=144 Identities=17% Similarity=0.170 Sum_probs=78.4
Q ss_pred cceeecCCceEEEEEECCCCe----eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCceEE
Q 011995 181 RCISEGLSSVMYRASFGDDAS----TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~l 255 (473)
+.|..|-...+|+....++.. ..+.+.+++ ..........+.+|..+++.+. +.-..++++++. + .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~--~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~----~--g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRL--YGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP----E--GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEE--CC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET----T--EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEE--CCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC----C--cc
Confidence 457778888899998643110 112332332 1221223456678999998884 333356666542 2 28
Q ss_pred EEEeccCCChhhh-----------------hhcCC--CCCCCC--HHHHHHHHHHHHH-------------------HHH
Q 011995 256 IYERLFHGSLDRL-----------------IYGRS--DGPPID--WNTRVKIALCAAQ-------------------GLT 295 (473)
Q Consensus 256 V~E~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~L~ 295 (473)
||||++|..|... |+... -+.... |..+.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999988655311 11111 011222 4555555544322 233
Q ss_pred Hhh----hc-CCCceeecCCCCCceeeCCC----CcEEEeccCCCc
Q 011995 296 FLH----EE-GPFQAMYNEFSTANIQIDKD----FSAKLSGYGCAG 332 (473)
Q Consensus 296 yLH----~~-~~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~ 332 (473)
.|. .. .+..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 21 23469999999999999876 789999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0085 Score=58.95 Aligned_cols=29 Identities=17% Similarity=0.246 Sum_probs=24.2
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
..++|+|+.+.|||++.++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 3599999999999998665 8999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0075 Score=54.36 Aligned_cols=98 Identities=14% Similarity=0.090 Sum_probs=62.9
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCccC
Q 011995 263 GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISN 341 (473)
Q Consensus 263 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 341 (473)
-+|.++|.. .+.+|++.++..++.|.+.+|.-+-. .. -..+=+.|..|+|..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc---------
Confidence 378898854 35689999999999999998877622 12 11223357899999999988764 2110
Q ss_pred cccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc
Q 011995 342 SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT 377 (473)
Q Consensus 342 ~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt 377 (473)
.....+.+||... ...+.+.=|||||+++|.-+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122445677653 234567789999999998876
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=94.36 E-value=0.013 Score=63.64 Aligned_cols=61 Identities=10% Similarity=0.080 Sum_probs=32.5
Q ss_pred CCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCCChhhhhhhhhhhccchhhhhhhhhhcc
Q 011995 34 PEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKSR 103 (473)
Q Consensus 34 ~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 103 (473)
..+.+..|.|+|.||..+..++.|+.|| ||+|+ +.|.+|..... +.+...+|.||...|+.
T Consensus 683 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~---ls~N~-l~g~iP~~~~~-----~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 683 NILDLSSNKLDGRIPQAMSALTMLTEID---LSNNN-LSGPIPEMGQF-----ETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CEEECCSSCCEECCCGGGGGCCCCSEEE---CCSSE-EEEECCSSSSG-----GGSCGGGGCSCTEEEST
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEE---CcCCc-ccccCCCchhh-----ccCCHHHhcCCchhcCC
Confidence 3344455555555555555555555555 55555 55555554221 12344567777777754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.14 E-value=0.24 Score=49.54 Aligned_cols=143 Identities=13% Similarity=0.114 Sum_probs=78.9
Q ss_pred cceeecCCceEEEEEECCCCee----eeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCC-cccceeeeecCCCCceEE
Q 011995 181 RCISEGLSSVMYRASFGDDAST----SKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPN-LCKLLGFHARDGSDQRML 255 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~~~l 255 (473)
+.|..|-...+|+....++... ...+.+.+. .......-...+|..+++.+...+ ..++++.+ . -++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~--g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIY--GKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEEC--CCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEEC--CCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCE
Confidence 5677788888999987532211 233333332 222222233468888888884333 34565433 2 268
Q ss_pred EEEeccCCChhh--h---------------hhc----C---C---CCCCCCHHHHHHHHHHH------------------
Q 011995 256 IYERLFHGSLDR--L---------------IYG----R---S---DGPPIDWNTRVKIALCA------------------ 290 (473)
Q Consensus 256 V~E~~~~gsL~~--~---------------l~~----~---~---~~~~l~~~~~~~i~~~i------------------ 290 (473)
||||++|..|.. + ||. . . ...+.-|..+.++..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 999998865421 0 011 0 0 11112344444443322
Q ss_pred -HHHHHHhh---------------------hcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 291 -AQGLTFLH---------------------EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 291 -~~~L~yLH---------------------~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
...+.+|. ...+..++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 12233332 112346899999999999 778899999998775
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=93.38 E-value=0.0004 Score=71.48 Aligned_cols=31 Identities=10% Similarity=-0.063 Sum_probs=25.4
Q ss_pred hhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 218 QGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 218 ~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
.+.++|..|++.+.+++|+|+|+++|||...
T Consensus 321 ~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 321 QGSETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred ccHHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 4467899999999999999999999999754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.46 E-value=0.73 Score=45.57 Aligned_cols=29 Identities=14% Similarity=0.153 Sum_probs=24.3
Q ss_pred ceeecCCCCCceee------CCCCcEEEeccCCCc
Q 011995 304 QAMYNEFSTANIQI------DKDFSAKLSGYGCAG 332 (473)
Q Consensus 304 ~ivHrDlkp~NILl------~~~~~vkl~DFGla~ 332 (473)
.++|+|+.+.|||+ +++..+.++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 456779999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.90 E-value=1.6 Score=39.06 Aligned_cols=115 Identities=10% Similarity=0.098 Sum_probs=77.3
Q ss_pred CCCCcccceeeeecCCCCceEEEEEeccCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCC
Q 011995 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHG-SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFST 312 (473)
Q Consensus 234 ~HpnIv~l~g~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp 312 (473)
.||+++.. .+..++ +.+.+.|+.-+++ ++.. + ..++...+++++.+|+....+++. -+|--|.|
T Consensus 43 ~~~~Fl~~-~I~e~e--D~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELR--DSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECS--SEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred cCCcccce-EEEEcc--cEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 68888876 344443 5665655543322 2222 3 236789999999999887765554 47888999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
+||+++.++.+++.-.|+-..+.... +..|.+ .-.+=|++..+++++..|.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~P~~----------~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVDPLP----------VSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBSCCC----------CCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccCCCCCC----------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999999888754432211 223333 3466788899999988774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.06 E-value=0.36 Score=46.63 Aligned_cols=32 Identities=6% Similarity=0.094 Sum_probs=27.6
Q ss_pred CCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 302 PFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 302 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999987654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=87.82 E-value=0.21 Score=54.12 Aligned_cols=46 Identities=13% Similarity=0.032 Sum_probs=27.8
Q ss_pred CCCCCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCCChhh
Q 011995 31 TTLPEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPSSLD 80 (473)
Q Consensus 31 ~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~~~~ 80 (473)
+.|..+.+..|.|+|.+|..+.+++.|+.|| ||+|+ ++|.+|+++.
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~---Ls~N~-l~g~ip~~l~ 677 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILN---LGHND-ISGSIPDEVG 677 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEE---CCSSC-CCSCCCGGGG
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEe---CcCCc-cCCCCChHHh
Confidence 3455556666666666666666666666666 66666 6666665543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=86.79 E-value=0.19 Score=47.91 Aligned_cols=65 Identities=11% Similarity=0.052 Sum_probs=53.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCCChhhhhhhhhhhccchhhhhhhhhhc
Q 011995 29 TPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKS 102 (473)
Q Consensus 29 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (473)
..+.|.++.+..|.|+|.+|..+..++.|+.|+ |++|+ +.|.+|.... -..+..+.+.+|...|+
T Consensus 242 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~---Ls~N~-l~~~ip~~~~-----l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN---VSFNN-LCGEIPQGGN-----LQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE---CCSSE-EEEECCCSTT-----GGGSCGGGTCSSSEEES
T ss_pred ccCCCCEEECcCCcccCcCChHHhcCcCCCEEE---CcCCc-ccccCCCCcc-----ccccChHHhcCCCCccC
Confidence 456788899999999999999999999999999 99999 9999998621 12456677888877765
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.00 E-value=2.2 Score=38.25 Aligned_cols=115 Identities=12% Similarity=0.146 Sum_probs=75.8
Q ss_pred CCCCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCceeecCCCC
Q 011995 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLT-FLHEEGPFQAMYNEFST 312 (473)
Q Consensus 234 ~HpnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-yLH~~~~~~ivHrDlkp 312 (473)
.||++ .. .+..++ +.+.+.|+.-+++-=...+. .++...+++++.+|+.... +++. -+|--|.|
T Consensus 48 ~~~~f-~~-~I~~~e--D~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI-VR-DIDVSE--DEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS-EE-EEEECS--SEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC-Ce-EEEEeC--CEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 67777 33 233333 67777776543432233332 3678899999999887766 5554 57888999
Q ss_pred CceeeCCCCcEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCC
Q 011995 313 ANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLD 383 (473)
Q Consensus 313 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~ 383 (473)
+||+++.++.++|.-.|+-..++... +..|.+ +-.+=|++..++.++..|.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lpP~e----------~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLPPDE----------WDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBSSCS----------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCcccCCCCC----------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999999988754432211 233433 3356678888888877664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=83.42 E-value=0.63 Score=39.79 Aligned_cols=46 Identities=15% Similarity=0.170 Sum_probs=39.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCCCh
Q 011995 29 TPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPSS 78 (473)
Q Consensus 29 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~~ 78 (473)
.++.|..+.+..|.|++.+|..+..++.|+.|+ |++|+ +.+-.|..
T Consensus 28 ~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~---Ls~N~-l~~l~~~~ 73 (170)
T 3g39_A 28 IPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLD---LDNNQ-LTVLPAGV 73 (170)
T ss_dssp CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEE---CCSSC-CCCCCTTT
T ss_pred CCCCCcEEEcCCCcCCccChhhhcCcccCCEEE---CCCCC-cCccChhh
Confidence 357788899999999999999999999999999 99999 77554443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=81.86 E-value=0.79 Score=39.41 Aligned_cols=44 Identities=9% Similarity=0.073 Sum_probs=38.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCC
Q 011995 29 TPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAP 76 (473)
Q Consensus 29 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p 76 (473)
.++.|..+.+..|.|++.+|..+..++.|+.|+ |++|+ +++-.+
T Consensus 31 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~---Ls~N~-l~~i~~ 74 (174)
T 2r9u_A 31 IPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLY---FNSNK-LTAIPT 74 (174)
T ss_dssp CCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE---CCSSC-CCCCCT
T ss_pred cCCCCcEEEeCCCCccccCHHHhcCCcCCCEEE---CCCCC-CCccCh
Confidence 357788899999999999999999999999999 99999 776433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=81.55 E-value=0.33 Score=42.53 Aligned_cols=40 Identities=13% Similarity=0.052 Sum_probs=20.4
Q ss_pred CCCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCC
Q 011995 33 LPEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAP 76 (473)
Q Consensus 33 ~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p 76 (473)
|..+.+..|.|++.+|..+..++.|+.|+ |++|+ +.+..|
T Consensus 56 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~---Ls~N~-l~~~~~ 95 (192)
T 1w8a_A 56 LVKLELKRNQLTGIEPNAFEGASHIQELQ---LGENK-IKEISN 95 (192)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEE---CCSCC-CCEECS
T ss_pred CCEEECCCCCCCCcCHhHcCCcccCCEEE---CCCCc-CCccCH
Confidence 44444555555555555555555555555 55555 444433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=80.50 E-value=0.58 Score=40.03 Aligned_cols=44 Identities=11% Similarity=0.157 Sum_probs=33.8
Q ss_pred CCCCCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCCCh
Q 011995 31 TTLPEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPSS 78 (473)
Q Consensus 31 ~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~~ 78 (473)
+.|..+.+..|.|++.+|..+..++.|+.|+ |++|+ +.+-.|..
T Consensus 54 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~---L~~N~-l~~~~~~~ 97 (170)
T 3g39_A 54 TQLTRLDLDNNQLTVLPAGVFDKLTQLTQLS---LNDNQ-LKSIPRGA 97 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEE---CCSSC-CCCCCTTT
T ss_pred ccCCEEECCCCCcCccChhhccCCCCCCEEE---CCCCc-cCEeCHHH
Confidence 3456677888888888888888888888888 88888 76655543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=80.29 E-value=0.58 Score=44.94 Aligned_cols=41 Identities=17% Similarity=0.072 Sum_probs=19.3
Q ss_pred CCCCCCCC-CCCCCCCCcccccCCcccccCccccccccccccCCCC
Q 011995 33 LPEPQIPT-RSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPS 77 (473)
Q Consensus 33 ~~~~~~~~-~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~ 77 (473)
|.++.+.+ |.|++.+|..|..++.|+.|+ |++|+ +++..|.
T Consensus 33 L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~---l~~N~-l~~~~~~ 74 (347)
T 2ifg_A 33 LTELYIENQQHLQHLELRDLRGLGELRNLT---IVKSG-LRFVAPD 74 (347)
T ss_dssp CSEEECCSCSSCCEECGGGSCSCCCCSEEE---CCSSC-CCEECTT
T ss_pred eeEEEccCCCCCCCcChhHhccccCCCEEE---CCCCc-cceeCHH
Confidence 33344443 455555444444455555555 55554 4444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 473 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-28 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-26 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-19 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-18 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-41
Identities = 51/281 (18%), Positives = 110/281 (39%), Gaps = 32/281 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ I G +Y+ + D + + P+ Q ++ F N+V L +H N+
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAV-----KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
+G+ + Q ++ + SL ++ + + IA AQG+ +LH +
Sbjct: 69 FMGYST---APQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAA-------ANLSVET 353
++ + + NI + +D + K+ +G A S+ A +
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 354 LERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413
++ + +S+V++FGIVL EL+TG+ + + +++ + D ++
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+K + CL+K+ ERP I ++
Sbjct: 241 AMK------------RLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-40
Identities = 49/306 (16%), Positives = 99/306 (32%), Gaps = 39/306 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
I +G ++R + E V + + ++ L+H N+
Sbjct: 9 ESIGKGRFGEVWRG-------KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 241 LLGFHARDGSD--QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
+ +D Q L+ + HGSL + + +K+AL A GL LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLH 117
Query: 299 EEGPFQAM-----YNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANL---- 349
E + + + NI + K+ + ++ G A + +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 350 --------SVETLERGLLTPKSNVWSFGIVLLELLTGRK----NLDSRHPKEERNLVKWS 397
++ ++++++ G+V E+ + D + P + S
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 398 RPFLADDCRLSLIMDPQLKGRF-PLKAARTVADIALRCLQKEPSERPTMRSI---FEELD 453
+ + P + R+ +A R +A I C + R T I +L
Sbjct: 238 VEEMRKV-VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 454 RQESRK 459
+QE K
Sbjct: 297 QQEGIK 302
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-40
Identities = 49/276 (17%), Positives = 104/276 (37%), Gaps = 34/276 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ I +G + + + V + + + F+ + + + L+H NL +
Sbjct: 13 QTIGKGEFGDVMLG-------DYRGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQ 64
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
LLG + ++ E + GSL + R + + +K +L + + +L
Sbjct: 65 LLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLT 360
+ + + N+ + +D AK+S +G T + + E L +
Sbjct: 123 NFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFS 178
Query: 361 PKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDPQLKGR 418
KS+VWSFGI+L E+ + + R P ++ + K + D C P +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC------PPAVY-- 230
Query: 419 FPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
++ C + + RP+ + E+L+
Sbjct: 231 ----------EVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-39
Identities = 51/283 (18%), Positives = 105/283 (37%), Gaps = 37/283 (13%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ I G +++ + + + + + + ++FI + + L HP L +
Sbjct: 11 QEIGSGQFGLVHLGYWLNKD------KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L G L++E + HG L Y R+ T + + L +G+ +L E
Sbjct: 65 LYGVCLEQ--APICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN---LSVETLERG 357
++ + + N + ++ K+S +G + + ++S+ S E
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDPQL 415
+ KS+VWSFG+++ E+ + K E ++ R +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--------------- 222
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR-QES 457
P A+ V I C ++ P +RP + +L ES
Sbjct: 223 ---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 5e-39
Identities = 49/296 (16%), Positives = 111/296 (37%), Gaps = 30/296 (10%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ 234
+ + G +Y S V L + V+EF+ + + ++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGV---WKKYSLTV--AVKTLKEDTMEVEEFLKEAAVMKEIK 71
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGL 294
HPNL +LLG R+ +I E + +G+L + + + + +A + +
Sbjct: 72 HPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAM 128
Query: 295 TFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANL---SV 351
+L ++ + + + N + ++ K++ +G + + + + A + +
Sbjct: 129 EYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
E+L + KS+VW+FG++L E+ T + + + ++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELL 229
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSSSSTVRR 467
+ + P V ++ C Q PS+RP+ I + + S S V +
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-39
Identities = 60/278 (21%), Positives = 106/278 (38%), Gaps = 36/278 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ G ++ + + V L S F+ + N + LQH L +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHT------KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L + +I E + +GSL + S G + N + +A A+G+ F+ E
Sbjct: 73 LYAVVT---QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN---LSVETLERG 357
++ + ANI + S K++ +G A I + + + A + E + G
Sbjct: 129 NY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDPQL 415
T KS+VWSFGI+L E++T + E +NL + R D+C L
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 240
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
+ C ++ P +RPT + L+
Sbjct: 241 -------------QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-38
Identities = 42/277 (15%), Positives = 102/277 (36%), Gaps = 36/277 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ + G V+ + +++ + + S EFI + + +L H L +
Sbjct: 10 KELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L G + +I E + +G L + +++ + + +L +
Sbjct: 64 LYGVCTKQ--RPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN---LSVETLERG 357
++ + + N ++ K+S +G + ++ + + ++S + E L
Sbjct: 120 QF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDPQL 415
+ KS++W+FG+++ E+ + K R E ++ + R +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 221
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
P A+ V I C ++ ERPT + + +
Sbjct: 222 ---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-38
Identities = 58/287 (20%), Positives = 110/287 (38%), Gaps = 34/287 (11%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASL 233
+F + I G +Y + D+ KK V LN + V +F+ + +
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
HPN+ LLG R +++ + HG L I + P + L A+G
Sbjct: 86 SHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPT--VKDLIGFGLQVAKG 142
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAA------ 347
+ FL + + + + N +D+ F+ K++ +G A + + + +
Sbjct: 143 MKFLASKKFV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 348 NLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407
+++E+L+ T KS+VWSFG++L EL+T P + N + L L
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRLL 254
Query: 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
P + ++ L+C + RP+ + +
Sbjct: 255 -----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-36
Identities = 53/303 (17%), Positives = 110/303 (36%), Gaps = 42/303 (13%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASL-QHPN 237
+ + G + A+ + V L PS+ + ++++ L+ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR---------------SDGPPIDWNT 282
+ LLG ++I E +G L + + D +D
Sbjct: 89 IVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 283 RVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNS 342
+ + A+G+ FL + ++ + + NI + K+ +G A I
Sbjct: 147 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 343 S----VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398
+ ++ E++ + T +S+VWS+GI L EL + + P + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------- 256
Query: 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458
++ + P A + DI C +P +RPT + I + +++Q S
Sbjct: 257 --------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
Query: 459 KSS 461
++
Sbjct: 309 STN 311
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-36
Identities = 56/301 (18%), Positives = 112/301 (37%), Gaps = 36/301 (11%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH 235
+F + G V+++ S + + L + I ++ L
Sbjct: 7 DFEKISELGAGNGGVVFKVS---HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 236 PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLT 295
P + G DG + + E + GSLD+++ I K+++ +GLT
Sbjct: 64 PYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 118
Query: 296 FLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLE 355
+L E+ M+ + +NI ++ KL +G +G + ++ ++ + +S E L+
Sbjct: 119 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 356 RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-------------------- 395
+ +S++WS G+ L+E+ GR + KE +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 396 ------WSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIF 449
SRP +A L I++ + D +CL K P+ER ++ +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 450 E 450
Sbjct: 297 V 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 6e-36
Identities = 60/309 (19%), Positives = 114/309 (36%), Gaps = 52/309 (16%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLAS 232
+N R I EG +++A V L S+ +F + +A
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 233 LQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS------------------- 273
+PN+ KLLG A L++E + +G L+ + S
Sbjct: 73 FDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 274 --DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331
PP+ ++ IA A G+ +L E ++ + +T N + ++ K++ +G +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLS 187
Query: 332 GHIPETDISNSS----VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHP 387
+I D + + + E++ T +S+VW++G+VL E+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 388 KEE--RNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTM 445
EE + + ++C L L ++ C K P++RP+
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELY------------------NLMRLCWSKLPADRPSF 289
Query: 446 RSIFEELDR 454
SI L R
Sbjct: 290 CSIHRILQR 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-36
Identities = 53/284 (18%), Positives = 108/284 (38%), Gaps = 36/284 (12%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ 234
+ + + +G ++ ++ + L P + + F+ + + L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTMSPEAFLQEAQVMKKLR 70
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGL 294
H L +L + + ++ E + GSL + G G + V +A A G+
Sbjct: 71 HEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGM 126
Query: 295 TFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANL---SV 351
++ + + ANI + ++ K++ +G A I + + + A + +
Sbjct: 127 AYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI- 410
E G T KS+VWSFGI+L EL T R ++
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKG------------------RVPYPGMVNREVLD 225
Query: 411 -MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
++ + P + ++ D+ +C +KEP ERPT + L+
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-35
Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 35/278 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ +G +Y+A + TS A V S + +++++ +++ LAS HPN+ K
Sbjct: 18 GELGDGAFGKVYKAQ---NKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVK 73
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
LL + + ++ E G++D ++ P+ + + L +LH+
Sbjct: 74 LLDAFYYE--NNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSV-------AAANLSVET 353
++ + NI D KL+ +G + T S A + ET
Sbjct: 130 K---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 354 LERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSRPFLADDCRLSLIMD 412
+ K++VWS GI L+E+ +P + K P LA R S
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS---- 242
Query: 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
K D +CL+K R T + +
Sbjct: 243 SNFK------------DFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-35
Identities = 59/308 (19%), Positives = 117/308 (37%), Gaps = 42/308 (13%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLAS 232
++ I EG + +A + +A + R+ S ++F ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKAR---IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 233 L-QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR-------------SDGPPI 278
L HPN+ LLG G L E HG+L + S +
Sbjct: 67 LGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 279 DWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD 338
+ A A+G+ +L ++ ++ + + NI + +++ AK++ +G +
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 339 ISNSSVAAAN-LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWS 397
+++E+L + T S+VWS+G++L E+++ P +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELY 236
Query: 398 RPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR-QE 456
+ + PL V D+ +C +++P ERP+ I L+R E
Sbjct: 237 E-----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 457 SRKSSSST 464
RK+ +T
Sbjct: 286 ERKTYVNT 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 50/279 (17%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 181 RCISEGLSSVMYRASF-GDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
+ + G +Y+ + + R S + KE +++ +AS+ +P++C
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
+LLG + LI + + G L L Y R I + + A+G+ +L +
Sbjct: 75 RLLGICL---TSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAA----ANLSVETLE 355
++ + + N+ + K++ +G A + + + +++E++
Sbjct: 130 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 356 RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415
+ T +S+VWS+G+ + EL+T P E +S I++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEKGE 230
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ P V I ++C + RP R + E +
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 4e-35
Identities = 51/307 (16%), Positives = 111/307 (36%), Gaps = 41/307 (13%)
Query: 165 FPLDEVAAACHNFFS---------DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP 215
F ++ A F ++ I G + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
+ + ++F+++ + + HPN+ L G + M+I E + +GSLD + R +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDS--FLRQND 122
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335
V + A G+ +L + ++ + + NI ++ + K+S +G + +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 336 ETDISNSSVAAAN-------LSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHP 387
+ + +A + E ++ T S+VWS+GIV+ E+++ G +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS 447
++ N ++ P+ + + L C QK+ + RP
Sbjct: 240 QDVINAIEQDYRL-----------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 448 IFEELDR 454
I LD+
Sbjct: 283 IVNTLDK 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-35
Identities = 53/281 (18%), Positives = 105/281 (37%), Gaps = 34/281 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP----SSQGVKEFINDVNTLASLQHP 236
+ +G V+ R + DA + K V L P + + +FI +VN + SL H
Sbjct: 14 EKLGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 237 NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
NL +L G + ++ E GSL + T + A+ A+G+ +
Sbjct: 72 NLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGY 126
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVE---- 352
L + ++ + + N+ + K+ +G +P+ D +
Sbjct: 127 LESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 353 -TLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
+L+ + S+ W FG+ L E+ T + P N + + RL
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQILHKIDKEGERLP--- 235
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
P + + ++ ++C +P +RPT ++ + L
Sbjct: 236 -------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-35
Identities = 40/283 (14%), Positives = 105/283 (37%), Gaps = 36/283 (12%)
Query: 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQH 235
+D + G + + K+ + + L + +E + + + L +
Sbjct: 12 IADIELGCGNFGSVRQGV---YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 236 PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLT 295
P + +L+G ++ ML+ E G L + + G+ I + ++ + G+
Sbjct: 69 PYIVRLIGVCQ---AEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMK 123
Query: 296 FLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVET-- 353
+L E+ ++ + + N+ + AK+S +G + + D ++ +A ++
Sbjct: 124 YLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 354 ---LERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409
+ + +S+VWS+G+ + E L+ G+K E ++ +
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--------- 231
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
P + + + C + +RP ++ + +
Sbjct: 232 --------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 7e-35
Identities = 46/279 (16%), Positives = 101/279 (36%), Gaps = 31/279 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
RCI EG +++ + + + + S ++F+ + T+ HP++ K
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L+G + +I E G L + R +D + + A + L +L +
Sbjct: 73 LIGVITEN---PVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK 127
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAA---ANLSVETLERG 357
++ + + N+ + + KL +G + ++ ++ +S ++ E++
Sbjct: 128 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMDPQL 415
T S+VW FG+ + E+L + + R + +C P L
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC------PPTL 238
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ +C +PS RP + +L
Sbjct: 239 Y------------SLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-34
Identities = 48/277 (17%), Positives = 90/277 (32%), Gaps = 28/277 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
I G + S K ++ K+ +++VN L L+HPN+
Sbjct: 10 YTIGTGSYGRCQKI---RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIY-GRSDGPPIDWNTRVKIALCAAQGLTFLH 298
+ + ++ E G L +I G + +D +++ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 299 EEGPFQA--MYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAA--ANLSVETL 354
++ + AN+ +D + KL +G A + + +S E +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 355 ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-ERNLVKWSRPFLADDCRLSLIMDP 413
R KS++WS G +L EL + KE + + +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY------SD 240
Query: 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+L +I R L + RP++ I E
Sbjct: 241 ELN------------EIITRMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-34
Identities = 50/294 (17%), Positives = 112/294 (38%), Gaps = 33/294 (11%)
Query: 168 DEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFIN 225
E+ +C + I G +Y+ + + A + L + + +F+
Sbjct: 2 TEIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA-IKTLKAGYTEKQRVDFLG 58
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVK 285
+ + H N+ +L G ++ M+I E + +G+LD+ + R V
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDK--FLREKDGEFSVLQLVG 114
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA 345
+ A G+ +L ++ + + NI ++ + K+S +G + + + + + +
Sbjct: 115 MLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 346 AANLSV-----ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPF 400
+ + E + T S+VWSFGIV+ E++T + E
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------- 221
Query: 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ ++ + P+ + + ++C Q+E + RP I LD+
Sbjct: 222 ------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-34
Identities = 41/282 (14%), Positives = 97/282 (34%), Gaps = 34/282 (12%)
Query: 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHP 236
D+ + G + + + K + + + E + + N + L +P
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 237 NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ +++G + ML+ E G L++ + + +++ + G+ +
Sbjct: 69 YIVRMIGICEAES---WMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKY 122
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV----- 351
L E ++ + + N+ + AK+S +G + + + + V
Sbjct: 123 LEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410
E + + KS+VWSFG+++ E + G+K E +++
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------- 229
Query: 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEEL 452
P R + D+ C + RP ++ L
Sbjct: 230 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 8e-34
Identities = 58/281 (20%), Positives = 103/281 (36%), Gaps = 37/281 (13%)
Query: 177 FFSD-RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLA 231
FSD R I G +Y A D S+ + +++ S + ++ I +V L
Sbjct: 16 LFSDLREIGHGSFGAVYFAR---DVRNSEVV--AIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAA 291
L+HPN + G + R+ L+ E + D L + P+ + A
Sbjct: 71 KLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGAL 125
Query: 292 QGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA-AANLS 350
QGL +LH ++ + NI + + KL +G A + + + A
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEV 182
Query: 351 VETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSRPFLADDCRLSL 409
+ ++ G K +VWS GI +EL + L + + ++ + P L
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH---- 238
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ + CLQK P +RPT + +
Sbjct: 239 -WSEYFR------------NFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-33
Identities = 51/274 (18%), Positives = 102/274 (37%), Gaps = 35/274 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS----SQGVKEFINDVNTLASLQHP 236
R + +G +Y A + + + L + + + +V + L+HP
Sbjct: 12 RPLGKGKFGNVYLAR---EKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 237 NLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
N+ +L G+ + LI E G++ R + S D A L++
Sbjct: 67 NILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSY 121
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER 356
H + ++ + N+ + K++ +G + H P + + L E +E
Sbjct: 122 CHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 357 GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416
+ K ++WS G++ E L G+ PF A+ + + +++
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGK------------------PPFEANTYQETYKRISRVE 220
Query: 417 GRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
FP D+ R L+ PS+RP +R + E
Sbjct: 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-33
Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 32/273 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
I +G S +Y A D +T ++ + ++N Q KE IN++ + ++PN+
Sbjct: 26 EKIGQGASGTVYTAM---DVATGQEV--AIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L + D+ ++ E L GSL ++ +D + Q L FLH
Sbjct: 81 NYLDSYLVG--DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS 134
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN--LSVETLERG 357
++ + + NI + D S KL+ +G I S++ ++ E + R
Sbjct: 135 NQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417
PK ++WS GI+ +E++ G + +P L+ + +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---------------ATNGTPEL 236
Query: 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ P K + D RCL + +R + + + +
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 52/302 (17%), Positives = 104/302 (34%), Gaps = 47/302 (15%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASL-QHPN 237
+ + G + A+ + T + V L + + ++++ + L H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR--------------------SDGPP 277
+ LLG LI+E +G L + + D
Sbjct: 103 IVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 278 IDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPET 337
+ + + A A+G+ FL + ++ + + N+ + K+ +G A I
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 338 D----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393
N+ + ++ E+L G+ T KS+VWS+GI+L E+ + N P +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-- 275
Query: 394 VKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
++ K P A + I C + +RP+ ++ L
Sbjct: 276 -------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
Query: 454 RQ 455
Q
Sbjct: 323 CQ 324
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-32
Identities = 55/294 (18%), Positives = 111/294 (37%), Gaps = 34/294 (11%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLAS 232
R + +G ++Y + + +N S + EF+N+ + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 233 LQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG-------PPIDWNTRVK 285
++ +LLG ++ ++I E + G L + P + ++
Sbjct: 80 FNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSS-- 343
+A A G+ +L+ ++ + + N + +DF+ K+ +G I ETD
Sbjct: 138 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 344 --VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401
+ +S E+L+ G+ T S+VWSFG+VL E+ T P + + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA-----EQPYQGLSNEQV----- 244
Query: 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455
L +M+ L P + ++ C Q P RP+ I + +
Sbjct: 245 -----LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-31
Identities = 48/293 (16%), Positives = 101/293 (34%), Gaps = 37/293 (12%)
Query: 181 RCISEGLSSVMYRASF--GDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
+ + G + A D +T + + + + + ++++ L + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP-------------PIDWNTRVK 285
L M+I E G+L + + + + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 286 IALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETD----ISN 341
+ A+G+ FL ++ + + NI + + K+ +G A I + +
Sbjct: 139 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 342 SSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL 401
+ + ++ ET+ + T +S+VWSFG++L E+ + P + + L
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----ASPYPGVKIDEEFCRRL 250
Query: 402 ADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+ R+ R P + L C EPS+RPT + E L
Sbjct: 251 KEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 8e-31
Identities = 55/296 (18%), Positives = 111/296 (37%), Gaps = 43/296 (14%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVT----RLNPSSQGVKEFINDVNTLASL-QH 235
+ + EG + A V + + + + + + I+++ + + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 236 PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGR-------------SDGPPIDWNT 282
N+ LLG +D +I E G+L + R + +
Sbjct: 79 KNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 283 RVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNS 342
V A A+G+ +L + ++ + + N+ + +D K++ +G A I D
Sbjct: 137 LVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 343 S----VAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398
+ + ++ E L + T +S+VWSFG++L E+ T + P EE
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 245
Query: 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
L ++ + P + + C PS+RPT + + E+LDR
Sbjct: 246 --------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-30
Identities = 44/275 (16%), Positives = 86/275 (31%), Gaps = 31/275 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ + EG + A + T + + + + + ++ L H N+ K
Sbjct: 11 QTLGEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
G + + L E G L I + + G+ +LH
Sbjct: 68 FYGHRREG--NIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAA----NLSVETLER 356
G + + N+ +D+ + K+S +G A + ++ E L+R
Sbjct: 123 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 357 G-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQL 415
+VWS GIVL +L G D + + + + +D
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK---KIDSAP 236
Query: 416 KGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ + L + PS R T+ I +
Sbjct: 237 L------------ALLHKILVENPSARITIPDIKK 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-30
Identities = 48/278 (17%), Positives = 95/278 (34%), Gaps = 33/278 (11%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEA-TVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
D I G +Y+ D T+ + + + + F + L LQHPN+
Sbjct: 14 DIEIGRGSFKTVYKGL---DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 239 CKLLGF--HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ G +L+ E + G+L + + +GL F
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQF 127
Query: 297 LHEEGPFQAMYNEFSTANIQI-DKDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVETL 354
LH P ++ + NI I S K+ G A + + + + ++ E
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMY 185
Query: 355 ERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPFLADDCRLSLIMD 412
E +V++FG+ +LE+ T + R + +P D +
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK-----VAI 239
Query: 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
P++K +I C+++ ER +++ +
Sbjct: 240 PEVK------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 111 bits (279), Expect = 6e-28
Identities = 51/273 (18%), Positives = 95/273 (34%), Gaps = 28/273 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ G V++R + + +T F A + P + ++ T++ L+HP L
Sbjct: 32 EELGTGAFGVVHRVT---ERATGNNF-AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L D + ++IYE + G L + + + V+ +GL +HE
Sbjct: 88 LHDAFEDDN--EMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 301 GPFQAMYNEFSTANIQIDKDFS--AKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERG 357
++ + NI S KL +G H+ + A + E E
Sbjct: 144 NY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417
+ +++WS G++ LL+G + E VK + D + K
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI--SEDGK- 257
Query: 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
D + L +P+ R T+ E
Sbjct: 258 -----------DFIRKLLLADPNTRMTIHQALE 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 9e-28
Identities = 41/298 (13%), Positives = 98/298 (32%), Gaps = 35/298 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ G +++R + S+ K + + +++ L +H N+
Sbjct: 11 EDLGRGEFGIVHRCV---ETSSKKTY--MAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L ++ ++I+E + + I + ++ V + L FLH
Sbjct: 66 LHESFESM--EELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 301 GPFQAMYNEFSTANIQIDKDFSA--KLSGYGCAGHIPETDISNSS-VAAANLSVETLERG 357
+ + NI S+ K+ +G A + D A + E +
Sbjct: 122 NI---GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417
+++ +++WS G ++ LL+G + ++ + + ++ + +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI--SIEAM- 235
Query: 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIF------EELDRQESRKSSSSTVRRAS 469
D R L KE R T ++++R ++ + RR
Sbjct: 236 -----------DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 108 bits (272), Expect = 6e-27
Identities = 58/273 (21%), Positives = 101/273 (36%), Gaps = 28/273 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ G V++R + +T + F A P N+++ + L HP L
Sbjct: 35 EELGSGAFGVVHRCV---EKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L + +LI E L G L I ++ + + A +GL +HE
Sbjct: 91 LHDAFEDK--YEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 301 GPFQAMYNEFSTANIQID--KDFSAKLSGYGCAGHIPETDISNSSVA-AANLSVETLERG 357
++ + NI + K S K+ +G A + +I + A A + E ++R
Sbjct: 147 SI---VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 358 LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKG 417
+ +++W+ G++ LL+G E VK +D S+ P+ K
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV--SPEAK- 260
Query: 418 RFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
D LQKEP +R T+ E
Sbjct: 261 -----------DFIKNLLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 45/284 (15%), Positives = 95/284 (33%), Gaps = 35/284 (12%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASL 233
+F + + EG S + A + +TS+++ + V + + ++ L
Sbjct: 9 DFKFGKILGEGSFSTVVLAR---ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
HP KL D ++ +G L + I D
Sbjct: 66 DHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSA 120
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN----L 349
L +LH + ++ + NI +++D +++ +G A + + + +
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 350 SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409
S E L S++W+ G ++ +L+ G PF A + L
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFRAGNEYLIF 219
Query: 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
+L+ FP K D+ + L + ++R +
Sbjct: 220 QKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 104 bits (261), Expect = 6e-26
Identities = 44/294 (14%), Positives = 96/294 (32%), Gaps = 45/294 (15%)
Query: 177 FFSD----RCISEGLSSVMYRASFGDDASTSKKF--------EATVTRLNPSSQGVKEFI 224
F+ + + G+SSV+ R T K++ + + +
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCI---HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 225 NDVNTLASLQ-HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTR 283
+V+ L + HPN+ +L + + + L+++ + G L + + +
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKET 112
Query: 284 VKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSS 343
KI + + LH+ ++ + NI +D D + KL+ +G + + +
Sbjct: 113 RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 169
Query: 344 VAAAN-------LSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW 396
+ + ++WS G+++ LL G R ++
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
Query: 397 SRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ Q + TV D+ R L +P +R T
Sbjct: 230 G--------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (261), Expect = 8e-26
Identities = 37/271 (13%), Positives = 84/271 (30%), Gaps = 23/271 (8%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
+ G S + A D T K N++ L ++HPN+
Sbjct: 15 DVLGTGAFSEVILAE---DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
L + LI + + G L I + ++ + +LH+
Sbjct: 72 LDDIYESG--GHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL 126
Query: 301 GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVETLERGLL 359
G + +D+D +S +G + + +++ ++ E L +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 360 TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRF 419
+ + WS G++ LL G + + + + + + +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--------------EYEFDSPY 232
Query: 420 PLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ + D ++K+P +R T +
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 9e-26
Identities = 51/300 (17%), Positives = 103/300 (34%), Gaps = 33/300 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS------QGVKEFINDVNTLASLQ 234
I EG +++A D +F A + R+ + + + L + +
Sbjct: 13 AEIGEGAYGKVFKAR---DLKNGGRFVA-LKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 235 HPNLCKLLGFHARDGSDQR---MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAA 291
HPN+ +L +D+ L++E + L + P + T +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLL 126
Query: 292 QGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA-AANLS 350
+GL FLH ++ + NI + KL+ +G A S V +
Sbjct: 127 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 351 VETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-RNLVKWSRPFLADDCRLSL 409
E L + ++WS G + E+ + ++ ++ +D +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 410 IM--------DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI-----FEELDRQE 456
+ Q +F D+ L+CL P++R + S F++L+R +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 103 bits (258), Expect = 1e-25
Identities = 55/284 (19%), Positives = 99/284 (34%), Gaps = 33/284 (11%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQHPNL 238
+ G S ++ A D + V R + + F + A+L HP +
Sbjct: 13 EILGFGGMSEVHLAR---DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 239 CKLLGFHARDGS--DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ + ++ E + +L +++ P+ +++ A Q L F
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 126
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA-----AANLSV 351
H+ G ++ + ANI I + K+ +G A I ++ S + A A LS
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
E + +S+V+S G VL E+LTG P +
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--------------VRE 229
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERP-TMRSIFEELDR 454
DP + + + L+ L K P R T + +L R
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (262), Expect = 2e-25
Identities = 40/279 (14%), Positives = 86/279 (30%), Gaps = 26/279 (9%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTS--KKFEATVTRLNPSSQGVKEFINDVNTLASL 233
+F R I G +Y D K + ++ ++ +++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
P + + D+ I + + G L + S A G
Sbjct: 65 DCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILG 119
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVET 353
L +H +Y + ANI +D+ ++S G A + S ++ E
Sbjct: 120 LEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 176
Query: 354 LERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412
L++G+ ++ +S G +L +LL G K++ + + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------------ 224
Query: 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451
P + + + LQ++ + R +
Sbjct: 225 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 5e-25
Identities = 51/277 (18%), Positives = 100/277 (36%), Gaps = 34/277 (12%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLA-S 232
+F + + +G ++ A T++ F + + V+ + + L+ +
Sbjct: 3 DFILHKMLGKGSFGKVFLAE---FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 233 LQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQ 292
+HP L + + + E L G L I D + A
Sbjct: 60 WEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIIL 114
Query: 293 GLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA--AANLS 350
GL FLH +G +Y + NI +DKD K++ +G D ++ ++
Sbjct: 115 GLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171
Query: 351 VETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410
E L + WSFG++L E+L G+ + +E + ++ PF
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL----- 226
Query: 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS 447
+ + K D+ ++ +EP +R +R
Sbjct: 227 -EKEAK------------DLLVKLFVREPEKRLGVRG 250
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 7e-25
Identities = 38/282 (13%), Positives = 81/282 (28%), Gaps = 29/282 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
R I G +Y + D + ++ + ++ + + +Q
Sbjct: 13 RKIGSGSFGDIYLGT---DIAAGEEV--AIKLECVKTK-HPQLHIESKIYKMMQGGVGIP 66
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
+ + +G D +++ E L D T + +A + ++H +
Sbjct: 67 TIRWCGAEG-DYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 301 G-------PFQAMYNEFSTANIQIDKDF--SAKLSGYGCAGHIPETDISNSSVAAANLSV 351
P + N+ DF + K HIP + N + A S+
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
T + + ++ S G VL+ G +R + ++S
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMS-TP 236
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453
L +P A C ++P + +
Sbjct: 237 IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 4e-23
Identities = 49/298 (16%), Positives = 105/298 (35%), Gaps = 40/298 (13%)
Query: 181 RCISEGLSSVMYRASFGDDASTS-----KKFEATVTRLNPSSQGVKEFINDVNTLASLQH 235
+ G +V+ + + ST K + T+ + ++ +V+ L +QH
Sbjct: 16 EELGSGQFAVVKKCR---EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 236 PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLT 295
PN+ L + + +LI E + G L + + + + G+
Sbjct: 73 PNVITLHEVY--ENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVY 127
Query: 296 FLHEEGPFQAMYNEFSTANIQIDKD----FSAKLSGYGCAGHIPETDISNSSVAAAN-LS 350
+LH Q + + NI + K+ +G A I + + ++
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 351 VETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410
E + L ++++WS G++ LL+G +E V
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------------- 230
Query: 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSI-----FEELDRQESRKSSSS 463
++ + + + + D R L K+P +R T++ + D Q++ S+ S
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWS 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.4 bits (239), Expect = 7e-23
Identities = 39/288 (13%), Positives = 80/288 (27%), Gaps = 37/288 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
R I EG V++ + + +++ + P + ++ T L
Sbjct: 11 RRIGEGSFGVIFEGT---NLLNNQQV---AIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE 300
+ + ++G +L+ + L D L G T A + +HE+
Sbjct: 65 NVYYFGQEG-LHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 301 GPFQAMYNEFSTANIQIDKDFS-----AKLSGYGCA---------GHIPETDISNSSVAA 346
+Y + N I + S + +G HIP + N S A
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 347 ANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406
+S+ T + + ++ + G V + L G + + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------K 231
Query: 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDR 454
+L FP P + +
Sbjct: 232 KQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 8e-23
Identities = 46/285 (16%), Positives = 95/285 (33%), Gaps = 28/285 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG----VKEFINDVNTLASLQHPNL 238
+ EG + +Y+A D +T++ +L S+ + + ++ L L HPN+
Sbjct: 6 LGEGQFATVYKAR---DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
LL L+++ + + + + + + L QGL +LH
Sbjct: 63 IGLLDAFGHK--SNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV---ETLE 355
+ ++ + N+ +D++ KL+ +G A + + +
Sbjct: 118 QHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 356 RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE-----ERNLVKWSRPFLADDCRLSLI 410
+ ++W+ G +L ELL L + L + D C L
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 411 MDPQLKGRFPL-----KAARTVADIALRCLQKEPSERPTMRSIFE 450
+ + PL A + D+ P R T +
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 1e-22
Identities = 38/291 (13%), Positives = 86/291 (29%), Gaps = 31/291 (10%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
I EG ++ A D + + + ++ L +H N+
Sbjct: 14 SYIGEGAYGMVCSAY---DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 241 LLGFHARDGSDQRMLIY--ERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
+ +Q +Y L L +L+ + + + +GL ++H
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH 126
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSV-----AAANLSVET 353
++ + +N+ ++ K+ +G A + + E
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 354 LERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412
+ T ++WS G +L E+L+ R +H ++ N + + + +I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 413 PQLKGRFPLKAARTV-------------ADIALRCLQKEPSERPTMRSIFE 450
L V D+ + L P +R +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 3e-22
Identities = 51/290 (17%), Positives = 104/290 (35%), Gaps = 25/290 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGL 294
HPN+ KLL ++ ++ + H L + + + I QGL
Sbjct: 60 HPNIVKLLDVIH---TENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGL 115
Query: 295 TFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV--- 351
F H + ++ + N+ I+ + + KL+ +G A + +
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 352 ETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
L + ++WS G + E++T R ++ + + + +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 412 DPQLKGRFPLKAARTVA-----------DIALRCLQKEPSERPTMRSIFE 450
P K FP A + + + + L +P++R + ++
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 93.4 bits (231), Expect = 6e-22
Identities = 46/285 (16%), Positives = 98/285 (34%), Gaps = 27/285 (9%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQHPNLC 239
I EG V+Y+A + + F RL +G+ I +++ L L+H N+
Sbjct: 8 EKIGEGTYGVVYKAQN----NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
KL + +L++E L L ++ T L G+ + H+
Sbjct: 64 KLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSV---ETLER 356
++ + N+ I+++ K++ +G A + +
Sbjct: 119 RRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 357 GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE-----RNLVKWSRPFLADDCRLS--- 408
+ ++WS G + E++ G ++ R L + + L
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 409 ---LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ +P F + D+ + L+ +P++R T + E
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 1e-21
Identities = 37/252 (14%), Positives = 73/252 (28%), Gaps = 21/252 (8%)
Query: 217 SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR----MLIYERLFHGSLDRLIYGR 272
Q + ++ + L H N+ +L F G + L+ + + +
Sbjct: 54 LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 273 SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYGCA 331
+ + L ++H G + + N+ +D D KL +G A
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 332 GHIPETDISNSSVAAA--NLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKE 389
+ + + S + + T +VWS G VL ELL G+ +
Sbjct: 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 390 ERNLV-----------KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKE 438
+ + + + I F + + R L+
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 439 PSERPTMRSIFE 450
P+ R T
Sbjct: 291 PTARLTPLEACA 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.2 bits (231), Expect = 1e-21
Identities = 44/275 (16%), Positives = 96/275 (34%), Gaps = 33/275 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNL 238
R + G ++ + + V + + V+ ++ L+ + HP +
Sbjct: 10 RTLGTGSFGRVHLIR---SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
++ G Q +I + + G L L+ P AA+ L
Sbjct: 67 IRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVA------KFYAAEVCLALE 118
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL 358
+Y + NI +DK+ K++ +G A ++P+ + ++ E +
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD-YIAPEVVSTKP 177
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
+ WSFGI++ E+L G + + + + R
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------------R 219
Query: 419 FPLKAARTVADIALRCLQKEPSERPT-MRSIFEEL 452
FP V D+ R + ++ S+R +++ E++
Sbjct: 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 2e-21
Identities = 41/277 (14%), Positives = 91/277 (32%), Gaps = 28/277 (10%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
+ + G++ + + + T +KF + L + +E + Q P++
Sbjct: 17 SQVLGLGINGKVLQIF---NKRTQEKF--ALKMLQDCPKARREV---ELHWRASQCPHIV 68
Query: 240 KLLGF--HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+++ + G +++ E L G L I R D +I + + +L
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYL 127
Query: 298 HEEGPFQAMYNEFSTANIQIDK---DFSAKLSGYGCAGHIPETDISNSSVAAAN-LSVET 353
H + + N+ + KL+ +G A + + ++ E
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 354 LERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413
L ++WS G+++ LL G S H +K +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------TRIRMGQY 234
Query: 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ + + V + L+ EP++R T+
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 7e-20
Identities = 42/271 (15%), Positives = 84/271 (30%), Gaps = 33/271 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNL 238
+ + +G + + +T + + + R + V + + L + +HP L
Sbjct: 11 KLLGKGTFGKVILVR---EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
L D+ + E G L + S L +LH
Sbjct: 68 TALKYAFQTH--DRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH 122
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA--AANLSVETLER 356
+Y + N+ +DKD K++ +G + + L+ E LE
Sbjct: 123 SRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 357 GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLK 416
+ W G+V+ E++ GR ++ + L+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------- 222
Query: 417 GRFPLKAARTVADIALRCLQKEPSERPTMRS 447
RFP + + L+K+P +R
Sbjct: 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 1e-19
Identities = 40/285 (14%), Positives = 93/285 (32%), Gaps = 23/285 (8%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHPNLC 239
+ + G + A D T K S+ K ++ L ++H N+
Sbjct: 24 QPVGSGAYGAVCSAV---DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 240 KLLG-FHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
LL F + D Y L + + + + + +GL ++H
Sbjct: 81 GLLDVFTPDETLDDFTDFY--LVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL 358
G ++ + N+ +++D K+ +G A L
Sbjct: 139 AAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV---------KWSRPFLADDCRLSL 409
T ++WS G ++ E++TG+ ++ + ++ + +D+ + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 410 IMDPQLKGRFPLKAARTVADIAL----RCLQKEPSERPTMRSIFE 450
P+L+ + + +A+ + L + +R T
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 2e-19
Identities = 43/298 (14%), Positives = 90/298 (30%), Gaps = 37/298 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHPNLC 239
I +G +++A T +K + +G + ++ L L+H N+
Sbjct: 16 AKIGQGTFGEVFKAR---HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 240 KLLGFHARDGS------DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
L+ S L+++ H L + ++ G
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNG 129
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANL---- 349
L ++H ++ + AN+ I +D KL+ +G A S + +
Sbjct: 130 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 350 ---SVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV------------ 394
L P ++W G ++ E+ T + + + L+
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 395 -KWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVA-DIALRCLQKEPSERPTMRSIFE 450
L + L ++K R A D+ + L +P++R
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 2e-19
Identities = 47/279 (16%), Positives = 83/279 (29%), Gaps = 43/279 (15%)
Query: 181 RCISEGLSSVMYRASFGDDASTS-----KKFEATVTRLNPSSQGVKEFINDVNTLASLQ- 234
+ G +Y S + K E +V L +
Sbjct: 10 PLLGSGGFGSVYSGI---RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 235 -HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQG 293
+ +LL + R D +LI ER ++ + +
Sbjct: 67 GFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEA 122
Query: 294 LTFLHEEGPFQAMYNEFSTANIQIDKD-FSAKLSGYGCAGHIPETDISNSSVAAANLSVE 352
+ H G ++ + NI ID + KL +G + +T ++ E
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 353 TLE-RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411
+ + VWS GI+L +++ G PF D+ I+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGD------------------IPFEHDEE----II 217
Query: 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
Q+ F + + + CL PS+RPT I
Sbjct: 218 RGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 1e-18
Identities = 39/278 (14%), Positives = 83/278 (29%), Gaps = 37/278 (13%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATV---TRLNPSSQGVKEFINDVNTLASLQHPN 237
+ + G ++ T K + V + ++ + + L ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 238 LCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
L + + + LI + + G L + R + + + + L
Sbjct: 90 FLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQ------IYVGEIVLAL 142
Query: 298 HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERG 357
+Y + NI +D + L+ +G + + + + +
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 358 LL-----TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR--LSLI 410
+ WS G+++ ELLTG PF D + + I
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA------------------SPFTVDGEKNSQAEI 244
Query: 411 MDPQLKGRFPL--KAARTVADIALRCLQKEPSERPTMR 446
LK P + + D+ R L K+P +R
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 1e-18
Identities = 47/286 (16%), Positives = 92/286 (32%), Gaps = 27/286 (9%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
I EG +++A + T + RL+ +GV + ++ L L+H N+
Sbjct: 8 EKIGEGTYGTVFKAK---NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
+L D + L++E D Y S +D +GL F H
Sbjct: 65 RLHDVLHSD--KKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 300 EGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAAN---LSVETLER 356
++ + N+ I+++ KL+ +G A S+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 357 GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE--RNLVKWSRPF----------LADD 404
L + ++WS G + EL + L + ++ + + + L D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450
+ K T D+ L+ P +R + +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.0 bits (204), Expect = 5e-18
Identities = 46/287 (16%), Positives = 95/287 (33%), Gaps = 27/287 (9%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEA-TVTRLNPSSQGVKEFINDVNTLASLQHPNLC 239
+ G + A D T + ++R S K ++ L ++H N+
Sbjct: 24 SPVGSGAYGSVCAAF---DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 240 KLLGFHARDGS---DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
LL S + + L L+ ++ + + + + +GL +
Sbjct: 81 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKY 136
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLER 356
+H ++ + +N+ +++D K+ +G A H + + L
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 357 GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLV------------KWSRPFLADD 404
++WS G ++ ELLTGR ++ L+ K A +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 405 CRLSLIMDPQLKGRFPLKAARTVA-DIALRCLQKEPSERPTMRSIFE 450
SL P++ A +A D+ + L + +R T
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 81.4 bits (200), Expect = 1e-17
Identities = 45/294 (15%), Positives = 94/294 (31%), Gaps = 40/294 (13%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLC 239
R + G S ++ A + + ++K V L P + K+ ++ L +L+ PN+
Sbjct: 41 RKLGRGKYSEVFEAI---NITNNEKV--VVKILKPVKK--KKIKREIKILENLRGGPNII 93
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L S L++E + + +L + + L + H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 300 EGPFQAMYNEFSTANIQID-KDFSAKLSGYGCAGHIPETDISNSSVAAANLSV--ETLER 356
G M+ + N+ ID + +L +G A N VA+ ++
Sbjct: 148 MGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 357 GLLTPKSNVWSFGIVLLELLTGRKNLDSRH---------------PKEERNLVKWSRPFL 401
+ ++WS G +L ++ ++ H + K++
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 402 ADDCRLSLIMDPQLKGRFPLKAARTVA-----DIALRCLQKEPSERPTMRSIFE 450
+ + RF + + D + L+ + R T R E
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 78.3 bits (192), Expect = 2e-16
Identities = 37/275 (13%), Positives = 86/275 (31%), Gaps = 33/275 (12%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNL 238
+ + G + + + + + ++ +N+ L ++ P L
Sbjct: 47 KTLGTGSFGRVMLVK---HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
KL + ++ E + G + + A +LH
Sbjct: 104 VKLEFSFKDN--SNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH 158
Query: 299 EEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGL 358
+Y + N+ ID+ +++ +G A + + A L+ E +
Sbjct: 159 SLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEA-LAPEIILSKG 214
Query: 359 LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGR 418
+ W+ G+++ E+ G PF AD K R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY------------------PPFFADQPIQIYEKIVSGKVR 256
Query: 419 FPLKAARTVADIALRCLQKEPSER-PTMRSIFEEL 452
FP + + D+ LQ + ++R +++ ++
Sbjct: 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.6 bits (182), Expect = 3e-15
Identities = 42/299 (14%), Positives = 99/299 (33%), Gaps = 40/299 (13%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQG-VKEFINDVNTLASLQHPNLC 239
+ I G ++ A DA + +Q K ++ + + H N+
Sbjct: 23 KPIGSGAQGIVCAAY---DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 240 KLLGFHARDGS---DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
LL + Q + + L +L ++I +D + G+
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKH 134
Query: 297 LHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA-AANLSVETLE 355
LH ++ + +NI + D + K+ +G A + + V + E +
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 356 RGLLTPKSNVWSFGIVLLELLTGR----------------KNLDSRHPKEERNLVKWSRP 399
++WS G ++ E++ + + L + P+ + L R
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 400 FLADDCRLSLIMDPQLKGRFPLKAARTVA--------DIALRCLQKEPSERPTMRSIFE 450
++ + + + + P+L A D+ + L +P++R ++ +
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.2 bits (160), Expect = 2e-12
Identities = 47/315 (14%), Positives = 89/315 (28%), Gaps = 51/315 (16%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCK 240
R + G S ++ A D + + + + +++ L + + K
Sbjct: 19 RKLGWGHFSTVWLAK---DMVNNTHV--AMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 241 LLGFHAR-----------DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALC 289
A G + ++ G + + + I +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 290 AAQGLTFLHEEGPFQAM----YNEFSTANIQIDKDFSAKLSGYGCAGHIPETDISNSSVA 345
GL ++H N + K++ G A E NS
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-NSIQT 192
Query: 346 AANLSVETLERGLLTPKSNVWSFGIVLLELLTGR------------KNLDSRH------- 386
S E L +++WS ++ EL+TG K+ D
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 387 --PKEERNLVKWSRPFLADDCRLSLIMDPQL---------KGRFPLKAARTVADIALRCL 435
P K++R F L I + K +F A+ ++D L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 436 QKEPSERPTMRSIFE 450
Q +P +R +
Sbjct: 313 QLDPRKRADAGGLVN 327
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 473 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.07 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 94.09 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-55 Score=424.13 Aligned_cols=271 Identities=18% Similarity=0.327 Sum_probs=208.1
Q ss_pred CCHHHHHHHhcc---------cccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC
Q 011995 165 FPLDEVAAACHN---------FFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH 235 (473)
Q Consensus 165 ~~~~el~~~~~~---------f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H 235 (473)
++++++..++.+ |+..+.||+|+||+||+|.+..+......++++...........+.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 455566555544 45568999999999999997654333333344443333445566789999999999999
Q ss_pred CCcccceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCce
Q 011995 236 PNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANI 315 (473)
Q Consensus 236 pnIv~l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NI 315 (473)
||||+++|++... +.+++|||||++|+|.+++.. ....++|..++.++.||+.||+|||+++ ||||||||+||
T Consensus 87 pnIv~l~g~~~~~--~~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NI 159 (299)
T d1jpaa_ 87 PNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNI 159 (299)
T ss_dssp TTBCCEEEEECSS--SSCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCccEEEEEeeC--CEEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceE
Confidence 9999999999766 789999999999999998864 3456999999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeccCCCcccCCCCc-------cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCCh
Q 011995 316 QIDKDFSAKLSGYGCAGHIPETDI-------SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHP 387 (473)
Q Consensus 316 Ll~~~~~vkl~DFGla~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~ 387 (473)
||+.++.+||+|||+++.+..... ....+|+.|||||.+.++.++.++|||||||++|||+| |+.||.+...
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999987643321 12346789999999999999999999999999999998 8999988766
Q ss_pred HHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 388 KEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
.+....+... .+...+..++.++.+|+.+||+.||.+|||+.||++.|+++.+..
T Consensus 240 ~~~~~~i~~~-----------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 240 QDVINAIEQD-----------------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHcC-----------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 5443333211 111224456788999999999999999999999999999987643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=410.81 Aligned_cols=247 Identities=20% Similarity=0.306 Sum_probs=210.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||+||+|+...+ ...+++|+.... ........+.+|+++|+.++|||||++++++.++ +.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCC---CcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CE
Confidence 6799999999999999999996543 355666665432 1233456789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++.
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred EEEEEeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceee
Confidence 99999999999999999543 46999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
...........||+.|||||++.+..++.++|||||||++|||++|+.||.+....+....+....
T Consensus 155 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-------------- 220 (263)
T d2j4za1 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------------- 220 (263)
T ss_dssp CCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------------
T ss_pred ecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 877666667789999999999999999999999999999999999999998876555443332111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..++..++.++.+|+.+||+.||.+|||++|+++
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1124456688999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=411.62 Aligned_cols=258 Identities=19% Similarity=0.337 Sum_probs=205.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC-CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN-PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|...+.||+|+||+||+|++.+ .+++|+.+.. ......+.|.+|+++|++++|||||+++|++.. +.+
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEE
Confidence 578889999999999999998543 2456655443 245567889999999999999999999998753 568
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+||||||++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceee
Confidence 9999999999999999643 346999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCC----CccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 334 IPET----DISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 334 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
.... ......+|+.|||||++.+ +.|+.++|||||||++|||+||+.||.+..............
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~-------- 225 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG-------- 225 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT--------
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC--------
Confidence 6432 2234578999999999964 347899999999999999999999998765544322111100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
...+.+ ...+.+++.++.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 226 ---~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 226 ---YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 001110 112445668899999999999999999999999999988753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=407.07 Aligned_cols=254 Identities=19% Similarity=0.341 Sum_probs=200.9
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||+||+|.+.++. .+++ |.+.......++|.+|++++++++|||||+++|+|..+ +..+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~----~vAv--K~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~ 76 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKD----KVAI--KTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APIC 76 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTE----EEEE--EECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCC----EEEE--EEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC--CceE
Confidence 47888899999999999999986542 3344 44444555667899999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 77 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred EEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheec
Confidence 999999999999998643 456899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ....+|+.|||||++.+..++.++|||||||++|||+| |.+||......+....+...
T Consensus 152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------------- 218 (263)
T d1sm2a_ 152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------------- 218 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-------------
T ss_pred cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-------------
Confidence 54332 23467899999999999999999999999999999999 56666655544333322211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.+...+..++.++.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 219 ----~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 ----FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 01112344567899999999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=410.79 Aligned_cols=251 Identities=17% Similarity=0.164 Sum_probs=202.1
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||+||+|+...+ ++.+|+|+..........+.+.+|+++|++++|||||++++++.++ +..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCC---CCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--cee
Confidence 46899999999999999999996543 4566777776554445567899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
||||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhee
Confidence 999999999999999943 346999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCC----CccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPET----DISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~----~~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
.... .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||...............
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~----------- 221 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----------- 221 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-----------
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----------
Confidence 6432 2345679999999999988776 57899999999999999999999765432221111000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
..........++.++.+|+.+||+.||++|||++|+++
T Consensus 222 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 222 ----KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000112345688899999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-53 Score=411.66 Aligned_cols=259 Identities=18% Similarity=0.298 Sum_probs=211.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||+||+|.+.++ ...+|+|+ +.......++|.+|+++|++++|||||+++|+|.++ +..
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~---~~~vAvK~--i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 88 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPF 88 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGG---TEEEEEEE--CCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCC---CeEEEEEE--ECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC--Cee
Confidence 45788889999999999999996543 34444544 444445567899999999999999999999999766 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+|||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999999654 3457999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCC-CCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNL-DSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
...... ....+++.|||||++.++.++.++|||||||++|||++|..|| .+.........+..
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~------------- 231 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------- 231 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-------------
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-------------
Confidence 754432 2335678999999999999999999999999999999976655 44333332222211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
.....++..++.++.+|+.+||+.||.+|||+.+|++.|+.+.+..+
T Consensus 232 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 232 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred ----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence 11122345567889999999999999999999999999998876544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-54 Score=420.61 Aligned_cols=272 Identities=20% Similarity=0.299 Sum_probs=210.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||+||+|.... ++..+|+|+............+.+|+.+|+.++|||||+++++|.++ +.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 5789999999999999999998644 34667777776655556677899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEE-GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
|||||||++|+|.+++.+. ..+++..+..++.|++.||.|||++ + ||||||||+||||+.++.+||+|||+|+
T Consensus 80 ~iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 9999999999999999643 3699999999999999999999974 7 9999999999999999999999999998
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhh-cccccc---------
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKW-SRPFLA--------- 402 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~--------- 402 (473)
..........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.......... ......
T Consensus 154 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 7755555667899999999999999999999999999999999999999987654322111000 000000
Q ss_pred ---------cc-------cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 011995 403 ---------DD-------CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQE 456 (473)
Q Consensus 403 ---------~~-------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~ 456 (473)
+. .....+.............+.++.+|+.+||+.||.+|||++|+|+. |++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00 00000000000000012346789999999999999999999999983 55433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=405.50 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=207.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||+||+|... .++..+|+|+..... ....+.+.+|+++|+.++|||||++++++.++ +.+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~---~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBT---TTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred cccEEEEEEecCcCcEEEEEEEC---CCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEE
Confidence 36999999999999999999844 345567777765442 22356789999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||||||++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.+
T Consensus 94 ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 99999999999998854 25999999999999999999999999 999999999999999999999999999876
Q ss_pred CCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+....
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-------------- 232 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-------------- 232 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------------
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 433 3345579999999999999999999999999999999999999998766554332221100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 233 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 233 -TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011224456788999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=405.70 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=206.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|+..+.||+|+||.||+|.+.++. .+|+|+ +.......+.|.+|+++|++++|||||+++|++.+ +..
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~----~vAvK~--~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~ 82 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHT----KVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPI 82 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTE----EEEEEE--ECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCC----EEEEEE--EccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCe
Confidence 357888899999999999999986542 344444 44444556789999999999999999999998854 567
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+|||||+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp EEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEE
Confidence 9999999999999987543 2345999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCC-CCCCCCChHHHHhHhhhccccccccccccc
Q 011995 334 IPETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGR-KNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 334 ~~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
..... .....+|+.|||||++.++.++.++|||||||++|||+||. +||......+....+...
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~------------ 226 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------------ 226 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc------------
Confidence 75443 23456788999999999999999999999999999999954 555554443332222110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
.+...+..++.++.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 227 -----~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 -----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111244566789999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=404.67 Aligned_cols=257 Identities=16% Similarity=0.279 Sum_probs=209.1
Q ss_pred cccccCcc-eeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRC-ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~-lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|..... ||+|+||+||+|.+.... ....+|+|+..........++|.+|+++|++++|||||+++|++.. +.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 45666664 999999999999875432 2234556655544455567889999999999999999999999864 468
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|||||||++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 84 ~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999999843 3456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
+..... ....+|+.|||||++.++.++.++|||||||++|||+| |+.||.+....+....+...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---------- 228 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---------- 228 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT----------
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 654321 23467889999999999999999999999999999998 99999877655433333211
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
.+..++..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 229 -------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 -------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0112345567889999999999999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-53 Score=414.41 Aligned_cols=258 Identities=19% Similarity=0.294 Sum_probs=206.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCe--eeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS--TSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
++|+..+.||+|+||+||+|++..... ....+++|+............+.+|+.+|.++ +|||||+++|++.+. +
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--G 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--C
Confidence 578889999999999999999754433 33444555444334455567899999999998 899999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSD--------------------GPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFS 311 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlk 311 (473)
.++||||||++|+|.++|..+.. ...+++..++.++.||+.||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 89999999999999999975421 245899999999999999999999999 9999999
Q ss_pred CCceeeCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCC
Q 011995 312 TANIQIDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRH 386 (473)
Q Consensus 312 p~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~ 386 (473)
|+|||++.++.+||+|||+|+....... ....+|+.|||||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987644322 24467899999999999999999999999999999998 899998765
Q ss_pred hHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 011995 387 PKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELD 453 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 453 (473)
.......+. ....+...+..++.++.+||.+||+.||++|||++||++.|.
T Consensus 272 ~~~~~~~~~----------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDANFYKLI----------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHHHHHHH----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHH----------------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 433221111 011112235566789999999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=405.10 Aligned_cols=261 Identities=18% Similarity=0.310 Sum_probs=203.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
..|+..++||+|+||.||+|.+..+.. ....+++|+...........+|.+|+.+|++++|||||+++|++.+. +..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--Cce
Confidence 457888999999999999999765432 23345555554444455566899999999999999999999999766 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++||||+.+|+|.+++... ...++|..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999988543 456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC-----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCC-CCCCChHHHHhHhhhccccccccccc
Q 011995 334 IPETD-----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKN-LDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 334 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
..... .....+|+.|||||++.++.++.++|||||||++|||++|..| +......+....+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~----------- 228 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----------- 228 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----------
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-----------
Confidence 64332 1233578899999999999999999999999999999996555 444443332222211
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
..+...+..++..+.+||.+||+.||++||||.||++.|+++.+..
T Consensus 229 ------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 229 ------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 1112234456688999999999999999999999999999887643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=405.96 Aligned_cols=256 Identities=18% Similarity=0.245 Sum_probs=198.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|++.+.||+|+||+||+|+...+ ++.+|+|+..... .....+.+.+|+++|++++|||||++++++.+...+.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT---CCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCC---CCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 6899999999999999999986543 4566677665543 33445678999999999999999999999876555778
Q ss_pred EEEEEeccCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCC--CceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 254 MLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQGLTFLHEEGP--FQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~--~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
|||||||++|+|.+++.... ....+++..+..++.||+.||.|||+++. .+||||||||+||||+.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999999985421 24579999999999999999999998752 2499999999999999999999999999
Q ss_pred CcccCCCC--ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 331 AGHIPETD--ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 331 a~~~~~~~--~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
++.+.... .....+|+.|||||++.+..++.++|||||||++|||+||+.||.+....+....+....
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~---------- 230 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---------- 230 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----------
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 98775432 245678999999999999999999999999999999999999998766554333222110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
. ..++..++.++.+|+.+||+.||.+|||+.||++
T Consensus 231 ------~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 ------F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 1124456688999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=394.79 Aligned_cols=251 Identities=16% Similarity=0.291 Sum_probs=209.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||+||+|+++++ ..+|+|+.+. .....++|.+|+.++++++|||||+++|+|.++ +.++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~l~~--~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~ 75 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIF 75 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTT----EEEEEEEEES--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCC----CEEEEEEECc--CcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceE
Confidence 5789999999999999999998643 3344554443 344567899999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ...+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 76 iv~Ey~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp EEEECCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred EEEEccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheec
Confidence 999999999999997543 346899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+....+...
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~------------- 217 (258)
T d1k2pa_ 151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------------- 217 (258)
T ss_dssp SSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-------------
T ss_pred cCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-------------
Confidence 54432 23467889999999999999999999999999999998 89999887765543333211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
.+...+..++.++.+||.+||+.||++|||+++|++.|.++
T Consensus 218 ----~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 ----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 01122445568899999999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=405.11 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=206.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
+.|++.+.||+|+||+||+|....+ +..+|+|+.... .....+.+.+|+++|++++|||||++++++.++ +..+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~---~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCC---CeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEE
Confidence 4588889999999999999996543 345566665433 445568899999999999999999999999876 7899
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
||||||++|+|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||++...
T Consensus 86 lvmEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 999999999999987542 346999999999999999999999999 999999999999999999999999999765
Q ss_pred CCC--CccCcccccccCChhhhh-----cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 335 PET--DISNSSVAAANLSVETLE-----RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 335 ~~~--~~~~~~~t~~y~aPE~~~-----~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
... ......||+.|||||++. +..|+.++|||||||++|||++|+.||.+....+....+....+
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-------- 232 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------- 232 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--------
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 332 234567899999999984 44589999999999999999999999988765544332221100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
+ ....+..++.++.+||.+||+.||.+|||+.|+++.
T Consensus 233 -----~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 -----P--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----C--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----C--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 011244567889999999999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=397.67 Aligned_cols=249 Identities=16% Similarity=0.295 Sum_probs=203.4
Q ss_pred cceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
+.||+|+||+||+|.+.+.. +.+.+|+|+..... .....++|.+|+++|++++|||||+++|+|.. +..+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEc
Confidence 57999999999999875433 45666777665432 34456789999999999999999999999864 467999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 339 (473)
+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 89 ~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 89 AELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp CTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999999999643 46999999999999999999999999 99999999999999999999999999987643321
Q ss_pred -----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 340 -----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 340 -----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
....+|+.|||||.+.+..++.++|||||||++|||+| |+.||.+....+....+...
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~---------------- 226 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---------------- 226 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------------
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC----------------
Confidence 23467899999999999999999999999999999998 89999887655433333211
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQE 456 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 456 (473)
.+..++..++.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 227 -~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 227 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 111234556788999999999999999999999999888653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=399.43 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=199.4
Q ss_pred ccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeec--CCCCceE
Q 011995 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHAR--DGSDQRM 254 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~~~ 254 (473)
+....||+|+||+||+|....+ ...+++|+..... .....+.|.+|+++|++++|||||++++++.+ .+...+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~---~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTT---CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCC---CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 5567899999999999996543 3455566554432 34456779999999999999999999999864 2335689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC-CCCcEEEeccCCCcc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID-KDFSAKLSGYGCAGH 333 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~ 333 (473)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||++++ +||||||||+||||+ .++.+||+|||+++.
T Consensus 89 ivmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999999543 469999999999999999999999863 499999999999996 579999999999987
Q ss_pred cCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhhhcccccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 412 (473)
..........||+.|||||++.+ .++.++|||||||++|||++|+.||.+....... ..+...
T Consensus 165 ~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~--------------- 228 (270)
T d1t4ha_ 165 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--------------- 228 (270)
T ss_dssp CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT---------------
T ss_pred ccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC---------------
Confidence 66655566789999999999865 5999999999999999999999999765443321 111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....++...+.++.+||.+||+.||++|||+.|+++
T Consensus 229 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 -VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0001112334567899999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=397.99 Aligned_cols=259 Identities=18% Similarity=0.313 Sum_probs=203.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||+|++..+......+++++..........+.|.+|+.+|++++|||||+++|++.+ +.++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeEE
Confidence 5789999999999999999998665544444555544433445556789999999999999999999999853 6789
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 84 iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999987543 356899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC---ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETD---ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~---~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+....+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~------------- 225 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------- 225 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------------
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 4332 234467899999999999999999999999999999998 89999877655443322211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
....++..++.++.+||.+||..||.+|||+.||++.|+.+.+.
T Consensus 226 ----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01123456678899999999999999999999999999987643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-52 Score=404.59 Aligned_cols=253 Identities=15% Similarity=0.176 Sum_probs=192.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+.|+..+.||+|+||+||+|.... +.+.+|+|+............+.+|+.+|+.++|||||++++++.++ +.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 4669999999999999999998654 34566777766544344456788999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC---CCCcEEEeccCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGC 330 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGl 330 (473)
|||||||++|+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+|||+. .++.+||+|||+
T Consensus 83 ~lvmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEEEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccce
Confidence 999999999999999954 346999999999999999999999999 99999999999994 578999999999
Q ss_pred CcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 331 AGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 331 a~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
++...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+....
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~----------- 225 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE----------- 225 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC-----------
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------
Confidence 98765443 345679999999999999999999999999999999999999998876555433332111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..........++.++.+|+.+||++||++|||+.|+++.
T Consensus 226 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 ---YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011112234567889999999999999999999999873
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=404.62 Aligned_cols=248 Identities=17% Similarity=0.206 Sum_probs=205.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||+||+|.... +++.+|+|+..... .....+.+.+|+++|++++|||||++++++.++ +.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CE
Confidence 679999999999999999998644 34566777665321 233456789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
+||||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccce
Confidence 99999999999999988543 46999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCC----CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 333 HIPET----DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 333 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
.+... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~---------- 226 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE---------- 226 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC----------
T ss_pred ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC----------
Confidence 76432 2234578999999999999999999999999999999999999998876554433222110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++..++.++.+||.+||+.||.+|||++|+++.
T Consensus 227 --------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 --------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 12344566889999999999999999999997543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-51 Score=399.12 Aligned_cols=266 Identities=21% Similarity=0.322 Sum_probs=216.2
Q ss_pred HHHHhcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeec
Q 011995 170 VAAACHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247 (473)
Q Consensus 170 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 247 (473)
++.-.++|+..+.||+|+||+||+|++.+ +......+|+|+..........++|.+|+++|++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 33345789999999999999999999754 2344566666665544455556789999999999999999999999976
Q ss_pred CCCCceEEEEEeccCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCcee
Q 011995 248 DGSDQRMLIYERLFHGSLDRLIYGRS---------------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAM 306 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iv 306 (473)
. +..++||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ ||
T Consensus 88 ~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 88 G--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred C--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 5 78999999999999999996432 1235899999999999999999999999 99
Q ss_pred ecCCCCCceeeCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCC-CC
Q 011995 307 YNEFSTANIQIDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGR-KN 381 (473)
Q Consensus 307 HrDlkp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~-~p 381 (473)
||||||+||||+.++.+||+|||+++...... .....+++.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999997654332 23456788999999999999999999999999999999985 67
Q ss_pred CCCCChHHHHhHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 382 LDSRHPKEERNLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
|.+....+....+.... ....+..++.++.+|+.+||+.||++||||.||++.|++|.+
T Consensus 243 ~~~~~~~e~~~~v~~~~-----------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGN-----------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTSCHHHHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCHHHHHHHHHcCC-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 87776655443332110 011244556789999999999999999999999999998853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=399.66 Aligned_cols=265 Identities=19% Similarity=0.294 Sum_probs=204.4
Q ss_pred hcccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGS 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 250 (473)
.++|+..+.||+|+||.||+|.+.. ...+++.+|+|+..........+.+.+|+.++.++ +|+|||.+++++...+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~- 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-
Confidence 3689999999999999999998754 34456777777655444555567788898888887 7899999999886653
Q ss_pred CceEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceee
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQI 317 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl 317 (473)
..+++|||||++|+|.++|.... ....+++..++.++.||+.||+|||+++ ||||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 67899999999999999996532 1245899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcC-CCCCCCCChHHHHh
Q 011995 318 DKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTG-RKNLDSRHPKEERN 392 (473)
Q Consensus 318 ~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG-~~p~~~~~~~~~~~ 392 (473)
+.++.+||+|||+++...... .....||+.|||||++.++.++.++|||||||++|||+|| .+||.+........
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998664332 2345789999999999999999999999999999999986 56787654333221
Q ss_pred HhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 393 LVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.. +..+ .....+..++.++.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus 248 ~~------~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 248 RR------LKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH------HHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH------HhcC----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 0000 11122445668899999999999999999999999999988643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-51 Score=403.89 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=208.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|++.+.||+|+||.||+|+... ++..+++|+.... .....+.+.+|+.+|++++|||||++++++.++ +.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 4689999999999999999998654 3455666665433 334457789999999999999999999999876 889
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC--CCCcEEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID--KDFSAKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~vkl~DFGla 331 (473)
|||||||++|+|.+++.. ....+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||++
T Consensus 99 ~ivmE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EEEECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 999999999999999854 2346999999999999999999999999 99999999999996 4588999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
+.+.... .....+|+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----------- 242 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------- 242 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------
T ss_pred eecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 8775443 3446889999999999999999999999999999999999999988766554433321110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
.........++.++.+||.+||+.||++|||+.|+++.
T Consensus 243 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111123456889999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-51 Score=401.48 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=202.4
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC--ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS--SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.|+..+.||+|+||+||+|+...+ ++.+|+|+...... ....+.+.+|+.+|++++|||||++++++.++ +..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTT---TEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCC---CcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEE
Confidence 488889999999999999986543 45667776655432 33456799999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|||||||.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||++..
T Consensus 91 ~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccc
Confidence 999999999999876643 346999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCccCcccccccCChhhhhc---CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 334 IPETDISNSSVAAANLSVETLER---GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 334 ~~~~~~~~~~~t~~y~aPE~~~~---~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
... .....||+.|||||++.+ +.|+.++|||||||++|||++|..||.+....+....+....
T Consensus 165 ~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~------------ 230 (309)
T d1u5ra_ 165 MAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------ 230 (309)
T ss_dssp SSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred cCC--CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------------
Confidence 643 345679999999999864 458999999999999999999999998766554332221100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.+.+ .+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 231 -~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 -SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0011 12345678999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=393.62 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=203.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|++.+.||+|+||.||+|++.++. .+|+| .+.......+.|.+|+.+|++++|||||+++|++.+ +..+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~----~vAiK--~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~ 87 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTT----RVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 87 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTE----EEEEE--ECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCC----EEEEE--EECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeE
Confidence 57999999999999999999976542 34444 444455556789999999999999999999999853 5679
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|..++... ....++|..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhc
Confidence 999999999999988643 2346999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCc---cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCC-CCCCChHHHHhHhhhcccccccccccccc
Q 011995 335 PETDI---SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKN-LDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 335 ~~~~~---~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..... ....+|+.|+|||++.++.++.++|||||||++|||++|..| +......+....+.+.
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~------------- 230 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------- 230 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------
Confidence 43322 334678999999999999999999999999999999996554 5554444333333211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhccc
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRK 459 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 459 (473)
.+...+..++.++.+||.+||+.||++|||+.+|++.|+.+....
T Consensus 231 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111234456688999999999999999999999999999877544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=398.57 Aligned_cols=258 Identities=19% Similarity=0.343 Sum_probs=207.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCe-eeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDAS-TSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.+|+..+.||+|+||+||+|.+..+.. ...++++|...........++|.+|+++|++++|||||+++|+|.+ +..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCe
Confidence 469999999999999999999764432 2334455544433445567889999999999999999999999975 467
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++++||+.+|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 8999999999999988653 457999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccccc
Q 011995 334 IPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLS 408 (473)
Q Consensus 334 ~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (473)
...... ....+|+.|||||++.++.++.++|||||||++|||+| |.+||.+....+....+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~----------- 229 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----------- 229 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-----------
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 654322 23357899999999999999999999999999999998 89999876654433333211
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 409 LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 409 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
.+...+..++.++.+|+.+||+.||.+|||+.||++.|+++..
T Consensus 230 ------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112245567889999999999999999999999999988753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-50 Score=402.14 Aligned_cols=253 Identities=20% Similarity=0.235 Sum_probs=209.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|++.+.||+|+||.||+|.... +++.+|+|+.... .......+.+|+.+|++++|||||++++++.++ +.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~ 101 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEM 101 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCc-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 4579999999999999999998543 3456677766543 223456788999999999999999999999876 889
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC--CCCcEEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID--KDFSAKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~vkl~DFGla 331 (473)
|||||||++|+|.+++.. ....+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||++
T Consensus 102 ~ivmE~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999999999988743 3456999999999999999999999999 99999999999998 6789999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
..+.... .....+|+.|||||++.+..++.++|||||||++|||+||+.||.+.........+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------ 244 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD------------ 244 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC------------
T ss_pred eecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 8876543 344578999999999999999999999999999999999999998876655443332111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..........++.++.+||.+||+.||.+|||+.|+++.
T Consensus 245 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 --WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112234567889999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=392.58 Aligned_cols=252 Identities=17% Similarity=0.228 Sum_probs=207.3
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-----CChhhHhHHHHHHHHHhCCCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-----SSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
.+.|+..+.||+|+||+||+|.... +++.+|+|+..... .....+.+.+|+.+|++++|||||++++++.++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3679999999999999999999654 34556677654432 122357799999999999999999999999876
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC----cEE
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF----SAK 324 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~vk 324 (473)
+.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+|
T Consensus 86 --~~~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 86 --TDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEE
T ss_pred --CEEEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceE
Confidence 8899999999999999999543 36999999999999999999999999 99999999999998776 499
Q ss_pred EeccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc
Q 011995 325 LSGYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD 403 (473)
Q Consensus 325 l~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 403 (473)
|+|||++...... ......+|+.|||||++.+..++.++|||||||++|||++|+.||.+....+....+.....
T Consensus 158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---- 233 (293)
T d1jksa_ 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY---- 233 (293)
T ss_dssp ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC----
T ss_pred ecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----
Confidence 9999999877544 34456789999999999999999999999999999999999999988766554333321110
Q ss_pred ccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 404 DCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 404 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
......+..++.++.+||.+||+.||.+|||++|+++
T Consensus 234 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000112245678999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=398.37 Aligned_cols=248 Identities=17% Similarity=0.239 Sum_probs=209.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|++.+.||+|+||.||+|+... +++.+|+|+..... .....+.+.+|+.+|+.++|||||++++++.++ +
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--S
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--c
Confidence 4689999999999999999998543 45677777765321 233457789999999999999999999999876 8
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+|||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccc
Confidence 99999999999999999854 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
+..... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+....
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----------- 221 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------- 221 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred cccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-----------
Confidence 876432 3345689999999999999999999999999999999999999999877655433332111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~ 450 (473)
..+|..++.++.+||.+||++||.+|++ ++|+++
T Consensus 222 -------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 -------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1234556788999999999999999994 888886
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=395.18 Aligned_cols=263 Identities=20% Similarity=0.327 Sum_probs=208.7
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||.||+|++.++.. ...++++.+.........+.|.+|+++|.++ +|||||+++|+|.+. +.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE-EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCe-EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Cee
Confidence 678888999999999999999755432 1223334333333445567899999999999 799999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 254 MLIYERLFHGSLDRLIYGR-------------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
++||||+++|+|.++|+.. .....+++..+..++.||+.||.|||+++ ||||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCC
Confidence 9999999999999999653 23467999999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCCcccCCCCc-cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCC-CCCCCCChHHHHhHhhhcc
Q 011995 321 FSAKLSGYGCAGHIPETDI-SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGR-KNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~-~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~ 398 (473)
+.+||+|||+++....... ....+|..|+|||.+.++.++.++|||||||++|||++|. +||.+....+....+..
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-- 241 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG--
T ss_pred CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--
Confidence 9999999999976643332 2346789999999999999999999999999999999965 57876655443332210
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
+ .+...+..++.++.+||.+||+.||++||||.||++.|+++.+...
T Consensus 242 -----~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 242 -----G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp -----T----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -----c----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 0 0112345567899999999999999999999999999999876554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=390.95 Aligned_cols=257 Identities=18% Similarity=0.297 Sum_probs=201.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|+..+.||+|+||.||+|++.........+|+|+.... ......++|.+|+.+|++++|||||+++|++.+ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 5789999999999999999987554433334444443322 234556789999999999999999999999964 46
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred hheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 78999999999999888543 346999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCc-----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhcccccccccc
Q 011995 333 HIPETDI-----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCR 406 (473)
Q Consensus 333 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (473)
....... ....++..|+|||.+.+..++.++|||||||++|||+| |..||.+....+....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--------- 230 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--------- 230 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---------
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC---------
Confidence 7744322 23356789999999999999999999999999999998 89999887665543322111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 011995 407 LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQ 455 (473)
Q Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 455 (473)
..+...+..++.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 231 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 -------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122445567899999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=390.48 Aligned_cols=257 Identities=19% Similarity=0.357 Sum_probs=202.0
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEEEEEe
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~lV~E~ 259 (473)
.++||+|+||+||+|++.++......+++|...........++|.+|+++|++++|||||+++|++.... ...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEEEEEE
Confidence 4689999999999999876543333344444433345556688999999999999999999999987542 578999999
Q ss_pred ccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccCCCCc
Q 011995 260 LFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIPETDI 339 (473)
Q Consensus 260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 339 (473)
|++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999864 3456789999999999999999999999 99999999999999999999999999987643322
Q ss_pred ------cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 340 ------SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 340 ------~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
....+|+.|+|||.+.++.++.++|||||||++|||+||..||........ ...+ +..+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~----i~~g~-------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY----LLQGR-------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTC--------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHcCC--------
Confidence 234578999999999999999999999999999999998887765332211 1110 00110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
+...+..++.++.+||.+||+.||++||++.||++.|+.+.+.
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1112345567899999999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=385.85 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=199.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceE
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM 254 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 254 (473)
++|+..+.||+|+||.||+|.+.+. .+++|+. . .....+.|.+|++++++++|||||+++|+|.++. +.++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~vAvK~i--~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~ 77 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGN-----KVAVKCI--K-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 77 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTE-----EEEEEEC--C-CCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred HHeEEeEEEecCCCeEEEEEEECCe-----EEEEEEE--C-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEE
Confidence 5788889999999999999997542 3444443 3 2344578999999999999999999999986542 5689
Q ss_pred EEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCccc
Q 011995 255 LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHI 334 (473)
Q Consensus 255 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 334 (473)
+||||+++|+|.++|..+ ....++|..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++..
T Consensus 78 lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence 999999999999999653 2235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHHhHhhhccccccccccccccccc
Q 011995 335 PETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMDP 413 (473)
Q Consensus 335 ~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
... .....++..|+|||++.++.++.++|||||||++|||+| |++||......+....+..
T Consensus 154 ~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~----------------- 215 (262)
T d1byga_ 154 SST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------------- 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----------------
T ss_pred CCC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-----------------
Confidence 433 234567889999999999999999999999999999998 7888877654443322210
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 414 QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 414 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
..+..++..++.++.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11223355566889999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-50 Score=393.19 Aligned_cols=248 Identities=18% Similarity=0.255 Sum_probs=208.5
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC--CCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN--PSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|++.+.||+|+||+||+|+... +++.+|+|+.... ......+.+.+|+.+|+.++|||||++++++.++ +
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--Q 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--S
T ss_pred hhHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--C
Confidence 3689999999999999999999644 3456677766532 1233457789999999999999999999999876 8
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|+|||||.+|+|..++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||++
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eeeeEeeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccc
Confidence 99999999999999998854 346889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccccc
Q 011995 332 GHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIM 411 (473)
Q Consensus 332 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (473)
+..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 152 ~~~~~~-~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------- 217 (316)
T d1fota_ 152 KYVPDV-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------- 217 (316)
T ss_dssp EECSSC-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------------
T ss_pred eEeccc-cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 876543 345689999999999999999999999999999999999999998876655443332111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011995 412 DPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFEE 451 (473)
Q Consensus 412 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 451 (473)
..++..++.++.+++.+||++||.+|+ |++++++.
T Consensus 218 -----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 122445568899999999999999996 89999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-50 Score=386.83 Aligned_cols=261 Identities=20% Similarity=0.238 Sum_probs=206.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC-
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS- 250 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~- 250 (473)
.++|++.+.||+|+||+||+|.... +++.+++|+..... .......|.+|+++|+.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 4679999999999999999998543 45667777765443 33445679999999999999999999999876532
Q ss_pred -CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 251 -DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 251 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...||||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++..+|+|||
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCT
T ss_pred CceEEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhh
Confidence 3489999999999999988543 46999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCC-----CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 330 CAGHIPET-----DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 330 la~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
++...... ......||+.|||||++.+..++.++|||||||++|||+||++||.+....+....+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~---- 232 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---- 232 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC----
Confidence 98755322 234457899999999999999999999999999999999999999887655443222111110
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhc
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-TMRSIFEELDRQES 457 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~l~~ 457 (473)
........++.++.+||.+||++||.+|| |++++++.|.++.+
T Consensus 233 ----------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 ----------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ----------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ----------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 00111234568899999999999999999 89999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=387.01 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=207.1
Q ss_pred cccccCcceeecCCceEEEEEECCCC----eeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDA----STSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDG 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 249 (473)
++|++.+.||+|+||.||+|+..... .....+|+|+...........++.+|+..+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~- 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD- 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-
Confidence 57888999999999999999864332 122344444443344445567899999999988 899999999999876
Q ss_pred CCceEEEEEeccCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRS-------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
+..++||||+++|+|.++|..+. ....+++..++.++.||+.||+|||+++ ||||||||+|||
T Consensus 92 -~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 92 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp -SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred -CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 78999999999999999996543 1346899999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHH
Q 011995 317 IDKDFSAKLSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEER 391 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~ 391 (473)
++.++.+||+|||+++...... .....+++.|+|||.+.++.|+.++|||||||++|||++ |.+||.+.......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999998764332 233567889999999999999999999999999999998 79999876655433
Q ss_pred hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 392 NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
..+... ....++..++.++.+||.+||+.||.+|||+.||++.|+++..
T Consensus 248 ~~i~~~-----------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KLLKEG-----------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTT-----------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcC-----------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 322211 1112244556789999999999999999999999999998854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=390.55 Aligned_cols=262 Identities=19% Similarity=0.328 Sum_probs=214.3
Q ss_pred cccccCcceeecCCceEEEEEECC--CCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGD--DASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 251 (473)
++|+..+.||+|+||.||+|++.. +....+.+|+|+............|.+|+.++.++ +|||||+++|+|.+. +
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--G 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--C
Confidence 678888999999999999998743 33466777777766555555667899999999999 799999999999776 7
Q ss_pred ceEEEEEeccCCChhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCcee
Q 011995 252 QRMLIYERLFHGSLDRLIYGRS---------------DGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQ 316 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NIL 316 (473)
..+||||||++|+|.++++... ....+++..+..++.||+.||+|||+++ ||||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 8999999999999999996542 2336899999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeccCCCcccCCCCc----cCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHc-CCCCCCCCChHHHH
Q 011995 317 IDKDFSAKLSGYGCAGHIPETDI----SNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLT-GRKNLDSRHPKEER 391 (473)
Q Consensus 317 l~~~~~vkl~DFGla~~~~~~~~----~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~ellt-G~~p~~~~~~~~~~ 391 (473)
++.++.+||+|||+++....... ....+|+.|+|||.+.++.++.++|||||||++|||+| |.+||.........
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987654321 33477899999999999999999999999999999998 66666665443322
Q ss_pred -hHhhhcccccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcc
Q 011995 392 -NLVKWSRPFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESR 458 (473)
Q Consensus 392 -~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 458 (473)
.++.. ..+...+..++.++.+||.+||+.||.+|||+.+|++.|+++...
T Consensus 258 ~~~i~~-----------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKE-----------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHH-----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhc-----------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 12211 111122445568899999999999999999999999999986554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.8e-50 Score=398.03 Aligned_cols=251 Identities=17% Similarity=0.194 Sum_probs=202.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhH---HHHHHHHHhCCCCCcccceeeeecC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEF---INDVNTLASLQHPNLCKLLGFHARD 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---~~Ei~~l~~l~HpnIv~l~g~~~~~ 248 (473)
.++|++.+.||+|+||.||+|+... +++.+|+|+..... .......+ .+|+.+++.++|||||++++++.++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 3689999999999999999999654 34566677654221 11112223 3457778888999999999999876
Q ss_pred CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 249 GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 249 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
+.+|||||||++|+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+||
T Consensus 80 --~~~~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 80 --DKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp --SEEEEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCC
T ss_pred --CEEEEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeee
Confidence 789999999999999999954 346899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccc
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRL 407 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
|+++.+.........||+.|||||++.. ..|+.++|||||||++|||+||+.||..........+.....
T Consensus 152 Gla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------- 222 (364)
T d1omwa3 152 GLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------- 222 (364)
T ss_dssp TTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS---------
T ss_pred ceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------
Confidence 9999887766677789999999999975 468999999999999999999999998755433222221110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011995 408 SLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPT-----MRSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~ 450 (473)
.....++..++.++.+||.+||++||.+||| ++|+++
T Consensus 223 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 ------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0011224456688999999999999999999 688875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=393.79 Aligned_cols=246 Identities=14% Similarity=0.195 Sum_probs=207.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCc
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 252 (473)
++|++.+.||+|+||.||+|+... +++.+|+|+..... .....+.+.+|+.+|+.++|||||++++++.+. ..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc--cc
Confidence 689999999999999999999644 34566677654321 233456789999999999999999999999876 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeee
Confidence 99999999999999998543 36999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccccc
Q 011995 333 HIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLIMD 412 (473)
Q Consensus 333 ~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.+... .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.........+....+
T Consensus 190 ~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------- 255 (350)
T d1rdqe_ 190 RVKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------- 255 (350)
T ss_dssp ECSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------
T ss_pred ecccc-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------------
Confidence 77543 3456899999999999999999999999999999999999999988765554433321111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 413 PQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 413 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
.++..++.++.+||.+||+.||.+|+ |+++|++
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12345668899999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=385.60 Aligned_cols=251 Identities=15% Similarity=0.171 Sum_probs=205.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|++.+.||+|+||+||+|....+ ++.+++|+.... ......+.+|+++|+.++|||||++++++.++ +.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~---~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESM--EEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC---CcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEE
Confidence 57899999999999999999996543 455666666543 34456688999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC--CcEEEeccCCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD--FSAKLSGYGCA 331 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~vkl~DFGla 331 (473)
|||||||++|+|.+++.. .+..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 77 ~lvmE~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 999999999999999954 2346999999999999999999999999 9999999999999854 58999999999
Q ss_pred cccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 332 GHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 332 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
....... .....+|+.|+|||.+.+..++.++|||||||++|||++|..||...........+.......
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 222 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--------- 222 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------
T ss_pred hccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence 8775443 344577899999999999999999999999999999999999998876655443332111000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 411 MDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 411 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.......++.++.+||.+||+.||.+|||+.|+++
T Consensus 223 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 -----DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001134678999999999999999999999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-49 Score=377.36 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=206.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC--------hhhHhHHHHHHHHHhCC-CCCcccceeee
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--------QGVKEFINDVNTLASLQ-HPNLCKLLGFH 245 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~ 245 (473)
++|+..+.||+|+||+||+|+... .++.+|+|+....... ...+.+.+|+.+|++++ |||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence 689999999999999999998544 3567778776654321 12346889999999997 99999999999
Q ss_pred ecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEE
Q 011995 246 ARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKL 325 (473)
Q Consensus 246 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl 325 (473)
.++ +..|||||||++|+|.++|.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||
T Consensus 80 ~~~--~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 80 ETN--TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp ECS--SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred ccC--cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEE
Confidence 876 889999999999999999954 346999999999999999999999999 999999999999999999999
Q ss_pred eccCCCcccCCC-CccCcccccccCChhhhhc------CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 326 SGYGCAGHIPET-DISNSSVAAANLSVETLER------GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 326 ~DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~------~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
+|||+++.+... ......+|..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.........+....
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 999999877543 3345678999999999864 246889999999999999999999999876555433322111
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .........+++++.+|+.+||+.||.+|||+.||++.
T Consensus 232 ~--------------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 Y--------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C--------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C--------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 01111234567899999999999999999999999763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=380.48 Aligned_cols=262 Identities=19% Similarity=0.316 Sum_probs=211.7
Q ss_pred hcccccCcceeecCCceEEEEEECCC--CeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCC
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDD--ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 251 (473)
.++|+..+.||+|+||+||+|.+... ......+|+|+............|.+|++++++++|||||+++|+|..+ +
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--Q 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--C
Confidence 36788889999999999999986432 2234455555554334445556789999999999999999999999765 7
Q ss_pred ceEEEEEeccCCChhhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEE
Q 011995 252 QRMLIYERLFHGSLDRLIYGR-------SDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAK 324 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vk 324 (473)
..++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+||||+.++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 899999999999999988542 12345799999999999999999999998 99999999999999999999
Q ss_pred EeccCCCcccCCCC----ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcC-CCCCCCCChHHHHhHhhhccc
Q 011995 325 LSGYGCAGHIPETD----ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTG-RKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 325 l~DFGla~~~~~~~----~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|+|||+++...... .....+|+.|+|||.+.++.++.++|||||||++|||+|| ++||.+....+....+..
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~--- 250 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--- 250 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT---
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---
Confidence 99999998764332 2334678999999999999999999999999999999998 578877665554433321
Q ss_pred ccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 011995 400 FLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQES 457 (473)
Q Consensus 400 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 457 (473)
+. ....+..++..+.++|.+||+.||.+|||+.+|++.|++..+
T Consensus 251 ----~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 ----GG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----CC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 011234556789999999999999999999999999987644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=388.55 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=205.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC--CChhhHhHHHHHHHHH-hCCCCCcccceeeeecCCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGVKEFINDVNTLA-SLQHPNLCKLLGFHARDGSD 251 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~Ei~~l~-~l~HpnIv~l~g~~~~~~~~ 251 (473)
++|++.+.||+|+||+||+|+... +.+.+|+|+..... .....+.+..|+.++. .++|||||++++++.++ +
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--C
Confidence 689999999999999999999654 45667777765321 2334456777777765 68999999999999876 7
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
.+|||||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchh
Confidence 89999999999999999954 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC--CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccccccc
Q 011995 332 GHIPET--DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSL 409 (473)
Q Consensus 332 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (473)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------- 220 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---------- 220 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 866432 33445789999999999999999999999999999999999999988776554443332211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011995 410 IMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMR-SIFE 450 (473)
Q Consensus 410 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 450 (473)
.++..++.++.+||.+||++||.+|||+. ++++
T Consensus 221 --------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22445678899999999999999999995 6753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=387.42 Aligned_cols=253 Identities=16% Similarity=0.218 Sum_probs=199.1
Q ss_pred hcccccC-cceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhC-CCCCcccceeeeec--CC
Q 011995 174 CHNFFSD-RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASL-QHPNLCKLLGFHAR--DG 249 (473)
Q Consensus 174 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~--~~ 249 (473)
.++|.+. +.||+|+||+||+|+... +.+.+|+|+... ...+.+|++++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 4688876 469999999999999544 345666776542 35678899987655 89999999998864 22
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC---CCcEEEe
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK---DFSAKLS 326 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~vkl~ 326 (473)
...+|||||||+||+|.++|..+ ....+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccc
Confidence 36789999999999999999754 2456999999999999999999999999 999999999999985 5679999
Q ss_pred ccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 327 GYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 327 DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
|||+++..... ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.........+.
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---------- 226 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------- 226 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH----------
Confidence 99999876543 3455689999999999999899999999999999999999999997654322211110
Q ss_pred cccccccc--ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 RLSLIMDP--QLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..+... .+.......++.++.+||.+||+.||++|||+.|+++.
T Consensus 227 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 --TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000000 11111123567899999999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=380.28 Aligned_cols=260 Identities=17% Similarity=0.185 Sum_probs=195.8
Q ss_pred CcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC----ChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCceEE
Q 011995 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS----SQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255 (473)
Q Consensus 180 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~l 255 (473)
.++||+|+||+||+|.. ..+++.+|+|+...... ....+.+.+|+.+|++++|||||++++++..+ +..||
T Consensus 3 l~~lG~G~fg~Vy~~~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARD---KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEEC---SSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEE
T ss_pred ceEeccCcCeEEEEEEE---CCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceee
Confidence 47899999999999984 33456667776554321 12245689999999999999999999999876 78999
Q ss_pred EEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcccC
Q 011995 256 IYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGHIP 335 (473)
Q Consensus 256 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 335 (473)
||||+.++++..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 vmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred hhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccC
Confidence 999998887766652 3456899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC--ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccc-----cccccc
Q 011995 336 ETD--ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFL-----ADDCRL 407 (473)
Q Consensus 336 ~~~--~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 407 (473)
... .....+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+....... .+....
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 432 2345789999999998655 57999999999999999999999998877665443332110000 000000
Q ss_pred ccccccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 408 SLIMDPQLKGRF-----PLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 408 ~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.....-...... ....+.++.+|+.+||+.||++|||++|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000000 1235678999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=375.22 Aligned_cols=271 Identities=18% Similarity=0.240 Sum_probs=202.5
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||+||+|.... ++..+|+|+..... ......++.+|+++|++++|||||++++++.+. +.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cce
Confidence 689999999999999999999643 33456677665433 233467899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
|+||||+.+ ++.+++... ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 77 ~iv~e~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp EEEEECCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred eEEEeecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCccee
Confidence 999999965 444444332 3456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCC--CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccccccccc
Q 011995 334 IPET--DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDCRLSLI 410 (473)
Q Consensus 334 ~~~~--~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (473)
.... ......+|+.|+|||.+.... ++.++|||||||++|||++|+.||.+.+..+....+................
T Consensus 152 ~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp HCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccc
Confidence 6543 234457899999999987665 5789999999999999999999998876554433221100000000000000
Q ss_pred cccccC--------CC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 011995 411 MDPQLK--------GR---FPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQ 455 (473)
Q Consensus 411 ~~~~l~--------~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l 455 (473)
..+... .. .....+.++.+|+.+||+.||.+|||+.|+++. |+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000 00 012456789999999999999999999999985 5443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=378.74 Aligned_cols=273 Identities=16% Similarity=0.227 Sum_probs=196.0
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHH--HHHHHHhCCCCCcccceeeeecCCC--
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN--DVNTLASLQHPNLCKLLGFHARDGS-- 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--Ei~~l~~l~HpnIv~l~g~~~~~~~-- 250 (473)
.+|...+.||+|+||.||+|++.+ ..+|+|+... . ....+.+ |+..+..++|||||+++|++.+++.
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g-----~~vAvK~~~~--~--~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRG-----EEVAVKIFSS--R--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT-----EEEEEEEECG--G--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-----EEEEEEEECc--c--chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 457777899999999999999753 3445554432 2 2334444 5555567899999999999986532
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceeecCCCCCceeeCCCCcEEE
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG-----PFQAMYNEFSTANIQIDKDFSAKL 325 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivHrDlkp~NILl~~~~~vkl 325 (473)
..+|+|||||++|+|.++|.+. .++|..+..++.|++.||+|||... ..+||||||||+||||+.++.+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 3689999999999999999653 5999999999999999999999741 123999999999999999999999
Q ss_pred eccCCCcccCCCC------ccCcccccccCChhhhhcCC------CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhH
Q 011995 326 SGYGCAGHIPETD------ISNSSVAAANLSVETLERGL------LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNL 393 (473)
Q Consensus 326 ~DFGla~~~~~~~------~~~~~~t~~y~aPE~~~~~~------~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~ 393 (473)
+|||++....... .....+|+.|||||++.+.. ++.++|||||||++|||+||..||...........
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 9999998764322 23457899999999987643 56789999999999999999988754322111000
Q ss_pred h-hhcccccccc--cccccccccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 394 V-KWSRPFLADD--CRLSLIMDPQLKGRF-PLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 394 ~-~~~~~~~~~~--~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
. ....+..... .......++.+...+ .......+.+|+.+||+.||++|||+.||++.|+++..+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 0 0000000000 000011122221111 23566789999999999999999999999999999876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=376.75 Aligned_cols=242 Identities=17% Similarity=0.231 Sum_probs=197.6
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCC-----ChhhHhHHHHHHHHHhCC--CCCcccceeeeec
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPS-----SQGVKEFINDVNTLASLQ--HPNLCKLLGFHAR 247 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~ 247 (473)
++|++.+.||+|+||+||+|+...+ +..+++|+...... .....++.+|+.+|++++ |||||++++++.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTT---CCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCC---CCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 5799999999999999999996543 45566776553211 112345789999999996 8999999999987
Q ss_pred CCCCceEEEEEeccC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-CCcEEE
Q 011995 248 DGSDQRMLIYERLFH-GSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-DFSAKL 325 (473)
Q Consensus 248 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~vkl 325 (473)
. +..++||||+.+ +++.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++. ++.+||
T Consensus 81 ~--~~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 81 P--DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp S--SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred C--CeEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEE
Confidence 6 789999999976 577777743 346999999999999999999999999 999999999999985 479999
Q ss_pred eccCCCcccCCCCccCcccccccCChhhhhcCCC-CCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc
Q 011995 326 SGYGCAGHIPETDISNSSVAAANLSVETLERGLL-TPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD 404 (473)
Q Consensus 326 ~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~-s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
+|||+++...........||+.|||||++.+..+ +.++|||||||++|||++|+.||..... ... ..
T Consensus 153 ~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i~~-~~------ 220 (273)
T d1xwsa_ 153 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR-GQ------ 220 (273)
T ss_dssp CCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH-CC------
T ss_pred CccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----Hhh-cc------
Confidence 9999998876666677789999999999988775 5779999999999999999999975311 111 00
Q ss_pred cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 405 CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 405 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..++..++.++.+||.+||+.||++|||++|+++.
T Consensus 221 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01233456789999999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=371.53 Aligned_cols=276 Identities=17% Similarity=0.224 Sum_probs=206.8
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhC---CCCCcccceeeeecC-
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASL---QHPNLCKLLGFHARD- 248 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~- 248 (473)
-++|++.+.||+|+||+||+|...... .+.+|+|+.+... .......+.+|+.+|+.+ +|||||++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT--TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCC--CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 468999999999999999999864321 2445666654432 223345677888877766 899999999988642
Q ss_pred --CCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 249 --GSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 249 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
....++++|||+.++++...... ....+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence 23578999999988777554432 3456899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCC-CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccc--
Q 011995 327 GYGCAGHIPET-DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLAD-- 403 (473)
Q Consensus 327 DFGla~~~~~~-~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 403 (473)
|||++...... ......||+.|||||++.+..|+.++|||||||++|||++|++||.+....+....+.........
T Consensus 159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred chhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 99999866443 335568899999999999999999999999999999999999999987766554433211100000
Q ss_pred ---ccccc----cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 011995 404 ---DCRLS----LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQE 456 (473)
Q Consensus 404 ---~~~~~----~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~ 456 (473)
..... ..........+....+..+.+|+.+||+.||++|||+.|+++. |++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 00000 0000111112334567889999999999999999999999874 55543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-47 Score=364.73 Aligned_cols=264 Identities=17% Similarity=0.235 Sum_probs=201.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||+||+|+..++ +.+|+|+..... .....+.+.+|+.+|++++|||||++++++..+ +..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred CCceeccEEecCCCcEEEEEEeCCC----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--Cce
Confidence 6899999999999999999987533 456777665543 233457899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
+++|||+.++.+..+.. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++..
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 99999998776666653 3457999999999999999999999999 99999999999999999999999999977
Q ss_pred cCCCC--ccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccc-----ccc
Q 011995 334 IPETD--ISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLA-----DDC 405 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----~~~ 405 (473)
..... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+....+........ ...
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 64432 2344678999999999765 468999999999999999999999988766554333221100000 000
Q ss_pred ccc------cccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 406 RLS------LIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 406 ~~~------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
... ....+.....+....+.++.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000111111223456688999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=372.40 Aligned_cols=270 Identities=16% Similarity=0.156 Sum_probs=200.2
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecC----CCC
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD----GSD 251 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~----~~~ 251 (473)
+|...++||+|+||+||+|+... +++.+|+|+..... ..+.+|+++|++++|||||++++++... +..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS-----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccc-----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 68888999999999999999654 34566677665332 2345799999999999999999998643 224
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGC 330 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGl 330 (473)
++|||||||+++.+..+.........+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence 57999999977644444322234557999999999999999999999999 99999999999999775 899999999
Q ss_pred CcccCCC-CccCcccccccCChhhhhc-CCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc--cc------
Q 011995 331 AGHIPET-DISNSSVAAANLSVETLER-GLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR--PF------ 400 (473)
Q Consensus 331 a~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--~~------ 400 (473)
+..+... ......+|..|+|||.+.+ ..++.++|||||||++|||++|++||......+....+.... +.
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 9876544 3445688999999999865 468999999999999999999999998776555433322110 00
Q ss_pred -cc--cccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 011995 401 -LA--DDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQE 456 (473)
Q Consensus 401 -~~--~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~ 456 (473)
.. .....................+.++.+|+.+||+.||.+|||+.|+|+. |+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 0000000000011111223456789999999999999999999999963 55543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=360.58 Aligned_cols=268 Identities=15% Similarity=0.185 Sum_probs=199.4
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|++.+.||+|+||+||+|+... .++.+|+|+..... .......+.+|+++|++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 3789999999999999999999643 34566677654432 3344577899999999999999999999875531
Q ss_pred ---CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEe
Q 011995 250 ---SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLS 326 (473)
Q Consensus 250 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~ 326 (473)
.+..|+||||+.++.+..+. .....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred cccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEee
Confidence 25689999999877665544 23456899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccCCC------CccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc
Q 011995 327 GYGCAGHIPET------DISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP 399 (473)
Q Consensus 327 DFGla~~~~~~------~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 399 (473)
|||++..+... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.....
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999765422 22345789999999999765 589999999999999999999999988776655444432211
Q ss_pred ccccccccccc--------cc-ccc-CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 FLADDCRLSLI--------MD-PQL-KGRF-----PLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ~~~~~~~~~~~--------~~-~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
..... ..... .. ... .... ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTT-TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChh-hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11000 00000 00 000 0000 01235677899999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-45 Score=357.90 Aligned_cols=263 Identities=13% Similarity=0.097 Sum_probs=199.9
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
.++|++.+.||+|+||+||+|+...+ ++.+|+|+..... ...++.+|+++++.++|+|+|.+++.+...+ +..
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTT---TEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEET-TEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCC---CCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecC-CEE
Confidence 35799999999999999999986543 3566777666542 3356889999999998888777766655443 788
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeC---CCCcEEEeccCC
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQID---KDFSAKLSGYGC 330 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGl 330 (473)
++||||+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+
T Consensus 79 ~ivme~~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EEEEECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEEEEEc-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCc
Confidence 9999999 5677666643 3456999999999999999999999999 99999999999986 456799999999
Q ss_pred CcccCCCC---------ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhh-hcccc
Q 011995 331 AGHIPETD---------ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVK-WSRPF 400 (473)
Q Consensus 331 a~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~ 400 (473)
++.+.... .....||+.|||||.+.+..++.++|||||||++|||++|+.||...........+. +....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence 98764322 234578999999999999999999999999999999999999998755433222111 10000
Q ss_pred cccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccC
Q 011995 401 LADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKS 460 (473)
Q Consensus 401 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 460 (473)
... ..+. ....++.++.+|+..||+.||++||++.+|.+.|+.+..+..
T Consensus 233 ~~~-------~~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 233 MST-------PIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHS-------CHHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CCC-------ChhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 000 0000 122455789999999999999999999999999998765443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=366.56 Aligned_cols=268 Identities=13% Similarity=0.163 Sum_probs=198.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCcccceeeeecCCC--C
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGS--D 251 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~--~ 251 (473)
+.+|+..+.||+|+||+||+|.... +++.+|+|++.........+.+.+|+++|+.++|||||++++++..+.. .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4579999999999999999998543 3456677776544445556789999999999999999999999865421 2
Q ss_pred ceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCC
Q 011995 252 QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCA 331 (473)
Q Consensus 252 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla 331 (473)
..+++++|+.+|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCce
Confidence 334555667799999999542 5999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC-----CccCcccccccCChhhhh-cCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 332 GHIPET-----DISNSSVAAANLSVETLE-RGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 332 ~~~~~~-----~~~~~~~t~~y~aPE~~~-~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
...... ......+|+.|+|||++. +..++.++||||+||++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 765332 224456889999999984 45578999999999999999999999988765443332211100000000
Q ss_pred c---------cccccccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 406 R---------LSLIMDPQLKG----RFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 406 ~---------~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. ......+.... ......+.++.+|+.+||+.||.+|||+.|+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000000 0112345688999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=364.97 Aligned_cols=269 Identities=14% Similarity=0.193 Sum_probs=200.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|+..+.||+|+||+||+|.... +++.+|+|+..... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 4689999999999999999998543 34566677665432 3344567899999999999999999999987642
Q ss_pred -CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEecc
Q 011995 250 -SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGY 328 (473)
Q Consensus 250 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF 328 (473)
...+|+||||+ +.+|..++.. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccc
Confidence 23679999999 5678777743 35999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccCCCCccCcccccccCChhhhhcC-CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcccccccc---
Q 011995 329 GCAGHIPETDISNSSVAAANLSVETLERG-LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADD--- 404 (473)
Q Consensus 329 Gla~~~~~~~~~~~~~t~~y~aPE~~~~~-~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 404 (473)
|++..... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||.+....................
T Consensus 166 g~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 166 GLARQADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp TTCEECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceeccCC-ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 99987644 34566889999999998764 47899999999999999999999998876554433221110000000
Q ss_pred -----------cccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 011995 405 -----------CRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQ 455 (473)
Q Consensus 405 -----------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l 455 (473)
..+.......+ .......+.++.+||.+||+.||.+|||+.|+|+. |+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00000000000 11223456788999999999999999999999985 5544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=355.81 Aligned_cols=260 Identities=16% Similarity=0.190 Sum_probs=199.4
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~ 253 (473)
++|++.+.||+|+||+||+|+... +++.+|+|+... ...+++.+|+++|..++ ||||+++++++.......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 689999999999999999998543 445666766542 23567899999999995 9999999999886655789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCC-cEEEeccCCCc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDF-SAKLSGYGCAG 332 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~ 332 (473)
++||||+.+++|..+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||++.
T Consensus 108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccce
Confidence 9999999999997764 24899999999999999999999999 99999999999998654 69999999998
Q ss_pred ccCCC-CccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHH-hHhh----------hccc
Q 011995 333 HIPET-DISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEER-NLVK----------WSRP 399 (473)
Q Consensus 333 ~~~~~-~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~----------~~~~ 399 (473)
..... ......+|+.|+|||.+.+.. ++.++|||||||++|||++|..||......... ..+. |...
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 77543 345567899999999987654 799999999999999999999999765432211 1110 0000
Q ss_pred -cccccccccccc--------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 400 -FLADDCRLSLIM--------DPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 400 -~~~~~~~~~~~~--------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
............ ...........++.++.+||.+||+.||.+|||++|+|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 001111123446788999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.9e-45 Score=353.88 Aligned_cols=264 Identities=13% Similarity=0.105 Sum_probs=206.2
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCC-CCcccceeeeecCCCCc
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQH-PNLCKLLGFHARDGSDQ 252 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~ 252 (473)
.++|++.+.||+|+||+||+|+... +++.+|+|+.... .....+.+|++++..+.| +|++.+++++... ..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~---~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~ 75 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LH 75 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECC---TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccc---cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecC--Cc
Confidence 3689999999999999999999654 3456677765543 233567889999999965 8999999988766 78
Q ss_pred eEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCC-----CCcEEEec
Q 011995 253 RMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDK-----DFSAKLSG 327 (473)
Q Consensus 253 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~vkl~D 327 (473)
.++||||+ +++|.+++... +..+++.++..++.|++.||+|||+++ ||||||||+|||++. ++.+||+|
T Consensus 76 ~~~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred cEEEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcc
Confidence 89999998 78999988543 446999999999999999999999999 999999999999974 57899999
Q ss_pred cCCCcccCCC---------CccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhcc
Q 011995 328 YGCAGHIPET---------DISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSR 398 (473)
Q Consensus 328 FGla~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 398 (473)
||+++..... ......||+.|||||.+.+..++.++|||||||++|||+||..||.+..............
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 9999875322 1234578999999999999999999999999999999999999998654432222111100
Q ss_pred cccccccccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcccCC
Q 011995 399 PFLADDCRLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFEELDRQESRKSS 461 (473)
Q Consensus 399 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~ 461 (473)
.. .. ....+.+ ...++.++.+++..|+..+|++||+++.+.+.|+++..+...
T Consensus 230 ~~-----~~-~~~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 230 EK-----KQ-STPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HH-----HH-HSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hc-----cC-CCChHHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 00 00 0000011 123457899999999999999999999999999988766544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=349.81 Aligned_cols=265 Identities=15% Similarity=0.167 Sum_probs=204.1
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCCCCce
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR 253 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 253 (473)
++|+..+.||+|+||+||+|+... +.+.+|+|+.+... ......++.+|+.+|+.++|||||++++++.+. +..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cce
Confidence 579999999999999999999544 34567777776554 334567899999999999999999999999876 789
Q ss_pred EEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 254 MLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 254 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
++|+|++.+++|..++.. ...+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.++.
T Consensus 77 ~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence 999999999998887743 456899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCC--ccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCC-hHHHHhHhhhccccccc-c----
Q 011995 334 IPETD--ISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRH-PKEERNLVKWSRPFLAD-D---- 404 (473)
Q Consensus 334 ~~~~~--~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~-~---- 404 (473)
..... .....++..|+|||.+.+.. ++.++|||||||++|||++|+.||.... ..+....+......... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 75432 23345678899999987665 6899999999999999999999865443 33322222111000000 0
Q ss_pred cc------cccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011995 405 CR------LSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERPTMRSIFE 450 (473)
Q Consensus 405 ~~------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 450 (473)
.. .................+..+.+|+.+||+.||.+|||++|+|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000001111223456788999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=359.28 Aligned_cols=254 Identities=17% Similarity=0.235 Sum_probs=202.3
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecC---CCChhhHhHHHHHHHHHhCCC-CCcccceeeeecCCC
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLN---PSSQGVKEFINDVNTLASLQH-PNLCKLLGFHARDGS 250 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~ 250 (473)
++|++.+.||+|+||+||+|....+..++..+|+|+.... ......+.+.+|+++|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 6799999999999999999987555555666777765432 123345678899999999966 8999999998876
Q ss_pred CceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccCC
Q 011995 251 DQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGC 330 (473)
Q Consensus 251 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl 330 (473)
...++||||+.+|+|.+++... ..+....+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred CceeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 7899999999999999998543 35788999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCC---ccCcccccccCChhhhhcC--CCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc
Q 011995 331 AGHIPETD---ISNSSVAAANLSVETLERG--LLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC 405 (473)
Q Consensus 331 a~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 405 (473)
++.+.... .....+++.|++||.+.+. .++.++|||||||+||||++|..||...........+....
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~------- 248 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------- 248 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-------
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-------
Confidence 97664322 2345788999999999765 36889999999999999999999997765433222211000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 011995 406 RLSLIMDPQLKGRFPLKAARTVADIALRCLQKEPSERP-----TMRSIFE 450 (473)
Q Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 450 (473)
. .....++...+.++.+|+.+||++||.+|| |++|+++
T Consensus 249 -----~--~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 -----L--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----H--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----c--cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 001123446678999999999999999999 5888886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=355.03 Aligned_cols=265 Identities=14% Similarity=0.180 Sum_probs=193.2
Q ss_pred cccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC----
Q 011995 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG---- 249 (473)
Q Consensus 175 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~---- 249 (473)
++|++.+.||+|+||+||+|.... ++..+|+|+..... .......+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 679999999999999999998543 45667777776543 3344567899999999999999999999986542
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
...+|+||||+.++ +.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CceeEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechh
Confidence 36889999999665 444442 24899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCC-ccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccc---------
Q 011995 330 CAGHIPETD-ISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRP--------- 399 (473)
Q Consensus 330 la~~~~~~~-~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------- 399 (473)
+++...... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp C---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 987765443 3445789999999999999999999999999999999999999987765443332210000
Q ss_pred c-------cccc-----cccccccccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011995 400 F-------LADD-----CRLSLIMDPQLK---GRFPLKAARTVADIALRCLQKEPSERPTMRSIFEE 451 (473)
Q Consensus 400 ~-------~~~~-----~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 451 (473)
. .... ............ .......+.++.+|+.+||+.||++|||++|||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000 000000000000 01123567889999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=354.80 Aligned_cols=271 Identities=14% Similarity=0.188 Sum_probs=200.7
Q ss_pred hcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCC-CChhhHhHHHHHHHHHhCCCCCcccceeeeecCC---
Q 011995 174 CHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP-SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDG--- 249 (473)
Q Consensus 174 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--- 249 (473)
.++|+..+.||+|+||+||+|+... +++.+|+|+..... .....+.+.+|+++|+.++|||||++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 5679999999999999999998543 44566677655432 2334567899999999999999999999886431
Q ss_pred CCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCCCcEEEeccC
Q 011995 250 SDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKDFSAKLSGYG 329 (473)
Q Consensus 250 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG 329 (473)
....++|++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC-
T ss_pred cCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccc
Confidence 1345667778889999999943 35999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCCCCccCcccccccCChhhhhcCC-CCCcCCchHHHHHHHHHHcCCCCCCCCChHHHHhHhhhccccccccc---
Q 011995 330 CAGHIPETDISNSSVAAANLSVETLERGL-LTPKSNVWSFGIVLLELLTGRKNLDSRHPKEERNLVKWSRPFLADDC--- 405 (473)
Q Consensus 330 la~~~~~~~~~~~~~t~~y~aPE~~~~~~-~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 405 (473)
++..... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|++||.+.+.......+...........
T Consensus 167 ~a~~~~~-~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 167 LARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp ---CCTG-GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hhcccCc-ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 9876533 335567889999999877654 68999999999999999999999988776554443321110000000
Q ss_pred ----ccccccc--cccC-CC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 011995 406 ----RLSLIMD--PQLK-GR---FPLKAARTVADIALRCLQKEPSERPTMRSIFEE--LDRQ 455 (473)
Q Consensus 406 ----~~~~~~~--~~l~-~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l 455 (473)
....... .... .. .....+.++.+||.+||+.||.+|||+.|+|+. |+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000000 0000 00 012356788999999999999999999999973 4443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-39 Score=322.32 Aligned_cols=267 Identities=17% Similarity=0.177 Sum_probs=193.1
Q ss_pred ccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-----------CCCcccceee
Q 011995 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-----------HPNLCKLLGF 244 (473)
Q Consensus 176 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~g~ 244 (473)
+|++.+.||+|+||+||+|+... ++..+|+|+.+ ......+.+.+|+.+++.++ |+|||+++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~--~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC--SCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEe--ccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 49999999999999999999543 33455666554 33344567788999998875 5789999999
Q ss_pred eecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceeecCCCCCceeeCCCC--
Q 011995 245 HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE-EGPFQAMYNEFSTANIQIDKDF-- 321 (473)
Q Consensus 245 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~-- 321 (473)
+...+....+++|+++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc
Confidence 8766556778888887666544333333455678999999999999999999998 77 99999999999998654
Q ss_pred ----cEEEeccCCCcccCCCCccCcccccccCChhhhhcCCCCCcCCchHHHHHHHHHHcCCCCCCCCChHHH------H
Q 011995 322 ----SAKLSGYGCAGHIPETDISNSSVAAANLSVETLERGLLTPKSNVWSFGIVLLELLTGRKNLDSRHPKEE------R 391 (473)
Q Consensus 322 ----~vkl~DFGla~~~~~~~~~~~~~t~~y~aPE~~~~~~~s~~sDvwSlGvvl~elltG~~p~~~~~~~~~------~ 391 (473)
.++++|||.+..... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||........ .
T Consensus 166 ~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp TTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cccceeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 399999999876543 33556789999999999999999999999999999999999999975432110 0
Q ss_pred hHhhhc---------------ccccccccccccccc---------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011995 392 NLVKWS---------------RPFLADDCRLSLIMD---------PQLKGRFPLKAARTVADIALRCLQKEPSERPTMRS 447 (473)
Q Consensus 392 ~~~~~~---------------~~~~~~~~~~~~~~~---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 447 (473)
....+. ..+.........+.. ......+....+.++.+|+.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000000 000000000000000 00122345678899999999999999999999999
Q ss_pred HHHH
Q 011995 448 IFEE 451 (473)
Q Consensus 448 il~~ 451 (473)
+|+.
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3e-23 Score=186.46 Aligned_cols=165 Identities=12% Similarity=0.115 Sum_probs=116.6
Q ss_pred ccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCC-----------------hhhHhHHHHHHHHHhCCCCCccc
Q 011995 178 FSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS-----------------QGVKEFINDVNTLASLQHPNLCK 240 (473)
Q Consensus 178 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~Ei~~l~~l~HpnIv~ 240 (473)
.+++.||+|+||+||+|...++ +.+++|+.+..... .....+.+|...+.++.|.+++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~ 78 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTT----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred hhCCEeeeCcceEEEEEECCCC----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcce
Confidence 4568999999999999986543 45666665432100 01233457889999999999998
Q ss_pred ceeeeecCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceeecCCCCCceeeCCC
Q 011995 241 LLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQAMYNEFSTANIQIDKD 320 (473)
Q Consensus 241 l~g~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 320 (473)
.+++. ..++||||+++..+.+ ++......++.|++.+|+|||+++ |+||||||+|||++++
T Consensus 79 ~~~~~------~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 79 VYAWE------GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp EEEEE------TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred EEEec------CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 87653 2379999998765543 223445689999999999999999 9999999999999976
Q ss_pred CcEEEeccCCCcccCCCCccCcccccccCC------hhhhhcCCCCCcCCchHHHHHHH
Q 011995 321 FSAKLSGYGCAGHIPETDISNSSVAAANLS------VETLERGLLTPKSNVWSFGIVLL 373 (473)
Q Consensus 321 ~~vkl~DFGla~~~~~~~~~~~~~t~~y~a------PE~~~~~~~s~~sDvwSlGvvl~ 373 (473)
.++|+|||+|......... .|+. .+. ....|+.++|+||+.--++
T Consensus 140 -~~~liDFG~a~~~~~~~~~------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence 4899999999765432211 1111 111 2345789999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=2.6e-07 Score=84.77 Aligned_cols=149 Identities=11% Similarity=0.074 Sum_probs=93.9
Q ss_pred HHHHHHhcccccCcceeecCCceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCC-CCCcccceeeee
Q 011995 168 DEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQ-HPNLCKLLGFHA 246 (473)
Q Consensus 168 ~el~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~ 246 (473)
.|+......|+..+..+.++.+.||+....+.. +.+++... ........+.+|...+..+. +--+.+++.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~-----~vlk~~~~-~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENEN-----LYLKMTDS-RYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCE-----EEEEEECG-GGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCe-----EEEEEcCC-CcccchhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 367777778876665544555789998633322 11222211 12223446788999888774 333566776665
Q ss_pred cCCCCceEEEEEeccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------
Q 011995 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG------------------------- 301 (473)
Q Consensus 247 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------- 301 (473)
.+ +..++||++++|..+.+..... .....++.+++..+..||+..
T Consensus 81 ~~--~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T d1j7la_ 81 HD--GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp ET--TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred cC--CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence 54 6789999999998876554211 112334455555566666421
Q ss_pred -------------------------------CCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 302 -------------------------------PFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 302 -------------------------------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987777799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=1.5e-05 Score=72.05 Aligned_cols=130 Identities=13% Similarity=0.115 Sum_probs=76.6
Q ss_pred ceeecCC-ceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCC--CcccceeeeecCCCCceEEEEE
Q 011995 182 CISEGLS-SVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHP--NLCKLLGFHARDGSDQRMLIYE 258 (473)
Q Consensus 182 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~~~~~~~lV~E 258 (473)
.+..|.. +.||+....+... +.+|... . .....+..|...|+.+... .+.+++++..++ +..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~----~vlK~~~--~--~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPV----LFVKTDL--S--GALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCC----EEEEEEC--S--CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEE
T ss_pred EcCCcccCCeEEEEEeCCCCE----EEEEeCC--c--cCHhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEE
Confidence 3445554 6799987544332 2233222 1 1234577888888877432 345667666554 67899999
Q ss_pred eccCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 011995 259 RLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLH---------------------------------------- 298 (473)
Q Consensus 259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~yLH---------------------------------------- 298 (473)
+++|.++.+.. ... ..++.++...|.-||
T Consensus 87 ~i~G~~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (255)
T d1nd4a_ 87 EVPGQDLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 155 (255)
T ss_dssp CCSSEETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred eeecccccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhh
Confidence 99886653311 110 111222233333333
Q ss_pred -----------hc----CCCceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 299 -----------EE----GPFQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 299 -----------~~----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.. .++.++|+|+.+.|||++.+..+-|+||+.+.
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 156 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 11247999999999999987777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.45 E-value=0.00027 Score=68.20 Aligned_cols=29 Identities=14% Similarity=0.013 Sum_probs=25.0
Q ss_pred ceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 304 QAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 304 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
.++|+|+.+.|||+++++ ++|+||-.+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 499999999999999775 89999987653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.66 E-value=0.0012 Score=63.59 Aligned_cols=76 Identities=16% Similarity=0.208 Sum_probs=46.7
Q ss_pred cceeecCCceEEEEEECCCCee----eeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCc-ccceeeeecCCCCceEE
Q 011995 181 RCISEGLSSVMYRASFGDDAST----SKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL-CKLLGFHARDGSDQRML 255 (473)
Q Consensus 181 ~~lG~G~~g~Vy~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~~~l 255 (473)
..|+.|-.-.+|+....+.... .+.+.+ |+...........+|..+++.+.-.++ .++++++.+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vll---Ri~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLL---RVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEE---EEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEE---EecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ce
Confidence 4677788888999987654322 122222 222222334456689999998843344 477776631 58
Q ss_pred EEEeccCCCh
Q 011995 256 IYERLFHGSL 265 (473)
Q Consensus 256 V~E~~~~gsL 265 (473)
|+||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.49 E-value=0.025 Score=52.25 Aligned_cols=163 Identities=11% Similarity=0.085 Sum_probs=81.9
Q ss_pred cCCCHHHHHHHhcccc---cCcceeecC-CceEEEEEECCCCeeeeEEEEEEEecCCCChhhHhHHHHHHHHHhCCCCCc
Q 011995 163 RNFPLDEVAAACHNFF---SDRCISEGL-SSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238 (473)
Q Consensus 163 ~~~~~~el~~~~~~f~---~~~~lG~G~-~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI 238 (473)
..++.+.|..+...+. ..+++-=++ --.||++...++.. +.+|+.+ ......+++..|...+..|....|
T Consensus 6 ~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~----~VlK~~r--p~~~s~~~i~~E~~~l~~L~~~gi 79 (325)
T d1zyla1 6 QTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRR----FVVKFYR--PERWTADQILEEHQFALQLVNDEV 79 (325)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCC----EEEEEEC--TTTSCHHHHHHHHHHHHHHHHTTC
T ss_pred cccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCE----EEEEEeC--CCCCCHHHHHHHHHHHHHHHhcCC
Confidence 3456666655554442 112222223 35799997655432 3344443 333456778889998888742222
Q ss_pred -----ccceeeeecCCCCceEEEEEeccCCChhh----hh----------hc----C--CCCCCCCHH------------
Q 011995 239 -----CKLLGFHARDGSDQRMLIYERLFHGSLDR----LI----------YG----R--SDGPPIDWN------------ 281 (473)
Q Consensus 239 -----v~l~g~~~~~~~~~~~lV~E~~~~gsL~~----~l----------~~----~--~~~~~l~~~------------ 281 (473)
+..-+-.........+.++++++|..+.. .+ +. . .....+++.
T Consensus 80 pv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~ 159 (325)
T d1zyla1 80 PVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED 159 (325)
T ss_dssp SBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred CCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHH
Confidence 11111000011256788999987643310 00 10 0 011122221
Q ss_pred ----------HHHHHHHHHHHHHHHh-hhcCCCceeecCCCCCceeeCCCCcEEEeccCCCcc
Q 011995 282 ----------TRVKIALCAAQGLTFL-HEEGPFQAMYNEFSTANIQIDKDFSAKLSGYGCAGH 333 (473)
Q Consensus 282 ----------~~~~i~~~i~~~L~yL-H~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 333 (473)
....++..+...+.-+ ....+..+||+|+.+.|||++++ ..++||+-++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 160 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1112222222222221 12234568999999999999754 45899997754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.07 E-value=0.008 Score=55.34 Aligned_cols=30 Identities=13% Similarity=0.006 Sum_probs=26.6
Q ss_pred CceeecCCCCCceeeCCCCcEEEeccCCCc
Q 011995 303 FQAMYNEFSTANIQIDKDFSAKLSGYGCAG 332 (473)
Q Consensus 303 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 332 (473)
.++||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 359999999999999998777899999774
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=94.09 E-value=0.0057 Score=56.20 Aligned_cols=65 Identities=11% Similarity=0.054 Sum_probs=52.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccCCcccccCccccccccccccCCCChhhhhhhhhhhccchhhhhhhhhhc
Q 011995 29 TPTTLPEPQIPTRSLQSAPPSFRTRVKPIPLNNTTKATNNRTRALSAPSSLDAAEAEQDALASVEFEEQEESKS 102 (473)
Q Consensus 29 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~ls~n~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (473)
..+.|..+.+..|.|+|.+|+.+.+++.|+.|| |++|+ ++|.+|+...- ..+..+.+.+|...|+
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~---Ls~N~-l~g~iP~~~~L-----~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN---VSFNN-LCGEIPQGGNL-----QRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE---CCSSE-EEEECCCSTTG-----GGSCGGGTCSSSEEES
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEE---CcCCc-ccccCCCcccC-----CCCCHHHhCCCccccC
Confidence 356778889999999999999999999999999 99999 99999975211 1455667777766664
|